data_2l5l_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l5l _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.446 ' HG3' ' H ' ' A' ' 11' ' ' VAL . 43.1 tptt -137.12 173.23 11.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.2 p -122.18 107.99 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.578 0.704 . . . . 0.0 110.296 175.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 43.8 mm -108.81 132.21 57.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.202 -176.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.653 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 4.6 p80 -89.09 127.9 35.73 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.461 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 1.1 pp -128.28 -179.99 5.31 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.968 -172.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.443 ' HA ' ' OE1' ' A' ' 81' ' ' GLU . 45.3 p -104.36 174.84 5.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.244 177.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.508 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 13.0 pttm -64.45 -26.69 68.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 111.198 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.449 ' HA ' HD13 ' A' ' 20' ' ' LEU . . . -65.97 -40.31 91.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.311 0.577 . . . . 0.0 110.404 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.533 ' CD ' ' HZ1' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -71.86 -34.51 69.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.804 178.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.443 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -59.07 -53.79 54.4 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.476 174.162 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.689 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 18.1 mt -46.91 -59.7 2.92 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.655 -1.612 . . . . 0.0 111.919 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.64 -48.48 72.06 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -170.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.533 ' HZ1' ' CD ' ' A' ' 18' ' ' GLU . 19.8 mtmm -104.13 -3.1 24.9 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.401 -170.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 61.1 t -129.06 -52.9 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.689 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 11.7 t80 -167.62 124.73 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.01 -164.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.71 91.4 7.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.951 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.502 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 25.2 p90 -79.99 12.99 2.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.11 0.481 . . . . 0.0 111.412 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -93.88 -53.07 4.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.593 ' C ' HD21 ' A' ' 29' ' ' ASN . 60.3 mttp -83.46 -23.71 32.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.735 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.642 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -121.58 69.37 23.63 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.376 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -57.58 -37.05 98.29 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.311 2.674 . . . . 0.0 112.279 173.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -105.13 -42.43 5.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.983 -174.437 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.522 ' CD ' ' HZ1' ' A' ' 104' ' ' LYS . 3.6 mm-40 -94.98 178.19 5.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.362 0.601 . . . . 0.0 112.375 -174.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.775 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 19.1 t-105 -125.19 108.6 11.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.569 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.47 ' C ' ' HD3' ' A' ' 34' ' ' LYS . 8.6 tmtt? -110.7 112.63 24.64 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 172.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 13.9 t80 -80.8 124.95 29.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.548 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -101.05 8.48 42.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.422 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.426 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -88.4 150.56 21.99 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 -177.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -92.29 -30.07 16.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.078 0.465 . . . . 0.0 110.961 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -115.09 155.22 46.93 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.912 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.92 132.17 50.01 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.352 2.034 . . . . 0.0 111.381 174.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -117.05 154.98 30.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.476 0.655 . . . . 0.0 111.676 -175.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.429 HD13 HG12 ' A' ' 121' ' ' ILE . 78.3 mt -128.1 110.3 21.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.077 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 23.9 t -100.54 114.07 38.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.974 0.416 . . . . 0.0 111.114 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.596 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 4.4 t70 -90.8 113.8 26.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.181 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -84.88 111.04 19.29 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 170.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.676 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.4 p90 -132.33 159.0 40.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.289 0.566 . . . . 0.0 111.089 -177.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.443 ' CB ' HG12 ' A' ' 93' ' ' ILE . . . -128.14 128.85 45.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.007 171.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.536 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 28.3 t70 -63.47 -28.86 70.25 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.565 -170.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -75.63 -2.78 30.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.683 0.277 . . . . 0.0 111.732 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 42.5 t -103.43 127.72 50.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.939 0.4 . . . . 0.0 110.785 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.81 -61.43 7.34 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.661 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.411 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 72.1 Cg_exo -47.84 -47.54 18.46 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.761 2.307 . . . . 0.0 112.537 176.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.676 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 65.1 m -56.86 -29.45 62.9 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.03 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.536 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 62.8 mttm -73.8 -42.95 60.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.172 174.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.645 ' O ' HG12 ' A' ' 59' ' ' ILE . 26.1 mtm -59.89 -40.13 87.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.917 0.389 . . . . 0.0 111.396 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 111' ' ' ALA . 11.5 p -64.04 -30.53 50.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.161 -171.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.621 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . . . -57.53 -57.55 24.49 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 118.833 -0.603 . . . . 0.0 112.021 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.638 ' HD2' ' O ' ' A' ' 55' ' ' MET . 47.0 Cg_exo -57.82 -39.96 82.72 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 121.811 1.674 . . . . 0.0 112.539 174.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.645 HG12 ' O ' ' A' ' 55' ' ' MET . 21.0 mm -61.15 -49.42 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 121.709 0.766 . . . . 0.0 109.916 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.66 HD22 HD13 ' A' ' 73' ' ' ILE . 11.6 mt -63.93 -37.51 87.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.543 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -62.4 -44.29 96.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.418 0.628 . . . . 0.0 109.451 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -58.71 -55.61 32.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.363 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.424 HD22 ' HG3' ' A' ' 114' ' ' LYS . 4.4 mm? -66.72 -33.93 76.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.315 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.528 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -60.79 -46.05 92.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.952 0.406 . . . . 0.0 110.239 177.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.806 ' HB3' ' HZ2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -69.45 -31.52 69.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.716 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.592 ' HG3' ' HZ3' ' A' ' 65' ' ' LYS . 43.7 mt-10 -72.02 -35.96 69.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.27 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -109.22 27.74 9.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.876 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.91 148.97 9.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.388 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.54 -44.5 2.59 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.843 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.427 ' HG3' HG23 ' A' ' 71' ' ' ILE . 16.5 pt20 -93.33 -38.62 11.39 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.427 HG23 ' HG3' ' A' ' 70' ' ' GLN . 38.9 pt -118.74 159.98 18.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.009 0.433 . . . . 0.0 111.713 -177.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 63.6 t -133.36 121.69 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.66 HD13 HD22 ' A' ' 60' ' ' LEU . 46.0 mt -103.86 139.43 24.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.486 0.66 . . . . 0.0 111.253 -175.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -128.04 173.49 10.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.898 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 0.6 OUTLIER -149.34 158.45 44.19 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 170.25 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.488 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 9.9 p -133.88 136.06 54.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.203 0.525 . . . . 0.0 110.438 -177.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.508 ' HB2' ' HZ2' ' A' ' 80' ' ' LYS . 3.6 m-20 -80.1 94.37 5.97 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.377 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.651 HG21 ' HA ' ' A' ' 92' ' ' SER . 74.6 m -58.49 -33.8 70.21 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -174.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -53.93 -31.16 49.4 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.508 ' HZ2' ' HB2' ' A' ' 77' ' ' ASP . 14.6 pttp -106.21 -32.04 8.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.179 0.514 . . . . 0.0 110.504 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.508 ' OE2' ' HG2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -90.83 44.23 1.19 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.367 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -61.06 -37.18 81.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.428 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -70.58 -37.72 73.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.228 0.537 . . . . 0.0 110.072 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.1 -49.14 59.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.789 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.14 84.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.969 0.414 . . . . 0.0 111.077 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -66.84 -31.18 77.49 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.903 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.68 93.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 0.0 111.616 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.552 ' HB2' HG12 ' A' ' 90' ' ' ILE . 72.5 m-85 -85.91 -1.68 57.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.84 0.352 . . . . 0.0 110.898 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.01 15.85 78.07 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.33 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.552 HG12 ' HB2' ' A' ' 88' ' ' PHE . 48.9 mm -65.46 -25.14 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 122.587 0.355 . . . . 0.0 110.866 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 26.4 mmt180 72.03 -67.77 0.25 Allowed 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.744 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.651 ' HA ' HG21 ' A' ' 78' ' ' THR . 33.7 m -151.77 -89.31 0.06 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.932 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.508 HG22 ' C ' ' A' ' 46' ' ' TYR . 2.4 pp -163.29 159.92 18.24 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.595 -170.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.576 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 2.3 Cg_endo -95.22 147.1 8.4 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 124.821 -0.908 . . . . 0.0 111.803 -4.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.4 t -141.73 138.77 32.6 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' A' ' 107' ' ' MET . 30.7 mm -118.77 113.8 42.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.454 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 25.6 tp -98.0 112.71 24.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.527 -176.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.24 110.11 22.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.538 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 32.2 mt -101.69 106.17 45.1 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.153 -174.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.36 163.27 27.5 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.583 2.189 . . . . 0.0 111.95 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 92.3 mmm -85.16 0.29 52.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.479 0.657 . . . . 0.0 110.082 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -138.77 111.1 7.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.117 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.71 -158.83 18.5 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.24 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.775 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 42.7 mtpt -113.24 154.36 45.27 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.538 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 73.1 Cg_endo -75.34 140.49 24.6 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.83 2.353 . . . . 0.0 114.563 -170.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.431 ' CG ' ' HZ ' ' A' ' 124' ' ' PHE . 18.8 mp0 -91.35 169.93 10.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.578 173.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.547 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 21.4 ptp -142.01 144.38 33.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.025 0.441 . . . . 0.0 111.177 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -124.68 126.43 45.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.292 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -86.49 126.72 34.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.089 0.471 . . . . 0.0 111.375 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.576 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 100.29 155.72 27.78 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.436 175.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.536 ' HB2' ' HB ' ' A' ' 56' ' ' VAL . . . -87.59 87.33 7.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.342 0.591 . . . . 0.0 111.068 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.586 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 12.7 ptt? -68.26 162.95 56.72 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.283 173.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 112' ' ' MET . 97.1 Cg_endo -75.09 179.14 6.4 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.633 2.222 . . . . 0.0 113.009 -173.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.456 ' HZ3' ' CD ' ' A' ' 66' ' ' GLU . 58.3 tttp -54.81 -35.77 64.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.847 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.62 -52.76 19.18 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.915 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 18.8 m -66.12 -34.66 78.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.559 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.536 ' O ' HG13 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -63.94 -43.18 96.64 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.049 178.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.42 ' HZ2' ' HB3' ' A' ' 122' ' ' ASP . 1.6 ttpp -57.03 -40.67 77.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 0.0 110.075 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -66.74 -41.36 87.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.606 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.33 -36.88 71.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.977 0.418 . . . . 0.0 111.583 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.568 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 62.9 mt -73.99 -56.64 8.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.493 0.664 . . . . 0.0 110.69 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.42 ' HB3' ' HZ2' ' A' ' 118' ' ' LYS . 14.6 t0 -72.47 -64.77 0.88 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.169 -174.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.594 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 24.4 mt-10 -80.04 11.93 3.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.595 -169.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.606 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 58.5 t80 -138.46 -50.35 0.56 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.164 -0.214 . . . . 0.0 111.554 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.568 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 42.8 tp -73.54 -40.91 63.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.65 0.262 . . . . 0.0 110.59 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -90.81 -53.82 4.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.418 0.628 . . . . 0.0 109.306 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.594 ' HB3' ' HA ' ' A' ' 123' ' ' GLU . 52.1 tptt . . . . . 0 C--N 1.322 -0.608 0 CA-C-O 121.702 0.763 . . . . 0.0 109.219 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.482 ' C ' ' HD2' ' A' ' 10' ' ' LYS . . . . . . . . 0 CA--C 1.51 -0.271 0 CA-C-O 121.089 0.272 . . . . 0.0 112.445 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.488 ' HZ2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -131.77 174.62 9.95 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.618 -0.342 . . . . 0.0 110.265 -176.213 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.646 HG22 HG23 ' A' ' 73' ' ' ILE . 13.0 p -113.58 123.46 69.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.323 0.582 . . . . 0.0 110.653 173.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.6 mm -124.67 120.4 58.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.254 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.721 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 7.1 p80 -86.74 129.91 34.69 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.154 175.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.637 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -124.01 178.56 5.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.981 -172.172 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.58 HG22 ' HE2' ' A' ' 80' ' ' LYS . 41.3 p -93.07 171.46 8.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.686 175.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HE3' ' HB3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -58.54 -37.4 75.6 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 178.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.439 ' N ' ' HG2' ' A' ' 16' ' ' LYS . . . -63.37 -37.93 89.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.477 0.656 . . . . 0.0 110.161 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.637 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 40.0 mt-10 -72.9 -34.82 66.89 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.751 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.454 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 6.8 t80 -54.89 -51.47 65.9 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 122.638 1.208 . . . . 0.0 108.761 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.629 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 25.9 mt -54.76 -58.39 7.76 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 112.481 -2.145 . . . . 0.0 111.931 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.94 -14.53 41.57 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -170.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.401 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 94.3 mttt -109.93 -5.84 15.37 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.202 -0.311 . . . . 0.0 111.368 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 59.4 t -141.02 -56.34 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 45.1 t80 -167.26 125.34 1.28 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.054 -164.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.542 ' OD1' ' HD3' ' A' ' 28' ' ' LYS . 2.8 t-20 -86.46 90.25 8.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.621 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -85.82 11.97 10.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.701 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 6.6 mt-10 -94.5 -54.29 3.58 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.938 0.875 . . . . 0.0 108.813 175.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.701 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 12.2 mptt -88.12 -23.45 23.67 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.628 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.659 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -120.62 68.64 15.4 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.899 -179.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -61.27 -43.7 27.36 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.966 2.444 . . . . 0.0 112.24 170.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -100.97 -29.93 11.92 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.161 0.505 . . . . 0.0 110.824 -175.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 22.9 mp0 -89.79 127.92 36.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.999 -169.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.711 ' HB2' ' HZ2' ' A' ' 104' ' ' LYS . 72.8 t-105 -89.95 89.57 7.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.223 0.535 . . . . 0.0 110.432 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -106.24 97.74 7.51 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.764 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.611 ' HH ' ' HB2' ' A' ' 41' ' ' ALA . 83.0 t80 -85.41 119.64 26.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.893 176.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -112.62 85.54 2.18 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.451 0.643 . . . . 0.0 110.184 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -147.24 -154.04 6.1 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.984 -176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -115.12 -58.84 2.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.247 0.546 . . . . 0.0 110.534 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.552 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 51.0 mttp -135.65 170.18 11.75 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.278 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 79.7 Cg_exo -45.25 132.52 11.85 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 122.735 2.29 . . . . 0.0 112.459 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.611 ' HB2' ' HH ' ' A' ' 35' ' ' TYR . . . -117.79 145.84 44.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.596 -171.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 121' ' ' ILE . 75.0 mt -119.8 114.31 43.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.118 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 28.7 t -98.57 110.3 25.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.767 0.317 . . . . 0.0 110.836 -177.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.547 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 7.6 t70 -98.4 111.61 23.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.961 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.578 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 79.9 m-85 -90.38 112.12 23.6 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.743 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.2 p90 -133.77 179.06 6.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.39 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.551 ' HB2' ' CD ' ' A' ' 79' ' ' GLU . . . -154.79 173.34 16.59 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.484 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.462 ' O ' ' HE3' ' A' ' 54' ' ' LYS . 20.6 t70 -80.68 -46.43 15.57 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -175.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -71.04 0.23 7.98 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -173.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 53' ' ' CYS . 45.4 t -112.85 114.03 26.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.943 0.401 . . . . 0.0 110.292 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.2 -51.62 58.09 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.256 -0.747 . . . . 0.0 113.64 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -47.42 -37.7 25.87 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.969 2.446 . . . . 0.0 112.929 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.743 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 59.9 m -59.75 -39.84 86.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.47 0.653 . . . . 0.0 111.485 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 48' ' ' ASP . 99.4 mttt -79.04 -29.99 43.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.161 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.52 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 4.5 tmm? -62.44 -46.05 90.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.811 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.578 HG23 ' HG ' ' A' ' 60' ' ' LEU . 14.5 p -71.18 -26.21 26.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.944 -175.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.614 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . . . -53.83 -56.33 26.54 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.614 ' HD3' ' HB2' ' A' ' 57' ' ' ALA . 36.5 Cg_exo -60.04 -47.06 16.31 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 121.708 1.605 . . . . 0.0 112.009 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.0 mt -58.34 -43.3 86.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.759 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.579 HD23 HD11 ' A' ' 73' ' ' ILE . 7.8 mt -64.87 -44.68 88.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.092 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.578 ' HB2' HG12 ' A' ' 11' ' ' VAL . 27.2 t70 -67.61 -40.96 84.72 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.403 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.526 ' CD ' ' HZ1' ' A' ' 114' ' ' LYS . 0.9 OUTLIER -61.18 -45.29 95.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.735 176.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 63' ' ' LEU . 16.6 tp -65.82 -34.76 78.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.823 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.515 ' HB1' HD13 ' A' ' 73' ' ' ILE . . . -64.99 -35.09 80.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.907 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 5.2 tmtm? -75.43 -32.5 60.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.483 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -52.5 -46.83 66.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.561 0.696 . . . . 0.0 109.968 172.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -104.97 28.08 7.53 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.578 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 9.0 t0 -48.88 131.01 18.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.229 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.34 -18.95 56.41 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.248 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -105.28 -48.81 3.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.635 0.255 . . . . 0.0 111.585 -176.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.445 HG23 ' HB2' ' A' ' 40' ' ' PRO . 34.0 pt -122.85 159.82 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.4 0.619 . . . . 0.0 112.544 -173.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 27.4 t -125.39 127.91 72.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.42 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.646 HG23 HG22 ' A' ' 11' ' ' VAL . 20.5 mt -112.09 130.49 65.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.381 0.61 . . . . 0.0 110.824 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -114.2 165.64 12.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.614 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.721 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 47.9 mttm -132.14 153.46 50.49 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.487 173.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.529 HG12 ' HG2' ' A' ' 81' ' ' GLU . 4.7 t -127.14 121.44 57.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.738 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -77.98 88.86 4.14 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 92' ' ' SER . 20.8 p -52.85 -30.02 31.25 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.111 0.481 . . . . 0.0 111.445 -175.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.551 ' CD ' ' HB2' ' A' ' 47' ' ' ALA . 2.6 mm-40 -50.56 -44.86 56.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.099 174.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.58 ' HE2' HG22 ' A' ' 15' ' ' THR . 19.3 pttm -103.33 -19.43 14.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.06 0.457 . . . . 0.0 110.672 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.529 ' HG2' HG12 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -97.85 42.87 1.08 Allowed 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.27 0.628 . . . . 0.0 111.453 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -57.24 -43.24 82.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.139 0.495 . . . . 0.0 110.812 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.36 -36.27 78.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.531 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.56 -47.77 74.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.565 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.548 ' HA ' HD11 ' A' ' 90' ' ' ILE . . . -63.94 -48.34 76.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.682 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.01 -32.76 76.48 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.129 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.06 -40.0 95.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.801 0.334 . . . . 0.0 111.525 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.415 ' HB2' HG13 ' A' ' 90' ' ' ILE . 96.4 m-85 -92.67 5.95 49.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.325 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.49 20.86 78.24 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.153 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.548 HD11 ' HA ' ' A' ' 85' ' ' ALA . 26.4 mt -76.84 137.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.684 ' H ' ' HD2' ' A' ' 91' ' ' ARG . 3.0 mpt_? -71.59 -64.68 0.88 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 78' ' ' THR . 5.2 p -177.65 -85.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.368 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.578 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 13.9 pt -150.55 146.82 20.18 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -167.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.778 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 11.3 Cg_exo -86.65 150.48 42.09 Favored 'Cis proline' 0 N--CA 1.473 0.282 0 C-N-CA 124.513 -1.036 . . . . 0.0 110.722 -6.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.578 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 4.5 m -139.95 128.93 23.5 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 107' ' ' MET . 57.0 mt -128.02 114.32 34.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.745 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.598 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.7 tp -102.45 113.32 26.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.74 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -92.3 102.62 15.11 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.849 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.551 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 65.4 mt -97.61 113.17 63.12 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.61 -175.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -86.5 165.34 9.33 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.742 2.294 . . . . 0.0 111.547 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 93.1 mmm -89.7 2.44 54.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.562 0.696 . . . . 0.0 109.345 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -140.82 98.25 3.36 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.844 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.16 -162.49 13.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.862 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.711 ' HZ2' ' HB2' ' A' ' 33' ' ' TRP . 25.8 mmmt -98.49 150.46 36.74 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.551 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 5.7 Cg_exo -79.36 155.94 25.27 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.196 2.597 . . . . 0.0 112.987 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.509 ' HG2' ' N ' ' A' ' 107' ' ' MET . 29.3 tt0 -109.07 163.6 13.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.133 174.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.588 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 22.4 ptp -142.74 129.06 19.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.359 0.599 . . . . 0.0 111.202 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.31 156.55 27.63 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.883 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -116.89 137.81 51.96 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.221 0.534 . . . . 0.0 111.364 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.778 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 104.59 150.46 20.55 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.195 178.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -84.5 88.23 7.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.166 0.508 . . . . 0.0 111.342 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.496 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 25.2 ptp -69.68 164.74 47.91 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.524 172.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.63 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 74.3 Cg_endo -75.41 169.27 22.78 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.847 1.698 . . . . 0.0 111.621 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.526 ' HZ1' ' CD ' ' A' ' 62' ' ' GLU . 65.6 tttp -55.69 -32.15 63.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.516 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 118' ' ' LYS . . . -71.33 -47.51 56.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.167 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.63 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 50.2 m -64.72 -33.8 76.82 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.687 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.688 ' O ' HG12 ' A' ' 121' ' ' ILE . 7.4 m-85 -61.57 -39.56 91.57 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.604 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.595 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 3.8 mmmm -54.01 -52.39 60.95 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.171 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.516 ' HG3' ' OE2' ' A' ' 123' ' ' GLU . 51.7 tttp -64.5 -32.98 74.84 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.677 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.32 -40.39 70.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.992 0.425 . . . . 0.0 111.214 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.688 HG12 ' O ' ' A' ' 117' ' ' PHE . 31.3 mm -73.58 -55.61 11.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.8 0.333 . . . . 0.0 110.278 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -65.36 -68.47 0.36 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.961 0.41 . . . . 0.0 110.825 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.518 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 48.2 mt-10 -77.4 12.0 1.74 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -169.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.533 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 77.8 t80 -143.51 -53.4 0.36 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.686 175.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.482 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 44.0 tp -69.6 -39.13 77.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.489 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 80.2 mt -88.54 -60.26 2.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 14.1 ttpp . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.429 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.57 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -150.4 152.3 34.14 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.852 0.834 . . . . 0.0 112.456 -167.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 5.0 p -134.83 119.48 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.098 174.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 60.0 mt -117.37 116.98 53.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.415 -173.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.704 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 11.0 p80 -83.8 119.67 25.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.815 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 2.0 pp -127.84 171.96 11.28 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.229 -171.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.7 p -99.18 177.89 5.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.161 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HZ1' ' CD ' ' A' ' 83' ' ' GLU . 63.5 pttt -59.22 -25.24 63.83 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 20' ' ' LEU . . . -68.49 -44.17 75.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.284 0.564 . . . . 0.0 110.233 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.815 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 3.2 mp0 -72.24 -33.71 67.75 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.399 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.522 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -55.08 -49.23 72.19 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.007 0.908 . . . . 0.0 109.201 174.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.661 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 13.9 mt -50.58 -61.15 2.36 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.357 -1.747 . . . . 0.0 111.742 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.11 -7.58 59.62 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -169.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.46 ' HB2' ' HZ1' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -111.02 -33.88 6.37 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.252 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 70.3 t -125.03 -40.78 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -169.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.661 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 21.5 t80 -164.95 117.88 1.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.866 -166.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.632 ' OD1' ' HD3' ' A' ' 28' ' ' LYS . 2.6 t-20 -91.66 89.68 7.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.485 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.646 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 18.9 p90 -81.12 6.89 12.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -86.16 -53.41 5.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.831 0.824 . . . . 0.0 108.903 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.632 ' HD3' ' OD1' ' A' ' 25' ' ' ASN . 11.0 mptt -88.43 -23.41 23.3 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.426 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.687 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -118.69 61.54 4.9 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.195 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.17 -44.71 44.04 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.683 2.255 . . . . 0.0 112.112 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.21 -13.7 15.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.852 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.448 ' O ' ' HE1' ' A' ' 24' ' ' TYR . 44.9 mt-10 -91.09 144.08 26.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.271 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.484 ' CZ2' ' HG2' ' A' ' 105' ' ' PRO . 65.0 t-105 -108.36 109.17 20.42 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 171.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.417 ' HG2' ' OE1' ' A' ' 36' ' ' GLU . 27.1 ttpp -134.21 117.65 16.73 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.602 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 29.4 t80 -90.05 110.97 21.93 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.714 -175.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.417 ' OE1' ' HG2' ' A' ' 34' ' ' LYS . 4.5 mm-40 -84.53 40.81 0.81 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.548 -176.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.6 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -98.3 165.7 21.73 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.731 -171.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -101.47 -56.88 2.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.302 0.572 . . . . 0.0 109.828 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -116.36 166.6 12.2 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.264 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.539 ' HB2' HG23 ' A' ' 71' ' ' ILE . 36.7 Cg_exo -55.83 137.15 77.78 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.165 1.91 . . . . 0.0 111.324 175.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -121.6 146.2 47.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.322 0.582 . . . . 0.0 112.02 -173.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.503 ' HB ' HG12 ' A' ' 73' ' ' ILE . 64.5 mt -113.18 112.31 39.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.905 172.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.769 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 20.7 t -98.94 113.59 34.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.863 0.363 . . . . 0.0 110.848 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.603 ' HB2' HD12 ' A' ' 60' ' ' LEU . 6.7 t70 -92.69 108.69 20.18 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.108 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.559 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 13.7 m-85 -88.07 109.94 20.25 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 171.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.69 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 3.9 p90 -130.25 160.77 32.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.186 0.517 . . . . 0.0 110.671 -175.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 50' ' ' CYS . . . -119.49 131.67 55.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.105 169.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.63 -11.26 59.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.01 0.434 . . . . 0.0 111.152 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -102.23 -6.39 23.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.096 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.507 ' HB2' ' HB1' ' A' ' 47' ' ' ALA . 50.2 t -88.73 118.05 28.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.81 0.338 . . . . 0.0 110.954 -174.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.13 -57.3 13.47 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.595 -0.729 . . . . 0.0 113.628 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.469 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 83.2 Cg_exo -47.32 -46.35 20.09 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.026 2.484 . . . . 0.0 113.552 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.69 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 74.9 m -68.78 -37.25 79.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.854 0.359 . . . . 0.0 111.215 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -55.25 -28.69 55.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.81 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.406 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 79.9 mtp -75.08 -50.92 14.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.025 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.578 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 32.8 m -71.82 -39.32 67.78 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -173.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.583 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -49.75 -56.8 14.82 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 23.3 Cg_exo -63.9 -35.76 53.84 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.732 1.622 . . . . 0.0 111.574 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.882 HG23 ' HB3' ' A' ' 114' ' ' LYS . 56.6 mt -62.75 -42.55 96.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.677 0.751 . . . . 0.0 110.464 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.603 HD12 ' HB2' ' A' ' 44' ' ' ASP . 28.2 mt -68.82 -35.51 77.07 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.119 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.553 ' OD1' HG12 ' A' ' 11' ' ' VAL . 57.1 m-20 -62.19 -45.77 91.91 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 173.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -54.92 -47.08 74.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.698 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.466 HD22 ' HE1' ' A' ' 67' ' ' TYR . 74.4 mt -69.3 -29.9 67.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.824 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.79 -42.65 84.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.826 0.346 . . . . 0.0 110.372 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.73 -28.69 58.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.396 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.551 ' CD ' ' HZ3' ' A' ' 114' ' ' LYS . 4.6 tt0 -80.62 -41.52 23.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.466 ' HE1' HD22 ' A' ' 63' ' ' LEU . 57.8 m-85 -98.94 24.96 7.11 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.847 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -64.53 163.57 13.27 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.232 0.539 . . . . 0.0 111.704 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.23 -50.51 3.88 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.296 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.499 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 23.9 pt20 -90.09 -40.33 12.34 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 -177.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.539 HG23 ' HB2' ' A' ' 40' ' ' PRO . 26.9 pt -127.56 166.77 23.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.293 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 51.4 t -134.06 139.5 48.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.719 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 39.1 mt -108.08 142.13 21.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.072 -175.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -127.47 165.96 18.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.799 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.704 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 86.1 mttt -132.39 166.36 22.15 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.554 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 5.1 p -146.06 133.49 15.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.169 0.509 . . . . 0.0 109.673 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 8.0 m-20 -81.98 91.89 6.68 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.476 HG22 ' HA ' ' A' ' 92' ' ' SER . 18.0 m -66.95 -27.66 67.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.304 -167.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.28 -38.95 66.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.794 0.331 . . . . 0.0 110.917 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -95.7 -34.88 11.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.101 0.477 . . . . 0.0 109.987 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.554 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -82.26 30.75 0.4 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.671 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -63.13 -26.74 68.96 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.539 ' CD ' ' HZ1' ' A' ' 16' ' ' LYS . 27.3 mt-10 -61.94 -45.33 94.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.617 175.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -70.8 -53.19 16.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.142 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.569 ' HA ' HD13 ' A' ' 90' ' ' ILE . . . -54.3 -51.51 64.41 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.496 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.55 -27.84 66.68 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.322 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.78 -26.99 67.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.645 0.26 . . . . 0.0 111.574 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.551 ' HB2' HG13 ' A' ' 90' ' ' ILE . 83.4 m-85 -100.86 -5.08 26.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.887 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.13 4.77 64.44 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.878 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 85' ' ' ALA . 36.8 mt -65.97 128.93 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -69.13 -53.42 20.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.265 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.476 ' HA ' HG22 ' A' ' 78' ' ' THR . 11.3 p 178.14 -94.83 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.714 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.492 HG22 ' C ' ' A' ' 46' ' ' TYR . 0.2 OUTLIER -145.07 157.59 53.6 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.613 -173.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.69 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 8.3 Cg_exo -83.53 133.39 20.86 Favored 'Cis proline' 0 N--CA 1.474 0.367 0 C-N-CA 124.71 -0.954 . . . . 0.0 111.995 -3.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.559 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 4.9 m -126.84 122.04 33.59 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 107' ' ' MET . 19.7 mm -114.36 114.66 47.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.205 -176.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.769 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.9 tp -99.77 114.76 28.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.015 0.436 . . . . 0.0 110.761 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.563 ' O ' ' HA ' ' A' ' 105' ' ' PRO . 97.5 m-85 -97.07 102.86 14.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.086 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.754 HG12 ' HB3' ' A' ' 105' ' ' PRO . 34.2 mt -107.02 106.46 58.35 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -176.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -87.1 165.9 8.36 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.771 2.314 . . . . 0.0 111.665 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.5 mmm -86.74 -1.93 58.13 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.981 0.419 . . . . 0.0 111.064 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -153.28 112.73 3.83 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 129.6 -136.17 8.81 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.852 ' HB3' ' HZ2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -137.38 151.16 70.81 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 175.313 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.754 ' HB3' HG12 ' A' ' 99' ' ' ILE . 3.8 Cg_exo -77.77 114.05 3.58 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.903 2.402 . . . . 0.0 111.22 175.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -95.69 167.18 11.44 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.315 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 49.0 ttm -140.06 130.97 26.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.444 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.97 141.66 48.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.44 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.486 ' OE1' ' HA ' ' A' ' 95' ' ' SER . 12.3 mm100 -106.13 134.73 48.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.874 0.369 . . . . 0.0 111.616 -175.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.69 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 114.39 177.15 19.06 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 169.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.578 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -94.2 87.61 5.32 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.508 -0.846 . . . . 0.0 111.932 -174.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.566 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 23.3 ptp -96.36 150.85 37.62 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.556 171.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.507 ' HA ' HD11 ' A' ' 59' ' ' ILE . 74.9 Cg_endo -75.49 173.19 14.92 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.343 2.029 . . . . 0.0 111.534 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.882 ' HB3' HG23 ' A' ' 59' ' ' ILE . 21.4 ptmt -63.17 -22.91 67.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.898 0.38 . . . . 0.0 110.284 177.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.97 -52.94 45.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.665 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 36.0 m -67.58 -34.06 76.27 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.235 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.528 ' HB2' ' HA ' ' A' ' 114' ' ' LYS . 7.3 m-85 -59.25 -47.01 86.97 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.489 174.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.812 ' HZ2' ' HB2' ' A' ' 122' ' ' ASP . 5.8 tmtm? -55.42 -35.92 65.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.346 0.117 . . . . 0.0 110.743 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.544 ' HZ3' ' CD ' ' A' ' 123' ' ' GLU . 62.0 tttm -64.03 -57.07 10.76 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.397 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.39 95.8 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.709 HG21 HD22 ' A' ' 125' ' ' LEU . 77.3 mt -59.46 -44.95 93.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.861 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.812 ' HB2' ' HZ2' ' A' ' 118' ' ' LYS . 10.0 t70 -62.79 -62.97 1.36 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.66 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.804 ' HA ' ' HZ2' ' A' ' 127' ' ' LYS . 62.2 mt-10 -63.13 -0.8 0.82 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -167.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -151.63 -48.41 0.11 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.649 -0.821 . . . . 0.0 112.528 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.709 HD22 HG21 ' A' ' 121' ' ' ILE . 42.4 tp -66.9 -30.62 70.81 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.633 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 74.6 mt -109.28 -56.3 2.31 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.854 0.835 . . . . 0.0 109.5 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.804 ' HZ2' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.852 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.331 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.325 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.439 ' HE3' ' HB3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -135.8 175.26 9.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.968 0.413 . . . . 0.0 110.431 178.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.835 HG21 ' HB ' ' A' ' 73' ' ' ILE . 39.7 t -114.02 143.35 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.244 -172.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.8 mt -124.3 107.96 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.734 172.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.729 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 9.8 p80 -83.32 116.31 22.39 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 173.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.699 HD23 ' HB3' ' A' ' 18' ' ' GLU . 1.1 pp -132.92 179.99 5.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.985 -166.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.686 HG22 ' HE2' ' A' ' 80' ' ' LYS . 66.4 p -94.0 175.25 6.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.589 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.464 ' HD2' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -59.62 -32.28 70.28 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 121.233 -0.187 . . . . 0.0 111.233 177.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.552 ' HA ' HD12 ' A' ' 20' ' ' LEU . . . -62.84 -41.89 99.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.468 0.651 . . . . 0.0 110.218 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.699 ' HB3' HD23 ' A' ' 14' ' ' LEU . 8.4 mm-40 -71.72 -36.4 70.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.366 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -56.92 -50.72 71.71 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 122.388 1.089 . . . . 0.0 109.452 175.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.568 HD22 HD21 ' A' ' 25' ' ' ASN . 16.1 mt -50.34 -59.0 4.41 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 112.838 -1.983 . . . . 0.0 111.857 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.3 -17.87 38.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -171.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.643 ' HZ1' ' CD ' ' A' ' 18' ' ' GLU . 55.1 mttp -110.81 -1.37 16.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.6 t -140.34 -50.69 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.514 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 7.5 t80 -175.14 116.02 0.16 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.155 0.502 . . . . 0.0 110.64 -167.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.568 HD21 HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -87.19 90.97 8.55 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.242 -177.265 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.514 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 18.9 p90 -78.4 14.96 1.07 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.83 -46.75 7.7 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.565 ' C ' HD21 ' A' ' 29' ' ' ASN . 49.9 mttp -96.31 -21.1 18.02 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.069 -173.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.609 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -121.11 62.97 11.63 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.366 177.212 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -61.26 -42.1 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.762 2.308 . . . . 0.0 112.374 172.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -103.02 -24.16 13.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.303 -176.365 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.445 ' CD ' ' HZ1' ' A' ' 34' ' ' LYS . 35.8 mt-10 -90.13 148.96 22.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.199 0.523 . . . . 0.0 111.259 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -113.95 93.77 4.52 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 168.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HZ1' ' CD ' ' A' ' 32' ' ' GLU . 35.7 mtmm -117.51 106.33 13.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.402 173.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.577 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 30.2 t80 -68.14 105.12 1.97 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.368 0.604 . . . . 0.0 109.831 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -90.22 84.22 6.06 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.565 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.577 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -149.52 -135.69 2.51 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.731 -174.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -141.54 -55.34 0.47 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.898 0.38 . . . . 0.0 111.055 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 43.6 mttp -129.33 168.71 15.27 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.814 -177.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 65.8 Cg_exo -49.18 131.36 26.3 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.99 1.794 . . . . 0.0 111.393 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -115.32 143.23 45.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.365 -170.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.679 ' HB ' HG12 ' A' ' 73' ' ' ILE . 65.4 mt -120.33 122.49 68.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.124 176.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 16.5 t -105.74 116.02 48.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.894 0.378 . . . . 0.0 110.984 -178.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.763 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 11.3 t0 -97.78 108.11 20.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.634 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -91.27 111.64 23.21 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.545 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 0.8 OUTLIER -147.02 178.6 8.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.735 0.779 . . . . 0.0 111.286 -172.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.65 124.07 5.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.855 -1.52 . . . . 0.0 107.449 170.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.28 -23.06 67.25 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -169.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -74.95 -14.07 60.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.951 0.405 . . . . 0.0 110.766 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.1 t -99.64 132.93 44.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.475 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.543 ' O ' ' HG2' ' A' ' 54' ' ' LYS . . . -49.14 -68.23 1.42 Allowed Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.716 -0.674 . . . . 0.0 114.672 -175.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -58.71 -34.27 98.84 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.71 2.273 . . . . 0.0 113.107 -175.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.761 ' HG ' ' HB ' ' A' ' 93' ' ' ILE . 11.9 m -73.98 -33.88 64.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.896 0.379 . . . . 0.0 111.514 -176.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 0.2 OUTLIER -78.85 -27.2 44.11 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.571 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 16.4 ttt -66.93 -52.41 43.46 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.166 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.473 HG22 HD23 ' A' ' 60' ' ' LEU . 3.9 p -63.45 -36.77 77.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.046 -174.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.638 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . . . -48.07 -60.28 4.58 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.326 -176.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.638 ' HD3' ' HB2' ' A' ' 57' ' ' ALA . 27.3 Cg_exo -62.21 -27.49 78.46 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.231 1.287 . . . . 0.0 112.272 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 55' ' ' MET . 45.0 mm -66.19 -57.28 11.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.34 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.582 HD22 ' NZ ' ' A' ' 75' ' ' LYS . 1.2 pt? -71.69 -30.03 65.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.178 -177.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.476 ' OD1' HG23 ' A' ' 11' ' ' VAL . 5.6 m-20 -66.43 -42.54 87.56 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.458 0.647 . . . . 0.0 109.846 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.945 ' HG3' ' HZ2' ' A' ' 114' ' ' LYS . 9.8 tp10 -54.79 -43.3 72.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.925 172.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.768 HD23 ' HA ' ' A' ' 118' ' ' LYS . 12.9 tp -71.52 -30.79 66.34 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.073 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.526 ' HB1' HD13 ' A' ' 73' ' ' ILE . . . -58.73 -59.07 6.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.745 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -64.7 -24.26 67.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.231 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -58.54 -30.86 67.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.462 0.649 . . . . 0.0 110.044 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.49 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 81.3 m-85 -113.75 25.74 10.96 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.447 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -52.36 114.46 1.37 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.93 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.04 -22.24 5.13 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.414 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 6.4 pt20 -127.55 -22.3 3.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' A' ' 64' ' ' ALA . 44.0 pt -125.24 150.34 30.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.418 0.628 . . . . 0.0 112.218 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 47.2 t -127.27 132.09 69.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.284 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.835 ' HB ' HG21 ' A' ' 11' ' ' VAL . 11.8 mt -115.62 136.45 52.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.474 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -117.1 161.19 19.82 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.763 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 63.8 mttm -129.69 148.21 51.56 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.012 0.434 . . . . 0.0 110.23 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.418 HG13 ' CB ' ' A' ' 81' ' ' GLU . 17.4 t -120.64 111.83 33.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.739 176.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.42 89.2 2.64 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 92' ' ' SER . 7.9 p -52.87 -36.96 59.78 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -168.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -53.43 -33.22 53.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.568 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.686 ' HE2' HG22 ' A' ' 15' ' ' THR . 18.1 pttm -103.45 -22.21 13.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.397 0.618 . . . . 0.0 110.161 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.486 ' OE1' ' HA ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -100.11 43.24 1.07 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.657 178.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -55.1 -46.71 75.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.964 0.411 . . . . 0.0 111.419 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -64.55 -38.74 92.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.735 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -70.05 -44.88 68.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.966 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.04 89.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.035 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.51 -29.5 73.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.963 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.54 -26.45 65.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 111.54 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -99.17 7.24 45.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.054 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.29 16.64 80.56 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.324 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.4 mm -77.63 122.11 31.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -58.88 -61.8 2.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.505 0.669 . . . . 0.0 109.592 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.522 ' O ' HG22 ' A' ' 78' ' ' THR . 13.9 m -160.82 -79.71 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.674 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.761 ' HB ' ' HG ' ' A' ' 53' ' ' CYS . 4.5 pt -162.02 152.77 14.75 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.182 -172.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.736 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.6 Cg_exo -90.01 149.54 22.61 Favored 'Cis proline' 0 C--N 1.348 0.552 0 CA-C-N 118.869 0.632 . . . . 0.0 112.286 -3.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.415 ' HB3' ' SD ' ' A' ' 107' ' ' MET . 50.1 m -142.67 140.99 31.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.58 114.48 20.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.156 0.503 . . . . 0.0 110.138 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 43.7 tp -97.31 115.25 27.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.455 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.417 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 44.3 m-85 -96.2 104.68 16.65 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.409 HG22 ' HG3' ' A' ' 105' ' ' PRO . 53.8 mt -102.57 102.83 28.33 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.347 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 98' ' ' PHE . 73.8 Cg_endo -83.7 155.66 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.579 2.186 . . . . 0.0 111.763 174.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.406 ' SD ' ' HD3' ' A' ' 40' ' ' PRO . 90.4 mtp -75.27 -30.35 60.41 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -106.5 138.93 41.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.633 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.2 -140.1 16.61 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.922 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.651 ' HE3' ' HA ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -139.38 154.65 71.97 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.575 ' HD3' ' HE3' ' A' ' 104' ' ' LYS . 15.6 Cg_exo -69.47 154.34 69.01 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.1 2.533 . . . . 0.0 113.574 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.463 ' O ' HD11 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.56 169.72 9.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.829 176.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.415 ' SD ' ' HB3' ' A' ' 95' ' ' SER . 32.9 tpp -142.37 105.61 4.61 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.107 -174.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.93 137.37 42.01 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -117.41 137.74 52.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.159 0.504 . . . . 0.0 111.536 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.736 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 103.16 170.43 26.05 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.967 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -94.69 82.75 3.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.095 0.474 . . . . 0.0 111.65 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.556 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 22.0 ptt? -79.59 166.44 41.22 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 170.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.556 ' HD2' ' HB2' ' A' ' 112' ' ' MET . 65.9 Cg_endo -75.17 170.73 19.73 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.558 1.505 . . . . 0.0 112.541 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.945 ' HZ2' ' HG3' ' A' ' 62' ' ' GLU . 60.5 tttp -57.54 -25.37 59.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.971 174.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.64 -52.44 31.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.336 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.5 m -68.04 -37.74 81.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.697 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.674 ' O ' HG12 ' A' ' 121' ' ' ILE . 12.7 m-85 -61.48 -43.56 98.64 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.634 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.768 ' HA ' HD23 ' A' ' 63' ' ' LEU . 64.6 tttp -60.6 -38.84 86.01 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.108 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.584 ' HZ2' ' CD ' ' A' ' 123' ' ' GLU . 27.4 mtpp -62.87 -43.93 97.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.869 0.366 . . . . 0.0 110.741 177.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -64.0 -41.1 97.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.253 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.674 HG12 ' O ' ' A' ' 117' ' ' PHE . 16.3 mm -74.93 -53.9 15.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.437 0.637 . . . . 0.0 110.998 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.525 ' HA ' HD13 ' A' ' 126' ' ' LEU . 19.0 t70 -68.45 -66.03 0.62 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.314 -173.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.584 ' CD ' ' HZ2' ' A' ' 119' ' ' LYS . 38.0 mt-10 -64.6 -49.36 71.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.767 -174.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.534 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 79.2 t80 -86.09 -37.61 18.65 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -170.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.612 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 29.5 tp -90.52 -38.31 13.29 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.525 HD13 ' HA ' ' A' ' 122' ' ' ASP . 79.6 mt -89.07 -66.84 0.88 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.911 0.386 . . . . 0.0 111.689 -173.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.507 -0.707 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.598 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 112.749 -0.14 . . . . 0.0 112.749 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -162.83 171.74 16.23 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 121.286 0.565 . . . . 0.0 110.968 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.528 HG23 ' HE3' ' A' ' 75' ' ' LYS . 7.9 m -113.16 145.08 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.382 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.1 mt -114.38 96.76 4.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.058 174.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 75' ' ' LYS . 27.1 p80 -77.71 121.89 24.63 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.737 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.4 pp -138.38 178.63 7.0 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.228 0.537 . . . . 0.0 112.282 -169.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.592 HG21 ' HE2' ' A' ' 80' ' ' LYS . 42.6 p -98.42 171.39 8.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.484 175.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.487 ' HZ2' ' CD ' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -56.06 -33.09 64.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 178.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.05 -42.01 90.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.35 0.595 . . . . 0.0 110.293 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.737 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 30.2 mt-10 -71.62 -32.27 67.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.123 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -57.31 -52.86 63.65 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-O 122.401 1.096 . . . . 0.0 109.285 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 7.9 mt -50.63 -59.58 3.91 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.634 -2.075 . . . . 0.0 111.893 -176.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.58 -8.01 59.66 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -171.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -109.43 -32.43 7.16 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 31.0 t -123.5 -40.13 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -168.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.576 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 14.6 t80 -167.63 120.04 0.9 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.921 -166.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.72 90.82 7.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.011 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.576 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 27.0 p90 -85.29 18.49 2.62 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 111.667 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -94.54 -49.57 5.59 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.547 ' C ' HD21 ' A' ' 29' ' ' ASN . 47.4 mttp -96.65 -21.6 17.52 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.153 -175.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.607 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -121.7 68.29 22.91 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.618 176.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.92 -32.28 97.12 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.547 2.831 . . . . 0.0 112.613 173.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -102.52 -40.3 6.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -172.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 3.2 tp10 -100.78 132.29 46.25 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.466 0.65 . . . . 0.0 111.705 -174.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -69.46 93.2 0.65 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.654 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -93.11 97.15 10.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.529 177.31 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.561 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 23.0 t80 -81.39 127.53 32.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.989 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -109.43 151.95 26.0 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 168.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.88 -127.63 2.19 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.809 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.447 ' CG ' ' HZ3' ' A' ' 39' ' ' LYS . 5.9 t0 -163.74 -60.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.019 0.437 . . . . 0.0 110.396 -173.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.447 ' HZ3' ' CG ' ' A' ' 38' ' ' ASP . 22.0 mttm -119.08 165.79 16.08 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.442 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 85.9 Cg_exo -44.2 131.74 8.87 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.68 2.253 . . . . 0.0 111.838 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -113.22 146.31 39.53 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.212 0.529 . . . . 0.0 111.764 -171.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.682 ' HB ' HG12 ' A' ' 73' ' ' ILE . 74.8 mt -122.4 122.53 66.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.063 174.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 21.5 t -107.28 110.06 30.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.399 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.594 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 30.1 t0 -86.74 106.59 17.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.998 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.554 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 96.6 m-85 -91.88 111.89 23.6 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.619 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.6 p90 -140.63 -179.87 6.28 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.832 -171.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.412 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -159.09 142.71 14.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.492 170.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.47 -28.96 68.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -76.75 -9.79 58.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.235 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.444 ' HB2' HD11 ' A' ' 93' ' ' ILE . 47.0 t -99.15 112.38 24.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.936 0.398 . . . . 0.0 110.643 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.08 -54.3 38.6 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.607 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.49 -38.46 27.71 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.952 2.434 . . . . 0.0 113.532 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.714 ' SG ' ' HB ' ' A' ' 93' ' ' ILE . 83.0 m -67.06 -43.86 81.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.38 . . . . 0.0 111.143 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -72.48 -26.04 61.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.93 0.395 . . . . 0.0 110.184 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -60.05 -46.97 87.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.669 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.583 ' HB ' ' HE2' ' A' ' 117' ' ' PHE . 30.4 m -87.16 -25.17 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.479 ' HB1' ' HD3' ' A' ' 58' ' ' PRO . . . -43.74 -59.93 3.08 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.479 ' HD3' ' HB1' ' A' ' 57' ' ' ALA . 50.2 Cg_endo -68.57 -26.78 33.49 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.725 1.617 . . . . 0.0 112.0 -177.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.07 -54.95 21.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.347 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.55 HD11 ' HE2' ' A' ' 75' ' ' LYS . 1.7 pp -69.03 -30.84 69.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.51 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.08 -49.98 75.53 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.246 0.546 . . . . 0.0 110.741 173.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -64.56 -36.24 83.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.41 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.45 -31.3 67.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.425 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.598 ' O ' ' HA2' ' A' ' 9' ' ' GLY . . . -56.98 -42.34 80.05 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 173.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.627 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 3.7 tmtm? -71.79 -41.22 68.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.043 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -56.54 -39.54 73.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.964 0.411 . . . . 0.0 110.739 176.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.441 ' OH ' ' HB3' ' A' ' 122' ' ' ASP . 83.8 m-85 -98.54 26.67 5.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.345 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 58.0 t0 -53.39 129.79 33.17 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.477 0.311 . . . . 0.0 110.666 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.53 -6.54 83.49 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.304 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.404 HE21 ' HA ' ' A' ' 67' ' ' TYR . 44.1 mt-30 -112.47 -44.34 3.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.607 0.242 . . . . 0.0 111.008 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.424 HG21 ' HB2' ' A' ' 40' ' ' PRO . 45.1 pt -128.89 159.05 41.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.147 0.499 . . . . 0.0 111.822 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 96.6 t -126.86 123.82 63.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.233 176.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.682 HG12 ' HB ' ' A' ' 42' ' ' ILE . 15.2 mt -107.62 138.32 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.72 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -118.01 162.31 18.37 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 173.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.594 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 55.8 mttt -135.91 144.46 45.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.889 0.376 . . . . 0.0 111.147 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.715 HG12 ' HG2' ' A' ' 81' ' ' GLU . 37.3 t -138.41 134.48 43.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.853 -175.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.464 ' HB2' ' HG2' ' A' ' 80' ' ' LYS . 7.5 m-20 -94.52 102.06 13.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 92' ' ' SER . 16.8 p -52.94 -37.41 60.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.2 0.524 . . . . 0.0 111.67 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -54.9 -36.28 65.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.981 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.592 ' HE2' HG21 ' A' ' 15' ' ' THR . 21.6 pttm -100.59 -20.39 15.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.357 0.599 . . . . 0.0 110.076 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.715 ' HG2' HG12 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -97.86 45.25 1.03 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.483 176.015 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -55.89 -53.31 58.38 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.58 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.487 ' CD ' ' HZ2' ' A' ' 16' ' ' LYS . 2.2 mp0 -61.85 -36.88 82.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.618 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.422 HD23 ' HG2' ' A' ' 81' ' ' GLU . 41.4 tp -67.86 -41.7 82.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.529 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.548 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -67.0 -44.54 80.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.67 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.14 -32.89 82.15 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.684 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.85 -35.37 76.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.814 0.34 . . . . 0.0 111.588 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.502 ' HB2' HG13 ' A' ' 90' ' ' ILE . 94.6 m-85 -97.26 3.06 51.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.854 0.359 . . . . 0.0 110.81 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.13 28.46 73.7 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.11 -176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.637 HG12 ' HE3' ' A' ' 107' ' ' MET . 28.9 mt -66.08 138.82 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -64.09 -61.39 2.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.445 ' O ' HG23 ' A' ' 78' ' ' THR . 24.3 p 175.65 -91.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.75 175.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.714 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 8.0 pt -151.55 146.34 18.77 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.881 -172.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.667 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 17.3 Cg_exo -78.59 142.78 70.09 Favored 'Cis proline' 0 N--CA 1.478 0.561 0 C-N-CA 124.78 -0.925 . . . . 0.0 112.037 -3.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.554 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 14.7 m -139.37 112.35 8.0 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.73 114.39 46.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.028 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.581 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 34.8 tp -92.96 113.18 25.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.714 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -94.23 112.39 24.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.88 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.471 HD13 ' HB1' ' A' ' 41' ' ' ALA . 36.9 mt -101.24 102.9 22.88 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.908 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.09 163.09 22.97 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.576 2.184 . . . . 0.0 112.325 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 92.6 mmm -87.39 -0.04 56.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.332 0.587 . . . . 0.0 109.559 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -138.2 123.68 19.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.928 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.25 -149.57 19.45 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.08 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.449 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 27.2 mmmt -123.31 159.1 56.26 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 104' ' ' LYS . 57.6 Cg_endo -70.48 154.1 65.13 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.564 2.176 . . . . 0.0 113.45 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -125.83 167.94 14.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.494 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.637 ' HE3' HG12 ' A' ' 90' ' ' ILE . 42.9 ttm -130.26 122.06 27.31 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.043 0.449 . . . . 0.0 112.029 -175.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.05 132.23 50.51 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -115.37 136.2 53.34 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.284 0.564 . . . . 0.0 112.437 -172.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.667 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 104.7 -175.6 22.55 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.173 -0.921 . . . . 0.0 114.898 169.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.471 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -92.12 85.64 5.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.026 -0.587 . . . . 0.0 111.633 -171.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.55 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 25.1 ptp -91.4 154.89 44.52 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.463 172.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 71.7 Cg_endo -75.44 177.54 8.52 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.28 1.987 . . . . 0.0 111.687 -177.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -58.85 -33.77 70.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 174.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.78 -52.86 61.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.529 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 34.6 m -66.7 -40.73 88.6 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.736 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.583 ' HE2' ' HB ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -60.93 -40.79 94.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.537 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.498 ' HZ1' ' CG ' ' A' ' 122' ' ' ASP . 14.6 tmtt? -58.97 -49.82 76.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.892 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.56 ' HA ' ' OD1' ' A' ' 122' ' ' ASP . 12.9 mptt -64.64 -39.86 94.43 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.951 0.405 . . . . 0.0 110.797 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -58.51 -38.9 78.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.611 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.505 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 74.7 mt -75.04 -56.29 9.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.472 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.56 ' OD1' ' HA ' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -74.24 -58.87 3.01 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.918 -173.036 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.26 -22.47 63.83 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -171.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.475 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 91.6 t80 -110.47 -46.29 3.42 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.973 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.505 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 36.7 tp -90.39 -41.64 11.36 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -172.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.503 ' HB3' ' HA ' ' A' ' 122' ' ' ASP . 45.3 tp -83.49 -52.5 6.44 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 121.392 0.615 . . . . 0.0 109.751 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 127' ' ' LYS . 30.1 mtmt . . . . . 0 C--N 1.318 -0.781 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 173.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.537 ' HA3' ' CG ' ' A' ' 68' ' ' ASP . . . . . . . . 0 C--O 1.227 -0.312 0 CA-C-O 120.514 -0.048 . . . . 0.0 113.058 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.474 ' HZ1' ' HB3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -166.98 172.09 10.53 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.339 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 12.9 p -113.36 132.21 62.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.713 0.768 . . . . 0.0 112.097 -176.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.0 mt -121.49 128.88 75.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.736 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.574 ' CB ' ' HG3' ' A' ' 75' ' ' LYS . 1.9 p80 -88.01 129.53 35.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.3 pp -133.21 173.98 10.87 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.918 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.43 166.97 12.59 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.852 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.742 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 30.7 pttt -62.16 -26.65 68.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.061 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.0 86.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.281 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 28.2 mm-40 -68.61 -43.58 76.08 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.868 176.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -57.39 -49.8 75.03 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 121.933 0.873 . . . . 0.0 109.502 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 25' ' ' ASN . 1.1 tt -48.64 -61.47 2.01 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 113.648 -1.615 . . . . 0.0 112.098 -178.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.09 -18.83 33.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.588 -168.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 34.5 ttmt -108.78 -16.87 14.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -172.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.45 -45.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.508 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 18.5 t80 -164.42 116.74 1.31 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.236 0.541 . . . . 0.0 111.261 -169.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.529 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -84.15 89.05 7.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.99 -177.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.497 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 27.2 p90 -82.81 4.88 23.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.644 0.735 . . . . 0.0 110.698 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -95.43 -52.27 4.22 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.253 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.579 ' C ' HD21 ' A' ' 29' ' ' ASN . 67.6 mttm -84.27 -27.77 27.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.287 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.649 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -120.71 69.04 16.24 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-O 120.862 0.363 . . . . 0.0 111.223 -177.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -64.12 -28.23 65.16 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.449 2.766 . . . . 0.0 112.306 171.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -31.46 8.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.752 -175.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -91.81 144.37 25.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.055 0.455 . . . . 0.0 111.407 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -91.94 89.47 7.02 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 171.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 87.2 tttt -94.23 97.58 10.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.007 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -99.31 120.6 39.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.054 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -112.0 114.51 27.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.218 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.84 163.52 33.16 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.496 ' OD2' ' HG3' ' A' ' 39' ' ' LYS . 12.0 p-10 -95.71 -37.32 10.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.949 0.375 . . . . 0.0 111.181 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.496 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 56.5 mttp -117.54 166.28 13.7 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.505 179.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.544 ' HB2' HD22 ' A' ' 125' ' ' LEU . 32.1 Cg_exo -59.8 141.03 96.03 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.746 2.297 . . . . 0.0 111.56 174.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -119.91 147.43 44.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.342 0.591 . . . . 0.0 112.365 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.738 ' HB ' HG12 ' A' ' 73' ' ' ILE . 4.2 mp -121.12 133.38 67.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.311 172.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 41.9 t -128.31 114.07 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.126 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.593 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 8.6 p-10 -100.41 115.87 31.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 122.222 1.01 . . . . 0.0 111.622 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.535 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 30.0 m-85 -81.1 112.88 18.87 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.431 -1.258 . . . . 0.0 108.936 173.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.687 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.8 p90 -129.91 168.17 17.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.503 0.668 . . . . 0.0 111.415 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.89 131.01 26.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.271 -1.332 . . . . 0.0 107.841 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.546 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 27.9 t70 -60.12 -34.34 73.37 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -171.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -71.57 -9.33 58.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.681 0.277 . . . . 0.0 111.62 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 48.0 t -95.64 123.55 39.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.92 0.39 . . . . 0.0 110.607 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.55 -59.01 10.27 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.755 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 77.4 Cg_exo -48.78 -36.71 34.04 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.047 2.498 . . . . 0.0 113.202 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.687 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 98.0 m -64.3 -44.89 90.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.99 0.424 . . . . 0.0 111.199 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 66.6 mttm -59.99 -29.71 68.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.905 175.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.55 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 75.0 mtp -71.59 -54.48 10.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.953 0.406 . . . . 0.0 111.16 177.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.48 HG23 HD11 ' A' ' 96' ' ' ILE . 10.2 p -68.6 -36.95 76.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -170.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.625 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -52.06 -55.79 27.74 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.625 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 16.8 Cg_exo -68.35 -42.62 5.25 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 121.938 1.759 . . . . 0.0 112.14 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 73.1 mt -58.54 -41.04 80.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.08 0.467 . . . . 0.0 110.769 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.698 HD23 HD13 ' A' ' 73' ' ' ILE . 1.3 mt -67.03 -38.28 85.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.898 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.29 -37.06 80.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.184 0.516 . . . . 0.0 109.802 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 59' ' ' ILE . 14.5 tp10 -54.37 -46.05 72.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.692 174.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.536 HD21 ' HA ' ' A' ' 114' ' ' LYS . 4.3 mm? -72.02 -35.12 69.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.807 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.566 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -57.16 -52.0 67.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.27 -25.92 62.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.099 -178.15 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.457 ' CD ' ' HZ1' ' A' ' 114' ' ' LYS . 1.8 tt0 -71.73 -19.83 61.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.329 0.585 . . . . 0.0 110.15 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.44 ' HD1' ' O ' ' A' ' 63' ' ' LEU . 85.7 m-85 -117.23 25.84 10.18 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.682 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.537 ' CG ' ' HA3' ' A' ' 9' ' ' GLY . 11.3 t0 -58.65 121.57 11.32 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.234 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.64 -28.45 6.75 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.26 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.469 ' HG3' HG23 ' A' ' 71' ' ' ILE . 17.6 pt20 -114.73 -28.21 7.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -176.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.469 HG23 ' HG3' ' A' ' 70' ' ' GLN . 37.5 pt -122.99 158.12 27.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.859 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 94.4 t -130.06 128.04 64.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.423 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.738 HG12 ' HB ' ' A' ' 42' ' ' ILE . 29.3 mt -121.6 135.22 62.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.465 0.65 . . . . 0.0 111.371 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 63.8 m-85 -122.7 164.56 18.05 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 173.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.593 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -136.65 149.8 48.17 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 174.185 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.528 HG13 ' HG2' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -122.75 137.14 57.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.441 -171.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.543 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 10.5 m-20 -87.82 86.57 7.18 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.644 HG22 ' HA ' ' A' ' 92' ' ' SER . 15.3 m -56.06 -29.75 60.95 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -169.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -53.42 -31.03 43.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.647 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.543 ' HE3' ' HB2' ' A' ' 77' ' ' ASP . 22.2 pttp -109.82 -23.78 11.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.196 0.522 . . . . 0.0 110.492 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.742 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 1.3 mp0 -85.93 39.63 0.82 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.424 175.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -61.95 -47.92 82.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.696 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.522 ' CD ' ' HZ1' ' A' ' 16' ' ' LYS . 5.7 mp0 -62.22 -38.95 91.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.218 0.532 . . . . 0.0 110.192 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.1 tp -61.03 -44.54 97.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.42 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.567 ' HA ' HD13 ' A' ' 90' ' ' ILE . . . -63.96 -49.08 73.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.753 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.65 -30.99 66.4 Favored Glycine 0 CA--C 1.517 0.181 0 CA-C-N 116.081 -0.509 . . . . 0.0 113.206 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.75 -33.32 73.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.752 0.31 . . . . 0.0 111.707 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.544 ' HB2' HG13 ' A' ' 90' ' ' ILE . 89.5 m-85 -104.15 7.47 36.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.174 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.67 30.63 68.35 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.799 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.567 HD13 ' HA ' ' A' ' 85' ' ' ALA . 55.6 mt -80.69 131.94 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.642 0.258 . . . . 0.0 110.524 -177.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.0 mtm105 -57.45 -64.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.666 0.746 . . . . 0.0 109.933 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.644 ' HA ' HG22 ' A' ' 78' ' ' THR . 13.0 p 177.17 -93.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.633 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -139.56 148.37 55.85 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.357 -175.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.715 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.1 Cg_exo -85.36 150.19 50.43 Favored 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 124.077 -1.218 . . . . 0.0 111.279 -3.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 11.6 m -141.36 140.19 33.69 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.489 HD12 ' HE1' ' A' ' 112' ' ' MET . 60.1 mt -136.24 117.76 19.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 119.025 0.83 . . . . 0.0 111.201 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.499 HD12 ' HB2' ' A' ' 105' ' ' PRO . 20.3 tp -98.26 114.35 26.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.209 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.587 ' HE2' ' HB1' ' A' ' 108' ' ' ALA . 96.6 m-85 -96.78 110.79 23.19 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.0 mt -103.3 105.97 49.13 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.819 0.343 . . . . 0.0 111.899 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 98' ' ' PHE . 2.9 Cg_exo -76.16 159.27 37.25 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.413 2.742 . . . . 0.0 111.5 172.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 89.8 mtp -83.02 -32.15 27.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.636 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.07 -30.91 7.83 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.91 0.862 . . . . 0.0 110.764 -177.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.69 -156.03 24.4 Favored Glycine 0 C--N 1.307 -1.031 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.99 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 35.2 mmtm -129.81 148.54 69.93 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.567 ' HA ' ' O ' ' A' ' 98' ' ' PHE . 38.3 Cg_endo -63.62 134.38 43.94 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.887 2.391 . . . . 0.0 113.854 -170.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.32 169.64 8.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.423 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 36.1 tpp -136.13 101.92 4.85 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.859 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.587 ' HB1' ' HE2' ' A' ' 98' ' ' PHE . . . -107.8 129.88 55.02 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 173.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.557 ' HB3' ' O ' ' A' ' 94' ' ' PRO . 58.4 mt-30 -117.51 128.52 55.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.149 0.499 . . . . 0.0 111.93 -171.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.715 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 133.12 -169.21 22.69 Favored Glycine 0 CA--C 1.506 -0.487 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.141 176.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.31 80.66 1.44 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.556 0.693 . . . . 0.0 110.858 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.671 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 5.0 mpp? -77.81 147.85 74.91 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.467 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.84 -177.69 3.8 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.052 2.502 . . . . 0.0 111.943 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.536 ' HA ' HD21 ' A' ' 63' ' ' LEU . 36.5 ttmt -60.13 -33.3 71.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 0.0 110.37 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.38 -52.9 59.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.558 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.671 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 20.3 m -70.31 -29.94 66.8 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.932 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.567 ' O ' HG13 ' A' ' 121' ' ' ILE . 5.4 m-85 -71.67 -37.29 70.77 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.426 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.433 ' HZ1' ' HB3' ' A' ' 122' ' ' ASP . 3.7 tttm -57.75 -43.99 85.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.847 0.356 . . . . 0.0 110.119 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.511 ' HG2' ' OE2' ' A' ' 123' ' ' GLU . 31.0 mtpp -64.14 -38.48 91.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.679 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -67.5 -45.22 76.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.489 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 117' ' ' PHE . 20.9 mt -74.38 -57.25 6.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.306 0.574 . . . . 0.0 110.472 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.499 ' HA ' HD13 ' A' ' 126' ' ' LEU . 22.2 t70 -72.42 -65.04 0.83 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.285 -175.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.511 ' OE2' ' HG2' ' A' ' 119' ' ' LYS . 34.5 mt-10 -75.47 -9.21 58.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.423 -168.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 89.2 t80 -120.81 -52.49 2.11 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.938 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.553 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 32.9 tp -72.75 -32.35 65.6 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.366 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 122' ' ' ASP . 64.5 mt -101.17 -59.69 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.112 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.892 -172.737 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.453 ' HA3' ' CG ' ' A' ' 68' ' ' ASP . . . . . . . . 0 CA--C 1.507 -0.468 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -131.09 173.05 11.4 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -174.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.5 p -133.29 134.33 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.183 0.516 . . . . 0.0 110.259 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 69.0 mt -129.57 133.65 64.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.176 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.73 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 6.5 p80 -93.8 116.34 28.8 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.371 0.605 . . . . 0.0 109.842 175.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.72 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.3 pp -116.09 179.8 3.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.759 -175.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.2 p -100.03 176.6 5.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 60.7 pttt -55.68 -30.74 61.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.521 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.24 78.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.769 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.72 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 4.0 mp0 -69.67 -31.66 69.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.33 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -64.61 -51.63 61.68 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.6 tt -51.76 -61.08 2.48 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 113.312 -1.767 . . . . 0.0 112.155 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.9 -25.69 61.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.781 -168.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.535 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 36.7 ttmt -98.45 -34.34 10.67 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.0 t -119.28 -47.7 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -167.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.7 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 20.0 t80 -151.54 116.47 5.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.297 0.57 . . . . 0.0 111.852 -165.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.512 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -88.2 90.69 8.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.262 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.7 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 24.3 p90 -84.27 12.09 7.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.154 0.502 . . . . 0.0 111.576 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -94.32 -45.7 7.37 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.425 ' C ' HD21 ' A' ' 29' ' ' ASN . 48.9 mttm -94.67 -25.9 16.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.584 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.572 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -122.26 68.85 29.23 Favored Pre-proline 0 N--CA 1.469 0.494 0 CA-C-O 120.791 0.329 . . . . 0.0 111.198 178.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -55.71 -42.18 70.09 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.163 2.576 . . . . 0.0 112.132 171.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -95.42 -33.25 12.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -173.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.436 ' CD ' ' HZ3' ' A' ' 34' ' ' LYS . 36.7 mt-10 -91.49 128.45 37.32 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.204 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 53.3 t-105 -82.13 101.37 10.37 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 171.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.436 ' HZ3' ' CD ' ' A' ' 32' ' ' GLU . 30.6 mmtp -102.65 139.21 38.54 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.331 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -126.92 115.79 19.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.162 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' A' ' 22' ' ' LYS . 35.0 mm-40 -97.5 123.73 41.47 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.443 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.85 179.48 46.37 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.201 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.469 ' OD2' ' HG3' ' A' ' 39' ' ' LYS . 1.7 p-10 -124.31 -38.51 2.42 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 117.011 0.405 . . . . 0.0 111.333 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.469 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 60.8 mttp -112.43 154.69 44.47 Favored Pre-proline 0 C--N 1.328 -0.348 0 O-C-N 122.474 -0.142 . . . . 0.0 110.86 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.443 ' HB2' HD22 ' A' ' 125' ' ' LEU . 6.2 Cg_endo -48.35 132.81 24.66 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.155 2.57 . . . . 0.0 111.851 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -116.85 149.57 39.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.388 0.613 . . . . 0.0 112.121 -170.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.416 ' HB ' HG12 ' A' ' 73' ' ' ILE . 76.5 mt -132.56 139.78 49.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.996 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.45 116.62 47.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.866 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.528 ' HB3' ' CB ' ' A' ' 75' ' ' LYS . 35.0 t70 -91.24 112.19 24.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.774 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.566 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 79.2 m-85 -93.51 110.64 22.22 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.7 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.2 p90 -137.87 162.6 33.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.559 0.695 . . . . 0.0 111.468 -171.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.19 133.4 50.29 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.692 170.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.24 -41.83 93.99 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.91 -172.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -68.25 -17.29 64.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.881 0.372 . . . . 0.0 111.624 -176.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 42.2 t -82.09 123.53 29.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.888 0.375 . . . . 0.0 110.168 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.83 -61.01 7.9 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.157 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HB3' ' HB1' ' A' ' 111' ' ' ALA . 87.4 Cg_exo -47.84 -45.7 23.64 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.842 2.361 . . . . 0.0 112.874 176.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 62.1 m -60.19 -45.63 92.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.527 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -76.02 -27.46 57.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.437 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 3.3 tmm? -67.31 -47.86 69.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.32 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.585 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 27.2 m -77.11 -24.95 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.588 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -50.74 -52.73 54.06 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 18.9 Cg_exo -66.81 -37.65 19.91 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.774 1.649 . . . . 0.0 112.339 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.3 mt -65.36 -47.5 86.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.358 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.33 -31.75 71.39 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.64 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.503 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 20.7 t70 -68.15 -37.81 81.44 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.153 174.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.519 ' CD ' ' HZ3' ' A' ' 114' ' ' LYS . 37.3 tt0 -55.95 -46.98 78.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.921 176.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.569 HD12 ' HG3' ' A' ' 114' ' ' LYS . 9.8 mp -65.25 -30.88 71.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.07 176.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.551 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -55.08 -53.78 51.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.635 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.503 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -78.2 -24.83 46.96 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.455 178.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -55.83 -33.97 64.95 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.677 0.751 . . . . 0.0 109.366 171.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.595 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 41.2 m-85 -111.34 26.5 10.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.042 176.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 3.1 t70 -55.36 132.6 48.51 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.336 -176.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.26 -21.06 36.29 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.962 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.595 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 10.8 pt20 -122.08 -36.0 3.06 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -176.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.528 HG23 ' HG3' ' A' ' 70' ' ' GLN . 45.4 pt -111.63 147.81 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.987 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 60.1 t -120.96 120.29 61.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.596 177.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.645 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 27.7 mt -115.57 134.98 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 121.612 0.72 . . . . 0.0 111.179 -177.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -121.45 173.27 7.49 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.824 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.73 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 3.5 ptmm? -151.97 156.34 39.82 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.557 HG22 HD13 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -133.62 148.23 30.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.097 -173.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 20.2 m-20 -89.82 85.87 6.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 92' ' ' SER . 1.7 m -62.0 -27.28 68.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.193 -166.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -54.42 -31.04 54.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.487 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 22.6 pttm -104.76 -26.16 12.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.231 0.538 . . . . 0.0 109.694 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.511 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 1.3 mp0 -84.85 33.6 0.53 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.72 176.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -62.04 -31.61 72.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.819 0.343 . . . . 0.0 110.977 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -63.05 -41.05 99.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.358 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -70.24 -45.61 66.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.41 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.54 ' HA ' HD11 ' A' ' 90' ' ' ILE . . . -61.57 -49.68 75.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.45 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.75 -30.26 72.19 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 116.154 -0.475 . . . . 0.0 113.116 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.57 -34.54 77.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.749 0.309 . . . . 0.0 111.677 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.498 ' HB2' HG13 ' A' ' 90' ' ' ILE . 77.7 m-85 -104.53 5.66 34.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.228 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.31 29.44 70.19 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.084 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.54 HD11 ' HA ' ' A' ' 85' ' ' ALA . 22.0 mt -75.1 139.82 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.024 0.44 . . . . 0.0 110.072 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.431 ' HD3' HE22 ' A' ' 109' ' ' GLN . 72.6 mtp180 -74.34 4.05 6.43 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.674 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.564 ' HA ' HG23 ' A' ' 78' ' ' THR . 30.3 t 82.5 -88.0 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.424 -176.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.568 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 2.7 pp -135.29 136.45 24.46 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -169.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.654 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 4.0 Cg_exo -85.35 146.45 42.14 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 124.591 -1.004 . . . . 0.0 111.726 -4.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.566 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 37.5 t -142.0 140.85 32.79 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 171.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.6 mt -134.18 115.15 20.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.7 tp -97.64 112.99 24.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.552 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.75 111.48 23.75 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.776 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.517 HG12 ' HB3' ' A' ' 105' ' ' PRO . 44.7 mt -102.17 105.12 40.95 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.127 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.92 161.17 36.39 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.722 2.281 . . . . 0.0 111.636 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 94.1 mmm -83.7 -1.39 53.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 0.0 110.454 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -141.76 112.93 7.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.1 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.89 -153.7 16.8 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.057 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.425 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 28.8 mmmt -116.1 156.9 46.33 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.517 ' HB3' HG12 ' A' ' 99' ' ' ILE . 59.2 Cg_endo -72.12 151.08 54.98 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.678 2.252 . . . . 0.0 113.721 -175.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -106.62 157.98 17.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.199 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 45.1 ttm -122.63 116.39 23.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.152 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.01 137.91 48.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 173.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.493 ' HG2' ' HA ' ' A' ' 95' ' ' SER . 43.9 mt-30 -123.06 137.97 54.8 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.389 -174.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.654 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 106.77 178.28 22.96 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.407 -0.815 . . . . 0.0 114.457 170.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.585 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -83.01 89.14 6.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.119 0.485 . . . . 0.0 111.814 -174.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.622 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 22.2 ptp -95.64 149.01 35.5 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.974 173.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 97.4 Cg_endo -76.18 -178.36 4.35 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.825 2.35 . . . . 0.0 112.141 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.569 ' HG3' HD12 ' A' ' 63' ' ' LEU . 20.5 ttmm -57.68 -35.51 70.69 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 120.851 0.357 . . . . 0.0 110.133 174.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.65 -52.54 60.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.445 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.622 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 28.5 m -68.61 -35.63 77.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.624 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.472 ' HB3' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -61.89 -46.4 89.54 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.462 176.645 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -62.63 -33.14 74.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.306 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 51.4 tptt -61.47 -42.75 99.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 174.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.34 -47.94 53.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.711 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.589 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 1.8 mp -70.63 -56.92 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.871 0.367 . . . . 0.0 110.763 -177.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.408 ' HB2' ' OH ' ' A' ' 67' ' ' TYR . 5.1 t70 -73.5 -62.63 1.42 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.549 0.69 . . . . 0.0 110.396 -176.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 3.9 mm-40 -78.12 11.47 2.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.835 -1.075 . . . . 0.0 113.329 -169.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.597 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 71.8 t80 -143.56 -47.5 0.29 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.441 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.589 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 32.5 tp -76.55 -35.03 58.47 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.488 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.2 mt -89.22 -65.56 1.01 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.411 ' HZ3' ' HB3' ' A' ' 127' ' ' LYS . 2.1 ttpm? . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 113.35 0.1 . . . . 0.0 113.35 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.593 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 2.9 tttm -162.0 175.33 11.92 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.279 0.562 . . . . 0.0 112.299 -175.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 9.9 p -106.7 130.58 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.128 176.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.6 mm -112.24 130.08 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.246 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.551 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 1.8 p80 -90.15 131.83 35.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.565 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.487 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 1.1 pp -131.25 176.1 8.56 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.369 -174.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.0 p -104.53 176.36 5.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.959 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 14.4 pttm -64.19 -30.66 71.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.672 0.273 . . . . 0.0 110.864 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.08 93.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.278 0.561 . . . . 0.0 110.081 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.487 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 2.5 mm-40 -71.92 -38.91 69.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.228 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.86 -49.37 75.69 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.706 175.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.697 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 13.9 mt -57.07 -60.62 3.32 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.253 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.54 -25.45 60.41 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -169.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.455 ' HZ3' ' CD ' ' A' ' 18' ' ' GLU . 4.3 ttpm? -110.05 -16.46 13.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 46.9 t -128.65 -45.24 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -171.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.697 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 17.5 t80 -173.03 132.41 0.51 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 117.925 0.33 . . . . 0.0 111.845 -165.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.65 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 2.5 t-20 -106.79 105.69 15.85 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.589 -177.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.444 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 5.3 p90 -90.5 1.46 56.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -171.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -89.57 -40.69 12.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.65 ' HB3' ' OD1' ' A' ' 25' ' ' ASN . 4.8 tptp -91.29 -24.96 19.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.637 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.671 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -116.42 55.63 1.35 Allowed Pre-proline 0 N--CA 1.48 1.045 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 178.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -62.25 -43.71 22.29 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.246 1.964 . . . . 0.0 111.773 175.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -108.46 -9.26 15.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.18 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.4 ' HB2' ' CB ' ' A' ' 29' ' ' ASN . 67.3 mt-10 -91.59 177.7 6.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.821 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.45 ' HZ3' ' HE1' ' A' ' 88' ' ' PHE . 76.8 t-105 -151.95 88.49 1.4 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.943 0.401 . . . . 0.0 110.195 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -105.83 98.87 8.5 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 26.2 t80 -91.47 118.8 30.88 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.308 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -89.78 125.96 35.5 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.835 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.99 146.14 4.63 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.037 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -91.73 -27.29 18.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.965 0.412 . . . . 0.0 110.279 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -120.08 159.68 46.21 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.852 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.14 145.58 89.4 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.524 2.15 . . . . 0.0 111.937 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -120.05 150.25 40.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.442 0.639 . . . . 0.0 111.99 -175.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.621 ' HB ' HG23 ' A' ' 73' ' ' ILE . 77.1 mt -119.47 116.07 49.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.341 176.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.3 t -103.22 109.15 26.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.75 0.309 . . . . 0.0 111.204 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 8.4 t70 -90.62 113.92 26.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.042 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -87.68 111.21 21.05 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.678 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.3 p90 -132.56 169.47 16.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.818 0.818 . . . . 0.0 111.783 -174.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.63 126.7 24.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.183 167.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.563 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 31.2 t70 -60.02 -35.0 74.12 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.484 -172.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -73.89 -0.65 16.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.785 0.326 . . . . 0.0 111.54 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.451 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 47.7 t -101.69 119.54 38.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.965 0.412 . . . . 0.0 110.316 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.65 -56.62 17.12 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.584 -0.734 . . . . 0.0 114.112 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.451 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 83.7 Cg_exo -47.74 -37.85 28.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.048 2.498 . . . . 0.0 113.444 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.678 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 78.2 m -69.68 -47.01 64.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.939 0.399 . . . . 0.0 111.155 177.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.563 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 53.6 mttm -52.7 -30.15 30.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.466 177.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.527 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 24.7 ptm -88.12 -40.77 13.51 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.924 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.522 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 31.6 m -69.96 -36.85 70.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.576 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.592 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . . . -53.42 -53.16 59.57 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' A' ' 57' ' ' ALA . 16.4 Cg_exo -69.05 -34.96 15.72 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.09 1.86 . . . . 0.0 112.428 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.504 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 68.1 mt -63.58 -48.7 85.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.97 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.586 HD13 HG21 ' A' ' 73' ' ' ILE . 4.2 pp -68.7 -30.69 69.4 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.66 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.593 ' OD1' ' HG2' ' A' ' 10' ' ' LYS . 18.7 t70 -64.76 -37.95 89.33 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.25 0.547 . . . . 0.0 109.815 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 7.2 mm-40 -54.63 -50.26 68.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.759 173.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.515 HD21 ' HG3' ' A' ' 114' ' ' LYS . 3.4 mm? -62.5 -31.81 72.62 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.926 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.542 ' HB2' HD13 ' A' ' 73' ' ' ILE . . . -63.29 -37.49 87.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.811 0.338 . . . . 0.0 110.456 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.873 ' HZ1' ' HB3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -74.02 -33.92 63.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.505 178.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -41.23 70.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.461 0.648 . . . . 0.0 111.116 176.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.646 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 30.1 m-85 -98.28 27.31 4.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.112 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.41 143.78 14.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.105 0.479 . . . . 0.0 111.432 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.39 -23.77 23.11 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.826 -0.624 . . . . 0.0 113.39 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.646 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 4.2 pt20 -117.28 -24.61 7.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.414 HD12 HG22 ' A' ' 121' ' ' ILE . 43.6 pt -126.36 145.57 33.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.306 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 68.0 t -120.99 118.75 57.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.621 HG23 ' HB ' ' A' ' 42' ' ' ILE . 14.3 mt -106.89 138.66 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.106 -175.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -123.65 170.37 10.54 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.666 175.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.637 ' HB3' ' HZ3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -152.45 149.42 28.55 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 172.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.24 138.2 55.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.263 0.554 . . . . 0.0 110.863 -174.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 1.2 m-20 -70.7 89.13 0.73 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.095 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.438 HG21 ' HB2' ' A' ' 85' ' ' ALA . 23.9 m -62.52 -37.07 84.63 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -169.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -21.27 62.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -174.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' A' ' 77' ' ' ASP . 8.9 ptpp? -106.39 -34.93 7.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.772 0.32 . . . . 0.0 110.224 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.521 ' HA ' ' OE1' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -82.75 47.35 1.18 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.989 0.515 . . . . 0.0 110.842 174.421 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -57.99 -38.69 76.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.02 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.457 ' CD ' ' HZ1' ' A' ' 16' ' ' LYS . 3.0 mp0 -69.11 -37.52 78.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.251 0.548 . . . . 0.0 110.166 -178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 3.4 tm? -67.1 -46.66 73.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.434 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -61.88 -48.18 81.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.135 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.5 -29.81 67.26 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.05 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.85 -27.4 69.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 0.0 111.399 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.542 ' HB2' HG12 ' A' ' 90' ' ' ILE . 68.1 m-85 -104.03 8.74 36.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.792 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.54 19.99 79.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.212 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.542 HG12 ' HB2' ' A' ' 88' ' ' PHE . 33.9 mm -74.77 108.12 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 120.623 0.249 . . . . 0.0 110.538 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -56.39 -56.37 21.98 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.787 0.803 . . . . 0.0 110.871 174.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.1 p -169.72 -137.63 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.167 -1.378 . . . . 0.0 108.985 -172.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.559 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -131.77 155.35 81.51 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.845 -0.161 . . . . 0.0 110.583 -172.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.627 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 2.9 Cg_exo -84.96 141.5 33.09 Favored 'Cis proline' 0 C--N 1.346 0.431 0 C-N-CA 124.827 -0.906 . . . . 0.0 112.726 -2.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.511 ' HG ' HD13 ' A' ' 90' ' ' ILE . 15.2 t -141.47 137.8 32.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 107' ' ' MET . 44.6 mt -131.53 120.11 44.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.691 -174.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.4 tp -100.05 112.03 24.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.373 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -94.31 109.38 21.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.59 HG12 ' HB3' ' A' ' 105' ' ' PRO . 49.6 mt -101.34 106.66 46.81 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.51 -174.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.43 164.89 25.94 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.836 2.357 . . . . 0.0 111.759 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.1 mtp -87.75 -6.31 58.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.421 0.629 . . . . 0.0 109.946 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -133.15 121.68 22.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.239 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.69 -140.84 15.1 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.198 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -132.27 153.27 81.21 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.59 ' HB3' HG12 ' A' ' 99' ' ' ILE . 35.5 Cg_endo -64.45 143.95 83.81 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.913 2.408 . . . . 0.0 113.543 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -104.8 169.75 8.27 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 35.0 ttm -142.84 101.59 3.88 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -172.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -96.75 134.0 40.59 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 172.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -120.74 136.86 54.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.143 0.497 . . . . 0.0 112.252 -171.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.627 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 102.17 -168.79 19.23 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.455 -0.793 . . . . 0.0 115.005 168.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.522 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -85.55 88.93 7.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.866 -0.667 . . . . 0.0 112.07 -171.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.574 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 23.3 ptt? -107.28 150.35 39.86 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.259 172.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.475 ' HD2' ' OG ' ' A' ' 116' ' ' SER . 84.6 Cg_endo -76.39 -178.09 4.2 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.987 2.458 . . . . 0.0 112.94 -173.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.515 ' HG3' HD21 ' A' ' 63' ' ' LEU . 29.4 ttmt -57.73 -35.21 70.39 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.391 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.12 -48.8 74.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.629 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.574 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 30.0 m -66.02 -41.21 91.27 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.592 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.623 ' O ' HG13 ' A' ' 121' ' ' ILE . 11.9 m-85 -58.46 -49.17 78.28 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.692 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.445 ' HZ3' ' CG ' ' A' ' 122' ' ' ASP . 11.9 tmtt? -54.59 -48.63 71.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.444 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -66.5 -34.42 77.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.707 0.289 . . . . 0.0 110.93 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -69.68 -44.19 70.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.083 0.468 . . . . 0.0 111.128 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 117' ' ' PHE . 31.2 mt -70.12 -51.72 36.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.267 0.556 . . . . 0.0 110.33 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.445 ' CG ' ' HZ3' ' A' ' 118' ' ' LYS . 9.7 t70 -64.0 -69.51 0.27 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.019 -176.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.527 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 38.4 mt-10 -80.79 12.31 3.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.399 -167.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 90.8 t80 -140.09 -49.92 0.47 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.398 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.419 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 20.2 tp -75.94 -31.58 59.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.682 0.277 . . . . 0.0 110.686 -175.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -106.0 -57.01 2.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.035 0.445 . . . . 0.0 110.3 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.527 ' HB3' ' HA ' ' A' ' 123' ' ' GLU . 2.3 tmmt? . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.581 ' HD3' ' H ' ' A' ' 11' ' ' VAL . 15.1 tppt? -150.96 157.47 42.93 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.095 -0.552 . . . . 0.0 109.533 -173.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 14.1 p -108.78 132.62 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.202 0.525 . . . . 0.0 110.758 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.8 mt -122.88 127.43 74.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.951 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.572 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 1.9 p80 -86.26 143.39 27.95 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.4 pp -137.86 168.84 18.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.966 0.412 . . . . 0.0 111.974 -177.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.814 HG21 ' HZ1' ' A' ' 80' ' ' LYS . 40.3 p -92.48 175.33 6.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.43 174.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.512 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 8.6 ptpp? -64.42 -31.83 73.2 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.663 0.268 . . . . 0.0 111.39 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.37 -39.5 92.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.399 0.618 . . . . 0.0 109.845 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 38.3 mt-10 -72.33 -36.02 68.75 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.155 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.437 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 2.5 t80 -54.06 -53.01 59.0 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.241 1.02 . . . . 0.0 108.995 175.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 17.0 mt -59.02 -60.2 4.25 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.274 -1.784 . . . . 0.0 112.213 -175.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.72 -20.53 27.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -169.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.614 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 35.0 ttpt -109.45 -7.49 15.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.64 0.257 . . . . 0.0 111.415 -174.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 68.8 t -134.79 -49.27 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.77 ' HE2' ' HZ ' ' A' ' 88' ' ' PHE . 1.1 t80 -177.88 125.62 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.298 0.571 . . . . 0.0 110.809 -168.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.577 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -92.94 87.31 5.74 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.793 -172.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.532 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 18.6 p90 -75.92 12.14 1.2 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.402 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . 11.2 tm-20 -88.34 -53.43 4.69 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.606 ' C ' HD21 ' A' ' 29' ' ' ASN . 0.0 OUTLIER -92.4 -12.26 32.69 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.353 171.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.633 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.9 OUTLIER -111.68 53.45 0.39 Allowed Pre-proline 0 N--CA 1.478 0.935 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -178.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.456 ' HD2' ' OE1' ' A' ' 31' ' ' GLU . 37.6 Cg_endo -74.68 -35.6 3.38 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 121.947 1.765 . . . . 0.0 111.103 166.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.542 ' OE1' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -100.21 -34.75 9.89 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.586 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.542 ' HG2' ' OE1' ' A' ' 31' ' ' GLU . 7.6 pt-20 -97.92 177.4 5.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.002 -177.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.584 ' CB ' ' HE2' ' A' ' 104' ' ' LYS . 76.3 t-105 -148.05 88.92 1.69 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.227 0.537 . . . . 0.0 110.628 -174.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.464 ' HZ3' ' CD ' ' A' ' 36' ' ' GLU . 61.9 tttm -102.92 104.49 14.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.282 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.582 ' OH ' ' HB3' ' A' ' 41' ' ' ALA . 18.9 t80 -96.79 124.3 40.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.018 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.464 ' CD ' ' HZ3' ' A' ' 34' ' ' LYS . 7.1 mm-40 -88.61 93.41 9.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.534 177.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.15 129.56 1.39 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.182 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.8 -27.8 58.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.387 0.613 . . . . 0.0 110.399 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.464 ' HB2' HG21 ' A' ' 72' ' ' VAL . 66.7 mttm -116.63 155.46 48.8 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.339 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.524 ' HG3' ' HG2' ' A' ' 101' ' ' MET . 36.4 Cg_exo -57.73 150.34 62.72 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.777 2.318 . . . . 0.0 111.79 177.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.582 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -120.49 147.55 44.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.423 0.63 . . . . 0.0 112.111 -173.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.565 ' HB ' HG12 ' A' ' 73' ' ' ILE . 74.7 mt -124.03 112.45 32.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 171.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 46.0 t -109.81 110.78 33.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 121.273 -0.171 . . . . 0.0 111.286 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.572 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 8.2 p-10 -101.06 116.66 33.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.217 1.008 . . . . 0.0 111.821 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.435 ' HB3' ' OG1' ' A' ' 78' ' ' THR . 13.2 m-85 -77.85 112.72 15.02 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.058 170.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.64 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.2 p90 -128.59 162.12 28.03 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.615 0.721 . . . . 0.0 111.844 -176.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.96 137.27 37.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.647 170.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.554 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 25.2 t70 -60.75 -42.06 96.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -171.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -67.66 -13.31 61.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.665 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 49.3 t -85.48 115.1 22.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.87 0.367 . . . . 0.0 110.355 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.92 -57.01 10.4 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.575 -0.738 . . . . 0.0 113.507 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.74 -40.97 31.64 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.068 2.512 . . . . 0.0 113.378 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.64 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 84.9 m -63.51 -45.31 91.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.93 0.395 . . . . 0.0 111.087 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.554 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 65.9 mttm -58.41 -29.6 66.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.073 174.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.503 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 74.3 mtp -74.42 -52.45 12.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.073 0.463 . . . . 0.0 111.234 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.444 HG11 ' HA ' ' A' ' 53' ' ' CYS . 14.2 p -70.98 -37.97 70.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.581 -170.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.586 ' HB1' ' HD3' ' A' ' 58' ' ' PRO . . . -52.71 -53.38 54.87 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -176.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.586 ' HD3' ' HB1' ' A' ' 57' ' ' ALA . 29.9 Cg_exo -62.83 -49.04 5.76 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.94 1.76 . . . . 0.0 112.113 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.5 mt -56.48 -40.46 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.155 0.502 . . . . 0.0 110.897 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.479 HD23 HD12 ' A' ' 73' ' ' ILE . 6.9 mt -68.16 -36.17 79.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.348 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.553 ' CG ' ' HZ2' ' A' ' 10' ' ' LYS . 28.3 t70 -68.57 -41.12 80.17 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.29 -54.73 39.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.903 173.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.7 tp -61.78 -31.74 71.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.698 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.551 ' HB1' HD11 ' A' ' 73' ' ' ILE . . . -59.53 -46.85 87.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.439 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.614 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 3.6 tmtm? -75.71 -40.29 55.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.422 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.444 ' CD ' ' HZ3' ' A' ' 114' ' ' LYS . 50.9 mt-10 -55.67 -31.35 62.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.395 175.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.435 ' HD2' ' NE2' ' A' ' 70' ' ' GLN . 72.8 m-85 -111.27 25.15 12.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.615 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 65' ' ' LYS . 24.1 t0 -54.13 148.39 11.19 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.736 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.63 -22.11 18.78 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.529 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.435 ' NE2' ' HD2' ' A' ' 67' ' ' TYR . 16.9 mt-30 -95.92 -56.39 2.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.924 0.362 . . . . 0.0 111.206 -175.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.627 HD11 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -122.69 174.41 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.67 -170.266 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 43.2 t -131.47 129.09 61.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 174.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 17.0 mt -106.19 135.09 45.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.295 0.569 . . . . 0.0 110.875 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 84.3 m-85 -122.04 163.9 18.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.125 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.572 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -147.33 153.47 39.73 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.045 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.65 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 9.4 p -133.94 144.29 36.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.607 -174.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.411 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 6.0 m-20 -86.6 88.66 7.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.435 ' OG1' ' HB3' ' A' ' 45' ' ' PHE . 7.1 m -60.53 -32.65 71.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -169.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -54.42 -30.85 53.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.814 ' HZ1' HG21 ' A' ' 15' ' ' THR . 22.3 pttp -107.75 -17.56 14.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.594 0.711 . . . . 0.0 110.187 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.65 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 0.3 OUTLIER -94.56 38.73 1.1 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.12 175.056 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -66.14 -36.29 82.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.323 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -64.32 -34.64 78.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.433 0.635 . . . . 0.0 109.627 177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.465 HD11 ' CE2' ' A' ' 26' ' ' PHE . 15.5 tp -70.2 -45.6 66.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.116 177.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.549 ' HA ' HD13 ' A' ' 90' ' ' ILE . . . -57.1 -49.47 75.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.879 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.28 -30.05 66.99 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.325 -0.464 . . . . 0.0 113.085 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.81 -32.81 74.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.328 . . . . 0.0 111.37 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.77 ' HZ ' ' HE2' ' A' ' 24' ' ' TYR . 96.6 m-85 -101.4 8.33 42.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.841 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.25 31.62 77.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.892 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.661 ' HA ' ' NH1' ' A' ' 91' ' ' ARG . 42.7 mt -82.26 136.93 21.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.906 0.384 . . . . 0.0 110.394 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.661 ' NH1' ' HA ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -66.52 -50.27 63.74 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t 170.26 -89.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.231 -1.349 . . . . 0.0 107.949 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.502 HG23 ' C ' ' A' ' 46' ' ' TYR . 0.2 OUTLIER -141.35 155.05 67.8 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.757 -178.316 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.767 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.5 Cg_exo -86.71 143.39 28.22 Favored 'Cis proline' 0 C--N 1.343 0.253 0 C-N-CA 124.585 -1.006 . . . . 0.0 111.983 -3.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 59.0 m -141.4 132.02 25.55 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.472 HD12 ' HE3' ' A' ' 112' ' ' MET . 64.0 mt -128.49 118.73 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.109 0.481 . . . . 0.0 111.073 -172.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.42 HD11 ' O ' ' A' ' 106' ' ' GLU . 23.9 tp -98.98 114.75 27.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.227 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -94.23 103.11 15.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 61.5 mt -96.42 111.38 56.66 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.431 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 98.3 Cg_endo -84.39 169.64 10.98 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.808 2.339 . . . . 0.0 111.612 174.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.524 ' HG2' ' HG3' ' A' ' 40' ' ' PRO . 95.1 mmm -89.99 -2.29 58.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 0.0 110.534 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -151.81 115.89 4.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.393 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 116.19 -144.71 18.53 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.77 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.584 ' HE2' ' CB ' ' A' ' 33' ' ' TRP . 28.0 mmtp -126.32 151.61 72.63 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.441 ' HG3' ' CH2' ' A' ' 33' ' ' TRP . 85.8 Cg_endo -73.79 148.65 41.57 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.815 2.344 . . . . 0.0 113.322 -175.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.474 ' HG2' ' N ' ' A' ' 107' ' ' MET . 37.4 tt0 -95.23 166.94 11.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.876 178.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.474 ' N ' ' HG2' ' A' ' 106' ' ' GLU . 32.3 tpp -142.68 107.56 4.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.087 0.47 . . . . 0.0 111.491 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.95 157.26 17.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.239 174.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -126.34 135.44 51.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.942 0.401 . . . . 0.0 111.129 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.767 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 107.15 -171.72 17.08 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.679 -0.691 . . . . 0.0 113.381 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.65 81.02 1.4 Allowed 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.542 0.687 . . . . 0.0 110.997 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.667 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 4.5 mpp? -65.49 148.97 97.75 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.329 172.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.32 172.65 15.64 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.125 1.883 . . . . 0.0 110.772 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.444 ' HZ3' ' CD ' ' A' ' 66' ' ' GLU . 36.5 ttmt -60.03 -24.53 64.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.109 0.48 . . . . 0.0 109.851 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.51 -53.29 44.44 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.238 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.667 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 18.5 m -71.94 -28.73 63.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.486 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -67.56 -40.2 84.92 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.985 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 122' ' ' ASP . 0.8 OUTLIER -58.25 -37.86 75.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.458 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -67.58 -51.89 45.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.48 -46.56 89.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.152 0.501 . . . . 0.0 111.284 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 1.7 mp -67.55 -43.89 86.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.14 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -72.44 -55.1 7.57 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.666 -177.021 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.649 ' HA ' ' HE2' ' A' ' 127' ' ' LYS . 31.9 tt0 -77.25 -8.33 57.41 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -169.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -127.65 -51.74 1.36 Allowed 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.82 -0.55 . . . . 0.0 111.656 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 32.5 tp -77.71 -29.76 51.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -173.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 122' ' ' ASP . 92.7 mt -96.92 -54.06 3.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.325 0.583 . . . . 0.0 110.009 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.649 ' HE2' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.726 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.071 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 CA--C 1.507 -0.457 0 N-CA-C 112.387 -0.285 . . . . 0.0 112.387 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.555 ' HZ2' ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -147.17 163.81 35.15 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -175.411 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 61' ' ' ASP . 26.1 m -89.76 119.15 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.405 0.621 . . . . 0.0 110.874 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.5 mm -111.49 105.34 18.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.925 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 75' ' ' LYS . 19.2 p80 -79.77 129.74 34.74 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.618 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.6 pp -143.75 168.57 19.61 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.495 -174.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.0 p -86.79 168.02 13.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.747 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -55.65 -34.23 64.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.656 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.71 -36.45 75.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.322 0.582 . . . . 0.0 110.242 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.651 ' HB3' ' HE2' ' A' ' 22' ' ' LYS . 42.6 mt-10 -72.08 -33.32 67.82 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.52 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -61.81 -49.37 76.58 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.993 0.901 . . . . 0.0 108.872 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.8 tt -46.62 -60.26 2.49 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 113.479 -1.691 . . . . 0.0 111.829 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.33 -24.99 31.88 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -170.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.651 ' HE2' ' HB3' ' A' ' 18' ' ' GLU . 47.5 mtmt -109.31 0.86 19.75 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.388 -0.525 . . . . 0.0 112.146 -173.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -142.68 -49.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 83.6 t80 -164.08 116.68 1.39 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.558 -165.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.427 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -80.67 90.75 5.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.814 -178.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -83.89 9.69 11.53 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 122.148 -0.345 . . . . 0.0 111.825 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -84.95 -54.34 4.71 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.974 0.892 . . . . 0.0 108.683 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.411 ' C ' HD21 ' A' ' 29' ' ' ASN . 7.6 ptpp? -97.54 -12.0 23.07 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.506 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.612 ' OD1' ' HB2' ' A' ' 34' ' ' LYS . 1.1 m-80 -123.08 67.46 33.49 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-O 121.184 0.516 . . . . 0.0 110.998 170.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -59.67 -43.18 40.46 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.096 2.531 . . . . 0.0 111.974 171.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -112.82 -25.51 9.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.797 -174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -90.72 154.64 19.4 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.135 0.493 . . . . 0.0 110.903 -176.129 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.457 ' HZ3' ' HE1' ' A' ' 88' ' ' PHE . 76.4 t-105 -97.22 111.57 23.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.643 -177.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.612 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -133.32 115.41 14.87 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.632 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 26.9 t80 -103.58 107.23 17.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.87 -176.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.5 ' OE2' ' HG3' ' A' ' 34' ' ' LYS . 1.1 mp0 -95.71 76.61 3.24 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.925 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.632 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -133.76 -136.22 3.67 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.401 -173.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -149.57 -58.79 0.2 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.882 0.372 . . . . 0.0 110.998 -173.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.422 ' HB2' HG22 ' A' ' 72' ' ' VAL . 48.8 mttp -125.5 159.04 62.33 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.966 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.539 ' HB2' HG22 ' A' ' 71' ' ' ILE . 83.8 Cg_exo -42.43 131.36 5.08 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.602 2.201 . . . . 0.0 111.65 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -116.52 150.18 38.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.265 0.555 . . . . 0.0 112.24 -167.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.779 ' HB ' HG12 ' A' ' 73' ' ' ILE . 67.8 mt -127.9 116.88 44.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.882 173.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 38.5 t -98.84 116.31 41.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 120.825 0.345 . . . . 0.0 110.68 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.502 ' HB2' HD13 ' A' ' 60' ' ' LEU . 7.1 t70 -91.09 110.58 21.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.554 177.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.514 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 97.8 m-85 -94.39 111.65 23.41 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 174.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.605 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.1 p90 -133.58 174.9 9.93 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.547 0.689 . . . . 0.0 111.11 -175.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.97 142.61 22.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.298 173.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.476 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 32.4 t70 -62.03 -28.89 69.91 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -83.38 -1.07 52.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.686 0.279 . . . . 0.0 111.553 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 41.1 t -99.68 113.08 25.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.097 0.475 . . . . 0.0 110.805 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 54' ' ' LYS . . . -58.16 -51.36 58.88 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.472 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.528 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 97.6 Cg_exo -47.28 -47.74 16.63 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.896 2.397 . . . . 0.0 113.113 175.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.605 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 71.0 m -63.78 -36.66 84.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.908 0.385 . . . . 0.0 111.482 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.476 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 67.5 mttm -56.46 -34.78 67.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.831 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.507 ' SD ' ' HB1' ' A' ' 111' ' ' ALA . 26.9 ptm -91.84 -26.95 18.26 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.793 -175.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.586 HG22 ' HA ' ' A' ' 53' ' ' CYS . 25.1 m -76.71 -31.04 19.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.702 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.451 ' HA ' ' HZ1' ' A' ' 75' ' ' LYS . . . -47.69 -58.25 8.06 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.429 ' HD3' ' HB1' ' A' ' 57' ' ' ALA . 33.7 Cg_endo -65.17 -39.64 22.73 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.75 1.634 . . . . 0.0 112.269 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.2 mt -63.59 -43.62 98.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.226 0.536 . . . . 0.0 110.304 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 44' ' ' ASP . 7.8 mt -57.8 -43.81 85.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.129 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.468 ' HA ' HG13 ' A' ' 11' ' ' VAL . 30.7 t70 -68.12 -37.43 81.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.827 0.346 . . . . 0.0 110.557 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.414 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 3.7 tp10 -59.69 -41.88 91.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.472 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.484 HD21 ' HG3' ' A' ' 114' ' ' LYS . 4.1 mm? -71.24 -31.72 67.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.725 176.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.482 ' HB1' HD13 ' A' ' 73' ' ' ILE . . . -56.45 -57.11 13.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.769 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.556 ' HZ3' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -74.83 -24.61 58.63 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.74 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.556 ' HG3' ' HZ3' ' A' ' 65' ' ' LYS . 19.1 mt-10 -66.08 -33.42 75.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.499 0.666 . . . . 0.0 110.167 173.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -104.2 25.61 9.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.936 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.507 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 6.4 t0 -59.31 133.91 56.53 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 110.138 -176.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.36 -22.04 34.73 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.769 -176.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -94.97 -53.17 3.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.906 0.384 . . . . 0.0 110.268 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.539 HG22 ' HB2' ' A' ' 40' ' ' PRO . 38.2 pt -127.15 163.5 29.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.216 -176.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 50.9 t -131.01 131.91 63.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.779 HG12 ' HB ' ' A' ' 42' ' ' ILE . 60.3 mt -111.83 133.48 57.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.101 0.477 . . . . 0.0 110.844 -176.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -115.21 160.63 19.49 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' A' ' 13' ' ' HIS . 44.6 mttm -129.13 136.02 49.64 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.748 0.308 . . . . 0.0 110.902 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.21 136.89 44.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.665 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 4.4 m-20 -97.32 106.19 18.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.2 p -57.2 -26.97 61.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -67.55 -21.39 65.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.403 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.467 ' HZ1' ' CD ' ' A' ' 81' ' ' GLU . 8.5 ptmm? -114.08 -33.67 5.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.448 0.642 . . . . 0.0 109.974 175.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.467 ' CD ' ' HZ1' ' A' ' 80' ' ' LYS . 2.0 mp0 -83.62 36.66 0.55 Allowed 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.979 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -57.27 -47.55 81.14 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.825 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -61.88 -36.76 82.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.377 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.7 tp -70.16 -50.38 40.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.902 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.466 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -63.22 -37.47 87.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.05 -31.36 78.45 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.846 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.02 -33.58 76.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 111.024 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.5 ' HB2' HG12 ' A' ' 90' ' ' ILE . 85.7 m-85 -90.32 -1.24 57.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.18 21.55 75.55 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.01 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.5 HG12 ' HB2' ' A' ' 88' ' ' PHE . 37.3 mm -81.03 126.56 39.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 122.444 0.298 . . . . 0.0 110.67 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -61.99 -64.46 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.047 0.451 . . . . 0.0 110.169 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.9 p -164.6 -101.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.535 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -142.3 157.75 62.42 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 120.508 0.194 . . . . 0.0 111.383 -173.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.753 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 15.0 Cg_exo -79.66 144.35 70.65 Favored 'Cis proline' 0 N--CA 1.476 0.454 0 C-N-CA 124.241 -1.15 . . . . 0.0 112.162 -3.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.514 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 14.8 m -140.91 137.41 33.14 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 107' ' ' MET . 66.6 mt -133.13 114.47 21.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.615 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.8 tp -96.45 115.13 26.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 -175.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.417 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 97.3 m-85 -95.23 107.03 19.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.04 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 67.5 mt -99.18 105.01 29.76 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 98' ' ' PHE . 79.4 Cg_endo -88.19 166.03 6.85 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.83 2.353 . . . . 0.0 111.988 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 20.0 mmt -89.86 -6.24 56.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.96 0.41 . . . . 0.0 110.381 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.92 104.96 5.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.876 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.26 -151.38 18.32 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.251 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 12.1 mmmm -121.1 154.4 58.24 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 104' ' ' LYS . 56.8 Cg_endo -68.85 151.15 74.1 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.976 2.451 . . . . 0.0 114.576 -171.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -104.83 169.45 8.44 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.175 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.658 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 21.3 ptp -143.84 129.62 19.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.688 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.41 140.21 50.21 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -119.93 138.27 53.55 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.495 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.753 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 105.04 -178.4 23.64 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.715 -0.675 . . . . 0.0 114.682 170.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 52' ' ' PRO . . . -90.75 86.34 6.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.036 -0.582 . . . . 0.0 111.53 -173.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.579 ' HB2' ' HB3' ' A' ' 116' ' ' SER . 23.5 ptp -92.47 151.6 41.43 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.784 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.789 ' HD2' ' HB3' ' A' ' 116' ' ' SER . 85.5 Cg_endo -75.73 177.16 9.06 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.58 2.187 . . . . 0.0 112.129 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.484 ' HG3' HD21 ' A' ' 63' ' ' LEU . 62.9 tttm -57.82 -35.57 71.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.494 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.45 -47.71 59.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.818 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.789 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 47.8 t -66.85 -30.47 70.65 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.336 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.493 ' O ' HG13 ' A' ' 121' ' ' ILE . 3.4 m-85 -58.58 -53.21 60.88 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 173.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.418 ' HZ2' ' CG ' ' A' ' 122' ' ' ASP . 62.5 tttp -56.82 -42.79 80.22 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.622 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -53.83 -48.35 70.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.022 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.12 -42.75 68.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.408 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 117' ' ' PHE . 68.0 mt -66.72 -55.33 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.088 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.418 ' CG ' ' HZ2' ' A' ' 118' ' ' LYS . 0.8 OUTLIER -52.61 -65.34 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.562 -178.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -48.48 -42.18 32.01 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -172.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -104.52 -47.22 4.15 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -171.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 23.9 tp -77.69 -38.73 46.82 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -169.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.6 mp -105.85 -42.8 5.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.097 0.475 . . . . 0.0 111.094 -176.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 37.7 tttm . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.858 -176.233 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . . . . . . 0 CA--C 1.509 -0.33 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.424 ' HE2' HD13 ' A' ' 12' ' ' ILE . 11.8 ptmt -156.05 155.75 33.19 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 121.126 0.489 . . . . 0.0 110.604 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 6.4 p -112.13 116.46 52.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.904 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.424 HD13 ' HE2' ' A' ' 10' ' ' LYS . 45.3 mm -102.96 115.49 45.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.117 -175.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.631 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 0.6 OUTLIER -85.19 125.43 32.84 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.248 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.7 pp -136.31 168.47 19.36 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.364 -173.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.0 p -102.87 177.12 4.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.114 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.62 -28.31 65.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.82 -43.28 99.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.181 0.515 . . . . 0.0 110.568 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.507 ' CD ' ' HZ3' ' A' ' 22' ' ' LYS . 3.4 mm-40 -71.9 -36.14 69.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.031 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.45 -54.06 50.12 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.587 177.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.628 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 12.5 mt -51.0 -61.02 2.48 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.001 -1.454 . . . . 0.0 112.164 -176.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.18 -31.49 60.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -167.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.507 ' HZ3' ' CD ' ' A' ' 18' ' ' GLU . 4.5 ttpm? -108.85 -20.29 13.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 95.9 t -119.43 -45.77 2.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -171.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 21.6 t80 -169.86 116.62 0.56 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.167 0.508 . . . . 0.0 111.344 -166.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -89.54 90.32 8.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.708 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.45 ' CE2' HD11 ' A' ' 84' ' ' LEU . 31.9 p90 -82.53 -2.25 52.98 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.413 ' HG3' HD21 ' A' ' 20' ' ' LEU . 15.2 mt-10 -70.64 -53.24 16.61 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.93 0.871 . . . . 0.0 108.698 174.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -100.13 -14.88 18.37 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.817 -172.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.419 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 12.7 m-80 -126.75 59.39 33.83 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 29' ' ' ASN . 10.5 Cg_endo -60.12 -30.14 90.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.396 2.731 . . . . 0.0 111.551 167.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -97.66 -41.22 8.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.776 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -94.91 149.6 21.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.204 -173.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.747 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 60.9 t-105 -108.29 109.56 20.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.044 176.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.447 ' HZ1' ' CD ' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -131.92 103.17 6.17 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.299 176.339 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.545 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 50.5 t80 -86.22 131.67 34.18 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.207 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.447 ' CD ' ' HZ1' ' A' ' 34' ' ' LYS . 14.6 mm-40 -112.1 -167.18 1.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.93 -119.61 3.36 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.787 -1.197 . . . . 0.0 112.991 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -158.92 -50.78 0.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.291 0.567 . . . . 0.0 109.815 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.539 ' HB2' HG21 ' A' ' 72' ' ' VAL . 48.7 mttp -121.76 168.78 10.55 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.864 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.547 ' HB3' HD12 ' A' ' 125' ' ' LEU . 33.1 Cg_exo -60.86 158.99 30.89 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.602 2.201 . . . . 0.0 111.534 173.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.545 ' HB1' ' OH ' ' A' ' 35' ' ' TYR . . . -127.61 142.31 51.39 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -169.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.539 ' HB ' HG12 ' A' ' 73' ' ' ILE . 44.0 mm -117.13 110.21 30.44 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.228 168.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 67.8 t -110.7 113.12 43.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 118.032 0.378 . . . . 0.0 111.523 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.652 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 5.8 p-10 -100.38 119.47 38.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.287 1.041 . . . . 0.0 111.477 176.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 93' ' ' ILE . 27.0 m-85 -77.02 113.87 15.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.297 -1.32 . . . . 0.0 108.84 171.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.63 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.4 p90 -130.98 168.28 17.62 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.29 0.567 . . . . 0.0 111.169 -176.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.09 135.89 19.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.439 174.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.502 ' CG ' ' HZ2' ' A' ' 54' ' ' LYS . 27.0 t70 -66.99 -33.13 74.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.761 0.315 . . . . 0.0 111.718 -173.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -71.89 -6.63 43.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.906 0.384 . . . . 0.0 111.236 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.43 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 37.4 t -113.34 113.64 25.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.101 0.477 . . . . 0.0 110.124 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.68 -53.11 41.15 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 119.263 -0.743 . . . . 0.0 113.975 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.43 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 84.3 Cg_exo -47.52 -31.41 13.7 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.099 2.533 . . . . 0.0 114.126 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.646 ' SG ' ' HB ' ' A' ' 93' ' ' ILE . 45.3 m -73.94 -45.11 52.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.855 0.36 . . . . 0.0 111.127 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.502 ' HZ2' ' CG ' ' A' ' 48' ' ' ASP . 15.1 ptpt -77.15 -27.4 53.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.129 0.49 . . . . 0.0 109.808 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.0 tmm? -51.47 -39.96 58.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.166 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.7 m -88.06 -15.99 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.881 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.7 -52.36 57.19 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.32 -33.68 37.88 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 121.766 1.644 . . . . 0.0 112.216 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.43 ' O ' HD12 ' A' ' 63' ' ' LEU . 92.5 mt -65.44 -44.49 94.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.524 0.678 . . . . 0.0 109.899 175.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.1 mt -67.98 -31.22 70.78 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.123 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -60.82 -48.27 82.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.171 0.51 . . . . 0.0 109.932 170.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -54.81 -46.52 74.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.154 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.771 HD21 HD13 ' A' ' 121' ' ' ILE . 7.7 mp -67.15 -31.25 71.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.363 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.451 ' O ' ' HA2' ' A' ' 9' ' ' GLY . . . -59.38 -42.09 90.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.765 0.317 . . . . 0.0 110.582 177.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -72.39 -49.67 32.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.313 0.577 . . . . 0.0 109.938 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -53.12 -35.79 60.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.705 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.56 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 45.0 m-85 -107.2 26.51 10.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.555 -178.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.36 153.92 42.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.268 0.556 . . . . 0.0 111.217 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.51 -18.58 28.54 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.508 -0.769 . . . . 0.0 113.496 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 4.2 pt20 -121.65 -53.42 1.99 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -171.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.462 HG12 ' HB3' ' A' ' 67' ' ' TYR . 40.8 pt -128.35 156.39 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 118.313 0.506 . . . . 0.0 112.199 -174.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.539 HG21 ' HB2' ' A' ' 39' ' ' LYS . 6.8 t -111.91 144.71 19.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.851 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 68.5 mt -112.59 128.99 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.139 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 36.3 m-85 -117.15 159.72 22.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.652 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -140.88 144.73 35.42 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.188 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.549 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 7.4 p -122.03 136.16 59.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.274 0.559 . . . . 0.0 111.057 -173.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.582 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 1.1 m-20 -73.56 87.08 1.61 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.962 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.495 HG22 ' HB2' ' A' ' 85' ' ' ALA . 4.4 m -65.5 -31.64 72.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -167.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -18.19 63.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.228 -0.295 . . . . 0.0 111.662 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.561 ' NZ ' ' HB3' ' A' ' 77' ' ' ASP . 8.7 ptpp? -110.32 -26.81 9.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.519 0.675 . . . . 0.0 110.033 175.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -89.47 42.73 1.1 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.669 172.318 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -64.48 -41.47 96.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.205 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -31.15 67.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.473 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.463 HD21 HG23 ' A' ' 76' ' ' VAL . 27.4 tp -66.79 -46.39 75.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.067 174.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.532 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -63.64 -43.01 98.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.967 177.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.69 -29.15 69.28 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.701 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.82 -32.21 73.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.903 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -89.28 -16.42 31.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.781 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.89 20.44 28.52 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.097 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.532 ' HB ' ' HB1' ' A' ' 85' ' ' ALA . 35.6 mm -80.51 135.89 24.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -69.22 -62.82 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.157 0.503 . . . . 0.0 110.215 177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.492 ' O ' HG23 ' A' ' 78' ' ' THR . 36.2 m -156.25 -88.44 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.615 176.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.646 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 1.8 pp -160.19 154.9 20.64 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.608 -172.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -97.11 144.88 5.7 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 124.548 -1.022 . . . . 0.0 112.215 -2.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.708 ' HB3' ' SD ' ' A' ' 107' ' ' MET . 61.3 m -141.07 143.26 34.25 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.404 HD11 ' C ' ' A' ' 95' ' ' SER . 3.7 mp -127.96 121.78 57.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.332 0.587 . . . . 0.0 110.734 -175.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.1 tp -98.02 112.5 24.42 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.764 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.572 ' HE2' ' HB3' ' A' ' 108' ' ' ALA . 93.1 m-85 -90.14 104.03 16.65 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.57 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 64.9 mt -101.73 113.51 65.82 Favored Pre-proline 0 C--O 1.235 0.312 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -169.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -87.47 174.64 4.95 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.124 2.549 . . . . 0.0 111.725 171.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.9 mmt -97.7 -24.73 15.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.251 0.548 . . . . 0.0 110.362 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.78 21.98 16.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.376 -171.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 178.62 -176.29 47.9 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.172 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.747 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 14.3 mptt -77.19 149.98 79.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.584 0.231 . . . . 0.0 110.689 177.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.57 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 91.1 Cg_endo -82.54 155.23 16.08 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.925 2.417 . . . . 0.0 113.068 -176.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -104.09 168.27 9.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.466 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.708 ' SD ' ' HB3' ' A' ' 95' ' ' SER . 27.2 tpp -132.59 124.15 27.82 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.608 -174.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.572 ' HB3' ' HE2' ' A' ' 98' ' ' PHE . . . -130.89 129.32 42.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.438 174.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 95' ' ' SER . 86.0 mt-30 -74.01 151.49 40.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.806 0.336 . . . . 0.0 110.977 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.79 -153.61 3.58 Favored Glycine 0 C--O 1.227 -0.336 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 -168.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 69.62 19.64 7.29 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.496 0.718 . . . . 0.0 111.025 -174.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.613 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 76.0 mtm -89.98 147.35 37.06 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.376 177.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.74 -174.85 2.18 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.411 2.074 . . . . 0.0 110.782 175.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.514 ' HG3' HD13 ' A' ' 63' ' ' LEU . 19.5 ttmt -56.83 -41.98 78.81 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.57 173.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.12 -51.96 67.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.613 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 19.8 m -69.51 -36.91 76.91 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.986 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.569 ' O ' HG13 ' A' ' 121' ' ' ILE . 3.5 m-85 -65.47 -52.24 54.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.935 0.398 . . . . 0.0 110.414 175.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -55.71 -44.1 77.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.103 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.485 ' HG3' ' OE2' ' A' ' 123' ' ' GLU . 28.1 tptp -56.57 -57.12 13.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.326 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.15 90.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.145 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.771 HD13 HD21 ' A' ' 63' ' ' LEU . 23.8 mt -67.71 -50.75 57.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 0.0 110.715 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.66 -56.35 14.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.834 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.658 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . 9.1 pt-20 -76.04 6.96 4.53 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.731 0.644 . . . . 0.0 112.688 -169.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -131.74 -48.19 0.96 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.4 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.547 HD12 ' HB3' ' A' ' 40' ' ' PRO . 31.1 tp -82.56 -46.26 13.58 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.413 -174.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.448 HD13 ' CE1' ' A' ' 67' ' ' TYR . 72.7 mt -81.32 -60.0 2.43 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.658 ' HG3' ' HA ' ' A' ' 123' ' ' GLU . 8.2 ptpp? . . . . . 0 N--CA 1.44 -0.966 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.346 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 CA-C-O 120.028 -0.318 . . . . 0.0 113.762 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -164.69 166.85 19.66 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 122.017 0.913 . . . . 0.0 112.879 178.201 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.754 HG11 HG22 ' A' ' 73' ' ' ILE . 42.0 t -110.61 115.04 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.421 170.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.0 mm -80.8 99.18 4.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.023 0.439 . . . . 0.0 110.546 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -74.09 112.68 10.47 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 171.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.78 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.8 pp -139.42 -179.88 6.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -167.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.3 p -109.25 177.73 4.66 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.582 173.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -59.5 -27.32 66.04 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 117.598 0.181 . . . . 0.0 111.221 -178.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.87 -39.78 76.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.287 0.565 . . . . 0.0 110.592 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.78 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 5.2 mm-40 -72.13 -35.88 69.23 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.519 175.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.411 ' CG ' HD13 ' A' ' 84' ' ' LEU . 13.8 t80 -61.23 -45.33 94.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 122.173 0.987 . . . . 0.0 108.588 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.7 tt -46.83 -61.05 2.03 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 113.19 -1.823 . . . . 0.0 111.868 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.81 -13.25 51.66 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -170.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.63 ' HZ1' ' CD ' ' A' ' 18' ' ' GLU . 56.5 mttp -109.49 -18.94 13.4 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 47.2 t -133.66 -45.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -171.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.631 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 9.5 t80 -161.32 115.38 1.99 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.232 0.539 . . . . 0.0 111.622 -167.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.432 ' ND2' HD22 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -91.91 95.51 9.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.602 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.416 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 6.2 p90 -73.89 7.38 2.61 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -97.55 -17.36 19.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.881 0.372 . . . . 0.0 110.27 170.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -90.38 -34.26 15.73 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.205 0.526 . . . . 0.0 110.296 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.711 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -147.98 62.08 6.49 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.289 -175.527 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 29' ' ' ASN . 4.8 Cg_exo -44.03 -35.28 7.31 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 124.907 3.738 . . . . 0.0 112.771 170.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -103.46 -30.87 10.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.77 -176.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.409 ' CD ' ' HZ2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -97.78 178.55 5.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.47 0.652 . . . . 0.0 112.017 -175.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.557 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 59.2 t-105 -123.14 104.92 9.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.947 175.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -119.12 105.79 11.74 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.483 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.55 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 38.2 t80 -72.09 123.48 22.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.342 178.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -97.15 15.61 22.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.371 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.55 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -98.98 -152.28 27.43 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.759 -173.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -124.79 -52.57 1.68 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 111.196 -172.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.526 ' HB2' HG21 ' A' ' 72' ' ' VAL . 36.5 mttm -113.35 165.27 13.66 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.493 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 70' ' ' GLN . 73.8 Cg_exo -47.77 131.74 20.64 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.158 1.905 . . . . 0.0 110.972 172.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.471 ' HB2' ' HH ' ' A' ' 35' ' ' TYR . . . -113.09 143.57 44.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.292 0.568 . . . . 0.0 111.811 -170.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.608 ' HB ' HG12 ' A' ' 73' ' ' ILE . 61.3 mt -130.26 110.4 19.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.034 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 74' ' ' TYR . 8.3 p -111.76 134.52 53.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.545 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 2.4 t70 -100.72 118.96 37.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.492 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.424 ' O ' HG23 ' A' ' 93' ' ' ILE . 97.3 m-85 -95.85 112.58 24.27 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.625 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 10.7 p90 -127.28 173.98 9.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.815 0.817 . . . . 0.0 111.762 -175.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.28 120.03 5.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 113.53 -1.668 . . . . 0.0 107.352 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.18 -34.7 68.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -169.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -67.86 -12.88 61.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.865 0.364 . . . . 0.0 111.383 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.708 ' HB3' ' HG ' ' A' ' 53' ' ' CYS . 42.4 t -99.01 117.3 33.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.805 0.336 . . . . 0.0 110.427 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.02 -54.62 22.09 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.701 -0.681 . . . . 0.0 114.21 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.518 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 81.6 Cg_exo -47.59 -36.68 25.32 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.025 2.484 . . . . 0.0 114.034 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.708 ' HG ' ' HB3' ' A' ' 50' ' ' CYS . 61.5 m -68.21 -31.86 71.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.205 0.526 . . . . 0.0 111.196 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -63.85 -28.63 69.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.857 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.516 ' O ' HD12 ' A' ' 59' ' ' ILE . 41.4 mmm -76.16 -42.97 44.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.106 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 53' ' ' CYS . 6.5 p -75.29 -39.18 42.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -173.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.52 -55.4 19.47 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.04 -46.2 6.56 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.075 1.85 . . . . 0.0 112.446 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.516 HD12 ' O ' ' A' ' 55' ' ' MET . 1.8 mp -55.71 -42.08 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 121.301 0.572 . . . . 0.0 110.333 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -58.68 -39.03 79.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.592 176.152 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.518 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 33.0 t70 -69.19 -42.64 75.55 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.662 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 66' ' ' GLU . 43.4 mt-10 -54.13 -55.22 29.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.371 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.542 HD11 ' HG3' ' A' ' 114' ' ' LYS . 10.9 mp -61.23 -30.67 70.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.3 -178.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.55 -56.56 16.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.081 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -77.96 -29.23 49.7 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.132 178.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.48 ' CD ' ' HZ3' ' A' ' 114' ' ' LYS . 57.9 mt-10 -66.15 -38.06 87.19 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.93 0.395 . . . . 0.0 111.63 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -105.47 19.33 20.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.037 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 65' ' ' LYS . 33.5 t0 -59.24 157.49 10.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.552 0.692 . . . . 0.0 112.82 -170.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.58 -32.8 7.14 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.428 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.566 ' HG3' HG23 ' A' ' 71' ' ' ILE . 23.6 pt20 -111.91 -35.14 5.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -174.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.566 HG23 ' HG3' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -119.44 162.47 17.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.503 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.526 HG21 ' HB2' ' A' ' 39' ' ' LYS . 40.7 t -125.34 129.29 73.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.754 HG22 HG11 ' A' ' 11' ' ' VAL . 26.7 mt -107.57 142.15 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.03 -176.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.519 ' HB2' HG21 ' A' ' 43' ' ' VAL . 44.0 m-85 -127.08 166.69 17.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.981 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.652 ' HZ2' ' HB3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -155.11 146.32 22.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.757 0.313 . . . . 0.0 110.219 171.321 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.668 HG23 ' HG2' ' A' ' 81' ' ' GLU . 8.1 p -152.33 159.94 3.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.396 -172.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.585 ' HB2' ' HG2' ' A' ' 80' ' ' LYS . 10.7 m-20 -99.46 111.85 24.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.844 -0.162 . . . . 0.0 110.736 -175.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.713 HG21 ' HA ' ' A' ' 92' ' ' SER . 59.6 m -57.21 -31.52 65.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.01 0.433 . . . . 0.0 111.695 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.87 -33.19 71.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.751 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.585 ' HG2' ' HB2' ' A' ' 77' ' ' ASP . 11.5 ptpt -102.04 -27.57 12.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.416 0.627 . . . . 0.0 109.669 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.668 ' HG2' HG23 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -93.91 46.21 1.17 Allowed 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.25 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.61 -35.89 81.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.475 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.78 -40.39 84.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.245 0.545 . . . . 0.0 109.669 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.411 HD13 ' CG ' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -62.47 -47.62 83.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.375 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.621 ' HB2' HG23 ' A' ' 78' ' ' THR . . . -66.03 -46.0 79.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.491 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.27 -29.67 71.96 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.151 -176.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.78 -35.34 79.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.895 0.378 . . . . 0.0 111.459 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.442 ' HB2' HG13 ' A' ' 90' ' ' ILE . 97.1 m-85 -100.09 7.64 44.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.408 -177.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.24 32.54 84.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.0 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.565 HG12 ' HE1' ' A' ' 107' ' ' MET . 39.5 mt -75.13 128.22 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -52.04 -64.37 0.84 Allowed 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.563 0.539 . . . . 0.0 110.25 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.713 ' HA ' HG21 ' A' ' 78' ' ' THR . 23.2 p -179.66 -85.45 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.558 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.455 ' O ' HD12 ' A' ' 93' ' ' ILE . 1.9 pp -156.26 148.24 17.36 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.622 -176.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.693 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 13.7 Cg_exo -78.89 148.68 83.29 Favored 'Cis proline' 0 N--CA 1.477 0.544 0 C-N-CA 124.856 -0.893 . . . . 0.0 112.395 -2.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.7 m -142.8 139.21 30.87 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.6 127.96 62.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 122.113 -0.367 . . . . 0.0 110.034 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.505 ' CB ' HG13 ' A' ' 43' ' ' VAL . 2.6 tp -97.05 127.89 43.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.629 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -108.74 100.19 9.46 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.521 HG12 ' HB3' ' A' ' 105' ' ' PRO . 50.3 mt -101.23 104.91 36.2 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.18 -172.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.62 158.79 22.0 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.39 2.06 . . . . 0.0 111.088 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.3 mmm -76.9 -26.84 54.59 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 175.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -102.44 103.84 14.26 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.053 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.38 -141.97 15.91 Favored Glycine 0 C--N 1.315 -0.626 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.446 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.557 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 21.8 mmmt -124.07 163.57 34.88 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.521 ' HB3' HG12 ' A' ' 99' ' ' ILE . 84.9 Cg_endo -82.45 140.03 10.55 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.359 2.039 . . . . 0.0 114.205 -173.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.49 171.24 9.03 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.111 173.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.565 ' HE1' HG12 ' A' ' 90' ' ' ILE . 41.8 ttm -142.89 135.22 27.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.811 -177.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.32 157.34 30.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 169.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -137.67 130.57 30.18 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.135 -0.626 . . . . 0.0 112.385 -175.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.693 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 117.78 -176.21 16.05 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.178 -0.919 . . . . 0.0 113.985 169.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -83.9 86.98 7.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.39 0.614 . . . . 0.0 110.604 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.543 ' HB2' ' HB3' ' A' ' 116' ' ' SER . 7.5 ptm -103.98 141.23 22.08 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.625 175.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 116' ' ' SER . 91.1 Cg_endo -75.24 177.3 8.81 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.59 2.193 . . . . 0.0 112.687 -173.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.542 ' HG3' HD11 ' A' ' 63' ' ' LEU . 37.8 ttmt -58.2 -30.47 66.49 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.262 175.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.7 -49.56 68.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.202 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' A' ' 112' ' ' MET . 17.0 t -67.74 -33.37 74.73 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.569 -0.453 . . . . 0.0 110.051 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.419 ' HB3' ' CD2' ' A' ' 63' ' ' LEU . 5.6 m-85 -72.52 -29.59 63.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.186 176.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.513 ' C ' ' HD3' ' A' ' 118' ' ' LYS . 12.7 tmtt? -56.44 -50.3 72.07 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.495 ' HG2' ' OE2' ' A' ' 123' ' ' GLU . 54.9 mttm -66.61 -38.23 86.52 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.539 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.641 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -66.74 -45.9 77.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.987 0.423 . . . . 0.0 111.402 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.498 HG12 HD23 ' A' ' 63' ' ' LEU . 1.6 mp -75.95 -56.03 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.052 0.453 . . . . 0.0 110.968 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.531 ' HA ' HD11 ' A' ' 126' ' ' LEU . 25.7 t70 -72.6 -60.55 2.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.566 -174.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.495 ' OE2' ' HG2' ' A' ' 119' ' ' LYS . 50.1 mt-10 -80.34 11.57 3.51 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -170.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.641 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 69.6 t80 -138.11 -42.57 0.52 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.568 0.211 . . . . 0.0 111.568 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 40' ' ' PRO . 26.6 tp -90.53 -37.93 13.54 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.89 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.531 HD11 ' HA ' ' A' ' 122' ' ' ASP . 10.8 mp -78.13 -48.47 15.88 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.5 tptm . . . . . 0 C--N 1.322 -0.607 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 168.179 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.632 ' CA ' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 CA--C 1.507 -0.415 0 N-CA-C 115.096 0.798 . . . . 0.0 115.096 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.472 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 1.3 ptpp? -168.52 173.39 7.51 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 117.035 0.417 . . . . 0.0 110.155 176.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.698 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 19.4 m -109.13 133.41 54.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.322 -174.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.0 mm -103.09 98.48 6.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.608 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -72.97 111.6 8.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 173.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.841 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.9 pp -140.21 179.15 6.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -168.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.0 p -109.74 177.94 4.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.599 173.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 19' ' ' PHE . 14.8 pttm -59.04 -23.2 61.77 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.9 -48.9 72.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.375 0.607 . . . . 0.0 110.257 176.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.841 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 6.1 mp0 -71.54 -34.19 69.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.761 177.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 2.0 t80 -54.36 -48.58 71.32 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 122.266 1.031 . . . . 0.0 109.224 174.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.459 HD21 HD21 ' A' ' 25' ' ' ASN . 2.9 mt -52.43 -59.77 4.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.161 -1.836 . . . . 0.0 111.153 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.94 -27.67 49.38 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -104.41 -14.18 15.82 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -173.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 21.4 t -126.9 -49.21 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.51 -0.476 . . . . 0.0 112.104 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.543 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 14.3 t80 -163.72 115.74 1.42 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.168 0.508 . . . . 0.0 110.66 -170.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.514 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -90.45 90.07 7.86 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.921 -176.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.543 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 23.9 p90 -90.58 22.1 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.412 ' CD ' ' HZ3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -107.46 -29.47 9.21 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.873 171.178 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.66 ' C ' HD21 ' A' ' 29' ' ' ASN . 6.5 ptpp? -106.77 -16.61 14.44 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.769 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.66 HD21 ' C ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -120.85 63.38 11.1 Favored Pre-proline 0 N--CA 1.474 0.739 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.0 174.343 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.456 ' HG2' ' OE1' ' A' ' 31' ' ' GLU . 12.0 Cg_endo -65.68 -44.98 7.29 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.437 2.091 . . . . 0.0 112.509 173.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.456 ' OE1' ' HG2' ' A' ' 30' ' ' PRO . 25.6 mp0 -88.41 -26.15 22.3 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.005 0.431 . . . . 0.0 110.88 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.28 147.99 22.65 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.202 0.525 . . . . 0.0 111.423 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.94 ' HD1' ' HZ1' ' A' ' 104' ' ' LYS . 35.7 t-105 -109.15 103.5 12.5 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 164.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.404 ' HZ2' ' HB2' ' A' ' 34' ' ' LYS . 5.6 mtmp? -119.02 124.25 46.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.046 173.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.543 ' OH ' ' HB3' ' A' ' 41' ' ' ALA . 18.3 t80 -85.17 108.8 17.88 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.4 0.45 33.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.147 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.46 162.63 36.52 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -93.1 -42.42 9.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.758 0.779 . . . . 0.0 111.76 -175.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.496 ' HB2' HG22 ' A' ' 72' ' ' VAL . 44.2 mttp -102.27 147.86 34.58 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 122.355 -0.215 . . . . 0.0 110.636 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -42.97 136.55 4.84 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.656 2.904 . . . . 0.0 112.818 176.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.543 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -119.07 149.01 42.39 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -170.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.886 ' HB ' HG12 ' A' ' 73' ' ' ILE . 45.3 mm -120.37 115.41 47.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.439 171.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.4 t -100.13 117.12 44.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.699 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.819 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 14.9 t70 -96.59 106.62 18.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.356 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.533 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 77.5 m-85 -94.65 112.13 23.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.434 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.622 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 52.3 p90 -134.7 176.31 8.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.611 0.72 . . . . 0.0 111.477 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.416 ' HB3' HD13 ' A' ' 93' ' ' ILE . . . -149.89 127.48 11.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.891 170.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.604 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 26.3 t70 -61.39 -24.83 66.77 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -168.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 55.6 p-90 -72.63 -9.36 58.51 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.747 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.567 ' HB3' ' SG ' ' A' ' 53' ' ' CYS . 26.0 t -105.74 137.68 43.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.057 0.456 . . . . 0.0 111.396 -174.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.94 -62.01 6.79 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.336 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.33 -26.92 55.03 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.105 2.537 . . . . 0.0 112.831 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.622 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 70.7 m -66.45 -50.61 62.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.079 0.466 . . . . 0.0 110.31 174.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.604 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 67.8 mttm -59.07 -29.88 67.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.833 175.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 84.5 mtp -66.29 -53.31 38.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.614 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.9 m -82.96 -34.52 11.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -170.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.49 ' HB1' ' HD3' ' A' ' 58' ' ' PRO . . . -47.16 -61.28 2.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -175.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.49 ' HD3' ' HB1' ' A' ' 57' ' ' ALA . 38.0 Cg_endo -66.43 -33.22 38.34 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.581 1.521 . . . . 0.0 112.078 -175.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.6 mt -66.46 -38.41 81.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.596 HD22 ' CZ ' ' A' ' 117' ' ' PHE . 0.8 OUTLIER -67.37 -39.91 85.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.845 177.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.571 ' OD2' HG22 ' A' ' 11' ' ' VAL . 1.2 m-20 -61.26 -49.78 75.72 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-O 121.869 0.842 . . . . 0.0 109.557 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.459 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 42.8 tt0 -62.17 -46.87 87.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.193 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.47 HD11 ' HG3' ' A' ' 114' ' ' LYS . 12.8 tp -61.14 -31.15 70.87 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -177.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.486 ' HB3' HD11 ' A' ' 73' ' ' ILE . . . -60.68 -54.16 48.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.023 177.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -73.25 -24.76 60.51 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.959 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.8 -38.66 75.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.257 0.551 . . . . 0.0 110.753 174.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.506 ' HH ' ' HG3' ' A' ' 118' ' ' LYS . 57.1 m-85 -103.44 27.36 7.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.153 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.632 ' HA ' ' CA ' ' A' ' 9' ' ' GLY . 10.1 t70 -52.21 129.62 28.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.141 0.496 . . . . 0.0 110.773 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.08 -42.19 1.92 Allowed Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.46 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -101.19 -47.81 4.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -173.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.8 pt -117.82 164.52 14.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.647 -171.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.496 HG22 ' HB2' ' A' ' 39' ' ' LYS . 14.5 t -128.34 139.12 52.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.189 176.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.886 HG12 ' HB ' ' A' ' 42' ' ' ILE . 53.9 mt -122.89 121.13 62.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.639 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -101.77 159.09 15.63 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.819 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 30.3 mttm -143.76 145.65 32.55 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.621 -176.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.465 HG21 ' HG2' ' A' ' 81' ' ' GLU . 9.8 p -156.15 156.02 5.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -177.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.791 ' HB3' ' HG2' ' A' ' 80' ' ' LYS . 11.3 t70 -98.27 116.76 31.17 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.467 HG21 ' HB3' ' A' ' 45' ' ' PHE . 21.0 p -63.69 -35.2 79.77 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -68.25 -31.69 71.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.791 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 4.5 mmtm -74.83 -55.14 6.12 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.465 ' HG2' HG21 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -87.52 57.92 4.67 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 113.608 -1.633 . . . . 0.0 112.278 -174.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -56.48 -46.02 80.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.75 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.409 ' CD ' ' HZ3' ' A' ' 16' ' ' LYS . 2.8 mp0 -68.98 -38.25 79.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.984 0.421 . . . . 0.0 110.572 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.428 ' CB ' ' HG3' ' A' ' 81' ' ' GLU . 3.0 tm? -66.86 -43.46 83.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.81 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.573 ' HA ' HD11 ' A' ' 90' ' ' ILE . . . -64.62 -47.05 80.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.894 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.22 -32.6 81.22 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.723 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.49 -27.51 68.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.701 0.286 . . . . 0.0 111.751 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -104.29 7.03 35.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.618 0.247 . . . . 0.0 111.271 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.98 22.26 79.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.381 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.573 HD11 ' HA ' ' A' ' 85' ' ' ALA . 23.6 mt -72.74 119.75 20.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -62.04 -46.68 88.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.745 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.4 p -179.23 -93.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.535 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.566 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 2.7 pt -152.66 147.62 19.54 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -168.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -95.31 134.1 4.89 Favored 'Cis proline' 0 N--CA 1.46 -0.458 0 C-N-CA 124.3 -1.125 . . . . 0.0 111.34 -3.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.533 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 17.2 t -108.26 146.76 32.39 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.569 HD12 ' CE1' ' A' ' 117' ' ' PHE . 27.6 mt -136.55 114.91 14.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.789 0.328 . . . . 0.0 110.146 -176.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.0 tp -103.28 116.7 32.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.4 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -93.32 103.83 16.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.457 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.458 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 41.9 mt -103.8 106.84 54.48 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -173.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.33 148.57 13.02 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.892 2.395 . . . . 0.0 111.625 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -42.26 99.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.25 0.548 . . . . 0.0 110.67 175.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -99.37 105.77 17.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.302 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.496 ' C ' ' HD2' ' A' ' 104' ' ' LYS . . . 114.53 -146.82 18.78 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.284 177.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.94 ' HZ1' ' HD1' ' A' ' 33' ' ' TRP . 0.8 OUTLIER -128.27 159.69 65.97 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.303 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.469 ' HG3' ' CZ2' ' A' ' 33' ' ' TRP . 97.0 Cg_endo -81.25 152.23 18.18 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.753 2.302 . . . . 0.0 113.838 -170.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -110.02 166.81 10.65 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.642 172.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 43.3 ttm -137.11 140.51 41.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.247 0.546 . . . . 0.0 112.118 -172.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -133.52 157.19 46.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.948 172.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -96.52 150.41 20.66 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.56 -142.72 1.36 Allowed Glycine 0 CA--C 1.518 0.23 0 N-CA-C 114.628 0.611 . . . . 0.0 114.628 -171.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 71.86 18.68 5.02 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.622 0.769 . . . . 0.0 111.441 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.495 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 23.0 ptt? -117.37 154.2 50.3 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.46 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.28 178.39 7.58 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.999 2.466 . . . . 0.0 113.003 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.47 ' HG3' HD11 ' A' ' 63' ' ' LEU . 41.9 ttmt -59.45 -28.54 67.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.634 174.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.13 -52.99 61.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.411 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 35.1 m -65.89 -37.16 85.38 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.894 0.378 . . . . 0.0 110.67 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.596 ' CZ ' HD22 ' A' ' 60' ' ' LEU . 16.0 m-85 -61.49 -48.24 81.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.256 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.506 ' HG3' ' HH ' ' A' ' 67' ' ' TYR . 9.8 ttpp -55.74 -40.03 71.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.552 -178.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.539 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -56.06 -55.63 30.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.798 177.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -69.06 -42.34 76.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.783 -175.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 117' ' ' PHE . 43.5 mt -64.61 -53.46 42.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.91 0.386 . . . . 0.0 111.104 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 38.8 t70 -65.02 -59.0 4.63 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.517 -173.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -83.35 11.26 7.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -168.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.449 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 42.0 t80 -134.38 -52.35 0.82 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.593 0.235 . . . . 0.0 111.123 174.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.677 HD21 HD11 ' A' ' 42' ' ' ILE . 16.8 tp -74.58 -38.52 62.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.725 -175.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 122' ' ' ASP . 4.2 mm? -82.45 -59.94 2.36 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.486 178.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 21.8 pttp . . . . . 0 N--CA 1.447 -0.597 0 CA-C-O 121.757 0.789 . . . . 0.0 110.267 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.658 ' O ' ' HE3' ' A' ' 10' ' ' LYS . . . . . . . . 0 C--O 1.223 -0.533 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.658 ' HE3' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -138.63 164.33 29.77 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -170.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 14.7 p -102.98 123.57 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.518 0.675 . . . . 0.0 111.431 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.1 mt -132.97 124.34 50.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.696 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.839 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 7.7 p80 -91.73 138.8 31.27 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.176 177.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.654 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.7 pp -139.5 168.62 19.42 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.179 -176.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.0 p -95.33 177.17 5.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.909 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.575 ' HZ2' ' CD ' ' A' ' 83' ' ' GLU . 20.3 ptmt -55.66 -33.32 63.99 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.2 90.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.351 0.596 . . . . 0.0 110.165 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.654 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 8.3 mm-40 -71.1 -34.07 70.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.298 178.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -60.81 -50.58 72.87 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.836 0.827 . . . . 0.0 109.308 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.633 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -49.25 -60.43 2.82 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.607 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.25 -19.45 39.6 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -169.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.639 ' HZ1' ' CD ' ' A' ' 18' ' ' GLU . 56.4 mttp -109.66 -12.39 14.65 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -176.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 72.6 t -136.34 -49.99 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -172.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 12.2 t80 -154.27 116.74 4.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.315 0.579 . . . . 0.0 112.023 -164.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.517 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -82.6 88.65 6.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.687 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -88.75 11.26 18.18 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.014 0.435 . . . . 0.0 111.275 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.527 ' HG2' HD23 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -93.92 -48.31 6.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.37 0.605 . . . . 0.0 109.392 174.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.55 ' C ' HD21 ' A' ' 29' ' ' ASN . 53.7 mttp -90.46 -22.97 21.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.267 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.619 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -120.85 67.48 14.96 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.819 178.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -58.29 -44.11 41.23 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.228 2.619 . . . . 0.0 112.382 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -103.2 -22.22 13.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.194 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -91.05 178.13 6.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.346 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -128.69 106.35 8.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.233 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' HZ2' ' CD ' ' A' ' 36' ' ' GLU . 18.8 tptm -113.55 113.13 24.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.846 174.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.569 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 25.4 t80 -92.59 119.53 32.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.842 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.48 ' CD ' ' HZ2' ' A' ' 34' ' ' LYS . 21.5 mm-40 -102.65 28.28 6.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.038 -176.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.81 156.92 18.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.245 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.74 -40.32 11.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.716 0.293 . . . . 0.0 111.037 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -107.61 158.45 33.29 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.339 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.517 ' HG2' HG23 ' A' ' 71' ' ' ILE . 18.6 Cg_endo -59.51 140.72 95.36 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.588 2.192 . . . . 0.0 111.094 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -131.54 157.17 44.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.665 0.745 . . . . 0.0 112.812 -170.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.707 ' HB ' HG12 ' A' ' 73' ' ' ILE . 3.6 mp -120.0 116.5 50.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.633 174.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 35.9 t -100.32 111.97 31.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.739 0.304 . . . . 0.0 110.898 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.634 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 15.6 t70 -95.92 110.31 22.53 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.292 0.567 . . . . 0.0 111.562 -179.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -83.4 111.75 19.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.875 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.702 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 4.1 p90 -141.27 171.28 14.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.209 0.528 . . . . 0.0 111.07 -173.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.72 146.77 51.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.081 173.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -65.72 -38.01 87.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.657 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -80.43 -6.96 58.9 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 49.5 t -97.32 134.95 39.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.089 0.471 . . . . 0.0 111.506 -174.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.96 -63.77 4.15 Favored Glycine 0 C--O 1.224 -0.528 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.356 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.489 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 82.0 Cg_exo -47.26 -35.07 19.58 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.008 2.472 . . . . 0.0 113.145 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.702 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 71.6 m -62.66 -47.71 82.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.244 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -77.6 -28.56 51.59 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -55.75 -43.71 76.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.307 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.0 m -83.21 -16.84 11.16 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -174.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . . . -49.63 -55.6 21.89 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' A' ' 57' ' ' ALA . 38.2 Cg_endo -68.49 -41.03 6.91 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.547 1.498 . . . . 0.0 111.725 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 69.0 mt -58.14 -43.98 86.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.272 0.558 . . . . 0.0 110.528 176.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.447 HD23 HD11 ' A' ' 73' ' ' ILE . 12.7 mt -63.33 -45.39 91.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.677 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -64.93 -35.6 81.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 110.002 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 8.3 mm-40 -52.63 -52.86 53.66 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.175 176.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.453 ' HG ' HD12 ' A' ' 121' ' ' ILE . 3.4 mm? -67.96 -42.69 80.52 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.188 -0.205 . . . . 0.0 110.848 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.494 ' HB1' HD13 ' A' ' 73' ' ' ILE . . . -56.14 -50.03 72.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.814 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -71.04 -31.7 68.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.403 -178.322 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.45 ' CD ' ' HZ1' ' A' ' 114' ' ' LYS . 0.2 OUTLIER -67.47 -29.01 68.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.448 0.642 . . . . 0.0 110.367 179.218 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.504 ' HB3' HE21 ' A' ' 70' ' ' GLN . 26.3 m-85 -111.82 26.4 10.66 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.219 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.403 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 23.0 t0 -53.93 131.55 40.4 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.249 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.18 -43.83 1.61 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.141 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.504 HE21 ' HB3' ' A' ' 67' ' ' TYR . 11.2 pt20 -101.85 -32.67 10.13 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -175.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.517 HG23 ' HG2' ' A' ' 40' ' ' PRO . 39.6 pt -124.43 159.04 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.684 -178.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 93.2 t -138.05 136.48 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.471 176.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.707 HG12 ' HB ' ' A' ' 42' ' ' ILE . 40.2 mt -114.78 131.95 65.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.312 0.577 . . . . 0.0 111.091 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -115.99 166.16 12.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.102 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.839 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 46.8 mttm -128.88 162.71 26.89 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.487 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 9.2 p -139.86 136.74 39.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.66 86.74 7.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.86 -176.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.1 p -51.58 -41.83 61.46 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -53.78 -23.58 12.5 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HG3' ' OE1' ' A' ' 81' ' ' GLU . 7.4 ptpp? -115.37 -34.34 4.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.187 0.518 . . . . 0.0 109.947 177.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 1.3 mp0 -81.5 39.48 0.53 Allowed 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 123.711 0.804 . . . . 0.0 110.992 173.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.66 -41.16 94.44 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.932 0.396 . . . . 0.0 110.942 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.575 ' CD ' ' HZ2' ' A' ' 16' ' ' LYS . 2.6 tt0 -61.66 -47.78 83.79 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.042 177.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.0 tp -62.66 -48.51 79.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.182 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.34 -40.97 94.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.814 0.34 . . . . 0.0 111.341 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.46 -28.33 72.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.638 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.82 -27.59 68.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.322 . . . . 0.0 111.276 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.463 ' HB2' HG12 ' A' ' 90' ' ' ILE . 82.0 m-85 -89.71 -16.53 30.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.739 0.304 . . . . 0.0 110.975 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.93 4.68 56.69 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.075 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 88' ' ' PHE . 33.1 mm -67.45 126.21 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -63.96 -60.81 2.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.068 0.461 . . . . 0.0 110.251 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.1 m -158.19 -84.3 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.943 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.51 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 8.8 pt -153.93 146.14 17.21 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.28 -167.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -105.2 147.57 1.18 Allowed 'Cis proline' 0 N--CA 1.461 -0.423 0 C-N-CA 124.833 -0.903 . . . . 0.0 111.405 -5.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.43 ' C ' HD11 ' A' ' 96' ' ' ILE . 18.9 t -131.74 138.39 48.61 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.43 HD11 ' C ' ' A' ' 95' ' ' SER . 3.0 mp -125.93 116.16 45.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.733 -177.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 37.4 tp -94.19 112.12 23.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.112 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -90.2 107.31 19.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.461 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 55.2 mt -96.92 109.47 49.09 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.318 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.536 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 84.9 Cg_endo -87.96 169.31 6.5 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.221 2.614 . . . . 0.0 112.422 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 89.7 mmm -96.4 3.03 53.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.56 0.695 . . . . 0.0 109.236 173.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -138.66 118.67 13.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.355 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.19 -141.36 15.51 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.52 176.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -120.78 151.0 53.94 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.536 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 17.2 Cg_exo -68.04 122.51 9.61 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.483 2.122 . . . . 0.0 112.05 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -90.79 160.68 15.64 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.415 ' HE1' HD11 ' A' ' 97' ' ' LEU . 18.4 ptp -141.79 144.35 33.91 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.213 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.3 145.84 49.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.231 174.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -72.15 137.23 46.83 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.34 -143.38 3.85 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 115.363 0.905 . . . . 0.0 115.363 -167.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.489 ' HB2' ' HB3' ' A' ' 52' ' ' PRO . . . 70.86 20.2 5.54 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.829 0.852 . . . . 0.0 110.403 -171.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.593 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 6.6 mtp -84.33 150.28 57.1 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.769 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.44 178.31 7.52 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.43 2.087 . . . . 0.0 111.141 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.45 ' HZ1' ' CD ' ' A' ' 66' ' ' GLU . 86.3 tttt -61.73 -26.29 67.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.05 0.452 . . . . 0.0 109.953 176.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.84 -52.38 20.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.043 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 18.8 m -68.61 -35.14 76.92 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.618 -177.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.489 ' O ' HG13 ' A' ' 121' ' ' ILE . 3.7 m-85 -64.77 -44.4 90.15 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.578 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -57.98 -48.81 78.87 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.87 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -57.42 -37.06 72.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.831 0.348 . . . . 0.0 110.772 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.42 -48.6 48.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.196 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 117' ' ' PHE . 56.8 mt -65.68 -52.1 54.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.237 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.42 -62.42 1.79 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.893 0.378 . . . . 0.0 110.942 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.675 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 18.2 mt-10 -64.25 -44.56 91.41 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -172.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -94.44 -35.16 12.45 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.217 -172.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.517 HD12 ' HB2' ' A' ' 40' ' ' PRO . 17.9 tp -89.02 -47.57 8.03 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.796 -175.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.8 mt -80.23 -58.92 2.91 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.675 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 25.1 ttpp . . . . . 0 N--CA 1.432 -1.355 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.505 ' CA ' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 CA--C 1.502 -0.738 0 N-CA-C 113.764 0.265 . . . . 0.0 113.764 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -124.8 172.32 9.42 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.9 p -142.2 132.36 24.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.119 0.485 . . . . 0.0 111.073 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.8 mm -131.45 124.95 55.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.544 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.624 ' CB ' ' HB2' ' A' ' 75' ' ' LYS . 6.0 p80 -82.81 116.13 22.01 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 172.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.472 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -116.99 179.73 3.94 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.464 -170.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.473 HG23 ' HE2' ' A' ' 80' ' ' LYS . 56.8 p -89.58 163.35 15.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.016 176.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.693 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 33.2 pttt -61.94 -24.1 66.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.681 175.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.3 -39.52 71.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.272 0.558 . . . . 0.0 110.08 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.472 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 10.4 mm-40 -65.89 -38.75 89.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.074 175.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -62.04 -51.26 68.73 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.965 0.888 . . . . 0.0 109.115 175.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.602 ' HG ' ' CE2' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -51.64 -60.73 2.83 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.466 -1.697 . . . . 0.0 111.733 -175.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.54 -24.17 45.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -168.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.412 ' HB3' ' HZ1' ' A' ' 22' ' ' LYS . 5.8 ttpm? -109.15 -23.33 11.69 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.5 t -121.33 -41.46 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -172.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.586 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 30.1 t80 -160.82 115.05 2.1 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.142 0.496 . . . . 0.0 111.011 -169.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.589 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -89.96 90.45 8.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.685 -175.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.602 ' CE2' ' HG ' ' A' ' 20' ' ' LEU . 28.6 p90 -85.26 20.68 1.9 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.417 0.627 . . . . 0.0 111.248 177.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.538 ' HG3' HD21 ' A' ' 20' ' ' LEU . 39.8 mt-10 -92.93 -47.33 7.07 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.483 ' HG3' ' ND2' ' A' ' 29' ' ' ASN . 18.3 ptmt -98.25 -11.09 23.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.412 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.614 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 9.9 m-80 -128.69 73.44 80.98 Favored Pre-proline 0 CA--C 1.515 -0.396 0 CA-C-O 121.686 0.755 . . . . 0.0 110.93 171.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -57.58 -43.47 50.48 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 123.744 2.962 . . . . 0.0 112.167 171.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -111.12 -31.5 7.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.016 -174.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.614 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -90.87 157.43 17.35 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.295 0.569 . . . . 0.0 111.317 -174.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.606 ' HB3' ' HZ2' ' A' ' 104' ' ' LYS . 40.7 t-105 -112.54 112.96 24.87 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.613 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -132.79 110.4 10.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.661 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -87.81 133.56 33.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.908 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -107.25 144.71 33.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 171.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.21 -122.58 1.48 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.798 -175.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.485 ' OD1' ' HG3' ' A' ' 39' ' ' LYS . 16.6 t70 -165.41 -61.38 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.117 0.484 . . . . 0.0 110.188 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.485 ' HG3' ' OD1' ' A' ' 38' ' ' ASP . 44.8 mttp -105.54 156.21 36.79 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.761 -173.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.518 ' HG2' HG22 ' A' ' 71' ' ' ILE . 6.0 Cg_endo -49.46 133.61 31.46 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.259 2.64 . . . . 0.0 111.999 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -118.51 146.67 44.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.438 -173.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.776 HD13 HD23 ' A' ' 125' ' ' LEU . 50.1 mm -115.71 136.5 52.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.718 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 17.5 t -120.69 120.28 62.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.061 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.665 ' HB2' HD12 ' A' ' 60' ' ' LEU . 13.5 t0 -94.26 103.55 15.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.754 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.402 ' HE1' ' HB2' ' A' ' 97' ' ' LEU . 80.8 m-85 -88.81 110.95 21.46 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 176.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.657 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.9 p90 -145.95 177.32 9.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.259 0.552 . . . . 0.0 111.456 -172.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.403 ' HB2' HD12 ' A' ' 93' ' ' ILE . . . -157.95 152.05 24.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.492 171.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -60.6 -44.83 95.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -173.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -69.4 -10.91 60.06 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -171.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.404 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 45.9 t -93.71 129.21 40.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.065 0.459 . . . . 0.0 110.838 -178.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.73 -60.5 7.66 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.811 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.535 ' HB3' ' HB1' ' A' ' 111' ' ' ALA . 81.6 Cg_exo -47.61 -35.66 23.23 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.315 2.676 . . . . 0.0 113.381 176.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.657 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 67.6 m -64.07 -50.64 67.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.985 0.422 . . . . 0.0 111.061 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -61.62 -28.11 69.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.006 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 84.3 mtp -66.97 -51.58 53.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.463 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.407 ' HB ' ' HZ ' ' A' ' 117' ' ' PHE . 30.0 m -77.29 -33.53 20.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -171.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.605 ' HB1' ' HD3' ' A' ' 58' ' ' PRO . . . -48.22 -56.64 13.2 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.605 ' HD3' ' HB1' ' A' ' 57' ' ' ALA . 21.7 Cg_exo -65.68 -35.72 35.92 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.057 1.838 . . . . 0.0 112.168 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.442 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 67.6 mt -64.19 -41.38 92.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.432 0.634 . . . . 0.0 109.536 176.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.665 HD12 ' HB2' ' A' ' 44' ' ' ASP . 7.6 mt -68.36 -33.49 74.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.454 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.439 ' OD1' HG13 ' A' ' 11' ' ' VAL . 58.9 m-20 -63.73 -42.66 97.85 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.661 0.743 . . . . 0.0 109.25 173.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.564 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 16.9 tp10 -57.09 -53.39 58.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.682 177.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.496 HD22 ' HG3' ' A' ' 114' ' ' LYS . 4.4 mm? -61.76 -31.91 72.13 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.626 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.487 ' HB2' HD13 ' A' ' 73' ' ' ILE . . . -58.49 -60.23 4.12 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.74 0.305 . . . . 0.0 110.921 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.564 ' HE3' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -75.17 -23.85 57.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.196 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.534 ' CD ' ' HZ1' ' A' ' 114' ' ' LYS . 32.1 tt0 -61.37 -38.57 87.48 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.246 0.546 . . . . 0.0 110.535 173.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.467 ' HD2' ' NE2' ' A' ' 70' ' ' GLN . 75.1 m-85 -103.67 27.1 7.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.298 178.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.52 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 6.7 t0 -48.43 134.42 15.18 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.366 -177.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.61 -33.84 4.79 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.658 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.467 ' NE2' ' HD2' ' A' ' 67' ' ' TYR . 14.1 mt-30 -86.53 -47.65 9.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.609 0.242 . . . . 0.0 111.384 -175.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.518 HG22 ' HG2' ' A' ' 40' ' ' PRO . 40.5 pt -125.1 164.01 24.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.186 0.517 . . . . 0.0 111.644 -175.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 60.3 t -128.27 127.78 67.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.3 175.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.755 HG12 ' HB ' ' A' ' 42' ' ' ILE . 46.7 mt -111.71 137.99 42.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.196 0.522 . . . . 0.0 111.118 -177.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -121.13 161.8 21.17 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.624 ' HB2' ' CB ' ' A' ' 13' ' ' HIS . 79.8 mttt -124.34 150.62 45.29 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.016 0.436 . . . . 0.0 110.034 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.696 HG13 ' HG2' ' A' ' 81' ' ' GLU . 2.8 t -127.95 126.13 65.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.025 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -90.33 89.64 7.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.659 HG21 ' HA ' ' A' ' 92' ' ' SER . 33.1 m -52.09 -30.04 24.23 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.215 -171.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -51.97 -34.23 41.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.76 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.473 ' HE2' HG23 ' A' ' 15' ' ' THR . 22.7 pttm -108.27 -20.89 12.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.207 0.527 . . . . 0.0 110.348 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.696 ' HG2' HG13 ' A' ' 76' ' ' VAL . 1.5 mp0 -91.18 40.99 1.05 Allowed 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.572 0.749 . . . . 0.0 111.67 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -55.6 -53.6 54.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.444 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.566 ' CD ' ' HZ2' ' A' ' 16' ' ' LYS . 2.6 mp0 -62.85 -36.39 83.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.631 -178.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.6 tp -64.1 -43.33 95.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.541 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.558 ' HB2' ' HB ' ' A' ' 90' ' ' ILE . . . -65.25 -47.15 77.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.669 175.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.88 -33.93 80.66 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.87 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.54 -35.18 77.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 111.402 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.516 ' HB3' ' HE2' ' A' ' 107' ' ' MET . 92.0 m-85 -95.3 4.06 53.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.941 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.16 10.17 85.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.867 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 85' ' ' ALA . 6.4 mt -69.72 143.01 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -72.09 -48.17 46.0 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.659 ' HA ' HG21 ' A' ' 78' ' ' THR . 15.0 p 179.69 -80.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.712 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.56 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 16.7 pt -149.2 149.83 30.43 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.107 -172.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.433 ' HG3' ' HB2' ' A' ' 52' ' ' PRO . 10.7 Cg_endo -101.2 150.27 3.44 Favored 'Cis proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.649 -0.979 . . . . 0.0 112.046 -3.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.6 t -138.95 136.66 35.65 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 107' ' ' MET . 15.3 mm -114.55 113.42 43.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.718 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 41.5 tp -94.58 119.44 33.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.03 0.443 . . . . 0.0 110.689 -175.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -100.72 107.89 19.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.424 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.13 108.12 50.62 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.393 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -84.65 168.77 11.02 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.744 2.296 . . . . 0.0 112.098 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 86.5 mtp -87.23 -12.34 47.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.503 0.668 . . . . 0.0 110.155 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -140.09 127.05 20.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.581 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.67 -151.93 18.19 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.227 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.606 ' HZ2' ' HB3' ' A' ' 33' ' ' TRP . 29.3 mmmt -115.4 155.13 47.46 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.43 ' HD3' ' CD1' ' A' ' 33' ' ' TRP . 92.3 Cg_endo -81.79 144.5 13.84 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.505 2.136 . . . . 0.0 112.302 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.2 169.92 8.67 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.318 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.527 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 22.3 ptp -142.19 121.33 12.98 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.775 0.798 . . . . 0.0 111.41 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.54 128.38 49.21 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -67.52 150.95 48.17 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.317 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.96 -162.99 2.27 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.559 -0.746 . . . . 0.0 114.753 -168.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.535 ' HB1' ' HB3' ' A' ' 52' ' ' PRO . . . 75.84 17.24 2.29 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.164 0.985 . . . . 0.0 111.55 -176.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.619 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 73.0 mtm -86.75 144.31 36.95 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.85 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 71.7 Cg_endo -75.43 178.92 6.72 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.567 2.178 . . . . 0.0 110.5 172.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.534 ' HZ1' ' CD ' ' A' ' 66' ' ' GLU . 64.3 tttm -62.06 -27.83 69.18 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.75 -45.89 63.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.037 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.619 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 50.7 m -70.62 -30.14 66.71 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.184 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.519 ' O ' HG13 ' A' ' 121' ' ' ILE . 13.7 m-85 -64.08 -52.44 59.27 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.172 172.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.455 ' O ' ' HD3' ' A' ' 118' ' ' LYS . 11.6 tmtt? -58.53 -38.32 77.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.83 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.489 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -56.59 -52.29 65.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.894 176.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.05 -43.28 68.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.853 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 117' ' ' PHE . 58.6 mt -62.97 -44.16 99.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 109.965 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -62.88 -68.4 0.34 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.596 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.792 ' HA ' ' HE2' ' A' ' 127' ' ' LYS . 3.8 tt0 -80.06 11.06 3.65 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.836 -163.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -143.17 -47.51 0.31 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.614 177.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.776 HD23 HD13 ' A' ' 42' ' ' ILE . 28.4 tp -79.44 -38.86 33.7 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.139 -174.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.2 mt -98.54 -47.91 5.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.666 0.746 . . . . 0.0 109.923 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.792 ' HE2' ' HA ' ' A' ' 123' ' ' GLU . 19.0 ttpt . . . . . 0 C--N 1.316 -0.872 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.693 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.504 ' CA ' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.229 0 N-CA-C 113.541 0.176 . . . . 0.0 113.541 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.42 ' HZ1' ' CG ' ' A' ' 61' ' ' ASP . 50.5 tttp -162.74 166.55 24.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.757 0.279 . . . . 0.0 110.295 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.527 HG21 HG23 ' A' ' 73' ' ' ILE . 9.0 p -98.85 133.59 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.495 0.664 . . . . 0.0 111.029 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 73.8 mt -111.61 122.25 65.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.732 177.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.449 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 2.2 p80 -91.84 119.36 31.57 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.589 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.2 pp -138.8 168.17 20.4 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.677 -178.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.9 p -94.25 176.61 6.25 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.396 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.551 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 13.8 pttm -57.21 -24.83 57.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 177.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.53 -47.43 69.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.308 0.575 . . . . 0.0 109.727 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 3.9 mp0 -71.13 -33.87 70.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.109 176.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -59.41 -47.9 83.68 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 122.195 0.997 . . . . 0.0 109.151 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -50.26 -59.35 4.04 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 113.155 -1.838 . . . . 0.0 111.046 -179.545 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.0 -45.03 36.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -89.04 -7.85 55.12 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.027 -168.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 62.1 t -134.52 -54.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.506 -0.477 . . . . 0.0 112.252 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 11.8 t80 -169.63 126.12 0.87 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.268 0.556 . . . . 0.0 112.025 -164.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.513 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -82.46 89.91 6.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.71 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.475 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 34.8 p90 -81.96 10.71 6.02 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.381 0.61 . . . . 0.0 111.092 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -107.78 -47.63 3.56 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.769 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -89.26 -28.31 20.0 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.29 -178.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.649 HD21 ' C ' ' A' ' 28' ' ' LYS . 0.7 OUTLIER -121.15 62.94 11.77 Favored Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.933 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -59.43 -35.73 95.52 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.706 2.271 . . . . 0.0 112.076 175.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.498 ' HG3' ' HG2' ' A' ' 32' ' ' GLU . 16.0 pt-20 -98.26 -23.77 15.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.47 -176.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.498 ' HG2' ' HG3' ' A' ' 31' ' ' GLU . 34.5 mm-40 -100.99 155.0 18.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.832 0.349 . . . . 0.0 110.982 -174.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.503 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 76.2 t-105 -105.71 92.07 4.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.205 0.526 . . . . 0.0 110.009 175.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.593 ' HG3' ' OE2' ' A' ' 36' ' ' GLU . 25.3 tptp -100.95 104.63 15.81 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 21.8 t80 -107.97 118.49 36.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.568 -177.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.593 ' OE2' ' HG3' ' A' ' 34' ' ' LYS . 12.9 mm-40 -86.32 87.76 7.49 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' A' ' 35' ' ' TYR . . . -106.89 129.19 9.59 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.142 -1.028 . . . . 0.0 114.306 -169.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -87.94 -53.32 4.8 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 170.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.544 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 47.1 mttp -126.16 171.52 7.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 172.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 9.1 Cg_endo -54.74 144.92 63.19 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.486 2.124 . . . . 0.0 111.283 170.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -128.04 155.88 43.64 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -170.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.844 ' HB ' HG21 ' A' ' 73' ' ' ILE . 21.4 mm -125.87 147.05 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.462 173.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 66.4 t -133.6 119.41 33.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 118.782 0.719 . . . . 0.0 111.412 176.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.58 113.38 26.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.636 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.562 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 69.7 m-85 -94.05 111.51 23.23 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 172.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.675 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.2 p90 -141.21 -177.1 4.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.342 0.591 . . . . 0.0 110.968 -172.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.47 139.3 25.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.614 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -61.39 -37.7 84.39 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -174.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -66.99 -16.31 64.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.008 0.432 . . . . 0.0 111.301 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.2 t -88.21 116.48 26.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.515 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.33 -53.9 37.86 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.758 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -48.07 -37.85 31.08 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.909 2.406 . . . . 0.0 113.214 175.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.675 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 93.0 m -66.75 -48.03 70.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.395 0.617 . . . . 0.0 110.475 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 mttp -53.59 -30.79 44.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.646 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 76.2 mtp -64.59 -49.1 72.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.993 0.425 . . . . 0.0 111.439 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.465 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 35.1 m -79.54 -27.9 12.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.757 -171.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.532 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -50.31 -59.97 6.15 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 55.7 Cg_endo -71.15 -40.76 3.02 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.733 1.622 . . . . 0.0 112.495 -177.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.401 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 64.4 mt -64.99 -51.63 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.331 -176.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.577 HD11 HG22 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -68.25 -29.9 68.82 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.487 -176.722 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.522 ' OD1' HG11 ' A' ' 11' ' ' VAL . 23.4 t70 -61.75 -40.21 94.29 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.423 0.63 . . . . 0.0 109.775 172.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 59' ' ' ILE . 8.5 tm-20 -63.31 -41.01 98.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.321 176.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 114' ' ' LYS . 3.1 mm? -58.71 -36.7 74.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.926 0.393 . . . . 0.0 110.699 174.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.526 ' HA ' HD12 ' A' ' 71' ' ' ILE . . . -60.97 -37.94 84.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.315 177.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 5.4 tmtm? -75.67 -33.12 60.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.527 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -55.32 -44.62 76.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.424 0.63 . . . . 0.0 109.931 172.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.58 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 48.0 m-85 -99.36 27.32 5.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.68 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.552 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 15.4 t0 -49.93 129.71 20.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.499 -177.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.49 -30.87 9.46 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.451 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 2.8 pt20 -106.86 -21.27 13.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 64' ' ' ALA . 30.6 pt -125.22 155.95 34.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.185 0.517 . . . . 0.0 112.059 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 40.5 t -127.96 129.93 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.348 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.844 HG21 ' HB ' ' A' ' 42' ' ' ILE . 24.8 mt -117.18 142.34 31.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 41.9 m-85 -124.47 158.57 32.53 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.469 ' HZ2' ' HB3' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -148.52 150.45 33.4 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 175.006 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.94 HG23 ' HG3' ' A' ' 81' ' ' GLU . 2.8 p -141.21 156.55 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.555 -173.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 10.8 m-20 -96.38 90.95 5.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.368 -175.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.459 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 10.2 m -50.05 -34.79 22.72 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -173.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -53.78 -41.04 66.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.98 0.419 . . . . 0.0 111.768 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 13.3 ptpt -94.57 -20.36 19.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.807 0.813 . . . . 0.0 109.344 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.94 ' HG3' HG23 ' A' ' 76' ' ' VAL . 10.3 mm-40 -98.2 39.71 1.22 Allowed 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.442 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -66.85 -30.98 71.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.625 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.55 -39.59 70.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.478 0.656 . . . . 0.0 109.243 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 33.4 tp -68.56 -37.8 80.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.832 176.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.583 ' HA ' HD11 ' A' ' 90' ' ' ILE . . . -63.9 -44.81 91.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.816 176.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.79 -29.16 66.85 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.92 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.29 -33.39 75.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.338 . . . . 0.0 111.444 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.573 ' HB2' HG13 ' A' ' 90' ' ' ILE . 91.2 m-85 -103.15 6.53 38.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.774 0.321 . . . . 0.0 110.626 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.39 33.67 87.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.862 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.583 HD11 ' HA ' ' A' ' 85' ' ' ALA . 41.9 mt -71.14 133.39 31.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.97 0.414 . . . . 0.0 110.745 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.474 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 0.4 OUTLIER -70.18 -51.41 31.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.096 178.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.9 p 175.39 -99.65 0.0 OUTLIER 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.145 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 26.6 pt -147.55 143.01 17.36 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.708 -172.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.697 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 11.9 Cg_exo -81.95 149.25 71.77 Favored 'Cis proline' 0 N--CA 1.474 0.368 0 C-N-CA 124.934 -0.861 . . . . 0.0 111.921 -3.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.562 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 14.5 m -140.19 128.28 22.26 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 107' ' ' MET . 52.5 mt -127.94 122.66 59.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.837 0.351 . . . . 0.0 110.603 -174.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.531 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 32.8 tp -104.81 122.13 45.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.397 -177.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.5 ' HZ ' ' HE2' ' A' ' 112' ' ' MET . 73.3 m-85 -100.07 111.35 23.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 54.9 mt -109.51 113.62 57.97 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -170.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -85.0 159.97 11.66 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.096 2.531 . . . . 0.0 111.621 172.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 86.1 mtp -80.28 -35.99 35.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -118.87 122.54 42.56 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.469 0.652 . . . . 0.0 109.54 173.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.0 -171.19 13.65 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -174.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.503 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 8.9 mmmm -117.97 150.31 47.07 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 117.335 0.567 . . . . 0.0 110.083 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.24 148.11 21.06 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.933 2.422 . . . . 0.0 114.216 -173.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -111.09 169.3 8.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.279 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 46.5 ttm -134.59 124.9 26.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.057 0.456 . . . . 0.0 111.695 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.88 157.71 21.09 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.442 ' HG2' ' HA ' ' A' ' 95' ' ' SER . 39.4 mt-30 -131.38 141.12 49.82 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.715 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.697 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 115.46 177.87 18.56 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.507 -0.77 . . . . 0.0 114.125 172.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.465 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -87.75 86.07 7.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.281 0.562 . . . . 0.0 111.227 -175.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.609 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 72.6 mtm -78.93 136.89 57.78 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.828 175.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 98.9 Cg_endo -75.46 -171.65 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.846 2.364 . . . . 0.0 111.792 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.523 ' HA ' HD23 ' A' ' 63' ' ' LEU . 13.8 tttm -57.97 -37.12 73.61 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.5 -50.59 62.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.326 -175.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.609 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 45.0 m -70.1 -37.47 75.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.926 -177.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.636 ' O ' HG13 ' A' ' 121' ' ' ILE . 4.6 m-85 -64.89 -44.51 89.41 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.829 176.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.527 ' C ' ' HD3' ' A' ' 118' ' ' LYS . 11.3 tmtt? -53.83 -47.68 70.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.673 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -65.15 -38.08 89.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.754 -177.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.06 78.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.257 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 117' ' ' PHE . 23.1 mt -74.19 -55.23 12.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.884 0.373 . . . . 0.0 110.821 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.507 ' HA ' HD11 ' A' ' 126' ' ' LEU . 12.4 t70 -71.43 -65.54 0.74 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.687 0.28 . . . . 0.0 111.623 -176.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.417 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 32.8 mt-10 -75.82 -4.76 42.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -166.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -128.04 -38.61 1.81 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.564 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 40.5 tp -88.87 -43.2 11.38 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.887 -0.508 . . . . 0.0 110.742 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.507 HD11 ' HA ' ' A' ' 122' ' ' ASP . 81.8 mt -82.92 -58.49 2.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.415 0.626 . . . . 0.0 109.68 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 12.7 ttpp . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.588 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.827 ' HA ' ' HZ1' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -152.98 151.47 30.33 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 121.519 0.676 . . . . 0.0 111.865 -172.42 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 5.1 p -103.79 108.18 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.006 168.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 63.0 mt -88.99 123.76 41.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.721 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.677 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 2.3 p80 -88.86 133.26 34.33 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.796 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.573 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 1.7 pp -140.65 172.8 12.21 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.887 -174.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.7 p -106.17 178.35 4.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.357 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.541 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 14.2 ptmm? -55.32 -35.72 65.45 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.83 -38.64 79.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.232 0.539 . . . . 0.0 110.286 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.573 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 2.6 mm-40 -71.0 -35.74 72.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.142 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -64.05 -48.34 76.67 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.78 0.8 . . . . 0.0 109.116 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.624 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.7 tt -50.82 -60.77 2.72 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.265 -178.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.6 -18.91 39.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -168.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -108.5 -12.71 14.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.972 0.415 . . . . 0.0 111.397 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 57.6 t -135.85 -55.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -174.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.64 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 9.7 t80 -167.09 122.53 1.09 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.261 0.553 . . . . 0.0 111.7 -164.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 1.8 t-20 -86.74 89.68 8.03 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.031 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.64 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 10.5 p90 -89.4 0.37 56.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.379 -174.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.541 ' CD ' ' HZ2' ' A' ' 16' ' ' LYS . 48.9 mt-10 -104.98 -22.1 13.18 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.976 ' HE3' HD22 ' A' ' 29' ' ' ASN . 3.7 ttpp -105.96 -26.04 11.85 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.409 167.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.976 HD22 ' HE3' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -119.12 67.97 9.03 Favored Pre-proline 0 N--CA 1.471 0.591 0 CA-C-O 120.886 0.374 . . . . 0.0 111.635 -178.132 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.77 -34.66 39.56 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.92 2.413 . . . . 0.0 111.527 167.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -97.52 -30.6 12.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.841 -177.534 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 22.9 mt-10 -91.36 128.6 37.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.063 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.497 ' CZ2' ' HG3' ' A' ' 105' ' ' PRO . 72.8 t-105 -91.16 103.44 16.12 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.784 172.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -107.93 134.66 50.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.56 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 37.3 t80 -133.0 96.72 3.83 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.82 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -90.32 31.43 1.01 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.51 -174.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.5 135.25 12.69 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.421 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.6 -41.47 92.77 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.19 0.519 . . . . 0.0 111.081 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -125.32 158.79 62.74 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.548 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.621 ' HB3' HD13 ' A' ' 125' ' ' LEU . 50.3 Cg_exo -54.64 140.22 76.2 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.362 2.041 . . . . 0.0 111.157 173.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -124.44 152.37 43.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.669 0.747 . . . . 0.0 112.391 -172.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.8 mt -117.95 114.17 44.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.128 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 21.4 t -99.78 120.26 48.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.397 -175.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.663 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 21.8 t70 -103.69 111.12 23.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.57 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -83.45 111.94 19.5 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 172.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.676 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.8 p90 -132.58 158.23 42.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.775 0.798 . . . . 0.0 112.031 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.506 ' CB ' HG12 ' A' ' 93' ' ' ILE . . . -133.4 108.85 8.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.244 -1.343 . . . . 0.0 107.706 167.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.544 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 33.9 t70 -55.4 -31.03 61.49 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -167.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 59.6 p-90 -69.95 -1.43 9.63 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.663 ' HB3' ' HG ' ' A' ' 53' ' ' CYS . 27.9 t -114.14 137.03 52.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.933 0.397 . . . . 0.0 110.627 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.4 -57.46 18.47 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 115.612 -0.722 . . . . 0.0 114.669 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.618 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 84.1 Cg_exo -47.37 -37.49 25.19 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.158 2.572 . . . . 0.0 113.636 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.676 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 30.1 m -64.11 -50.36 68.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.334 0.588 . . . . 0.0 111.022 177.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 66.7 mttm -58.23 -28.59 65.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.339 174.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.431 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 53.2 mmm -70.63 -50.77 33.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.794 0.33 . . . . 0.0 111.398 176.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.84 -38.73 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -172.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.59 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . . . -49.17 -54.49 28.58 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.59 ' HD3' ' HB2' ' A' ' 57' ' ' ALA . 15.8 Cg_exo -68.44 -42.67 5.01 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.212 1.941 . . . . 0.0 112.032 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.544 HD11 ' HA ' ' A' ' 113' ' ' PRO . 74.3 mt -57.26 -44.03 83.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.302 0.572 . . . . 0.0 110.497 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.524 ' CD1' ' HB2' ' A' ' 44' ' ' ASP . 5.8 mt -68.37 -35.15 77.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.621 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.535 ' OD1' HG13 ' A' ' 11' ' ' VAL . 14.7 t70 -68.02 -35.53 78.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.134 0.493 . . . . 0.0 109.69 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.602 ' HA ' ' HD2' ' A' ' 65' ' ' LYS . 13.9 mm-40 -54.09 -44.63 71.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.768 172.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.448 HD12 ' HG3' ' A' ' 114' ' ' LYS . 11.1 mp -65.4 -30.89 71.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.727 0.298 . . . . 0.0 110.833 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.409 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -61.7 -53.2 59.35 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.657 -178.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.602 ' HD2' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -76.09 -24.97 55.06 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.795 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' CD ' ' HZ1' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -73.33 -42.73 61.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.88 0.372 . . . . 0.0 111.478 178.795 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -107.26 26.95 9.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.684 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.48 159.8 7.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.353 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.2 -52.89 4.13 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.262 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.728 HE22 HD11 ' A' ' 126' ' ' LEU . 10.2 pt20 -80.96 -33.77 33.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.495 0.188 . . . . 0.0 111.049 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.527 HG23 ' HB2' ' A' ' 40' ' ' PRO . 42.2 pt -131.77 156.49 42.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.088 0.47 . . . . 0.0 111.763 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 86.8 t -124.28 136.49 60.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.647 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 21.9 mt -108.74 139.23 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.337 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -125.71 166.93 15.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.706 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.691 ' HB3' ' HZ1' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -147.75 148.89 31.45 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 171.097 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.498 HG21 HD21 ' A' ' 84' ' ' LEU . 8.1 p -121.17 138.24 52.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.116 0.484 . . . . 0.0 110.524 -175.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.563 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -72.84 85.69 1.25 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.427 179.402 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.562 HG23 ' HB3' ' A' ' 85' ' ' ALA . 17.3 m -66.38 -31.77 72.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -167.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.9 -27.23 68.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.609 0.242 . . . . 0.0 111.199 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.491 ' NZ ' ' HB3' ' A' ' 77' ' ' ASP . 8.6 ptpp? -99.79 -37.18 9.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.898 0.38 . . . . 0.0 110.108 175.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -78.86 39.63 0.37 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.36 0.664 . . . . 0.0 110.972 174.037 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -59.16 -43.98 92.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.529 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -65.15 -35.41 81.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.301 0.572 . . . . 0.0 110.379 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.498 HD21 HG21 ' A' ' 76' ' ' VAL . 14.8 tp -67.58 -48.94 65.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.322 177.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.562 ' HB3' HG23 ' A' ' 78' ' ' THR . . . -62.95 -36.28 82.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.915 0.388 . . . . 0.0 111.196 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.29 -27.75 71.18 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.777 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.37 -22.57 66.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.982 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -101.0 0.8 38.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.513 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.79 6.26 89.13 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.008 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.0 mm -68.72 130.29 33.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.514 0.197 . . . . 0.0 110.519 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -59.27 -55.79 30.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.61 0.719 . . . . 0.0 110.394 176.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.538 ' O ' HG21 ' A' ' 78' ' ' THR . 14.2 t -167.48 -88.15 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.902 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.519 HG23 ' C ' ' A' ' 46' ' ' TYR . 2.3 pp -152.5 157.47 33.61 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -173.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.531 ' HG3' ' HB2' ' A' ' 52' ' ' PRO . 10.9 Cg_endo -99.42 148.06 4.51 Favored 'Cis proline' 0 N--CA 1.458 -0.571 0 C-N-CA 124.365 -1.098 . . . . 0.0 112.018 -3.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.8 t -139.89 142.51 36.5 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.73 128.03 71.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.465 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.573 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.5 tp -106.14 116.85 32.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.077 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 105' ' ' PRO . 20.0 m-85 -93.74 107.4 19.28 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.43 HG12 ' HB3' ' A' ' 105' ' ' PRO . 42.5 mt -110.11 109.78 58.8 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -173.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.73 165.91 13.62 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.402 2.734 . . . . 0.0 111.144 170.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.462 ' HG2' ' HE2' ' A' ' 35' ' ' TYR . 82.7 mtp -97.0 -34.17 11.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.712 0.768 . . . . 0.0 109.304 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -96.83 2.81 52.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.363 -176.183 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -137.45 -156.33 7.21 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.051 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 60.6 mmtt -126.34 154.43 74.76 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.497 ' HG3' ' CZ2' ' A' ' 33' ' ' TRP . 98.3 Cg_endo -78.21 148.26 24.06 Favored 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.677 2.251 . . . . 0.0 114.168 -169.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.493 ' HG2' ' N ' ' A' ' 107' ' ' MET . 34.9 tt0 -119.33 163.25 17.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.716 172.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.493 ' N ' ' HG2' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -142.51 137.98 30.6 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.372 0.606 . . . . 0.0 111.766 -177.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -133.98 156.77 47.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.622 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -75.41 148.52 39.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.15 -144.06 6.82 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.743 -0.742 . . . . 0.0 113.804 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 71.99 20.86 4.26 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.435 0.694 . . . . 0.0 111.883 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.553 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 20.3 ptt? -112.37 153.7 44.73 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.529 177.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.544 ' HA ' HD11 ' A' ' 59' ' ' ILE . 93.6 Cg_endo -76.58 -177.56 3.83 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.13 2.553 . . . . 0.0 113.05 -173.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.473 ' HZ1' ' CD ' ' A' ' 66' ' ' GLU . 38.8 ttmt -61.77 -29.39 70.1 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.024 174.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.497 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . -64.72 -47.38 78.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.215 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.553 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 18.6 m -70.88 -38.45 73.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.881 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.439 ' HB3' HD23 ' A' ' 63' ' ' LEU . 9.0 m-85 -65.41 -40.83 93.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.305 177.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.67 ' O ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -57.31 -37.24 72.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.741 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.583 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 43.2 mmtm -65.88 -57.96 6.69 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.252 175.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.51 -46.78 86.04 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -174.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.8 mp -64.37 -48.09 86.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.666 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.4 ' HA ' HD21 ' A' ' 126' ' ' LEU . 3.8 t0 -66.37 -50.27 64.07 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.841 -178.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.583 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 4.0 mm-40 -54.98 -30.2 58.78 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -174.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -115.45 -35.98 4.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.964 0.411 . . . . 0.0 111.854 -172.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.621 HD13 ' HB3' ' A' ' 40' ' ' PRO . 20.0 tp -90.6 -47.26 7.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.88 -174.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.728 HD11 HE22 ' A' ' 70' ' ' GLN . 3.8 mm? -87.51 -53.43 4.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.261 0.553 . . . . 0.0 110.377 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.749 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.865 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 175.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.619 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . . . . . . 0 N--CA 1.448 -0.52 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.717 ' HE2' HD11 ' A' ' 12' ' ' ILE . 84.3 tttt -151.19 138.89 19.73 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -172.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 10.5 p -110.95 132.13 60.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.128 0.489 . . . . 0.0 110.693 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.717 HD11 ' HE2' ' A' ' 10' ' ' LYS . 36.9 mm -120.95 117.15 52.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.096 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.428 ' CB ' ' HG3' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -84.83 121.36 27.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 171.248 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.706 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.3 pp -120.68 178.27 4.76 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.751 -170.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.45 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -107.86 172.84 6.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.637 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 10.8 ptpt -54.68 -37.31 65.61 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.92 85.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.106 0.479 . . . . 0.0 110.971 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.706 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 30.8 mm-40 -71.97 -39.46 69.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.455 177.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -63.36 -50.24 70.72 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.163 0.983 . . . . 0.0 109.065 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -47.06 -60.95 2.12 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.152 -1.84 . . . . 0.0 112.232 -178.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.06 -28.14 27.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.799 -170.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 24.2 ttpt -110.56 1.5 18.17 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.933 0.397 . . . . 0.0 111.704 -170.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 40.7 t -141.46 -47.76 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 22.6 t80 -167.41 119.61 0.91 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.122 0.487 . . . . 0.0 111.737 -167.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -93.67 91.93 7.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.102 -178.374 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 2.9 p90 -80.41 8.9 6.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.309 0.576 . . . . 0.0 111.532 -177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -91.91 -50.15 5.86 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.046 176.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.617 ' C ' HD21 ' A' ' 29' ' ' ASN . 14.9 pttm -89.66 -15.45 32.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.647 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -123.33 68.79 39.52 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.505 174.786 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -59.5 -37.26 90.23 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.996 2.464 . . . . 0.0 112.447 173.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.85 -35.57 4.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -173.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.643 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 4.6 tp10 -90.96 153.71 19.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.038 0.447 . . . . 0.0 110.417 -176.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.641 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 33.4 t-105 -103.1 113.85 27.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.612 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -125.03 110.88 14.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.759 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.637 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 37.9 t80 -76.18 114.59 15.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.194 177.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -94.22 71.21 3.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.862 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.637 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -143.74 -139.76 3.56 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.522 -175.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -149.27 -42.47 0.14 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 111.892 -173.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 70' ' ' GLN . 35.2 mttp -126.14 165.65 26.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.245 -175.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.595 ' HD3' ' SD ' ' A' ' 101' ' ' MET . 10.3 Cg_endo -52.88 132.31 46.34 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.452 2.102 . . . . 0.0 111.237 177.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -124.42 149.97 46.15 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.174 0.512 . . . . 0.0 111.572 -172.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.504 ' HB ' HG12 ' A' ' 73' ' ' ILE . 75.7 mt -127.17 134.01 66.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 175.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 60.5 t -125.28 112.42 31.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.022 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.532 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 8.5 p-10 -102.28 114.12 28.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.962 0.887 . . . . 0.0 111.266 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.417 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 42.0 m-85 -80.3 112.55 17.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.884 172.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.691 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.9 p90 -127.39 159.91 33.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.376 0.608 . . . . 0.0 110.759 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.448 ' N ' HG23 ' A' ' 93' ' ' ILE . . . -130.86 122.99 28.04 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 170.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.571 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 15.8 t70 -66.06 -26.18 67.38 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.803 -169.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -75.78 -2.88 31.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.994 0.426 . . . . 0.0 111.17 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.859 ' HB3' ' HG ' ' A' ' 53' ' ' CYS . 32.6 t -108.28 122.34 46.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.197 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.28 -55.28 25.26 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.638 -0.71 . . . . 0.0 114.792 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.496 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 82.5 Cg_exo -47.2 -41.14 27.6 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.206 2.604 . . . . 0.0 113.786 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.859 ' HG ' ' HB3' ' A' ' 50' ' ' CYS . 3.0 m -63.63 -37.75 88.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.291 0.567 . . . . 0.0 110.921 -177.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.571 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 67.0 mttm -61.46 -28.61 69.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.071 176.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.453 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 76.6 mtp -65.57 -48.44 72.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.875 0.369 . . . . 0.0 111.573 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 96' ' ' ILE . 12.8 p -77.59 -32.33 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -169.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.447 ' HB1' ' HD3' ' A' ' 58' ' ' PRO . . . -48.02 -57.34 10.56 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.447 ' HD3' ' HB1' ' A' ' 57' ' ' ALA . 43.1 Cg_endo -69.21 -35.31 14.51 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.911 1.74 . . . . 0.0 112.702 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.6 mt -63.74 -50.86 76.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.686 HD23 HD11 ' A' ' 73' ' ' ILE . 5.6 mt -60.74 -36.09 78.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.361 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -62.03 -50.35 72.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.053 0.454 . . . . 0.0 110.673 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.13 -43.97 98.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.481 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 63' ' ' LEU . 3.8 mm? -62.63 -32.48 73.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.112 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.619 ' O ' ' HA2' ' A' ' 9' ' ' GLY . . . -63.17 -53.55 51.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.345 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 8.8 tmtm? -67.4 -34.28 76.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.644 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -58.63 -47.03 85.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.187 0.518 . . . . 0.0 110.274 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -95.04 26.33 3.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.102 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -47.12 136.56 8.69 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.918 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.23 -23.98 17.18 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.75 176.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.54 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 12.5 pt20 -125.88 -49.02 1.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.527 HG22 ' HG3' ' A' ' 70' ' ' GLN . 43.0 pt -95.15 148.59 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.327 0.584 . . . . 0.0 112.188 -173.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 39.8 t -128.26 125.26 63.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.098 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.686 HD11 HD23 ' A' ' 60' ' ' LEU . 27.8 mt -109.24 131.44 60.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.308 0.575 . . . . 0.0 111.379 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.5 m-85 -116.94 156.85 26.71 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.596 ' HB3' ' HZ3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -136.07 148.29 48.24 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.452 175.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.559 HG11 ' HG2' ' A' ' 81' ' ' GLU . 20.8 t -117.11 126.39 74.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.536 -171.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.537 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 4.7 m-20 -83.4 95.42 8.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 92' ' ' SER . 16.6 p -55.56 -35.66 65.98 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -171.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -54.76 -29.94 55.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.353 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 54.6 pttt -103.14 -32.85 9.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.56 0.695 . . . . 0.0 109.726 178.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.559 ' HG2' HG11 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -88.73 41.97 1.05 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.155 -179.016 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.1 -49.58 77.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.904 -176.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.19 -36.46 81.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.934 0.397 . . . . 0.0 110.232 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.04 -53.12 58.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.951 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.14 -40.01 93.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.688 178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.84 -28.26 72.41 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.704 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.81 -32.8 74.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.807 0.336 . . . . 0.0 110.963 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -89.29 0.75 56.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.933 0.397 . . . . 0.0 110.698 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.33 8.68 84.85 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.974 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.0 mm -75.01 130.21 36.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 122.341 0.257 . . . . 0.0 110.74 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -66.37 -64.28 0.89 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.221 0.534 . . . . 0.0 110.093 175.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.412 ' O ' HG23 ' A' ' 78' ' ' THR . 29.7 m -155.72 -90.3 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.589 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.51 HG13 ' SG ' ' A' ' 53' ' ' CYS . 0.2 OUTLIER -146.56 161.35 38.51 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.43 -172.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.732 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.1 Cg_exo -87.98 148.08 30.05 Favored 'Cis proline' 0 C--N 1.345 0.346 0 C-N-CA 124.507 -1.039 . . . . 0.0 111.705 -4.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 9.5 m -140.39 122.78 16.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.549 HD11 ' HZ ' ' A' ' 117' ' ' PHE . 64.5 mt -124.25 116.68 48.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.311 -175.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' A' ' 105' ' ' PRO . 39.3 tp -100.38 124.09 45.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.718 -176.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -100.05 105.59 17.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.722 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.488 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 45.8 mt -100.99 108.36 54.07 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.055 -175.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -87.46 169.24 7.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.815 2.343 . . . . 0.0 112.235 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.595 ' SD ' ' HD3' ' A' ' 40' ' ' PRO . 84.2 mtp -93.89 1.0 56.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.654 0.74 . . . . 0.0 109.427 175.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -139.39 102.95 4.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.025 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.11 -153.76 16.76 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.561 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.641 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 15.4 tptt -112.35 153.63 44.75 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.516 ' HB2' HD13 ' A' ' 97' ' ' LEU . 5.7 Cg_exo -79.41 144.89 18.35 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.028 2.485 . . . . 0.0 112.781 -176.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -107.99 168.3 9.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.522 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.428 ' HE1' HD12 ' A' ' 97' ' ' LEU . 49.3 ttm -142.48 139.1 31.4 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.939 0.4 . . . . 0.0 111.44 -174.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -126.9 137.78 53.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.566 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -100.12 123.4 44.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.02 0.438 . . . . 0.0 110.772 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.732 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 126.58 -169.02 18.56 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.268 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.24 80.01 1.4 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.601 0.715 . . . . 0.0 110.721 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.637 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 5.0 mpp? -59.05 144.47 82.48 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.626 174.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.29 -175.96 2.83 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.891 2.394 . . . . 0.0 112.14 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -56.6 -39.63 73.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.465 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.75 -51.15 66.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.096 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.637 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 33.1 m -68.17 -29.13 67.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.75 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.641 ' O ' HG12 ' A' ' 121' ' ' ILE . 10.6 m-85 -75.41 -39.1 59.42 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.293 176.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -53.88 -37.46 63.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.035 0.445 . . . . 0.0 110.388 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 45.3 tttp -69.06 -46.34 68.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.354 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.79 -44.46 81.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.049 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.641 HG12 ' O ' ' A' ' 117' ' ' PHE . 17.4 mm -74.0 -50.57 27.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.736 0.303 . . . . 0.0 111.098 -174.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 126' ' ' LEU . 11.9 t70 -68.37 -60.93 2.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.014 0.435 . . . . 0.0 110.808 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.824 ' HA ' ' HD2' ' A' ' 127' ' ' LYS . 22.2 mt-10 -75.73 -9.69 58.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.164 -167.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -127.69 -39.54 1.81 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.25 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 125' ' ' LEU . 3.3 tp -91.01 -32.42 15.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 23.8 tp -84.01 -65.26 1.03 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.824 ' HD2' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.747 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 167.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 65' ' ' LYS . . . . . . . . 0 CA--C 1.51 -0.279 0 N-CA-C 115.426 0.93 . . . . 0.0 115.426 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -169.6 173.06 6.56 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.906 0.86 . . . . 0.0 113.03 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 12.9 m -100.43 110.67 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 113.469 -1.696 . . . . 0.0 109.57 171.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.401 HD12 ' CE2' ' A' ' 74' ' ' TYR . 47.2 mt -83.84 103.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.113 -175.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -75.63 112.12 11.66 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 2.9 pp -140.28 158.31 44.23 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.744 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.492 HG22 ' CE ' ' A' ' 80' ' ' LYS . 40.0 p -82.49 166.15 19.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.774 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.714 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 42.8 pttt -56.15 -34.12 65.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.682 177.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.57 -37.47 82.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.102 0.477 . . . . 0.0 110.416 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 42.5 mt-10 -71.99 -34.84 69.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.504 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -63.47 -48.28 78.3 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.086 0.946 . . . . 0.0 108.935 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.6 tt -46.83 -61.33 1.9 Allowed 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.281 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.94 -25.02 40.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.428 -170.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -93.7 -37.68 11.7 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.644 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.0 t -118.82 -41.12 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -167.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.543 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 30.0 t80 -166.99 118.83 0.93 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.05 0.452 . . . . 0.0 111.809 -165.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.447 ' ND2' HD22 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -85.25 91.06 8.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.528 -178.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.543 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 49.0 p90 -86.17 18.81 2.92 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.676 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 27.6 mt-10 -102.1 -54.73 2.64 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 175.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.676 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 8.1 mptt -91.68 -19.56 22.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.694 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.626 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -119.79 65.63 9.75 Favored Pre-proline 0 C--O 1.224 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.972 178.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -63.78 -44.98 11.85 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.754 2.302 . . . . 0.0 112.189 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -106.58 -11.73 15.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.014 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 40.7 mt-10 -91.05 131.21 36.78 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.646 ' HZ3' ' HE1' ' A' ' 88' ' ' PHE . 69.9 t-105 -94.54 88.79 5.57 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.222 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -97.37 106.35 18.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.262 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -108.94 124.76 51.19 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.969 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -119.16 131.51 55.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.985 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 167.12 162.14 18.08 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.885 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -97.53 -14.95 20.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.969 0.414 . . . . 0.0 110.803 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.44 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 9.9 mmtp -127.17 161.25 55.28 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.406 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 23.4 Cg_exo -65.01 132.41 32.04 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.752 2.301 . . . . 0.0 110.1 166.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.52 138.36 43.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -168.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.742 ' HB ' HG12 ' A' ' 73' ' ' ILE . 4.6 mp -113.4 112.49 40.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 165.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.626 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 21.5 t -98.28 112.18 29.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.079 0.466 . . . . 0.0 110.297 -177.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.451 ' CG ' ' HZ3' ' A' ' 75' ' ' LYS . 9.2 t70 -91.39 109.44 20.73 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.306 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.549 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 97.3 m-85 -94.14 111.68 23.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 174.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.667 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.7 p90 -132.66 167.71 19.6 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.493 0.663 . . . . 0.0 110.852 -175.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.18 125.94 19.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.042 -1.435 . . . . 0.0 107.803 172.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -56.82 -40.33 75.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -67.69 -8.61 36.55 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 42.6 t -98.37 126.63 43.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.942 0.401 . . . . 0.0 110.521 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.82 -61.85 6.97 Favored Glycine 0 CA--C 1.518 0.246 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.255 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -47.65 -41.44 30.59 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.959 2.439 . . . . 0.0 113.149 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.667 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 97.2 m -66.26 -44.26 84.15 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.78 -27.73 61.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.313 0.578 . . . . 0.0 109.502 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -61.23 -43.82 98.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.26 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.609 ' HB ' HD23 ' A' ' 60' ' ' LEU . 24.1 m -84.97 -20.52 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -174.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.467 ' HA ' ' NZ ' ' A' ' 75' ' ' LYS . . . -41.58 -53.31 7.55 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.91 -40.98 5.96 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 121.735 1.623 . . . . 0.0 112.448 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.2 mt -60.6 -42.72 92.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.238 0.542 . . . . 0.0 110.503 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.609 HD23 ' HB ' ' A' ' 56' ' ' VAL . 2.6 mm? -56.42 -42.35 77.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.46 176.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 11.1 t70 -62.97 -42.41 99.82 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.406 176.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.807 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 21.5 mm-40 -54.08 -56.63 16.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.25 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.498 HD21 ' HG3' ' A' ' 114' ' ' LYS . 3.7 mm? -67.07 -31.82 72.58 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.103 -175.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.402 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -59.83 -57.47 12.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.459 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.807 ' HE2' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -76.39 -25.98 55.13 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.23 -47.51 67.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.992 0.425 . . . . 0.0 111.39 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.487 ' HB2' HD13 ' A' ' 71' ' ' ILE . 12.4 m-85 -101.88 24.8 9.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.323 -175.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.4 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 19.9 t70 -55.79 143.6 30.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.172 0.51 . . . . 0.0 111.439 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.87 -37.58 3.68 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.631 -178.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 8.8 pt20 -110.08 -12.63 14.49 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.178 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.487 HD13 ' HB2' ' A' ' 67' ' ' TYR . 43.9 pt -147.01 167.87 5.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.935 0.398 . . . . 0.0 110.685 174.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 39' ' ' LYS . 13.3 p -145.73 144.7 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 172.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.742 HG12 ' HB ' ' A' ' 42' ' ' ILE . 40.9 mt -121.07 139.12 49.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.322 -177.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.401 ' CE2' HD12 ' A' ' 12' ' ' ILE . 67.5 m-85 -115.49 162.93 16.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.431 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.539 ' HB3' ' CE1' ' A' ' 46' ' ' TYR . 54.1 mttm -135.64 132.06 36.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.849 0.357 . . . . 0.0 110.533 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.475 HG13 ' HG2' ' A' ' 81' ' ' GLU . 1.0 OUTLIER -131.46 137.32 55.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.482 -176.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -90.98 96.07 10.44 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.448 HG22 ' HA ' ' A' ' 92' ' ' SER . 17.0 m -60.13 -25.6 65.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -168.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -55.28 -40.43 71.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.462 0.172 . . . . 0.0 111.191 175.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.492 ' CE ' HG22 ' A' ' 15' ' ' THR . 22.6 pttm -98.71 -22.19 16.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.304 0.573 . . . . 0.0 110.2 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.714 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 1.3 mp0 -89.53 34.89 0.82 Allowed 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.281 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.41 ' HA ' ' OE1' ' A' ' 82' ' ' GLN . 14.2 mm-40 -64.01 -42.49 97.13 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -64.52 -35.33 80.62 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.254 0.55 . . . . 0.0 110.062 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.6 tp -63.7 -47.6 80.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.901 176.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.519 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -60.71 -42.27 96.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.797 176.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.4 -31.05 75.95 Favored Glycine 0 CA--C 1.517 0.168 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.698 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.19 -41.5 97.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.789 0.328 . . . . 0.0 111.012 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.646 ' HE1' ' HZ3' ' A' ' 33' ' ' TRP . 76.2 m-85 -82.7 -22.2 34.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.692 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.13 31.67 9.58 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.554 HG13 ' HB2' ' A' ' 88' ' ' PHE . 6.2 mt -85.4 154.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.717 0.294 . . . . 0.0 110.544 -176.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -69.11 -81.82 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.436 0.636 . . . . 0.0 109.373 171.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.448 ' HA ' HG22 ' A' ' 78' ' ' THR . 65.9 m -158.99 -81.26 0.05 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.925 173.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.632 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 2.2 pp -151.08 149.67 25.5 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.237 -174.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.742 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 5.1 Cg_exo -83.5 149.2 62.66 Favored 'Cis proline' 0 C--N 1.346 0.437 0 C-N-CA 124.743 -0.94 . . . . 0.0 112.356 -2.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 39.6 t -140.99 130.61 24.04 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.3 mm -120.92 113.96 41.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.626 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 31.4 tp -102.05 115.5 30.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.792 -175.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -97.78 106.09 18.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.972 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.506 HG12 ' HB3' ' A' ' 105' ' ' PRO . 53.6 mt -105.08 113.44 64.69 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.704 -174.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.8 155.54 20.55 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.466 2.111 . . . . 0.0 111.491 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 82.2 mtp -81.39 4.23 21.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.628 0.728 . . . . 0.0 110.823 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -151.27 117.43 5.59 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.974 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.14 -147.29 18.17 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.935 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.424 ' HZ2' ' HB3' ' A' ' 33' ' ' TRP . 51.7 mmtt -128.49 152.11 77.82 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.506 ' HB3' HG12 ' A' ' 99' ' ' ILE . 88.2 Cg_endo -79.59 147.96 20.16 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.752 2.301 . . . . 0.0 113.829 -172.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.428 ' O ' HD11 ' A' ' 97' ' ' LEU . 23.4 mm-40 -103.47 167.68 9.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.572 176.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.472 ' HE2' HG12 ' A' ' 90' ' ' ILE . 38.3 ttm -141.32 130.0 22.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.124 0.487 . . . . 0.0 111.958 -178.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.96 127.32 53.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.106 173.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -99.56 136.73 39.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.927 0.394 . . . . 0.0 111.541 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.742 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 106.95 174.13 22.78 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.806 -0.634 . . . . 0.0 114.635 171.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.92 86.7 5.54 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.818 -0.691 . . . . 0.0 111.464 -175.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.564 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 22.7 ptt? -87.53 158.43 51.47 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.651 171.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.548 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 74.4 Cg_endo -75.19 178.58 7.11 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.312 2.008 . . . . 0.0 112.847 -173.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.498 ' HG3' HD21 ' A' ' 63' ' ' LEU . 54.8 tttm -61.07 -28.7 69.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.047 177.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.79 -52.53 20.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.394 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.564 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 21.6 m -67.48 -32.76 73.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.774 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.523 ' O ' HG13 ' A' ' 121' ' ' ILE . 1.4 m-85 -62.23 -46.59 88.17 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.492 174.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -56.39 -44.27 80.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.525 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.585 ' HB3' ' OE1' ' A' ' 123' ' ' GLU . 9.2 mtpm? -63.06 -50.37 70.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.44 75.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.843 0.354 . . . . 0.0 111.32 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 117' ' ' PHE . 70.9 mt -74.23 -55.11 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.04 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 126' ' ' LEU . 31.0 t0 -69.68 -57.93 4.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.573 -173.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.585 ' OE1' ' HB3' ' A' ' 119' ' ' LYS . 44.6 mt-10 -58.15 -23.12 54.09 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -170.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -116.22 -47.8 2.74 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.1 tp -88.26 -38.7 15.01 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.488 -171.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 122' ' ' ASP . 73.5 mt -83.09 -52.96 6.16 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.431 0.634 . . . . 0.0 109.388 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.672 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 167.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.539 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . . . . . . 0 N--CA 1.448 -0.524 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.473 ' HG3' ' OD2' ' A' ' 61' ' ' ASP . 54.9 tttp -160.23 173.33 15.89 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.3 p -112.41 113.15 43.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.431 0.634 . . . . 0.0 110.129 174.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.8 mm -109.38 131.23 60.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.058 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.693 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 3.7 p80 -85.8 116.62 24.17 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.56 174.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -109.52 179.23 4.2 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.355 -176.099 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.6 p -100.53 164.23 11.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.952 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.693 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 35.6 pttt -61.91 -27.0 68.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.815 0.34 . . . . 0.0 110.511 176.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -41.09 96.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.656 174.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -71.71 -38.22 70.56 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.197 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.413 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 2.3 t80 -54.21 -53.81 48.44 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.813 0.816 . . . . 0.0 109.305 176.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 30.0 mt -50.56 -60.07 3.4 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 113.598 -1.637 . . . . 0.0 111.929 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.22 -36.63 39.75 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -102.79 -4.59 24.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -171.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 58.2 t -132.96 -51.99 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 7.5 t80 -179.19 131.0 0.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 110.746 -167.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.615 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 25.9 t-20 -91.21 136.24 33.23 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.655 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -123.91 20.8 9.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.171 0.51 . . . . 0.0 110.547 175.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -105.64 -53.93 2.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.593 0.711 . . . . 0.0 109.798 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.596 ' HG3' ' ND2' ' A' ' 29' ' ' ASN . 22.0 ptmt -97.02 -12.61 23.05 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.526 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.615 ' HB2' ' O ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -116.89 62.55 2.84 Favored Pre-proline 0 N--CA 1.473 0.723 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.239 174.451 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -63.43 -43.06 19.05 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.705 2.27 . . . . 0.0 112.614 174.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -100.59 -27.7 13.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.607 -175.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 37.7 mt-10 -92.69 128.67 38.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.044 0.449 . . . . 0.0 110.795 -177.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.691 ' HD1' ' HZ3' ' A' ' 104' ' ' LYS . 44.3 t-105 -92.55 93.13 8.38 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HD2' ' OD1' ' A' ' 29' ' ' ASN . 92.2 mttt -104.95 97.26 7.15 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.107 176.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.479 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 28.5 t80 -79.69 104.39 10.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.642 175.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -98.91 84.0 3.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.611 177.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.479 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -129.68 -143.51 5.47 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.844 -175.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -147.92 -64.64 0.26 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.8 0.333 . . . . 0.0 110.104 -173.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 70' ' ' GLN . 45.8 mttp -120.85 159.5 48.58 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.862 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.48 ' HG2' HG21 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -45.29 131.92 11.79 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.073 2.516 . . . . 0.0 112.084 179.054 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.52 139.18 54.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.567 -172.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.9 mt -117.76 114.57 45.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.418 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 16.4 t -101.76 112.99 36.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.791 0.329 . . . . 0.0 111.219 -176.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 8.2 t70 -92.56 112.13 23.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.969 176.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 75.6 m-85 -87.55 110.58 20.45 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 173.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.662 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 0.8 OUTLIER -132.11 163.83 27.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.159 0.504 . . . . 0.0 110.84 -175.365 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.72 137.03 52.49 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.478 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 19.6 t70 -62.98 -29.48 70.85 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -174.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -85.74 -6.91 59.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.79 0.328 . . . . 0.0 111.177 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.7 t -84.27 106.95 16.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.903 0.382 . . . . 0.0 111.081 -175.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.09 -50.76 54.11 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.673 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -46.92 -47.93 15.43 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.71 2.273 . . . . 0.0 113.191 175.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.662 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 83.0 m -66.97 -32.54 73.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.477 . . . . 0.0 111.257 -177.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.478 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 71.1 mmtt -58.76 -29.51 66.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.597 175.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.541 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 31.2 mtm -67.69 -39.56 84.43 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.712 0.291 . . . . 0.0 111.239 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 53' ' ' CYS . 16.6 m -78.21 -26.47 14.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -172.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.602 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . . . -51.31 -54.24 40.69 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.602 ' HD3' ' HB2' ' A' ' 57' ' ' ALA . 35.4 Cg_exo -61.61 -43.65 25.88 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 122.045 1.83 . . . . 0.0 112.283 176.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.5 mt -58.46 -49.9 80.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.305 0.574 . . . . 0.0 110.591 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.432 HD21 ' HA ' ' A' ' 60' ' ' LEU . 20.0 mt -61.92 -40.84 96.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.39 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.473 ' OD2' ' HG3' ' A' ' 10' ' ' LYS . 12.7 t70 -64.79 -45.71 85.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.956 0.408 . . . . 0.0 110.806 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -62.36 -51.1 68.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.999 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.66 -32.57 72.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.181 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.539 ' O ' ' HA2' ' A' ' 9' ' ' GLY . . . -62.28 -34.96 77.57 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.468 ' C ' ' HD3' ' A' ' 65' ' ' LYS . 2.8 tmtm? -73.96 -38.17 64.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.885 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -62.27 -48.14 81.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.238 0.542 . . . . 0.0 110.573 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -90.89 26.09 2.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.8 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -57.07 139.76 51.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.678 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.83 -25.98 26.19 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.955 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.534 ' HG3' HG22 ' A' ' 71' ' ' ILE . 11.7 pt20 -116.23 -44.46 2.89 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -177.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.534 HG22 ' HG3' ' A' ' 70' ' ' GLN . 33.6 pt -117.38 150.3 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.798 -177.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.8 t -121.56 127.25 75.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.268 176.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.663 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 31.8 mt -109.63 133.67 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 121.331 0.586 . . . . 0.0 110.278 -178.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -121.43 171.65 8.62 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.732 0.777 . . . . 0.0 110.373 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 1.1 ptpm? -146.09 159.15 43.68 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 168.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.688 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 2.6 p -140.38 143.52 29.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.596 -174.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.412 ' HB2' ' NZ ' ' A' ' 80' ' ' LYS . 20.2 m-20 -82.97 90.73 7.03 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -174.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.496 HG23 ' HB1' ' A' ' 85' ' ' ALA . 27.0 m -57.91 -24.54 58.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.085 -173.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.6 -40.84 84.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.762 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.412 ' NZ ' ' HB2' ' A' ' 77' ' ' ASP . 23.9 pttm -101.15 -22.59 14.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.097 0.475 . . . . 0.0 110.527 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.693 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 1.4 mp0 -89.06 42.89 1.11 Allowed 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.534 175.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -66.11 -38.39 88.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.072 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.468 ' CD ' ' HZ1' ' A' ' 16' ' ' LYS . 3.5 mp0 -65.92 -38.02 87.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.363 0.602 . . . . 0.0 109.672 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.1 tp -65.68 -50.43 64.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.734 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.496 ' HB1' HG23 ' A' ' 78' ' ' THR . . . -65.36 -39.89 92.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.989 0.423 . . . . 0.0 110.899 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.3 -27.58 69.49 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.882 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.04 -32.92 72.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.935 0.398 . . . . 0.0 110.85 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.508 ' HB2' HG12 ' A' ' 90' ' ' ILE . 90.5 m-85 -93.48 -3.41 53.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.646 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.15 13.39 74.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.005 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.508 HG12 ' HB2' ' A' ' 88' ' ' PHE . 26.9 mm -83.63 119.54 33.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.543 0.211 . . . . 0.0 110.517 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -59.53 -58.04 10.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 110.953 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.1 m -150.92 -96.96 0.06 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.7 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -146.86 163.18 30.21 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.903 -0.135 . . . . 0.0 111.043 -170.79 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.68 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 2.7 Cg_exo -89.18 150.16 26.81 Favored 'Cis proline' 0 C--N 1.347 0.498 0 C-N-CA 124.72 -0.95 . . . . 0.0 112.509 -4.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.468 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 34.7 t -140.68 145.28 36.32 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 107' ' ' MET . 30.5 mt -135.25 116.24 19.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.825 0.345 . . . . 0.0 110.304 -178.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 47.3 tp -102.91 116.61 32.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.403 -177.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -98.67 109.11 21.92 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.538 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 58.2 mt -104.48 113.39 65.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.691 -174.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -84.34 168.54 11.58 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.851 2.367 . . . . 0.0 111.786 174.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 87.2 mtp -82.31 -26.04 33.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.243 0.544 . . . . 0.0 109.949 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -130.66 138.1 49.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.223 176.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.69 161.35 36.66 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.691 ' HZ3' ' HD1' ' A' ' 33' ' ' TRP . 26.0 mmmt -92.37 143.93 28.12 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 117.377 0.589 . . . . 0.0 110.093 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.538 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 27.5 Cg_endo -61.03 159.59 29.24 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.722 2.948 . . . . 0.0 114.3 -170.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -117.15 168.84 9.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.091 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 47.7 ttm -142.03 127.04 18.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.285 0.564 . . . . 0.0 112.224 -175.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.5 140.54 49.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -114.59 141.41 47.8 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.904 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.68 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 107.46 169.75 21.98 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.378 174.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.06 85.29 6.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.218 0.532 . . . . 0.0 111.358 -176.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.569 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 24.1 ptp -80.85 152.11 71.58 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.029 176.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.653 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 98.2 Cg_endo -75.26 -178.24 4.08 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.681 2.254 . . . . 0.0 112.062 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -62.24 -36.75 82.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.142 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.38 -37.63 74.56 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.941 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.653 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 71.8 m -72.82 -34.62 66.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.756 174.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.652 ' O ' HG12 ' A' ' 121' ' ' ILE . 2.1 m-85 -63.27 -51.82 64.58 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 121.126 -0.229 . . . . 0.0 110.792 176.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -57.02 -36.53 70.55 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.964 0.411 . . . . 0.0 110.503 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.786 ' HZ2' ' HB2' ' A' ' 119' ' ' LYS . 4.8 ttmp? -57.22 -42.7 81.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.884 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.83 -34.96 69.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.047 176.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.652 HG12 ' O ' ' A' ' 117' ' ' PHE . 37.2 mm -64.85 -56.02 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.698 -178.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.469 ' HA ' HD13 ' A' ' 126' ' ' LEU . 2.0 m-20 -66.64 -64.39 0.86 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.011 0.434 . . . . 0.0 110.951 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.75 -34.39 69.49 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.535 -171.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.443 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 63.4 t80 -108.26 -50.27 3.06 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 18.1 tp -81.43 -30.99 33.33 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.476 -169.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' A' ' 122' ' ' ASP . 80.4 mt -87.44 -50.54 6.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.297 0.57 . . . . 0.0 109.635 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp . . . . . 0 C--N 1.322 -0.594 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 171.638 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.0 mmm . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.859 0.362 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.8 m -101.71 81.02 2.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.056 0.455 . . . . 0.0 110.877 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.752 HD21 ' H ' ' A' ' 3' ' ' LEU . 2.2 pt? -97.1 -34.4 11.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.291 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.14 87.44 1.33 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.0 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 p -108.94 19.85 19.11 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.215 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.468 ' HG2' ' H ' ' A' ' 7' ' ' GLY . 24.9 tt0 56.59 -132.85 1.47 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.738 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.468 ' H ' ' HG2' ' A' ' 6' ' ' GLU . . . 81.81 -58.02 4.92 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.326 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -72.08 133.99 45.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 68.83 29.49 72.59 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.731 -175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.446 ' HG3' ' H ' ' A' ' 11' ' ' VAL . 43.1 tptt -137.12 173.23 11.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.2 p -122.18 107.99 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.578 0.704 . . . . 0.0 110.296 175.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 43.8 mm -108.81 132.21 57.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.202 -176.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.653 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 4.6 p80 -89.09 127.9 35.73 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.461 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 1.1 pp -128.28 -179.99 5.31 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.968 -172.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.443 ' HA ' ' OE1' ' A' ' 81' ' ' GLU . 45.3 p -104.36 174.84 5.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.244 177.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.508 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 13.0 pttm -64.45 -26.69 68.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 111.198 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.449 ' HA ' HD13 ' A' ' 20' ' ' LEU . . . -65.97 -40.31 91.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.311 0.577 . . . . 0.0 110.404 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.533 ' CD ' ' HZ1' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -71.86 -34.51 69.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.804 178.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.443 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -59.07 -53.79 54.4 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.476 174.162 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.689 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 18.1 mt -46.91 -59.7 2.92 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.655 -1.612 . . . . 0.0 111.919 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.64 -48.48 72.06 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -170.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.533 ' HZ1' ' CD ' ' A' ' 18' ' ' GLU . 19.8 mtmm -104.13 -3.1 24.9 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.401 -170.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 61.1 t -129.06 -52.9 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.689 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 11.7 t80 -167.62 124.73 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.01 -164.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.71 91.4 7.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.951 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.502 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 25.2 p90 -79.99 12.99 2.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.11 0.481 . . . . 0.0 111.412 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -93.88 -53.07 4.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.593 ' C ' HD21 ' A' ' 29' ' ' ASN . 60.3 mttp -83.46 -23.71 32.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.735 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.642 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -121.58 69.37 23.63 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.376 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -57.58 -37.05 98.29 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.311 2.674 . . . . 0.0 112.279 173.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -105.13 -42.43 5.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.983 -174.437 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.522 ' CD ' ' HZ1' ' A' ' 104' ' ' LYS . 3.6 mm-40 -94.98 178.19 5.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.362 0.601 . . . . 0.0 112.375 -174.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.775 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 19.1 t-105 -125.19 108.6 11.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.569 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.47 ' C ' ' HD3' ' A' ' 34' ' ' LYS . 8.6 tmtt? -110.7 112.63 24.64 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 172.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 13.9 t80 -80.8 124.95 29.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.548 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -101.05 8.48 42.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.422 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.426 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -88.4 150.56 21.99 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 -177.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -92.29 -30.07 16.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.078 0.465 . . . . 0.0 110.961 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -115.09 155.22 46.93 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.912 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.92 132.17 50.01 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.352 2.034 . . . . 0.0 111.381 174.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -117.05 154.98 30.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.476 0.655 . . . . 0.0 111.676 -175.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.429 HD13 HG12 ' A' ' 121' ' ' ILE . 78.3 mt -128.1 110.3 21.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.077 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 23.9 t -100.54 114.07 38.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.974 0.416 . . . . 0.0 111.114 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.596 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 4.4 t70 -90.8 113.8 26.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.181 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -84.88 111.04 19.29 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 170.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.676 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.4 p90 -132.33 159.0 40.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.289 0.566 . . . . 0.0 111.089 -177.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.443 ' CB ' HG12 ' A' ' 93' ' ' ILE . . . -128.14 128.85 45.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.007 171.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.536 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 28.3 t70 -63.47 -28.86 70.25 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.565 -170.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -75.63 -2.78 30.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.683 0.277 . . . . 0.0 111.732 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 42.5 t -103.43 127.72 50.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.939 0.4 . . . . 0.0 110.785 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.81 -61.43 7.34 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.661 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.411 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 72.1 Cg_exo -47.84 -47.54 18.46 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.761 2.307 . . . . 0.0 112.537 176.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.676 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 65.1 m -56.86 -29.45 62.9 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.03 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.536 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 62.8 mttm -73.8 -42.95 60.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.172 174.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.645 ' O ' HG12 ' A' ' 59' ' ' ILE . 26.1 mtm -59.89 -40.13 87.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.917 0.389 . . . . 0.0 111.396 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 111' ' ' ALA . 11.5 p -64.04 -30.53 50.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.161 -171.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.621 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . . . -57.53 -57.55 24.49 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 118.833 -0.603 . . . . 0.0 112.021 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.638 ' HD2' ' O ' ' A' ' 55' ' ' MET . 47.0 Cg_exo -57.82 -39.96 82.72 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 121.811 1.674 . . . . 0.0 112.539 174.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.645 HG12 ' O ' ' A' ' 55' ' ' MET . 21.0 mm -61.15 -49.42 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 121.709 0.766 . . . . 0.0 109.916 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.66 HD22 HD13 ' A' ' 73' ' ' ILE . 11.6 mt -63.93 -37.51 87.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.543 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -62.4 -44.29 96.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.418 0.628 . . . . 0.0 109.451 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -58.71 -55.61 32.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.363 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.424 HD22 ' HG3' ' A' ' 114' ' ' LYS . 4.4 mm? -66.72 -33.93 76.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.315 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.528 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -60.79 -46.05 92.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.952 0.406 . . . . 0.0 110.239 177.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.806 ' HB3' ' HZ2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -69.45 -31.52 69.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.716 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.592 ' HG3' ' HZ3' ' A' ' 65' ' ' LYS . 43.7 mt-10 -72.02 -35.96 69.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.27 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -109.22 27.74 9.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.876 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.91 148.97 9.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.388 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.54 -44.5 2.59 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.843 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.427 ' HG3' HG23 ' A' ' 71' ' ' ILE . 16.5 pt20 -93.33 -38.62 11.39 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.427 HG23 ' HG3' ' A' ' 70' ' ' GLN . 38.9 pt -118.74 159.98 18.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.009 0.433 . . . . 0.0 111.713 -177.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 63.6 t -133.36 121.69 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.66 HD13 HD22 ' A' ' 60' ' ' LEU . 46.0 mt -103.86 139.43 24.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.486 0.66 . . . . 0.0 111.253 -175.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -128.04 173.49 10.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.898 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 0.6 OUTLIER -149.34 158.45 44.19 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 170.25 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.488 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 9.9 p -133.88 136.06 54.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.203 0.525 . . . . 0.0 110.438 -177.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.508 ' HB2' ' HZ2' ' A' ' 80' ' ' LYS . 3.6 m-20 -80.1 94.37 5.97 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.377 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.651 HG21 ' HA ' ' A' ' 92' ' ' SER . 74.6 m -58.49 -33.8 70.21 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -174.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -53.93 -31.16 49.4 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.508 ' HZ2' ' HB2' ' A' ' 77' ' ' ASP . 14.6 pttp -106.21 -32.04 8.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.179 0.514 . . . . 0.0 110.504 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.508 ' OE2' ' HG2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -90.83 44.23 1.19 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.367 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -61.06 -37.18 81.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.428 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -70.58 -37.72 73.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.228 0.537 . . . . 0.0 110.072 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.1 -49.14 59.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.789 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.14 84.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.969 0.414 . . . . 0.0 111.077 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -66.84 -31.18 77.49 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.903 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.68 93.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 0.0 111.616 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.552 ' HB2' HG12 ' A' ' 90' ' ' ILE . 72.5 m-85 -85.91 -1.68 57.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.84 0.352 . . . . 0.0 110.898 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.01 15.85 78.07 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.33 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.552 HG12 ' HB2' ' A' ' 88' ' ' PHE . 48.9 mm -65.46 -25.14 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 122.587 0.355 . . . . 0.0 110.866 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 26.4 mmt180 72.03 -67.77 0.25 Allowed 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.744 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.651 ' HA ' HG21 ' A' ' 78' ' ' THR . 33.7 m -151.77 -89.31 0.06 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.932 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.508 HG22 ' C ' ' A' ' 46' ' ' TYR . 2.4 pp -163.29 159.92 18.24 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.595 -170.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.576 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 2.3 Cg_endo -95.22 147.1 8.4 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 124.821 -0.908 . . . . 0.0 111.803 -4.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.4 t -141.73 138.77 32.6 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' A' ' 107' ' ' MET . 30.7 mm -118.77 113.8 42.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.454 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 25.6 tp -98.0 112.71 24.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.527 -176.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.24 110.11 22.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.538 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 32.2 mt -101.69 106.17 45.1 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.153 -174.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.36 163.27 27.5 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.583 2.189 . . . . 0.0 111.95 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 92.3 mmm -85.16 0.29 52.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.479 0.657 . . . . 0.0 110.082 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -138.77 111.1 7.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.117 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.71 -158.83 18.5 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.24 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.775 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 42.7 mtpt -113.24 154.36 45.27 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.538 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 73.1 Cg_endo -75.34 140.49 24.6 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.83 2.353 . . . . 0.0 114.563 -170.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.479 ' CD ' ' HE2' ' A' ' 131' ' ' HIS . 18.8 mp0 -91.35 169.93 10.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.578 173.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.547 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 21.4 ptp -142.01 144.38 33.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.025 0.441 . . . . 0.0 111.177 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -124.68 126.43 45.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.292 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -86.49 126.72 34.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.089 0.471 . . . . 0.0 111.375 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.576 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 100.29 155.72 27.78 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.436 175.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.536 ' HB2' ' HB ' ' A' ' 56' ' ' VAL . . . -87.59 87.33 7.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.342 0.591 . . . . 0.0 111.068 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.586 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 12.7 ptt? -68.26 162.95 56.72 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.283 173.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 112' ' ' MET . 97.1 Cg_endo -75.09 179.14 6.4 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.633 2.222 . . . . 0.0 113.009 -173.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.456 ' HZ3' ' CD ' ' A' ' 66' ' ' GLU . 58.3 tttp -54.81 -35.77 64.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.847 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.62 -52.76 19.18 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.915 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 18.8 m -66.12 -34.66 78.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.559 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.536 ' O ' HG13 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -63.94 -43.18 96.64 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.049 178.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' HZ2' ' HB3' ' A' ' 122' ' ' ASP . 1.6 ttpp -57.03 -40.67 77.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 0.0 110.075 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -66.74 -41.36 87.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.606 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.33 -36.88 71.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.977 0.418 . . . . 0.0 111.583 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.568 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 62.9 mt -73.99 -56.64 8.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.493 0.664 . . . . 0.0 110.69 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.42 ' HB3' ' HZ2' ' A' ' 118' ' ' LYS . 14.6 t0 -72.47 -64.77 0.88 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.169 -174.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.594 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 24.4 mt-10 -80.04 11.93 3.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.595 -169.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.606 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 58.5 t80 -138.46 -50.35 0.56 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.164 -0.214 . . . . 0.0 111.554 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.568 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 42.8 tp -73.54 -40.91 63.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.65 0.262 . . . . 0.0 110.59 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -90.81 -53.82 4.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.418 0.628 . . . . 0.0 109.306 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.594 ' HB3' ' HA ' ' A' ' 123' ' ' GLU . 52.1 tptt -81.52 70.47 8.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.702 0.763 . . . . 0.0 109.219 173.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 131' ' ' HIS . 17.8 pttp -77.31 67.66 3.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.916 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 133' ' ' HIS . 1.7 tp10 -72.7 -15.93 61.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.736 -176.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -100.24 7.5 58.48 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.492 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 128' ' ' LYS . 1.7 m-70 -118.05 106.51 12.97 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.54 -0.388 . . . . 0.0 111.377 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.9 m80 66.72 7.8 5.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.342 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.472 ' HB3' ' O ' ' A' ' 129' ' ' GLU . 70.7 t60 -100.09 106.33 18.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.195 0.522 . . . . 0.0 111.319 -176.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -113.06 -19.52 11.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.128 173.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 167.59 -46.8 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 113.372 -1.74 . . . . 0.0 107.1 165.805 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 110.695 -0.113 . . . . 0.0 110.695 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -171.37 157.26 4.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 tt -101.33 -72.08 0.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -161.03 136.61 7.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.908 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.5 m -156.49 98.06 1.79 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -114.6 -42.44 3.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.591 -179.229 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.8 -27.11 4.98 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.396 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.428 ' HA ' HG21 ' A' ' 72' ' ' VAL . 21.9 t-20 -67.67 133.7 49.8 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.482 ' C ' ' HD2' ' A' ' 10' ' ' LYS . . . 83.9 -8.59 65.81 Favored Glycine 0 CA--C 1.51 -0.271 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.445 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.488 ' HZ2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -131.77 174.62 9.95 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.618 -0.342 . . . . 0.0 110.265 -176.213 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.646 HG22 HG23 ' A' ' 73' ' ' ILE . 13.0 p -113.58 123.46 69.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.323 0.582 . . . . 0.0 110.653 173.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.6 mm -124.67 120.4 58.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.254 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.721 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 7.1 p80 -86.74 129.91 34.69 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.154 175.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.637 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -124.01 178.56 5.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.981 -172.172 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.58 HG22 ' HE2' ' A' ' 80' ' ' LYS . 41.3 p -93.07 171.46 8.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.686 175.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HE3' ' HB3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -58.54 -37.4 75.6 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 178.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.439 ' N ' ' HG2' ' A' ' 16' ' ' LYS . . . -63.37 -37.93 89.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.477 0.656 . . . . 0.0 110.161 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.637 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 40.0 mt-10 -72.9 -34.82 66.89 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.751 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.454 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 6.8 t80 -54.89 -51.47 65.9 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 122.638 1.208 . . . . 0.0 108.761 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.629 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 25.9 mt -54.76 -58.39 7.76 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 112.481 -2.145 . . . . 0.0 111.931 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.94 -14.53 41.57 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -170.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.401 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 94.3 mttt -109.93 -5.84 15.37 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.202 -0.311 . . . . 0.0 111.368 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 59.4 t -141.02 -56.34 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 45.1 t80 -167.26 125.34 1.28 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.054 -164.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.542 ' OD1' ' HD3' ' A' ' 28' ' ' LYS . 2.8 t-20 -86.46 90.25 8.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.621 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -85.82 11.97 10.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.701 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 6.6 mt-10 -94.5 -54.29 3.58 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.938 0.875 . . . . 0.0 108.813 175.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.701 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 12.2 mptt -88.12 -23.45 23.67 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.628 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.659 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -120.62 68.64 15.4 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.899 -179.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -61.27 -43.7 27.36 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.966 2.444 . . . . 0.0 112.24 170.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -100.97 -29.93 11.92 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.161 0.505 . . . . 0.0 110.824 -175.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 22.9 mp0 -89.79 127.92 36.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.999 -169.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.711 ' HB2' ' HZ2' ' A' ' 104' ' ' LYS . 72.8 t-105 -89.95 89.57 7.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.223 0.535 . . . . 0.0 110.432 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -106.24 97.74 7.51 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.764 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.611 ' HH ' ' HB2' ' A' ' 41' ' ' ALA . 83.0 t80 -85.41 119.64 26.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.893 176.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -112.62 85.54 2.18 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.451 0.643 . . . . 0.0 110.184 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -147.24 -154.04 6.1 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.984 -176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -115.12 -58.84 2.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.247 0.546 . . . . 0.0 110.534 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.552 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 51.0 mttp -135.65 170.18 11.75 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.278 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 79.7 Cg_exo -45.25 132.52 11.85 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 122.735 2.29 . . . . 0.0 112.459 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.611 ' HB2' ' HH ' ' A' ' 35' ' ' TYR . . . -117.79 145.84 44.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.596 -171.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 121' ' ' ILE . 75.0 mt -119.8 114.31 43.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.118 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 28.7 t -98.57 110.3 25.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.767 0.317 . . . . 0.0 110.836 -177.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.547 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 7.6 t70 -98.4 111.61 23.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.961 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.578 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 79.9 m-85 -90.38 112.12 23.6 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.743 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.2 p90 -133.77 179.06 6.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.39 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.551 ' HB2' ' CD ' ' A' ' 79' ' ' GLU . . . -154.79 173.34 16.59 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.484 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.462 ' O ' ' HE3' ' A' ' 54' ' ' LYS . 20.6 t70 -80.68 -46.43 15.57 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -175.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -71.04 0.23 7.98 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -173.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 53' ' ' CYS . 45.4 t -112.85 114.03 26.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.943 0.401 . . . . 0.0 110.292 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.2 -51.62 58.09 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.256 -0.747 . . . . 0.0 113.64 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -47.42 -37.7 25.87 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.969 2.446 . . . . 0.0 112.929 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.743 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 59.9 m -59.75 -39.84 86.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.47 0.653 . . . . 0.0 111.485 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 48' ' ' ASP . 99.4 mttt -79.04 -29.99 43.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.161 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.52 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 4.5 tmm? -62.44 -46.05 90.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.811 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.578 HG23 ' HG ' ' A' ' 60' ' ' LEU . 14.5 p -71.18 -26.21 26.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.944 -175.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.614 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . . . -53.83 -56.33 26.54 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.614 ' HD3' ' HB2' ' A' ' 57' ' ' ALA . 36.5 Cg_exo -60.04 -47.06 16.31 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 121.708 1.605 . . . . 0.0 112.009 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.0 mt -58.34 -43.3 86.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.759 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.579 HD23 HD11 ' A' ' 73' ' ' ILE . 7.8 mt -64.87 -44.68 88.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.092 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.578 ' HB2' HG12 ' A' ' 11' ' ' VAL . 27.2 t70 -67.61 -40.96 84.72 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.403 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.526 ' CD ' ' HZ1' ' A' ' 114' ' ' LYS . 0.9 OUTLIER -61.18 -45.29 95.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.735 176.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 63' ' ' LEU . 16.6 tp -65.82 -34.76 78.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.823 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.515 ' HB1' HD13 ' A' ' 73' ' ' ILE . . . -64.99 -35.09 80.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.907 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 5.2 tmtm? -75.43 -32.5 60.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.483 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -52.5 -46.83 66.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.561 0.696 . . . . 0.0 109.968 172.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -104.97 28.08 7.53 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.578 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 9.0 t0 -48.88 131.01 18.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.229 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.34 -18.95 56.41 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.248 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -105.28 -48.81 3.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.635 0.255 . . . . 0.0 111.585 -176.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.445 HG23 ' HB2' ' A' ' 40' ' ' PRO . 34.0 pt -122.85 159.82 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.4 0.619 . . . . 0.0 112.544 -173.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 27.4 t -125.39 127.91 72.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.42 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.646 HG23 HG22 ' A' ' 11' ' ' VAL . 20.5 mt -112.09 130.49 65.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.381 0.61 . . . . 0.0 110.824 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -114.2 165.64 12.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.614 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.721 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 47.9 mttm -132.14 153.46 50.49 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.487 173.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.529 HG12 ' HG2' ' A' ' 81' ' ' GLU . 4.7 t -127.14 121.44 57.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.738 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -77.98 88.86 4.14 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 92' ' ' SER . 20.8 p -52.85 -30.02 31.25 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.111 0.481 . . . . 0.0 111.445 -175.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.551 ' CD ' ' HB2' ' A' ' 47' ' ' ALA . 2.6 mm-40 -50.56 -44.86 56.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.099 174.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.58 ' HE2' HG22 ' A' ' 15' ' ' THR . 19.3 pttm -103.33 -19.43 14.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.06 0.457 . . . . 0.0 110.672 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.529 ' HG2' HG12 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -97.85 42.87 1.08 Allowed 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.27 0.628 . . . . 0.0 111.453 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -57.24 -43.24 82.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.139 0.495 . . . . 0.0 110.812 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.36 -36.27 78.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.531 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.56 -47.77 74.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.565 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.548 ' HA ' HD11 ' A' ' 90' ' ' ILE . . . -63.94 -48.34 76.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.682 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.01 -32.76 76.48 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.129 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.06 -40.0 95.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.801 0.334 . . . . 0.0 111.525 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.415 ' HB2' HG13 ' A' ' 90' ' ' ILE . 96.4 m-85 -92.67 5.95 49.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.325 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.49 20.86 78.24 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.153 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.548 HD11 ' HA ' ' A' ' 85' ' ' ALA . 26.4 mt -76.84 137.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.684 ' H ' ' HD2' ' A' ' 91' ' ' ARG . 3.0 mpt_? -71.59 -64.68 0.88 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 78' ' ' THR . 5.2 p -177.65 -85.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.368 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.578 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 13.9 pt -150.55 146.82 20.18 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -167.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.778 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 11.3 Cg_exo -86.65 150.48 42.09 Favored 'Cis proline' 0 N--CA 1.473 0.282 0 C-N-CA 124.513 -1.036 . . . . 0.0 110.722 -6.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.578 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 4.5 m -139.95 128.93 23.5 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 107' ' ' MET . 57.0 mt -128.02 114.32 34.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.745 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.598 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.7 tp -102.45 113.32 26.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.74 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -92.3 102.62 15.11 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.849 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.551 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 65.4 mt -97.61 113.17 63.12 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.61 -175.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -86.5 165.34 9.33 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.742 2.294 . . . . 0.0 111.547 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 93.1 mmm -89.7 2.44 54.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.562 0.696 . . . . 0.0 109.345 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -140.82 98.25 3.36 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.844 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.16 -162.49 13.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.862 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.711 ' HZ2' ' HB2' ' A' ' 33' ' ' TRP . 25.8 mmmt -98.49 150.46 36.74 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.551 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 5.7 Cg_exo -79.36 155.94 25.27 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.196 2.597 . . . . 0.0 112.987 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.509 ' HG2' ' N ' ' A' ' 107' ' ' MET . 29.3 tt0 -109.07 163.6 13.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.133 174.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.588 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 22.4 ptp -142.74 129.06 19.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.359 0.599 . . . . 0.0 111.202 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.31 156.55 27.63 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.883 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -116.89 137.81 51.96 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.221 0.534 . . . . 0.0 111.364 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.778 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 104.59 150.46 20.55 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.195 178.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -84.5 88.23 7.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.166 0.508 . . . . 0.0 111.342 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.496 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 25.2 ptp -69.68 164.74 47.91 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.524 172.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.63 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 74.3 Cg_endo -75.41 169.27 22.78 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.847 1.698 . . . . 0.0 111.621 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.526 ' HZ1' ' CD ' ' A' ' 62' ' ' GLU . 65.6 tttp -55.69 -32.15 63.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.516 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 118' ' ' LYS . . . -71.33 -47.51 56.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.167 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.63 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 50.2 m -64.72 -33.8 76.82 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.687 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.688 ' O ' HG12 ' A' ' 121' ' ' ILE . 7.4 m-85 -61.57 -39.56 91.57 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.604 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.595 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 3.8 mmmm -54.01 -52.39 60.95 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.171 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.516 ' HG3' ' OE2' ' A' ' 123' ' ' GLU . 51.7 tttp -64.5 -32.98 74.84 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.677 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.32 -40.39 70.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.992 0.425 . . . . 0.0 111.214 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.688 HG12 ' O ' ' A' ' 117' ' ' PHE . 31.3 mm -73.58 -55.61 11.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.8 0.333 . . . . 0.0 110.278 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -65.36 -68.47 0.36 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.961 0.41 . . . . 0.0 110.825 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.518 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 48.2 mt-10 -77.4 12.0 1.74 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -169.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.533 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 77.8 t80 -143.51 -53.4 0.36 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.686 175.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.482 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 44.0 tp -69.6 -39.13 77.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.489 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 80.2 mt -88.54 -60.26 2.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 14.1 ttpp -103.0 81.2 1.95 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.429 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -62.66 123.62 18.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.985 0.421 . . . . 0.0 110.2 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -69.22 165.26 20.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.466 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.43 -41.09 2.63 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.752 -174.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -95.27 10.3 36.63 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 122.75 0.42 . . . . 0.0 110.685 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -69.64 117.85 11.76 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.599 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 45.53 69.84 0.41 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.068 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -135.72 -179.81 5.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.754 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -93.6 0.23 56.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.196 0.522 . . . . 0.0 109.643 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 . . . . . 0 C--O 1.245 0.826 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.815 179.41 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.475 ' H2 ' ' CD ' ' A' ' 6' ' ' GLU . 48.9 mtt . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 110.551 -0.166 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.4 t 71.05 18.98 5.74 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.169 0.509 . . . . 0.0 110.599 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 60.2 tp -100.67 -70.53 0.74 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.232 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -171.81 -62.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.199 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.5 m -84.28 96.43 9.01 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.679 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.475 ' CD ' ' H2 ' ' A' ' 1' ' ' MET . 23.1 mm-40 -70.29 -21.14 62.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.347 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.21 29.29 56.71 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.737 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -85.65 167.72 15.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.879 0.371 . . . . 0.0 111.714 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 57.16 41.51 92.78 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -150.4 152.3 34.14 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.852 0.834 . . . . 0.0 112.456 -167.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 5.0 p -134.83 119.48 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.098 174.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 60.0 mt -117.37 116.98 53.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.415 -173.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.704 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 11.0 p80 -83.8 119.67 25.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.815 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 2.0 pp -127.84 171.96 11.28 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.229 -171.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.7 p -99.18 177.89 5.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.161 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HZ1' ' CD ' ' A' ' 83' ' ' GLU . 63.5 pttt -59.22 -25.24 63.83 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 20' ' ' LEU . . . -68.49 -44.17 75.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.284 0.564 . . . . 0.0 110.233 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.815 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 3.2 mp0 -72.24 -33.71 67.75 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.399 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.522 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -55.08 -49.23 72.19 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.007 0.908 . . . . 0.0 109.201 174.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.661 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 13.9 mt -50.58 -61.15 2.36 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.357 -1.747 . . . . 0.0 111.742 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.11 -7.58 59.62 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -169.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.46 ' HB2' ' HZ1' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -111.02 -33.88 6.37 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.252 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 70.3 t -125.03 -40.78 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -169.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.661 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 21.5 t80 -164.95 117.88 1.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.866 -166.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.632 ' OD1' ' HD3' ' A' ' 28' ' ' LYS . 2.6 t-20 -91.66 89.68 7.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.485 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.646 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 18.9 p90 -81.12 6.89 12.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -86.16 -53.41 5.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.831 0.824 . . . . 0.0 108.903 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.632 ' HD3' ' OD1' ' A' ' 25' ' ' ASN . 11.0 mptt -88.43 -23.41 23.3 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.426 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.687 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -118.69 61.54 4.9 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.195 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.17 -44.71 44.04 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.683 2.255 . . . . 0.0 112.112 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.21 -13.7 15.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.852 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.448 ' O ' ' HE1' ' A' ' 24' ' ' TYR . 44.9 mt-10 -91.09 144.08 26.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.271 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.484 ' CZ2' ' HG2' ' A' ' 105' ' ' PRO . 65.0 t-105 -108.36 109.17 20.42 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 171.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.417 ' HG2' ' OE1' ' A' ' 36' ' ' GLU . 27.1 ttpp -134.21 117.65 16.73 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.602 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 29.4 t80 -90.05 110.97 21.93 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.714 -175.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.417 ' OE1' ' HG2' ' A' ' 34' ' ' LYS . 4.5 mm-40 -84.53 40.81 0.81 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.548 -176.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.6 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -98.3 165.7 21.73 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.731 -171.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -101.47 -56.88 2.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.302 0.572 . . . . 0.0 109.828 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -116.36 166.6 12.2 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.264 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.539 ' HB2' HG23 ' A' ' 71' ' ' ILE . 36.7 Cg_exo -55.83 137.15 77.78 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.165 1.91 . . . . 0.0 111.324 175.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -121.6 146.2 47.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.322 0.582 . . . . 0.0 112.02 -173.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.503 ' HB ' HG12 ' A' ' 73' ' ' ILE . 64.5 mt -113.18 112.31 39.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.905 172.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.769 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 20.7 t -98.94 113.59 34.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.863 0.363 . . . . 0.0 110.848 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.603 ' HB2' HD12 ' A' ' 60' ' ' LEU . 6.7 t70 -92.69 108.69 20.18 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.108 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.559 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 13.7 m-85 -88.07 109.94 20.25 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 171.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.69 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 3.9 p90 -130.25 160.77 32.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.186 0.517 . . . . 0.0 110.671 -175.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 50' ' ' CYS . . . -119.49 131.67 55.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.105 169.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.63 -11.26 59.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.01 0.434 . . . . 0.0 111.152 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -102.23 -6.39 23.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.096 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.507 ' HB2' ' HB1' ' A' ' 47' ' ' ALA . 50.2 t -88.73 118.05 28.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.81 0.338 . . . . 0.0 110.954 -174.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.13 -57.3 13.47 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.595 -0.729 . . . . 0.0 113.628 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.469 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 83.2 Cg_exo -47.32 -46.35 20.09 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.026 2.484 . . . . 0.0 113.552 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.69 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 74.9 m -68.78 -37.25 79.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.854 0.359 . . . . 0.0 111.215 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -55.25 -28.69 55.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.81 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.406 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 79.9 mtp -75.08 -50.92 14.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.025 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.578 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 32.8 m -71.82 -39.32 67.78 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -173.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.583 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -49.75 -56.8 14.82 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 23.3 Cg_exo -63.9 -35.76 53.84 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.732 1.622 . . . . 0.0 111.574 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.882 HG23 ' HB3' ' A' ' 114' ' ' LYS . 56.6 mt -62.75 -42.55 96.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.677 0.751 . . . . 0.0 110.464 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.603 HD12 ' HB2' ' A' ' 44' ' ' ASP . 28.2 mt -68.82 -35.51 77.07 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.119 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.553 ' OD1' HG12 ' A' ' 11' ' ' VAL . 57.1 m-20 -62.19 -45.77 91.91 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 173.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -54.92 -47.08 74.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.698 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.466 HD22 ' HE1' ' A' ' 67' ' ' TYR . 74.4 mt -69.3 -29.9 67.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.824 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.79 -42.65 84.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.826 0.346 . . . . 0.0 110.372 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.73 -28.69 58.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.396 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.551 ' CD ' ' HZ3' ' A' ' 114' ' ' LYS . 4.6 tt0 -80.62 -41.52 23.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.466 ' HE1' HD22 ' A' ' 63' ' ' LEU . 57.8 m-85 -98.94 24.96 7.11 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.847 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -64.53 163.57 13.27 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.232 0.539 . . . . 0.0 111.704 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.23 -50.51 3.88 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.296 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.499 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 23.9 pt20 -90.09 -40.33 12.34 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 -177.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.539 HG23 ' HB2' ' A' ' 40' ' ' PRO . 26.9 pt -127.56 166.77 23.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.293 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 51.4 t -134.06 139.5 48.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.719 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 39.1 mt -108.08 142.13 21.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.072 -175.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -127.47 165.96 18.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.799 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.704 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 86.1 mttt -132.39 166.36 22.15 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.554 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 5.1 p -146.06 133.49 15.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.169 0.509 . . . . 0.0 109.673 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 8.0 m-20 -81.98 91.89 6.68 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.476 HG22 ' HA ' ' A' ' 92' ' ' SER . 18.0 m -66.95 -27.66 67.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.304 -167.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.28 -38.95 66.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.794 0.331 . . . . 0.0 110.917 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -95.7 -34.88 11.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.101 0.477 . . . . 0.0 109.987 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.554 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -82.26 30.75 0.4 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.671 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -63.13 -26.74 68.96 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.539 ' CD ' ' HZ1' ' A' ' 16' ' ' LYS . 27.3 mt-10 -61.94 -45.33 94.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.617 175.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -70.8 -53.19 16.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.142 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.569 ' HA ' HD13 ' A' ' 90' ' ' ILE . . . -54.3 -51.51 64.41 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.496 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.55 -27.84 66.68 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.322 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.78 -26.99 67.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.645 0.26 . . . . 0.0 111.574 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.551 ' HB2' HG13 ' A' ' 90' ' ' ILE . 83.4 m-85 -100.86 -5.08 26.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.887 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.13 4.77 64.44 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.878 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 85' ' ' ALA . 36.8 mt -65.97 128.93 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -69.13 -53.42 20.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.265 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.476 ' HA ' HG22 ' A' ' 78' ' ' THR . 11.3 p 178.14 -94.83 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.714 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.492 HG22 ' C ' ' A' ' 46' ' ' TYR . 0.2 OUTLIER -145.07 157.59 53.6 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.613 -173.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.69 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 8.3 Cg_exo -83.53 133.39 20.86 Favored 'Cis proline' 0 N--CA 1.474 0.367 0 C-N-CA 124.71 -0.954 . . . . 0.0 111.995 -3.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.559 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 4.9 m -126.84 122.04 33.59 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 107' ' ' MET . 19.7 mm -114.36 114.66 47.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.205 -176.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.769 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.9 tp -99.77 114.76 28.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.015 0.436 . . . . 0.0 110.761 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.563 ' O ' ' HA ' ' A' ' 105' ' ' PRO . 97.5 m-85 -97.07 102.86 14.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.086 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.754 HG12 ' HB3' ' A' ' 105' ' ' PRO . 34.2 mt -107.02 106.46 58.35 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -176.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -87.1 165.9 8.36 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.771 2.314 . . . . 0.0 111.665 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.5 mmm -86.74 -1.93 58.13 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.981 0.419 . . . . 0.0 111.064 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -153.28 112.73 3.83 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 129.6 -136.17 8.81 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.852 ' HB3' ' HZ2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -137.38 151.16 70.81 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 175.313 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.754 ' HB3' HG12 ' A' ' 99' ' ' ILE . 3.8 Cg_exo -77.77 114.05 3.58 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.903 2.402 . . . . 0.0 111.22 175.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -95.69 167.18 11.44 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.315 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 49.0 ttm -140.06 130.97 26.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.444 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.97 141.66 48.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.44 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.486 ' OE1' ' HA ' ' A' ' 95' ' ' SER . 12.3 mm100 -106.13 134.73 48.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.874 0.369 . . . . 0.0 111.616 -175.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.69 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 114.39 177.15 19.06 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 169.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.578 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -94.2 87.61 5.32 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.508 -0.846 . . . . 0.0 111.932 -174.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.566 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 23.3 ptp -96.36 150.85 37.62 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.556 171.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.507 ' HA ' HD11 ' A' ' 59' ' ' ILE . 74.9 Cg_endo -75.49 173.19 14.92 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.343 2.029 . . . . 0.0 111.534 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.882 ' HB3' HG23 ' A' ' 59' ' ' ILE . 21.4 ptmt -63.17 -22.91 67.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.898 0.38 . . . . 0.0 110.284 177.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.97 -52.94 45.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.665 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 36.0 m -67.58 -34.06 76.27 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.235 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.528 ' HB2' ' HA ' ' A' ' 114' ' ' LYS . 7.3 m-85 -59.25 -47.01 86.97 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.489 174.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.812 ' HZ2' ' HB2' ' A' ' 122' ' ' ASP . 5.8 tmtm? -55.42 -35.92 65.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.346 0.117 . . . . 0.0 110.743 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.544 ' HZ3' ' CD ' ' A' ' 123' ' ' GLU . 62.0 tttm -64.03 -57.07 10.76 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.397 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.39 95.8 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.709 HG21 HD22 ' A' ' 125' ' ' LEU . 77.3 mt -59.46 -44.95 93.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.861 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.812 ' HB2' ' HZ2' ' A' ' 118' ' ' LYS . 10.0 t70 -62.79 -62.97 1.36 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.66 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.804 ' HA ' ' HZ2' ' A' ' 127' ' ' LYS . 62.2 mt-10 -63.13 -0.8 0.82 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -167.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 69.2 t80 -151.63 -48.41 0.11 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.649 -0.821 . . . . 0.0 112.528 175.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.709 HD22 HG21 ' A' ' 121' ' ' ILE . 42.4 tp -66.9 -30.62 70.81 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.633 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 74.6 mt -109.28 -56.3 2.31 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.854 0.835 . . . . 0.0 109.5 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.804 ' HZ2' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -108.13 80.39 1.36 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.331 -179.053 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.743 ' H ' ' HD3' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -80.63 112.28 17.84 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.275 0.56 . . . . 0.0 110.172 179.339 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.515 ' HB2' ' CE1' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -62.78 -22.51 66.66 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.669 177.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.3 -102.9 1.64 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.272 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 129' ' ' GLU . 33.8 m80 49.77 -86.95 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.985 0.914 . . . . 0.0 112.694 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -68.06 -8.8 40.97 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.786 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -125.2 -84.77 0.64 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -78.45 97.07 5.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -65.44 -54.41 28.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 69.8 t60 . . . . . 0 C--O 1.241 0.612 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.637 177.417 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttm . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -85.96 -170.89 3.31 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 172.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.79 -68.35 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.702 0.287 . . . . 0.0 110.464 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -168.65 -80.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.686 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.0 m 63.33 88.95 0.09 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.514 0.673 . . . . 0.0 110.177 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.482 ' O ' ' HD3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -98.45 116.82 31.5 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.508 0.671 . . . . 0.0 112.092 -172.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.4 67.05 3.39 Favored Glycine 0 C--O 1.222 -0.597 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.599 HD22 ' HA2' ' A' ' 69' ' ' GLY . 6.0 t30 -144.76 109.8 5.1 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 122.324 0.25 . . . . 0.0 110.684 -172.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.2 1.65 81.38 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.488 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -135.8 175.26 9.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.968 0.413 . . . . 0.0 110.431 178.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.835 HG21 ' HB ' ' A' ' 73' ' ' ILE . 39.7 t -114.02 143.35 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.244 -172.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.8 mt -124.3 107.96 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.734 172.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.729 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 9.8 p80 -83.32 116.31 22.39 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 173.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.699 HD23 ' HB3' ' A' ' 18' ' ' GLU . 1.1 pp -132.92 179.99 5.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.985 -166.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.686 HG22 ' HE2' ' A' ' 80' ' ' LYS . 66.4 p -94.0 175.25 6.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.589 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.464 ' HD2' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -59.62 -32.28 70.28 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 121.233 -0.187 . . . . 0.0 111.233 177.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.552 ' HA ' HD12 ' A' ' 20' ' ' LEU . . . -62.84 -41.89 99.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.468 0.651 . . . . 0.0 110.218 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.699 ' HB3' HD23 ' A' ' 14' ' ' LEU . 8.4 mm-40 -71.72 -36.4 70.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.366 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -56.92 -50.72 71.71 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 122.388 1.089 . . . . 0.0 109.452 175.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.568 HD22 HD21 ' A' ' 25' ' ' ASN . 16.1 mt -50.34 -59.0 4.41 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 112.838 -1.983 . . . . 0.0 111.857 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.3 -17.87 38.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -171.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.643 ' HZ1' ' CD ' ' A' ' 18' ' ' GLU . 55.1 mttp -110.81 -1.37 16.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.6 t -140.34 -50.69 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.514 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 7.5 t80 -175.14 116.02 0.16 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.155 0.502 . . . . 0.0 110.64 -167.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.568 HD21 HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -87.19 90.97 8.55 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.242 -177.265 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.514 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 18.9 p90 -78.4 14.96 1.07 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.83 -46.75 7.7 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.565 ' C ' HD21 ' A' ' 29' ' ' ASN . 49.9 mttp -96.31 -21.1 18.02 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.069 -173.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.609 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -121.11 62.97 11.63 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.366 177.212 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -61.26 -42.1 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.762 2.308 . . . . 0.0 112.374 172.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -103.02 -24.16 13.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.303 -176.365 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.445 ' CD ' ' HZ1' ' A' ' 34' ' ' LYS . 35.8 mt-10 -90.13 148.96 22.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.199 0.523 . . . . 0.0 111.259 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -113.95 93.77 4.52 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 168.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HZ1' ' CD ' ' A' ' 32' ' ' GLU . 35.7 mtmm -117.51 106.33 13.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.402 173.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.577 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 30.2 t80 -68.14 105.12 1.97 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.368 0.604 . . . . 0.0 109.831 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -90.22 84.22 6.06 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.565 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.577 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -149.52 -135.69 2.51 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.731 -174.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -141.54 -55.34 0.47 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.898 0.38 . . . . 0.0 111.055 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 43.6 mttp -129.33 168.71 15.27 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.814 -177.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 65.8 Cg_exo -49.18 131.36 26.3 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.99 1.794 . . . . 0.0 111.393 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -115.32 143.23 45.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.365 -170.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.679 ' HB ' HG12 ' A' ' 73' ' ' ILE . 65.4 mt -120.33 122.49 68.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.124 176.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 16.5 t -105.74 116.02 48.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.894 0.378 . . . . 0.0 110.984 -178.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.763 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 11.3 t0 -97.78 108.11 20.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.634 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -91.27 111.64 23.21 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.545 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 0.8 OUTLIER -147.02 178.6 8.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.735 0.779 . . . . 0.0 111.286 -172.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.65 124.07 5.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.855 -1.52 . . . . 0.0 107.449 170.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.28 -23.06 67.25 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -169.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -74.95 -14.07 60.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.951 0.405 . . . . 0.0 110.766 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.1 t -99.64 132.93 44.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.475 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.543 ' O ' ' HG2' ' A' ' 54' ' ' LYS . . . -49.14 -68.23 1.42 Allowed Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.716 -0.674 . . . . 0.0 114.672 -175.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -58.71 -34.27 98.84 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.71 2.273 . . . . 0.0 113.107 -175.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.761 ' HG ' ' HB ' ' A' ' 93' ' ' ILE . 11.9 m -73.98 -33.88 64.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.896 0.379 . . . . 0.0 111.514 -176.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 0.2 OUTLIER -78.85 -27.2 44.11 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.571 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 16.4 ttt -66.93 -52.41 43.46 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.166 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.473 HG22 HD23 ' A' ' 60' ' ' LEU . 3.9 p -63.45 -36.77 77.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.046 -174.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.638 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . . . -48.07 -60.28 4.58 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.326 -176.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.638 ' HD3' ' HB2' ' A' ' 57' ' ' ALA . 27.3 Cg_exo -62.21 -27.49 78.46 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.231 1.287 . . . . 0.0 112.272 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 55' ' ' MET . 45.0 mm -66.19 -57.28 11.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.34 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.582 HD22 ' NZ ' ' A' ' 75' ' ' LYS . 1.2 pt? -71.69 -30.03 65.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.178 -177.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.476 ' OD1' HG23 ' A' ' 11' ' ' VAL . 5.6 m-20 -66.43 -42.54 87.56 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.458 0.647 . . . . 0.0 109.846 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.945 ' HG3' ' HZ2' ' A' ' 114' ' ' LYS . 9.8 tp10 -54.79 -43.3 72.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.925 172.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.768 HD23 ' HA ' ' A' ' 118' ' ' LYS . 12.9 tp -71.52 -30.79 66.34 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.073 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.526 ' HB1' HD13 ' A' ' 73' ' ' ILE . . . -58.73 -59.07 6.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.745 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -64.7 -24.26 67.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.231 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -58.54 -30.86 67.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.462 0.649 . . . . 0.0 110.044 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.49 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 81.3 m-85 -113.75 25.74 10.96 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.447 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -52.36 114.46 1.37 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.93 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.599 ' HA2' HD22 ' A' ' 8' ' ' ASN . . . 129.04 -22.24 5.13 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.414 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 6.4 pt20 -127.55 -22.3 3.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' A' ' 64' ' ' ALA . 44.0 pt -125.24 150.34 30.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.418 0.628 . . . . 0.0 112.218 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 47.2 t -127.27 132.09 69.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.284 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.835 ' HB ' HG21 ' A' ' 11' ' ' VAL . 11.8 mt -115.62 136.45 52.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.474 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -117.1 161.19 19.82 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.763 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 63.8 mttm -129.69 148.21 51.56 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.012 0.434 . . . . 0.0 110.23 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.418 HG13 ' CB ' ' A' ' 81' ' ' GLU . 17.4 t -120.64 111.83 33.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.739 176.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.42 89.2 2.64 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 92' ' ' SER . 7.9 p -52.87 -36.96 59.78 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -168.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -53.43 -33.22 53.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.568 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.686 ' HE2' HG22 ' A' ' 15' ' ' THR . 18.1 pttm -103.45 -22.21 13.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.397 0.618 . . . . 0.0 110.161 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.486 ' OE1' ' HA ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -100.11 43.24 1.07 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.657 178.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -55.1 -46.71 75.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.964 0.411 . . . . 0.0 111.419 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -64.55 -38.74 92.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.735 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -70.05 -44.88 68.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.966 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.04 89.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.035 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.51 -29.5 73.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.963 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.54 -26.45 65.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 111.54 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -99.17 7.24 45.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.054 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.29 16.64 80.56 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.324 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.4 mm -77.63 122.11 31.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -58.88 -61.8 2.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.505 0.669 . . . . 0.0 109.592 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.522 ' O ' HG22 ' A' ' 78' ' ' THR . 13.9 m -160.82 -79.71 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.674 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.761 ' HB ' ' HG ' ' A' ' 53' ' ' CYS . 4.5 pt -162.02 152.77 14.75 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.182 -172.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.736 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.6 Cg_exo -90.01 149.54 22.61 Favored 'Cis proline' 0 C--N 1.348 0.552 0 CA-C-N 118.869 0.632 . . . . 0.0 112.286 -3.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.415 ' HB3' ' SD ' ' A' ' 107' ' ' MET . 50.1 m -142.67 140.99 31.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.58 114.48 20.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.156 0.503 . . . . 0.0 110.138 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 43.7 tp -97.31 115.25 27.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.455 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.417 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 44.3 m-85 -96.2 104.68 16.65 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.409 HG22 ' HG3' ' A' ' 105' ' ' PRO . 53.8 mt -102.57 102.83 28.33 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.347 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 98' ' ' PHE . 73.8 Cg_endo -83.7 155.66 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.579 2.186 . . . . 0.0 111.763 174.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.406 ' SD ' ' HD3' ' A' ' 40' ' ' PRO . 90.4 mtp -75.27 -30.35 60.41 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -106.5 138.93 41.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.633 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.2 -140.1 16.61 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.922 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.651 ' HE3' ' HA ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -139.38 154.65 71.97 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.575 ' HD3' ' HE3' ' A' ' 104' ' ' LYS . 15.6 Cg_exo -69.47 154.34 69.01 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.1 2.533 . . . . 0.0 113.574 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.463 ' O ' HD11 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.56 169.72 9.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.829 176.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.415 ' SD ' ' HB3' ' A' ' 95' ' ' SER . 32.9 tpp -142.37 105.61 4.61 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.107 -174.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.93 137.37 42.01 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -117.41 137.74 52.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.159 0.504 . . . . 0.0 111.536 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.736 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 103.16 170.43 26.05 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.967 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -94.69 82.75 3.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.095 0.474 . . . . 0.0 111.65 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.556 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 22.0 ptt? -79.59 166.44 41.22 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 170.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.556 ' HD2' ' HB2' ' A' ' 112' ' ' MET . 65.9 Cg_endo -75.17 170.73 19.73 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.558 1.505 . . . . 0.0 112.541 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.945 ' HZ2' ' HG3' ' A' ' 62' ' ' GLU . 60.5 tttp -57.54 -25.37 59.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.971 174.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.64 -52.44 31.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.336 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.5 m -68.04 -37.74 81.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.697 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.674 ' O ' HG12 ' A' ' 121' ' ' ILE . 12.7 m-85 -61.48 -43.56 98.64 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.634 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.768 ' HA ' HD23 ' A' ' 63' ' ' LEU . 64.6 tttp -60.6 -38.84 86.01 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.108 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.584 ' HZ2' ' CD ' ' A' ' 123' ' ' GLU . 27.4 mtpp -62.87 -43.93 97.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.869 0.366 . . . . 0.0 110.741 177.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -64.0 -41.1 97.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.253 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.674 HG12 ' O ' ' A' ' 117' ' ' PHE . 16.3 mm -74.93 -53.9 15.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.437 0.637 . . . . 0.0 110.998 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.525 ' HA ' HD13 ' A' ' 126' ' ' LEU . 19.0 t70 -68.45 -66.03 0.62 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.314 -173.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.584 ' CD ' ' HZ2' ' A' ' 119' ' ' LYS . 38.0 mt-10 -64.6 -49.36 71.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.767 -174.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.534 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 79.2 t80 -86.09 -37.61 18.65 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -170.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.612 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 29.5 tp -90.52 -38.31 13.29 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.525 HD13 ' HA ' ' A' ' 122' ' ' ASP . 79.6 mt -89.07 -66.84 0.88 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.911 0.386 . . . . 0.0 111.689 -173.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.04 81.65 5.61 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -51.69 96.9 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.282 0.989 . . . . 0.0 111.983 -170.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -19.41 12.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.7 170.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.56 -19.01 39.9 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.532 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -58.02 -34.76 70.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.89 0.376 . . . . 0.0 110.162 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -147.82 61.58 1.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.896 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -78.07 68.72 4.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.423 0.63 . . . . 0.0 109.468 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -169.21 155.73 6.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -76.99 43.92 0.37 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.852 -0.594 . . . . 0.0 109.508 175.56 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.489 ' HB3' HD23 ' A' ' 3' ' ' LEU . 1.8 mpt? . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.147 0.022 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.6 m 75.82 -31.2 0.2 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.346 0.658 . . . . 0.0 112.674 174.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.489 HD23 ' HB3' ' A' ' 1' ' ' MET . 2.6 pt? -78.15 16.9 0.68 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.76 0.315 . . . . 0.0 111.483 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.64 157.5 9.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.964 0.412 . . . . 0.0 111.047 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.6 t -99.82 14.95 28.56 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.987 0.423 . . . . 0.0 111.372 -175.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.3 125.73 45.58 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.601 ' HA2' ' HE2' ' A' ' 10' ' ' LYS . . . -141.59 28.27 2.31 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.74 -174.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.41 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 29.2 m-80 -72.88 134.76 44.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.244 0.522 . . . . 0.0 110.667 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.598 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . 69.84 22.2 76.88 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.749 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.601 ' HE2' ' HA2' ' A' ' 7' ' ' GLY . 17.8 pttm -162.83 171.74 16.23 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 121.286 0.565 . . . . 0.0 110.968 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.528 HG23 ' HE3' ' A' ' 75' ' ' LYS . 7.9 m -113.16 145.08 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.382 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.1 mt -114.38 96.76 4.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.058 174.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 75' ' ' LYS . 27.1 p80 -77.71 121.89 24.63 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.737 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.4 pp -138.38 178.63 7.0 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.228 0.537 . . . . 0.0 112.282 -169.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.592 HG21 ' HE2' ' A' ' 80' ' ' LYS . 42.6 p -98.42 171.39 8.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.484 175.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.487 ' HZ2' ' CD ' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -56.06 -33.09 64.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 178.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.05 -42.01 90.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.35 0.595 . . . . 0.0 110.293 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.737 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 30.2 mt-10 -71.62 -32.27 67.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.123 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -57.31 -52.86 63.65 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-O 122.401 1.096 . . . . 0.0 109.285 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 7.9 mt -50.63 -59.58 3.91 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.634 -2.075 . . . . 0.0 111.893 -176.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.58 -8.01 59.66 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -171.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -109.43 -32.43 7.16 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 31.0 t -123.5 -40.13 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -168.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.576 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 14.6 t80 -167.63 120.04 0.9 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.921 -166.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.72 90.82 7.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.011 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.576 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 27.0 p90 -85.29 18.49 2.62 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 111.667 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -94.54 -49.57 5.59 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.547 ' C ' HD21 ' A' ' 29' ' ' ASN . 47.4 mttp -96.65 -21.6 17.52 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.153 -175.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.607 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -121.7 68.29 22.91 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.618 176.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.92 -32.28 97.12 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.547 2.831 . . . . 0.0 112.613 173.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -102.52 -40.3 6.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -172.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 3.2 tp10 -100.78 132.29 46.25 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.466 0.65 . . . . 0.0 111.705 -174.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -69.46 93.2 0.65 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.654 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -93.11 97.15 10.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.529 177.31 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.561 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 23.0 t80 -81.39 127.53 32.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.989 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -109.43 151.95 26.0 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 168.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.88 -127.63 2.19 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.809 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.447 ' CG ' ' HZ3' ' A' ' 39' ' ' LYS . 5.9 t0 -163.74 -60.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.019 0.437 . . . . 0.0 110.396 -173.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.447 ' HZ3' ' CG ' ' A' ' 38' ' ' ASP . 22.0 mttm -119.08 165.79 16.08 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.442 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 85.9 Cg_exo -44.2 131.74 8.87 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.68 2.253 . . . . 0.0 111.838 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -113.22 146.31 39.53 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.212 0.529 . . . . 0.0 111.764 -171.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.682 ' HB ' HG12 ' A' ' 73' ' ' ILE . 74.8 mt -122.4 122.53 66.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.063 174.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 21.5 t -107.28 110.06 30.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.399 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.594 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 30.1 t0 -86.74 106.59 17.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.998 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.554 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 96.6 m-85 -91.88 111.89 23.6 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.619 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.6 p90 -140.63 -179.87 6.28 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.832 -171.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.412 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -159.09 142.71 14.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.492 170.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.47 -28.96 68.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -76.75 -9.79 58.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.235 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.444 ' HB2' HD11 ' A' ' 93' ' ' ILE . 47.0 t -99.15 112.38 24.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.936 0.398 . . . . 0.0 110.643 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.08 -54.3 38.6 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.607 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.49 -38.46 27.71 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.952 2.434 . . . . 0.0 113.532 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.714 ' SG ' ' HB ' ' A' ' 93' ' ' ILE . 83.0 m -67.06 -43.86 81.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.38 . . . . 0.0 111.143 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -72.48 -26.04 61.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.93 0.395 . . . . 0.0 110.184 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -60.05 -46.97 87.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.669 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.583 ' HB ' ' HE2' ' A' ' 117' ' ' PHE . 30.4 m -87.16 -25.17 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.479 ' HB1' ' HD3' ' A' ' 58' ' ' PRO . . . -43.74 -59.93 3.08 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.479 ' HD3' ' HB1' ' A' ' 57' ' ' ALA . 50.2 Cg_endo -68.57 -26.78 33.49 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.725 1.617 . . . . 0.0 112.0 -177.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.07 -54.95 21.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.347 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.55 HD11 ' HE2' ' A' ' 75' ' ' LYS . 1.7 pp -69.03 -30.84 69.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.51 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.08 -49.98 75.53 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.246 0.546 . . . . 0.0 110.741 173.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -64.56 -36.24 83.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.41 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.45 -31.3 67.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.425 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.598 ' O ' ' HA2' ' A' ' 9' ' ' GLY . . . -56.98 -42.34 80.05 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 173.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.627 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 3.7 tmtm? -71.79 -41.22 68.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.043 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -56.54 -39.54 73.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.964 0.411 . . . . 0.0 110.739 176.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.441 ' OH ' ' HB3' ' A' ' 122' ' ' ASP . 83.8 m-85 -98.54 26.67 5.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.345 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 58.0 t0 -53.39 129.79 33.17 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.477 0.311 . . . . 0.0 110.666 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.53 -6.54 83.49 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.304 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.404 HE21 ' HA ' ' A' ' 67' ' ' TYR . 44.1 mt-30 -112.47 -44.34 3.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.607 0.242 . . . . 0.0 111.008 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.424 HG21 ' HB2' ' A' ' 40' ' ' PRO . 45.1 pt -128.89 159.05 41.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.147 0.499 . . . . 0.0 111.822 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 96.6 t -126.86 123.82 63.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.233 176.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.682 HG12 ' HB ' ' A' ' 42' ' ' ILE . 15.2 mt -107.62 138.32 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.72 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -118.01 162.31 18.37 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 173.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.594 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 55.8 mttt -135.91 144.46 45.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.889 0.376 . . . . 0.0 111.147 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.715 HG12 ' HG2' ' A' ' 81' ' ' GLU . 37.3 t -138.41 134.48 43.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.853 -175.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.464 ' HB2' ' HG2' ' A' ' 80' ' ' LYS . 7.5 m-20 -94.52 102.06 13.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 92' ' ' SER . 16.8 p -52.94 -37.41 60.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.2 0.524 . . . . 0.0 111.67 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -54.9 -36.28 65.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.981 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.592 ' HE2' HG21 ' A' ' 15' ' ' THR . 21.6 pttm -100.59 -20.39 15.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.357 0.599 . . . . 0.0 110.076 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.715 ' HG2' HG12 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -97.86 45.25 1.03 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.483 176.015 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -55.89 -53.31 58.38 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.58 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.487 ' CD ' ' HZ2' ' A' ' 16' ' ' LYS . 2.2 mp0 -61.85 -36.88 82.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.618 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.422 HD23 ' HG2' ' A' ' 81' ' ' GLU . 41.4 tp -67.86 -41.7 82.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.529 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.548 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -67.0 -44.54 80.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.67 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.14 -32.89 82.15 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.684 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.85 -35.37 76.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.814 0.34 . . . . 0.0 111.588 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.502 ' HB2' HG13 ' A' ' 90' ' ' ILE . 94.6 m-85 -97.26 3.06 51.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.854 0.359 . . . . 0.0 110.81 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.13 28.46 73.7 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.11 -176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.637 HG12 ' HE3' ' A' ' 107' ' ' MET . 28.9 mt -66.08 138.82 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -64.09 -61.39 2.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.445 ' O ' HG23 ' A' ' 78' ' ' THR . 24.3 p 175.65 -91.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.75 175.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.714 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 8.0 pt -151.55 146.34 18.77 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.881 -172.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.667 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 17.3 Cg_exo -78.59 142.78 70.09 Favored 'Cis proline' 0 N--CA 1.478 0.561 0 C-N-CA 124.78 -0.925 . . . . 0.0 112.037 -3.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.554 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 14.7 m -139.37 112.35 8.0 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.73 114.39 46.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.028 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.581 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 34.8 tp -92.96 113.18 25.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.714 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -94.23 112.39 24.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.88 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.471 HD13 ' HB1' ' A' ' 41' ' ' ALA . 36.9 mt -101.24 102.9 22.88 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.908 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.09 163.09 22.97 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.576 2.184 . . . . 0.0 112.325 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 92.6 mmm -87.39 -0.04 56.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.332 0.587 . . . . 0.0 109.559 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.564 ' HB3' ' HG2' ' A' ' 128' ' ' LYS . 1.1 tm-20 -138.2 123.68 19.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.928 177.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.25 -149.57 19.45 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.08 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.449 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 27.2 mmmt -123.31 159.1 56.26 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 104' ' ' LYS . 57.6 Cg_endo -70.48 154.1 65.13 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.564 2.176 . . . . 0.0 113.45 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -125.83 167.94 14.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.494 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.637 ' HE3' HG12 ' A' ' 90' ' ' ILE . 42.9 ttm -130.26 122.06 27.31 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.043 0.449 . . . . 0.0 112.029 -175.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.05 132.23 50.51 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -115.37 136.2 53.34 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.284 0.564 . . . . 0.0 112.437 -172.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.667 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 104.7 -175.6 22.55 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.173 -0.921 . . . . 0.0 114.898 169.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.471 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -92.12 85.64 5.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.026 -0.587 . . . . 0.0 111.633 -171.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.55 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 25.1 ptp -91.4 154.89 44.52 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.463 172.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 71.7 Cg_endo -75.44 177.54 8.52 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.28 1.987 . . . . 0.0 111.687 -177.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -58.85 -33.77 70.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 174.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.78 -52.86 61.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.529 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 34.6 m -66.7 -40.73 88.6 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.736 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.583 ' HE2' ' HB ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -60.93 -40.79 94.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.537 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.498 ' HZ1' ' CG ' ' A' ' 122' ' ' ASP . 14.6 tmtt? -58.97 -49.82 76.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.892 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.56 ' HA ' ' OD1' ' A' ' 122' ' ' ASP . 12.9 mptt -64.64 -39.86 94.43 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.951 0.405 . . . . 0.0 110.797 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -58.51 -38.9 78.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.611 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.505 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 74.7 mt -75.04 -56.29 9.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.472 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.56 ' OD1' ' HA ' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -74.24 -58.87 3.01 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.918 -173.036 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.26 -22.47 63.83 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -171.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.475 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 91.6 t80 -110.47 -46.29 3.42 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.973 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.505 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 36.7 tp -90.39 -41.64 11.36 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -172.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.503 ' HB3' ' HA ' ' A' ' 122' ' ' ASP . 45.3 tp -83.49 -52.5 6.44 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 121.392 0.615 . . . . 0.0 109.751 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 127' ' ' LYS . 30.1 mtmt -99.97 73.86 1.77 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.564 ' HG2' ' HB3' ' A' ' 102' ' ' GLU . 24.4 tptp -48.42 99.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 O-C-N 124.096 0.873 . . . . 0.0 111.887 -175.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -175.33 2.8 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.704 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.25 8.04 23.93 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -173.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -133.28 58.97 1.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.6 t60 -81.52 66.73 7.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.375 -169.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -89.47 -50.64 5.98 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 164.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -171.66 62.83 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.08 163.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -77.52 -19.54 55.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.691 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.246 0.887 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.348 173.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.69 0.281 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.0 m -83.35 112.51 19.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.619 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.6 tt -98.46 -54.6 2.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.41 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -126.45 29.09 5.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.867 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.574 HG21 HG23 ' A' ' 72' ' ' VAL . 19.4 m 67.14 87.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.231 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.456 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 5.0 pm0 -74.2 -11.13 60.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.926 -178.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.403 ' O ' HG12 ' A' ' 72' ' ' VAL . . . -86.43 25.35 7.26 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.29 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.585 HD22 ' HA2' ' A' ' 69' ' ' GLY . 4.5 t30 -69.9 113.04 6.75 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 122.376 0.271 . . . . 0.0 110.823 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.537 ' HA3' ' CG ' ' A' ' 68' ' ' ASP . . . 69.0 31.85 72.76 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.058 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.474 ' HZ1' ' HB3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -166.98 172.09 10.53 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.339 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 12.9 p -113.36 132.21 62.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.713 0.768 . . . . 0.0 112.097 -176.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.0 mt -121.49 128.88 75.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.736 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.574 ' CB ' ' HG3' ' A' ' 75' ' ' LYS . 1.9 p80 -88.01 129.53 35.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.3 pp -133.21 173.98 10.87 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.918 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.43 166.97 12.59 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.852 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.742 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 30.7 pttt -62.16 -26.65 68.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.061 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.0 86.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.281 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 28.2 mm-40 -68.61 -43.58 76.08 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.868 176.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -57.39 -49.8 75.03 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 121.933 0.873 . . . . 0.0 109.502 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 25' ' ' ASN . 1.1 tt -48.64 -61.47 2.01 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 113.648 -1.615 . . . . 0.0 112.098 -178.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.09 -18.83 33.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.588 -168.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 34.5 ttmt -108.78 -16.87 14.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -172.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.45 -45.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.508 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 18.5 t80 -164.42 116.74 1.31 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.236 0.541 . . . . 0.0 111.261 -169.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.529 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -84.15 89.05 7.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.99 -177.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.497 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 27.2 p90 -82.81 4.88 23.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.644 0.735 . . . . 0.0 110.698 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -95.43 -52.27 4.22 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.253 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.579 ' C ' HD21 ' A' ' 29' ' ' ASN . 67.6 mttm -84.27 -27.77 27.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.287 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.649 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -120.71 69.04 16.24 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-O 120.862 0.363 . . . . 0.0 111.223 -177.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -64.12 -28.23 65.16 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.449 2.766 . . . . 0.0 112.306 171.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -31.46 8.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.752 -175.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -91.81 144.37 25.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.055 0.455 . . . . 0.0 111.407 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -91.94 89.47 7.02 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 171.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 87.2 tttt -94.23 97.58 10.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.007 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -99.31 120.6 39.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.054 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -112.0 114.51 27.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.218 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.84 163.52 33.16 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.496 ' OD2' ' HG3' ' A' ' 39' ' ' LYS . 12.0 p-10 -95.71 -37.32 10.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.949 0.375 . . . . 0.0 111.181 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.496 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 56.5 mttp -117.54 166.28 13.7 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.505 179.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.544 ' HB2' HD22 ' A' ' 125' ' ' LEU . 32.1 Cg_exo -59.8 141.03 96.03 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.746 2.297 . . . . 0.0 111.56 174.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -119.91 147.43 44.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.342 0.591 . . . . 0.0 112.365 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.738 ' HB ' HG12 ' A' ' 73' ' ' ILE . 4.2 mp -121.12 133.38 67.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.311 172.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 41.9 t -128.31 114.07 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.126 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.593 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 8.6 p-10 -100.41 115.87 31.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 122.222 1.01 . . . . 0.0 111.622 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.535 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 30.0 m-85 -81.1 112.88 18.87 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.431 -1.258 . . . . 0.0 108.936 173.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.687 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.8 p90 -129.91 168.17 17.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.503 0.668 . . . . 0.0 111.415 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.89 131.01 26.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.271 -1.332 . . . . 0.0 107.841 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.546 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 27.9 t70 -60.12 -34.34 73.37 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -171.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -71.57 -9.33 58.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.681 0.277 . . . . 0.0 111.62 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 48.0 t -95.64 123.55 39.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.92 0.39 . . . . 0.0 110.607 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.55 -59.01 10.27 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.755 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 77.4 Cg_exo -48.78 -36.71 34.04 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.047 2.498 . . . . 0.0 113.202 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.687 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 98.0 m -64.3 -44.89 90.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.99 0.424 . . . . 0.0 111.199 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 66.6 mttm -59.99 -29.71 68.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.905 175.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.55 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 75.0 mtp -71.59 -54.48 10.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.953 0.406 . . . . 0.0 111.16 177.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.48 HG23 HD11 ' A' ' 96' ' ' ILE . 10.2 p -68.6 -36.95 76.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -170.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.625 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -52.06 -55.79 27.74 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.625 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 16.8 Cg_exo -68.35 -42.62 5.25 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 121.938 1.759 . . . . 0.0 112.14 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 73.1 mt -58.54 -41.04 80.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.08 0.467 . . . . 0.0 110.769 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.698 HD23 HD13 ' A' ' 73' ' ' ILE . 1.3 mt -67.03 -38.28 85.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.898 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.29 -37.06 80.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.184 0.516 . . . . 0.0 109.802 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 59' ' ' ILE . 14.5 tp10 -54.37 -46.05 72.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.692 174.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.536 HD21 ' HA ' ' A' ' 114' ' ' LYS . 4.3 mm? -72.02 -35.12 69.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.807 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.566 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -57.16 -52.0 67.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.27 -25.92 62.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.099 -178.15 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.457 ' CD ' ' HZ1' ' A' ' 114' ' ' LYS . 1.8 tt0 -71.73 -19.83 61.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.329 0.585 . . . . 0.0 110.15 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.44 ' HD1' ' O ' ' A' ' 63' ' ' LEU . 85.7 m-85 -117.23 25.84 10.18 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.682 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.537 ' CG ' ' HA3' ' A' ' 9' ' ' GLY . 11.3 t0 -58.65 121.57 11.32 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.234 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.585 ' HA2' HD22 ' A' ' 8' ' ' ASN . . . 118.64 -28.45 6.75 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.26 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.469 ' HG3' HG23 ' A' ' 71' ' ' ILE . 17.6 pt20 -114.73 -28.21 7.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -176.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.469 HG23 ' HG3' ' A' ' 70' ' ' GLN . 37.5 pt -122.99 158.12 27.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.859 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.574 HG23 HG21 ' A' ' 5' ' ' THR . 94.4 t -130.06 128.04 64.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.423 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.738 HG12 ' HB ' ' A' ' 42' ' ' ILE . 29.3 mt -121.6 135.22 62.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.465 0.65 . . . . 0.0 111.371 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 63.8 m-85 -122.7 164.56 18.05 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 173.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.593 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -136.65 149.8 48.17 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 174.185 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.528 HG13 ' HG2' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -122.75 137.14 57.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.441 -171.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.543 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 10.5 m-20 -87.82 86.57 7.18 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.644 HG22 ' HA ' ' A' ' 92' ' ' SER . 15.3 m -56.06 -29.75 60.95 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -169.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -53.42 -31.03 43.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.647 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.543 ' HE3' ' HB2' ' A' ' 77' ' ' ASP . 22.2 pttp -109.82 -23.78 11.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.196 0.522 . . . . 0.0 110.492 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.742 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 1.3 mp0 -85.93 39.63 0.82 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.424 175.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -61.95 -47.92 82.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.696 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.522 ' CD ' ' HZ1' ' A' ' 16' ' ' LYS . 5.7 mp0 -62.22 -38.95 91.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.218 0.532 . . . . 0.0 110.192 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.1 tp -61.03 -44.54 97.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.42 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.567 ' HA ' HD13 ' A' ' 90' ' ' ILE . . . -63.96 -49.08 73.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.753 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.65 -30.99 66.4 Favored Glycine 0 CA--C 1.517 0.181 0 CA-C-N 116.081 -0.509 . . . . 0.0 113.206 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.75 -33.32 73.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.752 0.31 . . . . 0.0 111.707 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.544 ' HB2' HG13 ' A' ' 90' ' ' ILE . 89.5 m-85 -104.15 7.47 36.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.174 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.67 30.63 68.35 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.799 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.567 HD13 ' HA ' ' A' ' 85' ' ' ALA . 55.6 mt -80.69 131.94 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.642 0.258 . . . . 0.0 110.524 -177.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.0 mtm105 -57.45 -64.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.666 0.746 . . . . 0.0 109.933 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.644 ' HA ' HG22 ' A' ' 78' ' ' THR . 13.0 p 177.17 -93.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.633 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -139.56 148.37 55.85 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.357 -175.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.715 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.1 Cg_exo -85.36 150.19 50.43 Favored 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 124.077 -1.218 . . . . 0.0 111.279 -3.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 11.6 m -141.36 140.19 33.69 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.489 HD12 ' HE1' ' A' ' 112' ' ' MET . 60.1 mt -136.24 117.76 19.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 119.025 0.83 . . . . 0.0 111.201 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.499 HD12 ' HB2' ' A' ' 105' ' ' PRO . 20.3 tp -98.26 114.35 26.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.209 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.587 ' HE2' ' HB1' ' A' ' 108' ' ' ALA . 96.6 m-85 -96.78 110.79 23.19 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.0 mt -103.3 105.97 49.13 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.819 0.343 . . . . 0.0 111.899 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 98' ' ' PHE . 2.9 Cg_exo -76.16 159.27 37.25 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.413 2.742 . . . . 0.0 111.5 172.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 89.8 mtp -83.02 -32.15 27.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.636 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.07 -30.91 7.83 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.91 0.862 . . . . 0.0 110.764 -177.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.69 -156.03 24.4 Favored Glycine 0 C--N 1.307 -1.031 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.99 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 35.2 mmtm -129.81 148.54 69.93 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.567 ' HA ' ' O ' ' A' ' 98' ' ' PHE . 38.3 Cg_endo -63.62 134.38 43.94 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.887 2.391 . . . . 0.0 113.854 -170.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.32 169.64 8.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.423 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 36.1 tpp -136.13 101.92 4.85 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.859 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.587 ' HB1' ' HE2' ' A' ' 98' ' ' PHE . . . -107.8 129.88 55.02 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 173.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.557 ' HB3' ' O ' ' A' ' 94' ' ' PRO . 58.4 mt-30 -117.51 128.52 55.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.149 0.499 . . . . 0.0 111.93 -171.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.715 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 133.12 -169.21 22.69 Favored Glycine 0 CA--C 1.506 -0.487 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.141 176.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.31 80.66 1.44 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.556 0.693 . . . . 0.0 110.858 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.671 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 5.0 mpp? -77.81 147.85 74.91 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.467 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.84 -177.69 3.8 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.052 2.502 . . . . 0.0 111.943 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.536 ' HA ' HD21 ' A' ' 63' ' ' LEU . 36.5 ttmt -60.13 -33.3 71.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 0.0 110.37 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.38 -52.9 59.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.558 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.671 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 20.3 m -70.31 -29.94 66.8 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.932 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.567 ' O ' HG13 ' A' ' 121' ' ' ILE . 5.4 m-85 -71.67 -37.29 70.77 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.426 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.433 ' HZ1' ' HB3' ' A' ' 122' ' ' ASP . 3.7 tttm -57.75 -43.99 85.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.847 0.356 . . . . 0.0 110.119 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.511 ' HG2' ' OE2' ' A' ' 123' ' ' GLU . 31.0 mtpp -64.14 -38.48 91.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.679 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -67.5 -45.22 76.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.489 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 117' ' ' PHE . 20.9 mt -74.38 -57.25 6.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.306 0.574 . . . . 0.0 110.472 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.499 ' HA ' HD13 ' A' ' 126' ' ' LEU . 22.2 t70 -72.42 -65.04 0.83 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.285 -175.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.511 ' OE2' ' HG2' ' A' ' 119' ' ' LYS . 34.5 mt-10 -75.47 -9.21 58.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.423 -168.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 89.2 t80 -120.81 -52.49 2.11 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.938 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.553 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 32.9 tp -72.75 -32.35 65.6 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.366 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.542 ' O ' ' HE3' ' A' ' 128' ' ' LYS . 64.5 mt -101.17 -59.69 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.112 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -87.29 -10.19 52.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.892 -172.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.542 ' HE3' ' O ' ' A' ' 126' ' ' LEU . 0.7 OUTLIER 30.77 82.66 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.488 1.117 . . . . 0.0 113.312 -177.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -67.91 160.61 28.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.523 -176.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 118.45 -9.93 13.04 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.975 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.408 ' HD2' ' O ' ' A' ' 128' ' ' LYS . 82.7 m-70 -76.52 73.99 3.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.249 0.547 . . . . 0.0 112.106 -174.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -80.11 -24.46 40.5 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 171.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.462 ' HD1' ' C ' ' A' ' 136' ' ' HIS . 45.1 m-70 -111.25 142.86 42.91 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 167.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -89.24 -67.85 0.81 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.075 0.464 . . . . 0.0 109.942 -174.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -143.26 18.23 1.9 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.462 ' C ' ' HD1' ' A' ' 133' ' ' HIS . 66.9 t60 . . . . . 0 C--O 1.242 0.704 0 CA-C-N 113.619 -1.628 . . . . 0.0 107.763 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.45 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -142.23 150.04 40.43 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.2 tp -89.46 -30.72 18.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.313 0.577 . . . . 0.0 110.306 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -118.55 110.29 17.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.839 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER 56.79 -147.21 0.53 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -175.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.419 ' OE2' ' NZ ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -131.75 -52.09 0.99 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.612 0.642 . . . . 0.0 111.796 178.278 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.84 22.81 23.28 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.038 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.468 ' HA ' HG21 ' A' ' 72' ' ' VAL . 2.6 t-20 -71.35 119.38 15.41 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.453 ' HA3' ' CG ' ' A' ' 68' ' ' ASP . . . 83.39 1.73 90.27 Favored Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.944 -176.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -131.09 173.05 11.4 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -174.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.5 p -133.29 134.33 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.183 0.516 . . . . 0.0 110.259 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 69.0 mt -129.57 133.65 64.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.176 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.73 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 6.5 p80 -93.8 116.34 28.8 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.371 0.605 . . . . 0.0 109.842 175.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.72 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.3 pp -116.09 179.8 3.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.759 -175.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.2 p -100.03 176.6 5.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 60.7 pttt -55.68 -30.74 61.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.521 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.24 78.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.769 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.72 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 4.0 mp0 -69.67 -31.66 69.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.33 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -64.61 -51.63 61.68 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.6 tt -51.76 -61.08 2.48 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 113.312 -1.767 . . . . 0.0 112.155 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.9 -25.69 61.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.781 -168.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.535 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 36.7 ttmt -98.45 -34.34 10.67 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.0 t -119.28 -47.7 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -167.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.7 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 20.0 t80 -151.54 116.47 5.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.297 0.57 . . . . 0.0 111.852 -165.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.512 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -88.2 90.69 8.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.262 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.7 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 24.3 p90 -84.27 12.09 7.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.154 0.502 . . . . 0.0 111.576 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -94.32 -45.7 7.37 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.425 ' C ' HD21 ' A' ' 29' ' ' ASN . 48.9 mttm -94.67 -25.9 16.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.584 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.572 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -122.26 68.85 29.23 Favored Pre-proline 0 N--CA 1.469 0.494 0 CA-C-O 120.791 0.329 . . . . 0.0 111.198 178.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -55.71 -42.18 70.09 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.163 2.576 . . . . 0.0 112.132 171.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -95.42 -33.25 12.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -173.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.436 ' CD ' ' HZ3' ' A' ' 34' ' ' LYS . 36.7 mt-10 -91.49 128.45 37.32 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.204 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 53.3 t-105 -82.13 101.37 10.37 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 171.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.436 ' HZ3' ' CD ' ' A' ' 32' ' ' GLU . 30.6 mmtp -102.65 139.21 38.54 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.331 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -126.92 115.79 19.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.162 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' A' ' 22' ' ' LYS . 35.0 mm-40 -97.5 123.73 41.47 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.443 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.85 179.48 46.37 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.201 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.469 ' OD2' ' HG3' ' A' ' 39' ' ' LYS . 1.7 p-10 -124.31 -38.51 2.42 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 117.011 0.405 . . . . 0.0 111.333 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.469 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 60.8 mttp -112.43 154.69 44.47 Favored Pre-proline 0 C--N 1.328 -0.348 0 O-C-N 122.474 -0.142 . . . . 0.0 110.86 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.443 ' HB2' HD22 ' A' ' 125' ' ' LEU . 6.2 Cg_endo -48.35 132.81 24.66 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.155 2.57 . . . . 0.0 111.851 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -116.85 149.57 39.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.388 0.613 . . . . 0.0 112.121 -170.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.416 ' HB ' HG12 ' A' ' 73' ' ' ILE . 76.5 mt -132.56 139.78 49.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.996 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.45 116.62 47.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.866 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.528 ' HB3' ' CB ' ' A' ' 75' ' ' LYS . 35.0 t70 -91.24 112.19 24.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.774 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.566 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 79.2 m-85 -93.51 110.64 22.22 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.7 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.2 p90 -137.87 162.6 33.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.559 0.695 . . . . 0.0 111.468 -171.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.19 133.4 50.29 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.692 170.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.24 -41.83 93.99 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.91 -172.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -68.25 -17.29 64.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.881 0.372 . . . . 0.0 111.624 -176.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 42.2 t -82.09 123.53 29.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.888 0.375 . . . . 0.0 110.168 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.83 -61.01 7.9 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.157 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HB3' ' HB1' ' A' ' 111' ' ' ALA . 87.4 Cg_exo -47.84 -45.7 23.64 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.842 2.361 . . . . 0.0 112.874 176.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 62.1 m -60.19 -45.63 92.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.527 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -76.02 -27.46 57.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.437 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 3.3 tmm? -67.31 -47.86 69.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.32 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.585 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 27.2 m -77.11 -24.95 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.588 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -50.74 -52.73 54.06 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 18.9 Cg_exo -66.81 -37.65 19.91 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.774 1.649 . . . . 0.0 112.339 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.3 mt -65.36 -47.5 86.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.358 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.33 -31.75 71.39 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.64 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.503 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 20.7 t70 -68.15 -37.81 81.44 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.153 174.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.519 ' CD ' ' HZ3' ' A' ' 114' ' ' LYS . 37.3 tt0 -55.95 -46.98 78.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.921 176.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.569 HD12 ' HG3' ' A' ' 114' ' ' LYS . 9.8 mp -65.25 -30.88 71.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.07 176.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.551 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -55.08 -53.78 51.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.635 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.503 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -78.2 -24.83 46.96 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.455 178.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -55.83 -33.97 64.95 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.677 0.751 . . . . 0.0 109.366 171.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.595 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 41.2 m-85 -111.34 26.5 10.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.042 176.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 3.1 t70 -55.36 132.6 48.51 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.336 -176.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.26 -21.06 36.29 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.962 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.595 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 10.8 pt20 -122.08 -36.0 3.06 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -176.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.528 HG23 ' HG3' ' A' ' 70' ' ' GLN . 45.4 pt -111.63 147.81 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.987 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 8' ' ' ASN . 60.1 t -120.96 120.29 61.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.596 177.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.645 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 27.7 mt -115.57 134.98 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 121.612 0.72 . . . . 0.0 111.179 -177.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -121.45 173.27 7.49 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.824 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.73 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 3.5 ptmm? -151.97 156.34 39.82 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.557 HG22 HD13 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -133.62 148.23 30.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.097 -173.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 20.2 m-20 -89.82 85.87 6.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 92' ' ' SER . 1.7 m -62.0 -27.28 68.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.193 -166.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -54.42 -31.04 54.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.487 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 22.6 pttm -104.76 -26.16 12.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.231 0.538 . . . . 0.0 109.694 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.511 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 1.3 mp0 -84.85 33.6 0.53 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.72 176.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -62.04 -31.61 72.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.819 0.343 . . . . 0.0 110.977 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -63.05 -41.05 99.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.358 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -70.24 -45.61 66.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.41 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.54 ' HA ' HD11 ' A' ' 90' ' ' ILE . . . -61.57 -49.68 75.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.45 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.75 -30.26 72.19 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 116.154 -0.475 . . . . 0.0 113.116 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.57 -34.54 77.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.749 0.309 . . . . 0.0 111.677 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.498 ' HB2' HG13 ' A' ' 90' ' ' ILE . 77.7 m-85 -104.53 5.66 34.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.228 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.31 29.44 70.19 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.084 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.54 HD11 ' HA ' ' A' ' 85' ' ' ALA . 22.0 mt -75.1 139.82 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.024 0.44 . . . . 0.0 110.072 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.431 ' HD3' HE22 ' A' ' 109' ' ' GLN . 72.6 mtp180 -74.34 4.05 6.43 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.674 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.564 ' HA ' HG23 ' A' ' 78' ' ' THR . 30.3 t 82.5 -88.0 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.424 -176.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.568 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 2.7 pp -135.29 136.45 24.46 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -169.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.654 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 4.0 Cg_exo -85.35 146.45 42.14 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 124.591 -1.004 . . . . 0.0 111.726 -4.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.566 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 37.5 t -142.0 140.85 32.79 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 171.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.6 mt -134.18 115.15 20.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.7 tp -97.64 112.99 24.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.552 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.75 111.48 23.75 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.776 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.517 HG12 ' HB3' ' A' ' 105' ' ' PRO . 44.7 mt -102.17 105.12 40.95 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.127 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.92 161.17 36.39 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.722 2.281 . . . . 0.0 111.636 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 94.1 mmm -83.7 -1.39 53.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 0.0 110.454 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.435 ' CD ' ' HZ3' ' A' ' 128' ' ' LYS . 1.3 tm-20 -141.76 112.93 7.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.1 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.89 -153.7 16.8 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.057 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.425 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 28.8 mmmt -116.1 156.9 46.33 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.517 ' HB3' HG12 ' A' ' 99' ' ' ILE . 59.2 Cg_endo -72.12 151.08 54.98 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.678 2.252 . . . . 0.0 113.721 -175.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.623 ' OE2' ' HB2' ' A' ' 131' ' ' HIS . 27.2 tt0 -106.62 157.98 17.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.199 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 45.1 ttm -122.63 116.39 23.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.152 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.01 137.91 48.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 173.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.493 ' HG2' ' HA ' ' A' ' 95' ' ' SER . 43.9 mt-30 -123.06 137.97 54.8 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.389 -174.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.654 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 106.77 178.28 22.96 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.407 -0.815 . . . . 0.0 114.457 170.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.585 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -83.01 89.14 6.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.119 0.485 . . . . 0.0 111.814 -174.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.622 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 22.2 ptp -95.64 149.01 35.5 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.974 173.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 97.4 Cg_endo -76.18 -178.36 4.35 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.825 2.35 . . . . 0.0 112.141 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.569 ' HG3' HD12 ' A' ' 63' ' ' LEU . 20.5 ttmm -57.68 -35.51 70.69 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 120.851 0.357 . . . . 0.0 110.133 174.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.65 -52.54 60.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.445 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.622 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 28.5 m -68.61 -35.63 77.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.624 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.472 ' HB3' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -61.89 -46.4 89.54 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.462 176.645 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -62.63 -33.14 74.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.306 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 51.4 tptt -61.47 -42.75 99.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 174.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.34 -47.94 53.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.711 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.589 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 1.8 mp -70.63 -56.92 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.871 0.367 . . . . 0.0 110.763 -177.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.408 ' HB2' ' OH ' ' A' ' 67' ' ' TYR . 5.1 t70 -73.5 -62.63 1.42 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.549 0.69 . . . . 0.0 110.396 -176.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 3.9 mm-40 -78.12 11.47 2.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.835 -1.075 . . . . 0.0 113.329 -169.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.597 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 71.8 t80 -143.56 -47.5 0.29 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.441 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.589 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 32.5 tp -76.55 -35.03 58.47 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.488 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.2 mt -89.22 -65.56 1.01 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.411 ' HZ3' ' HB3' ' A' ' 127' ' ' LYS . 2.1 ttpm? -92.97 92.07 7.68 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.435 ' HZ3' ' CD ' ' A' ' 102' ' ' GLU . 87.9 tttt -54.31 100.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.65 0.594 . . . . 0.0 111.113 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -88.84 -34.57 16.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.653 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 73.88 85.56 0.26 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.002 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.623 ' HB2' ' OE2' ' A' ' 106' ' ' GLU . 32.2 m170 -65.36 93.23 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.693 0.759 . . . . 0.0 110.49 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -63.11 103.68 0.5 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.917 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -82.44 37.06 0.5 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.069 -177.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -71.12 138.78 49.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.269 -174.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -128.88 141.57 51.24 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 25.5 p80 . . . . . 0 C--O 1.245 0.855 0 O-C-N 124.508 1.13 . . . . 0.0 111.66 -172.242 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 m -136.16 96.29 3.36 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.003 -175.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -101.3 -74.46 0.62 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.041 174.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.87 22.84 10.67 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.012 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p -91.51 154.07 19.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.407 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 72.39 -56.57 0.65 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 168.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.99 32.88 5.17 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -165.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -76.34 158.54 31.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.147 -1.027 . . . . 0.0 110.749 -173.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.65 9.1 83.68 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.35 176.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.593 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 2.9 tttm -162.0 175.33 11.92 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.279 0.562 . . . . 0.0 112.299 -175.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 9.9 p -106.7 130.58 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.128 176.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.6 mm -112.24 130.08 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.246 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.551 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 1.8 p80 -90.15 131.83 35.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.565 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.487 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 1.1 pp -131.25 176.1 8.56 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.369 -174.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.0 p -104.53 176.36 5.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.959 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 14.4 pttm -64.19 -30.66 71.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.672 0.273 . . . . 0.0 110.864 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.08 93.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.278 0.561 . . . . 0.0 110.081 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.487 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 2.5 mm-40 -71.92 -38.91 69.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.228 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.86 -49.37 75.69 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.706 175.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.697 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 13.9 mt -57.07 -60.62 3.32 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.253 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.54 -25.45 60.41 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -169.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.455 ' HZ3' ' CD ' ' A' ' 18' ' ' GLU . 4.3 ttpm? -110.05 -16.46 13.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 46.9 t -128.65 -45.24 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -171.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.697 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 17.5 t80 -173.03 132.41 0.51 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 117.925 0.33 . . . . 0.0 111.845 -165.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.65 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 2.5 t-20 -106.79 105.69 15.85 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.589 -177.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.444 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 5.3 p90 -90.5 1.46 56.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -171.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -89.57 -40.69 12.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.65 ' HB3' ' OD1' ' A' ' 25' ' ' ASN . 4.8 tptp -91.29 -24.96 19.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.637 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.671 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -116.42 55.63 1.35 Allowed Pre-proline 0 N--CA 1.48 1.045 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 178.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -62.25 -43.71 22.29 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.246 1.964 . . . . 0.0 111.773 175.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -108.46 -9.26 15.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.18 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.4 ' HB2' ' CB ' ' A' ' 29' ' ' ASN . 67.3 mt-10 -91.59 177.7 6.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.821 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.45 ' HZ3' ' HE1' ' A' ' 88' ' ' PHE . 76.8 t-105 -151.95 88.49 1.4 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.943 0.401 . . . . 0.0 110.195 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -105.83 98.87 8.5 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 26.2 t80 -91.47 118.8 30.88 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.308 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -89.78 125.96 35.5 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.835 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.99 146.14 4.63 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.037 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -91.73 -27.29 18.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.965 0.412 . . . . 0.0 110.279 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -120.08 159.68 46.21 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.852 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.14 145.58 89.4 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.524 2.15 . . . . 0.0 111.937 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -120.05 150.25 40.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.442 0.639 . . . . 0.0 111.99 -175.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.621 ' HB ' HG23 ' A' ' 73' ' ' ILE . 77.1 mt -119.47 116.07 49.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.341 176.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.3 t -103.22 109.15 26.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.75 0.309 . . . . 0.0 111.204 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 8.4 t70 -90.62 113.92 26.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.042 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -87.68 111.21 21.05 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.678 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.3 p90 -132.56 169.47 16.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.818 0.818 . . . . 0.0 111.783 -174.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.63 126.7 24.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.183 167.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.563 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 31.2 t70 -60.02 -35.0 74.12 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.484 -172.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -73.89 -0.65 16.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.785 0.326 . . . . 0.0 111.54 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.451 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 47.7 t -101.69 119.54 38.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.965 0.412 . . . . 0.0 110.316 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.65 -56.62 17.12 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.584 -0.734 . . . . 0.0 114.112 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.451 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 83.7 Cg_exo -47.74 -37.85 28.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.048 2.498 . . . . 0.0 113.444 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.678 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 78.2 m -69.68 -47.01 64.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.939 0.399 . . . . 0.0 111.155 177.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.563 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 53.6 mttm -52.7 -30.15 30.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.466 177.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.527 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 24.7 ptm -88.12 -40.77 13.51 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.924 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.522 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 31.6 m -69.96 -36.85 70.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.576 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.592 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . . . -53.42 -53.16 59.57 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' A' ' 57' ' ' ALA . 16.4 Cg_exo -69.05 -34.96 15.72 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.09 1.86 . . . . 0.0 112.428 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.504 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 68.1 mt -63.58 -48.7 85.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.97 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.586 HD13 HG21 ' A' ' 73' ' ' ILE . 4.2 pp -68.7 -30.69 69.4 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.66 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.593 ' OD1' ' HG2' ' A' ' 10' ' ' LYS . 18.7 t70 -64.76 -37.95 89.33 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.25 0.547 . . . . 0.0 109.815 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 7.2 mm-40 -54.63 -50.26 68.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.759 173.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.515 HD21 ' HG3' ' A' ' 114' ' ' LYS . 3.4 mm? -62.5 -31.81 72.62 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.926 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.542 ' HB2' HD13 ' A' ' 73' ' ' ILE . . . -63.29 -37.49 87.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.811 0.338 . . . . 0.0 110.456 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.873 ' HZ1' ' HB3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -74.02 -33.92 63.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.505 178.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -41.23 70.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.461 0.648 . . . . 0.0 111.116 176.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.646 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 30.1 m-85 -98.28 27.31 4.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.112 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.41 143.78 14.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.105 0.479 . . . . 0.0 111.432 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.39 -23.77 23.11 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.826 -0.624 . . . . 0.0 113.39 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.646 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 4.2 pt20 -117.28 -24.61 7.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.414 HD12 HG22 ' A' ' 121' ' ' ILE . 43.6 pt -126.36 145.57 33.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.306 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 68.0 t -120.99 118.75 57.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.621 HG23 ' HB ' ' A' ' 42' ' ' ILE . 14.3 mt -106.89 138.66 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.106 -175.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -123.65 170.37 10.54 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.666 175.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.637 ' HB3' ' HZ3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -152.45 149.42 28.55 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 172.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.24 138.2 55.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.263 0.554 . . . . 0.0 110.863 -174.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 1.2 m-20 -70.7 89.13 0.73 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.095 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.438 HG21 ' HB2' ' A' ' 85' ' ' ALA . 23.9 m -62.52 -37.07 84.63 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -169.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -21.27 62.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -174.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' A' ' 77' ' ' ASP . 8.9 ptpp? -106.39 -34.93 7.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.772 0.32 . . . . 0.0 110.224 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.521 ' HA ' ' OE1' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -82.75 47.35 1.18 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.989 0.515 . . . . 0.0 110.842 174.421 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -57.99 -38.69 76.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.02 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.457 ' CD ' ' HZ1' ' A' ' 16' ' ' LYS . 3.0 mp0 -69.11 -37.52 78.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.251 0.548 . . . . 0.0 110.166 -178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 3.4 tm? -67.1 -46.66 73.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.434 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -61.88 -48.18 81.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.135 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.5 -29.81 67.26 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.05 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.85 -27.4 69.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 0.0 111.399 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.542 ' HB2' HG12 ' A' ' 90' ' ' ILE . 68.1 m-85 -104.03 8.74 36.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.792 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.54 19.99 79.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.212 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.542 HG12 ' HB2' ' A' ' 88' ' ' PHE . 33.9 mm -74.77 108.12 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 120.623 0.249 . . . . 0.0 110.538 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -56.39 -56.37 21.98 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.787 0.803 . . . . 0.0 110.871 174.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.1 p -169.72 -137.63 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.167 -1.378 . . . . 0.0 108.985 -172.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.559 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -131.77 155.35 81.51 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.845 -0.161 . . . . 0.0 110.583 -172.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.627 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 2.9 Cg_exo -84.96 141.5 33.09 Favored 'Cis proline' 0 C--N 1.346 0.431 0 C-N-CA 124.827 -0.906 . . . . 0.0 112.726 -2.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.511 ' HG ' HD13 ' A' ' 90' ' ' ILE . 15.2 t -141.47 137.8 32.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 107' ' ' MET . 44.6 mt -131.53 120.11 44.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.691 -174.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.4 tp -100.05 112.03 24.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.373 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -94.31 109.38 21.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.59 HG12 ' HB3' ' A' ' 105' ' ' PRO . 49.6 mt -101.34 106.66 46.81 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.51 -174.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.43 164.89 25.94 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.836 2.357 . . . . 0.0 111.759 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.1 mtp -87.75 -6.31 58.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.421 0.629 . . . . 0.0 109.946 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -133.15 121.68 22.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.239 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.69 -140.84 15.1 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.198 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -132.27 153.27 81.21 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.59 ' HB3' HG12 ' A' ' 99' ' ' ILE . 35.5 Cg_endo -64.45 143.95 83.81 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.913 2.408 . . . . 0.0 113.543 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -104.8 169.75 8.27 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 35.0 ttm -142.84 101.59 3.88 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -172.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -96.75 134.0 40.59 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 172.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -120.74 136.86 54.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.143 0.497 . . . . 0.0 112.252 -171.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.627 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 102.17 -168.79 19.23 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.455 -0.793 . . . . 0.0 115.005 168.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.522 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -85.55 88.93 7.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.866 -0.667 . . . . 0.0 112.07 -171.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.574 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 23.3 ptt? -107.28 150.35 39.86 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.259 172.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.475 ' HD2' ' OG ' ' A' ' 116' ' ' SER . 84.6 Cg_endo -76.39 -178.09 4.2 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.987 2.458 . . . . 0.0 112.94 -173.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.515 ' HG3' HD21 ' A' ' 63' ' ' LEU . 29.4 ttmt -57.73 -35.21 70.39 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.391 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.12 -48.8 74.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.629 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.574 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 30.0 m -66.02 -41.21 91.27 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.592 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.623 ' O ' HG13 ' A' ' 121' ' ' ILE . 11.9 m-85 -58.46 -49.17 78.28 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.692 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.445 ' HZ3' ' CG ' ' A' ' 122' ' ' ASP . 11.9 tmtt? -54.59 -48.63 71.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.444 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -66.5 -34.42 77.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.707 0.289 . . . . 0.0 110.93 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -69.68 -44.19 70.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.083 0.468 . . . . 0.0 111.128 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 117' ' ' PHE . 31.2 mt -70.12 -51.72 36.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.267 0.556 . . . . 0.0 110.33 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.445 ' CG ' ' HZ3' ' A' ' 118' ' ' LYS . 9.7 t70 -64.0 -69.51 0.27 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.019 -176.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.527 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 38.4 mt-10 -80.79 12.31 3.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.399 -167.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 90.8 t80 -140.09 -49.92 0.47 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.398 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.419 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 20.2 tp -75.94 -31.58 59.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.682 0.277 . . . . 0.0 110.686 -175.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -106.0 -57.01 2.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.035 0.445 . . . . 0.0 110.3 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.527 ' HB3' ' HA ' ' A' ' 123' ' ' GLU . 2.3 tmmt? -85.22 93.81 8.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -60.03 100.32 0.09 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.616 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -97.68 167.27 11.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.641 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 125.27 -0.18 8.14 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -84.44 55.23 3.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.869 0.366 . . . . 0.0 111.431 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.4 p80 179.82 107.68 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.43 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.413 ' O ' ' HB2' ' A' ' 134' ' ' HIS . 67.4 t60 -81.15 -33.49 33.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.536 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 133' ' ' HIS . 22.3 t-80 176.34 -30.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.408 0.623 . . . . 0.0 109.765 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -158.16 -26.67 0.08 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 1.9 m170 . . . . . 0 C--O 1.244 0.774 0 CA-C-N 113.979 -1.464 . . . . 0.0 108.037 164.396 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.7 mtm . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.514 ' HB3' ' OE2' ' A' ' 6' ' ' GLU . 34.7 m -76.96 -179.0 5.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.332 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.24 -63.51 1.37 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.925 0.393 . . . . 0.0 110.852 -175.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.8 33.95 0.44 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.169 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.5 m 74.98 96.96 0.07 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.564 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.514 ' OE2' ' HB3' ' A' ' 2' ' ' SER . 7.8 mm-40 -61.82 132.37 52.89 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.476 -174.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.55 137.03 13.4 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.999 -170.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' ND2' ' H ' ' A' ' 9' ' ' GLY . 2.3 t-20 -95.12 165.0 12.63 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.4 ' H ' ' ND2' ' A' ' 8' ' ' ASN . . . 62.51 44.88 96.95 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.62 -172.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.581 ' HD3' ' H ' ' A' ' 11' ' ' VAL . 15.1 tppt? -150.96 157.47 42.93 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.095 -0.552 . . . . 0.0 109.533 -173.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 14.1 p -108.78 132.62 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.202 0.525 . . . . 0.0 110.758 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.8 mt -122.88 127.43 74.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.951 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.572 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 1.9 p80 -86.26 143.39 27.95 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.4 pp -137.86 168.84 18.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.966 0.412 . . . . 0.0 111.974 -177.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.814 HG21 ' HZ1' ' A' ' 80' ' ' LYS . 40.3 p -92.48 175.33 6.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.43 174.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.512 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 8.6 ptpp? -64.42 -31.83 73.2 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.663 0.268 . . . . 0.0 111.39 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.37 -39.5 92.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.399 0.618 . . . . 0.0 109.845 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 38.3 mt-10 -72.33 -36.02 68.75 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.155 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.437 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 2.5 t80 -54.06 -53.01 59.0 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.241 1.02 . . . . 0.0 108.995 175.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 17.0 mt -59.02 -60.2 4.25 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.274 -1.784 . . . . 0.0 112.213 -175.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.72 -20.53 27.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -169.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.614 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 35.0 ttpt -109.45 -7.49 15.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.64 0.257 . . . . 0.0 111.415 -174.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 68.8 t -134.79 -49.27 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.77 ' HE2' ' HZ ' ' A' ' 88' ' ' PHE . 1.1 t80 -177.88 125.62 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.298 0.571 . . . . 0.0 110.809 -168.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.577 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -92.94 87.31 5.74 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.793 -172.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.532 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 18.6 p90 -75.92 12.14 1.2 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.402 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . 11.2 tm-20 -88.34 -53.43 4.69 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.606 ' C ' HD21 ' A' ' 29' ' ' ASN . 0.0 OUTLIER -92.4 -12.26 32.69 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.353 171.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.633 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.9 OUTLIER -111.68 53.45 0.39 Allowed Pre-proline 0 N--CA 1.478 0.935 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -178.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.456 ' HD2' ' OE1' ' A' ' 31' ' ' GLU . 37.6 Cg_endo -74.68 -35.6 3.38 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 121.947 1.765 . . . . 0.0 111.103 166.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.542 ' OE1' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -100.21 -34.75 9.89 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.586 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.542 ' HG2' ' OE1' ' A' ' 31' ' ' GLU . 7.6 pt-20 -97.92 177.4 5.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.002 -177.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.584 ' CB ' ' HE2' ' A' ' 104' ' ' LYS . 76.3 t-105 -148.05 88.92 1.69 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.227 0.537 . . . . 0.0 110.628 -174.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.464 ' HZ3' ' CD ' ' A' ' 36' ' ' GLU . 61.9 tttm -102.92 104.49 14.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.282 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.582 ' OH ' ' HB3' ' A' ' 41' ' ' ALA . 18.9 t80 -96.79 124.3 40.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.018 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.464 ' CD ' ' HZ3' ' A' ' 34' ' ' LYS . 7.1 mm-40 -88.61 93.41 9.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.534 177.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.15 129.56 1.39 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.182 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.8 -27.8 58.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.387 0.613 . . . . 0.0 110.399 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.464 ' HB2' HG21 ' A' ' 72' ' ' VAL . 66.7 mttm -116.63 155.46 48.8 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.339 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.524 ' HG3' ' HG2' ' A' ' 101' ' ' MET . 36.4 Cg_exo -57.73 150.34 62.72 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.777 2.318 . . . . 0.0 111.79 177.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.582 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -120.49 147.55 44.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.423 0.63 . . . . 0.0 112.111 -173.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.565 ' HB ' HG12 ' A' ' 73' ' ' ILE . 74.7 mt -124.03 112.45 32.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 171.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 46.0 t -109.81 110.78 33.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 121.273 -0.171 . . . . 0.0 111.286 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.572 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 8.2 p-10 -101.06 116.66 33.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.217 1.008 . . . . 0.0 111.821 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.435 ' HB3' ' OG1' ' A' ' 78' ' ' THR . 13.2 m-85 -77.85 112.72 15.02 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.058 170.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.64 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.2 p90 -128.59 162.12 28.03 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.615 0.721 . . . . 0.0 111.844 -176.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.96 137.27 37.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.647 170.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.554 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 25.2 t70 -60.75 -42.06 96.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -171.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -67.66 -13.31 61.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.665 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 49.3 t -85.48 115.1 22.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.87 0.367 . . . . 0.0 110.355 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.92 -57.01 10.4 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.575 -0.738 . . . . 0.0 113.507 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.74 -40.97 31.64 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.068 2.512 . . . . 0.0 113.378 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.64 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 84.9 m -63.51 -45.31 91.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.93 0.395 . . . . 0.0 111.087 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.554 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 65.9 mttm -58.41 -29.6 66.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.073 174.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.503 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 74.3 mtp -74.42 -52.45 12.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.073 0.463 . . . . 0.0 111.234 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.444 HG11 ' HA ' ' A' ' 53' ' ' CYS . 14.2 p -70.98 -37.97 70.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.581 -170.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.586 ' HB1' ' HD3' ' A' ' 58' ' ' PRO . . . -52.71 -53.38 54.87 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -176.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.586 ' HD3' ' HB1' ' A' ' 57' ' ' ALA . 29.9 Cg_exo -62.83 -49.04 5.76 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.94 1.76 . . . . 0.0 112.113 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.5 mt -56.48 -40.46 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.155 0.502 . . . . 0.0 110.897 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.479 HD23 HD12 ' A' ' 73' ' ' ILE . 6.9 mt -68.16 -36.17 79.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.348 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.553 ' CG ' ' HZ2' ' A' ' 10' ' ' LYS . 28.3 t70 -68.57 -41.12 80.17 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.29 -54.73 39.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.903 173.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.7 tp -61.78 -31.74 71.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.698 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.551 ' HB1' HD11 ' A' ' 73' ' ' ILE . . . -59.53 -46.85 87.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.439 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.614 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 3.6 tmtm? -75.71 -40.29 55.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.422 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.444 ' CD ' ' HZ3' ' A' ' 114' ' ' LYS . 50.9 mt-10 -55.67 -31.35 62.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.395 175.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.435 ' HD2' ' NE2' ' A' ' 70' ' ' GLN . 72.8 m-85 -111.27 25.15 12.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.615 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 65' ' ' LYS . 24.1 t0 -54.13 148.39 11.19 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.736 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.63 -22.11 18.78 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.529 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.435 ' NE2' ' HD2' ' A' ' 67' ' ' TYR . 16.9 mt-30 -95.92 -56.39 2.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.924 0.362 . . . . 0.0 111.206 -175.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.627 HD11 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -122.69 174.41 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.67 -170.266 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 43.2 t -131.47 129.09 61.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 174.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 17.0 mt -106.19 135.09 45.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.295 0.569 . . . . 0.0 110.875 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 84.3 m-85 -122.04 163.9 18.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.125 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.572 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -147.33 153.47 39.73 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.045 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.65 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 9.4 p -133.94 144.29 36.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.607 -174.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.411 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 6.0 m-20 -86.6 88.66 7.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.435 ' OG1' ' HB3' ' A' ' 45' ' ' PHE . 7.1 m -60.53 -32.65 71.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -169.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -54.42 -30.85 53.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.814 ' HZ1' HG21 ' A' ' 15' ' ' THR . 22.3 pttp -107.75 -17.56 14.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.594 0.711 . . . . 0.0 110.187 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.65 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 0.3 OUTLIER -94.56 38.73 1.1 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.12 175.056 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -66.14 -36.29 82.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.323 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -64.32 -34.64 78.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.433 0.635 . . . . 0.0 109.627 177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.465 HD11 ' CE2' ' A' ' 26' ' ' PHE . 15.5 tp -70.2 -45.6 66.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.116 177.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.549 ' HA ' HD13 ' A' ' 90' ' ' ILE . . . -57.1 -49.47 75.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.879 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.28 -30.05 66.99 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.325 -0.464 . . . . 0.0 113.085 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.81 -32.81 74.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.328 . . . . 0.0 111.37 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.77 ' HZ ' ' HE2' ' A' ' 24' ' ' TYR . 96.6 m-85 -101.4 8.33 42.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.841 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.25 31.62 77.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.892 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.661 ' HA ' ' NH1' ' A' ' 91' ' ' ARG . 42.7 mt -82.26 136.93 21.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.906 0.384 . . . . 0.0 110.394 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.661 ' NH1' ' HA ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -66.52 -50.27 63.74 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t 170.26 -89.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.231 -1.349 . . . . 0.0 107.949 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.502 HG23 ' C ' ' A' ' 46' ' ' TYR . 0.2 OUTLIER -141.35 155.05 67.8 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.757 -178.316 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.767 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.5 Cg_exo -86.71 143.39 28.22 Favored 'Cis proline' 0 C--N 1.343 0.253 0 C-N-CA 124.585 -1.006 . . . . 0.0 111.983 -3.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 59.0 m -141.4 132.02 25.55 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.472 HD12 ' HE3' ' A' ' 112' ' ' MET . 64.0 mt -128.49 118.73 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.109 0.481 . . . . 0.0 111.073 -172.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.42 HD11 ' O ' ' A' ' 106' ' ' GLU . 23.9 tp -98.98 114.75 27.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.227 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -94.23 103.11 15.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 61.5 mt -96.42 111.38 56.66 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.431 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 98.3 Cg_endo -84.39 169.64 10.98 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.808 2.339 . . . . 0.0 111.612 174.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.524 ' HG2' ' HG3' ' A' ' 40' ' ' PRO . 95.1 mmm -89.99 -2.29 58.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 0.0 110.534 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.589 ' CD ' ' HZ2' ' A' ' 128' ' ' LYS . 1.7 tm-20 -151.81 115.89 4.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.393 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 116.19 -144.71 18.53 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.77 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.584 ' HE2' ' CB ' ' A' ' 33' ' ' TRP . 28.0 mmtp -126.32 151.61 72.63 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.441 ' HG3' ' CH2' ' A' ' 33' ' ' TRP . 85.8 Cg_endo -73.79 148.65 41.57 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.815 2.344 . . . . 0.0 113.322 -175.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.474 ' HG2' ' N ' ' A' ' 107' ' ' MET . 37.4 tt0 -95.23 166.94 11.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.876 178.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.474 ' N ' ' HG2' ' A' ' 106' ' ' GLU . 32.3 tpp -142.68 107.56 4.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.087 0.47 . . . . 0.0 111.491 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.95 157.26 17.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.239 174.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -126.34 135.44 51.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.942 0.401 . . . . 0.0 111.129 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.767 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 107.15 -171.72 17.08 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.679 -0.691 . . . . 0.0 113.381 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.65 81.02 1.4 Allowed 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.542 0.687 . . . . 0.0 110.997 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.667 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 4.5 mpp? -65.49 148.97 97.75 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.329 172.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.32 172.65 15.64 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.125 1.883 . . . . 0.0 110.772 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.444 ' HZ3' ' CD ' ' A' ' 66' ' ' GLU . 36.5 ttmt -60.03 -24.53 64.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.109 0.48 . . . . 0.0 109.851 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.51 -53.29 44.44 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.238 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.667 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 18.5 m -71.94 -28.73 63.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.486 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -67.56 -40.2 84.92 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.985 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 122' ' ' ASP . 0.8 OUTLIER -58.25 -37.86 75.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.458 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -67.58 -51.89 45.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.48 -46.56 89.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.152 0.501 . . . . 0.0 111.284 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 1.7 mp -67.55 -43.89 86.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.14 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -72.44 -55.1 7.57 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.666 -177.021 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.649 ' HA ' ' HE2' ' A' ' 127' ' ' LYS . 31.9 tt0 -77.25 -8.33 57.41 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -169.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 90.4 t80 -127.65 -51.74 1.36 Allowed 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.82 -0.55 . . . . 0.0 111.656 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 32.5 tp -77.71 -29.76 51.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -173.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 122' ' ' ASP . 92.7 mt -96.92 -54.06 3.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.325 0.583 . . . . 0.0 110.009 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.649 ' HE2' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -135.84 82.29 1.94 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.071 179.623 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.589 ' HZ2' ' CD ' ' A' ' 102' ' ' GLU . 52.6 pttt -57.77 104.05 0.17 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.551 0.691 . . . . 0.0 110.838 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.603 ' HB2' ' HD2' ' A' ' 134' ' ' HIS . 44.8 mt-10 -77.75 46.41 0.56 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.157 -175.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.62 62.56 4.11 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 171.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -146.45 -157.25 0.79 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -80.0 32.93 0.27 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.862 0.363 . . . . 0.0 111.425 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -171.4 136.02 0.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.135 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.603 ' HD2' ' HB2' ' A' ' 129' ' ' GLU . 11.6 t-80 -157.58 139.97 14.59 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -68.52 -52.21 34.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.98 0.419 . . . . 0.0 110.219 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.3 -0.857 . . . . 0.0 109.788 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 110.582 -0.155 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.4 p -177.3 -82.76 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.942 0.401 . . . . 0.0 111.675 -176.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 90.4 mt -71.21 -25.41 62.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.652 -174.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.68 -30.32 67.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.639 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m 58.17 64.57 1.47 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.818 0.818 . . . . 0.0 109.698 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.1 pm0 -86.98 79.24 8.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.07 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.533 ' HA3' HD12 ' A' ' 12' ' ' ILE . . . -83.02 84.63 1.54 Allowed Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.424 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.591 HD22 ' HA2' ' A' ' 69' ' ' GLY . 4.8 t30 -60.33 129.77 43.3 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 177.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . 57.7 36.92 81.22 Favored Glycine 0 CA--C 1.507 -0.457 0 O-C-N 123.552 0.533 . . . . 0.0 112.387 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.555 ' HZ2' ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -147.17 163.81 35.15 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -175.411 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 61' ' ' ASP . 26.1 m -89.76 119.15 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.405 0.621 . . . . 0.0 110.874 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.533 HD12 ' HA3' ' A' ' 7' ' ' GLY . 41.5 mm -111.49 105.34 18.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.925 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 75' ' ' LYS . 19.2 p80 -79.77 129.74 34.74 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.618 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.6 pp -143.75 168.57 19.61 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.495 -174.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.0 p -86.79 168.02 13.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.747 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -55.65 -34.23 64.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.656 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.71 -36.45 75.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.322 0.582 . . . . 0.0 110.242 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.651 ' HB3' ' HE2' ' A' ' 22' ' ' LYS . 42.6 mt-10 -72.08 -33.32 67.82 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.52 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -61.81 -49.37 76.58 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.993 0.901 . . . . 0.0 108.872 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.8 tt -46.62 -60.26 2.49 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 113.479 -1.691 . . . . 0.0 111.829 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.33 -24.99 31.88 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -170.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.651 ' HE2' ' HB3' ' A' ' 18' ' ' GLU . 47.5 mtmt -109.31 0.86 19.75 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.388 -0.525 . . . . 0.0 112.146 -173.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -142.68 -49.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 83.6 t80 -164.08 116.68 1.39 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.558 -165.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.427 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -80.67 90.75 5.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.814 -178.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -83.89 9.69 11.53 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 122.148 -0.345 . . . . 0.0 111.825 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -84.95 -54.34 4.71 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.974 0.892 . . . . 0.0 108.683 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.411 ' C ' HD21 ' A' ' 29' ' ' ASN . 7.6 ptpp? -97.54 -12.0 23.07 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.506 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.612 ' OD1' ' HB2' ' A' ' 34' ' ' LYS . 1.1 m-80 -123.08 67.46 33.49 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-O 121.184 0.516 . . . . 0.0 110.998 170.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -59.67 -43.18 40.46 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.096 2.531 . . . . 0.0 111.974 171.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -112.82 -25.51 9.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.797 -174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -90.72 154.64 19.4 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.135 0.493 . . . . 0.0 110.903 -176.129 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.457 ' HZ3' ' HE1' ' A' ' 88' ' ' PHE . 76.4 t-105 -97.22 111.57 23.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.643 -177.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.612 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -133.32 115.41 14.87 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.632 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 26.9 t80 -103.58 107.23 17.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.87 -176.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.5 ' OE2' ' HG3' ' A' ' 34' ' ' LYS . 1.1 mp0 -95.71 76.61 3.24 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.925 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.632 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -133.76 -136.22 3.67 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.401 -173.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -149.57 -58.79 0.2 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.882 0.372 . . . . 0.0 110.998 -173.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.422 ' HB2' HG22 ' A' ' 72' ' ' VAL . 48.8 mttp -125.5 159.04 62.33 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.966 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.539 ' HB2' HG22 ' A' ' 71' ' ' ILE . 83.8 Cg_exo -42.43 131.36 5.08 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.602 2.201 . . . . 0.0 111.65 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -116.52 150.18 38.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.265 0.555 . . . . 0.0 112.24 -167.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.779 ' HB ' HG12 ' A' ' 73' ' ' ILE . 67.8 mt -127.9 116.88 44.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.882 173.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 38.5 t -98.84 116.31 41.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 120.825 0.345 . . . . 0.0 110.68 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.502 ' HB2' HD13 ' A' ' 60' ' ' LEU . 7.1 t70 -91.09 110.58 21.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.554 177.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.514 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 97.8 m-85 -94.39 111.65 23.41 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 174.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.605 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.1 p90 -133.58 174.9 9.93 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.547 0.689 . . . . 0.0 111.11 -175.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.97 142.61 22.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.298 173.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.476 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 32.4 t70 -62.03 -28.89 69.91 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -83.38 -1.07 52.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.686 0.279 . . . . 0.0 111.553 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 41.1 t -99.68 113.08 25.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.097 0.475 . . . . 0.0 110.805 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 54' ' ' LYS . . . -58.16 -51.36 58.88 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.472 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.528 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 97.6 Cg_exo -47.28 -47.74 16.63 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.896 2.397 . . . . 0.0 113.113 175.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.605 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 71.0 m -63.78 -36.66 84.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.908 0.385 . . . . 0.0 111.482 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.476 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 67.5 mttm -56.46 -34.78 67.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.831 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.507 ' SD ' ' HB1' ' A' ' 111' ' ' ALA . 26.9 ptm -91.84 -26.95 18.26 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.793 -175.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.586 HG22 ' HA ' ' A' ' 53' ' ' CYS . 25.1 m -76.71 -31.04 19.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.702 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.451 ' HA ' ' HZ1' ' A' ' 75' ' ' LYS . . . -47.69 -58.25 8.06 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.429 ' HD3' ' HB1' ' A' ' 57' ' ' ALA . 33.7 Cg_endo -65.17 -39.64 22.73 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.75 1.634 . . . . 0.0 112.269 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.2 mt -63.59 -43.62 98.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.226 0.536 . . . . 0.0 110.304 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 44' ' ' ASP . 7.8 mt -57.8 -43.81 85.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.129 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.468 ' HA ' HG13 ' A' ' 11' ' ' VAL . 30.7 t70 -68.12 -37.43 81.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.827 0.346 . . . . 0.0 110.557 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.414 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 3.7 tp10 -59.69 -41.88 91.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.472 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.484 HD21 ' HG3' ' A' ' 114' ' ' LYS . 4.1 mm? -71.24 -31.72 67.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.725 176.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.482 ' HB1' HD13 ' A' ' 73' ' ' ILE . . . -56.45 -57.11 13.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.769 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.556 ' HZ3' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -74.83 -24.61 58.63 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.74 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.556 ' HG3' ' HZ3' ' A' ' 65' ' ' LYS . 19.1 mt-10 -66.08 -33.42 75.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.499 0.666 . . . . 0.0 110.167 173.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -104.2 25.61 9.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.936 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.507 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 6.4 t0 -59.31 133.91 56.53 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 110.138 -176.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.591 ' HA2' HD22 ' A' ' 8' ' ' ASN . . . 92.36 -22.04 34.73 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.769 -176.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -94.97 -53.17 3.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.906 0.384 . . . . 0.0 110.268 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.539 HG22 ' HB2' ' A' ' 40' ' ' PRO . 38.2 pt -127.15 163.5 29.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.216 -176.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 50.9 t -131.01 131.91 63.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.779 HG12 ' HB ' ' A' ' 42' ' ' ILE . 60.3 mt -111.83 133.48 57.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.101 0.477 . . . . 0.0 110.844 -176.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -115.21 160.63 19.49 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' A' ' 13' ' ' HIS . 44.6 mttm -129.13 136.02 49.64 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.748 0.308 . . . . 0.0 110.902 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.21 136.89 44.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.665 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 4.4 m-20 -97.32 106.19 18.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.2 p -57.2 -26.97 61.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -67.55 -21.39 65.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.403 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.467 ' HZ1' ' CD ' ' A' ' 81' ' ' GLU . 8.5 ptmm? -114.08 -33.67 5.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.448 0.642 . . . . 0.0 109.974 175.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.467 ' CD ' ' HZ1' ' A' ' 80' ' ' LYS . 2.0 mp0 -83.62 36.66 0.55 Allowed 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.979 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -57.27 -47.55 81.14 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.825 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -61.88 -36.76 82.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.377 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.7 tp -70.16 -50.38 40.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.902 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.466 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -63.22 -37.47 87.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.05 -31.36 78.45 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.846 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.02 -33.58 76.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 111.024 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.5 ' HB2' HG12 ' A' ' 90' ' ' ILE . 85.7 m-85 -90.32 -1.24 57.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.18 21.55 75.55 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.01 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.5 HG12 ' HB2' ' A' ' 88' ' ' PHE . 37.3 mm -81.03 126.56 39.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 122.444 0.298 . . . . 0.0 110.67 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -61.99 -64.46 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.047 0.451 . . . . 0.0 110.169 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.9 p -164.6 -101.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.535 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -142.3 157.75 62.42 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 120.508 0.194 . . . . 0.0 111.383 -173.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.753 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 15.0 Cg_exo -79.66 144.35 70.65 Favored 'Cis proline' 0 N--CA 1.476 0.454 0 C-N-CA 124.241 -1.15 . . . . 0.0 112.162 -3.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.514 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 14.8 m -140.91 137.41 33.14 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 107' ' ' MET . 66.6 mt -133.13 114.47 21.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.615 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.8 tp -96.45 115.13 26.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 -175.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.417 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 97.3 m-85 -95.23 107.03 19.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.04 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 67.5 mt -99.18 105.01 29.76 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 98' ' ' PHE . 79.4 Cg_endo -88.19 166.03 6.85 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.83 2.353 . . . . 0.0 111.988 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 20.0 mmt -89.86 -6.24 56.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.96 0.41 . . . . 0.0 110.381 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.92 104.96 5.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.876 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.26 -151.38 18.32 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.251 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 12.1 mmmm -121.1 154.4 58.24 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 104' ' ' LYS . 56.8 Cg_endo -68.85 151.15 74.1 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.976 2.451 . . . . 0.0 114.576 -171.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -104.83 169.45 8.44 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.175 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.658 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 21.3 ptp -143.84 129.62 19.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.688 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.41 140.21 50.21 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -119.93 138.27 53.55 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.495 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.753 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 105.04 -178.4 23.64 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.715 -0.675 . . . . 0.0 114.682 170.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 52' ' ' PRO . . . -90.75 86.34 6.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.036 -0.582 . . . . 0.0 111.53 -173.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.579 ' HB2' ' HB3' ' A' ' 116' ' ' SER . 23.5 ptp -92.47 151.6 41.43 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.784 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.789 ' HD2' ' HB3' ' A' ' 116' ' ' SER . 85.5 Cg_endo -75.73 177.16 9.06 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.58 2.187 . . . . 0.0 112.129 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.484 ' HG3' HD21 ' A' ' 63' ' ' LEU . 62.9 tttm -57.82 -35.57 71.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.494 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.45 -47.71 59.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.818 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.789 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 47.8 t -66.85 -30.47 70.65 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.336 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.493 ' O ' HG13 ' A' ' 121' ' ' ILE . 3.4 m-85 -58.58 -53.21 60.88 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 173.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.418 ' HZ2' ' CG ' ' A' ' 122' ' ' ASP . 62.5 tttp -56.82 -42.79 80.22 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.622 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -53.83 -48.35 70.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.022 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.12 -42.75 68.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.408 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 117' ' ' PHE . 68.0 mt -66.72 -55.33 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.088 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.418 ' CG ' ' HZ2' ' A' ' 118' ' ' LYS . 0.8 OUTLIER -52.61 -65.34 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.562 -178.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -48.48 -42.18 32.01 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -172.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -104.52 -47.22 4.15 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -171.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 23.9 tp -77.69 -38.73 46.82 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -169.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.6 mp -105.85 -42.8 5.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.097 0.475 . . . . 0.0 111.094 -176.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -80.52 -20.48 43.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.858 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.3 pttt 37.73 33.57 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.65 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -148.93 105.41 3.54 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 133' ' ' HIS . . . -92.85 100.61 2.68 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.654 -175.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -70.46 -35.9 73.59 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -128.08 -22.98 3.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.932 174.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.511 ' O ' ' HA3' ' A' ' 130' ' ' GLY . 14.3 t-160 -102.85 85.09 2.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.105 0.479 . . . . 0.0 110.361 174.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -134.5 134.25 41.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.097 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -71.4 -22.34 61.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.193 0.521 . . . . 0.0 110.373 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.389 177.173 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.7 p 42.64 -113.65 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.14 0.9 . . . . 0.0 112.646 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 pp -101.04 1.36 39.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.747 0.308 . . . . 0.0 111.742 -174.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.56 -9.05 59.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.254 0.55 . . . . 0.0 110.668 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 p -139.88 124.52 18.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.449 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.58 146.05 42.2 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.32 70.47 0.48 Allowed Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.408 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.624 ' ND2' ' H ' ' A' ' 69' ' ' GLY . 2.0 t30 -169.91 163.44 9.56 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 172.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . 63.15 28.32 71.98 Favored Glycine 0 CA--C 1.509 -0.33 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.424 ' HE2' HD13 ' A' ' 12' ' ' ILE . 11.8 ptmt -156.05 155.75 33.19 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 121.126 0.489 . . . . 0.0 110.604 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 6.4 p -112.13 116.46 52.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.904 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.424 HD13 ' HE2' ' A' ' 10' ' ' LYS . 45.3 mm -102.96 115.49 45.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.117 -175.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.631 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 0.6 OUTLIER -85.19 125.43 32.84 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.248 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.7 pp -136.31 168.47 19.36 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.364 -173.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.0 p -102.87 177.12 4.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.114 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.62 -28.31 65.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.82 -43.28 99.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.181 0.515 . . . . 0.0 110.568 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.507 ' CD ' ' HZ3' ' A' ' 22' ' ' LYS . 3.4 mm-40 -71.9 -36.14 69.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.031 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.45 -54.06 50.12 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.587 177.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.628 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 12.5 mt -51.0 -61.02 2.48 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.001 -1.454 . . . . 0.0 112.164 -176.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.18 -31.49 60.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -167.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.507 ' HZ3' ' CD ' ' A' ' 18' ' ' GLU . 4.5 ttpm? -108.85 -20.29 13.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 95.9 t -119.43 -45.77 2.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -171.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 21.6 t80 -169.86 116.62 0.56 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.167 0.508 . . . . 0.0 111.344 -166.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -89.54 90.32 8.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.708 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.45 ' CE2' HD11 ' A' ' 84' ' ' LEU . 31.9 p90 -82.53 -2.25 52.98 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.413 ' HG3' HD21 ' A' ' 20' ' ' LEU . 15.2 mt-10 -70.64 -53.24 16.61 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.93 0.871 . . . . 0.0 108.698 174.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -100.13 -14.88 18.37 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.817 -172.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.419 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 12.7 m-80 -126.75 59.39 33.83 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 29' ' ' ASN . 10.5 Cg_endo -60.12 -30.14 90.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.396 2.731 . . . . 0.0 111.551 167.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -97.66 -41.22 8.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.776 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -94.91 149.6 21.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.204 -173.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.747 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 60.9 t-105 -108.29 109.56 20.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.044 176.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.447 ' HZ1' ' CD ' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -131.92 103.17 6.17 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.299 176.339 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.545 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 50.5 t80 -86.22 131.67 34.18 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.207 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.447 ' CD ' ' HZ1' ' A' ' 34' ' ' LYS . 14.6 mm-40 -112.1 -167.18 1.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.93 -119.61 3.36 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.787 -1.197 . . . . 0.0 112.991 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -158.92 -50.78 0.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.291 0.567 . . . . 0.0 109.815 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.539 ' HB2' HG21 ' A' ' 72' ' ' VAL . 48.7 mttp -121.76 168.78 10.55 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.864 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.547 ' HB3' HD12 ' A' ' 125' ' ' LEU . 33.1 Cg_exo -60.86 158.99 30.89 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.602 2.201 . . . . 0.0 111.534 173.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.545 ' HB1' ' OH ' ' A' ' 35' ' ' TYR . . . -127.61 142.31 51.39 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -169.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.539 ' HB ' HG12 ' A' ' 73' ' ' ILE . 44.0 mm -117.13 110.21 30.44 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.228 168.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 67.8 t -110.7 113.12 43.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 118.032 0.378 . . . . 0.0 111.523 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.652 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 5.8 p-10 -100.38 119.47 38.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.287 1.041 . . . . 0.0 111.477 176.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 93' ' ' ILE . 27.0 m-85 -77.02 113.87 15.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.297 -1.32 . . . . 0.0 108.84 171.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.63 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.4 p90 -130.98 168.28 17.62 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.29 0.567 . . . . 0.0 111.169 -176.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.09 135.89 19.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.439 174.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.502 ' CG ' ' HZ2' ' A' ' 54' ' ' LYS . 27.0 t70 -66.99 -33.13 74.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.761 0.315 . . . . 0.0 111.718 -173.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -71.89 -6.63 43.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.906 0.384 . . . . 0.0 111.236 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.43 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 37.4 t -113.34 113.64 25.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.101 0.477 . . . . 0.0 110.124 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.68 -53.11 41.15 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 119.263 -0.743 . . . . 0.0 113.975 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.43 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 84.3 Cg_exo -47.52 -31.41 13.7 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.099 2.533 . . . . 0.0 114.126 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.646 ' SG ' ' HB ' ' A' ' 93' ' ' ILE . 45.3 m -73.94 -45.11 52.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.855 0.36 . . . . 0.0 111.127 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.502 ' HZ2' ' CG ' ' A' ' 48' ' ' ASP . 15.1 ptpt -77.15 -27.4 53.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.129 0.49 . . . . 0.0 109.808 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.0 tmm? -51.47 -39.96 58.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.166 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.7 m -88.06 -15.99 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.881 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.7 -52.36 57.19 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.32 -33.68 37.88 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 121.766 1.644 . . . . 0.0 112.216 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.43 ' O ' HD12 ' A' ' 63' ' ' LEU . 92.5 mt -65.44 -44.49 94.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.524 0.678 . . . . 0.0 109.899 175.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.1 mt -67.98 -31.22 70.78 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.123 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -60.82 -48.27 82.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.171 0.51 . . . . 0.0 109.932 170.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -54.81 -46.52 74.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.154 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.771 HD21 HD13 ' A' ' 121' ' ' ILE . 7.7 mp -67.15 -31.25 71.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.363 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.451 ' O ' ' HA2' ' A' ' 9' ' ' GLY . . . -59.38 -42.09 90.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.765 0.317 . . . . 0.0 110.582 177.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -72.39 -49.67 32.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.313 0.577 . . . . 0.0 109.938 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -53.12 -35.79 60.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.705 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.56 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 45.0 m-85 -107.2 26.51 10.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.555 -178.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.569 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 25.5 t70 -67.36 153.92 42.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.268 0.556 . . . . 0.0 111.217 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.624 ' H ' ' ND2' ' A' ' 8' ' ' ASN . . . 85.51 -18.58 28.54 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.508 -0.769 . . . . 0.0 113.496 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 4.2 pt20 -121.65 -53.42 1.99 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -171.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.462 HG12 ' HB3' ' A' ' 67' ' ' TYR . 40.8 pt -128.35 156.39 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 118.313 0.506 . . . . 0.0 112.199 -174.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.539 HG21 ' HB2' ' A' ' 39' ' ' LYS . 6.8 t -111.91 144.71 19.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.851 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 68.5 mt -112.59 128.99 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.139 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 36.3 m-85 -117.15 159.72 22.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.652 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -140.88 144.73 35.42 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.188 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.549 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 7.4 p -122.03 136.16 59.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.274 0.559 . . . . 0.0 111.057 -173.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.582 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 1.1 m-20 -73.56 87.08 1.61 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.962 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.495 HG22 ' HB2' ' A' ' 85' ' ' ALA . 4.4 m -65.5 -31.64 72.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -167.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -18.19 63.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.228 -0.295 . . . . 0.0 111.662 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.561 ' NZ ' ' HB3' ' A' ' 77' ' ' ASP . 8.7 ptpp? -110.32 -26.81 9.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.519 0.675 . . . . 0.0 110.033 175.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -89.47 42.73 1.1 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.669 172.318 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -64.48 -41.47 96.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.205 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -31.15 67.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.473 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.463 HD21 HG23 ' A' ' 76' ' ' VAL . 27.4 tp -66.79 -46.39 75.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.067 174.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.532 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -63.64 -43.01 98.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.967 177.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.69 -29.15 69.28 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.701 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.82 -32.21 73.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.903 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -89.28 -16.42 31.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.781 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.89 20.44 28.52 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.097 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.532 ' HB ' ' HB1' ' A' ' 85' ' ' ALA . 35.6 mm -80.51 135.89 24.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -69.22 -62.82 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.157 0.503 . . . . 0.0 110.215 177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.492 ' O ' HG23 ' A' ' 78' ' ' THR . 36.2 m -156.25 -88.44 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.615 176.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.646 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 1.8 pp -160.19 154.9 20.64 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.608 -172.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -97.11 144.88 5.7 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 124.548 -1.022 . . . . 0.0 112.215 -2.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.708 ' HB3' ' SD ' ' A' ' 107' ' ' MET . 61.3 m -141.07 143.26 34.25 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.404 HD11 ' C ' ' A' ' 95' ' ' SER . 3.7 mp -127.96 121.78 57.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.332 0.587 . . . . 0.0 110.734 -175.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.1 tp -98.02 112.5 24.42 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.764 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.572 ' HE2' ' HB3' ' A' ' 108' ' ' ALA . 93.1 m-85 -90.14 104.03 16.65 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.57 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 64.9 mt -101.73 113.51 65.82 Favored Pre-proline 0 C--O 1.235 0.312 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -169.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -87.47 174.64 4.95 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.124 2.549 . . . . 0.0 111.725 171.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.9 mmt -97.7 -24.73 15.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.251 0.548 . . . . 0.0 110.362 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.78 21.98 16.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.376 -171.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 178.62 -176.29 47.9 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.172 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.747 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 14.3 mptt -77.19 149.98 79.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.584 0.231 . . . . 0.0 110.689 177.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.57 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 91.1 Cg_endo -82.54 155.23 16.08 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.925 2.417 . . . . 0.0 113.068 -176.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -104.09 168.27 9.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.466 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.708 ' SD ' ' HB3' ' A' ' 95' ' ' SER . 27.2 tpp -132.59 124.15 27.82 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.608 -174.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.572 ' HB3' ' HE2' ' A' ' 98' ' ' PHE . . . -130.89 129.32 42.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.438 174.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 95' ' ' SER . 86.0 mt-30 -74.01 151.49 40.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.806 0.336 . . . . 0.0 110.977 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.79 -153.61 3.58 Favored Glycine 0 C--O 1.227 -0.336 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 -168.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 69.62 19.64 7.29 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.496 0.718 . . . . 0.0 111.025 -174.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.613 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 76.0 mtm -89.98 147.35 37.06 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.376 177.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.74 -174.85 2.18 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.411 2.074 . . . . 0.0 110.782 175.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.514 ' HG3' HD13 ' A' ' 63' ' ' LEU . 19.5 ttmt -56.83 -41.98 78.81 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.57 173.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.12 -51.96 67.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.613 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 19.8 m -69.51 -36.91 76.91 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.986 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.569 ' O ' HG13 ' A' ' 121' ' ' ILE . 3.5 m-85 -65.47 -52.24 54.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.935 0.398 . . . . 0.0 110.414 175.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -55.71 -44.1 77.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.103 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.485 ' HG3' ' OE2' ' A' ' 123' ' ' GLU . 28.1 tptp -56.57 -57.12 13.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.326 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.15 90.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.145 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.771 HD13 HD21 ' A' ' 63' ' ' LEU . 23.8 mt -67.71 -50.75 57.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 0.0 110.715 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.66 -56.35 14.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.834 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.658 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . 9.1 pt-20 -76.04 6.96 4.53 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.731 0.644 . . . . 0.0 112.688 -169.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -131.74 -48.19 0.96 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.4 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.547 HD12 ' HB3' ' A' ' 40' ' ' PRO . 31.1 tp -82.56 -46.26 13.58 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.413 -174.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.448 HD13 ' CE1' ' A' ' 67' ' ' TYR . 72.7 mt -81.32 -60.0 2.43 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.658 ' HG3' ' HA ' ' A' ' 123' ' ' GLU . 8.2 ptpp? -105.1 101.11 10.68 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.346 173.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.48 ' H ' ' HG2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -71.45 70.37 0.63 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.069 0.461 . . . . 0.0 111.073 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.438 ' HG2' ' N ' ' A' ' 130' ' ' GLY . 6.1 tt0 73.52 150.27 0.11 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.164 175.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.438 ' N ' ' HG2' ' A' ' 129' ' ' GLU . . . -74.48 70.84 1.61 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 174.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 133' ' ' HIS . 14.1 m80 -73.08 67.46 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.699 0.761 . . . . 0.0 111.649 -177.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -116.68 38.86 3.33 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.366 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 131' ' ' HIS . 20.3 m-70 -76.91 2.41 14.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.832 -175.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -82.76 85.72 7.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -99.83 153.63 18.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.47 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 33.8 m80 . . . . . 0 C--O 1.244 0.764 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 169.043 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.858 0.361 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.5 m -145.6 -44.75 0.21 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.167 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.407 HD11 ' N ' ' A' ' 3' ' ' LEU . 6.2 mp -99.34 -47.43 5.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -162.94 -66.67 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.042 177.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.5 p -133.47 -37.44 0.95 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.13 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 55.92 -90.72 0.03 OUTLIER 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.573 -173.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -109.56 87.41 0.48 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -164.29 102.43 0.85 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.23 36.84 19.91 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 116.108 -0.497 . . . . 0.0 113.762 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -164.69 166.85 19.66 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 122.017 0.913 . . . . 0.0 112.879 178.201 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.754 HG11 HG22 ' A' ' 73' ' ' ILE . 42.0 t -110.61 115.04 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.421 170.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.0 mm -80.8 99.18 4.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.023 0.439 . . . . 0.0 110.546 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -74.09 112.68 10.47 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 171.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.78 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.8 pp -139.42 -179.88 6.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -167.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.3 p -109.25 177.73 4.66 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.582 173.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -59.5 -27.32 66.04 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 117.598 0.181 . . . . 0.0 111.221 -178.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.87 -39.78 76.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.287 0.565 . . . . 0.0 110.592 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.78 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 5.2 mm-40 -72.13 -35.88 69.23 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.519 175.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.411 ' CG ' HD13 ' A' ' 84' ' ' LEU . 13.8 t80 -61.23 -45.33 94.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 122.173 0.987 . . . . 0.0 108.588 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.7 tt -46.83 -61.05 2.03 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 113.19 -1.823 . . . . 0.0 111.868 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.81 -13.25 51.66 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -170.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.63 ' HZ1' ' CD ' ' A' ' 18' ' ' GLU . 56.5 mttp -109.49 -18.94 13.4 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 47.2 t -133.66 -45.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -171.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.631 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 9.5 t80 -161.32 115.38 1.99 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.232 0.539 . . . . 0.0 111.622 -167.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.432 ' ND2' HD22 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -91.91 95.51 9.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.602 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.416 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 6.2 p90 -73.89 7.38 2.61 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -97.55 -17.36 19.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.881 0.372 . . . . 0.0 110.27 170.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -90.38 -34.26 15.73 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.205 0.526 . . . . 0.0 110.296 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.711 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -147.98 62.08 6.49 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.289 -175.527 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 29' ' ' ASN . 4.8 Cg_exo -44.03 -35.28 7.31 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 124.907 3.738 . . . . 0.0 112.771 170.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -103.46 -30.87 10.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.77 -176.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.409 ' CD ' ' HZ2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -97.78 178.55 5.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.47 0.652 . . . . 0.0 112.017 -175.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.557 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 59.2 t-105 -123.14 104.92 9.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.947 175.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -119.12 105.79 11.74 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.483 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.55 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 38.2 t80 -72.09 123.48 22.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.342 178.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -97.15 15.61 22.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.371 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.55 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -98.98 -152.28 27.43 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.759 -173.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -124.79 -52.57 1.68 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 111.196 -172.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.526 ' HB2' HG21 ' A' ' 72' ' ' VAL . 36.5 mttm -113.35 165.27 13.66 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.493 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 70' ' ' GLN . 73.8 Cg_exo -47.77 131.74 20.64 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.158 1.905 . . . . 0.0 110.972 172.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.471 ' HB2' ' HH ' ' A' ' 35' ' ' TYR . . . -113.09 143.57 44.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.292 0.568 . . . . 0.0 111.811 -170.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.608 ' HB ' HG12 ' A' ' 73' ' ' ILE . 61.3 mt -130.26 110.4 19.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.034 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 74' ' ' TYR . 8.3 p -111.76 134.52 53.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.545 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 2.4 t70 -100.72 118.96 37.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.492 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.424 ' O ' HG23 ' A' ' 93' ' ' ILE . 97.3 m-85 -95.85 112.58 24.27 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.625 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 10.7 p90 -127.28 173.98 9.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.815 0.817 . . . . 0.0 111.762 -175.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.28 120.03 5.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 113.53 -1.668 . . . . 0.0 107.352 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.18 -34.7 68.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -169.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -67.86 -12.88 61.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.865 0.364 . . . . 0.0 111.383 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.708 ' HB3' ' HG ' ' A' ' 53' ' ' CYS . 42.4 t -99.01 117.3 33.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.805 0.336 . . . . 0.0 110.427 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.02 -54.62 22.09 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.701 -0.681 . . . . 0.0 114.21 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.518 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 81.6 Cg_exo -47.59 -36.68 25.32 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.025 2.484 . . . . 0.0 114.034 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.708 ' HG ' ' HB3' ' A' ' 50' ' ' CYS . 61.5 m -68.21 -31.86 71.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.205 0.526 . . . . 0.0 111.196 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -63.85 -28.63 69.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.857 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.516 ' O ' HD12 ' A' ' 59' ' ' ILE . 41.4 mmm -76.16 -42.97 44.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.106 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 53' ' ' CYS . 6.5 p -75.29 -39.18 42.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -173.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.52 -55.4 19.47 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.04 -46.2 6.56 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.075 1.85 . . . . 0.0 112.446 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.516 HD12 ' O ' ' A' ' 55' ' ' MET . 1.8 mp -55.71 -42.08 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 121.301 0.572 . . . . 0.0 110.333 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -58.68 -39.03 79.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.592 176.152 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.518 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 33.0 t70 -69.19 -42.64 75.55 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.662 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 66' ' ' GLU . 43.4 mt-10 -54.13 -55.22 29.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.371 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.542 HD11 ' HG3' ' A' ' 114' ' ' LYS . 10.9 mp -61.23 -30.67 70.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.3 -178.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.55 -56.56 16.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.081 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -77.96 -29.23 49.7 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.132 178.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.48 ' CD ' ' HZ3' ' A' ' 114' ' ' LYS . 57.9 mt-10 -66.15 -38.06 87.19 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.93 0.395 . . . . 0.0 111.63 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -105.47 19.33 20.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.037 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 65' ' ' LYS . 33.5 t0 -59.24 157.49 10.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.552 0.692 . . . . 0.0 112.82 -170.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.58 -32.8 7.14 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.428 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.566 ' HG3' HG23 ' A' ' 71' ' ' ILE . 23.6 pt20 -111.91 -35.14 5.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -174.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.566 HG23 ' HG3' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -119.44 162.47 17.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.503 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.526 HG21 ' HB2' ' A' ' 39' ' ' LYS . 40.7 t -125.34 129.29 73.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.754 HG22 HG11 ' A' ' 11' ' ' VAL . 26.7 mt -107.57 142.15 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.03 -176.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.519 ' HB2' HG21 ' A' ' 43' ' ' VAL . 44.0 m-85 -127.08 166.69 17.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.981 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.652 ' HZ2' ' HB3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -155.11 146.32 22.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.757 0.313 . . . . 0.0 110.219 171.321 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.668 HG23 ' HG2' ' A' ' 81' ' ' GLU . 8.1 p -152.33 159.94 3.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.396 -172.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.585 ' HB2' ' HG2' ' A' ' 80' ' ' LYS . 10.7 m-20 -99.46 111.85 24.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.844 -0.162 . . . . 0.0 110.736 -175.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.713 HG21 ' HA ' ' A' ' 92' ' ' SER . 59.6 m -57.21 -31.52 65.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.01 0.433 . . . . 0.0 111.695 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.87 -33.19 71.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.751 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.585 ' HG2' ' HB2' ' A' ' 77' ' ' ASP . 11.5 ptpt -102.04 -27.57 12.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.416 0.627 . . . . 0.0 109.669 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.668 ' HG2' HG23 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -93.91 46.21 1.17 Allowed 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.25 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.61 -35.89 81.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.475 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.78 -40.39 84.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.245 0.545 . . . . 0.0 109.669 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.411 HD13 ' CG ' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -62.47 -47.62 83.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.375 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.621 ' HB2' HG23 ' A' ' 78' ' ' THR . . . -66.03 -46.0 79.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.491 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.27 -29.67 71.96 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.151 -176.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.78 -35.34 79.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.895 0.378 . . . . 0.0 111.459 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.442 ' HB2' HG13 ' A' ' 90' ' ' ILE . 97.1 m-85 -100.09 7.64 44.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.408 -177.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.24 32.54 84.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.0 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.565 HG12 ' HE1' ' A' ' 107' ' ' MET . 39.5 mt -75.13 128.22 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -52.04 -64.37 0.84 Allowed 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.563 0.539 . . . . 0.0 110.25 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.713 ' HA ' HG21 ' A' ' 78' ' ' THR . 23.2 p -179.66 -85.45 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.558 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.455 ' O ' HD12 ' A' ' 93' ' ' ILE . 1.9 pp -156.26 148.24 17.36 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.622 -176.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.693 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 13.7 Cg_exo -78.89 148.68 83.29 Favored 'Cis proline' 0 N--CA 1.477 0.544 0 C-N-CA 124.856 -0.893 . . . . 0.0 112.395 -2.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.7 m -142.8 139.21 30.87 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.6 127.96 62.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 122.113 -0.367 . . . . 0.0 110.034 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.505 ' CB ' HG13 ' A' ' 43' ' ' VAL . 2.6 tp -97.05 127.89 43.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.629 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -108.74 100.19 9.46 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.521 HG12 ' HB3' ' A' ' 105' ' ' PRO . 50.3 mt -101.23 104.91 36.2 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.18 -172.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.62 158.79 22.0 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.39 2.06 . . . . 0.0 111.088 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.3 mmm -76.9 -26.84 54.59 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 175.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -102.44 103.84 14.26 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.053 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.38 -141.97 15.91 Favored Glycine 0 C--N 1.315 -0.626 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.446 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.557 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 21.8 mmmt -124.07 163.57 34.88 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.521 ' HB3' HG12 ' A' ' 99' ' ' ILE . 84.9 Cg_endo -82.45 140.03 10.55 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.359 2.039 . . . . 0.0 114.205 -173.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.49 171.24 9.03 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.111 173.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.565 ' HE1' HG12 ' A' ' 90' ' ' ILE . 41.8 ttm -142.89 135.22 27.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.811 -177.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.32 157.34 30.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 169.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -137.67 130.57 30.18 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.135 -0.626 . . . . 0.0 112.385 -175.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.693 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 117.78 -176.21 16.05 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.178 -0.919 . . . . 0.0 113.985 169.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -83.9 86.98 7.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.39 0.614 . . . . 0.0 110.604 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.543 ' HB2' ' HB3' ' A' ' 116' ' ' SER . 7.5 ptm -103.98 141.23 22.08 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.625 175.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 116' ' ' SER . 91.1 Cg_endo -75.24 177.3 8.81 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.59 2.193 . . . . 0.0 112.687 -173.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.542 ' HG3' HD11 ' A' ' 63' ' ' LEU . 37.8 ttmt -58.2 -30.47 66.49 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.262 175.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.7 -49.56 68.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.202 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' A' ' 112' ' ' MET . 17.0 t -67.74 -33.37 74.73 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.569 -0.453 . . . . 0.0 110.051 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.419 ' HB3' ' CD2' ' A' ' 63' ' ' LEU . 5.6 m-85 -72.52 -29.59 63.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.186 176.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.513 ' C ' ' HD3' ' A' ' 118' ' ' LYS . 12.7 tmtt? -56.44 -50.3 72.07 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.495 ' HG2' ' OE2' ' A' ' 123' ' ' GLU . 54.9 mttm -66.61 -38.23 86.52 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.539 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.641 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -66.74 -45.9 77.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.987 0.423 . . . . 0.0 111.402 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.498 HG12 HD23 ' A' ' 63' ' ' LEU . 1.6 mp -75.95 -56.03 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.052 0.453 . . . . 0.0 110.968 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.531 ' HA ' HD11 ' A' ' 126' ' ' LEU . 25.7 t70 -72.6 -60.55 2.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.566 -174.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.495 ' OE2' ' HG2' ' A' ' 119' ' ' LYS . 50.1 mt-10 -80.34 11.57 3.51 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -170.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.641 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 69.6 t80 -138.11 -42.57 0.52 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.568 0.211 . . . . 0.0 111.568 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 40' ' ' PRO . 26.6 tp -90.53 -37.93 13.54 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.89 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.531 HD11 ' HA ' ' A' ' 122' ' ' ASP . 10.8 mp -78.13 -48.47 15.88 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -87.95 71.69 9.39 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 168.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.672 ' H ' ' HD3' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -76.84 83.35 3.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.756 0.788 . . . . 0.0 112.24 -173.196 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.722 ' HA ' ' HE1' ' A' ' 134' ' ' HIS . 14.9 pt-20 -111.72 28.5 8.69 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.058 169.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -43.48 141.05 2.67 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.475 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.41 ' O ' ' HB2' ' A' ' 132' ' ' HIS . 36.7 m80 62.93 -93.93 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -170.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER 160.39 21.92 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.487 1.117 . . . . 0.0 110.914 169.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -77.47 82.64 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.958 0.409 . . . . 0.0 110.163 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.722 ' HE1' ' HA ' ' A' ' 129' ' ' GLU . 35.0 m80 -139.73 89.94 2.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.467 178.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 3.3 t60 179.05 -44.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 17.7 p80 . . . . . 0 C--O 1.249 1.043 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.119 171.665 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m 65.26 -80.12 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.936 0.772 . . . . 0.0 111.415 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.59 -73.79 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.175 0.512 . . . . 0.0 110.327 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.98 125.87 35.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.701 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.7 m -121.65 -76.29 0.59 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.209 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' CD ' ' HZ1' ' A' ' 22' ' ' LYS . 14.4 pt-20 -151.65 -169.67 3.43 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.19 39.42 97.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.437 -176.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.68 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -175.34 112.32 0.13 Allowed 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 122.408 0.283 . . . . 0.0 110.909 -175.277 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.632 ' CA ' ' HA ' ' A' ' 68' ' ' ASP . . . 56.44 35.39 66.02 Favored Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 115.096 0.798 . . . . 0.0 115.096 164.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.68 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 1.3 ptpp? -168.52 173.39 7.51 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 117.035 0.417 . . . . 0.0 110.155 176.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.698 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 19.4 m -109.13 133.41 54.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.322 -174.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.0 mm -103.09 98.48 6.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.608 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -72.97 111.6 8.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 173.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.841 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.9 pp -140.21 179.15 6.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -168.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.0 p -109.74 177.94 4.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.599 173.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 19' ' ' PHE . 14.8 pttm -59.04 -23.2 61.77 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.9 -48.9 72.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.375 0.607 . . . . 0.0 110.257 176.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.841 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 6.1 mp0 -71.54 -34.19 69.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.761 177.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 2.0 t80 -54.36 -48.58 71.32 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 122.266 1.031 . . . . 0.0 109.224 174.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.459 HD21 HD21 ' A' ' 25' ' ' ASN . 2.9 mt -52.43 -59.77 4.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.161 -1.836 . . . . 0.0 111.153 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.94 -27.67 49.38 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.512 ' HZ1' ' CD ' ' A' ' 6' ' ' GLU . 94.1 mttt -104.41 -14.18 15.82 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -173.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 21.4 t -126.9 -49.21 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.51 -0.476 . . . . 0.0 112.104 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.543 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 14.3 t80 -163.72 115.74 1.42 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.168 0.508 . . . . 0.0 110.66 -170.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.514 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -90.45 90.07 7.86 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.921 -176.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.543 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 23.9 p90 -90.58 22.1 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.412 ' CD ' ' HZ3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -107.46 -29.47 9.21 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.873 171.178 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.66 ' C ' HD21 ' A' ' 29' ' ' ASN . 6.5 ptpp? -106.77 -16.61 14.44 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.769 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.66 HD21 ' C ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -120.85 63.38 11.1 Favored Pre-proline 0 N--CA 1.474 0.739 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.0 174.343 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.456 ' HG2' ' OE1' ' A' ' 31' ' ' GLU . 12.0 Cg_endo -65.68 -44.98 7.29 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.437 2.091 . . . . 0.0 112.509 173.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.456 ' OE1' ' HG2' ' A' ' 30' ' ' PRO . 25.6 mp0 -88.41 -26.15 22.3 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.005 0.431 . . . . 0.0 110.88 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.28 147.99 22.65 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.202 0.525 . . . . 0.0 111.423 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.94 ' HD1' ' HZ1' ' A' ' 104' ' ' LYS . 35.7 t-105 -109.15 103.5 12.5 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 164.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.404 ' HZ2' ' HB2' ' A' ' 34' ' ' LYS . 5.6 mtmp? -119.02 124.25 46.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.046 173.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.543 ' OH ' ' HB3' ' A' ' 41' ' ' ALA . 18.3 t80 -85.17 108.8 17.88 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.4 0.45 33.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.147 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.46 162.63 36.52 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -93.1 -42.42 9.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.758 0.779 . . . . 0.0 111.76 -175.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.496 ' HB2' HG22 ' A' ' 72' ' ' VAL . 44.2 mttp -102.27 147.86 34.58 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 122.355 -0.215 . . . . 0.0 110.636 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -42.97 136.55 4.84 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.656 2.904 . . . . 0.0 112.818 176.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.543 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -119.07 149.01 42.39 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -170.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.886 ' HB ' HG12 ' A' ' 73' ' ' ILE . 45.3 mm -120.37 115.41 47.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.439 171.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.4 t -100.13 117.12 44.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.699 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.819 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 14.9 t70 -96.59 106.62 18.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.356 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.533 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 77.5 m-85 -94.65 112.13 23.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.434 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.622 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 52.3 p90 -134.7 176.31 8.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.611 0.72 . . . . 0.0 111.477 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.416 ' HB3' HD13 ' A' ' 93' ' ' ILE . . . -149.89 127.48 11.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.891 170.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.604 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 26.3 t70 -61.39 -24.83 66.77 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -168.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 55.6 p-90 -72.63 -9.36 58.51 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.747 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.567 ' HB3' ' SG ' ' A' ' 53' ' ' CYS . 26.0 t -105.74 137.68 43.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.057 0.456 . . . . 0.0 111.396 -174.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.94 -62.01 6.79 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.336 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.33 -26.92 55.03 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.105 2.537 . . . . 0.0 112.831 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.622 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 70.7 m -66.45 -50.61 62.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.079 0.466 . . . . 0.0 110.31 174.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.604 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 67.8 mttm -59.07 -29.88 67.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.833 175.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 84.5 mtp -66.29 -53.31 38.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.614 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.9 m -82.96 -34.52 11.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -170.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.49 ' HB1' ' HD3' ' A' ' 58' ' ' PRO . . . -47.16 -61.28 2.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -175.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.49 ' HD3' ' HB1' ' A' ' 57' ' ' ALA . 38.0 Cg_endo -66.43 -33.22 38.34 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.581 1.521 . . . . 0.0 112.078 -175.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.6 mt -66.46 -38.41 81.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.596 HD22 ' CZ ' ' A' ' 117' ' ' PHE . 0.8 OUTLIER -67.37 -39.91 85.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.845 177.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.571 ' OD2' HG22 ' A' ' 11' ' ' VAL . 1.2 m-20 -61.26 -49.78 75.72 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-O 121.869 0.842 . . . . 0.0 109.557 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.459 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 42.8 tt0 -62.17 -46.87 87.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.193 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.47 HD11 ' HG3' ' A' ' 114' ' ' LYS . 12.8 tp -61.14 -31.15 70.87 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -177.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.486 ' HB3' HD11 ' A' ' 73' ' ' ILE . . . -60.68 -54.16 48.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.023 177.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -73.25 -24.76 60.51 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.959 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.8 -38.66 75.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.257 0.551 . . . . 0.0 110.753 174.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.506 ' HH ' ' HG3' ' A' ' 118' ' ' LYS . 57.1 m-85 -103.44 27.36 7.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.153 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.632 ' HA ' ' CA ' ' A' ' 9' ' ' GLY . 10.1 t70 -52.21 129.62 28.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.141 0.496 . . . . 0.0 110.773 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.08 -42.19 1.92 Allowed Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.46 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -101.19 -47.81 4.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -173.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.8 pt -117.82 164.52 14.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.647 -171.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.496 HG22 ' HB2' ' A' ' 39' ' ' LYS . 14.5 t -128.34 139.12 52.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.189 176.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.886 HG12 ' HB ' ' A' ' 42' ' ' ILE . 53.9 mt -122.89 121.13 62.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.639 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -101.77 159.09 15.63 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.819 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 30.3 mttm -143.76 145.65 32.55 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.621 -176.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.465 HG21 ' HG2' ' A' ' 81' ' ' GLU . 9.8 p -156.15 156.02 5.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -177.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.791 ' HB3' ' HG2' ' A' ' 80' ' ' LYS . 11.3 t70 -98.27 116.76 31.17 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.467 HG21 ' HB3' ' A' ' 45' ' ' PHE . 21.0 p -63.69 -35.2 79.77 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -68.25 -31.69 71.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.791 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 4.5 mmtm -74.83 -55.14 6.12 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.465 ' HG2' HG21 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -87.52 57.92 4.67 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 113.608 -1.633 . . . . 0.0 112.278 -174.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -56.48 -46.02 80.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.75 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.409 ' CD ' ' HZ3' ' A' ' 16' ' ' LYS . 2.8 mp0 -68.98 -38.25 79.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.984 0.421 . . . . 0.0 110.572 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.428 ' CB ' ' HG3' ' A' ' 81' ' ' GLU . 3.0 tm? -66.86 -43.46 83.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.81 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.573 ' HA ' HD11 ' A' ' 90' ' ' ILE . . . -64.62 -47.05 80.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.894 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.22 -32.6 81.22 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.723 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.49 -27.51 68.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.701 0.286 . . . . 0.0 111.751 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -104.29 7.03 35.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.618 0.247 . . . . 0.0 111.271 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.98 22.26 79.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.381 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.573 HD11 ' HA ' ' A' ' 85' ' ' ALA . 23.6 mt -72.74 119.75 20.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -62.04 -46.68 88.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.745 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.4 p -179.23 -93.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.535 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.566 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 2.7 pt -152.66 147.62 19.54 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -168.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -95.31 134.1 4.89 Favored 'Cis proline' 0 N--CA 1.46 -0.458 0 C-N-CA 124.3 -1.125 . . . . 0.0 111.34 -3.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.533 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 17.2 t -108.26 146.76 32.39 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.569 HD12 ' CE1' ' A' ' 117' ' ' PHE . 27.6 mt -136.55 114.91 14.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.789 0.328 . . . . 0.0 110.146 -176.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.0 tp -103.28 116.7 32.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.4 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -93.32 103.83 16.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.457 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.458 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 41.9 mt -103.8 106.84 54.48 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -173.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.33 148.57 13.02 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.892 2.395 . . . . 0.0 111.625 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -42.26 99.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.25 0.548 . . . . 0.0 110.67 175.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.79 ' HB3' ' HE3' ' A' ' 128' ' ' LYS . 18.8 tt0 -99.37 105.77 17.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.302 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.496 ' C ' ' HD2' ' A' ' 104' ' ' LYS . . . 114.53 -146.82 18.78 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.284 177.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.94 ' HZ1' ' HD1' ' A' ' 33' ' ' TRP . 0.8 OUTLIER -128.27 159.69 65.97 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.303 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.469 ' HG3' ' CZ2' ' A' ' 33' ' ' TRP . 97.0 Cg_endo -81.25 152.23 18.18 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.753 2.302 . . . . 0.0 113.838 -170.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -110.02 166.81 10.65 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.642 172.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 43.3 ttm -137.11 140.51 41.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.247 0.546 . . . . 0.0 112.118 -172.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -133.52 157.19 46.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.948 172.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -96.52 150.41 20.66 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.56 -142.72 1.36 Allowed Glycine 0 CA--C 1.518 0.23 0 N-CA-C 114.628 0.611 . . . . 0.0 114.628 -171.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 71.86 18.68 5.02 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.622 0.769 . . . . 0.0 111.441 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.495 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 23.0 ptt? -117.37 154.2 50.3 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.46 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.28 178.39 7.58 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.999 2.466 . . . . 0.0 113.003 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.47 ' HG3' HD11 ' A' ' 63' ' ' LEU . 41.9 ttmt -59.45 -28.54 67.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.634 174.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.13 -52.99 61.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.411 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 35.1 m -65.89 -37.16 85.38 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.894 0.378 . . . . 0.0 110.67 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.596 ' CZ ' HD22 ' A' ' 60' ' ' LEU . 16.0 m-85 -61.49 -48.24 81.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.256 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.506 ' HG3' ' HH ' ' A' ' 67' ' ' TYR . 9.8 ttpp -55.74 -40.03 71.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.552 -178.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.539 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -56.06 -55.63 30.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.798 177.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -69.06 -42.34 76.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.783 -175.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 117' ' ' PHE . 43.5 mt -64.61 -53.46 42.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.91 0.386 . . . . 0.0 111.104 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 38.8 t70 -65.02 -59.0 4.63 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.517 -173.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -83.35 11.26 7.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -168.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.449 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 42.0 t80 -134.38 -52.35 0.82 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.593 0.235 . . . . 0.0 111.123 174.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.677 HD21 HD11 ' A' ' 42' ' ' ILE . 16.8 tp -74.58 -38.52 62.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.725 -175.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 122' ' ' ASP . 4.2 mm? -82.45 -59.94 2.36 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.486 178.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 21.8 pttp -104.73 97.77 7.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.757 0.789 . . . . 0.0 110.267 175.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.79 ' HE3' ' HB3' ' A' ' 102' ' ' GLU . 9.1 ptmm? -73.38 72.75 1.34 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.7 175.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -44.38 -76.69 0.02 OUTLIER 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.606 -171.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.63 12.87 1.35 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.228 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -56.88 -30.24 63.69 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.82 0.343 . . . . 0.0 111.433 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -138.95 51.45 1.8 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -77.3 151.1 35.15 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.043 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -159.11 74.74 0.65 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.067 0.46 . . . . 0.0 111.844 -174.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -177.35 138.86 0.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.487 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.385 -0.817 . . . . 0.0 109.626 177.353 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -142.5 171.74 13.65 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.4 -48.3 81.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.108 0.48 . . . . 0.0 109.998 176.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.44 76.7 9.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.873 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -112.14 6.61 19.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.857 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.91 165.49 29.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.793 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 139.38 -3.28 2.67 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.989 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -87.48 138.24 31.65 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.658 ' O ' ' HE3' ' A' ' 10' ' ' LYS . . . 57.46 34.36 68.58 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.65 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.658 ' HE3' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -138.63 164.33 29.77 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -170.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 14.7 p -102.98 123.57 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.518 0.675 . . . . 0.0 111.431 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.1 mt -132.97 124.34 50.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.696 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.839 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 7.7 p80 -91.73 138.8 31.27 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.176 177.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.654 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.7 pp -139.5 168.62 19.42 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.179 -176.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.0 p -95.33 177.17 5.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.909 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.575 ' HZ2' ' CD ' ' A' ' 83' ' ' GLU . 20.3 ptmt -55.66 -33.32 63.99 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.2 90.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.351 0.596 . . . . 0.0 110.165 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.654 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 8.3 mm-40 -71.1 -34.07 70.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.298 178.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -60.81 -50.58 72.87 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.836 0.827 . . . . 0.0 109.308 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.633 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -49.25 -60.43 2.82 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.607 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.25 -19.45 39.6 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -169.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.639 ' HZ1' ' CD ' ' A' ' 18' ' ' GLU . 56.4 mttp -109.66 -12.39 14.65 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -176.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 72.6 t -136.34 -49.99 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -172.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 12.2 t80 -154.27 116.74 4.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.315 0.579 . . . . 0.0 112.023 -164.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.517 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -82.6 88.65 6.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.687 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -88.75 11.26 18.18 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.014 0.435 . . . . 0.0 111.275 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.527 ' HG2' HD23 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -93.92 -48.31 6.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.37 0.605 . . . . 0.0 109.392 174.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.55 ' C ' HD21 ' A' ' 29' ' ' ASN . 53.7 mttp -90.46 -22.97 21.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.267 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.619 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -120.85 67.48 14.96 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.819 178.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -58.29 -44.11 41.23 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.228 2.619 . . . . 0.0 112.382 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -103.2 -22.22 13.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.194 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -91.05 178.13 6.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.346 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -128.69 106.35 8.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.233 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' HZ2' ' CD ' ' A' ' 36' ' ' GLU . 18.8 tptm -113.55 113.13 24.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.846 174.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.569 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 25.4 t80 -92.59 119.53 32.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.842 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.48 ' CD ' ' HZ2' ' A' ' 34' ' ' LYS . 21.5 mm-40 -102.65 28.28 6.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.038 -176.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.81 156.92 18.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.245 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.74 -40.32 11.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.716 0.293 . . . . 0.0 111.037 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -107.61 158.45 33.29 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.339 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.517 ' HG2' HG23 ' A' ' 71' ' ' ILE . 18.6 Cg_endo -59.51 140.72 95.36 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.588 2.192 . . . . 0.0 111.094 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -131.54 157.17 44.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.665 0.745 . . . . 0.0 112.812 -170.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.707 ' HB ' HG12 ' A' ' 73' ' ' ILE . 3.6 mp -120.0 116.5 50.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.633 174.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 35.9 t -100.32 111.97 31.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.739 0.304 . . . . 0.0 110.898 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.634 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 15.6 t70 -95.92 110.31 22.53 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.292 0.567 . . . . 0.0 111.562 -179.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -83.4 111.75 19.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.875 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.702 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 4.1 p90 -141.27 171.28 14.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.209 0.528 . . . . 0.0 111.07 -173.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.72 146.77 51.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.081 173.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -65.72 -38.01 87.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.657 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -80.43 -6.96 58.9 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 49.5 t -97.32 134.95 39.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.089 0.471 . . . . 0.0 111.506 -174.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.96 -63.77 4.15 Favored Glycine 0 C--O 1.224 -0.528 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.356 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.489 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 82.0 Cg_exo -47.26 -35.07 19.58 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.008 2.472 . . . . 0.0 113.145 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.702 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 71.6 m -62.66 -47.71 82.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.244 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -77.6 -28.56 51.59 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -55.75 -43.71 76.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.307 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.0 m -83.21 -16.84 11.16 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -174.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . . . -49.63 -55.6 21.89 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' A' ' 57' ' ' ALA . 38.2 Cg_endo -68.49 -41.03 6.91 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.547 1.498 . . . . 0.0 111.725 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 69.0 mt -58.14 -43.98 86.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.272 0.558 . . . . 0.0 110.528 176.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.447 HD23 HD11 ' A' ' 73' ' ' ILE . 12.7 mt -63.33 -45.39 91.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.677 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -64.93 -35.6 81.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 110.002 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 8.3 mm-40 -52.63 -52.86 53.66 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.175 176.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.453 ' HG ' HD12 ' A' ' 121' ' ' ILE . 3.4 mm? -67.96 -42.69 80.52 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.188 -0.205 . . . . 0.0 110.848 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.494 ' HB1' HD13 ' A' ' 73' ' ' ILE . . . -56.14 -50.03 72.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.814 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -71.04 -31.7 68.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.403 -178.322 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.45 ' CD ' ' HZ1' ' A' ' 114' ' ' LYS . 0.2 OUTLIER -67.47 -29.01 68.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.448 0.642 . . . . 0.0 110.367 179.218 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.504 ' HB3' HE21 ' A' ' 70' ' ' GLN . 26.3 m-85 -111.82 26.4 10.66 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.219 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.403 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 23.0 t0 -53.93 131.55 40.4 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.249 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.18 -43.83 1.61 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.141 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.504 HE21 ' HB3' ' A' ' 67' ' ' TYR . 11.2 pt20 -101.85 -32.67 10.13 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -175.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.517 HG23 ' HG2' ' A' ' 40' ' ' PRO . 39.6 pt -124.43 159.04 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.684 -178.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 93.2 t -138.05 136.48 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.471 176.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.707 HG12 ' HB ' ' A' ' 42' ' ' ILE . 40.2 mt -114.78 131.95 65.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.312 0.577 . . . . 0.0 111.091 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -115.99 166.16 12.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.102 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.839 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 46.8 mttm -128.88 162.71 26.89 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.487 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 9.2 p -139.86 136.74 39.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.66 86.74 7.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.86 -176.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.1 p -51.58 -41.83 61.46 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -53.78 -23.58 12.5 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HG3' ' OE1' ' A' ' 81' ' ' GLU . 7.4 ptpp? -115.37 -34.34 4.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.187 0.518 . . . . 0.0 109.947 177.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 1.3 mp0 -81.5 39.48 0.53 Allowed 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 123.711 0.804 . . . . 0.0 110.992 173.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.66 -41.16 94.44 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.932 0.396 . . . . 0.0 110.942 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.575 ' CD ' ' HZ2' ' A' ' 16' ' ' LYS . 2.6 tt0 -61.66 -47.78 83.79 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.042 177.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.0 tp -62.66 -48.51 79.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.182 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.34 -40.97 94.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.814 0.34 . . . . 0.0 111.341 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.46 -28.33 72.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.638 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.82 -27.59 68.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.322 . . . . 0.0 111.276 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.463 ' HB2' HG12 ' A' ' 90' ' ' ILE . 82.0 m-85 -89.71 -16.53 30.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.739 0.304 . . . . 0.0 110.975 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.93 4.68 56.69 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.075 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 88' ' ' PHE . 33.1 mm -67.45 126.21 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -63.96 -60.81 2.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.068 0.461 . . . . 0.0 110.251 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.1 m -158.19 -84.3 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.943 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.51 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 8.8 pt -153.93 146.14 17.21 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.28 -167.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -105.2 147.57 1.18 Allowed 'Cis proline' 0 N--CA 1.461 -0.423 0 C-N-CA 124.833 -0.903 . . . . 0.0 111.405 -5.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.43 ' C ' HD11 ' A' ' 96' ' ' ILE . 18.9 t -131.74 138.39 48.61 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.43 HD11 ' C ' ' A' ' 95' ' ' SER . 3.0 mp -125.93 116.16 45.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.733 -177.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 37.4 tp -94.19 112.12 23.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.112 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -90.2 107.31 19.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.461 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 55.2 mt -96.92 109.47 49.09 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.318 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.536 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 84.9 Cg_endo -87.96 169.31 6.5 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.221 2.614 . . . . 0.0 112.422 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 89.7 mmm -96.4 3.03 53.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.56 0.695 . . . . 0.0 109.236 173.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -138.66 118.67 13.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.355 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.19 -141.36 15.51 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.52 176.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -120.78 151.0 53.94 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.536 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 17.2 Cg_exo -68.04 122.51 9.61 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.483 2.122 . . . . 0.0 112.05 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -90.79 160.68 15.64 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.415 ' HE1' HD11 ' A' ' 97' ' ' LEU . 18.4 ptp -141.79 144.35 33.91 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.213 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.3 145.84 49.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.231 174.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -72.15 137.23 46.83 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.34 -143.38 3.85 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 115.363 0.905 . . . . 0.0 115.363 -167.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.489 ' HB2' ' HB3' ' A' ' 52' ' ' PRO . . . 70.86 20.2 5.54 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.829 0.852 . . . . 0.0 110.403 -171.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.593 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 6.6 mtp -84.33 150.28 57.1 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.769 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.44 178.31 7.52 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.43 2.087 . . . . 0.0 111.141 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.45 ' HZ1' ' CD ' ' A' ' 66' ' ' GLU . 86.3 tttt -61.73 -26.29 67.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.05 0.452 . . . . 0.0 109.953 176.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.84 -52.38 20.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.043 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 18.8 m -68.61 -35.14 76.92 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.618 -177.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.489 ' O ' HG13 ' A' ' 121' ' ' ILE . 3.7 m-85 -64.77 -44.4 90.15 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.578 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -57.98 -48.81 78.87 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.87 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -57.42 -37.06 72.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.831 0.348 . . . . 0.0 110.772 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.42 -48.6 48.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.196 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 117' ' ' PHE . 56.8 mt -65.68 -52.1 54.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.237 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.42 -62.42 1.79 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.893 0.378 . . . . 0.0 110.942 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.675 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 18.2 mt-10 -64.25 -44.56 91.41 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -172.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -94.44 -35.16 12.45 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.217 -172.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.517 HD12 ' HB2' ' A' ' 40' ' ' PRO . 17.9 tp -89.02 -47.57 8.03 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.796 -175.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.8 mt -80.23 -58.92 2.91 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.675 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 25.1 ttpp -76.11 159.32 30.86 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.637 ' HZ3' ' HB2' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -138.23 117.17 12.43 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.535 -178.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -66.43 -6.38 14.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.447 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.52 69.66 1.27 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -175.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -66.04 -69.15 0.32 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -171.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 47.6 m80 56.04 -79.54 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 174.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -109.57 -100.7 0.39 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.562 0.22 . . . . 0.0 110.621 -175.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.531 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 6.3 m80 -129.16 -12.15 4.62 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.531 ' HB2' ' O ' ' A' ' 134' ' ' HIS . 57.9 m80 73.31 18.85 3.64 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -164.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 63.7 t60 . . . . . 0 C--O 1.242 0.682 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.013 -177.036 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.698 ' HB3' ' HA ' ' A' ' 5' ' ' THR . 55.5 tpp . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.9 m 59.04 -91.39 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 O-C-N 123.835 0.709 . . . . 0.0 110.278 -172.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.9 mp -100.41 -72.93 0.66 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -107.64 -81.12 0.56 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.86 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.698 ' HA ' ' HB3' ' A' ' 1' ' ' MET . 8.9 t -132.83 5.26 3.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.183 0.516 . . . . 0.0 109.92 175.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.643 ' HG2' ' H ' ' A' ' 7' ' ' GLY . 26.0 tt0 -171.85 -178.66 2.24 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.055 -175.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.643 ' H ' ' HG2' ' A' ' 6' ' ' GLU . . . -114.01 45.99 1.23 Allowed Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.558 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 18.1 m120 -52.61 119.86 5.0 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 122.782 0.433 . . . . 0.0 111.704 -178.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.505 ' CA ' ' HA ' ' A' ' 68' ' ' ASP . . . 69.98 18.55 74.62 Favored Glycine 0 CA--C 1.502 -0.738 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.764 173.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -124.8 172.32 9.42 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.9 p -142.2 132.36 24.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.119 0.485 . . . . 0.0 111.073 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.8 mm -131.45 124.95 55.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.544 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.624 ' CB ' ' HB2' ' A' ' 75' ' ' LYS . 6.0 p80 -82.81 116.13 22.01 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 172.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.472 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -116.99 179.73 3.94 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.464 -170.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.473 HG23 ' HE2' ' A' ' 80' ' ' LYS . 56.8 p -89.58 163.35 15.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.016 176.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.693 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 33.2 pttt -61.94 -24.1 66.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.681 175.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.3 -39.52 71.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.272 0.558 . . . . 0.0 110.08 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.472 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 10.4 mm-40 -65.89 -38.75 89.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.074 175.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -62.04 -51.26 68.73 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.965 0.888 . . . . 0.0 109.115 175.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.602 ' HG ' ' CE2' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -51.64 -60.73 2.83 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.466 -1.697 . . . . 0.0 111.733 -175.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.54 -24.17 45.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -168.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.412 ' HB3' ' HZ1' ' A' ' 22' ' ' LYS . 5.8 ttpm? -109.15 -23.33 11.69 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.5 t -121.33 -41.46 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -172.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.586 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 30.1 t80 -160.82 115.05 2.1 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.142 0.496 . . . . 0.0 111.011 -169.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.589 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -89.96 90.45 8.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.685 -175.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.602 ' CE2' ' HG ' ' A' ' 20' ' ' LEU . 28.6 p90 -85.26 20.68 1.9 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.417 0.627 . . . . 0.0 111.248 177.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.538 ' HG3' HD21 ' A' ' 20' ' ' LEU . 39.8 mt-10 -92.93 -47.33 7.07 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.483 ' HG3' ' ND2' ' A' ' 29' ' ' ASN . 18.3 ptmt -98.25 -11.09 23.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.412 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.614 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 9.9 m-80 -128.69 73.44 80.98 Favored Pre-proline 0 CA--C 1.515 -0.396 0 CA-C-O 121.686 0.755 . . . . 0.0 110.93 171.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -57.58 -43.47 50.48 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 123.744 2.962 . . . . 0.0 112.167 171.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -111.12 -31.5 7.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.016 -174.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.614 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -90.87 157.43 17.35 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.295 0.569 . . . . 0.0 111.317 -174.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.606 ' HB3' ' HZ2' ' A' ' 104' ' ' LYS . 40.7 t-105 -112.54 112.96 24.87 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.613 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -132.79 110.4 10.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.661 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -87.81 133.56 33.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.908 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -107.25 144.71 33.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 171.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.21 -122.58 1.48 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.798 -175.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.485 ' OD1' ' HG3' ' A' ' 39' ' ' LYS . 16.6 t70 -165.41 -61.38 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.117 0.484 . . . . 0.0 110.188 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.485 ' HG3' ' OD1' ' A' ' 38' ' ' ASP . 44.8 mttp -105.54 156.21 36.79 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.761 -173.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.518 ' HG2' HG22 ' A' ' 71' ' ' ILE . 6.0 Cg_endo -49.46 133.61 31.46 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.259 2.64 . . . . 0.0 111.999 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -118.51 146.67 44.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.438 -173.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.776 HD13 HD23 ' A' ' 125' ' ' LEU . 50.1 mm -115.71 136.5 52.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.718 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 17.5 t -120.69 120.28 62.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.061 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.665 ' HB2' HD12 ' A' ' 60' ' ' LEU . 13.5 t0 -94.26 103.55 15.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.754 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.402 ' HE1' ' HB2' ' A' ' 97' ' ' LEU . 80.8 m-85 -88.81 110.95 21.46 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 176.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.657 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.9 p90 -145.95 177.32 9.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.259 0.552 . . . . 0.0 111.456 -172.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.403 ' HB2' HD12 ' A' ' 93' ' ' ILE . . . -157.95 152.05 24.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.492 171.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -60.6 -44.83 95.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -173.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -69.4 -10.91 60.06 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -171.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.404 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 45.9 t -93.71 129.21 40.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.065 0.459 . . . . 0.0 110.838 -178.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.73 -60.5 7.66 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.811 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.535 ' HB3' ' HB1' ' A' ' 111' ' ' ALA . 81.6 Cg_exo -47.61 -35.66 23.23 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.315 2.676 . . . . 0.0 113.381 176.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.657 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 67.6 m -64.07 -50.64 67.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.985 0.422 . . . . 0.0 111.061 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -61.62 -28.11 69.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.006 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 84.3 mtp -66.97 -51.58 53.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.463 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.407 ' HB ' ' HZ ' ' A' ' 117' ' ' PHE . 30.0 m -77.29 -33.53 20.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -171.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.605 ' HB1' ' HD3' ' A' ' 58' ' ' PRO . . . -48.22 -56.64 13.2 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.605 ' HD3' ' HB1' ' A' ' 57' ' ' ALA . 21.7 Cg_exo -65.68 -35.72 35.92 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.057 1.838 . . . . 0.0 112.168 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.442 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 67.6 mt -64.19 -41.38 92.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.432 0.634 . . . . 0.0 109.536 176.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.665 HD12 ' HB2' ' A' ' 44' ' ' ASP . 7.6 mt -68.36 -33.49 74.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.454 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.439 ' OD1' HG13 ' A' ' 11' ' ' VAL . 58.9 m-20 -63.73 -42.66 97.85 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.661 0.743 . . . . 0.0 109.25 173.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.564 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 16.9 tp10 -57.09 -53.39 58.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.682 177.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.496 HD22 ' HG3' ' A' ' 114' ' ' LYS . 4.4 mm? -61.76 -31.91 72.13 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.626 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.487 ' HB2' HD13 ' A' ' 73' ' ' ILE . . . -58.49 -60.23 4.12 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.74 0.305 . . . . 0.0 110.921 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.564 ' HE3' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -75.17 -23.85 57.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.196 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.534 ' CD ' ' HZ1' ' A' ' 114' ' ' LYS . 32.1 tt0 -61.37 -38.57 87.48 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.246 0.546 . . . . 0.0 110.535 173.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.467 ' HD2' ' NE2' ' A' ' 70' ' ' GLN . 75.1 m-85 -103.67 27.1 7.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.298 178.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.52 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 6.7 t0 -48.43 134.42 15.18 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.366 -177.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.472 ' HA2' ' HB3' ' A' ' 8' ' ' ASN . . . 92.61 -33.84 4.79 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.658 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.467 ' NE2' ' HD2' ' A' ' 67' ' ' TYR . 14.1 mt-30 -86.53 -47.65 9.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.609 0.242 . . . . 0.0 111.384 -175.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.518 HG22 ' HG2' ' A' ' 40' ' ' PRO . 40.5 pt -125.1 164.01 24.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.186 0.517 . . . . 0.0 111.644 -175.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 60.3 t -128.27 127.78 67.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.3 175.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.755 HG12 ' HB ' ' A' ' 42' ' ' ILE . 46.7 mt -111.71 137.99 42.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.196 0.522 . . . . 0.0 111.118 -177.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -121.13 161.8 21.17 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.624 ' HB2' ' CB ' ' A' ' 13' ' ' HIS . 79.8 mttt -124.34 150.62 45.29 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.016 0.436 . . . . 0.0 110.034 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.696 HG13 ' HG2' ' A' ' 81' ' ' GLU . 2.8 t -127.95 126.13 65.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.025 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -90.33 89.64 7.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.659 HG21 ' HA ' ' A' ' 92' ' ' SER . 33.1 m -52.09 -30.04 24.23 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.215 -171.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -51.97 -34.23 41.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.76 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.473 ' HE2' HG23 ' A' ' 15' ' ' THR . 22.7 pttm -108.27 -20.89 12.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.207 0.527 . . . . 0.0 110.348 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.696 ' HG2' HG13 ' A' ' 76' ' ' VAL . 1.5 mp0 -91.18 40.99 1.05 Allowed 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.572 0.749 . . . . 0.0 111.67 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -55.6 -53.6 54.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.444 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.566 ' CD ' ' HZ2' ' A' ' 16' ' ' LYS . 2.6 mp0 -62.85 -36.39 83.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.631 -178.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.6 tp -64.1 -43.33 95.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.541 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.558 ' HB2' ' HB ' ' A' ' 90' ' ' ILE . . . -65.25 -47.15 77.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.669 175.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.88 -33.93 80.66 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.87 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.54 -35.18 77.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 111.402 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.516 ' HB3' ' HE2' ' A' ' 107' ' ' MET . 92.0 m-85 -95.3 4.06 53.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.941 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.16 10.17 85.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.867 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 85' ' ' ALA . 6.4 mt -69.72 143.01 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -72.09 -48.17 46.0 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.659 ' HA ' HG21 ' A' ' 78' ' ' THR . 15.0 p 179.69 -80.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.712 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.56 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 16.7 pt -149.2 149.83 30.43 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.107 -172.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.433 ' HG3' ' HB2' ' A' ' 52' ' ' PRO . 10.7 Cg_endo -101.2 150.27 3.44 Favored 'Cis proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.649 -0.979 . . . . 0.0 112.046 -3.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.6 t -138.95 136.66 35.65 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 107' ' ' MET . 15.3 mm -114.55 113.42 43.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.718 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 41.5 tp -94.58 119.44 33.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.03 0.443 . . . . 0.0 110.689 -175.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -100.72 107.89 19.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.424 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.13 108.12 50.62 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.393 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -84.65 168.77 11.02 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.744 2.296 . . . . 0.0 112.098 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 86.5 mtp -87.23 -12.34 47.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.503 0.668 . . . . 0.0 110.155 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -140.09 127.05 20.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.581 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.67 -151.93 18.19 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.227 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.606 ' HZ2' ' HB3' ' A' ' 33' ' ' TRP . 29.3 mmmt -115.4 155.13 47.46 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.43 ' HD3' ' CD1' ' A' ' 33' ' ' TRP . 92.3 Cg_endo -81.79 144.5 13.84 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.505 2.136 . . . . 0.0 112.302 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.2 169.92 8.67 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.318 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.527 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 22.3 ptp -142.19 121.33 12.98 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.775 0.798 . . . . 0.0 111.41 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.54 128.38 49.21 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -67.52 150.95 48.17 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.317 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.96 -162.99 2.27 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.559 -0.746 . . . . 0.0 114.753 -168.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.535 ' HB1' ' HB3' ' A' ' 52' ' ' PRO . . . 75.84 17.24 2.29 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.164 0.985 . . . . 0.0 111.55 -176.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.619 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 73.0 mtm -86.75 144.31 36.95 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.85 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 71.7 Cg_endo -75.43 178.92 6.72 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.567 2.178 . . . . 0.0 110.5 172.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.534 ' HZ1' ' CD ' ' A' ' 66' ' ' GLU . 64.3 tttm -62.06 -27.83 69.18 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.75 -45.89 63.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.037 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.619 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 50.7 m -70.62 -30.14 66.71 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.184 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.519 ' O ' HG13 ' A' ' 121' ' ' ILE . 13.7 m-85 -64.08 -52.44 59.27 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.172 172.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.455 ' O ' ' HD3' ' A' ' 118' ' ' LYS . 11.6 tmtt? -58.53 -38.32 77.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.83 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.489 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -56.59 -52.29 65.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.894 176.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.05 -43.28 68.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.853 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 117' ' ' PHE . 58.6 mt -62.97 -44.16 99.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 109.965 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -62.88 -68.4 0.34 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.596 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.792 ' HA ' ' HE2' ' A' ' 127' ' ' LYS . 3.8 tt0 -80.06 11.06 3.65 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.836 -163.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -143.17 -47.51 0.31 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.614 177.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.776 HD23 HD13 ' A' ' 42' ' ' ILE . 28.4 tp -79.44 -38.86 33.7 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.139 -174.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.2 mt -98.54 -47.91 5.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.666 0.746 . . . . 0.0 109.923 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.792 ' HE2' ' HA ' ' A' ' 123' ' ' GLU . 19.0 ttpt -96.47 84.44 3.7 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.693 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -67.7 109.15 3.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.173 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 76.89 144.75 0.08 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 124.277 0.986 . . . . 0.0 110.868 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.94 -20.05 79.64 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.274 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.4 m170 70.97 89.09 0.1 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.674 0.75 . . . . 0.0 109.927 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -80.32 92.34 5.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.076 -171.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -74.47 99.43 3.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.615 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -89.25 150.57 22.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.892 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -89.23 150.37 22.67 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 . . . . . 0 C--O 1.245 0.818 0 CA-C-O 117.802 -1.094 . . . . 0.0 108.4 170.135 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptm . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.765 0.316 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -91.56 113.09 25.26 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 175.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 pp -85.75 -4.44 59.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.658 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -163.29 127.69 2.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.959 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 p -109.24 141.14 41.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.173 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.478 ' CD ' ' HZ1' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -78.65 77.17 5.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.332 1.063 . . . . 0.0 110.261 -179.18 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 72' ' ' VAL . . . 145.19 89.7 0.1 OUTLIER Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.234 -175.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -155.22 106.0 2.56 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.846 -0.208 . . . . 0.0 110.655 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.504 ' CA ' ' HA ' ' A' ' 68' ' ' ASP . . . 67.44 28.26 73.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.541 173.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.42 ' HZ1' ' CG ' ' A' ' 61' ' ' ASP . 50.5 tttp -162.74 166.55 24.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.757 0.279 . . . . 0.0 110.295 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.527 HG21 HG23 ' A' ' 73' ' ' ILE . 9.0 p -98.85 133.59 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.495 0.664 . . . . 0.0 111.029 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 73.8 mt -111.61 122.25 65.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.732 177.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.449 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 2.2 p80 -91.84 119.36 31.57 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.589 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.2 pp -138.8 168.17 20.4 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.677 -178.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.9 p -94.25 176.61 6.25 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.396 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.551 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 13.8 pttm -57.21 -24.83 57.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 177.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.53 -47.43 69.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.308 0.575 . . . . 0.0 109.727 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 3.9 mp0 -71.13 -33.87 70.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.109 176.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -59.41 -47.9 83.68 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 122.195 0.997 . . . . 0.0 109.151 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -50.26 -59.35 4.04 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 113.155 -1.838 . . . . 0.0 111.046 -179.545 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.0 -45.03 36.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HZ1' ' CD ' ' A' ' 6' ' ' GLU . 19.1 tptm -89.04 -7.85 55.12 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.027 -168.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 62.1 t -134.52 -54.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.506 -0.477 . . . . 0.0 112.252 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 11.8 t80 -169.63 126.12 0.87 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.268 0.556 . . . . 0.0 112.025 -164.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.513 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -82.46 89.91 6.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.71 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.475 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 34.8 p90 -81.96 10.71 6.02 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.381 0.61 . . . . 0.0 111.092 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -107.78 -47.63 3.56 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.769 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -89.26 -28.31 20.0 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.29 -178.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.649 HD21 ' C ' ' A' ' 28' ' ' LYS . 0.7 OUTLIER -121.15 62.94 11.77 Favored Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.933 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -59.43 -35.73 95.52 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.706 2.271 . . . . 0.0 112.076 175.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.498 ' HG3' ' HG2' ' A' ' 32' ' ' GLU . 16.0 pt-20 -98.26 -23.77 15.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.47 -176.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.498 ' HG2' ' HG3' ' A' ' 31' ' ' GLU . 34.5 mm-40 -100.99 155.0 18.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.832 0.349 . . . . 0.0 110.982 -174.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.503 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 76.2 t-105 -105.71 92.07 4.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.205 0.526 . . . . 0.0 110.009 175.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.593 ' HG3' ' OE2' ' A' ' 36' ' ' GLU . 25.3 tptp -100.95 104.63 15.81 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 21.8 t80 -107.97 118.49 36.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.568 -177.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.593 ' OE2' ' HG3' ' A' ' 34' ' ' LYS . 12.9 mm-40 -86.32 87.76 7.49 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' A' ' 35' ' ' TYR . . . -106.89 129.19 9.59 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.142 -1.028 . . . . 0.0 114.306 -169.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -87.94 -53.32 4.8 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 170.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.544 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 47.1 mttp -126.16 171.52 7.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 172.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 9.1 Cg_endo -54.74 144.92 63.19 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.486 2.124 . . . . 0.0 111.283 170.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -128.04 155.88 43.64 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -170.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.844 ' HB ' HG21 ' A' ' 73' ' ' ILE . 21.4 mm -125.87 147.05 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.462 173.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 66.4 t -133.6 119.41 33.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 118.782 0.719 . . . . 0.0 111.412 176.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.58 113.38 26.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.636 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.562 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 69.7 m-85 -94.05 111.51 23.23 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 172.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.675 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.2 p90 -141.21 -177.1 4.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.342 0.591 . . . . 0.0 110.968 -172.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.47 139.3 25.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.614 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -61.39 -37.7 84.39 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -174.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -66.99 -16.31 64.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.008 0.432 . . . . 0.0 111.301 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.2 t -88.21 116.48 26.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.515 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.33 -53.9 37.86 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.758 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -48.07 -37.85 31.08 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.909 2.406 . . . . 0.0 113.214 175.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.675 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 93.0 m -66.75 -48.03 70.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.395 0.617 . . . . 0.0 110.475 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 mttp -53.59 -30.79 44.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.646 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 76.2 mtp -64.59 -49.1 72.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.993 0.425 . . . . 0.0 111.439 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.465 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 35.1 m -79.54 -27.9 12.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.757 -171.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -50.31 -59.97 6.15 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 55.7 Cg_endo -71.15 -40.76 3.02 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.733 1.622 . . . . 0.0 112.495 -177.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.401 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 64.4 mt -64.99 -51.63 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.331 -176.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.577 HD11 HG22 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -68.25 -29.9 68.82 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.487 -176.722 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.522 ' OD1' HG11 ' A' ' 11' ' ' VAL . 23.4 t70 -61.75 -40.21 94.29 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.423 0.63 . . . . 0.0 109.775 172.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 59' ' ' ILE . 8.5 tm-20 -63.31 -41.01 98.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.321 176.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 114' ' ' LYS . 3.1 mm? -58.71 -36.7 74.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.926 0.393 . . . . 0.0 110.699 174.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.526 ' HA ' HD12 ' A' ' 71' ' ' ILE . . . -60.97 -37.94 84.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.315 177.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 5.4 tmtm? -75.67 -33.12 60.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.527 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -55.32 -44.62 76.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.424 0.63 . . . . 0.0 109.931 172.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.58 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 48.0 m-85 -99.36 27.32 5.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.68 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.552 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 15.4 t0 -49.93 129.71 20.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.499 -177.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.49 -30.87 9.46 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.451 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 2.8 pt20 -106.86 -21.27 13.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 64' ' ' ALA . 30.6 pt -125.22 155.95 34.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.185 0.517 . . . . 0.0 112.059 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 40.5 t -127.96 129.93 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.348 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.844 HG21 ' HB ' ' A' ' 42' ' ' ILE . 24.8 mt -117.18 142.34 31.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 41.9 m-85 -124.47 158.57 32.53 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.469 ' HZ2' ' HB3' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -148.52 150.45 33.4 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 175.006 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.94 HG23 ' HG3' ' A' ' 81' ' ' GLU . 2.8 p -141.21 156.55 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.555 -173.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 10.8 m-20 -96.38 90.95 5.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.368 -175.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.459 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 10.2 m -50.05 -34.79 22.72 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -173.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -53.78 -41.04 66.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.98 0.419 . . . . 0.0 111.768 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 13.3 ptpt -94.57 -20.36 19.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.807 0.813 . . . . 0.0 109.344 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.94 ' HG3' HG23 ' A' ' 76' ' ' VAL . 10.3 mm-40 -98.2 39.71 1.22 Allowed 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.442 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -66.85 -30.98 71.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.625 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.55 -39.59 70.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.478 0.656 . . . . 0.0 109.243 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 33.4 tp -68.56 -37.8 80.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.832 176.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.583 ' HA ' HD11 ' A' ' 90' ' ' ILE . . . -63.9 -44.81 91.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.816 176.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.79 -29.16 66.85 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.92 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.29 -33.39 75.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.338 . . . . 0.0 111.444 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.573 ' HB2' HG13 ' A' ' 90' ' ' ILE . 91.2 m-85 -103.15 6.53 38.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.774 0.321 . . . . 0.0 110.626 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.39 33.67 87.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.862 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.583 HD11 ' HA ' ' A' ' 85' ' ' ALA . 41.9 mt -71.14 133.39 31.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.97 0.414 . . . . 0.0 110.745 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.474 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 0.4 OUTLIER -70.18 -51.41 31.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.096 178.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.9 p 175.39 -99.65 0.0 OUTLIER 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.145 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 26.6 pt -147.55 143.01 17.36 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.708 -172.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.697 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 11.9 Cg_exo -81.95 149.25 71.77 Favored 'Cis proline' 0 N--CA 1.474 0.368 0 C-N-CA 124.934 -0.861 . . . . 0.0 111.921 -3.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.562 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 14.5 m -140.19 128.28 22.26 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 107' ' ' MET . 52.5 mt -127.94 122.66 59.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.837 0.351 . . . . 0.0 110.603 -174.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.531 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 32.8 tp -104.81 122.13 45.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.397 -177.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.5 ' HZ ' ' HE2' ' A' ' 112' ' ' MET . 73.3 m-85 -100.07 111.35 23.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 54.9 mt -109.51 113.62 57.97 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -170.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.601 ' CB ' ' HE2' ' A' ' 128' ' ' LYS . 88.1 Cg_endo -85.0 159.97 11.66 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.096 2.531 . . . . 0.0 111.621 172.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 86.1 mtp -80.28 -35.99 35.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -118.87 122.54 42.56 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.469 0.652 . . . . 0.0 109.54 173.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.0 -171.19 13.65 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -174.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.503 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 8.9 mmmm -117.97 150.31 47.07 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 117.335 0.567 . . . . 0.0 110.083 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.24 148.11 21.06 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.933 2.422 . . . . 0.0 114.216 -173.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -111.09 169.3 8.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.279 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 46.5 ttm -134.59 124.9 26.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.057 0.456 . . . . 0.0 111.695 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.88 157.71 21.09 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.442 ' HG2' ' HA ' ' A' ' 95' ' ' SER . 39.4 mt-30 -131.38 141.12 49.82 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.715 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.697 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 115.46 177.87 18.56 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.507 -0.77 . . . . 0.0 114.125 172.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.465 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -87.75 86.07 7.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.281 0.562 . . . . 0.0 111.227 -175.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.609 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 72.6 mtm -78.93 136.89 57.78 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.828 175.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 98.9 Cg_endo -75.46 -171.65 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.846 2.364 . . . . 0.0 111.792 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.523 ' HA ' HD23 ' A' ' 63' ' ' LEU . 13.8 tttm -57.97 -37.12 73.61 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.5 -50.59 62.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.326 -175.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.609 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 45.0 m -70.1 -37.47 75.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.926 -177.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.636 ' O ' HG13 ' A' ' 121' ' ' ILE . 4.6 m-85 -64.89 -44.51 89.41 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.829 176.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.527 ' C ' ' HD3' ' A' ' 118' ' ' LYS . 11.3 tmtt? -53.83 -47.68 70.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.673 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -65.15 -38.08 89.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.754 -177.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.06 78.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.257 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 117' ' ' PHE . 23.1 mt -74.19 -55.23 12.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.884 0.373 . . . . 0.0 110.821 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.507 ' HA ' HD11 ' A' ' 126' ' ' LEU . 12.4 t70 -71.43 -65.54 0.74 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.687 0.28 . . . . 0.0 111.623 -176.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.417 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 32.8 mt-10 -75.82 -4.76 42.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -166.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -128.04 -38.61 1.81 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.564 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 40.5 tp -88.87 -43.2 11.38 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.887 -0.508 . . . . 0.0 110.742 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.507 HD11 ' HA ' ' A' ' 122' ' ' ASP . 81.8 mt -82.92 -58.49 2.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.415 0.626 . . . . 0.0 109.68 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 12.7 ttpp -89.1 45.89 1.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.588 177.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.601 ' HE2' ' CB ' ' A' ' 100' ' ' PRO . 23.5 ttpp -59.18 116.69 4.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.232 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -74.31 63.8 1.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.698 0.761 . . . . 0.0 112.644 -176.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -114.53 24.88 10.81 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 167.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -70.27 -12.12 61.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.406 -0.897 . . . . 0.0 111.571 -173.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -141.75 94.45 2.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -88.3 -43.99 11.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.694 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -107.43 125.03 50.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.817 0.341 . . . . 0.0 110.847 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -151.57 -52.46 0.12 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.082 174.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 48.1 t60 . . . . . 0 C--O 1.247 0.924 0 O-C-N 124.059 0.849 . . . . 0.0 109.177 -170.542 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 mtm . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 121.185 0.516 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.652 ' HB2' ' HB ' ' A' ' 5' ' ' THR . 7.0 m -82.39 153.17 25.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.585 -176.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.76 -30.4 29.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.33 0.586 . . . . 0.0 109.886 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.19 20.32 13.71 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.004 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.652 ' HB ' ' HB2' ' A' ' 2' ' ' SER . 53.1 m -151.57 105.78 3.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.067 0.461 . . . . 0.0 110.92 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.663 ' HG2' ' H ' ' A' ' 7' ' ' GLY . 2.0 tt0 -138.24 -163.03 1.38 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.663 ' H ' ' HG2' ' A' ' 6' ' ' GLU . . . -80.22 57.2 4.65 Favored Glycine 0 C--O 1.228 -0.222 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 172.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -100.51 115.16 29.44 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.068 -0.566 . . . . 0.0 111.435 -168.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 56.23 40.72 85.14 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.473 177.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.827 ' HA ' ' HZ1' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -152.98 151.47 30.33 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 121.519 0.676 . . . . 0.0 111.865 -172.42 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 5.1 p -103.79 108.18 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.006 168.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 63.0 mt -88.99 123.76 41.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.721 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.677 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 2.3 p80 -88.86 133.26 34.33 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.796 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.573 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 1.7 pp -140.65 172.8 12.21 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.887 -174.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.7 p -106.17 178.35 4.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.357 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.541 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 14.2 ptmm? -55.32 -35.72 65.45 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.83 -38.64 79.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.232 0.539 . . . . 0.0 110.286 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.573 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 2.6 mm-40 -71.0 -35.74 72.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.142 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -64.05 -48.34 76.67 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.78 0.8 . . . . 0.0 109.116 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.624 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.7 tt -50.82 -60.77 2.72 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.265 -178.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.6 -18.91 39.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -168.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -108.5 -12.71 14.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.972 0.415 . . . . 0.0 111.397 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 57.6 t -135.85 -55.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -174.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.64 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 9.7 t80 -167.09 122.53 1.09 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.261 0.553 . . . . 0.0 111.7 -164.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 1.8 t-20 -86.74 89.68 8.03 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.031 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.64 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 10.5 p90 -89.4 0.37 56.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.379 -174.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.541 ' CD ' ' HZ2' ' A' ' 16' ' ' LYS . 48.9 mt-10 -104.98 -22.1 13.18 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.976 ' HE3' HD22 ' A' ' 29' ' ' ASN . 3.7 ttpp -105.96 -26.04 11.85 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.409 167.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.976 HD22 ' HE3' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -119.12 67.97 9.03 Favored Pre-proline 0 N--CA 1.471 0.591 0 CA-C-O 120.886 0.374 . . . . 0.0 111.635 -178.132 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.77 -34.66 39.56 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.92 2.413 . . . . 0.0 111.527 167.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -97.52 -30.6 12.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.841 -177.534 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 22.9 mt-10 -91.36 128.6 37.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.063 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.497 ' CZ2' ' HG3' ' A' ' 105' ' ' PRO . 72.8 t-105 -91.16 103.44 16.12 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.784 172.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -107.93 134.66 50.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.56 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 37.3 t80 -133.0 96.72 3.83 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.82 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -90.32 31.43 1.01 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.51 -174.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.5 135.25 12.69 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.421 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.6 -41.47 92.77 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.19 0.519 . . . . 0.0 111.081 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -125.32 158.79 62.74 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.548 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.621 ' HB3' HD13 ' A' ' 125' ' ' LEU . 50.3 Cg_exo -54.64 140.22 76.2 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.362 2.041 . . . . 0.0 111.157 173.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -124.44 152.37 43.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.669 0.747 . . . . 0.0 112.391 -172.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.8 mt -117.95 114.17 44.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.128 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 21.4 t -99.78 120.26 48.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.397 -175.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.663 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 21.8 t70 -103.69 111.12 23.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.57 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -83.45 111.94 19.5 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 172.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.676 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.8 p90 -132.58 158.23 42.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.775 0.798 . . . . 0.0 112.031 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.506 ' CB ' HG12 ' A' ' 93' ' ' ILE . . . -133.4 108.85 8.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.244 -1.343 . . . . 0.0 107.706 167.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.544 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 33.9 t70 -55.4 -31.03 61.49 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -167.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 59.6 p-90 -69.95 -1.43 9.63 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.663 ' HB3' ' HG ' ' A' ' 53' ' ' CYS . 27.9 t -114.14 137.03 52.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.933 0.397 . . . . 0.0 110.627 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.4 -57.46 18.47 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 115.612 -0.722 . . . . 0.0 114.669 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.618 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 84.1 Cg_exo -47.37 -37.49 25.19 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.158 2.572 . . . . 0.0 113.636 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.676 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 30.1 m -64.11 -50.36 68.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.334 0.588 . . . . 0.0 111.022 177.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 66.7 mttm -58.23 -28.59 65.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.339 174.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.431 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 53.2 mmm -70.63 -50.77 33.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.794 0.33 . . . . 0.0 111.398 176.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.84 -38.73 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -172.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.59 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . . . -49.17 -54.49 28.58 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.59 ' HD3' ' HB2' ' A' ' 57' ' ' ALA . 15.8 Cg_exo -68.44 -42.67 5.01 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.212 1.941 . . . . 0.0 112.032 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.544 HD11 ' HA ' ' A' ' 113' ' ' PRO . 74.3 mt -57.26 -44.03 83.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.302 0.572 . . . . 0.0 110.497 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.524 ' CD1' ' HB2' ' A' ' 44' ' ' ASP . 5.8 mt -68.37 -35.15 77.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.621 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.535 ' OD1' HG13 ' A' ' 11' ' ' VAL . 14.7 t70 -68.02 -35.53 78.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.134 0.493 . . . . 0.0 109.69 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.602 ' HA ' ' HD2' ' A' ' 65' ' ' LYS . 13.9 mm-40 -54.09 -44.63 71.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.768 172.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.448 HD12 ' HG3' ' A' ' 114' ' ' LYS . 11.1 mp -65.4 -30.89 71.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.727 0.298 . . . . 0.0 110.833 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.409 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -61.7 -53.2 59.35 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.657 -178.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.602 ' HD2' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -76.09 -24.97 55.06 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.795 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' CD ' ' HZ1' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -73.33 -42.73 61.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.88 0.372 . . . . 0.0 111.478 178.795 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -107.26 26.95 9.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.684 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.48 159.8 7.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.353 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.2 -52.89 4.13 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.262 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.728 HE22 HD11 ' A' ' 126' ' ' LEU . 10.2 pt20 -80.96 -33.77 33.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.495 0.188 . . . . 0.0 111.049 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.527 HG23 ' HB2' ' A' ' 40' ' ' PRO . 42.2 pt -131.77 156.49 42.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.088 0.47 . . . . 0.0 111.763 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 86.8 t -124.28 136.49 60.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.647 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 21.9 mt -108.74 139.23 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.337 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -125.71 166.93 15.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.706 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.691 ' HB3' ' HZ1' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -147.75 148.89 31.45 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 171.097 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.498 HG21 HD21 ' A' ' 84' ' ' LEU . 8.1 p -121.17 138.24 52.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.116 0.484 . . . . 0.0 110.524 -175.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.563 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -72.84 85.69 1.25 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.427 179.402 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.562 HG23 ' HB3' ' A' ' 85' ' ' ALA . 17.3 m -66.38 -31.77 72.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -167.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.9 -27.23 68.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.609 0.242 . . . . 0.0 111.199 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.491 ' NZ ' ' HB3' ' A' ' 77' ' ' ASP . 8.6 ptpp? -99.79 -37.18 9.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.898 0.38 . . . . 0.0 110.108 175.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -78.86 39.63 0.37 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.36 0.664 . . . . 0.0 110.972 174.037 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -59.16 -43.98 92.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.529 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -65.15 -35.41 81.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.301 0.572 . . . . 0.0 110.379 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.498 HD21 HG21 ' A' ' 76' ' ' VAL . 14.8 tp -67.58 -48.94 65.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.322 177.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.562 ' HB3' HG23 ' A' ' 78' ' ' THR . . . -62.95 -36.28 82.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.915 0.388 . . . . 0.0 111.196 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.29 -27.75 71.18 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.777 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.37 -22.57 66.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.982 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -101.0 0.8 38.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.513 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.79 6.26 89.13 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.008 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.0 mm -68.72 130.29 33.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.514 0.197 . . . . 0.0 110.519 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -59.27 -55.79 30.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.61 0.719 . . . . 0.0 110.394 176.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.538 ' O ' HG21 ' A' ' 78' ' ' THR . 14.2 t -167.48 -88.15 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.902 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.519 HG23 ' C ' ' A' ' 46' ' ' TYR . 2.3 pp -152.5 157.47 33.61 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -173.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.531 ' HG3' ' HB2' ' A' ' 52' ' ' PRO . 10.9 Cg_endo -99.42 148.06 4.51 Favored 'Cis proline' 0 N--CA 1.458 -0.571 0 C-N-CA 124.365 -1.098 . . . . 0.0 112.018 -3.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.8 t -139.89 142.51 36.5 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.73 128.03 71.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.465 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.573 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.5 tp -106.14 116.85 32.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.077 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 105' ' ' PRO . 20.0 m-85 -93.74 107.4 19.28 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.43 HG12 ' HB3' ' A' ' 105' ' ' PRO . 42.5 mt -110.11 109.78 58.8 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -173.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.73 165.91 13.62 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.402 2.734 . . . . 0.0 111.144 170.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.462 ' HG2' ' HE2' ' A' ' 35' ' ' TYR . 82.7 mtp -97.0 -34.17 11.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.712 0.768 . . . . 0.0 109.304 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -96.83 2.81 52.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.363 -176.183 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -137.45 -156.33 7.21 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.051 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 60.6 mmtt -126.34 154.43 74.76 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.497 ' HG3' ' CZ2' ' A' ' 33' ' ' TRP . 98.3 Cg_endo -78.21 148.26 24.06 Favored 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.677 2.251 . . . . 0.0 114.168 -169.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.493 ' HG2' ' N ' ' A' ' 107' ' ' MET . 34.9 tt0 -119.33 163.25 17.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.716 172.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.493 ' N ' ' HG2' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -142.51 137.98 30.6 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.372 0.606 . . . . 0.0 111.766 -177.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -133.98 156.77 47.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.622 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -75.41 148.52 39.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.15 -144.06 6.82 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.743 -0.742 . . . . 0.0 113.804 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 71.99 20.86 4.26 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.435 0.694 . . . . 0.0 111.883 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.553 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 20.3 ptt? -112.37 153.7 44.73 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.529 177.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.544 ' HA ' HD11 ' A' ' 59' ' ' ILE . 93.6 Cg_endo -76.58 -177.56 3.83 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.13 2.553 . . . . 0.0 113.05 -173.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.473 ' HZ1' ' CD ' ' A' ' 66' ' ' GLU . 38.8 ttmt -61.77 -29.39 70.1 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.024 174.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.497 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . -64.72 -47.38 78.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.215 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.553 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 18.6 m -70.88 -38.45 73.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.881 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.439 ' HB3' HD23 ' A' ' 63' ' ' LEU . 9.0 m-85 -65.41 -40.83 93.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.305 177.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.67 ' O ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -57.31 -37.24 72.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.741 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.583 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 43.2 mmtm -65.88 -57.96 6.69 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.252 175.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.51 -46.78 86.04 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -174.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.8 mp -64.37 -48.09 86.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.666 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.4 ' HA ' HD21 ' A' ' 126' ' ' LEU . 3.8 t0 -66.37 -50.27 64.07 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.841 -178.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.583 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 4.0 mm-40 -54.98 -30.2 58.78 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -174.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -115.45 -35.98 4.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.964 0.411 . . . . 0.0 111.854 -172.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.621 HD13 ' HB3' ' A' ' 40' ' ' PRO . 20.0 tp -90.6 -47.26 7.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.88 -174.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.728 HD11 HE22 ' A' ' 70' ' ' GLN . 3.8 mm? -87.51 -53.43 4.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.261 0.553 . . . . 0.0 110.377 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.749 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -76.9 105.19 7.82 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 175.248 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 2.6 tppt? -72.65 78.26 1.09 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.492 177.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 128' ' ' LYS . 26.1 mm-40 80.42 57.65 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.34 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.3 -48.57 57.68 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 175.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -48.76 104.4 0.06 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.594 0.711 . . . . 0.0 110.968 170.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -70.26 126.72 30.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.791 -174.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -64.69 135.01 55.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.943 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -95.65 21.72 8.02 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -173.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.12 150.78 15.14 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.289 -0.862 . . . . 0.0 109.529 177.19 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.445 ' OG ' ' HB ' ' A' ' 5' ' ' THR . 22.7 t -164.56 90.79 0.56 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.115 0.483 . . . . 0.0 109.83 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 tt -95.89 -37.24 10.79 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.71 28.99 0.46 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.45 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.445 ' HB ' ' OG ' ' A' ' 2' ' ' SER . 8.9 t -79.56 -11.15 59.89 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.199 0.523 . . . . 0.0 110.464 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -111.11 102.53 10.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.458 ' H ' ' HD3' ' A' ' 10' ' ' LYS . . . 96.66 -173.13 29.31 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -172.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.64 ' H ' HG23 ' A' ' 72' ' ' VAL . 0.9 OUTLIER 64.02 96.82 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.059 0.457 . . . . 0.0 111.052 178.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.619 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . 68.32 34.74 80.83 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.332 -177.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.717 ' HE2' HD11 ' A' ' 12' ' ' ILE . 84.3 tttt -151.19 138.89 19.73 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -172.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 10.5 p -110.95 132.13 60.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.128 0.489 . . . . 0.0 110.693 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.717 HD11 ' HE2' ' A' ' 10' ' ' LYS . 36.9 mm -120.95 117.15 52.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.096 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.428 ' CB ' ' HG3' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -84.83 121.36 27.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 171.248 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.706 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.3 pp -120.68 178.27 4.76 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.751 -170.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.45 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -107.86 172.84 6.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.637 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 10.8 ptpt -54.68 -37.31 65.61 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.92 85.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.106 0.479 . . . . 0.0 110.971 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.706 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 30.8 mm-40 -71.97 -39.46 69.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.455 177.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -63.36 -50.24 70.72 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.163 0.983 . . . . 0.0 109.065 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -47.06 -60.95 2.12 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.152 -1.84 . . . . 0.0 112.232 -178.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.06 -28.14 27.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.799 -170.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 24.2 ttpt -110.56 1.5 18.17 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.933 0.397 . . . . 0.0 111.704 -170.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 40.7 t -141.46 -47.76 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 22.6 t80 -167.41 119.61 0.91 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.122 0.487 . . . . 0.0 111.737 -167.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -93.67 91.93 7.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.102 -178.374 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 2.9 p90 -80.41 8.9 6.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.309 0.576 . . . . 0.0 111.532 -177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -91.91 -50.15 5.86 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.046 176.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.617 ' C ' HD21 ' A' ' 29' ' ' ASN . 14.9 pttm -89.66 -15.45 32.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.647 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -123.33 68.79 39.52 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.505 174.786 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -59.5 -37.26 90.23 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.996 2.464 . . . . 0.0 112.447 173.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.85 -35.57 4.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -173.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.643 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 4.6 tp10 -90.96 153.71 19.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.038 0.447 . . . . 0.0 110.417 -176.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.641 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 33.4 t-105 -103.1 113.85 27.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.612 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -125.03 110.88 14.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.759 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.637 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 37.9 t80 -76.18 114.59 15.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.194 177.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -94.22 71.21 3.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.862 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.637 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -143.74 -139.76 3.56 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.522 -175.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -149.27 -42.47 0.14 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 111.892 -173.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 70' ' ' GLN . 35.2 mttp -126.14 165.65 26.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.245 -175.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.595 ' HD3' ' SD ' ' A' ' 101' ' ' MET . 10.3 Cg_endo -52.88 132.31 46.34 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.452 2.102 . . . . 0.0 111.237 177.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -124.42 149.97 46.15 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.174 0.512 . . . . 0.0 111.572 -172.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.504 ' HB ' HG12 ' A' ' 73' ' ' ILE . 75.7 mt -127.17 134.01 66.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 175.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 60.5 t -125.28 112.42 31.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.022 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.532 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 8.5 p-10 -102.28 114.12 28.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.962 0.887 . . . . 0.0 111.266 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.417 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 42.0 m-85 -80.3 112.55 17.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.884 172.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.691 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.9 p90 -127.39 159.91 33.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.376 0.608 . . . . 0.0 110.759 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.448 ' N ' HG23 ' A' ' 93' ' ' ILE . . . -130.86 122.99 28.04 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 170.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.571 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 15.8 t70 -66.06 -26.18 67.38 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.803 -169.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -75.78 -2.88 31.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.994 0.426 . . . . 0.0 111.17 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.859 ' HB3' ' HG ' ' A' ' 53' ' ' CYS . 32.6 t -108.28 122.34 46.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.197 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.28 -55.28 25.26 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.638 -0.71 . . . . 0.0 114.792 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.496 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 82.5 Cg_exo -47.2 -41.14 27.6 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.206 2.604 . . . . 0.0 113.786 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.859 ' HG ' ' HB3' ' A' ' 50' ' ' CYS . 3.0 m -63.63 -37.75 88.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.291 0.567 . . . . 0.0 110.921 -177.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.571 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 67.0 mttm -61.46 -28.61 69.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.071 176.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.453 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 76.6 mtp -65.57 -48.44 72.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.875 0.369 . . . . 0.0 111.573 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 96' ' ' ILE . 12.8 p -77.59 -32.33 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -169.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.447 ' HB1' ' HD3' ' A' ' 58' ' ' PRO . . . -48.02 -57.34 10.56 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.447 ' HD3' ' HB1' ' A' ' 57' ' ' ALA . 43.1 Cg_endo -69.21 -35.31 14.51 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.911 1.74 . . . . 0.0 112.702 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.6 mt -63.74 -50.86 76.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.686 HD23 HD11 ' A' ' 73' ' ' ILE . 5.6 mt -60.74 -36.09 78.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.361 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -62.03 -50.35 72.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.053 0.454 . . . . 0.0 110.673 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.13 -43.97 98.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.481 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 63' ' ' LEU . 3.8 mm? -62.63 -32.48 73.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.112 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.619 ' O ' ' HA2' ' A' ' 9' ' ' GLY . . . -63.17 -53.55 51.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.345 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 8.8 tmtm? -67.4 -34.28 76.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.644 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -58.63 -47.03 85.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.187 0.518 . . . . 0.0 110.274 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -95.04 26.33 3.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.102 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -47.12 136.56 8.69 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.918 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.23 -23.98 17.18 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.75 176.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.54 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 12.5 pt20 -125.88 -49.02 1.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.527 HG22 ' HG3' ' A' ' 70' ' ' GLN . 43.0 pt -95.15 148.59 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.327 0.584 . . . . 0.0 112.188 -173.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.64 HG23 ' H ' ' A' ' 8' ' ' ASN . 39.8 t -128.26 125.26 63.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.098 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.686 HD11 HD23 ' A' ' 60' ' ' LEU . 27.8 mt -109.24 131.44 60.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.308 0.575 . . . . 0.0 111.379 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.5 m-85 -116.94 156.85 26.71 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.596 ' HB3' ' HZ3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -136.07 148.29 48.24 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.452 175.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.559 HG11 ' HG2' ' A' ' 81' ' ' GLU . 20.8 t -117.11 126.39 74.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.536 -171.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.537 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 4.7 m-20 -83.4 95.42 8.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 92' ' ' SER . 16.6 p -55.56 -35.66 65.98 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -171.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -54.76 -29.94 55.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.353 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 54.6 pttt -103.14 -32.85 9.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.56 0.695 . . . . 0.0 109.726 178.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.559 ' HG2' HG11 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -88.73 41.97 1.05 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.155 -179.016 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.1 -49.58 77.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.904 -176.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.19 -36.46 81.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.934 0.397 . . . . 0.0 110.232 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.04 -53.12 58.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.951 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.14 -40.01 93.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.688 178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.84 -28.26 72.41 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.704 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.81 -32.8 74.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.807 0.336 . . . . 0.0 110.963 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -89.29 0.75 56.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.933 0.397 . . . . 0.0 110.698 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.33 8.68 84.85 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.974 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.0 mm -75.01 130.21 36.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 122.341 0.257 . . . . 0.0 110.74 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -66.37 -64.28 0.89 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.221 0.534 . . . . 0.0 110.093 175.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.412 ' O ' HG23 ' A' ' 78' ' ' THR . 29.7 m -155.72 -90.3 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.589 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.51 HG13 ' SG ' ' A' ' 53' ' ' CYS . 0.2 OUTLIER -146.56 161.35 38.51 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.43 -172.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.732 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.1 Cg_exo -87.98 148.08 30.05 Favored 'Cis proline' 0 C--N 1.345 0.346 0 C-N-CA 124.507 -1.039 . . . . 0.0 111.705 -4.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 9.5 m -140.39 122.78 16.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.549 HD11 ' HZ ' ' A' ' 117' ' ' PHE . 64.5 mt -124.25 116.68 48.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.311 -175.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' A' ' 105' ' ' PRO . 39.3 tp -100.38 124.09 45.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.718 -176.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -100.05 105.59 17.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.722 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.488 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 45.8 mt -100.99 108.36 54.07 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.055 -175.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -87.46 169.24 7.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.815 2.343 . . . . 0.0 112.235 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.595 ' SD ' ' HD3' ' A' ' 40' ' ' PRO . 84.2 mtp -93.89 1.0 56.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.654 0.74 . . . . 0.0 109.427 175.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -139.39 102.95 4.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.025 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.11 -153.76 16.76 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.561 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.641 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 15.4 tptt -112.35 153.63 44.75 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.516 ' HB2' HD13 ' A' ' 97' ' ' LEU . 5.7 Cg_exo -79.41 144.89 18.35 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.028 2.485 . . . . 0.0 112.781 -176.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -107.99 168.3 9.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.522 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.428 ' HE1' HD12 ' A' ' 97' ' ' LEU . 49.3 ttm -142.48 139.1 31.4 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.939 0.4 . . . . 0.0 111.44 -174.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -126.9 137.78 53.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.566 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -100.12 123.4 44.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.02 0.438 . . . . 0.0 110.772 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.732 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 126.58 -169.02 18.56 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.268 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.24 80.01 1.4 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.601 0.715 . . . . 0.0 110.721 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.637 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 5.0 mpp? -59.05 144.47 82.48 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.626 174.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.29 -175.96 2.83 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.891 2.394 . . . . 0.0 112.14 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -56.6 -39.63 73.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.465 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.75 -51.15 66.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.096 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.637 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 33.1 m -68.17 -29.13 67.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.75 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.641 ' O ' HG12 ' A' ' 121' ' ' ILE . 10.6 m-85 -75.41 -39.1 59.42 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.293 176.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -53.88 -37.46 63.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.035 0.445 . . . . 0.0 110.388 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 45.3 tttp -69.06 -46.34 68.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.354 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.79 -44.46 81.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.049 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.641 HG12 ' O ' ' A' ' 117' ' ' PHE . 17.4 mm -74.0 -50.57 27.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.736 0.303 . . . . 0.0 111.098 -174.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 126' ' ' LEU . 11.9 t70 -68.37 -60.93 2.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.014 0.435 . . . . 0.0 110.808 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.824 ' HA ' ' HD2' ' A' ' 127' ' ' LYS . 22.2 mt-10 -75.73 -9.69 58.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.164 -167.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -127.69 -39.54 1.81 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.25 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 125' ' ' LEU . 3.3 tp -91.01 -32.42 15.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 23.8 tp -84.01 -65.26 1.03 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.824 ' HD2' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -101.05 -156.72 0.57 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 167.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.657 ' HG3' ' HB2' ' A' ' 132' ' ' HIS . 0.2 OUTLIER -147.92 93.96 2.27 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.162 -176.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.754 ' HB2' ' HE2' ' A' ' 127' ' ' LYS . 0.8 OUTLIER -105.13 -175.33 2.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.256 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.42 -87.03 0.25 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.729 176.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -69.71 -27.03 64.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.955 0.407 . . . . 0.0 110.801 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.657 ' HB2' ' HG3' ' A' ' 128' ' ' LYS . 0.6 OUTLIER -95.39 -30.35 13.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.383 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -132.74 92.03 2.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.289 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -78.11 -64.19 1.22 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -91.82 126.83 37.05 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.679 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 . . . . . 0 C--O 1.244 0.813 0 CA-C-O 118.521 -0.752 . . . . 0.0 109.877 -179.66 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 m -80.48 -45.5 17.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.251 0.548 . . . . 0.0 110.099 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.753 HD22 ' H ' ' A' ' 3' ' ' LEU . 2.3 pt? -100.27 10.94 40.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.974 -177.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -149.8 148.04 28.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.474 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 t -116.07 97.38 6.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.18 0.514 . . . . 0.0 110.759 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.9 -85.44 0.09 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.634 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.34 64.97 4.18 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.053 -0.521 . . . . 0.0 113.39 -173.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.437 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 2.6 m120 -147.92 123.22 10.27 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 65' ' ' LYS . . . 58.01 38.68 90.12 Favored Glycine 0 CA--C 1.51 -0.279 0 O-C-N 124.558 1.161 . . . . 0.0 115.426 166.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 20.5 pttm -169.6 173.06 6.56 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.906 0.86 . . . . 0.0 113.03 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 12.9 m -100.43 110.67 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 113.469 -1.696 . . . . 0.0 109.57 171.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.401 HD12 ' CE2' ' A' ' 74' ' ' TYR . 47.2 mt -83.84 103.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.113 -175.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -75.63 112.12 11.66 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 2.9 pp -140.28 158.31 44.23 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.744 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.492 HG22 ' CE ' ' A' ' 80' ' ' LYS . 40.0 p -82.49 166.15 19.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.774 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.714 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 42.8 pttt -56.15 -34.12 65.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.682 177.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.57 -37.47 82.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.102 0.477 . . . . 0.0 110.416 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 42.5 mt-10 -71.99 -34.84 69.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.504 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -63.47 -48.28 78.3 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.086 0.946 . . . . 0.0 108.935 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.6 tt -46.83 -61.33 1.9 Allowed 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.281 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.94 -25.02 40.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.428 -170.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -93.7 -37.68 11.7 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.644 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.0 t -118.82 -41.12 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -167.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.543 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 30.0 t80 -166.99 118.83 0.93 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.05 0.452 . . . . 0.0 111.809 -165.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.447 ' ND2' HD22 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -85.25 91.06 8.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.528 -178.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.543 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 49.0 p90 -86.17 18.81 2.92 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.676 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 27.6 mt-10 -102.1 -54.73 2.64 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 175.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.676 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 8.1 mptt -91.68 -19.56 22.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.694 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.626 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -119.79 65.63 9.75 Favored Pre-proline 0 C--O 1.224 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.972 178.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -63.78 -44.98 11.85 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.754 2.302 . . . . 0.0 112.189 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -106.58 -11.73 15.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.014 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 40.7 mt-10 -91.05 131.21 36.78 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.646 ' HZ3' ' HE1' ' A' ' 88' ' ' PHE . 69.9 t-105 -94.54 88.79 5.57 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.222 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -97.37 106.35 18.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.262 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -108.94 124.76 51.19 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.969 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -119.16 131.51 55.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.985 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 167.12 162.14 18.08 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.885 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -97.53 -14.95 20.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.969 0.414 . . . . 0.0 110.803 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.44 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 9.9 mmtp -127.17 161.25 55.28 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.406 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 23.4 Cg_exo -65.01 132.41 32.04 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.752 2.301 . . . . 0.0 110.1 166.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.52 138.36 43.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -168.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.742 ' HB ' HG12 ' A' ' 73' ' ' ILE . 4.6 mp -113.4 112.49 40.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 165.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.626 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 21.5 t -98.28 112.18 29.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.079 0.466 . . . . 0.0 110.297 -177.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.451 ' CG ' ' HZ3' ' A' ' 75' ' ' LYS . 9.2 t70 -91.39 109.44 20.73 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.306 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.549 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 97.3 m-85 -94.14 111.68 23.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 174.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.667 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.7 p90 -132.66 167.71 19.6 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.493 0.663 . . . . 0.0 110.852 -175.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.18 125.94 19.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.042 -1.435 . . . . 0.0 107.803 172.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -56.82 -40.33 75.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -67.69 -8.61 36.55 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 42.6 t -98.37 126.63 43.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.942 0.401 . . . . 0.0 110.521 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.82 -61.85 6.97 Favored Glycine 0 CA--C 1.518 0.246 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.255 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -47.65 -41.44 30.59 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.959 2.439 . . . . 0.0 113.149 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.667 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 97.2 m -66.26 -44.26 84.15 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.78 -27.73 61.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.313 0.578 . . . . 0.0 109.502 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -61.23 -43.82 98.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.26 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.609 ' HB ' HD23 ' A' ' 60' ' ' LEU . 24.1 m -84.97 -20.52 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -174.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.467 ' HA ' ' NZ ' ' A' ' 75' ' ' LYS . . . -41.58 -53.31 7.55 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.91 -40.98 5.96 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 121.735 1.623 . . . . 0.0 112.448 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.2 mt -60.6 -42.72 92.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.238 0.542 . . . . 0.0 110.503 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.609 HD23 ' HB ' ' A' ' 56' ' ' VAL . 2.6 mm? -56.42 -42.35 77.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.46 176.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 11.1 t70 -62.97 -42.41 99.82 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.406 176.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.807 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 21.5 mm-40 -54.08 -56.63 16.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.25 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.498 HD21 ' HG3' ' A' ' 114' ' ' LYS . 3.7 mm? -67.07 -31.82 72.58 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.103 -175.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.402 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -59.83 -57.47 12.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.459 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.807 ' HE2' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -76.39 -25.98 55.13 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.23 -47.51 67.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.992 0.425 . . . . 0.0 111.39 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.487 ' HB2' HD13 ' A' ' 71' ' ' ILE . 12.4 m-85 -101.88 24.8 9.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.323 -175.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.4 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 19.9 t70 -55.79 143.6 30.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.172 0.51 . . . . 0.0 111.439 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.87 -37.58 3.68 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.631 -178.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 8.8 pt20 -110.08 -12.63 14.49 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.178 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.487 HD13 ' HB2' ' A' ' 67' ' ' TYR . 43.9 pt -147.01 167.87 5.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.935 0.398 . . . . 0.0 110.685 174.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 39' ' ' LYS . 13.3 p -145.73 144.7 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 172.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.742 HG12 ' HB ' ' A' ' 42' ' ' ILE . 40.9 mt -121.07 139.12 49.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.322 -177.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.401 ' CE2' HD12 ' A' ' 12' ' ' ILE . 67.5 m-85 -115.49 162.93 16.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.431 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.539 ' HB3' ' CE1' ' A' ' 46' ' ' TYR . 54.1 mttm -135.64 132.06 36.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.849 0.357 . . . . 0.0 110.533 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.475 HG13 ' HG2' ' A' ' 81' ' ' GLU . 1.0 OUTLIER -131.46 137.32 55.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.482 -176.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -90.98 96.07 10.44 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.448 HG22 ' HA ' ' A' ' 92' ' ' SER . 17.0 m -60.13 -25.6 65.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -168.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -55.28 -40.43 71.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.462 0.172 . . . . 0.0 111.191 175.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.492 ' CE ' HG22 ' A' ' 15' ' ' THR . 22.6 pttm -98.71 -22.19 16.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.304 0.573 . . . . 0.0 110.2 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.714 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 1.3 mp0 -89.53 34.89 0.82 Allowed 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.281 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.41 ' HA ' ' OE1' ' A' ' 82' ' ' GLN . 14.2 mm-40 -64.01 -42.49 97.13 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -64.52 -35.33 80.62 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.254 0.55 . . . . 0.0 110.062 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.6 tp -63.7 -47.6 80.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.901 176.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.519 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -60.71 -42.27 96.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.797 176.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.4 -31.05 75.95 Favored Glycine 0 CA--C 1.517 0.168 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.698 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.19 -41.5 97.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.789 0.328 . . . . 0.0 111.012 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.646 ' HE1' ' HZ3' ' A' ' 33' ' ' TRP . 76.2 m-85 -82.7 -22.2 34.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.692 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.13 31.67 9.58 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.554 HG13 ' HB2' ' A' ' 88' ' ' PHE . 6.2 mt -85.4 154.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.717 0.294 . . . . 0.0 110.544 -176.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -69.11 -81.82 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.436 0.636 . . . . 0.0 109.373 171.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.448 ' HA ' HG22 ' A' ' 78' ' ' THR . 65.9 m -158.99 -81.26 0.05 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.925 173.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.632 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 2.2 pp -151.08 149.67 25.5 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.237 -174.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.742 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 5.1 Cg_exo -83.5 149.2 62.66 Favored 'Cis proline' 0 C--N 1.346 0.437 0 C-N-CA 124.743 -0.94 . . . . 0.0 112.356 -2.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 39.6 t -140.99 130.61 24.04 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.3 mm -120.92 113.96 41.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.626 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 31.4 tp -102.05 115.5 30.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.792 -175.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -97.78 106.09 18.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.972 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.506 HG12 ' HB3' ' A' ' 105' ' ' PRO . 53.6 mt -105.08 113.44 64.69 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.704 -174.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.8 155.54 20.55 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.466 2.111 . . . . 0.0 111.491 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 82.2 mtp -81.39 4.23 21.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.628 0.728 . . . . 0.0 110.823 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.808 ' HB3' ' HE3' ' A' ' 128' ' ' LYS . 2.9 tm-20 -151.27 117.43 5.59 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.974 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.14 -147.29 18.17 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.935 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.424 ' HZ2' ' HB3' ' A' ' 33' ' ' TRP . 51.7 mmtt -128.49 152.11 77.82 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.506 ' HB3' HG12 ' A' ' 99' ' ' ILE . 88.2 Cg_endo -79.59 147.96 20.16 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.752 2.301 . . . . 0.0 113.829 -172.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.428 ' O ' HD11 ' A' ' 97' ' ' LEU . 23.4 mm-40 -103.47 167.68 9.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.572 176.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.472 ' HE2' HG12 ' A' ' 90' ' ' ILE . 38.3 ttm -141.32 130.0 22.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.124 0.487 . . . . 0.0 111.958 -178.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.96 127.32 53.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.106 173.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -99.56 136.73 39.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.927 0.394 . . . . 0.0 111.541 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.742 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 106.95 174.13 22.78 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.806 -0.634 . . . . 0.0 114.635 171.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.92 86.7 5.54 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.818 -0.691 . . . . 0.0 111.464 -175.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.564 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 22.7 ptt? -87.53 158.43 51.47 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.651 171.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.548 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 74.4 Cg_endo -75.19 178.58 7.11 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.312 2.008 . . . . 0.0 112.847 -173.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.498 ' HG3' HD21 ' A' ' 63' ' ' LEU . 54.8 tttm -61.07 -28.7 69.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.047 177.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.79 -52.53 20.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.394 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.564 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 21.6 m -67.48 -32.76 73.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.774 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.523 ' O ' HG13 ' A' ' 121' ' ' ILE . 1.4 m-85 -62.23 -46.59 88.17 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.492 174.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -56.39 -44.27 80.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.525 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.585 ' HB3' ' OE1' ' A' ' 123' ' ' GLU . 9.2 mtpm? -63.06 -50.37 70.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.44 75.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.843 0.354 . . . . 0.0 111.32 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 117' ' ' PHE . 70.9 mt -74.23 -55.11 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.04 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 126' ' ' LEU . 31.0 t0 -69.68 -57.93 4.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.573 -173.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.585 ' OE1' ' HB3' ' A' ' 119' ' ' LYS . 44.6 mt-10 -58.15 -23.12 54.09 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -170.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -116.22 -47.8 2.74 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.1 tp -88.26 -38.7 15.01 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.488 -171.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 122' ' ' ASP . 73.5 mt -83.09 -52.96 6.16 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.431 0.634 . . . . 0.0 109.388 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.672 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -80.92 81.27 7.21 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 167.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.808 ' HE3' ' HB3' ' A' ' 102' ' ' GLU . 48.5 tttm -64.97 84.12 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.575 0.703 . . . . 0.0 112.61 -166.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -53.39 134.11 40.18 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.064 164.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -86.14 29.99 4.53 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.881 -172.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 54.45 55.41 8.08 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -18.66 112.89 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 O-C-N 125.299 1.625 . . . . 0.0 114.66 -172.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -83.76 148.68 26.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.751 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -73.66 -44.61 56.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.041 0.448 . . . . 0.0 110.051 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -140.58 -49.34 0.44 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 21.8 p80 . . . . . 0 C--O 1.242 0.665 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.696 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 120.729 0.3 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -122.42 151.71 40.97 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.657 HD21 ' H ' ' A' ' 3' ' ' LEU . 1.9 pt? -84.47 -4.55 59.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.702 0.287 . . . . 0.0 111.387 -174.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.46 34.4 0.75 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.734 0.302 . . . . 0.0 110.627 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 48.43 -98.18 0.04 OUTLIER 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.681 -175.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -176.65 -72.51 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.726 0.298 . . . . 0.0 110.518 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.35 43.62 3.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.131 -176.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.613 HD21 ' N ' ' A' ' 9' ' ' GLY . 0.2 OUTLIER -76.0 128.36 34.88 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.613 ' N ' HD21 ' A' ' 8' ' ' ASN . . . 98.24 18.98 24.88 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.465 177.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.473 ' HG3' ' OD2' ' A' ' 61' ' ' ASP . 54.9 tttp -160.23 173.33 15.89 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.3 p -112.41 113.15 43.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.431 0.634 . . . . 0.0 110.129 174.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.8 mm -109.38 131.23 60.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.058 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.693 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 3.7 p80 -85.8 116.62 24.17 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.56 174.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -109.52 179.23 4.2 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.355 -176.099 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.6 p -100.53 164.23 11.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.952 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.693 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 35.6 pttt -61.91 -27.0 68.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.815 0.34 . . . . 0.0 110.511 176.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -41.09 96.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.656 174.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -71.71 -38.22 70.56 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.197 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.413 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 2.3 t80 -54.21 -53.81 48.44 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.813 0.816 . . . . 0.0 109.305 176.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 30.0 mt -50.56 -60.07 3.4 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 113.598 -1.637 . . . . 0.0 111.929 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.22 -36.63 39.75 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -102.79 -4.59 24.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -171.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 58.2 t -132.96 -51.99 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 7.5 t80 -179.19 131.0 0.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 110.746 -167.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.615 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 25.9 t-20 -91.21 136.24 33.23 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.655 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -123.91 20.8 9.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.171 0.51 . . . . 0.0 110.547 175.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -105.64 -53.93 2.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.593 0.711 . . . . 0.0 109.798 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.596 ' HG3' ' ND2' ' A' ' 29' ' ' ASN . 22.0 ptmt -97.02 -12.61 23.05 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.526 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.615 ' HB2' ' O ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -116.89 62.55 2.84 Favored Pre-proline 0 N--CA 1.473 0.723 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.239 174.451 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -63.43 -43.06 19.05 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.705 2.27 . . . . 0.0 112.614 174.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -100.59 -27.7 13.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.607 -175.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 37.7 mt-10 -92.69 128.67 38.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.044 0.449 . . . . 0.0 110.795 -177.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.691 ' HD1' ' HZ3' ' A' ' 104' ' ' LYS . 44.3 t-105 -92.55 93.13 8.38 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HD2' ' OD1' ' A' ' 29' ' ' ASN . 92.2 mttt -104.95 97.26 7.15 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.107 176.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.479 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 28.5 t80 -79.69 104.39 10.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.642 175.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -98.91 84.0 3.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.611 177.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.479 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -129.68 -143.51 5.47 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.844 -175.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -147.92 -64.64 0.26 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.8 0.333 . . . . 0.0 110.104 -173.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 70' ' ' GLN . 45.8 mttp -120.85 159.5 48.58 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.862 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.48 ' HG2' HG21 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -45.29 131.92 11.79 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.073 2.516 . . . . 0.0 112.084 179.054 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.52 139.18 54.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.567 -172.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.9 mt -117.76 114.57 45.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.418 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 16.4 t -101.76 112.99 36.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.791 0.329 . . . . 0.0 111.219 -176.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 8.2 t70 -92.56 112.13 23.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.969 176.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 75.6 m-85 -87.55 110.58 20.45 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 173.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.662 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 0.8 OUTLIER -132.11 163.83 27.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.159 0.504 . . . . 0.0 110.84 -175.365 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.72 137.03 52.49 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.478 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 19.6 t70 -62.98 -29.48 70.85 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -174.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -85.74 -6.91 59.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.79 0.328 . . . . 0.0 111.177 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.7 t -84.27 106.95 16.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.903 0.382 . . . . 0.0 111.081 -175.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.09 -50.76 54.11 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.673 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -46.92 -47.93 15.43 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.71 2.273 . . . . 0.0 113.191 175.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.662 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 83.0 m -66.97 -32.54 73.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.477 . . . . 0.0 111.257 -177.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.478 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 71.1 mmtt -58.76 -29.51 66.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.597 175.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.541 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 31.2 mtm -67.69 -39.56 84.43 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.712 0.291 . . . . 0.0 111.239 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 53' ' ' CYS . 16.6 m -78.21 -26.47 14.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -172.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.602 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . . . -51.31 -54.24 40.69 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.602 ' HD3' ' HB2' ' A' ' 57' ' ' ALA . 35.4 Cg_exo -61.61 -43.65 25.88 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 122.045 1.83 . . . . 0.0 112.283 176.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.5 mt -58.46 -49.9 80.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.305 0.574 . . . . 0.0 110.591 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.432 HD21 ' HA ' ' A' ' 60' ' ' LEU . 20.0 mt -61.92 -40.84 96.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.39 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.473 ' OD2' ' HG3' ' A' ' 10' ' ' LYS . 12.7 t70 -64.79 -45.71 85.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.956 0.408 . . . . 0.0 110.806 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -62.36 -51.1 68.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.999 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.66 -32.57 72.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.181 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.539 ' O ' ' HA2' ' A' ' 9' ' ' GLY . . . -62.28 -34.96 77.57 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.468 ' C ' ' HD3' ' A' ' 65' ' ' LYS . 2.8 tmtm? -73.96 -38.17 64.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.885 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -62.27 -48.14 81.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.238 0.542 . . . . 0.0 110.573 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -90.89 26.09 2.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.8 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -57.07 139.76 51.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.678 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.529 ' H ' ' ND2' ' A' ' 8' ' ' ASN . . . 99.83 -25.98 26.19 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.955 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.534 ' HG3' HG22 ' A' ' 71' ' ' ILE . 11.7 pt20 -116.23 -44.46 2.89 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -177.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.534 HG22 ' HG3' ' A' ' 70' ' ' GLN . 33.6 pt -117.38 150.3 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.798 -177.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.8 t -121.56 127.25 75.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.268 176.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.663 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 31.8 mt -109.63 133.67 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 121.331 0.586 . . . . 0.0 110.278 -178.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -121.43 171.65 8.62 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.732 0.777 . . . . 0.0 110.373 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 1.1 ptpm? -146.09 159.15 43.68 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 168.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.688 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 2.6 p -140.38 143.52 29.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.596 -174.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.412 ' HB2' ' NZ ' ' A' ' 80' ' ' LYS . 20.2 m-20 -82.97 90.73 7.03 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -174.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.496 HG23 ' HB1' ' A' ' 85' ' ' ALA . 27.0 m -57.91 -24.54 58.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.085 -173.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.6 -40.84 84.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.762 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.412 ' NZ ' ' HB2' ' A' ' 77' ' ' ASP . 23.9 pttm -101.15 -22.59 14.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.097 0.475 . . . . 0.0 110.527 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.693 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 1.4 mp0 -89.06 42.89 1.11 Allowed 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.534 175.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -66.11 -38.39 88.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.072 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.468 ' CD ' ' HZ1' ' A' ' 16' ' ' LYS . 3.5 mp0 -65.92 -38.02 87.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.363 0.602 . . . . 0.0 109.672 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.1 tp -65.68 -50.43 64.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.734 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.496 ' HB1' HG23 ' A' ' 78' ' ' THR . . . -65.36 -39.89 92.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.989 0.423 . . . . 0.0 110.899 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.3 -27.58 69.49 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.882 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.04 -32.92 72.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.935 0.398 . . . . 0.0 110.85 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.508 ' HB2' HG12 ' A' ' 90' ' ' ILE . 90.5 m-85 -93.48 -3.41 53.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.646 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.15 13.39 74.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.005 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.508 HG12 ' HB2' ' A' ' 88' ' ' PHE . 26.9 mm -83.63 119.54 33.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.543 0.211 . . . . 0.0 110.517 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -59.53 -58.04 10.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 110.953 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.1 m -150.92 -96.96 0.06 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.7 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -146.86 163.18 30.21 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.903 -0.135 . . . . 0.0 111.043 -170.79 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.68 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 2.7 Cg_exo -89.18 150.16 26.81 Favored 'Cis proline' 0 C--N 1.347 0.498 0 C-N-CA 124.72 -0.95 . . . . 0.0 112.509 -4.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.468 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 34.7 t -140.68 145.28 36.32 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 107' ' ' MET . 30.5 mt -135.25 116.24 19.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.825 0.345 . . . . 0.0 110.304 -178.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 47.3 tp -102.91 116.61 32.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.403 -177.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -98.67 109.11 21.92 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.538 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 58.2 mt -104.48 113.39 65.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.691 -174.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -84.34 168.54 11.58 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.851 2.367 . . . . 0.0 111.786 174.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 87.2 mtp -82.31 -26.04 33.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.243 0.544 . . . . 0.0 109.949 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -130.66 138.1 49.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.223 176.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.69 161.35 36.66 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.691 ' HZ3' ' HD1' ' A' ' 33' ' ' TRP . 26.0 mmmt -92.37 143.93 28.12 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 117.377 0.589 . . . . 0.0 110.093 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.538 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 27.5 Cg_endo -61.03 159.59 29.24 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.722 2.948 . . . . 0.0 114.3 -170.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.513 ' HG2' ' CE1' ' A' ' 131' ' ' HIS . 21.1 mt-10 -117.15 168.84 9.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.091 176.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 47.7 ttm -142.03 127.04 18.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.285 0.564 . . . . 0.0 112.224 -175.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.5 140.54 49.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -114.59 141.41 47.8 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.904 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.68 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 107.46 169.75 21.98 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.378 174.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.06 85.29 6.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.218 0.532 . . . . 0.0 111.358 -176.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.569 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 24.1 ptp -80.85 152.11 71.58 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.029 176.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.653 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 98.2 Cg_endo -75.26 -178.24 4.08 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.681 2.254 . . . . 0.0 112.062 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -62.24 -36.75 82.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.142 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.38 -37.63 74.56 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.941 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.653 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 71.8 m -72.82 -34.62 66.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.756 174.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.652 ' O ' HG12 ' A' ' 121' ' ' ILE . 2.1 m-85 -63.27 -51.82 64.58 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 121.126 -0.229 . . . . 0.0 110.792 176.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -57.02 -36.53 70.55 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.964 0.411 . . . . 0.0 110.503 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.786 ' HZ2' ' HB2' ' A' ' 119' ' ' LYS . 4.8 ttmp? -57.22 -42.7 81.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.884 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.83 -34.96 69.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.047 176.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.652 HG12 ' O ' ' A' ' 117' ' ' PHE . 37.2 mm -64.85 -56.02 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.698 -178.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.469 ' HA ' HD13 ' A' ' 126' ' ' LEU . 2.0 m-20 -66.64 -64.39 0.86 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.011 0.434 . . . . 0.0 110.951 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.75 -34.39 69.49 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.535 -171.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.704 ' HE1' ' HA2' ' A' ' 130' ' ' GLY . 63.4 t80 -108.26 -50.27 3.06 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 18.1 tp -81.43 -30.99 33.33 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.476 -169.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' A' ' 122' ' ' ASP . 80.4 mt -87.44 -50.54 6.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.297 0.57 . . . . 0.0 109.635 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -96.8 90.99 5.46 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 171.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -49.44 96.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.613 0.72 . . . . 0.0 112.391 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -114.76 46.72 1.36 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.359 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.704 ' HA2' ' HE1' ' A' ' 124' ' ' PHE . . . -58.79 101.64 0.23 Allowed Glycine 0 C--N 1.33 0.241 0 CA-C-N 115.503 -0.772 . . . . 0.0 113.626 -175.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.513 ' CE1' ' HG2' ' A' ' 106' ' ' GLU . 97.8 m-70 59.37 74.37 0.44 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.319 0.648 . . . . 0.0 111.657 177.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -145.26 -56.65 0.32 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.179 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -172.12 130.23 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.403 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.467 ' CE1' ' HB2' ' A' ' 124' ' ' PHE . 45.1 m-70 -138.66 8.48 2.59 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 110.467 174.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -113.57 -8.52 13.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.918 0.39 . . . . 0.0 110.332 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 117.396 -1.288 . . . . 0.0 108.289 -179.716 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HG3' ' H ' ' A' ' 11' ' ' VAL . 43.1 tptt -137.12 173.23 11.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.2 p -122.18 107.99 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.578 0.704 . . . . 0.0 110.296 175.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 43.8 mm -108.81 132.21 57.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.202 -176.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.657 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 4.6 p80 -89.09 127.9 35.73 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.475 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 1.1 pp -128.28 -179.99 5.31 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.968 -172.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.443 ' HA ' ' OE1' ' A' ' 81' ' ' GLU . 45.3 p -104.36 174.84 5.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.244 177.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.498 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 13.0 pttm -64.45 -26.69 68.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 111.198 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.468 ' HA ' HD12 ' A' ' 20' ' ' LEU . . . -65.97 -40.31 91.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.311 0.577 . . . . 0.0 110.404 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.475 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -71.86 -34.51 69.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.804 178.638 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.458 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -59.07 -53.79 54.4 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.476 174.162 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.712 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 18.1 mt -46.91 -59.7 2.92 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.655 -1.612 . . . . 0.0 111.919 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.64 -48.48 72.06 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -170.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -104.13 -3.1 24.9 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.401 -170.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 61.1 t -129.06 -52.9 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.712 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 11.7 t80 -167.62 124.73 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.01 -164.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.71 91.4 7.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.951 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.512 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 25.2 p90 -79.99 12.99 2.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.11 0.481 . . . . 0.0 111.412 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -93.88 -53.07 4.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -83.46 -23.71 32.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.735 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.449 ' ND2' ' HB2' ' A' ' 34' ' ' LYS . 2.3 m-20 -121.58 69.37 23.63 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.376 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -57.58 -37.05 98.29 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.311 2.674 . . . . 0.0 112.279 173.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -105.13 -42.43 5.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.983 -174.437 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -94.98 178.19 5.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.362 0.601 . . . . 0.0 112.375 -174.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.799 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 19.1 t-105 -125.19 108.6 11.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.569 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.476 ' C ' ' HD3' ' A' ' 34' ' ' LYS . 8.6 tmtt? -110.7 112.63 24.64 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 172.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.527 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 13.9 t80 -80.8 124.95 29.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.548 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -101.05 8.48 42.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.422 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.423 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -88.4 150.56 21.99 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 -177.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -92.29 -30.07 16.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.078 0.465 . . . . 0.0 110.961 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -115.09 155.22 46.93 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.912 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 70' ' ' GLN . 47.8 Cg_exo -56.92 132.17 50.01 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.352 2.034 . . . . 0.0 111.381 174.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -117.05 154.98 30.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.476 0.655 . . . . 0.0 111.676 -175.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.429 HD13 HG12 ' A' ' 121' ' ' ILE . 78.3 mt -128.1 110.3 21.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.077 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 23.9 t -100.54 114.07 38.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.974 0.416 . . . . 0.0 111.114 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.609 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 4.4 t70 -90.8 113.8 26.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.181 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -84.88 111.04 19.29 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 170.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.689 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.4 p90 -132.33 159.0 40.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.289 0.566 . . . . 0.0 111.089 -177.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.447 ' CB ' HG12 ' A' ' 93' ' ' ILE . . . -128.14 128.85 45.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.007 171.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.532 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 28.3 t70 -63.47 -28.86 70.25 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.565 -170.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -75.63 -2.78 30.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.683 0.277 . . . . 0.0 111.732 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 42.5 t -103.43 127.72 50.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.939 0.4 . . . . 0.0 110.785 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.81 -61.43 7.34 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.661 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 72.1 Cg_exo -47.84 -47.54 18.46 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.761 2.307 . . . . 0.0 112.537 176.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.689 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 65.1 m -56.86 -29.45 62.9 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.03 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 62.8 mttm -73.8 -42.95 60.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.172 174.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.652 ' O ' HG12 ' A' ' 59' ' ' ILE . 26.1 mtm -59.89 -40.13 87.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.917 0.389 . . . . 0.0 111.396 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.501 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 11.5 p -64.04 -30.53 50.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.161 -171.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.684 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -57.53 -57.55 24.49 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 118.833 -0.603 . . . . 0.0 112.021 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.684 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 47.0 Cg_exo -57.82 -39.96 82.72 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 121.811 1.674 . . . . 0.0 112.539 174.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.652 HG12 ' O ' ' A' ' 55' ' ' MET . 21.0 mm -61.15 -49.42 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 121.709 0.766 . . . . 0.0 109.916 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.683 HD22 HD13 ' A' ' 73' ' ' ILE . 11.6 mt -63.93 -37.51 87.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.543 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -62.4 -44.29 96.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.418 0.628 . . . . 0.0 109.451 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -58.71 -55.61 32.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.363 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.431 HD21 ' HG3' ' A' ' 114' ' ' LYS . 4.4 mm? -66.72 -33.93 76.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.315 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.55 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -60.79 -46.05 92.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.952 0.406 . . . . 0.0 110.239 177.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.561 ' NZ ' ' HB3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -69.45 -31.52 69.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.716 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.02 -35.96 69.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.27 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -109.22 27.74 9.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.876 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.91 148.97 9.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.388 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.54 -44.5 2.59 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.843 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.442 ' HG3' HG23 ' A' ' 71' ' ' ILE . 9.4 pt20 -93.33 -38.62 11.39 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.442 HG23 ' HG3' ' A' ' 70' ' ' GLN . 38.9 pt -118.74 159.98 18.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.009 0.433 . . . . 0.0 111.713 -177.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 63.6 t -133.36 121.69 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.683 HD13 HD22 ' A' ' 60' ' ' LEU . 46.0 mt -103.86 139.43 24.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.486 0.66 . . . . 0.0 111.253 -175.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -128.04 173.49 10.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.898 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 0.6 OUTLIER -149.34 158.45 44.19 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 170.25 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.496 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 9.9 p -133.88 136.06 54.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.203 0.525 . . . . 0.0 110.438 -177.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.469 ' HB2' ' HZ2' ' A' ' 80' ' ' LYS . 3.6 m-20 -80.1 94.37 5.97 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.377 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.666 HG21 ' HA ' ' A' ' 92' ' ' SER . 74.6 m -58.49 -33.8 70.21 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -174.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -53.93 -31.16 49.4 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HZ2' ' HB2' ' A' ' 77' ' ' ASP . 14.6 pttp -106.21 -32.04 8.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.179 0.514 . . . . 0.0 110.504 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.498 ' OE2' ' HG2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -90.83 44.23 1.19 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.367 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -61.06 -37.18 81.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.428 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -70.58 -37.72 73.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.228 0.537 . . . . 0.0 110.072 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.1 -49.14 59.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.789 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.14 84.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.969 0.414 . . . . 0.0 111.077 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -66.84 -31.18 77.49 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.903 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.68 93.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 0.0 111.616 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.602 ' HB2' HG12 ' A' ' 90' ' ' ILE . 72.5 m-85 -85.91 -1.68 57.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.84 0.352 . . . . 0.0 110.898 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.01 15.85 78.07 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.33 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.602 HG12 ' HB2' ' A' ' 88' ' ' PHE . 48.9 mm -65.46 -25.14 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 122.587 0.355 . . . . 0.0 110.866 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 72.03 -67.77 0.25 Allowed 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.744 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.666 ' HA ' HG21 ' A' ' 78' ' ' THR . 33.7 m -151.77 -89.31 0.06 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.932 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.531 HG21 ' C ' ' A' ' 46' ' ' TYR . 2.4 pp -163.29 159.92 18.24 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.595 -170.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.577 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 2.3 Cg_endo -95.22 147.1 8.4 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 124.821 -0.908 . . . . 0.0 111.803 -4.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.4 t -141.73 138.77 32.6 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 107' ' ' MET . 30.7 mm -118.77 113.8 42.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 25.6 tp -98.0 112.71 24.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.527 -176.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.24 110.11 22.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.545 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 32.2 mt -101.69 106.17 45.1 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.153 -174.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.36 163.27 27.5 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.583 2.189 . . . . 0.0 111.95 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 92.3 mmm -85.16 0.29 52.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.479 0.657 . . . . 0.0 110.082 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -138.77 111.1 7.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.117 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.71 -158.83 18.5 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.24 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.799 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 42.7 mtpt -113.24 154.36 45.27 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.545 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 73.1 Cg_endo -75.34 140.49 24.6 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.83 2.353 . . . . 0.0 114.563 -170.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.432 ' CG ' ' HZ ' ' A' ' 124' ' ' PHE . 18.8 mp0 -91.35 169.93 10.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.578 173.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.555 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 21.4 ptp -142.01 144.38 33.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.025 0.441 . . . . 0.0 111.177 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -124.68 126.43 45.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.292 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -86.49 126.72 34.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.089 0.471 . . . . 0.0 111.375 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.577 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 100.29 155.72 27.78 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.436 175.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.501 ' HB1' ' HB ' ' A' ' 56' ' ' VAL . . . -87.59 87.33 7.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.342 0.591 . . . . 0.0 111.068 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.61 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 12.7 ptt? -68.26 162.95 56.72 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.283 173.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.566 ' HD2' ' HB2' ' A' ' 112' ' ' MET . 97.1 Cg_endo -75.09 179.14 6.4 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.633 2.222 . . . . 0.0 113.009 -173.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.431 ' HG3' HD21 ' A' ' 63' ' ' LEU . 58.3 tttp -54.81 -35.77 64.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.847 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.62 -52.76 19.18 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.915 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.61 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 18.8 m -66.12 -34.66 78.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.559 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.535 ' O ' HG13 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -63.94 -43.18 96.64 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.049 178.527 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.409 ' HZ2' ' HB3' ' A' ' 122' ' ' ASP . 1.6 ttpp -57.03 -40.67 77.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 0.0 110.075 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -66.74 -41.36 87.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.609 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.33 -36.88 71.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.977 0.418 . . . . 0.0 111.583 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.581 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 62.9 mt -73.99 -56.64 8.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.493 0.664 . . . . 0.0 110.69 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.409 ' HB3' ' HZ2' ' A' ' 118' ' ' LYS . 14.6 t0 -72.47 -64.77 0.88 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.169 -174.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.646 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 24.4 mt-10 -80.04 11.93 3.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.595 -169.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.609 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 58.5 t80 -138.46 -50.35 0.56 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.164 -0.214 . . . . 0.0 111.554 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.581 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 42.8 tp -73.54 -40.91 63.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.65 0.262 . . . . 0.0 110.59 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -90.81 -53.82 4.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.418 0.628 . . . . 0.0 109.306 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.646 ' HB3' ' HA ' ' A' ' 123' ' ' GLU . 52.1 tptt . . . . . 0 C--N 1.322 -0.608 0 CA-C-O 121.702 0.763 . . . . 0.0 109.219 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.481 ' C ' ' HD2' ' A' ' 10' ' ' LYS . . . . . . . . 0 CA--C 1.51 -0.271 0 CA-C-O 121.089 0.272 . . . . 0.0 112.445 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.481 ' HD2' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -131.77 174.62 9.95 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.618 -0.342 . . . . 0.0 110.265 -176.213 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.68 HG23 HG22 ' A' ' 73' ' ' ILE . 13.0 p -113.58 123.46 69.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.323 0.582 . . . . 0.0 110.653 173.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.6 mm -124.67 120.4 58.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.254 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.753 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 7.1 p80 -86.74 129.91 34.69 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.154 175.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -124.01 178.56 5.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.981 -172.172 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.604 HG22 ' HE2' ' A' ' 80' ' ' LYS . 41.3 p -93.07 171.46 8.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.686 175.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.457 ' HE3' ' HB3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -58.54 -37.4 75.6 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 178.752 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.44 ' N ' ' HG2' ' A' ' 16' ' ' LYS . . . -63.37 -37.93 89.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.477 0.656 . . . . 0.0 110.161 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 40.0 mt-10 -72.9 -34.82 66.89 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.751 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.474 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 6.8 t80 -54.89 -51.47 65.9 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 122.638 1.208 . . . . 0.0 108.761 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.656 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 25.9 mt -54.76 -58.39 7.76 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 112.481 -2.145 . . . . 0.0 111.931 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.94 -14.53 41.57 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -170.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 94.3 mttt -109.93 -5.84 15.37 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.202 -0.311 . . . . 0.0 111.368 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 59.4 t -141.02 -56.34 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.656 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 45.1 t80 -167.26 125.34 1.28 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.054 -164.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.539 ' OD1' ' HD3' ' A' ' 28' ' ' LYS . 2.8 t-20 -86.46 90.25 8.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.621 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -85.82 11.97 10.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.743 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 6.6 mt-10 -94.5 -54.29 3.58 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.938 0.875 . . . . 0.0 108.813 175.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.743 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 12.2 mptt -88.12 -23.45 23.67 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.628 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.57 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 2.0 m-20 -120.62 68.64 15.4 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.899 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -61.27 -43.7 27.36 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.966 2.444 . . . . 0.0 112.24 170.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -100.97 -29.93 11.92 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.161 0.505 . . . . 0.0 110.824 -175.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.57 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 22.9 mp0 -89.79 127.92 36.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.999 -169.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.543 ' HB2' ' NZ ' ' A' ' 104' ' ' LYS . 72.8 t-105 -89.95 89.57 7.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.223 0.535 . . . . 0.0 110.432 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.506 ' HE3' ' ND2' ' A' ' 29' ' ' ASN . 28.0 ttpp -106.24 97.74 7.51 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.764 175.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 83.0 t80 -85.41 119.64 26.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.893 176.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -112.62 85.54 2.18 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.451 0.643 . . . . 0.0 110.184 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -147.24 -154.04 6.1 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.984 -176.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -115.12 -58.84 2.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.247 0.546 . . . . 0.0 110.534 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 51.0 mttp -135.65 170.18 11.75 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.278 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 79.7 Cg_exo -45.25 132.52 11.85 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 122.735 2.29 . . . . 0.0 112.459 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -117.79 145.84 44.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.596 -171.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.414 HD11 HD12 ' A' ' 121' ' ' ILE . 75.0 mt -119.8 114.31 43.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.118 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 28.7 t -98.57 110.3 25.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.767 0.317 . . . . 0.0 110.836 -177.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.562 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 7.6 t70 -98.4 111.61 23.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.961 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.573 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 79.9 m-85 -90.38 112.12 23.6 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.768 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.2 p90 -133.77 179.06 6.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.39 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.655 ' HB3' HD13 ' A' ' 93' ' ' ILE . . . -154.79 173.34 16.59 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.484 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.463 ' HA ' ' HE3' ' A' ' 54' ' ' LYS . 20.6 t70 -80.68 -46.43 15.57 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -175.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.404 ' CZ2' HD11 ' A' ' 93' ' ' ILE . 51.8 p-90 -71.04 0.23 7.98 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -173.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.504 ' CB ' HD12 ' A' ' 93' ' ' ILE . 45.4 t -112.85 114.03 26.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.943 0.401 . . . . 0.0 110.292 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.2 -51.62 58.09 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.256 -0.747 . . . . 0.0 113.64 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -47.42 -37.7 25.87 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.969 2.446 . . . . 0.0 112.929 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 59.9 m -59.75 -39.84 86.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.47 0.653 . . . . 0.0 111.485 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HE3' ' HA ' ' A' ' 48' ' ' ASP . 99.4 mttt -79.04 -29.99 43.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.161 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.527 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 4.5 tmm? -62.44 -46.05 90.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.811 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.57 HG22 ' HG ' ' A' ' 60' ' ' LEU . 14.5 p -71.18 -26.21 26.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.944 -175.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.633 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -53.83 -56.33 26.54 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 36.5 Cg_exo -60.04 -47.06 16.31 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 121.708 1.605 . . . . 0.0 112.009 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.0 mt -58.34 -43.3 86.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.759 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.63 HD22 HD13 ' A' ' 73' ' ' ILE . 7.8 mt -64.87 -44.68 88.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.092 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.58 ' HB2' HG12 ' A' ' 11' ' ' VAL . 27.2 t70 -67.61 -40.96 84.72 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.403 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.18 -45.29 95.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.735 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 63' ' ' LEU . 16.6 tp -65.82 -34.76 78.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.823 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.609 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -64.99 -35.09 80.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.907 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.583 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 5.2 tmtm? -75.43 -32.5 60.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.483 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -52.5 -46.83 66.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.561 0.696 . . . . 0.0 109.968 172.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -104.97 28.08 7.53 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.578 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.583 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 9.0 t0 -48.88 131.01 18.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.229 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.34 -18.95 56.41 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.248 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -105.28 -48.81 3.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.635 0.255 . . . . 0.0 111.585 -176.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 40' ' ' PRO . 34.0 pt -122.85 159.82 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.4 0.619 . . . . 0.0 112.544 -173.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 27.4 t -125.39 127.91 72.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.42 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.68 HG22 HG23 ' A' ' 11' ' ' VAL . 20.5 mt -112.09 130.49 65.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.381 0.61 . . . . 0.0 110.824 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -114.2 165.64 12.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.614 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.753 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 47.9 mttm -132.14 153.46 50.49 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.487 173.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.53 HG13 ' HG2' ' A' ' 81' ' ' GLU . 4.7 t -127.14 121.44 57.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.738 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.406 ' HB2' ' HG2' ' A' ' 80' ' ' LYS . 11.3 m-20 -77.98 88.86 4.14 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 92' ' ' SER . 20.8 p -52.85 -30.02 31.25 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.111 0.481 . . . . 0.0 111.445 -175.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.473 ' CD ' ' HB1' ' A' ' 47' ' ' ALA . 2.6 mm-40 -50.56 -44.86 56.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.099 174.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.604 ' HE2' HG22 ' A' ' 15' ' ' THR . 19.3 pttm -103.33 -19.43 14.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.06 0.457 . . . . 0.0 110.672 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.53 ' HG2' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -97.85 42.87 1.08 Allowed 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.27 0.628 . . . . 0.0 111.453 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -57.24 -43.24 82.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.139 0.495 . . . . 0.0 110.812 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.36 -36.27 78.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.531 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.56 -47.77 74.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.565 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.56 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -63.94 -48.34 76.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.682 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.01 -32.76 76.48 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.129 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.06 -40.0 95.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.801 0.334 . . . . 0.0 111.525 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.438 ' HB2' HG13 ' A' ' 90' ' ' ILE . 96.4 m-85 -92.67 5.95 49.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.325 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.49 20.86 78.24 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.153 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 85' ' ' ALA . 26.4 mt -76.84 137.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.749 ' H ' ' HD2' ' A' ' 91' ' ' ARG . 3.0 mpt_? -71.59 -64.68 0.88 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.427 ' O ' HG21 ' A' ' 78' ' ' THR . 5.2 p -177.65 -85.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.368 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.655 HD13 ' HB3' ' A' ' 47' ' ' ALA . 13.9 pt -150.55 146.82 20.18 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -167.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.766 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 11.3 Cg_exo -86.65 150.48 42.09 Favored 'Cis proline' 0 N--CA 1.473 0.282 0 C-N-CA 124.513 -1.036 . . . . 0.0 110.722 -6.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 4.5 m -139.95 128.93 23.5 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 107' ' ' MET . 57.0 mt -128.02 114.32 34.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.745 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.62 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.7 tp -102.45 113.32 26.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.74 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -92.3 102.62 15.11 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.849 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.567 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 65.4 mt -97.61 113.17 63.12 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.61 -175.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -86.5 165.34 9.33 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.742 2.294 . . . . 0.0 111.547 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 93.1 mmm -89.7 2.44 54.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.562 0.696 . . . . 0.0 109.345 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -140.82 98.25 3.36 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.844 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.16 -162.49 13.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.862 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.543 ' NZ ' ' HB2' ' A' ' 33' ' ' TRP . 25.8 mmmt -98.49 150.46 36.74 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.567 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 5.7 Cg_exo -79.36 155.94 25.27 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.196 2.597 . . . . 0.0 112.987 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 107' ' ' MET . 29.3 tt0 -109.07 163.6 13.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.133 174.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.596 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 22.4 ptp -142.74 129.06 19.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.359 0.599 . . . . 0.0 111.202 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.31 156.55 27.63 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.883 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -116.89 137.81 51.96 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.221 0.534 . . . . 0.0 111.364 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.766 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 104.59 150.46 20.55 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.195 178.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -84.5 88.23 7.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.166 0.508 . . . . 0.0 111.342 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.516 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 25.2 ptp -69.68 164.74 47.91 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.524 172.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.606 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 74.3 Cg_endo -75.41 169.27 22.78 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.847 1.698 . . . . 0.0 111.621 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -55.69 -32.15 63.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.516 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 118' ' ' LYS . . . -71.33 -47.51 56.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.167 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.606 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 50.2 m -64.72 -33.8 76.82 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.687 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.696 ' O ' HG12 ' A' ' 121' ' ' ILE . 7.4 m-85 -61.57 -39.56 91.57 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.604 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.597 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 3.8 mmmm -54.01 -52.39 60.95 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.171 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.526 ' HG3' ' OE2' ' A' ' 123' ' ' GLU . 51.7 tttp -64.5 -32.98 74.84 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.677 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.546 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.32 -40.39 70.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.992 0.425 . . . . 0.0 111.214 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.696 HG12 ' O ' ' A' ' 117' ' ' PHE . 31.3 mm -73.58 -55.61 11.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.8 0.333 . . . . 0.0 110.278 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -65.36 -68.47 0.36 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.961 0.41 . . . . 0.0 110.825 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.526 ' OE2' ' HG3' ' A' ' 119' ' ' LYS . 48.2 mt-10 -77.4 12.0 1.74 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -169.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.546 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 77.8 t80 -143.51 -53.4 0.36 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.686 175.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 44.0 tp -69.6 -39.13 77.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.489 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 80.2 mt -88.54 -60.26 2.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.509 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 14.1 ttpp . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.429 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.57 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -150.4 152.3 34.14 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.852 0.834 . . . . 0.0 112.456 -167.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.731 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 5.0 p -134.83 119.48 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.098 174.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 60.0 mt -117.37 116.98 53.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.415 -173.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.738 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 11.0 p80 -83.8 119.67 25.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.842 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 2.0 pp -127.84 171.96 11.28 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.229 -171.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.7 p -99.18 177.89 5.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.161 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 19' ' ' PHE . 63.5 pttt -59.22 -25.24 63.83 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 20' ' ' LEU . . . -68.49 -44.17 75.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.284 0.564 . . . . 0.0 110.233 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.842 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 3.2 mp0 -72.24 -33.71 67.75 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.399 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.55 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -55.08 -49.23 72.19 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.007 0.908 . . . . 0.0 109.201 174.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.685 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 13.9 mt -50.58 -61.15 2.36 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.357 -1.747 . . . . 0.0 111.742 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.11 -7.58 59.62 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -169.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.02 -33.88 6.37 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 70.3 t -125.03 -40.78 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -169.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.685 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 21.5 t80 -164.95 117.88 1.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.866 -166.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.621 ' OD1' ' HD3' ' A' ' 28' ' ' LYS . 2.6 t-20 -91.66 89.68 7.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.485 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.657 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 18.9 p90 -81.12 6.89 12.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -86.16 -53.41 5.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.831 0.824 . . . . 0.0 108.903 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.621 ' HD3' ' OD1' ' A' ' 25' ' ' ASN . 11.0 mptt -88.43 -23.41 23.3 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.426 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.743 HD22 ' HE3' ' A' ' 34' ' ' LYS . 2.1 m-20 -118.69 61.54 4.9 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.195 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.17 -44.71 44.04 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.683 2.255 . . . . 0.0 112.112 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.21 -13.7 15.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.852 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.45 ' O ' ' HE1' ' A' ' 24' ' ' TYR . 44.9 mt-10 -91.09 144.08 26.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.271 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.505 ' CZ2' ' HG2' ' A' ' 105' ' ' PRO . 65.0 t-105 -108.36 109.17 20.42 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 171.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.743 ' HE3' HD22 ' A' ' 29' ' ' ASN . 27.1 ttpp -134.21 117.65 16.73 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.621 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 29.4 t80 -90.05 110.97 21.93 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.714 -175.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.413 ' OE1' ' HG2' ' A' ' 34' ' ' LYS . 4.5 mm-40 -84.53 40.81 0.81 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.548 -176.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.613 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -98.3 165.7 21.73 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.731 -171.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -101.47 -56.88 2.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.302 0.572 . . . . 0.0 109.828 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -116.36 166.6 12.2 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.264 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.567 ' HB2' HG22 ' A' ' 71' ' ' ILE . 36.7 Cg_exo -55.83 137.15 77.78 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.165 1.91 . . . . 0.0 111.324 175.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -121.6 146.2 47.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.322 0.582 . . . . 0.0 112.02 -173.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.509 ' HB ' HG12 ' A' ' 73' ' ' ILE . 64.5 mt -113.18 112.31 39.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.905 172.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.793 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 20.7 t -98.94 113.59 34.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.863 0.363 . . . . 0.0 110.848 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.614 ' HB2' HD13 ' A' ' 60' ' ' LEU . 6.7 t70 -92.69 108.69 20.18 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.108 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.545 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 13.7 m-85 -88.07 109.94 20.25 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 171.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.767 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 3.9 p90 -130.25 160.77 32.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.186 0.517 . . . . 0.0 110.671 -175.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 50' ' ' CYS . . . -119.49 131.67 55.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.105 169.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.63 -11.26 59.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.01 0.434 . . . . 0.0 111.152 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.406 ' HE1' ' HG2' ' A' ' 79' ' ' GLU . 65.8 p-90 -102.23 -6.39 23.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.096 176.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 50.2 t -88.73 118.05 28.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.81 0.338 . . . . 0.0 110.954 -174.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 54' ' ' LYS . . . -52.13 -57.3 13.47 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.595 -0.729 . . . . 0.0 113.628 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.462 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 83.2 Cg_exo -47.32 -46.35 20.09 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.026 2.484 . . . . 0.0 113.552 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.767 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 74.9 m -68.78 -37.25 79.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.854 0.359 . . . . 0.0 111.215 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 68.1 mttm -55.25 -28.69 55.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.81 173.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 79.9 mtp -75.08 -50.92 14.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.025 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.58 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 32.8 m -71.82 -39.32 67.78 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -173.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -49.75 -56.8 14.82 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 23.3 Cg_exo -63.9 -35.76 53.84 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.732 1.622 . . . . 0.0 111.574 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.887 HG23 ' HB3' ' A' ' 114' ' ' LYS . 56.6 mt -62.75 -42.55 96.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.677 0.751 . . . . 0.0 110.464 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' A' ' 44' ' ' ASP . 28.2 mt -68.82 -35.51 77.07 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.119 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.563 ' OD1' HG11 ' A' ' 11' ' ' VAL . 57.1 m-20 -62.19 -45.77 91.91 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 173.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -54.92 -47.08 74.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.698 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.48 HD21 ' HB2' ' A' ' 114' ' ' LYS . 74.4 mt -69.3 -29.9 67.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.824 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.79 -42.65 84.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.826 0.346 . . . . 0.0 110.372 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.73 -28.69 58.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.396 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.464 ' CD ' ' HZ1' ' A' ' 114' ' ' LYS . 4.6 tt0 -80.62 -41.52 23.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.473 ' HE1' HD22 ' A' ' 63' ' ' LEU . 57.8 m-85 -98.94 24.96 7.11 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.847 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -64.53 163.57 13.27 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.232 0.539 . . . . 0.0 111.704 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.23 -50.51 3.88 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.296 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.511 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 23.9 pt20 -90.09 -40.33 12.34 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 -177.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.567 HG22 ' HB2' ' A' ' 40' ' ' PRO . 26.9 pt -127.56 166.77 23.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.293 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 51.4 t -134.06 139.5 48.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.731 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 39.1 mt -108.08 142.13 21.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.072 -175.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -127.47 165.96 18.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.799 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.738 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 86.1 mttt -132.39 166.36 22.15 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.56 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 5.1 p -146.06 133.49 15.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.169 0.509 . . . . 0.0 109.673 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 8.0 m-20 -81.98 91.89 6.68 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.489 HG21 ' HA ' ' A' ' 92' ' ' SER . 18.0 m -66.95 -27.66 67.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.304 -167.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.406 ' HG2' ' HE1' ' A' ' 49' ' ' TRP . 3.2 mp0 -54.28 -38.95 66.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.794 0.331 . . . . 0.0 110.917 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -95.7 -34.88 11.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.101 0.477 . . . . 0.0 109.987 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.56 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -82.26 30.75 0.4 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.671 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -63.13 -26.74 68.96 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -61.94 -45.33 94.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.617 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -70.8 -53.19 16.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.142 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -54.3 -51.51 64.41 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.496 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.55 -27.84 66.68 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.322 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.78 -26.99 67.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.645 0.26 . . . . 0.0 111.574 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.574 ' HB2' HG13 ' A' ' 90' ' ' ILE . 83.4 m-85 -100.86 -5.08 26.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.887 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.13 4.77 64.44 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.878 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 85' ' ' ALA . 36.8 mt -65.97 128.93 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -69.13 -53.42 20.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.265 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.489 ' HA ' HG21 ' A' ' 78' ' ' THR . 11.3 p 178.14 -94.83 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.714 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.519 HG21 ' C ' ' A' ' 46' ' ' TYR . 0.2 OUTLIER -145.07 157.59 53.6 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.613 -173.829 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.668 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 8.3 Cg_exo -83.53 133.39 20.86 Favored 'Cis proline' 0 N--CA 1.474 0.367 0 C-N-CA 124.71 -0.954 . . . . 0.0 111.995 -3.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 4.9 m -126.84 122.04 33.59 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 107' ' ' MET . 19.7 mm -114.36 114.66 47.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.205 -176.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.793 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.9 tp -99.77 114.76 28.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.015 0.436 . . . . 0.0 110.761 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 105' ' ' PRO . 97.5 m-85 -97.07 102.86 14.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.086 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.796 HG12 ' HB3' ' A' ' 105' ' ' PRO . 34.2 mt -107.02 106.46 58.35 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -176.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -87.1 165.9 8.36 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.771 2.314 . . . . 0.0 111.665 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.5 mmm -86.74 -1.93 58.13 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.981 0.419 . . . . 0.0 111.064 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -153.28 112.73 3.83 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 129.6 -136.17 8.81 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.536 ' HB3' ' HZ2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -137.38 151.16 70.81 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 175.313 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.796 ' HB3' HG12 ' A' ' 99' ' ' ILE . 3.8 Cg_exo -77.77 114.05 3.58 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.903 2.402 . . . . 0.0 111.22 175.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -95.69 167.18 11.44 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.315 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.508 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 49.0 ttm -140.06 130.97 26.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.444 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.97 141.66 48.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.44 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.508 ' OE1' ' HA ' ' A' ' 95' ' ' SER . 12.3 mm100 -106.13 134.73 48.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.874 0.369 . . . . 0.0 111.616 -175.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.668 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 114.39 177.15 19.06 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 169.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.58 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -94.2 87.61 5.32 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.508 -0.846 . . . . 0.0 111.932 -174.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.589 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 23.3 ptp -96.36 150.85 37.62 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.556 171.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.545 ' HA ' HD13 ' A' ' 59' ' ' ILE . 74.9 Cg_endo -75.49 173.19 14.92 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.343 2.029 . . . . 0.0 111.534 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.887 ' HB3' HG23 ' A' ' 59' ' ' ILE . 21.4 ptmt -63.17 -22.91 67.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.898 0.38 . . . . 0.0 110.284 177.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.97 -52.94 45.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.665 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.589 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 36.0 m -67.58 -34.06 76.27 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.235 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.535 ' HB2' ' HA ' ' A' ' 114' ' ' LYS . 7.3 m-85 -59.25 -47.01 86.97 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.489 174.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.512 ' NZ ' ' HB2' ' A' ' 122' ' ' ASP . 5.8 tmtm? -55.42 -35.92 65.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.346 0.117 . . . . 0.0 110.743 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.551 ' HG2' ' OE1' ' A' ' 123' ' ' GLU . 62.0 tttm -64.03 -57.07 10.76 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.397 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.39 95.8 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.72 HG23 HD23 ' A' ' 125' ' ' LEU . 77.3 mt -59.46 -44.95 93.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.861 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.512 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 10.0 t70 -62.79 -62.97 1.36 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.66 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.731 ' HA ' ' HZ3' ' A' ' 127' ' ' LYS . 62.2 mt-10 -63.13 -0.8 0.82 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -167.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -151.63 -48.41 0.11 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.649 -0.821 . . . . 0.0 112.528 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.72 HD23 HG23 ' A' ' 121' ' ' ILE . 42.4 tp -66.9 -30.62 70.81 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.633 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 74.6 mt -109.28 -56.3 2.31 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.854 0.835 . . . . 0.0 109.5 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.731 ' HZ3' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.852 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.331 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.325 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.439 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -135.8 175.26 9.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.968 0.413 . . . . 0.0 110.431 178.112 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.848 HG22 ' HB ' ' A' ' 73' ' ' ILE . 39.7 t -114.02 143.35 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.244 -172.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.8 mt -124.3 107.96 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.734 172.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.748 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 9.8 p80 -83.32 116.31 22.39 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 173.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.733 HD22 ' HB3' ' A' ' 18' ' ' GLU . 1.1 pp -132.92 179.99 5.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.985 -166.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.698 HG22 ' HE2' ' A' ' 80' ' ' LYS . 66.4 p -94.0 175.25 6.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.589 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.533 ' HD2' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -59.62 -32.28 70.28 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 121.233 -0.187 . . . . 0.0 111.233 177.825 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.559 ' HA ' HD12 ' A' ' 20' ' ' LEU . . . -62.84 -41.89 99.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.468 0.651 . . . . 0.0 110.218 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.733 ' HB3' HD22 ' A' ' 14' ' ' LEU . 8.4 mm-40 -71.72 -36.4 70.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.366 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -56.92 -50.72 71.71 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 122.388 1.089 . . . . 0.0 109.452 175.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.643 HD22 HD22 ' A' ' 25' ' ' ASN . 16.1 mt -50.34 -59.0 4.41 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 112.838 -1.983 . . . . 0.0 111.857 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.3 -17.87 38.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -171.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -110.81 -1.37 16.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.6 t -140.34 -50.69 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 7.5 t80 -175.14 116.02 0.16 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.155 0.502 . . . . 0.0 110.64 -167.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.643 HD22 HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -87.19 90.97 8.55 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.242 -177.265 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.522 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 18.9 p90 -78.4 14.96 1.07 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.83 -46.75 7.7 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.622 ' C ' HD22 ' A' ' 29' ' ' ASN . 49.9 mttp -96.31 -21.1 18.02 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.069 -173.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.622 HD22 ' C ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -121.11 62.97 11.63 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.366 177.212 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -61.26 -42.1 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.762 2.308 . . . . 0.0 112.374 172.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.589 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -103.02 -24.16 13.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.303 -176.365 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.404 ' CD ' ' HZ2' ' A' ' 34' ' ' LYS . 35.8 mt-10 -90.13 148.96 22.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.199 0.523 . . . . 0.0 111.259 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -113.95 93.77 4.52 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 168.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.404 ' HZ2' ' CD ' ' A' ' 32' ' ' GLU . 35.7 mtmm -117.51 106.33 13.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.402 173.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.578 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 30.2 t80 -68.14 105.12 1.97 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.368 0.604 . . . . 0.0 109.831 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -90.22 84.22 6.06 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.565 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -149.52 -135.69 2.51 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.731 -174.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -141.54 -55.34 0.47 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.898 0.38 . . . . 0.0 111.055 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 43.6 mttp -129.33 168.71 15.27 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.814 -177.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 65.8 Cg_exo -49.18 131.36 26.3 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.99 1.794 . . . . 0.0 111.393 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -115.32 143.23 45.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.365 -170.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.676 ' HB ' HG12 ' A' ' 73' ' ' ILE . 65.4 mt -120.33 122.49 68.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.124 176.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 16.5 t -105.74 116.02 48.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.894 0.378 . . . . 0.0 110.984 -178.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.778 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 11.3 t0 -97.78 108.11 20.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.634 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -91.27 111.64 23.21 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.593 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 0.8 OUTLIER -147.02 178.6 8.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.735 0.779 . . . . 0.0 111.286 -172.369 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.65 124.07 5.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.855 -1.52 . . . . 0.0 107.449 170.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.28 -23.06 67.25 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -169.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -74.95 -14.07 60.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.951 0.405 . . . . 0.0 110.766 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.1 t -99.64 132.93 44.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.475 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.561 ' O ' ' HG2' ' A' ' 54' ' ' LYS . . . -49.14 -68.23 1.42 Allowed Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.716 -0.674 . . . . 0.0 114.672 -175.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -58.71 -34.27 98.84 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.71 2.273 . . . . 0.0 113.107 -175.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.749 ' SG ' ' HB ' ' A' ' 93' ' ' ILE . 11.9 m -73.98 -33.88 64.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.896 0.379 . . . . 0.0 111.514 -176.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 0.2 OUTLIER -78.85 -27.2 44.11 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.581 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 16.4 ttt -66.93 -52.41 43.46 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.166 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.509 HG22 HD22 ' A' ' 60' ' ' LEU . 3.9 p -63.45 -36.77 77.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.046 -174.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.692 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -48.07 -60.28 4.58 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.326 -176.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.692 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 27.3 Cg_exo -62.21 -27.49 78.46 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.231 1.287 . . . . 0.0 112.272 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 55' ' ' MET . 45.0 mm -66.19 -57.28 11.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.34 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.571 HD21 ' NZ ' ' A' ' 75' ' ' LYS . 1.2 pt? -71.69 -30.03 65.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.178 -177.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.49 ' OD1' HG21 ' A' ' 11' ' ' VAL . 5.6 m-20 -66.43 -42.54 87.56 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.458 0.647 . . . . 0.0 109.846 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.531 ' HG3' ' NZ ' ' A' ' 114' ' ' LYS . 9.8 tp10 -54.79 -43.3 72.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.925 172.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.795 HD21 ' HA ' ' A' ' 118' ' ' LYS . 12.9 tp -71.52 -30.79 66.34 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.073 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.69 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -58.73 -59.07 6.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.745 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -64.7 -24.26 67.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.231 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -58.54 -30.86 67.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.462 0.649 . . . . 0.0 110.044 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.501 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 81.3 m-85 -113.75 25.74 10.96 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.447 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -52.36 114.46 1.37 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.93 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.04 -22.24 5.13 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.414 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 6.4 pt20 -127.55 -22.3 3.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 64' ' ' ALA . 44.0 pt -125.24 150.34 30.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.418 0.628 . . . . 0.0 112.218 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 47.2 t -127.27 132.09 69.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.284 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.848 ' HB ' HG22 ' A' ' 11' ' ' VAL . 11.8 mt -115.62 136.45 52.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.474 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -117.1 161.19 19.82 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.778 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 63.8 mttm -129.69 148.21 51.56 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.012 0.434 . . . . 0.0 110.23 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.424 HG13 ' CB ' ' A' ' 81' ' ' GLU . 17.4 t -120.64 111.83 33.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.739 176.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.42 89.2 2.64 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.533 HG21 ' O ' ' A' ' 92' ' ' SER . 7.9 p -52.87 -36.96 59.78 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -168.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.419 ' HG2' ' H ' ' A' ' 79' ' ' GLU . 1.1 mm-40 -53.43 -33.22 53.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.568 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.698 ' HE2' HG22 ' A' ' 15' ' ' THR . 18.1 pttm -103.45 -22.21 13.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.397 0.618 . . . . 0.0 110.161 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -100.11 43.24 1.07 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.657 178.656 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -55.1 -46.71 75.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.964 0.411 . . . . 0.0 111.419 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -64.55 -38.74 92.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.735 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -70.05 -44.88 68.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.966 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.04 89.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.035 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.51 -29.5 73.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.963 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.54 -26.45 65.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 111.54 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -99.17 7.24 45.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.054 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.29 16.64 80.56 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.324 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.4 mm -77.63 122.11 31.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -58.88 -61.8 2.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.505 0.669 . . . . 0.0 109.592 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.533 ' O ' HG21 ' A' ' 78' ' ' THR . 13.9 m -160.82 -79.71 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.674 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.749 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 4.5 pt -162.02 152.77 14.75 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.182 -172.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.719 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.6 Cg_exo -90.01 149.54 22.61 Favored 'Cis proline' 0 C--N 1.348 0.552 0 CA-C-N 118.869 0.632 . . . . 0.0 112.286 -3.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.416 ' HB3' ' SD ' ' A' ' 107' ' ' MET . 50.1 m -142.67 140.99 31.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.58 114.48 20.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.156 0.503 . . . . 0.0 110.138 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.554 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 43.7 tp -97.31 115.25 27.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.455 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.439 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 44.3 m-85 -96.2 104.68 16.65 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.437 HG23 ' HG3' ' A' ' 105' ' ' PRO . 53.8 mt -102.57 102.83 28.33 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.347 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 98' ' ' PHE . 73.8 Cg_endo -83.7 155.66 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.579 2.186 . . . . 0.0 111.763 174.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.403 ' SD ' ' HD3' ' A' ' 40' ' ' PRO . 90.4 mtp -75.27 -30.35 60.41 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -106.5 138.93 41.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.633 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.2 -140.1 16.61 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.922 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.667 ' HE3' ' HA ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -139.38 154.65 71.97 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.613 ' HD3' ' HE3' ' A' ' 104' ' ' LYS . 15.6 Cg_exo -69.47 154.34 69.01 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.1 2.533 . . . . 0.0 113.574 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.475 ' O ' HD12 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.56 169.72 9.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.829 176.623 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.416 ' SD ' ' HB3' ' A' ' 95' ' ' SER . 32.9 tpp -142.37 105.61 4.61 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.107 -174.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.93 137.37 42.01 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -117.41 137.74 52.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.159 0.504 . . . . 0.0 111.536 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.719 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 103.16 170.43 26.05 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.967 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -94.69 82.75 3.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.095 0.474 . . . . 0.0 111.65 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.586 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 22.0 ptt? -79.59 166.44 41.22 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 170.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.586 ' HD2' ' HB2' ' A' ' 112' ' ' MET . 65.9 Cg_endo -75.17 170.73 19.73 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.558 1.505 . . . . 0.0 112.541 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.531 ' NZ ' ' HG3' ' A' ' 62' ' ' GLU . 60.5 tttp -57.54 -25.37 59.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.971 174.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.64 -52.44 31.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.336 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.5 m -68.04 -37.74 81.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.697 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.679 ' O ' HG12 ' A' ' 121' ' ' ILE . 12.7 m-85 -61.48 -43.56 98.64 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.634 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.795 ' HA ' HD21 ' A' ' 63' ' ' LEU . 64.6 tttp -60.6 -38.84 86.01 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.108 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -62.87 -43.93 97.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.869 0.366 . . . . 0.0 110.741 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -64.0 -41.1 97.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.253 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.679 HG12 ' O ' ' A' ' 117' ' ' PHE . 16.3 mm -74.93 -53.9 15.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.437 0.637 . . . . 0.0 110.998 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.548 ' HA ' HD12 ' A' ' 126' ' ' LEU . 19.0 t70 -68.45 -66.03 0.62 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.314 -173.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.6 -49.36 71.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.767 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.543 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 79.2 t80 -86.09 -37.61 18.65 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -170.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.622 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 29.5 tp -90.52 -38.31 13.29 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 122' ' ' ASP . 79.6 mt -89.07 -66.84 0.88 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.911 0.386 . . . . 0.0 111.689 -173.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.507 -0.707 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 112.749 -0.14 . . . . 0.0 112.749 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -162.83 171.74 16.23 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 121.286 0.565 . . . . 0.0 110.968 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.536 HG21 ' HE3' ' A' ' 75' ' ' LYS . 7.9 m -113.16 145.08 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.382 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.1 mt -114.38 96.76 4.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.058 174.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.538 ' HA ' ' HB2' ' A' ' 75' ' ' LYS . 27.1 p80 -77.71 121.89 24.63 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.76 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.4 pp -138.38 178.63 7.0 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.228 0.537 . . . . 0.0 112.282 -169.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.633 HG22 ' HE2' ' A' ' 80' ' ' LYS . 42.6 p -98.42 171.39 8.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.484 175.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.535 ' HZ1' ' CD ' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -56.06 -33.09 64.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 178.909 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.05 -42.01 90.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.35 0.595 . . . . 0.0 110.293 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.76 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 30.2 mt-10 -71.62 -32.27 67.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.123 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -57.31 -52.86 63.65 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-O 122.401 1.096 . . . . 0.0 109.285 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.575 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 7.9 mt -50.63 -59.58 3.91 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.634 -2.075 . . . . 0.0 111.893 -176.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.58 -8.01 59.66 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -171.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -109.43 -32.43 7.16 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 31.0 t -123.5 -40.13 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -168.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.585 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 14.6 t80 -167.63 120.04 0.9 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.921 -166.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.72 90.82 7.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.011 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.585 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 27.0 p90 -85.29 18.49 2.62 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 111.667 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -94.54 -49.57 5.59 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -96.65 -21.6 17.52 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.153 -175.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.596 ' ND2' ' HB2' ' A' ' 34' ' ' LYS . 2.4 m-20 -121.7 68.29 22.91 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.618 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.92 -32.28 97.12 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.547 2.831 . . . . 0.0 112.613 173.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -102.52 -40.3 6.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -172.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 3.2 tp10 -100.78 132.29 46.25 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.466 0.65 . . . . 0.0 111.705 -174.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -69.46 93.2 0.65 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.654 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.596 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -93.11 97.15 10.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.529 177.31 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.57 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 23.0 t80 -81.39 127.53 32.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.989 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -109.43 151.95 26.0 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 168.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.88 -127.63 2.19 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.809 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -163.74 -60.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.019 0.437 . . . . 0.0 110.396 -173.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.465 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 22.0 mttm -119.08 165.79 16.08 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.442 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 85.9 Cg_exo -44.2 131.74 8.87 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.68 2.253 . . . . 0.0 111.838 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -113.22 146.31 39.53 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.212 0.529 . . . . 0.0 111.764 -171.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.692 ' HB ' HG12 ' A' ' 73' ' ' ILE . 74.8 mt -122.4 122.53 66.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.063 174.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 21.5 t -107.28 110.06 30.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.399 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.598 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 30.1 t0 -86.74 106.59 17.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.998 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.561 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 96.6 m-85 -91.88 111.89 23.6 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.673 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.6 p90 -140.63 -179.87 6.28 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.832 -171.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.421 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -159.09 142.71 14.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.492 170.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.47 -28.96 68.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -76.75 -9.79 58.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.235 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.466 ' HB2' HD12 ' A' ' 93' ' ' ILE . 47.0 t -99.15 112.38 24.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.936 0.398 . . . . 0.0 110.643 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.08 -54.3 38.6 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.607 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.49 -38.46 27.71 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.952 2.434 . . . . 0.0 113.532 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.726 ' SG ' ' HB ' ' A' ' 93' ' ' ILE . 83.0 m -67.06 -43.86 81.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.38 . . . . 0.0 111.143 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -72.48 -26.04 61.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.93 0.395 . . . . 0.0 110.184 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -60.05 -46.97 87.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.669 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.581 ' HB ' ' HE2' ' A' ' 117' ' ' PHE . 30.4 m -87.16 -25.17 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.481 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -43.74 -59.93 3.08 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 50.2 Cg_endo -68.57 -26.78 33.49 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.725 1.617 . . . . 0.0 112.0 -177.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.07 -54.95 21.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.347 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.583 HD11 ' HE2' ' A' ' 75' ' ' LYS . 1.7 pp -69.03 -30.84 69.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.51 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.08 -49.98 75.53 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.246 0.546 . . . . 0.0 110.741 173.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -64.56 -36.24 83.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.41 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.45 -31.3 67.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.425 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.689 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -56.98 -42.34 80.05 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 173.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.636 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 3.7 tmtm? -71.79 -41.22 68.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.043 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -56.54 -39.54 73.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.964 0.411 . . . . 0.0 110.739 176.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.452 ' OH ' ' HB3' ' A' ' 122' ' ' ASP . 83.8 m-85 -98.54 26.67 5.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.345 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 58.0 t0 -53.39 129.79 33.17 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.477 0.311 . . . . 0.0 110.666 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.53 -6.54 83.49 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.304 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -112.47 -44.34 3.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.607 0.242 . . . . 0.0 111.008 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 40' ' ' PRO . 45.1 pt -128.89 159.05 41.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.147 0.499 . . . . 0.0 111.822 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 96.6 t -126.86 123.82 63.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.233 176.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.692 HG12 ' HB ' ' A' ' 42' ' ' ILE . 15.2 mt -107.62 138.32 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.72 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -118.01 162.31 18.37 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 173.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.598 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 55.8 mttt -135.91 144.46 45.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.889 0.376 . . . . 0.0 111.147 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.691 HG13 ' HG2' ' A' ' 81' ' ' GLU . 37.3 t -138.41 134.48 43.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.853 -175.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.471 ' HB2' ' HG2' ' A' ' 80' ' ' LYS . 7.5 m-20 -94.52 102.06 13.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.449 HG21 ' O ' ' A' ' 92' ' ' SER . 16.8 p -52.94 -37.41 60.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.2 0.524 . . . . 0.0 111.67 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -54.9 -36.28 65.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.981 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.633 ' HE2' HG22 ' A' ' 15' ' ' THR . 21.6 pttm -100.59 -20.39 15.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.357 0.599 . . . . 0.0 110.076 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.691 ' HG2' HG13 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -97.86 45.25 1.03 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.483 176.015 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -55.89 -53.31 58.38 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.58 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.535 ' CD ' ' HZ1' ' A' ' 16' ' ' LYS . 2.2 mp0 -61.85 -36.88 82.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.618 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.466 HD23 ' HG2' ' A' ' 81' ' ' GLU . 41.4 tp -67.86 -41.7 82.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.529 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -67.0 -44.54 80.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.67 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.14 -32.89 82.15 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.684 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.85 -35.37 76.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.814 0.34 . . . . 0.0 111.588 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.532 ' HB2' HG13 ' A' ' 90' ' ' ILE . 94.6 m-85 -97.26 3.06 51.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.854 0.359 . . . . 0.0 110.81 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.13 28.46 73.7 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.11 -176.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 85' ' ' ALA . 28.9 mt -66.08 138.82 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -64.09 -61.39 2.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.449 ' O ' HG21 ' A' ' 78' ' ' THR . 24.3 p 175.65 -91.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.75 175.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.726 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 8.0 pt -151.55 146.34 18.77 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.881 -172.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.68 ' HB2' ' H ' ' A' ' 110' ' ' GLY . 17.3 Cg_exo -78.59 142.78 70.09 Favored 'Cis proline' 0 N--CA 1.478 0.561 0 C-N-CA 124.78 -0.925 . . . . 0.0 112.037 -3.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 14.7 m -139.37 112.35 8.0 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.73 114.39 46.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.028 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.606 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 34.8 tp -92.96 113.18 25.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.714 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -94.23 112.39 24.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.88 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 41' ' ' ALA . 36.9 mt -101.24 102.9 22.88 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.908 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.09 163.09 22.97 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.576 2.184 . . . . 0.0 112.325 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 92.6 mmm -87.39 -0.04 56.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.332 0.587 . . . . 0.0 109.559 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -138.2 123.68 19.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.928 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.25 -149.57 19.45 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.08 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 27.2 mmmt -123.31 159.1 56.26 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.467 ' HB2' HD11 ' A' ' 97' ' ' LEU . 57.6 Cg_endo -70.48 154.1 65.13 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.564 2.176 . . . . 0.0 113.45 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -125.83 167.94 14.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.494 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.506 ' SD ' ' HB3' ' A' ' 95' ' ' SER . 42.9 ttm -130.26 122.06 27.31 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.043 0.449 . . . . 0.0 112.029 -175.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.05 132.23 50.51 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -115.37 136.2 53.34 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.284 0.564 . . . . 0.0 112.437 -172.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.68 ' H ' ' HB2' ' A' ' 94' ' ' PRO . . . 104.7 -175.6 22.55 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.173 -0.921 . . . . 0.0 114.898 169.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.482 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -92.12 85.64 5.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.026 -0.587 . . . . 0.0 111.633 -171.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.568 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 25.1 ptp -91.4 154.89 44.52 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.463 172.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 71.7 Cg_endo -75.44 177.54 8.52 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.28 1.987 . . . . 0.0 111.687 -177.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -58.85 -33.77 70.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 174.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.78 -52.86 61.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.529 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.568 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 34.6 m -66.7 -40.73 88.6 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.736 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.581 ' HE2' ' HB ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -60.93 -40.79 94.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.537 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.434 ' C ' ' HD3' ' A' ' 118' ' ' LYS . 14.6 tmtt? -58.97 -49.82 76.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.892 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.559 ' HA ' ' OD1' ' A' ' 122' ' ' ASP . 12.9 mptt -64.64 -39.86 94.43 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.951 0.405 . . . . 0.0 110.797 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -58.51 -38.9 78.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.611 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.514 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 74.7 mt -75.04 -56.29 9.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.472 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.559 ' OD1' ' HA ' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -74.24 -58.87 3.01 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.918 -173.036 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.432 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 6.0 mm-40 -69.26 -22.47 63.83 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -171.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 91.6 t80 -110.47 -46.29 3.42 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.973 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.514 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 36.7 tp -90.39 -41.64 11.36 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -172.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.534 ' HB3' ' HA ' ' A' ' 122' ' ' ASP . 45.3 tp -83.49 -52.5 6.44 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 121.392 0.615 . . . . 0.0 109.751 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 30.1 mtmt . . . . . 0 C--N 1.318 -0.781 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 173.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.543 ' HA3' ' CG ' ' A' ' 68' ' ' ASP . . . . . . . . 0 C--O 1.227 -0.312 0 CA-C-O 120.514 -0.048 . . . . 0.0 113.058 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.98 172.09 10.53 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.701 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 12.9 p -113.36 132.21 62.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.713 0.768 . . . . 0.0 112.097 -176.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.0 mt -121.49 128.88 75.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.736 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.594 ' CB ' ' HG3' ' A' ' 75' ' ' LYS . 1.9 p80 -88.01 129.53 35.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.3 pp -133.21 173.98 10.87 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.918 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.43 166.97 12.59 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.852 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.759 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 30.7 pttt -62.16 -26.65 68.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.061 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.0 86.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.281 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 28.2 mm-40 -68.61 -43.58 76.08 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.868 176.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -57.39 -49.8 75.03 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 121.933 0.873 . . . . 0.0 109.502 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' ' 25' ' ' ASN . 1.1 tt -48.64 -61.47 2.01 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 113.648 -1.615 . . . . 0.0 112.098 -178.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.09 -18.83 33.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.588 -168.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 34.5 ttmt -108.78 -16.87 14.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -172.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.45 -45.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 18.5 t80 -164.42 116.74 1.31 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.236 0.541 . . . . 0.0 111.261 -169.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.598 ' HA ' HD23 ' A' ' 20' ' ' LEU . 10.4 t-20 -84.15 89.05 7.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.99 -177.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.511 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 27.2 p90 -82.81 4.88 23.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.644 0.735 . . . . 0.0 110.698 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.4 ' OE1' ' HG3' ' A' ' 28' ' ' LYS . 5.4 tm-20 -95.43 -52.27 4.22 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.253 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.538 ' HD2' ' ND2' ' A' ' 25' ' ' ASN . 67.6 mttm -84.27 -27.77 27.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.287 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -120.71 69.04 16.24 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-O 120.862 0.363 . . . . 0.0 111.223 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -64.12 -28.23 65.16 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.449 2.766 . . . . 0.0 112.306 171.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -31.46 8.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.752 -175.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -91.81 144.37 25.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.055 0.455 . . . . 0.0 111.407 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -91.94 89.47 7.02 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 171.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 87.2 tttt -94.23 97.58 10.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.007 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -99.31 120.6 39.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.054 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -112.0 114.51 27.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.218 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.84 163.52 33.16 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.511 ' OD2' ' HG3' ' A' ' 39' ' ' LYS . 12.0 p-10 -95.71 -37.32 10.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.949 0.375 . . . . 0.0 111.181 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.511 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 56.5 mttp -117.54 166.28 13.7 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.505 179.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.577 ' HB2' HD21 ' A' ' 125' ' ' LEU . 32.1 Cg_exo -59.8 141.03 96.03 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.746 2.297 . . . . 0.0 111.56 174.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -119.91 147.43 44.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.342 0.591 . . . . 0.0 112.365 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.745 ' HB ' HG12 ' A' ' 73' ' ' ILE . 4.2 mp -121.12 133.38 67.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.311 172.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 41.9 t -128.31 114.07 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.126 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.608 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 8.6 p-10 -100.41 115.87 31.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 122.222 1.01 . . . . 0.0 111.622 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.535 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 30.0 m-85 -81.1 112.88 18.87 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.431 -1.258 . . . . 0.0 108.936 173.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.71 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.8 p90 -129.91 168.17 17.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.503 0.668 . . . . 0.0 111.415 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.89 131.01 26.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.271 -1.332 . . . . 0.0 107.841 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.542 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 27.9 t70 -60.12 -34.34 73.37 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -171.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -71.57 -9.33 58.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.681 0.277 . . . . 0.0 111.62 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.455 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 48.0 t -95.64 123.55 39.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.92 0.39 . . . . 0.0 110.607 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.55 -59.01 10.27 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.755 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 77.4 Cg_exo -48.78 -36.71 34.04 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.047 2.498 . . . . 0.0 113.202 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.71 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 98.0 m -64.3 -44.89 90.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.99 0.424 . . . . 0.0 111.199 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.542 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 66.6 mttm -59.99 -29.71 68.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.905 175.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.56 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 75.0 mtp -71.59 -54.48 10.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.953 0.406 . . . . 0.0 111.16 177.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 96' ' ' ILE . 10.2 p -68.6 -36.95 76.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -170.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.634 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -52.06 -55.79 27.74 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 16.8 Cg_exo -68.35 -42.62 5.25 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 121.938 1.759 . . . . 0.0 112.14 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.442 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 73.1 mt -58.54 -41.04 80.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.08 0.467 . . . . 0.0 110.769 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.706 HD22 HD13 ' A' ' 73' ' ' ILE . 1.3 mt -67.03 -38.28 85.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.898 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.405 ' OD1' HG12 ' A' ' 11' ' ' VAL . 20.8 t70 -68.29 -37.06 80.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.184 0.516 . . . . 0.0 109.802 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 59' ' ' ILE . 14.5 tp10 -54.37 -46.05 72.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.692 174.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.582 HD21 ' HA ' ' A' ' 114' ' ' LYS . 4.3 mm? -72.02 -35.12 69.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.807 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.666 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -57.16 -52.0 67.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.404 ' HD3' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.27 -25.92 62.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.099 -178.15 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.491 ' CD ' ' HZ3' ' A' ' 114' ' ' LYS . 1.8 tt0 -71.73 -19.83 61.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.329 0.585 . . . . 0.0 110.15 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.438 ' HD1' ' O ' ' A' ' 63' ' ' LEU . 85.7 m-85 -117.23 25.84 10.18 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.682 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.543 ' CG ' ' HA3' ' A' ' 9' ' ' GLY . 11.3 t0 -58.65 121.57 11.32 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.234 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.64 -28.45 6.75 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.26 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.481 ' HG3' HG23 ' A' ' 71' ' ' ILE . 10.3 pt20 -114.73 -28.21 7.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -176.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.481 HG23 ' HG3' ' A' ' 70' ' ' GLN . 37.5 pt -122.99 158.12 27.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.859 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 94.4 t -130.06 128.04 64.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.423 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.745 HG12 ' HB ' ' A' ' 42' ' ' ILE . 29.3 mt -121.6 135.22 62.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.465 0.65 . . . . 0.0 111.371 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 63.8 m-85 -122.7 164.56 18.05 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 173.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.663 ' HB3' ' HZ3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -136.65 149.8 48.17 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 174.185 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.516 HG13 ' HG2' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -122.75 137.14 57.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.441 -171.807 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.531 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 10.5 m-20 -87.82 86.57 7.18 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.638 HG21 ' HA ' ' A' ' 92' ' ' SER . 15.3 m -56.06 -29.75 60.95 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -169.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -53.42 -31.03 43.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.647 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.531 ' HE3' ' HB2' ' A' ' 77' ' ' ASP . 22.2 pttp -109.82 -23.78 11.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.196 0.522 . . . . 0.0 110.492 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.759 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 1.3 mp0 -85.93 39.63 0.82 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.424 175.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -61.95 -47.92 82.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.696 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -62.22 -38.95 91.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.218 0.532 . . . . 0.0 110.192 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.1 tp -61.03 -44.54 97.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.42 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.583 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -63.96 -49.08 73.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.753 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.65 -30.99 66.4 Favored Glycine 0 CA--C 1.517 0.181 0 CA-C-N 116.081 -0.509 . . . . 0.0 113.206 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.75 -33.32 73.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.752 0.31 . . . . 0.0 111.707 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.572 ' HB2' HG13 ' A' ' 90' ' ' ILE . 89.5 m-85 -104.15 7.47 36.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.174 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.67 30.63 68.35 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.799 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 85' ' ' ALA . 55.6 mt -80.69 131.94 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.642 0.258 . . . . 0.0 110.524 -177.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.0 mtm105 -57.45 -64.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.666 0.746 . . . . 0.0 109.933 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.638 ' HA ' HG21 ' A' ' 78' ' ' THR . 13.0 p 177.17 -93.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.633 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.517 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -139.56 148.37 55.85 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.357 -175.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.712 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.1 Cg_exo -85.36 150.19 50.43 Favored 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 124.077 -1.218 . . . . 0.0 111.279 -3.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 11.6 m -141.36 140.19 33.69 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.558 HD11 HG21 ' A' ' 56' ' ' VAL . 60.1 mt -136.24 117.76 19.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 119.025 0.83 . . . . 0.0 111.201 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 105' ' ' PRO . 20.3 tp -98.26 114.35 26.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.209 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.595 ' HE2' ' HB3' ' A' ' 108' ' ' ALA . 96.6 m-85 -96.78 110.79 23.19 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.0 mt -103.3 105.97 49.13 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.819 0.343 . . . . 0.0 111.899 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 98' ' ' PHE . 2.9 Cg_exo -76.16 159.27 37.25 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.413 2.742 . . . . 0.0 111.5 172.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 89.8 mtp -83.02 -32.15 27.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.636 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.07 -30.91 7.83 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.91 0.862 . . . . 0.0 110.764 -177.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.69 -156.03 24.4 Favored Glycine 0 C--N 1.307 -1.031 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.99 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 35.2 mmtm -129.81 148.54 69.93 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 98' ' ' PHE . 38.3 Cg_endo -63.62 134.38 43.94 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.887 2.391 . . . . 0.0 113.854 -170.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.32 169.64 8.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.423 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 36.1 tpp -136.13 101.92 4.85 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.859 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.595 ' HB3' ' HE2' ' A' ' 98' ' ' PHE . . . -107.8 129.88 55.02 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 173.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.557 ' HB3' ' O ' ' A' ' 94' ' ' PRO . 58.4 mt-30 -117.51 128.52 55.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.149 0.499 . . . . 0.0 111.93 -171.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.712 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 133.12 -169.21 22.69 Favored Glycine 0 CA--C 1.506 -0.487 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.141 176.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.31 80.66 1.44 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.556 0.693 . . . . 0.0 110.858 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.702 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 5.0 mpp? -77.81 147.85 74.91 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.467 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.84 -177.69 3.8 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.052 2.502 . . . . 0.0 111.943 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.582 ' HA ' HD21 ' A' ' 63' ' ' LEU . 36.5 ttmt -60.13 -33.3 71.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 0.0 110.37 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.38 -52.9 59.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.558 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.702 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 20.3 m -70.31 -29.94 66.8 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.932 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.572 ' O ' HG13 ' A' ' 121' ' ' ILE . 5.4 m-85 -71.67 -37.29 70.77 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.426 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -57.75 -43.99 85.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.847 0.356 . . . . 0.0 110.119 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.528 ' HG2' ' OE2' ' A' ' 123' ' ' GLU . 31.0 mtpp -64.14 -38.48 91.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.679 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.561 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -67.5 -45.22 76.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.489 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 117' ' ' PHE . 20.9 mt -74.38 -57.25 6.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.306 0.574 . . . . 0.0 110.472 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.517 ' HA ' HD12 ' A' ' 126' ' ' LEU . 22.2 t70 -72.42 -65.04 0.83 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.285 -175.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.528 ' OE2' ' HG2' ' A' ' 119' ' ' LYS . 34.5 mt-10 -75.47 -9.21 58.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.423 -168.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.561 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 89.2 t80 -120.81 -52.49 2.11 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.938 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 40' ' ' PRO . 32.9 tp -72.75 -32.35 65.6 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.366 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 122' ' ' ASP . 64.5 mt -101.17 -59.69 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.112 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.892 -172.737 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.475 ' HA3' ' CG ' ' A' ' 68' ' ' ASP . . . . . . . . 0 CA--C 1.507 -0.468 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -131.09 173.05 11.4 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -174.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.655 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.5 p -133.29 134.33 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.183 0.516 . . . . 0.0 110.259 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 69.0 mt -129.57 133.65 64.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.176 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.741 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 6.5 p80 -93.8 116.34 28.8 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.371 0.605 . . . . 0.0 109.842 175.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.3 pp -116.09 179.8 3.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.759 -175.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.403 HG22 ' CE ' ' A' ' 80' ' ' LYS . 23.2 p -100.03 176.6 5.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 60.7 pttt -55.68 -30.74 61.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.521 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.24 78.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.769 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 4.0 mp0 -69.67 -31.66 69.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.33 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -64.61 -51.63 61.68 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.653 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.6 tt -51.76 -61.08 2.48 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 113.312 -1.767 . . . . 0.0 112.155 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.9 -25.69 61.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.781 -168.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 36.7 ttmt -98.45 -34.34 10.67 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.405 HG13 ' HD1' ' A' ' 35' ' ' TYR . 81.0 t -119.28 -47.7 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -167.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.709 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 20.0 t80 -151.54 116.47 5.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.297 0.57 . . . . 0.0 111.852 -165.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.566 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -88.2 90.69 8.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.262 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.709 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 24.3 p90 -84.27 12.09 7.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.154 0.502 . . . . 0.0 111.576 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -94.32 -45.7 7.37 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.505 ' C ' HD22 ' A' ' 29' ' ' ASN . 48.9 mttm -94.67 -25.9 16.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.584 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.612 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -122.26 68.85 29.23 Favored Pre-proline 0 N--CA 1.469 0.494 0 CA-C-O 120.791 0.329 . . . . 0.0 111.198 178.796 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -55.71 -42.18 70.09 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.163 2.576 . . . . 0.0 112.132 171.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -95.42 -33.25 12.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -173.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.408 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 36.7 mt-10 -91.49 128.45 37.32 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.204 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 53.3 t-105 -82.13 101.37 10.37 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 171.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 32' ' ' GLU . 30.6 mmtp -102.65 139.21 38.54 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.331 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.405 ' HD1' HG13 ' A' ' 23' ' ' VAL . 21.6 t80 -126.92 115.79 19.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.162 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 22' ' ' LYS . 35.0 mm-40 -97.5 123.73 41.47 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.443 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.85 179.48 46.37 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.201 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.483 ' OD2' ' HG3' ' A' ' 39' ' ' LYS . 1.7 p-10 -124.31 -38.51 2.42 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 117.011 0.405 . . . . 0.0 111.333 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.483 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 60.8 mttp -112.43 154.69 44.47 Favored Pre-proline 0 C--N 1.328 -0.348 0 O-C-N 122.474 -0.142 . . . . 0.0 110.86 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.458 ' HB2' HD21 ' A' ' 125' ' ' LEU . 6.2 Cg_endo -48.35 132.81 24.66 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.155 2.57 . . . . 0.0 111.851 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -116.85 149.57 39.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.388 0.613 . . . . 0.0 112.121 -170.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.424 ' HB ' HG12 ' A' ' 73' ' ' ILE . 76.5 mt -132.56 139.78 49.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.996 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.45 116.62 47.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.866 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.537 ' HB3' ' CB ' ' A' ' 75' ' ' LYS . 35.0 t70 -91.24 112.19 24.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.774 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 79.2 m-85 -93.51 110.64 22.22 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.74 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.2 p90 -137.87 162.6 33.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.559 0.695 . . . . 0.0 111.468 -171.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.19 133.4 50.29 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.692 170.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.24 -41.83 93.99 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.91 -172.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -68.25 -17.29 64.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.881 0.372 . . . . 0.0 111.624 -176.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 42.2 t -82.09 123.53 29.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.888 0.375 . . . . 0.0 110.168 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 55' ' ' MET . . . -55.83 -61.01 7.9 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.157 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -47.84 -45.7 23.64 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.842 2.361 . . . . 0.0 112.874 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.74 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 62.1 m -60.19 -45.63 92.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.527 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -76.02 -27.46 57.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.454 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 3.3 tmm? -67.31 -47.86 69.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.32 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.595 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 27.2 m -77.11 -24.95 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.601 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -50.74 -52.73 54.06 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 18.9 Cg_exo -66.81 -37.65 19.91 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.774 1.649 . . . . 0.0 112.339 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.3 mt -65.36 -47.5 86.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.358 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 117' ' ' PHE . 3.5 pp -68.33 -31.75 71.39 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.64 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.51 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 20.7 t70 -68.15 -37.81 81.44 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.153 174.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.95 -46.98 78.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.921 176.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.61 HD11 ' HG3' ' A' ' 114' ' ' LYS . 9.8 mp -65.25 -30.88 71.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.07 176.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.636 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -55.08 -53.78 51.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.635 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.51 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -78.2 -24.83 46.96 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.455 178.671 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -55.83 -33.97 64.95 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.677 0.751 . . . . 0.0 109.366 171.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.613 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 41.2 m-85 -111.34 26.5 10.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.042 176.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 3.1 t70 -55.36 132.6 48.51 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.336 -176.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.26 -21.06 36.29 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.962 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 10.8 pt20 -122.08 -36.0 3.06 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -176.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.551 HG23 ' HG3' ' A' ' 70' ' ' GLN . 45.4 pt -111.63 147.81 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.987 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 60.1 t -120.96 120.29 61.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.596 177.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 27.7 mt -115.57 134.98 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 121.612 0.72 . . . . 0.0 111.179 -177.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -121.45 173.27 7.49 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.824 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.741 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 3.5 ptmm? -151.97 156.34 39.82 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.574 HG23 HD12 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -133.62 148.23 30.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.097 -173.808 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 20.2 m-20 -89.82 85.87 6.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.573 HG21 ' HA ' ' A' ' 92' ' ' SER . 1.7 m -62.0 -27.28 68.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.193 -166.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -54.42 -31.04 54.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.487 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 22.6 pttm -104.76 -26.16 12.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.231 0.538 . . . . 0.0 109.694 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.52 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 1.3 mp0 -84.85 33.6 0.53 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.72 176.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -62.04 -31.61 72.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.819 0.343 . . . . 0.0 110.977 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -63.05 -41.05 99.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.358 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 84' ' ' LEU . 1.7 tm? -70.24 -45.61 66.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.41 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.56 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -61.57 -49.68 75.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.45 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.75 -30.26 72.19 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 116.154 -0.475 . . . . 0.0 113.116 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.57 -34.54 77.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.749 0.309 . . . . 0.0 111.677 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.518 ' HB2' HG13 ' A' ' 90' ' ' ILE . 77.7 m-85 -104.53 5.66 34.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.228 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.31 29.44 70.19 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.084 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 85' ' ' ALA . 22.0 mt -75.1 139.82 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.024 0.44 . . . . 0.0 110.072 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.415 ' HD3' HE22 ' A' ' 109' ' ' GLN . 72.6 mtp180 -74.34 4.05 6.43 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.674 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.573 ' HA ' HG21 ' A' ' 78' ' ' THR . 30.3 t 82.5 -88.0 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.424 -176.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.574 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 2.7 pp -135.29 136.45 24.46 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -169.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.665 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 4.0 Cg_exo -85.35 146.45 42.14 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 124.591 -1.004 . . . . 0.0 111.726 -4.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 37.5 t -142.0 140.85 32.79 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 171.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.6 mt -134.18 115.15 20.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.7 tp -97.64 112.99 24.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.552 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.75 111.48 23.75 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.776 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.563 HG12 ' HB3' ' A' ' 105' ' ' PRO . 44.7 mt -102.17 105.12 40.95 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.127 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.92 161.17 36.39 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.722 2.281 . . . . 0.0 111.636 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 94.1 mmm -83.7 -1.39 53.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 0.0 110.454 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -141.76 112.93 7.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.1 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.89 -153.7 16.8 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.057 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.45 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 28.8 mmmt -116.1 156.9 46.33 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.563 ' HB3' HG12 ' A' ' 99' ' ' ILE . 59.2 Cg_endo -72.12 151.08 54.98 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.678 2.252 . . . . 0.0 113.721 -175.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -106.62 157.98 17.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.199 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 45.1 ttm -122.63 116.39 23.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.152 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.01 137.91 48.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 173.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.516 ' HG2' ' HA ' ' A' ' 95' ' ' SER . 43.9 mt-30 -123.06 137.97 54.8 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.389 -174.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.665 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 106.77 178.28 22.96 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.407 -0.815 . . . . 0.0 114.457 170.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.595 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -83.01 89.14 6.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.119 0.485 . . . . 0.0 111.814 -174.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.656 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 22.2 ptp -95.64 149.01 35.5 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.974 173.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 97.4 Cg_endo -76.18 -178.36 4.35 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.825 2.35 . . . . 0.0 112.141 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.61 ' HG3' HD11 ' A' ' 63' ' ' LEU . 20.5 ttmm -57.68 -35.51 70.69 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 120.851 0.357 . . . . 0.0 110.133 174.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.65 -52.54 60.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.445 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.656 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 28.5 m -68.61 -35.63 77.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.624 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.503 ' HB3' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -61.89 -46.4 89.54 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.462 176.645 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -62.63 -33.14 74.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.306 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 51.4 tptt -61.47 -42.75 99.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 174.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.61 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.34 -47.94 53.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.711 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.598 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 1.8 mp -70.63 -56.92 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.871 0.367 . . . . 0.0 110.763 -177.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.403 ' HB2' ' OH ' ' A' ' 67' ' ' TYR . 5.1 t70 -73.5 -62.63 1.42 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.549 0.69 . . . . 0.0 110.396 -176.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 3.9 mm-40 -78.12 11.47 2.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.835 -1.075 . . . . 0.0 113.329 -169.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.61 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 71.8 t80 -143.56 -47.5 0.29 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.441 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.598 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 32.5 tp -76.55 -35.03 58.47 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.488 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.2 mt -89.22 -65.56 1.01 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.132 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 113.35 0.1 . . . . 0.0 113.35 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.6 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 2.9 tttm -162.0 175.33 11.92 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.279 0.562 . . . . 0.0 112.299 -175.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 9.9 p -106.7 130.58 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.128 176.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.6 mm -112.24 130.08 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.246 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.568 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 1.8 p80 -90.15 131.83 35.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.565 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.502 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 1.1 pp -131.25 176.1 8.56 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.369 -174.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.0 p -104.53 176.36 5.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.959 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 14.4 pttm -64.19 -30.66 71.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.672 0.273 . . . . 0.0 110.864 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.08 93.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.278 0.561 . . . . 0.0 110.081 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.502 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 2.5 mm-40 -71.92 -38.91 69.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.228 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.86 -49.37 75.69 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.706 175.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.724 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 13.9 mt -57.07 -60.62 3.32 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.253 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.54 -25.45 60.41 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -169.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 4.3 ttpm? -110.05 -16.46 13.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 46.9 t -128.65 -45.24 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -171.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.724 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 17.5 t80 -173.03 132.41 0.51 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 117.925 0.33 . . . . 0.0 111.845 -165.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.813 ' ND2' ' HB3' ' A' ' 28' ' ' LYS . 63.1 t30 -106.79 105.69 15.85 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.589 -177.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.451 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 5.3 p90 -90.5 1.46 56.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -171.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -89.57 -40.69 12.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.813 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . 4.8 tptp -91.29 -24.96 19.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.637 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 25' ' ' ASN . 2.4 m-20 -116.42 55.63 1.35 Allowed Pre-proline 0 N--CA 1.48 1.045 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -62.25 -43.71 22.29 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.246 1.964 . . . . 0.0 111.773 175.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -108.46 -9.26 15.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.18 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.412 ' HB2' ' CB ' ' A' ' 29' ' ' ASN . 67.3 mt-10 -91.59 177.7 6.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.821 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.447 ' HZ3' ' HE1' ' A' ' 88' ' ' PHE . 76.8 t-105 -151.95 88.49 1.4 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.943 0.401 . . . . 0.0 110.195 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.485 ' H ' HD21 ' A' ' 29' ' ' ASN . 59.6 tttm -105.83 98.87 8.5 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 26.2 t80 -91.47 118.8 30.88 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.308 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 22' ' ' LYS . 4.4 mm-40 -89.78 125.96 35.5 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.835 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.99 146.14 4.63 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.037 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -91.73 -27.29 18.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.965 0.412 . . . . 0.0 110.279 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -120.08 159.68 46.21 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.852 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.14 145.58 89.4 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.524 2.15 . . . . 0.0 111.937 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -120.05 150.25 40.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.442 0.639 . . . . 0.0 111.99 -175.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.624 ' HB ' HG23 ' A' ' 73' ' ' ILE . 77.1 mt -119.47 116.07 49.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.341 176.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.3 t -103.22 109.15 26.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.75 0.309 . . . . 0.0 111.204 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 8.4 t70 -90.62 113.92 26.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.042 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -87.68 111.21 21.05 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.729 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.3 p90 -132.56 169.47 16.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.818 0.818 . . . . 0.0 111.783 -174.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.63 126.7 24.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.183 167.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.558 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 31.2 t70 -60.02 -35.0 74.12 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.484 -172.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.434 ' HE1' ' HG2' ' A' ' 79' ' ' GLU . 67.0 p-90 -73.89 -0.65 16.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.785 0.326 . . . . 0.0 111.54 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.443 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 47.7 t -101.69 119.54 38.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.965 0.412 . . . . 0.0 110.316 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.65 -56.62 17.12 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.584 -0.734 . . . . 0.0 114.112 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.443 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . 83.7 Cg_exo -47.74 -37.85 28.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.048 2.498 . . . . 0.0 113.444 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.729 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 78.2 m -69.68 -47.01 64.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.939 0.399 . . . . 0.0 111.155 177.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.558 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 53.6 mttm -52.7 -30.15 30.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.466 177.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.533 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 24.7 ptm -88.12 -40.77 13.51 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.924 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.532 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 31.6 m -69.96 -36.85 70.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.576 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.603 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -53.42 -53.16 59.57 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 16.4 Cg_exo -69.05 -34.96 15.72 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.09 1.86 . . . . 0.0 112.428 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.517 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 68.1 mt -63.58 -48.7 85.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.97 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.601 HD13 HG21 ' A' ' 73' ' ' ILE . 4.2 pp -68.7 -30.69 69.4 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.66 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.6 ' OD1' ' HG2' ' A' ' 10' ' ' LYS . 18.7 t70 -64.76 -37.95 89.33 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.25 0.547 . . . . 0.0 109.815 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 7.2 mm-40 -54.63 -50.26 68.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.759 173.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.604 HD21 ' HG3' ' A' ' 114' ' ' LYS . 3.4 mm? -62.5 -31.81 72.62 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.926 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.646 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -63.29 -37.49 87.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.811 0.338 . . . . 0.0 110.456 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.611 ' HB3' ' HZ2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -74.02 -33.92 63.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.505 178.335 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -41.23 70.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.461 0.648 . . . . 0.0 111.116 176.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.656 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 30.1 m-85 -98.28 27.31 4.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.112 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.41 143.78 14.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.105 0.479 . . . . 0.0 111.432 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.39 -23.77 23.11 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.826 -0.624 . . . . 0.0 113.39 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.656 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 4.2 pt20 -117.28 -24.61 7.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 121' ' ' ILE . 43.6 pt -126.36 145.57 33.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.306 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 68.0 t -120.99 118.75 57.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.646 HD12 ' HB2' ' A' ' 64' ' ' ALA . 14.3 mt -106.89 138.66 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.106 -175.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -123.65 170.37 10.54 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.666 175.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.618 ' HB3' ' HB3' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -152.45 149.42 28.55 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 172.373 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.24 138.2 55.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.263 0.554 . . . . 0.0 110.863 -174.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 1.2 m-20 -70.7 89.13 0.73 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.095 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.497 HG23 ' HB2' ' A' ' 85' ' ' ALA . 23.9 m -62.52 -37.07 84.63 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -169.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HG2' ' HE1' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -70.6 -21.27 62.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -174.235 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.5 ' NZ ' ' HB3' ' A' ' 77' ' ' ASP . 8.9 ptpp? -106.39 -34.93 7.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.772 0.32 . . . . 0.0 110.224 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -82.75 47.35 1.18 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.989 0.515 . . . . 0.0 110.842 174.421 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -57.99 -38.69 76.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.02 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -69.11 -37.52 78.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.251 0.548 . . . . 0.0 110.166 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.53 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 3.4 tm? -67.1 -46.66 73.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.434 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -61.88 -48.18 81.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.135 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.5 -29.81 67.26 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.05 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.85 -27.4 69.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 0.0 111.399 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.58 ' HB2' HG12 ' A' ' 90' ' ' ILE . 68.1 m-85 -104.03 8.74 36.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.792 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.54 19.99 79.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.212 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.58 HG12 ' HB2' ' A' ' 88' ' ' PHE . 33.9 mm -74.77 108.12 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 120.623 0.249 . . . . 0.0 110.538 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -56.39 -56.37 21.98 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.787 0.803 . . . . 0.0 110.871 174.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.1 p -169.72 -137.63 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.167 -1.378 . . . . 0.0 108.985 -172.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.627 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -131.77 155.35 81.51 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.845 -0.161 . . . . 0.0 110.583 -172.7 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.611 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 2.9 Cg_exo -84.96 141.5 33.09 Favored 'Cis proline' 0 C--N 1.346 0.431 0 C-N-CA 124.827 -0.906 . . . . 0.0 112.726 -2.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 t -141.47 137.8 32.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 107' ' ' MET . 44.6 mt -131.53 120.11 44.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.691 -174.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.4 tp -100.05 112.03 24.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.373 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -94.31 109.38 21.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.636 HG12 ' HB3' ' A' ' 105' ' ' PRO . 49.6 mt -101.34 106.66 46.81 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.51 -174.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.43 164.89 25.94 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.836 2.357 . . . . 0.0 111.759 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.1 mtp -87.75 -6.31 58.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.421 0.629 . . . . 0.0 109.946 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -133.15 121.68 22.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.239 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.69 -140.84 15.1 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.198 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 31.9 mmtp -132.27 153.27 81.21 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.636 ' HB3' HG12 ' A' ' 99' ' ' ILE . 35.5 Cg_endo -64.45 143.95 83.81 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.913 2.408 . . . . 0.0 113.543 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -104.8 169.75 8.27 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.506 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 35.0 ttm -142.84 101.59 3.88 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -172.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -96.75 134.0 40.59 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 172.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -120.74 136.86 54.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.143 0.497 . . . . 0.0 112.252 -171.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.611 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 102.17 -168.79 19.23 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.455 -0.793 . . . . 0.0 115.005 168.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.532 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -85.55 88.93 7.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.866 -0.667 . . . . 0.0 112.07 -171.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.595 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 23.3 ptt? -107.28 150.35 39.86 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.259 172.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.478 ' HD2' ' OG ' ' A' ' 116' ' ' SER . 84.6 Cg_endo -76.39 -178.09 4.2 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.987 2.458 . . . . 0.0 112.94 -173.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.604 ' HG3' HD21 ' A' ' 63' ' ' LEU . 29.4 ttmt -57.73 -35.21 70.39 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.391 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.12 -48.8 74.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.629 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 30.0 m -66.02 -41.21 91.27 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.592 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.621 ' O ' HG13 ' A' ' 121' ' ' ILE . 11.9 m-85 -58.46 -49.17 78.28 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.692 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -54.59 -48.63 71.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.444 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -66.5 -34.42 77.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.707 0.289 . . . . 0.0 110.93 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -69.68 -44.19 70.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.083 0.468 . . . . 0.0 111.128 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.621 HG13 ' O ' ' A' ' 117' ' ' PHE . 31.2 mt -70.12 -51.72 36.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.267 0.556 . . . . 0.0 110.33 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -64.0 -69.51 0.27 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.019 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 38.4 mt-10 -80.79 12.31 3.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.399 -167.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.461 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 90.8 t80 -140.09 -49.92 0.47 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.398 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 20.2 tp -75.94 -31.58 59.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.682 0.277 . . . . 0.0 110.686 -175.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -106.0 -57.01 2.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.035 0.445 . . . . 0.0 110.3 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.57 ' HB3' ' HA ' ' A' ' 123' ' ' GLU . 2.3 tmmt? . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.574 ' HD3' ' H ' ' A' ' 11' ' ' VAL . 15.1 tppt? -150.96 157.47 42.93 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.095 -0.552 . . . . 0.0 109.533 -173.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 14.1 p -108.78 132.62 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.202 0.525 . . . . 0.0 110.758 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.8 mt -122.88 127.43 74.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.951 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.582 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 1.9 p80 -86.26 143.39 27.95 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.4 pp -137.86 168.84 18.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.966 0.412 . . . . 0.0 111.974 -177.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.615 HG22 ' HZ3' ' A' ' 80' ' ' LYS . 40.3 p -92.48 175.33 6.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.43 174.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.52 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 8.6 ptpp? -64.42 -31.83 73.2 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.663 0.268 . . . . 0.0 111.39 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.37 -39.5 92.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.399 0.618 . . . . 0.0 109.845 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 38.3 mt-10 -72.33 -36.02 68.75 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.155 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.451 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 2.5 t80 -54.06 -53.01 59.0 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.241 1.02 . . . . 0.0 108.995 175.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 17.0 mt -59.02 -60.2 4.25 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.274 -1.784 . . . . 0.0 112.213 -175.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.72 -20.53 27.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -169.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.624 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 35.0 ttpt -109.45 -7.49 15.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.64 0.257 . . . . 0.0 111.415 -174.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 68.8 t -134.79 -49.27 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.771 ' HE2' ' HZ ' ' A' ' 88' ' ' PHE . 1.1 t80 -177.88 125.62 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.298 0.571 . . . . 0.0 110.809 -168.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 13.3 t-20 -92.94 87.31 5.74 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.793 -172.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.543 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 18.6 p90 -75.92 12.14 1.2 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -88.34 -53.43 4.69 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.647 ' C ' HD22 ' A' ' 29' ' ' ASN . 0.0 OUTLIER -92.4 -12.26 32.69 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.353 171.779 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.647 HD22 ' C ' ' A' ' 28' ' ' LYS . 0.9 OUTLIER -111.68 53.45 0.39 Allowed Pre-proline 0 N--CA 1.478 0.935 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -178.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.439 ' HD2' ' OE1' ' A' ' 31' ' ' GLU . 37.6 Cg_endo -74.68 -35.6 3.38 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 121.947 1.765 . . . . 0.0 111.103 166.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.554 ' OE1' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -100.21 -34.75 9.89 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.586 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.554 ' HG2' ' OE1' ' A' ' 31' ' ' GLU . 7.6 pt-20 -97.92 177.4 5.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.002 -177.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.589 ' CB ' ' HE2' ' A' ' 104' ' ' LYS . 76.3 t-105 -148.05 88.92 1.69 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.227 0.537 . . . . 0.0 110.628 -174.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HG2' ' OE2' ' A' ' 36' ' ' GLU . 61.9 tttm -102.92 104.49 14.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.282 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.559 ' OH ' ' HB2' ' A' ' 41' ' ' ALA . 18.9 t80 -96.79 124.3 40.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.018 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.424 ' OE2' ' HG2' ' A' ' 34' ' ' LYS . 7.1 mm-40 -88.61 93.41 9.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.534 177.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.15 129.56 1.39 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.182 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.8 -27.8 58.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.387 0.613 . . . . 0.0 110.399 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HB2' HG23 ' A' ' 72' ' ' VAL . 66.7 mttm -116.63 155.46 48.8 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.339 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.538 ' HG3' ' HG2' ' A' ' 101' ' ' MET . 36.4 Cg_exo -57.73 150.34 62.72 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.777 2.318 . . . . 0.0 111.79 177.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.559 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -120.49 147.55 44.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.423 0.63 . . . . 0.0 112.111 -173.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.57 ' HB ' HG12 ' A' ' 73' ' ' ILE . 74.7 mt -124.03 112.45 32.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 171.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 46.0 t -109.81 110.78 33.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 121.273 -0.171 . . . . 0.0 111.286 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.589 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 8.2 p-10 -101.06 116.66 33.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.217 1.008 . . . . 0.0 111.821 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.432 ' HB3' ' OG1' ' A' ' 78' ' ' THR . 13.2 m-85 -77.85 112.72 15.02 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.058 170.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.678 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.2 p90 -128.59 162.12 28.03 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.615 0.721 . . . . 0.0 111.844 -176.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.96 137.27 37.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.647 170.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.55 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 25.2 t70 -60.75 -42.06 96.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -171.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -67.66 -13.31 61.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.665 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 49.3 t -85.48 115.1 22.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.87 0.367 . . . . 0.0 110.355 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.92 -57.01 10.4 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.575 -0.738 . . . . 0.0 113.507 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.74 -40.97 31.64 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.068 2.512 . . . . 0.0 113.378 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.678 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 84.9 m -63.51 -45.31 91.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.93 0.395 . . . . 0.0 111.087 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.55 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 65.9 mttm -58.41 -29.6 66.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.073 174.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.506 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 74.3 mtp -74.42 -52.45 12.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.073 0.463 . . . . 0.0 111.234 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 53' ' ' CYS . 14.2 p -70.98 -37.97 70.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.581 -170.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.595 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -52.71 -53.38 54.87 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -176.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 29.9 Cg_exo -62.83 -49.04 5.76 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.94 1.76 . . . . 0.0 112.113 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.5 mt -56.48 -40.46 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.155 0.502 . . . . 0.0 110.897 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.488 HD22 HD13 ' A' ' 73' ' ' ILE . 6.9 mt -68.16 -36.17 79.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.348 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD1' ' HD3' ' A' ' 10' ' ' LYS . 28.3 t70 -68.57 -41.12 80.17 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.29 -54.73 39.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.903 173.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.7 tp -61.78 -31.74 71.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.698 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.623 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -59.53 -46.85 87.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.439 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.624 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 3.6 tmtm? -75.71 -40.29 55.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.422 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -55.67 -31.35 62.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.395 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -111.27 25.15 12.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.615 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.426 ' HB2' ' HA ' ' A' ' 65' ' ' LYS . 24.1 t0 -54.13 148.39 11.19 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.736 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.63 -22.11 18.78 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.529 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -95.92 -56.39 2.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.924 0.362 . . . . 0.0 111.206 -175.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -122.69 174.41 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.67 -170.266 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 43.2 t -131.47 129.09 61.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 174.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 17.0 mt -106.19 135.09 45.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.295 0.569 . . . . 0.0 110.875 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 84.3 m-85 -122.04 163.9 18.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.125 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.589 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -147.33 153.47 39.73 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.045 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.666 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 9.4 p -133.94 144.29 36.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.607 -174.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.415 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 6.0 m-20 -86.6 88.66 7.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 45' ' ' PHE . 7.1 m -60.53 -32.65 71.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -169.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -54.42 -30.85 53.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.615 ' HZ3' HG22 ' A' ' 15' ' ' THR . 22.3 pttp -107.75 -17.56 14.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.594 0.711 . . . . 0.0 110.187 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.666 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 0.3 OUTLIER -94.56 38.73 1.1 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.12 175.056 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -66.14 -36.29 82.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.323 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.417 ' HB2' ' HE2' ' A' ' 16' ' ' LYS . 2.5 mp0 -64.32 -34.64 78.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.433 0.635 . . . . 0.0 109.627 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.474 HD13 ' CE2' ' A' ' 26' ' ' PHE . 15.5 tp -70.2 -45.6 66.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.116 177.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.561 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -57.1 -49.47 75.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.879 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.28 -30.05 66.99 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.325 -0.464 . . . . 0.0 113.085 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.81 -32.81 74.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.328 . . . . 0.0 111.37 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.771 ' HZ ' ' HE2' ' A' ' 24' ' ' TYR . 96.6 m-85 -101.4 8.33 42.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.841 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.25 31.62 77.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.892 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.663 ' HA ' ' NH1' ' A' ' 91' ' ' ARG . 42.7 mt -82.26 136.93 21.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.906 0.384 . . . . 0.0 110.394 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.663 ' NH1' ' HA ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -66.52 -50.27 63.74 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.536 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t 170.26 -89.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.231 -1.349 . . . . 0.0 107.949 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.527 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -141.35 155.05 67.8 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.757 -178.316 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.753 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.5 Cg_exo -86.71 143.39 28.22 Favored 'Cis proline' 0 C--N 1.343 0.253 0 C-N-CA 124.585 -1.006 . . . . 0.0 111.983 -3.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 59.0 m -141.4 132.02 25.55 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 107' ' ' MET . 64.0 mt -128.49 118.73 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.109 0.481 . . . . 0.0 111.073 -172.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 106' ' ' GLU . 23.9 tp -98.98 114.75 27.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.227 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -94.23 103.11 15.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 61.5 mt -96.42 111.38 56.66 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.431 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 98.3 Cg_endo -84.39 169.64 10.98 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.808 2.339 . . . . 0.0 111.612 174.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.538 ' HG2' ' HG3' ' A' ' 40' ' ' PRO . 95.1 mmm -89.99 -2.29 58.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 0.0 110.534 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -151.81 115.89 4.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.393 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 116.19 -144.71 18.53 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.77 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.589 ' HE2' ' CB ' ' A' ' 33' ' ' TRP . 28.0 mmtp -126.32 151.61 72.63 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.452 ' HG3' ' CH2' ' A' ' 33' ' ' TRP . 85.8 Cg_endo -73.79 148.65 41.57 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.815 2.344 . . . . 0.0 113.322 -175.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.486 ' HG2' ' N ' ' A' ' 107' ' ' MET . 37.4 tt0 -95.23 166.94 11.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.876 178.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.486 ' N ' ' HG2' ' A' ' 106' ' ' GLU . 32.3 tpp -142.68 107.56 4.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.087 0.47 . . . . 0.0 111.491 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.95 157.26 17.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.239 174.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -126.34 135.44 51.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.942 0.401 . . . . 0.0 111.129 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.753 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 107.15 -171.72 17.08 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.679 -0.691 . . . . 0.0 113.381 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.65 81.02 1.4 Allowed 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.542 0.687 . . . . 0.0 110.997 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.701 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 4.5 mpp? -65.49 148.97 97.75 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.329 172.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.401 ' HG2' ' H ' ' A' ' 116' ' ' SER . 73.4 Cg_endo -74.32 172.65 15.64 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.125 1.883 . . . . 0.0 110.772 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -60.03 -24.53 64.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.109 0.48 . . . . 0.0 109.851 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.51 -53.29 44.44 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.238 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.701 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 18.5 m -71.94 -28.73 63.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.486 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -67.56 -40.2 84.92 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.985 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 122' ' ' ASP . 0.8 OUTLIER -58.25 -37.86 75.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.458 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -67.58 -51.89 45.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.48 -46.56 89.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.152 0.501 . . . . 0.0 111.284 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.44 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 1.7 mp -67.55 -43.89 86.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.14 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.506 ' HA ' HD12 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -72.44 -55.1 7.57 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.666 -177.021 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.671 ' HA ' ' HE2' ' A' ' 127' ' ' LYS . 31.9 tt0 -77.25 -8.33 57.41 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -169.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -127.65 -51.74 1.36 Allowed 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.82 -0.55 . . . . 0.0 111.656 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.44 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 32.5 tp -77.71 -29.76 51.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -173.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 122' ' ' ASP . 92.7 mt -96.92 -54.06 3.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.325 0.583 . . . . 0.0 110.009 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.671 ' HE2' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.726 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.071 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 CA--C 1.507 -0.457 0 N-CA-C 112.387 -0.285 . . . . 0.0 112.387 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 163.81 35.15 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -175.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' A' ' 61' ' ' ASP . 26.1 m -89.76 119.15 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.405 0.621 . . . . 0.0 110.874 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.5 mm -111.49 105.34 18.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.925 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.553 ' HA ' ' HB2' ' A' ' 75' ' ' LYS . 19.2 p80 -79.77 129.74 34.74 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.6 pp -143.75 168.57 19.61 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.495 -174.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.0 p -86.79 168.02 13.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.747 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -55.65 -34.23 64.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.656 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.71 -36.45 75.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.322 0.582 . . . . 0.0 110.242 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.665 ' HB3' ' HE2' ' A' ' 22' ' ' LYS . 42.6 mt-10 -72.08 -33.32 67.82 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.52 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -61.81 -49.37 76.58 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.993 0.901 . . . . 0.0 108.872 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.8 tt -46.62 -60.26 2.49 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 113.479 -1.691 . . . . 0.0 111.829 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.33 -24.99 31.88 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -170.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.665 ' HE2' ' HB3' ' A' ' 18' ' ' GLU . 47.5 mtmt -109.31 0.86 19.75 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.388 -0.525 . . . . 0.0 112.146 -173.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -142.68 -49.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 83.6 t80 -164.08 116.68 1.39 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.558 -165.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.423 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -80.67 90.75 5.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.814 -178.783 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -83.89 9.69 11.53 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 122.148 -0.345 . . . . 0.0 111.825 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -84.95 -54.34 4.71 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.974 0.892 . . . . 0.0 108.683 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.464 ' C ' HD22 ' A' ' 29' ' ' ASN . 7.6 ptpp? -97.54 -12.0 23.07 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.506 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' A' ' 34' ' ' LYS . 1.1 m-80 -123.08 67.46 33.49 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-O 121.184 0.516 . . . . 0.0 110.998 170.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -59.67 -43.18 40.46 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.096 2.531 . . . . 0.0 111.974 171.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -112.82 -25.51 9.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.797 -174.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.567 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -90.72 154.64 19.4 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.135 0.493 . . . . 0.0 110.903 -176.129 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.459 ' HZ3' ' HE1' ' A' ' 88' ' ' PHE . 76.4 t-105 -97.22 111.57 23.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.643 -177.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.627 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -133.32 115.41 14.87 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.387 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.63 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 26.9 t80 -103.58 107.23 17.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.87 -176.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.512 ' OE2' ' HG3' ' A' ' 34' ' ' LYS . 1.1 mp0 -95.71 76.61 3.24 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.925 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.63 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -133.76 -136.22 3.67 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.401 -173.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -149.57 -58.79 0.2 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.882 0.372 . . . . 0.0 110.998 -173.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.43 ' HB2' HG23 ' A' ' 72' ' ' VAL . 48.8 mttp -125.5 159.04 62.33 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.966 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.567 ' HB2' HG22 ' A' ' 71' ' ' ILE . 83.8 Cg_exo -42.43 131.36 5.08 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.602 2.201 . . . . 0.0 111.65 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -116.52 150.18 38.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.265 0.555 . . . . 0.0 112.24 -167.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.796 ' HB ' HG12 ' A' ' 73' ' ' ILE . 67.8 mt -127.9 116.88 44.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.882 173.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.639 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 38.5 t -98.84 116.31 41.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 120.825 0.345 . . . . 0.0 110.68 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.521 ' HB2' HD13 ' A' ' 60' ' ' LEU . 7.1 t70 -91.09 110.58 21.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.554 177.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.506 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 97.8 m-85 -94.39 111.65 23.41 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 174.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.656 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.1 p90 -133.58 174.9 9.93 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.547 0.689 . . . . 0.0 111.11 -175.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.97 142.61 22.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.298 173.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.476 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 32.4 t70 -62.03 -28.89 69.91 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -83.38 -1.07 52.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.686 0.279 . . . . 0.0 111.553 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 41.1 t -99.68 113.08 25.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.097 0.475 . . . . 0.0 110.805 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 54' ' ' LYS . . . -58.16 -51.36 58.88 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.472 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 97.6 Cg_exo -47.28 -47.74 16.63 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.896 2.397 . . . . 0.0 113.113 175.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 71.0 m -63.78 -36.66 84.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.908 0.385 . . . . 0.0 111.482 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.476 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 67.5 mttm -56.46 -34.78 67.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.831 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.513 ' SD ' ' HB1' ' A' ' 111' ' ' ALA . 26.9 ptm -91.84 -26.95 18.26 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.793 -175.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.633 HG22 ' HA ' ' A' ' 53' ' ' CYS . 25.1 m -76.71 -31.04 19.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.702 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.433 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -47.69 -58.25 8.06 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 33.7 Cg_endo -65.17 -39.64 22.73 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.75 1.634 . . . . 0.0 112.269 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.2 mt -63.59 -43.62 98.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.226 0.536 . . . . 0.0 110.304 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 44' ' ' ASP . 7.8 mt -57.8 -43.81 85.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.129 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.478 ' HA ' HG13 ' A' ' 11' ' ' VAL . 30.7 t70 -68.12 -37.43 81.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.827 0.346 . . . . 0.0 110.557 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.431 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 3.7 tp10 -59.69 -41.88 91.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.472 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.515 HD21 ' HG3' ' A' ' 114' ' ' LYS . 4.1 mm? -71.24 -31.72 67.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.725 176.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.544 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -56.45 -57.11 13.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.769 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -74.83 -24.61 58.63 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.74 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.08 -33.42 75.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.499 0.666 . . . . 0.0 110.167 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -104.2 25.61 9.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.936 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.546 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 6.4 t0 -59.31 133.91 56.53 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 110.138 -176.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.36 -22.04 34.73 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.769 -176.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -94.97 -53.17 3.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.906 0.384 . . . . 0.0 110.268 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.567 HG22 ' HB2' ' A' ' 40' ' ' PRO . 38.2 pt -127.15 163.5 29.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.216 -176.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 50.9 t -131.01 131.91 63.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.796 HG12 ' HB ' ' A' ' 42' ' ' ILE . 60.3 mt -111.83 133.48 57.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.101 0.477 . . . . 0.0 110.844 -176.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -115.21 160.63 19.49 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 13' ' ' HIS . 44.6 mttm -129.13 136.02 49.64 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.748 0.308 . . . . 0.0 110.902 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.407 HG13 ' HG2' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -138.21 136.89 44.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.665 -178.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 4.4 m-20 -97.32 106.19 18.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.2 p -57.2 -26.97 61.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -67.55 -21.39 65.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.403 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.432 ' HG2' ' HB2' ' A' ' 77' ' ' ASP . 8.5 ptmm? -114.08 -33.67 5.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.448 0.642 . . . . 0.0 109.974 175.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 2.0 mp0 -83.62 36.66 0.55 Allowed 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.979 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -57.27 -47.55 81.14 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.825 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -61.88 -36.76 82.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.377 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.7 tp -70.16 -50.38 40.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.902 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.482 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -63.22 -37.47 87.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.05 -31.36 78.45 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.846 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.02 -33.58 76.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 111.024 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.552 ' HB2' HG12 ' A' ' 90' ' ' ILE . 85.7 m-85 -90.32 -1.24 57.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.18 21.55 75.55 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.01 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.552 HG12 ' HB2' ' A' ' 88' ' ' PHE . 37.3 mm -81.03 126.56 39.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 122.444 0.298 . . . . 0.0 110.67 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -61.99 -64.46 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.047 0.451 . . . . 0.0 110.169 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.9 p -164.6 -101.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.535 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.496 ' HB ' ' HA ' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -142.3 157.75 62.42 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 120.508 0.194 . . . . 0.0 111.383 -173.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.828 ' HB2' ' H ' ' A' ' 110' ' ' GLY . 15.0 Cg_exo -79.66 144.35 70.65 Favored 'Cis proline' 0 N--CA 1.476 0.454 0 C-N-CA 124.241 -1.15 . . . . 0.0 112.162 -3.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 14.8 m -140.91 137.41 33.14 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.662 ' O ' ' HA ' ' A' ' 107' ' ' MET . 66.6 mt -133.13 114.47 21.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.639 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.8 tp -96.45 115.13 26.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 -175.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.432 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 97.3 m-85 -95.23 107.03 19.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.04 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.4 ' HB ' ' HB3' ' A' ' 41' ' ' ALA . 67.5 mt -99.18 105.01 29.76 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -177.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 98' ' ' PHE . 79.4 Cg_endo -88.19 166.03 6.85 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.83 2.353 . . . . 0.0 111.988 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 20.0 mmt -89.86 -6.24 56.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.96 0.41 . . . . 0.0 110.381 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.92 104.96 5.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.876 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.26 -151.38 18.32 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.251 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.437 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 12.1 mmmm -121.1 154.4 58.24 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 104' ' ' LYS . 56.8 Cg_endo -68.85 151.15 74.1 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.976 2.451 . . . . 0.0 114.576 -171.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -104.83 169.45 8.44 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.175 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.662 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 21.3 ptp -143.84 129.62 19.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.688 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.41 140.21 50.21 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -119.93 138.27 53.55 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.495 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.828 ' H ' ' HB2' ' A' ' 94' ' ' PRO . . . 105.04 -178.4 23.64 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.715 -0.675 . . . . 0.0 114.682 170.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.513 ' HB1' ' SD ' ' A' ' 55' ' ' MET . . . -90.75 86.34 6.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.036 -0.582 . . . . 0.0 111.53 -173.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.579 ' HB2' ' HB3' ' A' ' 116' ' ' SER . 23.5 ptp -92.47 151.6 41.43 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.784 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.781 ' HD2' ' HB3' ' A' ' 116' ' ' SER . 85.5 Cg_endo -75.73 177.16 9.06 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.58 2.187 . . . . 0.0 112.129 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.515 ' HG3' HD21 ' A' ' 63' ' ' LEU . 62.9 tttm -57.82 -35.57 71.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.494 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.45 -47.71 59.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.818 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.781 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 47.8 t -66.85 -30.47 70.65 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.336 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.489 ' O ' HG13 ' A' ' 121' ' ' ILE . 3.4 m-85 -58.58 -53.21 60.88 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 173.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -56.82 -42.79 80.22 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.622 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -53.83 -48.35 70.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.022 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.12 -42.75 68.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.408 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 117' ' ' PHE . 68.0 mt -66.72 -55.33 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.088 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.61 -65.34 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.562 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -48.48 -42.18 32.01 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -172.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -104.52 -47.22 4.15 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -171.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 23.9 tp -77.69 -38.73 46.82 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -169.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.6 mp -105.85 -42.8 5.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.097 0.475 . . . . 0.0 111.094 -176.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 37.7 tttm . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.858 -176.233 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . . . . . . 0 CA--C 1.509 -0.33 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.444 ' HE2' HD11 ' A' ' 12' ' ' ILE . 11.8 ptmt -156.05 155.75 33.19 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 121.126 0.489 . . . . 0.0 110.604 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 6.4 p -112.13 116.46 52.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.904 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.444 HD11 ' HE2' ' A' ' 10' ' ' LYS . 45.3 mm -102.96 115.49 45.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.117 -175.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.656 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 0.6 OUTLIER -85.19 125.43 32.84 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.248 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.7 pp -136.31 168.47 19.36 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.364 -173.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.0 p -102.87 177.12 4.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.114 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.412 ' HB2' ' HZ ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -58.62 -28.31 65.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.82 -43.28 99.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.181 0.515 . . . . 0.0 110.568 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 3.4 mm-40 -71.9 -36.14 69.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.031 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.45 -54.06 50.12 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.587 177.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.653 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 12.5 mt -51.0 -61.02 2.48 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.001 -1.454 . . . . 0.0 112.164 -176.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.18 -31.49 60.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -167.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -108.85 -20.29 13.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 95.9 t -119.43 -45.77 2.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -171.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.653 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 21.6 t80 -169.86 116.62 0.56 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.167 0.508 . . . . 0.0 111.344 -166.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.446 HD22 HD22 ' A' ' 20' ' ' LEU . 2.5 t-20 -89.54 90.32 8.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.708 -178.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.465 ' CE2' HD13 ' A' ' 84' ' ' LEU . 31.9 p90 -82.53 -2.25 52.98 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.41 ' HG3' ' CD2' ' A' ' 20' ' ' LEU . 15.2 mt-10 -70.64 -53.24 16.61 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.93 0.871 . . . . 0.0 108.698 174.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -100.13 -14.88 18.37 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.817 -172.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.419 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 12.7 m-80 -126.75 59.39 33.83 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 29' ' ' ASN . 10.5 Cg_endo -60.12 -30.14 90.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.396 2.731 . . . . 0.0 111.551 167.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -97.66 -41.22 8.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.776 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -94.91 149.6 21.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.204 -173.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.769 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 60.9 t-105 -108.29 109.56 20.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.044 176.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.92 103.17 6.17 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.299 176.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 50.5 t80 -86.22 131.67 34.18 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.207 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.429 ' HA ' ' OE1' ' A' ' 36' ' ' GLU . 14.6 mm-40 -112.1 -167.18 1.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.93 -119.61 3.36 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.787 -1.197 . . . . 0.0 112.991 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -158.92 -50.78 0.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.291 0.567 . . . . 0.0 109.815 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.588 ' HB2' HG23 ' A' ' 72' ' ' VAL . 48.7 mttp -121.76 168.78 10.55 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.864 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.61 ' HB3' HD11 ' A' ' 125' ' ' LEU . 33.1 Cg_exo -60.86 158.99 30.89 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.602 2.201 . . . . 0.0 111.534 173.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -127.61 142.31 51.39 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -169.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.558 ' HB ' HG12 ' A' ' 73' ' ' ILE . 44.0 mm -117.13 110.21 30.44 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.228 168.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 67.8 t -110.7 113.12 43.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 118.032 0.378 . . . . 0.0 111.523 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.666 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 5.8 p-10 -100.38 119.47 38.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.287 1.041 . . . . 0.0 111.477 176.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -77.02 113.87 15.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.297 -1.32 . . . . 0.0 108.84 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.678 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.4 p90 -130.98 168.28 17.62 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.29 0.567 . . . . 0.0 111.169 -176.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.09 135.89 19.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.439 174.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.418 ' O ' ' HE3' ' A' ' 54' ' ' LYS . 27.0 t70 -66.99 -33.13 74.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.761 0.315 . . . . 0.0 111.718 -173.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -71.89 -6.63 43.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.906 0.384 . . . . 0.0 111.236 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.423 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 37.4 t -113.34 113.64 25.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.101 0.477 . . . . 0.0 110.124 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.68 -53.11 41.15 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 119.263 -0.743 . . . . 0.0 113.975 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.423 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 84.3 Cg_exo -47.52 -31.41 13.7 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.099 2.533 . . . . 0.0 114.126 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.678 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 45.3 m -73.94 -45.11 52.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.855 0.36 . . . . 0.0 111.127 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 48' ' ' ASP . 15.1 ptpt -77.15 -27.4 53.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.129 0.49 . . . . 0.0 109.808 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.0 tmm? -51.47 -39.96 58.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.166 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.7 m -88.06 -15.99 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.881 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.7 -52.36 57.19 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.32 -33.68 37.88 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 121.766 1.644 . . . . 0.0 112.216 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 113' ' ' PRO . 92.5 mt -65.44 -44.49 94.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.524 0.678 . . . . 0.0 109.899 175.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.1 mt -67.98 -31.22 70.78 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.123 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -60.82 -48.27 82.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.171 0.51 . . . . 0.0 109.932 170.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -54.81 -46.52 74.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.154 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.821 HD23 HD12 ' A' ' 121' ' ' ILE . 7.7 mp -67.15 -31.25 71.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.363 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.454 ' O ' ' HA2' ' A' ' 9' ' ' GLY . . . -59.38 -42.09 90.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.765 0.317 . . . . 0.0 110.582 177.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -72.39 -49.67 32.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.313 0.577 . . . . 0.0 109.938 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -53.12 -35.79 60.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.705 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.579 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 45.0 m-85 -107.2 26.51 10.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.555 -178.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.36 153.92 42.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.268 0.556 . . . . 0.0 111.217 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.51 -18.58 28.54 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.508 -0.769 . . . . 0.0 113.496 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 4.2 pt20 -121.65 -53.42 1.99 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -171.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 67' ' ' TYR . 40.8 pt -128.35 156.39 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 118.313 0.506 . . . . 0.0 112.199 -174.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.588 HG23 ' HB2' ' A' ' 39' ' ' LYS . 6.8 t -111.91 144.71 19.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.851 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 68.5 mt -112.59 128.99 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.139 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 36.3 m-85 -117.15 159.72 22.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.666 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -140.88 144.73 35.42 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.188 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.557 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 7.4 p -122.03 136.16 59.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.274 0.559 . . . . 0.0 111.057 -173.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.587 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 1.1 m-20 -73.56 87.08 1.61 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.962 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.528 HG23 ' HB2' ' A' ' 85' ' ' ALA . 4.4 m -65.5 -31.64 72.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -167.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.41 ' HG3' ' H ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -69.92 -18.19 63.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.228 -0.295 . . . . 0.0 111.662 -178.546 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.567 ' NZ ' ' HB3' ' A' ' 77' ' ' ASP . 8.7 ptpp? -110.32 -26.81 9.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.519 0.675 . . . . 0.0 110.033 175.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -89.47 42.73 1.1 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.669 172.318 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -64.48 -41.47 96.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.205 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -31.15 67.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.473 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.482 HD23 HG21 ' A' ' 76' ' ' VAL . 27.4 tp -66.79 -46.39 75.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.067 174.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.55 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -63.64 -43.01 98.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.967 177.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.69 -29.15 69.28 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.701 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.82 -32.21 73.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.903 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -89.28 -16.42 31.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.781 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.89 20.44 28.52 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.097 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.55 ' HB ' ' HB1' ' A' ' 85' ' ' ALA . 35.6 mm -80.51 135.89 24.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -69.22 -62.82 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.157 0.503 . . . . 0.0 110.215 177.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.506 ' O ' HG21 ' A' ' 78' ' ' THR . 36.2 m -156.25 -88.44 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.615 176.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.656 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 1.8 pp -160.19 154.9 20.64 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.608 -172.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -97.11 144.88 5.7 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 124.548 -1.022 . . . . 0.0 112.215 -2.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.714 ' HB3' ' SD ' ' A' ' 107' ' ' MET . 61.3 m -141.07 143.26 34.25 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.411 HD12 ' C ' ' A' ' 95' ' ' SER . 3.7 mp -127.96 121.78 57.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.332 0.587 . . . . 0.0 110.734 -175.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.1 tp -98.02 112.5 24.42 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.764 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.594 ' HE2' ' HB3' ' A' ' 108' ' ' ALA . 93.1 m-85 -90.14 104.03 16.65 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.567 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 64.9 mt -101.73 113.51 65.82 Favored Pre-proline 0 C--O 1.235 0.312 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -169.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -87.47 174.64 4.95 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.124 2.549 . . . . 0.0 111.725 171.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.9 mmt -97.7 -24.73 15.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.251 0.548 . . . . 0.0 110.362 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.78 21.98 16.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.376 -171.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 178.62 -176.29 47.9 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.172 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.769 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 14.3 mptt -77.19 149.98 79.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.584 0.231 . . . . 0.0 110.689 177.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.567 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 91.1 Cg_endo -82.54 155.23 16.08 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.925 2.417 . . . . 0.0 113.068 -176.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -104.09 168.27 9.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.466 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.714 ' SD ' ' HB3' ' A' ' 95' ' ' SER . 27.2 tpp -132.59 124.15 27.82 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.608 -174.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.594 ' HB3' ' HE2' ' A' ' 98' ' ' PHE . . . -130.89 129.32 42.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.438 174.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 95' ' ' SER . 86.0 mt-30 -74.01 151.49 40.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.806 0.336 . . . . 0.0 110.977 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.79 -153.61 3.58 Favored Glycine 0 C--O 1.227 -0.336 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 -168.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 69.62 19.64 7.29 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.496 0.718 . . . . 0.0 111.025 -174.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.642 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 76.0 mtm -89.98 147.35 37.06 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.376 177.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.431 ' HA ' HD13 ' A' ' 59' ' ' ILE . 72.2 Cg_endo -75.74 -174.85 2.18 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.411 2.074 . . . . 0.0 110.782 175.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.534 ' HG3' HD11 ' A' ' 63' ' ' LEU . 19.5 ttmt -56.83 -41.98 78.81 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.57 173.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.12 -51.96 67.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.642 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 19.8 m -69.51 -36.91 76.91 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.986 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.572 ' O ' HG13 ' A' ' 121' ' ' ILE . 3.5 m-85 -65.47 -52.24 54.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.935 0.398 . . . . 0.0 110.414 175.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 114' ' ' LYS . 2.8 tmtm? -55.71 -44.1 77.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.103 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.501 ' HG3' ' OE2' ' A' ' 123' ' ' GLU . 28.1 tptp -56.57 -57.12 13.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.326 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.15 90.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.145 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.821 HD12 HD23 ' A' ' 63' ' ' LEU . 23.8 mt -67.71 -50.75 57.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 0.0 110.715 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.66 -56.35 14.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.834 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.696 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . 9.1 pt-20 -76.04 6.96 4.53 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.731 0.644 . . . . 0.0 112.688 -169.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -131.74 -48.19 0.96 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.4 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' A' ' 40' ' ' PRO . 31.1 tp -82.56 -46.26 13.58 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.413 -174.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.45 HD11 ' CE1' ' A' ' 67' ' ' TYR . 72.7 mt -81.32 -60.0 2.43 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.696 ' HG3' ' HA ' ' A' ' 123' ' ' GLU . 8.2 ptpp? . . . . . 0 N--CA 1.44 -0.966 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.346 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 CA-C-O 120.028 -0.318 . . . . 0.0 113.762 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.69 166.85 19.66 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 122.017 0.913 . . . . 0.0 112.879 178.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.743 HG13 HG22 ' A' ' 73' ' ' ILE . 42.0 t -110.61 115.04 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.421 170.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.402 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 50.0 mm -80.8 99.18 4.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.023 0.439 . . . . 0.0 110.546 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 14.4 p80 -74.09 112.68 10.47 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 171.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.809 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.8 pp -139.42 -179.88 6.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -167.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.3 p -109.25 177.73 4.66 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.582 173.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.576 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -59.5 -27.32 66.04 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 117.598 0.181 . . . . 0.0 111.221 -178.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.87 -39.78 76.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.287 0.565 . . . . 0.0 110.592 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.809 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 5.2 mm-40 -72.13 -35.88 69.23 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.519 175.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.421 ' CG ' HD11 ' A' ' 84' ' ' LEU . 13.8 t80 -61.23 -45.33 94.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 122.173 0.987 . . . . 0.0 108.588 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.686 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.7 tt -46.83 -61.05 2.03 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 113.19 -1.823 . . . . 0.0 111.868 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.81 -13.25 51.66 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -170.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -109.49 -18.94 13.4 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 47.2 t -133.66 -45.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -171.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.686 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 9.5 t80 -161.32 115.38 1.99 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.232 0.539 . . . . 0.0 111.622 -167.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.433 ' ND2' HD21 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -91.91 95.51 9.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.602 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.423 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 6.2 p90 -73.89 7.38 2.61 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -97.55 -17.36 19.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.881 0.372 . . . . 0.0 110.27 170.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -90.38 -34.26 15.73 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.205 0.526 . . . . 0.0 110.296 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.752 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -147.98 62.08 6.49 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.289 -175.527 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 29' ' ' ASN . 4.8 Cg_exo -44.03 -35.28 7.31 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 124.907 3.738 . . . . 0.0 112.771 170.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -103.46 -30.87 10.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.77 -176.887 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.78 178.55 5.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.47 0.652 . . . . 0.0 112.017 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.564 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 59.2 t-105 -123.14 104.92 9.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.947 175.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -119.12 105.79 11.74 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.483 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.549 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 38.2 t80 -72.09 123.48 22.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.342 178.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -97.15 15.61 22.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.371 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -98.98 -152.28 27.43 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.759 -173.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -124.79 -52.57 1.68 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 111.196 -172.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.559 ' HB2' HG23 ' A' ' 72' ' ' VAL . 36.5 mttm -113.35 165.27 13.66 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.493 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.546 ' HB3' HD11 ' A' ' 125' ' ' LEU . 73.8 Cg_exo -47.77 131.74 20.64 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.158 1.905 . . . . 0.0 110.972 172.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -113.09 143.57 44.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.292 0.568 . . . . 0.0 111.811 -170.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.616 ' HB ' HG12 ' A' ' 73' ' ' ILE . 61.3 mt -130.26 110.4 19.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.034 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.571 HG23 ' HB2' ' A' ' 74' ' ' TYR . 8.3 p -111.76 134.52 53.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.545 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 2.4 t70 -100.72 118.96 37.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.492 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.445 ' O ' HG22 ' A' ' 93' ' ' ILE . 97.3 m-85 -95.85 112.58 24.27 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.676 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 10.7 p90 -127.28 173.98 9.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.815 0.817 . . . . 0.0 111.762 -175.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.28 120.03 5.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 113.53 -1.668 . . . . 0.0 107.352 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.18 -34.7 68.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -169.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -67.86 -12.88 61.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.865 0.364 . . . . 0.0 111.383 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.51 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 42.4 t -99.01 117.3 33.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.805 0.336 . . . . 0.0 110.427 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.02 -54.62 22.09 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.701 -0.681 . . . . 0.0 114.21 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.51 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 81.6 Cg_exo -47.59 -36.68 25.32 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.025 2.484 . . . . 0.0 114.034 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.676 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 61.5 m -68.21 -31.86 71.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.205 0.526 . . . . 0.0 111.196 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -63.85 -28.63 69.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.857 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.535 ' O ' HD13 ' A' ' 59' ' ' ILE . 41.4 mmm -76.16 -42.97 44.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.106 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 53' ' ' CYS . 6.5 p -75.29 -39.18 42.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -173.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.52 -55.4 19.47 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.04 -46.2 6.56 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.075 1.85 . . . . 0.0 112.446 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.535 HD13 ' O ' ' A' ' 55' ' ' MET . 1.8 mp -55.71 -42.08 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 121.301 0.572 . . . . 0.0 110.333 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -58.68 -39.03 79.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.592 176.152 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.546 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 33.0 t70 -69.19 -42.64 75.55 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.662 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 66' ' ' GLU . 43.4 mt-10 -54.13 -55.22 29.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.371 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.578 HD11 ' HG3' ' A' ' 114' ' ' LYS . 10.9 mp -61.23 -30.67 70.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.3 -178.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 61' ' ' ASP . . . -53.55 -56.56 16.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.081 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.546 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -77.96 -29.23 49.7 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.132 178.835 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 57.9 mt-10 -66.15 -38.06 87.19 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.93 0.395 . . . . 0.0 111.63 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -105.47 19.33 20.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.037 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.54 ' HB2' ' HA ' ' A' ' 65' ' ' LYS . 33.5 t0 -59.24 157.49 10.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.552 0.692 . . . . 0.0 112.82 -170.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.58 -32.8 7.14 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.428 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.597 ' HG3' HG23 ' A' ' 71' ' ' ILE . 23.6 pt20 -111.91 -35.14 5.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -174.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.597 HG23 ' HG3' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -119.44 162.47 17.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.503 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.559 HG23 ' HB2' ' A' ' 39' ' ' LYS . 40.7 t -125.34 129.29 73.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.743 HG22 HG13 ' A' ' 11' ' ' VAL . 26.7 mt -107.57 142.15 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.03 -176.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.571 ' HB2' HG23 ' A' ' 43' ' ' VAL . 44.0 m-85 -127.08 166.69 17.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.981 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.551 ' HG2' HG12 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -155.11 146.32 22.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.757 0.313 . . . . 0.0 110.219 171.321 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.673 HG21 ' HG2' ' A' ' 81' ' ' GLU . 8.1 p -152.33 159.94 3.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.396 -172.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.604 ' HB2' ' HG2' ' A' ' 80' ' ' LYS . 10.7 m-20 -99.46 111.85 24.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.844 -0.162 . . . . 0.0 110.736 -175.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.713 HG21 ' HA ' ' A' ' 92' ' ' SER . 59.6 m -57.21 -31.52 65.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.01 0.433 . . . . 0.0 111.695 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.87 -33.19 71.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.751 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.604 ' HG2' ' HB2' ' A' ' 77' ' ' ASP . 11.5 ptpt -102.04 -27.57 12.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.416 0.627 . . . . 0.0 109.669 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.673 ' HG2' HG21 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -93.91 46.21 1.17 Allowed 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.25 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.61 -35.89 81.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.475 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.78 -40.39 84.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.245 0.545 . . . . 0.0 109.669 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.421 HD11 ' CG ' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -62.47 -47.62 83.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.375 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.639 ' HB2' HG23 ' A' ' 78' ' ' THR . . . -66.03 -46.0 79.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.491 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.27 -29.67 71.96 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.151 -176.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.78 -35.34 79.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.895 0.378 . . . . 0.0 111.459 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.463 ' HB2' HG13 ' A' ' 90' ' ' ILE . 97.1 m-85 -100.09 7.64 44.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.408 -177.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.24 32.54 84.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.0 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' A' ' 85' ' ' ALA . 39.5 mt -75.13 128.22 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -52.04 -64.37 0.84 Allowed 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.563 0.539 . . . . 0.0 110.25 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.713 ' HA ' HG21 ' A' ' 78' ' ' THR . 23.2 p -179.66 -85.45 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.558 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.463 ' O ' HD12 ' A' ' 93' ' ' ILE . 1.9 pp -156.26 148.24 17.36 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.622 -176.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.658 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 13.7 Cg_exo -78.89 148.68 83.29 Favored 'Cis proline' 0 N--CA 1.477 0.544 0 C-N-CA 124.856 -0.893 . . . . 0.0 112.395 -2.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.401 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 67.7 m -142.8 139.21 30.87 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.6 127.96 62.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 122.113 -0.367 . . . . 0.0 110.034 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.531 ' CB ' HG12 ' A' ' 43' ' ' VAL . 2.6 tp -97.05 127.89 43.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.629 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -108.74 100.19 9.46 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 105' ' ' PRO . 50.3 mt -101.23 104.91 36.2 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.18 -172.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.62 158.79 22.0 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.39 2.06 . . . . 0.0 111.088 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.3 mmm -76.9 -26.84 54.59 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 175.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -102.44 103.84 14.26 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.053 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.38 -141.97 15.91 Favored Glycine 0 C--N 1.315 -0.626 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.446 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.564 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 21.8 mmmt -124.07 163.57 34.88 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.566 ' HB3' HG12 ' A' ' 99' ' ' ILE . 84.9 Cg_endo -82.45 140.03 10.55 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.359 2.039 . . . . 0.0 114.205 -173.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.49 171.24 9.03 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.111 173.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 41.8 ttm -142.89 135.22 27.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.811 -177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.32 157.34 30.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 169.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -137.67 130.57 30.18 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.135 -0.626 . . . . 0.0 112.385 -175.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.658 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 117.78 -176.21 16.05 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.178 -0.919 . . . . 0.0 113.985 169.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -83.9 86.98 7.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.39 0.614 . . . . 0.0 110.604 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.545 ' HB2' ' HB3' ' A' ' 116' ' ' SER . 7.5 ptm -103.98 141.23 22.08 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.625 175.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 116' ' ' SER . 91.1 Cg_endo -75.24 177.3 8.81 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.59 2.193 . . . . 0.0 112.687 -173.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.578 ' HG3' HD11 ' A' ' 63' ' ' LEU . 37.8 ttmt -58.2 -30.47 66.49 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.262 175.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.7 -49.56 68.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.202 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.545 ' HB3' ' HB2' ' A' ' 112' ' ' MET . 17.0 t -67.74 -33.37 74.73 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.569 -0.453 . . . . 0.0 110.051 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.437 ' HB3' HD21 ' A' ' 63' ' ' LEU . 5.6 m-85 -72.52 -29.59 63.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.186 176.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.516 ' C ' ' HD3' ' A' ' 118' ' ' LYS . 12.7 tmtt? -56.44 -50.3 72.07 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.514 ' HG2' ' OE2' ' A' ' 123' ' ' GLU . 54.9 mttm -66.61 -38.23 86.52 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.539 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.651 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -66.74 -45.9 77.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.987 0.423 . . . . 0.0 111.402 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.502 HG13 HD13 ' A' ' 42' ' ' ILE . 1.6 mp -75.95 -56.03 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.052 0.453 . . . . 0.0 110.968 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.547 ' HA ' HD13 ' A' ' 126' ' ' LEU . 25.7 t70 -72.6 -60.55 2.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.566 -174.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.514 ' OE2' ' HG2' ' A' ' 119' ' ' LYS . 50.1 mt-10 -80.34 11.57 3.51 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -170.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.651 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 69.6 t80 -138.11 -42.57 0.52 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.568 0.211 . . . . 0.0 111.568 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.546 HD11 ' HB3' ' A' ' 40' ' ' PRO . 26.6 tp -90.53 -37.93 13.54 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.89 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.547 HD13 ' HA ' ' A' ' 122' ' ' ASP . 10.8 mp -78.13 -48.47 15.88 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.5 tptm . . . . . 0 C--N 1.322 -0.607 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 168.179 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.652 ' CA ' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 CA--C 1.507 -0.415 0 N-CA-C 115.096 0.798 . . . . 0.0 115.096 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.463 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 1.3 ptpp? -168.52 173.39 7.51 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 117.035 0.417 . . . . 0.0 110.155 176.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 19.4 m -109.13 133.41 54.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.322 -174.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.0 mm -103.09 98.48 6.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.608 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -72.97 111.6 8.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 173.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.868 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.9 pp -140.21 179.15 6.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -168.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.0 p -109.74 177.94 4.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.599 173.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.554 ' HA ' ' HB2' ' A' ' 19' ' ' PHE . 14.8 pttm -59.04 -23.2 61.77 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.9 -48.9 72.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.375 0.607 . . . . 0.0 110.257 176.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.868 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 6.1 mp0 -71.54 -34.19 69.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.761 177.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.554 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 2.0 t80 -54.36 -48.58 71.32 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 122.266 1.031 . . . . 0.0 109.224 174.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.543 HD22 HD22 ' A' ' 25' ' ' ASN . 2.9 mt -52.43 -59.77 4.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.161 -1.836 . . . . 0.0 111.153 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.94 -27.67 49.38 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -104.41 -14.18 15.82 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -173.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 21.4 t -126.9 -49.21 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.51 -0.476 . . . . 0.0 112.104 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 14.3 t80 -163.72 115.74 1.42 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.168 0.508 . . . . 0.0 110.66 -170.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.543 HD22 HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -90.45 90.07 7.86 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.921 -176.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.551 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 23.9 p90 -90.58 22.1 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.46 -29.47 9.21 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.873 171.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.708 ' C ' HD22 ' A' ' 29' ' ' ASN . 6.5 ptpp? -106.77 -16.61 14.44 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.769 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.708 HD22 ' C ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -120.85 63.38 11.1 Favored Pre-proline 0 N--CA 1.474 0.739 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.0 174.343 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.453 ' HG2' ' OE1' ' A' ' 31' ' ' GLU . 12.0 Cg_endo -65.68 -44.98 7.29 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.437 2.091 . . . . 0.0 112.509 173.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.453 ' OE1' ' HG2' ' A' ' 30' ' ' PRO . 25.6 mp0 -88.41 -26.15 22.3 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.005 0.431 . . . . 0.0 110.88 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.28 147.99 22.65 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.202 0.525 . . . . 0.0 111.423 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.658 ' HD1' ' HZ1' ' A' ' 104' ' ' LYS . 35.7 t-105 -109.15 103.5 12.5 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 164.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -119.02 124.25 46.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.046 173.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.543 ' OH ' ' HB2' ' A' ' 41' ' ' ALA . 18.3 t80 -85.17 108.8 17.88 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.4 0.45 33.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.147 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.46 162.63 36.52 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -93.1 -42.42 9.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.758 0.779 . . . . 0.0 111.76 -175.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.524 ' HB2' HG23 ' A' ' 72' ' ' VAL . 44.2 mttp -102.27 147.86 34.58 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 122.355 -0.215 . . . . 0.0 110.636 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -42.97 136.55 4.84 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.656 2.904 . . . . 0.0 112.818 176.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.543 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -119.07 149.01 42.39 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -170.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.9 ' HB ' HG12 ' A' ' 73' ' ' ILE . 45.3 mm -120.37 115.41 47.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.439 171.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.4 t -100.13 117.12 44.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.699 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.841 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 14.9 t70 -96.59 106.62 18.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.356 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.543 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 77.5 m-85 -94.65 112.13 23.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.434 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.641 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 52.3 p90 -134.7 176.31 8.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.611 0.72 . . . . 0.0 111.477 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.497 ' HB3' HD13 ' A' ' 93' ' ' ILE . . . -149.89 127.48 11.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.891 170.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.603 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 26.3 t70 -61.39 -24.83 66.77 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -168.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 55.6 p-90 -72.63 -9.36 58.51 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.747 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.569 ' HB3' ' SG ' ' A' ' 53' ' ' CYS . 26.0 t -105.74 137.68 43.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.057 0.456 . . . . 0.0 111.396 -174.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.404 ' N ' ' HD2' ' A' ' 52' ' ' PRO . . . -57.94 -62.01 6.79 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.336 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 51' ' ' GLY . 9.3 Cg_endo -55.33 -26.92 55.03 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.105 2.537 . . . . 0.0 112.831 -178.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.641 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 70.7 m -66.45 -50.61 62.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.079 0.466 . . . . 0.0 110.31 174.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.603 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 67.8 mttm -59.07 -29.88 67.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.833 175.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 84.5 mtp -66.29 -53.31 38.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.614 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.9 m -82.96 -34.52 11.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -170.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -47.16 -61.28 2.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -175.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 38.0 Cg_endo -66.43 -33.22 38.34 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.581 1.521 . . . . 0.0 112.078 -175.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.6 mt -66.46 -38.41 81.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.613 HD21 ' CZ ' ' A' ' 117' ' ' PHE . 0.8 OUTLIER -67.37 -39.91 85.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.845 177.268 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.579 ' OD2' HG21 ' A' ' 11' ' ' VAL . 1.2 m-20 -61.26 -49.78 75.72 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-O 121.869 0.842 . . . . 0.0 109.557 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.474 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 42.8 tt0 -62.17 -46.87 87.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.193 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.496 HD13 ' HG3' ' A' ' 114' ' ' LYS . 12.8 tp -61.14 -31.15 70.87 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -177.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.522 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -60.68 -54.16 48.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.023 177.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -73.25 -24.76 60.51 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.959 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.8 -38.66 75.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.257 0.551 . . . . 0.0 110.753 174.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -103.44 27.36 7.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.153 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.652 ' HA ' ' CA ' ' A' ' 9' ' ' GLY . 10.1 t70 -52.21 129.62 28.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.141 0.496 . . . . 0.0 110.773 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.08 -42.19 1.92 Allowed Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.46 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -101.19 -47.81 4.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -173.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.8 pt -117.82 164.52 14.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.647 -171.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.524 HG23 ' HB2' ' A' ' 39' ' ' LYS . 14.5 t -128.34 139.12 52.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.189 176.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.9 HG12 ' HB ' ' A' ' 42' ' ' ILE . 53.9 mt -122.89 121.13 62.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.639 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -101.77 159.09 15.63 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.841 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 30.3 mttm -143.76 145.65 32.55 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.621 -176.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.486 HG21 ' HG2' ' A' ' 81' ' ' GLU . 9.8 p -156.15 156.02 5.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -177.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.798 ' HB3' ' HG2' ' A' ' 80' ' ' LYS . 11.3 t70 -98.27 116.76 31.17 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.481 HG23 ' HB3' ' A' ' 45' ' ' PHE . 21.0 p -63.69 -35.2 79.77 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -68.25 -31.69 71.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.798 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 4.5 mmtm -74.83 -55.14 6.12 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.486 ' HG2' HG21 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -87.52 57.92 4.67 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 113.608 -1.633 . . . . 0.0 112.278 -174.476 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -56.48 -46.02 80.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.75 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -68.98 -38.25 79.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.984 0.421 . . . . 0.0 110.572 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.441 ' CB ' ' HG3' ' A' ' 81' ' ' GLU . 3.0 tm? -66.86 -43.46 83.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.81 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -64.62 -47.05 80.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.894 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.22 -32.6 81.22 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.723 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.49 -27.51 68.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.701 0.286 . . . . 0.0 111.751 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -104.29 7.03 35.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.618 0.247 . . . . 0.0 111.271 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.98 22.26 79.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.381 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 85' ' ' ALA . 23.6 mt -72.74 119.75 20.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -62.04 -46.68 88.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.745 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.4 p -179.23 -93.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.535 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.588 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 2.7 pt -152.66 147.62 19.54 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -168.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -95.31 134.1 4.89 Favored 'Cis proline' 0 N--CA 1.46 -0.458 0 C-N-CA 124.3 -1.125 . . . . 0.0 111.34 -3.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 17.2 t -108.26 146.76 32.39 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.561 HD13 ' CE1' ' A' ' 117' ' ' PHE . 27.6 mt -136.55 114.91 14.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.789 0.328 . . . . 0.0 110.146 -176.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.0 tp -103.28 116.7 32.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.4 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -93.32 103.83 16.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.457 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.46 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 41.9 mt -103.8 106.84 54.48 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -173.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.33 148.57 13.02 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.892 2.395 . . . . 0.0 111.625 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -42.26 99.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.25 0.548 . . . . 0.0 110.67 175.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -99.37 105.77 17.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.302 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.495 ' C ' ' HD2' ' A' ' 104' ' ' LYS . . . 114.53 -146.82 18.78 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.284 177.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.658 ' HZ1' ' HD1' ' A' ' 33' ' ' TRP . 0.8 OUTLIER -128.27 159.69 65.97 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.303 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.469 ' HG3' ' CZ2' ' A' ' 33' ' ' TRP . 97.0 Cg_endo -81.25 152.23 18.18 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.753 2.302 . . . . 0.0 113.838 -170.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -110.02 166.81 10.65 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.642 172.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 43.3 ttm -137.11 140.51 41.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.247 0.546 . . . . 0.0 112.118 -172.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -133.52 157.19 46.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.948 172.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -96.52 150.41 20.66 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.56 -142.72 1.36 Allowed Glycine 0 CA--C 1.518 0.23 0 N-CA-C 114.628 0.611 . . . . 0.0 114.628 -171.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 71.86 18.68 5.02 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.622 0.769 . . . . 0.0 111.441 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.503 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 23.0 ptt? -117.37 154.2 50.3 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.46 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.28 178.39 7.58 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.999 2.466 . . . . 0.0 113.003 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.496 ' HG3' HD13 ' A' ' 63' ' ' LEU . 41.9 ttmt -59.45 -28.54 67.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.634 174.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.13 -52.99 61.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.411 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 35.1 m -65.89 -37.16 85.38 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.894 0.378 . . . . 0.0 110.67 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.613 ' CZ ' HD21 ' A' ' 60' ' ' LEU . 16.0 m-85 -61.49 -48.24 81.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.256 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -55.74 -40.03 71.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.552 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.558 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -56.06 -55.63 30.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.798 177.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -69.06 -42.34 76.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.783 -175.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 117' ' ' PHE . 43.5 mt -64.61 -53.46 42.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.91 0.386 . . . . 0.0 111.104 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 38.8 t70 -65.02 -59.0 4.63 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.517 -173.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -83.35 11.26 7.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -168.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.466 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 42.0 t80 -134.38 -52.35 0.82 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.593 0.235 . . . . 0.0 111.123 174.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.678 HD22 HD11 ' A' ' 42' ' ' ILE . 16.8 tp -74.58 -38.52 62.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.725 -175.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 122' ' ' ASP . 4.2 mm? -82.45 -59.94 2.36 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.486 178.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 21.8 pttp . . . . . 0 N--CA 1.447 -0.597 0 CA-C-O 121.757 0.789 . . . . 0.0 110.267 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.672 ' O ' ' HE3' ' A' ' 10' ' ' LYS . . . . . . . . 0 C--O 1.223 -0.533 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.672 ' HE3' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -138.63 164.33 29.77 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -170.13 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 14.7 p -102.98 123.57 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.518 0.675 . . . . 0.0 111.431 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.1 mt -132.97 124.34 50.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.696 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.875 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 7.7 p80 -91.73 138.8 31.27 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.176 177.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.674 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.7 pp -139.5 168.62 19.42 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.179 -176.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.0 p -95.33 177.17 5.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.909 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -55.66 -33.32 63.99 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.2 90.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.351 0.596 . . . . 0.0 110.165 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.674 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 8.3 mm-40 -71.1 -34.07 70.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.298 178.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -60.81 -50.58 72.87 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.836 0.827 . . . . 0.0 109.308 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.671 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -49.25 -60.43 2.82 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.607 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.25 -19.45 39.6 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -169.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -109.66 -12.39 14.65 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 72.6 t -136.34 -49.99 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -172.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.671 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 12.2 t80 -154.27 116.74 4.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.315 0.579 . . . . 0.0 112.023 -164.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.624 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -82.6 88.65 6.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.687 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -88.75 11.26 18.18 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.014 0.435 . . . . 0.0 111.275 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.649 ' HG2' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -93.92 -48.31 6.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.37 0.605 . . . . 0.0 109.392 174.356 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -90.46 -22.97 21.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.267 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 25' ' ' ASN . 2.3 m-20 -120.85 67.48 14.96 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.819 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -58.29 -44.11 41.23 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.228 2.619 . . . . 0.0 112.382 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -103.2 -22.22 13.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.194 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -91.05 178.13 6.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.346 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -128.69 106.35 8.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.233 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 18.8 tptm -113.55 113.13 24.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.846 174.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.586 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 25.4 t80 -92.59 119.53 32.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.842 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -102.65 28.28 6.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.038 -176.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.81 156.92 18.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.245 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.74 -40.32 11.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.716 0.293 . . . . 0.0 111.037 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -107.61 158.45 33.29 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.339 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.548 ' HG2' HG22 ' A' ' 71' ' ' ILE . 18.6 Cg_endo -59.51 140.72 95.36 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.588 2.192 . . . . 0.0 111.094 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -131.54 157.17 44.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.665 0.745 . . . . 0.0 112.812 -170.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.717 ' HB ' HG12 ' A' ' 73' ' ' ILE . 3.6 mp -120.0 116.5 50.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.633 174.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 35.9 t -100.32 111.97 31.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.739 0.304 . . . . 0.0 110.898 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.651 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 15.6 t70 -95.92 110.31 22.53 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.292 0.567 . . . . 0.0 111.562 -179.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -83.4 111.75 19.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.875 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.708 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 4.1 p90 -141.27 171.28 14.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.209 0.528 . . . . 0.0 111.07 -173.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.72 146.77 51.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.081 173.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -65.72 -38.01 87.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.657 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -80.43 -6.96 58.9 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 49.5 t -97.32 134.95 39.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.089 0.471 . . . . 0.0 111.506 -174.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.96 -63.77 4.15 Favored Glycine 0 C--O 1.224 -0.528 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.356 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.618 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 82.0 Cg_exo -47.26 -35.07 19.58 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.008 2.472 . . . . 0.0 113.145 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.708 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 71.6 m -62.66 -47.71 82.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.244 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -77.6 -28.56 51.59 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -55.75 -43.71 76.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.307 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.0 m -83.21 -16.84 11.16 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -174.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.424 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -49.63 -55.6 21.89 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 38.2 Cg_endo -68.49 -41.03 6.91 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.547 1.498 . . . . 0.0 111.725 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 69.0 mt -58.14 -43.98 86.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.272 0.558 . . . . 0.0 110.528 176.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' A' ' 60' ' ' LEU . 12.7 mt -63.33 -45.39 91.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.677 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -64.93 -35.6 81.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 110.002 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 8.3 mm-40 -52.63 -52.86 53.66 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.175 176.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.483 HD21 ' HG3' ' A' ' 114' ' ' LYS . 3.4 mm? -67.96 -42.69 80.52 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.188 -0.205 . . . . 0.0 110.848 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.505 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -56.14 -50.03 72.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.814 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -71.04 -31.7 68.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.403 -178.322 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -67.47 -29.01 68.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.448 0.642 . . . . 0.0 110.367 179.218 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -111.82 26.4 10.66 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.219 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.44 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 23.0 t0 -53.93 131.55 40.4 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.249 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.18 -43.83 1.61 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.141 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -101.85 -32.67 10.13 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.548 HG22 ' HG2' ' A' ' 40' ' ' PRO . 39.6 pt -124.43 159.04 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.684 -178.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 93.2 t -138.05 136.48 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.471 176.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.717 HG12 ' HB ' ' A' ' 42' ' ' ILE . 40.2 mt -114.78 131.95 65.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.312 0.577 . . . . 0.0 111.091 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -115.99 166.16 12.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.102 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.875 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 46.8 mttm -128.88 162.71 26.89 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.491 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 9.2 p -139.86 136.74 39.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.405 ' HB3' ' HG2' ' A' ' 80' ' ' LYS . 0.9 OUTLIER -83.66 86.74 7.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.86 -176.486 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.1 p -51.58 -41.83 61.46 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -53.78 -23.58 12.5 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.436 ' HG3' ' OE1' ' A' ' 81' ' ' GLU . 7.4 ptpp? -115.37 -34.34 4.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.187 0.518 . . . . 0.0 109.947 177.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.491 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 1.3 mp0 -81.5 39.48 0.53 Allowed 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 123.711 0.804 . . . . 0.0 110.992 173.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.66 -41.16 94.44 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.932 0.396 . . . . 0.0 110.942 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -61.66 -47.78 83.79 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.042 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.0 tp -62.66 -48.51 79.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.182 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.34 -40.97 94.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.814 0.34 . . . . 0.0 111.341 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.46 -28.33 72.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.638 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.82 -27.59 68.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.322 . . . . 0.0 111.276 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.504 ' HB2' HG12 ' A' ' 90' ' ' ILE . 82.0 m-85 -89.71 -16.53 30.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.739 0.304 . . . . 0.0 110.975 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.93 4.68 56.69 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.075 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 88' ' ' PHE . 33.1 mm -67.45 126.21 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -63.96 -60.81 2.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.068 0.461 . . . . 0.0 110.251 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.1 m -158.19 -84.3 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.943 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 8.8 pt -153.93 146.14 17.21 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.28 -167.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -105.2 147.57 1.18 Allowed 'Cis proline' 0 N--CA 1.461 -0.423 0 C-N-CA 124.833 -0.903 . . . . 0.0 111.405 -5.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.438 ' C ' HD12 ' A' ' 96' ' ' ILE . 18.9 t -131.74 138.39 48.61 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.438 HD12 ' C ' ' A' ' 95' ' ' SER . 3.0 mp -125.93 116.16 45.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.733 -177.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 105' ' ' PRO . 37.4 tp -94.19 112.12 23.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.112 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.41 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 96.4 m-85 -90.2 107.31 19.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.461 178.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 55.2 mt -96.92 109.47 49.09 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.318 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.556 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 84.9 Cg_endo -87.96 169.31 6.5 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.221 2.614 . . . . 0.0 112.422 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 89.7 mmm -96.4 3.03 53.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.56 0.695 . . . . 0.0 109.236 173.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -138.66 118.67 13.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.355 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.19 -141.36 15.51 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.52 176.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -120.78 151.0 53.94 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.556 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 17.2 Cg_exo -68.04 122.51 9.61 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.483 2.122 . . . . 0.0 112.05 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -90.79 160.68 15.64 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 18.4 ptp -141.79 144.35 33.91 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.213 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.3 145.84 49.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.231 174.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -72.15 137.23 46.83 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.34 -143.38 3.85 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 115.363 0.905 . . . . 0.0 115.363 -167.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' A' ' 52' ' ' PRO . . . 70.86 20.2 5.54 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.829 0.852 . . . . 0.0 110.403 -171.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.611 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 6.6 mtp -84.33 150.28 57.1 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.769 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.44 178.31 7.52 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.43 2.087 . . . . 0.0 111.141 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.483 ' HG3' HD21 ' A' ' 63' ' ' LEU . 86.3 tttt -61.73 -26.29 67.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.05 0.452 . . . . 0.0 109.953 176.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.84 -52.38 20.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.043 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.611 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 18.8 m -68.61 -35.14 76.92 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.618 -177.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.49 ' O ' HG13 ' A' ' 121' ' ' ILE . 3.7 m-85 -64.77 -44.4 90.15 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.578 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -57.98 -48.81 78.87 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.87 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -57.42 -37.06 72.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.831 0.348 . . . . 0.0 110.772 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.42 -48.6 48.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.196 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 117' ' ' PHE . 56.8 mt -65.68 -52.1 54.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.237 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.42 -62.42 1.79 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.893 0.378 . . . . 0.0 110.942 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.662 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 18.2 mt-10 -64.25 -44.56 91.41 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -172.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -94.44 -35.16 12.45 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.217 -172.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 40' ' ' PRO . 17.9 tp -89.02 -47.57 8.03 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.796 -175.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.8 mt -80.23 -58.92 2.91 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.662 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 25.1 ttpp . . . . . 0 N--CA 1.432 -1.355 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.513 ' CA ' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 CA--C 1.502 -0.738 0 N-CA-C 113.764 0.265 . . . . 0.0 113.764 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -124.8 172.32 9.42 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.9 p -142.2 132.36 24.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.119 0.485 . . . . 0.0 111.073 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.8 mm -131.45 124.95 55.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.544 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.645 ' CB ' ' HB2' ' A' ' 75' ' ' LYS . 6.0 p80 -82.81 116.13 22.01 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 172.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.486 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -116.99 179.73 3.94 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.464 -170.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.514 HG22 ' HE2' ' A' ' 80' ' ' LYS . 56.8 p -89.58 163.35 15.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.016 176.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.712 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 33.2 pttt -61.94 -24.1 66.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.681 175.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.3 -39.52 71.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.272 0.558 . . . . 0.0 110.08 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.486 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 10.4 mm-40 -65.89 -38.75 89.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.074 175.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -62.04 -51.26 68.73 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.965 0.888 . . . . 0.0 109.115 175.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.637 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -51.64 -60.73 2.83 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.466 -1.697 . . . . 0.0 111.733 -175.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.54 -24.17 45.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -168.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -109.15 -23.33 11.69 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 48.5 t -121.33 -41.46 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -172.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.637 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 30.1 t80 -160.82 115.05 2.1 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.142 0.496 . . . . 0.0 111.011 -169.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.624 ' HA ' HD23 ' A' ' 20' ' ' LEU . 3.1 t-20 -89.96 90.45 8.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.685 -175.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.613 ' CE2' ' HG ' ' A' ' 20' ' ' LEU . 28.6 p90 -85.26 20.68 1.9 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.417 0.627 . . . . 0.0 111.248 177.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.533 ' HG3' HD21 ' A' ' 20' ' ' LEU . 39.8 mt-10 -92.93 -47.33 7.07 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.501 ' HG3' ' ND2' ' A' ' 29' ' ' ASN . 18.3 ptmt -98.25 -11.09 23.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.412 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.631 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 9.9 m-80 -128.69 73.44 80.98 Favored Pre-proline 0 CA--C 1.515 -0.396 0 CA-C-O 121.686 0.755 . . . . 0.0 110.93 171.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -57.58 -43.47 50.48 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 123.744 2.962 . . . . 0.0 112.167 171.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.526 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -111.12 -31.5 7.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.016 -174.805 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.631 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -90.87 157.43 17.35 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.295 0.569 . . . . 0.0 111.317 -174.817 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.586 ' HB3' ' NZ ' ' A' ' 104' ' ' LYS . 40.7 t-105 -112.54 112.96 24.87 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.613 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -132.79 110.4 10.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.661 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 5.2 t80 -87.81 133.56 33.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.908 -177.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -107.25 144.71 33.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 171.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.21 -122.58 1.48 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.798 -175.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.504 ' OD1' ' HG3' ' A' ' 39' ' ' LYS . 16.6 t70 -165.41 -61.38 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.117 0.484 . . . . 0.0 110.188 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.504 ' HG3' ' OD1' ' A' ' 38' ' ' ASP . 44.8 mttp -105.54 156.21 36.79 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.761 -173.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.538 ' HG2' HG22 ' A' ' 71' ' ' ILE . 6.0 Cg_endo -49.46 133.61 31.46 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.259 2.64 . . . . 0.0 111.999 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -118.51 146.67 44.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.438 -173.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.794 HD11 HD22 ' A' ' 125' ' ' LEU . 50.1 mm -115.71 136.5 52.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.74 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 17.5 t -120.69 120.28 62.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.061 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.663 ' HB2' HD13 ' A' ' 60' ' ' LEU . 13.5 t0 -94.26 103.55 15.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.754 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.428 ' HE1' ' HB2' ' A' ' 97' ' ' LEU . 80.8 m-85 -88.81 110.95 21.46 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 176.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.665 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.9 p90 -145.95 177.32 9.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.259 0.552 . . . . 0.0 111.456 -172.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.504 ' HB3' HD13 ' A' ' 93' ' ' ILE . . . -157.95 152.05 24.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.492 171.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -60.6 -44.83 95.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -173.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -69.4 -10.91 60.06 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -171.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 45.9 t -93.71 129.21 40.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.065 0.459 . . . . 0.0 110.838 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.73 -60.5 7.66 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.811 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.551 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 81.6 Cg_exo -47.61 -35.66 23.23 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.315 2.676 . . . . 0.0 113.381 176.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.665 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 67.6 m -64.07 -50.64 67.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.985 0.422 . . . . 0.0 111.061 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -61.62 -28.11 69.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.006 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.404 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 84.3 mtp -66.97 -51.58 53.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.463 176.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.408 ' HB ' ' HZ ' ' A' ' 117' ' ' PHE . 30.0 m -77.29 -33.53 20.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -171.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -48.22 -56.64 13.2 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 21.7 Cg_exo -65.68 -35.72 35.92 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.057 1.838 . . . . 0.0 112.168 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.455 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 67.6 mt -64.19 -41.38 92.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.432 0.634 . . . . 0.0 109.536 176.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.663 HD13 ' HB2' ' A' ' 44' ' ' ASP . 7.6 mt -68.36 -33.49 74.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.454 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD1' HG11 ' A' ' 11' ' ' VAL . 58.9 m-20 -63.73 -42.66 97.85 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.661 0.743 . . . . 0.0 109.25 173.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.579 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 16.9 tp10 -57.09 -53.39 58.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.682 177.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.537 HD21 ' HG3' ' A' ' 114' ' ' LYS . 4.4 mm? -61.76 -31.91 72.13 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.626 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.531 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -58.49 -60.23 4.12 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.74 0.305 . . . . 0.0 110.921 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.579 ' HE3' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -75.17 -23.85 57.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.196 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -61.37 -38.57 87.48 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.246 0.546 . . . . 0.0 110.535 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -103.67 27.1 7.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.298 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 6.7 t0 -48.43 134.42 15.18 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.366 -177.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.61 -33.84 4.79 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.658 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -86.53 -47.65 9.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.609 0.242 . . . . 0.0 111.384 -175.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.538 HG22 ' HG2' ' A' ' 40' ' ' PRO . 40.5 pt -125.1 164.01 24.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.186 0.517 . . . . 0.0 111.644 -175.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 60.3 t -128.27 127.78 67.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.3 175.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.763 HG12 ' HB ' ' A' ' 42' ' ' ILE . 46.7 mt -111.71 137.99 42.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.196 0.522 . . . . 0.0 111.118 -177.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -121.13 161.8 21.17 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.645 ' HB2' ' CB ' ' A' ' 13' ' ' HIS . 79.8 mttt -124.34 150.62 45.29 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.016 0.436 . . . . 0.0 110.034 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.717 HG13 ' HG2' ' A' ' 81' ' ' GLU . 2.8 t -127.95 126.13 65.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.025 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -90.33 89.64 7.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.657 HG21 ' HA ' ' A' ' 92' ' ' SER . 33.1 m -52.09 -30.04 24.23 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.215 -171.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -51.97 -34.23 41.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.76 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.514 ' HE2' HG22 ' A' ' 15' ' ' THR . 22.7 pttm -108.27 -20.89 12.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.207 0.527 . . . . 0.0 110.348 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.717 ' HG2' HG13 ' A' ' 76' ' ' VAL . 1.5 mp0 -91.18 40.99 1.05 Allowed 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.572 0.749 . . . . 0.0 111.67 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -55.6 -53.6 54.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.444 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -62.85 -36.39 83.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.631 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.6 tp -64.1 -43.33 95.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.541 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.568 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -65.25 -47.15 77.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.669 175.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.88 -33.93 80.66 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.87 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.54 -35.18 77.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 111.402 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -95.3 4.06 53.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.941 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.16 10.17 85.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.867 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.568 ' HB ' ' HB1' ' A' ' 85' ' ' ALA . 6.4 mt -69.72 143.01 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -72.09 -48.17 46.0 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.657 ' HA ' HG21 ' A' ' 78' ' ' THR . 15.0 p 179.69 -80.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.712 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.576 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 16.7 pt -149.2 149.83 30.43 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.107 -172.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.483 ' HG3' ' HB2' ' A' ' 52' ' ' PRO . 10.7 Cg_endo -101.2 150.27 3.44 Favored 'Cis proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.649 -0.979 . . . . 0.0 112.046 -3.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.6 t -138.95 136.66 35.65 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 107' ' ' MET . 15.3 mm -114.55 113.42 43.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.74 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 41.5 tp -94.58 119.44 33.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.03 0.443 . . . . 0.0 110.689 -175.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -100.72 107.89 19.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.424 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.13 108.12 50.62 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.393 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -84.65 168.77 11.02 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.744 2.296 . . . . 0.0 112.098 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 86.5 mtp -87.23 -12.34 47.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.503 0.668 . . . . 0.0 110.155 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -140.09 127.05 20.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.581 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.67 -151.93 18.19 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.227 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.586 ' NZ ' ' HB3' ' A' ' 33' ' ' TRP . 29.3 mmmt -115.4 155.13 47.46 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.441 ' HD3' ' CD1' ' A' ' 33' ' ' TRP . 92.3 Cg_endo -81.79 144.5 13.84 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.505 2.136 . . . . 0.0 112.302 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.2 169.92 8.67 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.318 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.534 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 22.3 ptp -142.19 121.33 12.98 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.775 0.798 . . . . 0.0 111.41 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.54 128.38 49.21 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -67.52 150.95 48.17 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.317 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.96 -162.99 2.27 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.559 -0.746 . . . . 0.0 114.753 -168.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.551 ' HB2' ' HB3' ' A' ' 52' ' ' PRO . . . 75.84 17.24 2.29 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.164 0.985 . . . . 0.0 111.55 -176.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.642 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 73.0 mtm -86.75 144.31 36.95 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.85 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 71.7 Cg_endo -75.43 178.92 6.72 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.567 2.178 . . . . 0.0 110.5 172.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.537 ' HG3' HD21 ' A' ' 63' ' ' LEU . 64.3 tttm -62.06 -27.83 69.18 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.75 -45.89 63.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.037 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.642 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 50.7 m -70.62 -30.14 66.71 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.184 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.512 ' O ' HG13 ' A' ' 121' ' ' ILE . 13.7 m-85 -64.08 -52.44 59.27 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.172 172.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.456 ' O ' ' HD3' ' A' ' 118' ' ' LYS . 11.6 tmtt? -58.53 -38.32 77.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.83 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.508 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -56.59 -52.29 65.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.894 176.64 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.05 -43.28 68.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.853 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 117' ' ' PHE . 58.6 mt -62.97 -44.16 99.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 109.965 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -62.88 -68.4 0.34 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.596 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.798 ' HA ' ' HE2' ' A' ' 127' ' ' LYS . 3.8 tt0 -80.06 11.06 3.65 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.836 -163.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -143.17 -47.51 0.31 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.614 177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.794 HD22 HD11 ' A' ' 42' ' ' ILE . 28.4 tp -79.44 -38.86 33.7 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.139 -174.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.2 mt -98.54 -47.91 5.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.666 0.746 . . . . 0.0 109.923 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.798 ' HE2' ' HA ' ' A' ' 123' ' ' GLU . 19.0 ttpt . . . . . 0 C--N 1.316 -0.872 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.693 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.513 ' CA ' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.229 0 N-CA-C 113.541 0.176 . . . . 0.0 113.541 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -162.74 166.55 24.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.757 0.279 . . . . 0.0 110.295 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.537 HG23 HG22 ' A' ' 73' ' ' ILE . 9.0 p -98.85 133.59 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.495 0.664 . . . . 0.0 111.029 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 73.8 mt -111.61 122.25 65.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.732 177.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.476 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 2.2 p80 -91.84 119.36 31.57 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.589 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.72 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.2 pp -138.8 168.17 20.4 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.677 -178.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.9 p -94.25 176.61 6.25 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.396 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 13.8 pttm -57.21 -24.83 57.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 177.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.53 -47.43 69.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.308 0.575 . . . . 0.0 109.727 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.72 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 3.9 mp0 -71.13 -33.87 70.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.109 176.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.413 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 7.2 t80 -59.41 -47.9 83.68 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 122.195 0.997 . . . . 0.0 109.151 176.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -50.26 -59.35 4.04 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 113.155 -1.838 . . . . 0.0 111.046 -179.545 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.0 -45.03 36.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 19.1 tptm -89.04 -7.85 55.12 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.027 -168.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 62.1 t -134.52 -54.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.506 -0.477 . . . . 0.0 112.252 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.492 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 11.8 t80 -169.63 126.12 0.87 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.268 0.556 . . . . 0.0 112.025 -164.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.528 ' HA ' HD23 ' A' ' 20' ' ' LEU . 24.3 t-20 -82.46 89.91 6.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.71 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.492 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 34.8 p90 -81.96 10.71 6.02 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.381 0.61 . . . . 0.0 111.092 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -107.78 -47.63 3.56 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.568 ' NZ ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -89.26 -28.31 20.0 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.29 -178.751 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.435 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 2.8 m-20 -121.15 62.94 11.77 Favored Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.933 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -59.43 -35.73 95.52 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.706 2.271 . . . . 0.0 112.076 175.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.512 ' HG3' ' HG2' ' A' ' 32' ' ' GLU . 16.0 pt-20 -98.26 -23.77 15.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.47 -176.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.512 ' HG2' ' HG3' ' A' ' 31' ' ' GLU . 34.5 mm-40 -100.99 155.0 18.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.832 0.349 . . . . 0.0 110.982 -174.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.532 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 76.2 t-105 -105.71 92.07 4.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.205 0.526 . . . . 0.0 110.009 175.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.606 ' HG3' ' OE2' ' A' ' 36' ' ' GLU . 25.3 tptp -100.95 104.63 15.81 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.58 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 21.8 t80 -107.97 118.49 36.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.568 -177.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.606 ' OE2' ' HG3' ' A' ' 34' ' ' LYS . 12.9 mm-40 -86.32 87.76 7.49 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA3' ' CE2' ' A' ' 35' ' ' TYR . . . -106.89 129.19 9.59 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.142 -1.028 . . . . 0.0 114.306 -169.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -87.94 -53.32 4.8 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 170.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HB2' HG23 ' A' ' 72' ' ' VAL . 47.1 mttp -126.16 171.52 7.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 172.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 9.1 Cg_endo -54.74 144.92 63.19 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.486 2.124 . . . . 0.0 111.283 170.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -128.04 155.88 43.64 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -170.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.856 ' HB ' HG23 ' A' ' 73' ' ' ILE . 21.4 mm -125.87 147.05 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.462 173.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 66.4 t -133.6 119.41 33.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 118.782 0.719 . . . . 0.0 111.412 176.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.58 113.38 26.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.636 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.576 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 69.7 m-85 -94.05 111.51 23.23 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 172.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.688 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.2 p90 -141.21 -177.1 4.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.342 0.591 . . . . 0.0 110.968 -172.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.47 139.3 25.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.614 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -61.39 -37.7 84.39 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -174.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -66.99 -16.31 64.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.008 0.432 . . . . 0.0 111.301 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.2 t -88.21 116.48 26.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.515 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.33 -53.9 37.86 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.758 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 55' ' ' MET . 84.9 Cg_exo -48.07 -37.85 31.08 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.909 2.406 . . . . 0.0 113.214 175.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.688 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 93.0 m -66.75 -48.03 70.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.395 0.617 . . . . 0.0 110.475 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 mttp -53.59 -30.79 44.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.646 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 76.2 mtp -64.59 -49.1 72.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.993 0.425 . . . . 0.0 111.439 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.478 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 35.1 m -79.54 -27.9 12.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.757 -171.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.516 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -50.31 -59.97 6.15 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 55.7 Cg_endo -71.15 -40.76 3.02 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.733 1.622 . . . . 0.0 112.495 -177.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 64.4 mt -64.99 -51.63 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.331 -176.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -68.25 -29.9 68.82 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.487 -176.722 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.535 ' OD1' HG12 ' A' ' 11' ' ' VAL . 23.4 t70 -61.75 -40.21 94.29 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.423 0.63 . . . . 0.0 109.775 172.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 59' ' ' ILE . 8.5 tm-20 -63.31 -41.01 98.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.321 176.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.537 HD21 ' HA ' ' A' ' 114' ' ' LYS . 3.1 mm? -58.71 -36.7 74.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.926 0.393 . . . . 0.0 110.699 174.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.658 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -60.97 -37.94 84.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.315 177.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 5.4 tmtm? -75.67 -33.12 60.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.527 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -55.32 -44.62 76.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.424 0.63 . . . . 0.0 109.931 172.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.599 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 48.0 m-85 -99.36 27.32 5.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.68 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 15.4 t0 -49.93 129.71 20.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.499 -177.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.49 -30.87 9.46 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.451 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 13.1 pt20 -106.86 -21.27 13.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 64' ' ' ALA . 30.6 pt -125.22 155.95 34.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.185 0.517 . . . . 0.0 112.059 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 40.5 t -127.96 129.93 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.348 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.856 HG23 ' HB ' ' A' ' 42' ' ' ILE . 24.8 mt -117.18 142.34 31.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 41.9 m-85 -124.47 158.57 32.53 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 0.2 OUTLIER -148.52 150.45 33.4 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 175.006 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.972 HG22 ' HG3' ' A' ' 81' ' ' GLU . 2.8 p -141.21 156.55 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.555 -173.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.516 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 10.8 m-20 -96.38 90.95 5.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.368 -175.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.547 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 10.2 m -50.05 -34.79 22.72 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -173.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' A' ' 79' ' ' GLU . 2.6 mm-40 -53.78 -41.04 66.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.98 0.419 . . . . 0.0 111.768 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 13.3 ptpt -94.57 -20.36 19.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.807 0.813 . . . . 0.0 109.344 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.972 ' HG3' HG22 ' A' ' 76' ' ' VAL . 10.3 mm-40 -98.2 39.71 1.22 Allowed 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.442 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -66.85 -30.98 71.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.625 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.55 -39.59 70.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.478 0.656 . . . . 0.0 109.243 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 33.4 tp -68.56 -37.8 80.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.832 176.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.618 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -63.9 -44.81 91.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.816 176.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.79 -29.16 66.85 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.92 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.29 -33.39 75.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.338 . . . . 0.0 111.444 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.607 ' HB2' HG13 ' A' ' 90' ' ' ILE . 91.2 m-85 -103.15 6.53 38.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.774 0.321 . . . . 0.0 110.626 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.39 33.67 87.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.862 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.618 HD12 ' HA ' ' A' ' 85' ' ' ALA . 41.9 mt -71.14 133.39 31.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.97 0.414 . . . . 0.0 110.745 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.458 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 0.4 OUTLIER -70.18 -51.41 31.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.096 178.761 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.9 p 175.39 -99.65 0.0 OUTLIER 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.145 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 26.6 pt -147.55 143.01 17.36 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.708 -172.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.733 ' HB2' ' H ' ' A' ' 110' ' ' GLY . 11.9 Cg_exo -81.95 149.25 71.77 Favored 'Cis proline' 0 N--CA 1.474 0.368 0 C-N-CA 124.934 -0.861 . . . . 0.0 111.921 -3.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.576 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 14.5 m -140.19 128.28 22.26 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 107' ' ' MET . 52.5 mt -127.94 122.66 59.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.837 0.351 . . . . 0.0 110.603 -174.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 32.8 tp -104.81 122.13 45.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.397 -177.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -100.07 111.35 23.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 54.9 mt -109.51 113.62 57.97 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -170.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -85.0 159.97 11.66 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.096 2.531 . . . . 0.0 111.621 172.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 86.1 mtp -80.28 -35.99 35.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -118.87 122.54 42.56 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.469 0.652 . . . . 0.0 109.54 173.842 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.0 -171.19 13.65 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -174.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.532 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 8.9 mmmm -117.97 150.31 47.07 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 117.335 0.567 . . . . 0.0 110.083 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.24 148.11 21.06 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.933 2.422 . . . . 0.0 114.216 -173.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -111.09 169.3 8.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.279 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 46.5 ttm -134.59 124.9 26.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.057 0.456 . . . . 0.0 111.695 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.88 157.71 21.09 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.469 ' HG2' ' HA ' ' A' ' 95' ' ' SER . 39.4 mt-30 -131.38 141.12 49.82 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.715 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.733 ' H ' ' HB2' ' A' ' 94' ' ' PRO . . . 115.46 177.87 18.56 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.507 -0.77 . . . . 0.0 114.125 172.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.478 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -87.75 86.07 7.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.281 0.562 . . . . 0.0 111.227 -175.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.639 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 72.6 mtm -78.93 136.89 57.78 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.828 175.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -75.46 -171.65 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.846 2.364 . . . . 0.0 111.792 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.537 ' HA ' HD21 ' A' ' 63' ' ' LEU . 13.8 tttm -57.97 -37.12 73.61 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.5 -50.59 62.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.326 -175.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.639 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 45.0 m -70.1 -37.47 75.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.926 -177.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.643 ' O ' HG13 ' A' ' 121' ' ' ILE . 4.6 m-85 -64.89 -44.51 89.41 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.829 176.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.526 ' HG2' ' OH ' ' A' ' 67' ' ' TYR . 11.3 tmtt? -53.83 -47.68 70.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.673 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -65.15 -38.08 89.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.754 -177.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.06 78.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.257 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.643 HG13 ' O ' ' A' ' 117' ' ' PHE . 23.1 mt -74.19 -55.23 12.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.884 0.373 . . . . 0.0 110.821 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.52 ' HA ' HD12 ' A' ' 126' ' ' LEU . 12.4 t70 -71.43 -65.54 0.74 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.687 0.28 . . . . 0.0 111.623 -176.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.437 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 32.8 mt-10 -75.82 -4.76 42.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -166.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -128.04 -38.61 1.81 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.572 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 40.5 tp -88.87 -43.2 11.38 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.887 -0.508 . . . . 0.0 110.742 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 122' ' ' ASP . 81.8 mt -82.92 -58.49 2.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.415 0.626 . . . . 0.0 109.68 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 12.7 ttpp . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.588 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.488 ' HZ1' ' CG ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -152.98 151.47 30.33 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 121.519 0.676 . . . . 0.0 111.865 -172.42 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 5.1 p -103.79 108.18 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.006 168.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 63.0 mt -88.99 123.76 41.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.721 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.695 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 2.3 p80 -88.86 133.26 34.33 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.796 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.586 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 1.7 pp -140.65 172.8 12.21 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.887 -174.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.7 p -106.17 178.35 4.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.357 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.459 ' HB2' ' HZ ' ' A' ' 26' ' ' PHE . 14.2 ptmm? -55.32 -35.72 65.45 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.83 -38.64 79.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.232 0.539 . . . . 0.0 110.286 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.586 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 2.6 mm-40 -71.0 -35.74 72.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.142 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -64.05 -48.34 76.67 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.78 0.8 . . . . 0.0 109.116 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.643 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.7 tt -50.82 -60.77 2.72 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.265 -178.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.6 -18.91 39.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -168.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 34.5 ttmt -108.5 -12.71 14.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.972 0.415 . . . . 0.0 111.397 -174.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 57.6 t -135.85 -55.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -174.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.653 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 9.7 t80 -167.09 122.53 1.09 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.261 0.553 . . . . 0.0 111.7 -164.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.505 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 1.8 t-20 -86.74 89.68 8.03 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.031 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.653 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 10.5 p90 -89.4 0.37 56.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.379 -174.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -104.98 -22.1 13.18 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.928 ' HE3' HD21 ' A' ' 29' ' ' ASN . 3.7 ttpp -105.96 -26.04 11.85 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.409 167.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.928 HD21 ' HE3' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -119.12 67.97 9.03 Favored Pre-proline 0 N--CA 1.471 0.591 0 CA-C-O 120.886 0.374 . . . . 0.0 111.635 -178.132 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.77 -34.66 39.56 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.92 2.413 . . . . 0.0 111.527 167.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -97.52 -30.6 12.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.841 -177.534 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.681 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 22.9 mt-10 -91.36 128.6 37.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.063 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.486 ' CZ2' ' HG3' ' A' ' 105' ' ' PRO . 72.8 t-105 -91.16 103.44 16.12 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.784 172.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -107.93 134.66 50.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.56 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.575 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 37.3 t80 -133.0 96.72 3.83 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.82 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -90.32 31.43 1.01 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.51 -174.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.5 135.25 12.69 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.421 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' OD2' ' HG3' ' A' ' 39' ' ' LYS . 25.2 t70 -65.6 -41.47 92.77 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.19 0.519 . . . . 0.0 111.081 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.414 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 72.5 mttt -125.32 158.79 62.74 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.548 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.662 ' HB3' HD11 ' A' ' 125' ' ' LEU . 50.3 Cg_exo -54.64 140.22 76.2 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.362 2.041 . . . . 0.0 111.157 173.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -124.44 152.37 43.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.669 0.747 . . . . 0.0 112.391 -172.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.8 mt -117.95 114.17 44.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.128 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 21.4 t -99.78 120.26 48.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.397 -175.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.682 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 21.8 t70 -103.69 111.12 23.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.57 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -83.45 111.94 19.5 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 172.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.71 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.8 p90 -132.58 158.23 42.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.775 0.798 . . . . 0.0 112.031 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.524 ' HB3' HG12 ' A' ' 93' ' ' ILE . . . -133.4 108.85 8.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.244 -1.343 . . . . 0.0 107.706 167.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.541 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 33.9 t70 -55.4 -31.03 61.49 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -167.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 59.6 p-90 -69.95 -1.43 9.63 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.625 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 27.9 t -114.14 137.03 52.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.933 0.397 . . . . 0.0 110.627 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.4 -57.46 18.47 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 115.612 -0.722 . . . . 0.0 114.669 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.625 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 84.1 Cg_exo -47.37 -37.49 25.19 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.158 2.572 . . . . 0.0 113.636 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.71 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 30.1 m -64.11 -50.36 68.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.334 0.588 . . . . 0.0 111.022 177.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.541 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 66.7 mttm -58.23 -28.59 65.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.339 174.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.443 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 53.2 mmm -70.63 -50.77 33.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.794 0.33 . . . . 0.0 111.398 176.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.84 -38.73 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -172.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.613 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -49.17 -54.49 28.58 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 15.8 Cg_exo -68.44 -42.67 5.01 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.212 1.941 . . . . 0.0 112.032 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.617 HD13 ' HA ' ' A' ' 113' ' ' PRO . 74.3 mt -57.26 -44.03 83.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.302 0.572 . . . . 0.0 110.497 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 44' ' ' ASP . 5.8 mt -68.37 -35.15 77.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.621 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.547 ' OD1' HG12 ' A' ' 11' ' ' VAL . 14.7 t70 -68.02 -35.53 78.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.134 0.493 . . . . 0.0 109.69 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.639 ' HA ' ' HD2' ' A' ' 65' ' ' LYS . 13.9 mm-40 -54.09 -44.63 71.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.768 172.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' A' ' 117' ' ' PHE . 11.1 mp -65.4 -30.89 71.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.727 0.298 . . . . 0.0 110.833 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -61.7 -53.2 59.35 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.657 -178.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.639 ' HD2' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -76.09 -24.97 55.06 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.795 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -42.73 61.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.88 0.372 . . . . 0.0 111.478 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.415 ' O ' HG12 ' A' ' 71' ' ' ILE . 94.0 m-85 -107.26 26.95 9.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.684 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.48 159.8 7.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.353 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.2 -52.89 4.13 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.262 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.534 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 7.1 pt20 -80.96 -33.77 33.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.495 0.188 . . . . 0.0 111.049 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 40' ' ' PRO . 42.2 pt -131.77 156.49 42.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.088 0.47 . . . . 0.0 111.763 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 86.8 t -124.28 136.49 60.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.648 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 21.9 mt -108.74 139.23 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.337 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -125.71 166.93 15.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.706 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.695 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -147.75 148.89 31.45 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 171.097 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.497 HG21 HD23 ' A' ' 84' ' ' LEU . 8.1 p -121.17 138.24 52.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.116 0.484 . . . . 0.0 110.524 -175.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.572 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -72.84 85.69 1.25 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.427 179.402 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.576 HG23 ' HB2' ' A' ' 85' ' ' ALA . 17.3 m -66.38 -31.77 72.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -167.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -65.9 -27.23 68.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.609 0.242 . . . . 0.0 111.199 -178.882 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.504 ' HZ2' ' HB3' ' A' ' 77' ' ' ASP . 8.6 ptpp? -99.79 -37.18 9.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.898 0.38 . . . . 0.0 110.108 175.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.572 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -78.86 39.63 0.37 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.36 0.664 . . . . 0.0 110.972 174.037 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -59.16 -43.98 92.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.529 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -65.15 -35.41 81.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.301 0.572 . . . . 0.0 110.379 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.497 HD23 HG21 ' A' ' 76' ' ' VAL . 14.8 tp -67.58 -48.94 65.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.322 177.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.576 ' HB2' HG23 ' A' ' 78' ' ' THR . . . -62.95 -36.28 82.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.915 0.388 . . . . 0.0 111.196 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.29 -27.75 71.18 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.777 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.37 -22.57 66.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.982 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -101.0 0.8 38.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.513 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.79 6.26 89.13 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.008 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.0 mm -68.72 130.29 33.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.514 0.197 . . . . 0.0 110.519 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 91' ' ' ARG . 39.2 mtm180 -59.27 -55.79 30.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.61 0.719 . . . . 0.0 110.394 176.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.544 ' O ' HG21 ' A' ' 78' ' ' THR . 14.2 t -167.48 -88.15 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.902 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.547 HG21 ' C ' ' A' ' 46' ' ' TYR . 2.3 pp -152.5 157.47 33.61 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -173.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.574 ' HG3' ' HB2' ' A' ' 52' ' ' PRO . 10.9 Cg_endo -99.42 148.06 4.51 Favored 'Cis proline' 0 N--CA 1.458 -0.571 0 C-N-CA 124.365 -1.098 . . . . 0.0 112.018 -3.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.8 t -139.89 142.51 36.5 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.73 128.03 71.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.465 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.595 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.5 tp -106.14 116.85 32.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.077 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 105' ' ' PRO . 20.0 m-85 -93.74 107.4 19.28 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.471 HG12 ' HB3' ' A' ' 105' ' ' PRO . 42.5 mt -110.11 109.78 58.8 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -173.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.73 165.91 13.62 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.402 2.734 . . . . 0.0 111.144 170.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.487 ' HG2' ' HE2' ' A' ' 35' ' ' TYR . 82.7 mtp -97.0 -34.17 11.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.712 0.768 . . . . 0.0 109.304 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -96.83 2.81 52.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.363 -176.183 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -137.45 -156.33 7.21 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.051 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 60.6 mmtt -126.34 154.43 74.76 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.486 ' HG3' ' CZ2' ' A' ' 33' ' ' TRP . 98.3 Cg_endo -78.21 148.26 24.06 Favored 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.677 2.251 . . . . 0.0 114.168 -169.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.507 ' HG2' ' N ' ' A' ' 107' ' ' MET . 34.9 tt0 -119.33 163.25 17.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.716 172.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.507 ' N ' ' HG2' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -142.51 137.98 30.6 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.372 0.606 . . . . 0.0 111.766 -177.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -133.98 156.77 47.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.622 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -75.41 148.52 39.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.15 -144.06 6.82 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.743 -0.742 . . . . 0.0 113.804 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 52' ' ' PRO . . . 71.99 20.86 4.26 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.435 0.694 . . . . 0.0 111.883 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.558 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 20.3 ptt? -112.37 153.7 44.73 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.529 177.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.617 ' HA ' HD13 ' A' ' 59' ' ' ILE . 93.6 Cg_endo -76.58 -177.56 3.83 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.13 2.553 . . . . 0.0 113.05 -173.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.46 ' HG3' HD11 ' A' ' 63' ' ' LEU . 38.8 ttmt -61.77 -29.39 70.1 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.024 174.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . -64.72 -47.38 78.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.215 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.558 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 18.6 m -70.88 -38.45 73.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.881 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.482 ' HB3' HD21 ' A' ' 63' ' ' LEU . 9.0 m-85 -65.41 -40.83 93.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.305 177.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.674 ' O ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -57.31 -37.24 72.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.741 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.583 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 43.2 mmtm -65.88 -57.96 6.69 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.252 175.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.51 -46.78 86.04 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -174.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.8 mp -64.37 -48.09 86.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.666 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.419 ' HA ' HD23 ' A' ' 126' ' ' LEU . 3.8 t0 -66.37 -50.27 64.07 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.841 -178.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.583 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 4.0 mm-40 -54.98 -30.2 58.78 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -174.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -115.45 -35.98 4.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.964 0.411 . . . . 0.0 111.854 -172.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.662 HD11 ' HB3' ' A' ' 40' ' ' PRO . 20.0 tp -90.6 -47.26 7.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.88 -174.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 122' ' ' ASP . 3.8 mm? -87.51 -53.43 4.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.261 0.553 . . . . 0.0 110.377 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.771 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.865 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 175.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.63 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . . . . . . 0 N--CA 1.448 -0.52 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.703 ' HE2' HD11 ' A' ' 12' ' ' ILE . 84.3 tttt -151.19 138.89 19.73 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -172.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 10.5 p -110.95 132.13 60.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.128 0.489 . . . . 0.0 110.693 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.703 HD11 ' HE2' ' A' ' 10' ' ' LYS . 36.9 mm -120.95 117.15 52.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.096 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.446 ' CB ' ' HG3' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -84.83 121.36 27.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 171.248 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.739 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.3 pp -120.68 178.27 4.76 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.751 -170.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.475 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -107.86 172.84 6.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.818 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.649 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 10.8 ptpt -54.68 -37.31 65.61 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.92 85.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.106 0.479 . . . . 0.0 110.971 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.739 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 30.8 mm-40 -71.97 -39.46 69.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.455 177.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -63.36 -50.24 70.72 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.163 0.983 . . . . 0.0 109.065 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.649 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -47.06 -60.95 2.12 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.152 -1.84 . . . . 0.0 112.232 -178.858 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.06 -28.14 27.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.799 -170.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 24.2 ttpt -110.56 1.5 18.17 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.933 0.397 . . . . 0.0 111.704 -170.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 40.7 t -141.46 -47.76 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 22.6 t80 -167.41 119.61 0.91 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.122 0.487 . . . . 0.0 111.737 -167.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -93.67 91.93 7.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.102 -178.374 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 2.9 p90 -80.41 8.9 6.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.309 0.576 . . . . 0.0 111.532 -177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -91.91 -50.15 5.86 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.046 176.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.456 ' HG3' ' OD1' ' A' ' 29' ' ' ASN . 14.9 pttm -89.66 -15.45 32.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.656 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 2.5 m-20 -123.33 68.79 39.52 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.505 174.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -59.5 -37.26 90.23 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.996 2.464 . . . . 0.0 112.447 173.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.85 -35.57 4.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -173.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.656 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 4.6 tp10 -90.96 153.71 19.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.038 0.447 . . . . 0.0 110.417 -176.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.653 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 33.4 t-105 -103.1 113.85 27.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.612 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -125.03 110.88 14.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.759 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.635 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 37.9 t80 -76.18 114.59 15.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.194 177.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -94.22 71.21 3.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.862 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.635 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -143.74 -139.76 3.56 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.522 -175.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -149.27 -42.47 0.14 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 111.892 -173.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' A' ' 70' ' ' GLN . 35.2 mttp -126.14 165.65 26.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.245 -175.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.614 ' HD3' ' SD ' ' A' ' 101' ' ' MET . 10.3 Cg_endo -52.88 132.31 46.34 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.452 2.102 . . . . 0.0 111.237 177.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -124.42 149.97 46.15 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.174 0.512 . . . . 0.0 111.572 -172.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.509 ' HB ' HG12 ' A' ' 73' ' ' ILE . 75.7 mt -127.17 134.01 66.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 175.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 60.5 t -125.28 112.42 31.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.022 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.548 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 8.5 p-10 -102.28 114.12 28.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.962 0.887 . . . . 0.0 111.266 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 42.0 m-85 -80.3 112.55 17.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.884 172.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.776 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.9 p90 -127.39 159.91 33.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.376 0.608 . . . . 0.0 110.759 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.459 ' N ' HG21 ' A' ' 93' ' ' ILE . . . -130.86 122.99 28.04 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 170.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.576 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 15.8 t70 -66.06 -26.18 67.38 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.803 -169.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -75.78 -2.88 31.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.994 0.426 . . . . 0.0 111.17 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.577 ' HB3' ' SG ' ' A' ' 53' ' ' CYS . 32.6 t -108.28 122.34 46.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.197 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.28 -55.28 25.26 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.638 -0.71 . . . . 0.0 114.792 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.498 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 82.5 Cg_exo -47.2 -41.14 27.6 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.206 2.604 . . . . 0.0 113.786 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.776 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 3.0 m -63.63 -37.75 88.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.291 0.567 . . . . 0.0 110.921 -177.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.576 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 67.0 mttm -61.46 -28.61 69.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.071 176.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 76.6 mtp -65.57 -48.44 72.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.875 0.369 . . . . 0.0 111.573 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.435 HG21 HD11 ' A' ' 96' ' ' ILE . 12.8 p -77.59 -32.33 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -169.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.448 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -48.02 -57.34 10.56 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 43.1 Cg_endo -69.21 -35.31 14.51 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.911 1.74 . . . . 0.0 112.702 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.6 mt -63.74 -50.86 76.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.681 HD22 HD13 ' A' ' 73' ' ' ILE . 5.6 mt -60.74 -36.09 78.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.361 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -62.03 -50.35 72.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.053 0.454 . . . . 0.0 110.673 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.13 -43.97 98.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.481 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HA ' HD13 ' A' ' 63' ' ' LEU . 3.8 mm? -62.63 -32.48 73.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.112 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.658 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -63.17 -53.55 51.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.345 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 8.8 tmtm? -67.4 -34.28 76.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.644 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -58.63 -47.03 85.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.187 0.518 . . . . 0.0 110.274 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -95.04 26.33 3.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.102 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -47.12 136.56 8.69 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.918 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.23 -23.98 17.18 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.75 176.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.542 ' HG3' HG23 ' A' ' 71' ' ' ILE . 12.5 pt20 -125.88 -49.02 1.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.542 HG23 ' HG3' ' A' ' 70' ' ' GLN . 43.0 pt -95.15 148.59 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.327 0.584 . . . . 0.0 112.188 -173.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 39.8 t -128.26 125.26 63.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.098 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.681 HD13 HD22 ' A' ' 60' ' ' LEU . 27.8 mt -109.24 131.44 60.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.308 0.575 . . . . 0.0 111.379 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.5 m-85 -116.94 156.85 26.71 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.548 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -136.07 148.29 48.24 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.452 175.224 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.58 HG13 ' HG2' ' A' ' 81' ' ' GLU . 20.8 t -117.11 126.39 74.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.536 -171.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 4.7 m-20 -83.4 95.42 8.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.417 HG21 ' O ' ' A' ' 92' ' ' SER . 16.6 p -55.56 -35.66 65.98 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -171.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -54.76 -29.94 55.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.353 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 54.6 pttt -103.14 -32.85 9.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.56 0.695 . . . . 0.0 109.726 178.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.58 ' HG2' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -88.73 41.97 1.05 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.155 -179.016 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.1 -49.58 77.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.904 -176.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.19 -36.46 81.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.934 0.397 . . . . 0.0 110.232 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.04 -53.12 58.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.951 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.14 -40.01 93.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.688 178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.84 -28.26 72.41 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.704 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.81 -32.8 74.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.807 0.336 . . . . 0.0 110.963 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.429 ' HB2' HG12 ' A' ' 90' ' ' ILE . 74.5 m-85 -89.29 0.75 56.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.933 0.397 . . . . 0.0 110.698 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.33 8.68 84.85 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.974 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.429 HG12 ' HB2' ' A' ' 88' ' ' PHE . 50.0 mm -75.01 130.21 36.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 122.341 0.257 . . . . 0.0 110.74 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -66.37 -64.28 0.89 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.221 0.534 . . . . 0.0 110.093 175.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.417 ' O ' HG21 ' A' ' 78' ' ' THR . 29.7 m -155.72 -90.3 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.589 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.534 HG13 ' SG ' ' A' ' 53' ' ' CYS . 0.2 OUTLIER -146.56 161.35 38.51 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.43 -172.905 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.717 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.1 Cg_exo -87.98 148.08 30.05 Favored 'Cis proline' 0 C--N 1.345 0.346 0 C-N-CA 124.507 -1.039 . . . . 0.0 111.705 -4.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.406 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 9.5 m -140.39 122.78 16.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.547 HD13 ' HZ ' ' A' ' 117' ' ' PHE . 64.5 mt -124.25 116.68 48.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.311 -175.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 105' ' ' PRO . 39.3 tp -100.38 124.09 45.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.718 -176.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -100.05 105.59 17.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.722 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.495 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 45.8 mt -100.99 108.36 54.07 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.055 -175.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -87.46 169.24 7.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.815 2.343 . . . . 0.0 112.235 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.614 ' SD ' ' HD3' ' A' ' 40' ' ' PRO . 84.2 mtp -93.89 1.0 56.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.654 0.74 . . . . 0.0 109.427 175.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -139.39 102.95 4.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.025 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.11 -153.76 16.76 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.561 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.653 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 15.4 tptt -112.35 153.63 44.75 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.537 ' HB2' HD11 ' A' ' 97' ' ' LEU . 5.7 Cg_exo -79.41 144.89 18.35 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.028 2.485 . . . . 0.0 112.781 -176.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -107.99 168.3 9.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.522 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 49.3 ttm -142.48 139.1 31.4 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.939 0.4 . . . . 0.0 111.44 -174.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -126.9 137.78 53.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.566 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -100.12 123.4 44.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.02 0.438 . . . . 0.0 110.772 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.717 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 126.58 -169.02 18.56 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.268 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.24 80.01 1.4 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.601 0.715 . . . . 0.0 110.721 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.674 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 5.0 mpp? -59.05 144.47 82.48 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.626 174.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.29 -175.96 2.83 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.891 2.394 . . . . 0.0 112.14 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -56.6 -39.63 73.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.465 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.75 -51.15 66.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.096 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.674 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 33.1 m -68.17 -29.13 67.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.75 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.647 ' O ' HG12 ' A' ' 121' ' ' ILE . 10.6 m-85 -75.41 -39.1 59.42 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.293 176.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -53.88 -37.46 63.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.035 0.445 . . . . 0.0 110.388 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 45.3 tttp -69.06 -46.34 68.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.354 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -66.79 -44.46 81.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.049 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.647 HG12 ' O ' ' A' ' 117' ' ' PHE . 17.4 mm -74.0 -50.57 27.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.736 0.303 . . . . 0.0 111.098 -174.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 126' ' ' LEU . 11.9 t70 -68.37 -60.93 2.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.014 0.435 . . . . 0.0 110.808 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.872 ' HA ' ' HD2' ' A' ' 127' ' ' LYS . 22.2 mt-10 -75.73 -9.69 58.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.164 -167.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.411 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 79.9 t80 -127.69 -39.54 1.81 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.25 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 125' ' ' LEU . 3.3 tp -91.01 -32.42 15.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.458 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 23.8 tp -84.01 -65.26 1.03 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.872 ' HD2' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.747 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 167.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 65' ' ' LYS . . . . . . . . 0 CA--C 1.51 -0.279 0 N-CA-C 115.426 0.93 . . . . 0.0 115.426 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -169.6 173.06 6.56 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.906 0.86 . . . . 0.0 113.03 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 12.9 m -100.43 110.67 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 113.469 -1.696 . . . . 0.0 109.57 171.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.401 HD12 ' CE2' ' A' ' 74' ' ' TYR . 47.2 mt -83.84 103.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.113 -175.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -75.63 112.12 11.66 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 2.9 pp -140.28 158.31 44.23 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.744 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.501 HG22 ' CE ' ' A' ' 80' ' ' LYS . 40.0 p -82.49 166.15 19.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.774 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.731 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 42.8 pttt -56.15 -34.12 65.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.682 177.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.57 -37.47 82.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.102 0.477 . . . . 0.0 110.416 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 42.5 mt-10 -71.99 -34.84 69.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.504 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -63.47 -48.28 78.3 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.086 0.946 . . . . 0.0 108.935 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.6 tt -46.83 -61.33 1.9 Allowed 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.281 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.94 -25.02 40.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.428 -170.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -93.7 -37.68 11.7 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.644 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.0 t -118.82 -41.12 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -167.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.578 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 30.0 t80 -166.99 118.83 0.93 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.05 0.452 . . . . 0.0 111.809 -165.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.57 HD22 ' HD3' ' A' ' 28' ' ' LYS . 25.4 t-20 -85.25 91.06 8.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.528 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.557 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 49.0 p90 -86.17 18.81 2.92 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.698 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 27.6 mt-10 -102.1 -54.73 2.64 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 175.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.698 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 8.1 mptt -91.68 -19.56 22.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.694 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.555 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 2.4 m-20 -119.79 65.63 9.75 Favored Pre-proline 0 C--O 1.224 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.972 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -63.78 -44.98 11.85 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.754 2.302 . . . . 0.0 112.189 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -106.58 -11.73 15.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.014 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 40.7 mt-10 -91.05 131.21 36.78 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.643 ' HZ3' ' HE1' ' A' ' 88' ' ' PHE . 69.9 t-105 -94.54 88.79 5.57 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.222 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -97.37 106.35 18.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.262 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -108.94 124.76 51.19 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.969 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -119.16 131.51 55.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.985 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 167.12 162.14 18.08 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.885 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -97.53 -14.95 20.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.969 0.414 . . . . 0.0 110.803 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.457 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 9.9 mmtp -127.17 161.25 55.28 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HB3' HD11 ' A' ' 125' ' ' LEU . 23.4 Cg_exo -65.01 132.41 32.04 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.752 2.301 . . . . 0.0 110.1 166.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.52 138.36 43.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -168.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.757 ' HB ' HG12 ' A' ' 73' ' ' ILE . 4.6 mp -113.4 112.49 40.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 165.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.652 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 21.5 t -98.28 112.18 29.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.079 0.466 . . . . 0.0 110.297 -177.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.39 109.44 20.73 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.306 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 97.3 m-85 -94.14 111.68 23.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 174.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.695 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.7 p90 -132.66 167.71 19.6 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.493 0.663 . . . . 0.0 110.852 -175.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.411 ' H ' ' CB ' ' A' ' 53' ' ' CYS . . . -140.18 125.94 19.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.042 -1.435 . . . . 0.0 107.803 172.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -56.82 -40.33 75.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.437 ' HE1' ' HG2' ' A' ' 79' ' ' GLU . 62.2 p-90 -67.69 -8.61 36.55 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.6 t -98.37 126.63 43.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.942 0.401 . . . . 0.0 110.521 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.82 -61.85 6.97 Favored Glycine 0 CA--C 1.518 0.246 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.255 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -47.65 -41.44 30.59 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.959 2.439 . . . . 0.0 113.149 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.695 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 97.2 m -66.26 -44.26 84.15 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.78 -27.73 61.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.313 0.578 . . . . 0.0 109.502 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -61.23 -43.82 98.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.26 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.619 ' HB ' HD23 ' A' ' 60' ' ' LEU . 24.1 m -84.97 -20.52 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -174.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.467 ' HA ' ' NZ ' ' A' ' 75' ' ' LYS . . . -41.58 -53.31 7.55 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.91 -40.98 5.96 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 121.735 1.623 . . . . 0.0 112.448 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.2 mt -60.6 -42.72 92.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.238 0.542 . . . . 0.0 110.503 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.619 HD23 ' HB ' ' A' ' 56' ' ' VAL . 2.6 mm? -56.42 -42.35 77.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.46 176.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.493 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 11.1 t70 -62.97 -42.41 99.82 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.406 176.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.833 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 21.5 mm-40 -54.08 -56.63 16.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.25 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.538 HD21 ' HG3' ' A' ' 114' ' ' LYS . 3.7 mm? -67.07 -31.82 72.58 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.103 -175.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.416 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -59.83 -57.47 12.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.459 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.833 ' HE2' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -76.39 -25.98 55.13 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.825 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.23 -47.51 67.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.992 0.425 . . . . 0.0 111.39 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.511 ' HB2' HD11 ' A' ' 71' ' ' ILE . 12.4 m-85 -101.88 24.8 9.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.323 -175.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.41 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 19.9 t70 -55.79 143.6 30.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.172 0.51 . . . . 0.0 111.439 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.87 -37.58 3.68 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.631 -178.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 8.8 pt20 -110.08 -12.63 14.49 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.178 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 67' ' ' TYR . 43.9 pt -147.01 167.87 5.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.935 0.398 . . . . 0.0 110.685 174.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 39' ' ' LYS . 13.3 p -145.73 144.7 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 172.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.757 HG12 ' HB ' ' A' ' 42' ' ' ILE . 40.9 mt -121.07 139.12 49.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.322 -177.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.401 ' CE2' HD12 ' A' ' 12' ' ' ILE . 67.5 m-85 -115.49 162.93 16.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.431 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.545 ' HB3' ' CE1' ' A' ' 46' ' ' TYR . 54.1 mttm -135.64 132.06 36.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.849 0.357 . . . . 0.0 110.533 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.481 HG13 ' HG2' ' A' ' 81' ' ' GLU . 1.0 OUTLIER -131.46 137.32 55.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.482 -176.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -90.98 96.07 10.44 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.461 HG21 ' HA ' ' A' ' 92' ' ' SER . 17.0 m -60.13 -25.6 65.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -168.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.437 ' HG2' ' HE1' ' A' ' 49' ' ' TRP . 2.8 mp0 -55.28 -40.43 71.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.462 0.172 . . . . 0.0 111.191 175.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.501 ' CE ' HG22 ' A' ' 15' ' ' THR . 22.6 pttm -98.71 -22.19 16.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.304 0.573 . . . . 0.0 110.2 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.731 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 1.3 mp0 -89.53 34.89 0.82 Allowed 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.281 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.411 ' HA ' ' OE1' ' A' ' 82' ' ' GLN . 14.2 mm-40 -64.01 -42.49 97.13 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -64.52 -35.33 80.62 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.254 0.55 . . . . 0.0 110.062 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.6 tp -63.7 -47.6 80.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.901 176.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.537 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -60.71 -42.27 96.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.797 176.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.4 -31.05 75.95 Favored Glycine 0 CA--C 1.517 0.168 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.698 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.19 -41.5 97.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.789 0.328 . . . . 0.0 111.012 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.643 ' HE1' ' HZ3' ' A' ' 33' ' ' TRP . 76.2 m-85 -82.7 -22.2 34.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.692 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.13 31.67 9.58 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.582 HG13 ' HB2' ' A' ' 88' ' ' PHE . 6.2 mt -85.4 154.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.717 0.294 . . . . 0.0 110.544 -176.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -69.11 -81.82 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.436 0.636 . . . . 0.0 109.373 171.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.461 ' HA ' HG21 ' A' ' 78' ' ' THR . 65.9 m -158.99 -81.26 0.05 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.925 173.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.638 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 2.2 pp -151.08 149.67 25.5 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.237 -174.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.721 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 5.1 Cg_exo -83.5 149.2 62.66 Favored 'Cis proline' 0 C--N 1.346 0.437 0 C-N-CA 124.743 -0.94 . . . . 0.0 112.356 -2.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.556 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 39.6 t -140.99 130.61 24.04 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 107' ' ' MET . 23.3 mm -120.92 113.96 41.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.652 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 31.4 tp -102.05 115.5 30.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.792 -175.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -97.78 106.09 18.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.972 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 105' ' ' PRO . 53.6 mt -105.08 113.44 64.69 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.704 -174.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.8 155.54 20.55 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.466 2.111 . . . . 0.0 111.491 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 82.2 mtp -81.39 4.23 21.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.628 0.728 . . . . 0.0 110.823 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -151.27 117.43 5.59 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.974 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.14 -147.29 18.17 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.935 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.427 ' NZ ' ' HB3' ' A' ' 33' ' ' TRP . 51.7 mmtt -128.49 152.11 77.82 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.558 ' HB3' HG12 ' A' ' 99' ' ' ILE . 88.2 Cg_endo -79.59 147.96 20.16 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.752 2.301 . . . . 0.0 113.829 -172.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.439 ' O ' HD12 ' A' ' 97' ' ' LEU . 23.4 mm-40 -103.47 167.68 9.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.572 176.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 38.3 ttm -141.32 130.0 22.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.124 0.487 . . . . 0.0 111.958 -178.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.96 127.32 53.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.106 173.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -99.56 136.73 39.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.927 0.394 . . . . 0.0 111.541 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.721 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 106.95 174.13 22.78 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.806 -0.634 . . . . 0.0 114.635 171.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.92 86.7 5.54 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.818 -0.691 . . . . 0.0 111.464 -175.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.586 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 22.7 ptt? -87.53 158.43 51.47 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.651 171.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 74.4 Cg_endo -75.19 178.58 7.11 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.312 2.008 . . . . 0.0 112.847 -173.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.538 ' HG3' HD21 ' A' ' 63' ' ' LEU . 54.8 tttm -61.07 -28.7 69.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.047 177.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.79 -52.53 20.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.394 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 21.6 m -67.48 -32.76 73.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.774 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.52 ' O ' HG13 ' A' ' 121' ' ' ILE . 1.4 m-85 -62.23 -46.59 88.17 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.492 174.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -56.39 -44.27 80.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.525 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.59 ' HB3' ' OE1' ' A' ' 123' ' ' GLU . 9.2 mtpm? -63.06 -50.37 70.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.44 75.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.843 0.354 . . . . 0.0 111.32 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 117' ' ' PHE . 70.9 mt -74.23 -55.11 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.04 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.556 ' HA ' ' HB2' ' A' ' 126' ' ' LEU . 31.0 t0 -69.68 -57.93 4.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.573 -173.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.59 ' OE1' ' HB3' ' A' ' 119' ' ' LYS . 44.6 mt-10 -58.15 -23.12 54.09 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -170.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -116.22 -47.8 2.74 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 40' ' ' PRO . 30.1 tp -88.26 -38.7 15.01 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.488 -171.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 122' ' ' ASP . 73.5 mt -83.09 -52.96 6.16 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.431 0.634 . . . . 0.0 109.388 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.687 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 167.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . . . . . . 0 N--CA 1.448 -0.524 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.492 ' HG3' ' OD2' ' A' ' 61' ' ' ASP . 54.9 tttp -160.23 173.33 15.89 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.3 p -112.41 113.15 43.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.431 0.634 . . . . 0.0 110.129 174.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.8 mm -109.38 131.23 60.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.058 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.709 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 3.7 p80 -85.8 116.62 24.17 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.56 174.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.508 HD12 HG23 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -109.52 179.23 4.2 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.355 -176.099 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.6 p -100.53 164.23 11.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.952 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.706 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 35.6 pttt -61.91 -27.0 68.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.815 0.34 . . . . 0.0 110.511 176.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -41.09 96.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.656 174.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -71.71 -38.22 70.56 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.197 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.443 ' HE1' HG11 ' A' ' 43' ' ' VAL . 2.3 t80 -54.21 -53.81 48.44 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.813 0.816 . . . . 0.0 109.305 176.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.582 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 30.0 mt -50.56 -60.07 3.4 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 113.598 -1.637 . . . . 0.0 111.929 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.22 -36.63 39.75 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -102.79 -4.59 24.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -171.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 58.2 t -132.96 -51.99 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.582 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 7.5 t80 -179.19 131.0 0.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 110.746 -167.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.635 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 25.9 t-20 -91.21 136.24 33.23 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.655 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.404 ' HZ ' ' HB2' ' A' ' 16' ' ' LYS . 7.6 p90 -123.91 20.8 9.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.171 0.51 . . . . 0.0 110.547 175.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -105.64 -53.93 2.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.593 0.711 . . . . 0.0 109.798 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.498 ' HG2' ' OD1' ' A' ' 25' ' ' ASN . 22.0 ptmt -97.02 -12.61 23.05 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.526 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.859 HD22 ' HD2' ' A' ' 34' ' ' LYS . 5.0 m-20 -116.89 62.55 2.84 Favored Pre-proline 0 N--CA 1.473 0.723 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.239 174.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -63.43 -43.06 19.05 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.705 2.27 . . . . 0.0 112.614 174.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.516 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -100.59 -27.7 13.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.607 -175.92 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 37.7 mt-10 -92.69 128.67 38.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.044 0.449 . . . . 0.0 110.795 -177.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.421 ' HA ' ' CE1' ' A' ' 24' ' ' TYR . 44.3 t-105 -92.55 93.13 8.38 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.859 ' HD2' HD22 ' A' ' 29' ' ' ASN . 92.2 mttt -104.95 97.26 7.15 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.107 176.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.481 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 28.5 t80 -79.69 104.39 10.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.642 175.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -98.91 84.0 3.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.611 177.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.481 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -129.68 -143.51 5.47 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.844 -175.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -147.92 -64.64 0.26 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.8 0.333 . . . . 0.0 110.104 -173.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 70' ' ' GLN . 45.8 mttp -120.85 159.5 48.58 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.862 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.47 ' HG2' HG22 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -45.29 131.92 11.79 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.073 2.516 . . . . 0.0 112.084 179.054 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.52 139.18 54.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.567 -172.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.9 mt -117.76 114.57 45.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.418 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 16.4 t -101.76 112.99 36.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.791 0.329 . . . . 0.0 111.219 -176.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 8.2 t70 -92.56 112.13 23.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.969 176.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.477 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 75.6 m-85 -87.55 110.58 20.45 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 173.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.728 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 0.8 OUTLIER -132.11 163.83 27.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.159 0.504 . . . . 0.0 110.84 -175.365 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.406 ' N ' HG21 ' A' ' 93' ' ' ILE . . . -116.72 137.03 52.49 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.497 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 19.6 t70 -62.98 -29.48 70.85 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -174.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -85.74 -6.91 59.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.79 0.328 . . . . 0.0 111.177 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.7 t -84.27 106.95 16.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.903 0.382 . . . . 0.0 111.081 -175.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.09 -50.76 54.11 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.673 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -46.92 -47.93 15.43 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.71 2.273 . . . . 0.0 113.191 175.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.728 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 83.0 m -66.97 -32.54 73.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.477 . . . . 0.0 111.257 -177.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 71.1 mmtt -58.76 -29.51 66.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.597 175.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.545 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 31.2 mtm -67.69 -39.56 84.43 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.712 0.291 . . . . 0.0 111.239 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 53' ' ' CYS . 16.6 m -78.21 -26.47 14.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -172.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.608 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -51.31 -54.24 40.69 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.608 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 35.4 Cg_exo -61.61 -43.65 25.88 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 122.045 1.83 . . . . 0.0 112.283 176.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.5 mt -58.46 -49.9 80.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.305 0.574 . . . . 0.0 110.591 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.432 HD22 HD13 ' A' ' 73' ' ' ILE . 20.0 mt -61.92 -40.84 96.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.39 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.492 ' OD2' ' HG3' ' A' ' 10' ' ' LYS . 12.7 t70 -64.79 -45.71 85.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.956 0.408 . . . . 0.0 110.806 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -62.36 -51.1 68.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.999 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.66 -32.57 72.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.181 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.552 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -62.28 -34.96 77.57 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.465 ' C ' ' HD3' ' A' ' 65' ' ' LYS . 2.8 tmtm? -73.96 -38.17 64.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.885 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -62.27 -48.14 81.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.238 0.542 . . . . 0.0 110.573 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -90.89 26.09 2.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.8 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -57.07 139.76 51.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.678 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.83 -25.98 26.19 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.955 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.549 ' HG3' HG23 ' A' ' 71' ' ' ILE . 11.7 pt20 -116.23 -44.46 2.89 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -177.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.549 HG23 ' HG3' ' A' ' 70' ' ' GLN . 33.6 pt -117.38 150.3 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.798 -177.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.8 t -121.56 127.25 75.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.268 176.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.671 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 31.8 mt -109.63 133.67 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 121.331 0.586 . . . . 0.0 110.278 -178.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -121.43 171.65 8.62 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.732 0.777 . . . . 0.0 110.373 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.709 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 1.1 ptpm? -146.09 159.15 43.68 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 168.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.685 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 2.6 p -140.38 143.52 29.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.596 -174.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' HB2' ' NZ ' ' A' ' 80' ' ' LYS . 20.2 m-20 -82.97 90.73 7.03 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -174.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 85' ' ' ALA . 27.0 m -57.91 -24.54 58.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.085 -173.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.6 -40.84 84.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.762 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.409 ' NZ ' ' HB2' ' A' ' 77' ' ' ASP . 23.9 pttm -101.15 -22.59 14.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.097 0.475 . . . . 0.0 110.527 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.706 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 1.4 mp0 -89.06 42.89 1.11 Allowed 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.534 175.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -66.11 -38.39 88.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.072 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -65.92 -38.02 87.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.363 0.602 . . . . 0.0 109.672 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.1 tp -65.68 -50.43 64.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.734 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.509 ' HB2' HG23 ' A' ' 78' ' ' THR . . . -65.36 -39.89 92.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.989 0.423 . . . . 0.0 110.899 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.3 -27.58 69.49 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.882 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.04 -32.92 72.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.935 0.398 . . . . 0.0 110.85 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.551 ' HB2' HG12 ' A' ' 90' ' ' ILE . 90.5 m-85 -93.48 -3.41 53.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.646 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.15 13.39 74.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.005 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.551 HG12 ' HB2' ' A' ' 88' ' ' PHE . 26.9 mm -83.63 119.54 33.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.543 0.211 . . . . 0.0 110.517 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -59.53 -58.04 10.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 110.953 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.402 ' O ' HG21 ' A' ' 78' ' ' THR . 32.1 m -150.92 -96.96 0.06 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.7 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -146.86 163.18 30.21 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.903 -0.135 . . . . 0.0 111.043 -170.79 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.666 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 2.7 Cg_exo -89.18 150.16 26.81 Favored 'Cis proline' 0 C--N 1.347 0.498 0 C-N-CA 124.72 -0.95 . . . . 0.0 112.509 -4.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.477 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 34.7 t -140.68 145.28 36.32 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 107' ' ' MET . 30.5 mt -135.25 116.24 19.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.825 0.345 . . . . 0.0 110.304 -178.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.497 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 47.3 tp -102.91 116.61 32.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.403 -177.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -98.67 109.11 21.92 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.55 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 58.2 mt -104.48 113.39 65.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.691 -174.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -84.34 168.54 11.58 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.851 2.367 . . . . 0.0 111.786 174.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 87.2 mtp -82.31 -26.04 33.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.243 0.544 . . . . 0.0 109.949 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -130.66 138.1 49.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.223 176.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.69 161.35 36.66 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -92.37 143.93 28.12 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 117.377 0.589 . . . . 0.0 110.093 -177.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.55 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 27.5 Cg_endo -61.03 159.59 29.24 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.722 2.948 . . . . 0.0 114.3 -170.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -117.15 168.84 9.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.091 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 47.7 ttm -142.03 127.04 18.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.285 0.564 . . . . 0.0 112.224 -175.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.5 140.54 49.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -114.59 141.41 47.8 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.904 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.666 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 107.46 169.75 21.98 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.378 174.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.06 85.29 6.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.218 0.532 . . . . 0.0 111.358 -176.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.593 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 24.1 ptp -80.85 152.11 71.58 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.029 176.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.636 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 98.2 Cg_endo -75.26 -178.24 4.08 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.681 2.254 . . . . 0.0 112.062 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -62.24 -36.75 82.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.142 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.38 -37.63 74.56 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.941 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.636 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 71.8 m -72.82 -34.62 66.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.756 174.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.661 ' O ' HG12 ' A' ' 121' ' ' ILE . 2.1 m-85 -63.27 -51.82 64.58 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 121.126 -0.229 . . . . 0.0 110.792 176.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -57.02 -36.53 70.55 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.964 0.411 . . . . 0.0 110.503 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.467 ' NZ ' ' HB2' ' A' ' 119' ' ' LYS . 4.8 ttmp? -57.22 -42.7 81.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.884 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.83 -34.96 69.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.047 176.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.661 HG12 ' O ' ' A' ' 117' ' ' PHE . 37.2 mm -64.85 -56.02 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.698 -178.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.477 ' HA ' HD12 ' A' ' 126' ' ' LEU . 2.0 m-20 -66.64 -64.39 0.86 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.011 0.434 . . . . 0.0 110.951 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.75 -34.39 69.49 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.535 -171.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.453 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 63.4 t80 -108.26 -50.27 3.06 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 18.1 tp -81.43 -30.99 33.33 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.476 -169.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 122' ' ' ASP . 80.4 mt -87.44 -50.54 6.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.297 0.57 . . . . 0.0 109.635 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp . . . . . 0 C--N 1.322 -0.594 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 171.638 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.0 mmm . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.859 0.362 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.8 m -101.71 81.02 2.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.056 0.455 . . . . 0.0 110.877 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.815 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.2 pt? -97.1 -34.4 11.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.291 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.14 87.44 1.33 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.0 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 p -108.94 19.85 19.11 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.215 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.437 ' HG2' ' H ' ' A' ' 7' ' ' GLY . 24.9 tt0 56.59 -132.85 1.47 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.738 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.437 ' H ' ' HG2' ' A' ' 6' ' ' GLU . . . 81.81 -58.02 4.92 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.326 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -72.08 133.99 45.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 68.83 29.49 72.59 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.731 -175.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HG3' ' H ' ' A' ' 11' ' ' VAL . 43.1 tptt -137.12 173.23 11.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.2 p -122.18 107.99 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.578 0.704 . . . . 0.0 110.296 175.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 43.8 mm -108.81 132.21 57.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.202 -176.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.657 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 4.6 p80 -89.09 127.9 35.73 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.475 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 1.1 pp -128.28 -179.99 5.31 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.968 -172.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.443 ' HA ' ' OE1' ' A' ' 81' ' ' GLU . 45.3 p -104.36 174.84 5.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.244 177.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.498 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 13.0 pttm -64.45 -26.69 68.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 111.198 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.468 ' HA ' HD12 ' A' ' 20' ' ' LEU . . . -65.97 -40.31 91.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.311 0.577 . . . . 0.0 110.404 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.475 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -71.86 -34.51 69.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.804 178.638 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.458 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -59.07 -53.79 54.4 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.476 174.162 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.712 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 18.1 mt -46.91 -59.7 2.92 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.655 -1.612 . . . . 0.0 111.919 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.64 -48.48 72.06 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -170.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -104.13 -3.1 24.9 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.401 -170.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 61.1 t -129.06 -52.9 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.712 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 11.7 t80 -167.62 124.73 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.01 -164.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.71 91.4 7.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.951 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.512 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 25.2 p90 -79.99 12.99 2.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.11 0.481 . . . . 0.0 111.412 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -93.88 -53.07 4.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -83.46 -23.71 32.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.735 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.449 ' ND2' ' HB2' ' A' ' 34' ' ' LYS . 2.3 m-20 -121.58 69.37 23.63 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.376 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -57.58 -37.05 98.29 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.311 2.674 . . . . 0.0 112.279 173.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -105.13 -42.43 5.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.983 -174.437 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -94.98 178.19 5.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.362 0.601 . . . . 0.0 112.375 -174.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.799 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 19.1 t-105 -125.19 108.6 11.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.569 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.476 ' C ' ' HD3' ' A' ' 34' ' ' LYS . 8.6 tmtt? -110.7 112.63 24.64 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 172.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.527 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 13.9 t80 -80.8 124.95 29.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.548 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -101.05 8.48 42.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.422 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.423 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -88.4 150.56 21.99 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 -177.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -92.29 -30.07 16.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.078 0.465 . . . . 0.0 110.961 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -115.09 155.22 46.93 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.912 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 70' ' ' GLN . 47.8 Cg_exo -56.92 132.17 50.01 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.352 2.034 . . . . 0.0 111.381 174.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -117.05 154.98 30.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.476 0.655 . . . . 0.0 111.676 -175.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.429 HD13 HG12 ' A' ' 121' ' ' ILE . 78.3 mt -128.1 110.3 21.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.077 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 23.9 t -100.54 114.07 38.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.974 0.416 . . . . 0.0 111.114 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.609 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 4.4 t70 -90.8 113.8 26.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.181 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -84.88 111.04 19.29 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 170.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.689 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.4 p90 -132.33 159.0 40.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.289 0.566 . . . . 0.0 111.089 -177.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.447 ' CB ' HG12 ' A' ' 93' ' ' ILE . . . -128.14 128.85 45.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.007 171.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.532 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 28.3 t70 -63.47 -28.86 70.25 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.565 -170.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -75.63 -2.78 30.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.683 0.277 . . . . 0.0 111.732 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 42.5 t -103.43 127.72 50.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.939 0.4 . . . . 0.0 110.785 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.81 -61.43 7.34 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.661 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 72.1 Cg_exo -47.84 -47.54 18.46 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.761 2.307 . . . . 0.0 112.537 176.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.689 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 65.1 m -56.86 -29.45 62.9 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.03 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 62.8 mttm -73.8 -42.95 60.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.172 174.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.652 ' O ' HG12 ' A' ' 59' ' ' ILE . 26.1 mtm -59.89 -40.13 87.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.917 0.389 . . . . 0.0 111.396 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.501 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 11.5 p -64.04 -30.53 50.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.161 -171.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.684 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -57.53 -57.55 24.49 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 118.833 -0.603 . . . . 0.0 112.021 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.684 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 47.0 Cg_exo -57.82 -39.96 82.72 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 121.811 1.674 . . . . 0.0 112.539 174.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.652 HG12 ' O ' ' A' ' 55' ' ' MET . 21.0 mm -61.15 -49.42 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 121.709 0.766 . . . . 0.0 109.916 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.683 HD22 HD13 ' A' ' 73' ' ' ILE . 11.6 mt -63.93 -37.51 87.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.543 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -62.4 -44.29 96.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.418 0.628 . . . . 0.0 109.451 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -58.71 -55.61 32.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.363 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.431 HD21 ' HG3' ' A' ' 114' ' ' LYS . 4.4 mm? -66.72 -33.93 76.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.315 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.55 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -60.79 -46.05 92.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.952 0.406 . . . . 0.0 110.239 177.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.561 ' NZ ' ' HB3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -69.45 -31.52 69.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.716 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.02 -35.96 69.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.27 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -109.22 27.74 9.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.876 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.91 148.97 9.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.388 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.54 -44.5 2.59 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.843 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.442 ' HG3' HG23 ' A' ' 71' ' ' ILE . 9.4 pt20 -93.33 -38.62 11.39 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.442 HG23 ' HG3' ' A' ' 70' ' ' GLN . 38.9 pt -118.74 159.98 18.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.009 0.433 . . . . 0.0 111.713 -177.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 63.6 t -133.36 121.69 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.683 HD13 HD22 ' A' ' 60' ' ' LEU . 46.0 mt -103.86 139.43 24.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.486 0.66 . . . . 0.0 111.253 -175.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -128.04 173.49 10.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.898 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 0.6 OUTLIER -149.34 158.45 44.19 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 170.25 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.496 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 9.9 p -133.88 136.06 54.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.203 0.525 . . . . 0.0 110.438 -177.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.469 ' HB2' ' HZ2' ' A' ' 80' ' ' LYS . 3.6 m-20 -80.1 94.37 5.97 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.377 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.666 HG21 ' HA ' ' A' ' 92' ' ' SER . 74.6 m -58.49 -33.8 70.21 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -174.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -53.93 -31.16 49.4 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HZ2' ' HB2' ' A' ' 77' ' ' ASP . 14.6 pttp -106.21 -32.04 8.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.179 0.514 . . . . 0.0 110.504 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.498 ' OE2' ' HG2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -90.83 44.23 1.19 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.367 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -61.06 -37.18 81.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.428 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -70.58 -37.72 73.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.228 0.537 . . . . 0.0 110.072 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.1 -49.14 59.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.789 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.14 84.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.969 0.414 . . . . 0.0 111.077 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -66.84 -31.18 77.49 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.903 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.68 93.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 0.0 111.616 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.602 ' HB2' HG12 ' A' ' 90' ' ' ILE . 72.5 m-85 -85.91 -1.68 57.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.84 0.352 . . . . 0.0 110.898 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.01 15.85 78.07 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.33 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.602 HG12 ' HB2' ' A' ' 88' ' ' PHE . 48.9 mm -65.46 -25.14 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 122.587 0.355 . . . . 0.0 110.866 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 72.03 -67.77 0.25 Allowed 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.744 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.666 ' HA ' HG21 ' A' ' 78' ' ' THR . 33.7 m -151.77 -89.31 0.06 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.932 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.531 HG21 ' C ' ' A' ' 46' ' ' TYR . 2.4 pp -163.29 159.92 18.24 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.595 -170.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.577 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 2.3 Cg_endo -95.22 147.1 8.4 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 124.821 -0.908 . . . . 0.0 111.803 -4.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.4 t -141.73 138.77 32.6 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 107' ' ' MET . 30.7 mm -118.77 113.8 42.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 25.6 tp -98.0 112.71 24.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.527 -176.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.24 110.11 22.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.545 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 32.2 mt -101.69 106.17 45.1 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.153 -174.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.36 163.27 27.5 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.583 2.189 . . . . 0.0 111.95 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 92.3 mmm -85.16 0.29 52.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.479 0.657 . . . . 0.0 110.082 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -138.77 111.1 7.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.117 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.71 -158.83 18.5 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.24 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.799 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 42.7 mtpt -113.24 154.36 45.27 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.545 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 73.1 Cg_endo -75.34 140.49 24.6 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.83 2.353 . . . . 0.0 114.563 -170.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.432 ' CG ' ' HZ ' ' A' ' 124' ' ' PHE . 18.8 mp0 -91.35 169.93 10.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.578 173.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.555 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 21.4 ptp -142.01 144.38 33.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.025 0.441 . . . . 0.0 111.177 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -124.68 126.43 45.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.292 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -86.49 126.72 34.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.089 0.471 . . . . 0.0 111.375 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.577 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 100.29 155.72 27.78 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.436 175.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.501 ' HB1' ' HB ' ' A' ' 56' ' ' VAL . . . -87.59 87.33 7.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.342 0.591 . . . . 0.0 111.068 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.61 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 12.7 ptt? -68.26 162.95 56.72 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.283 173.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.566 ' HD2' ' HB2' ' A' ' 112' ' ' MET . 97.1 Cg_endo -75.09 179.14 6.4 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.633 2.222 . . . . 0.0 113.009 -173.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.431 ' HG3' HD21 ' A' ' 63' ' ' LEU . 58.3 tttp -54.81 -35.77 64.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.847 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.62 -52.76 19.18 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.915 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.61 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 18.8 m -66.12 -34.66 78.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.559 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.535 ' O ' HG13 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -63.94 -43.18 96.64 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.049 178.527 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.409 ' HZ2' ' HB3' ' A' ' 122' ' ' ASP . 1.6 ttpp -57.03 -40.67 77.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 0.0 110.075 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -66.74 -41.36 87.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.609 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.33 -36.88 71.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.977 0.418 . . . . 0.0 111.583 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.581 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 62.9 mt -73.99 -56.64 8.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.493 0.664 . . . . 0.0 110.69 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.409 ' HB3' ' HZ2' ' A' ' 118' ' ' LYS . 14.6 t0 -72.47 -64.77 0.88 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.169 -174.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.646 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 24.4 mt-10 -80.04 11.93 3.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.595 -169.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.609 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 58.5 t80 -138.46 -50.35 0.56 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.164 -0.214 . . . . 0.0 111.554 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.581 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 42.8 tp -73.54 -40.91 63.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.65 0.262 . . . . 0.0 110.59 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -90.81 -53.82 4.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.418 0.628 . . . . 0.0 109.306 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.646 ' HB3' ' HA ' ' A' ' 123' ' ' GLU . 52.1 tptt -81.52 70.47 8.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.702 0.763 . . . . 0.0 109.219 173.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 131' ' ' HIS . 17.8 pttp -77.31 67.66 3.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.916 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 133' ' ' HIS . 1.7 tp10 -72.7 -15.93 61.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.736 -176.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -100.24 7.5 58.48 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.492 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 128' ' ' LYS . 1.7 m-70 -118.05 106.51 12.97 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.54 -0.388 . . . . 0.0 111.377 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.9 m80 66.72 7.8 5.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.342 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.478 ' HB3' ' O ' ' A' ' 129' ' ' GLU . 70.7 t60 -100.09 106.33 18.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.195 0.522 . . . . 0.0 111.319 -176.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.41 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 3.9 p-80 -113.06 -19.52 11.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.128 173.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 134' ' ' HIS . 36.6 t-80 167.59 -46.8 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 113.372 -1.74 . . . . 0.0 107.1 165.805 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.415 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 110.695 -0.113 . . . . 0.0 110.695 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -171.37 157.26 4.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 tt -101.33 -72.08 0.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -161.03 136.61 7.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.908 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.5 m -156.49 98.06 1.79 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -114.6 -42.44 3.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.591 -179.229 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.8 -27.11 4.98 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.396 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.444 ' HA ' HG22 ' A' ' 72' ' ' VAL . 21.9 t-20 -67.67 133.7 49.8 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.481 ' C ' ' HD2' ' A' ' 10' ' ' LYS . . . 83.9 -8.59 65.81 Favored Glycine 0 CA--C 1.51 -0.271 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.445 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.481 ' HD2' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -131.77 174.62 9.95 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.618 -0.342 . . . . 0.0 110.265 -176.213 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.68 HG23 HG22 ' A' ' 73' ' ' ILE . 13.0 p -113.58 123.46 69.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.323 0.582 . . . . 0.0 110.653 173.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.6 mm -124.67 120.4 58.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.254 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.753 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 7.1 p80 -86.74 129.91 34.69 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.154 175.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -124.01 178.56 5.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.981 -172.172 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.604 HG22 ' HE2' ' A' ' 80' ' ' LYS . 41.3 p -93.07 171.46 8.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.686 175.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.457 ' HE3' ' HB3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -58.54 -37.4 75.6 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 178.752 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.44 ' N ' ' HG2' ' A' ' 16' ' ' LYS . . . -63.37 -37.93 89.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.477 0.656 . . . . 0.0 110.161 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 40.0 mt-10 -72.9 -34.82 66.89 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.751 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.474 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 6.8 t80 -54.89 -51.47 65.9 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 122.638 1.208 . . . . 0.0 108.761 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.656 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 25.9 mt -54.76 -58.39 7.76 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 112.481 -2.145 . . . . 0.0 111.931 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.94 -14.53 41.57 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -170.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 94.3 mttt -109.93 -5.84 15.37 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.202 -0.311 . . . . 0.0 111.368 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 59.4 t -141.02 -56.34 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.656 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 45.1 t80 -167.26 125.34 1.28 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.054 -164.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.539 ' OD1' ' HD3' ' A' ' 28' ' ' LYS . 2.8 t-20 -86.46 90.25 8.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.621 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -85.82 11.97 10.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.743 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 6.6 mt-10 -94.5 -54.29 3.58 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.938 0.875 . . . . 0.0 108.813 175.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.743 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 12.2 mptt -88.12 -23.45 23.67 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.628 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.57 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 2.0 m-20 -120.62 68.64 15.4 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.899 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -61.27 -43.7 27.36 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.966 2.444 . . . . 0.0 112.24 170.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -100.97 -29.93 11.92 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.161 0.505 . . . . 0.0 110.824 -175.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.57 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 22.9 mp0 -89.79 127.92 36.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.999 -169.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.543 ' HB2' ' NZ ' ' A' ' 104' ' ' LYS . 72.8 t-105 -89.95 89.57 7.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.223 0.535 . . . . 0.0 110.432 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.506 ' HE3' ' ND2' ' A' ' 29' ' ' ASN . 28.0 ttpp -106.24 97.74 7.51 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.764 175.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 83.0 t80 -85.41 119.64 26.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.893 176.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -112.62 85.54 2.18 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.451 0.643 . . . . 0.0 110.184 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -147.24 -154.04 6.1 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.984 -176.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -115.12 -58.84 2.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.247 0.546 . . . . 0.0 110.534 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 51.0 mttp -135.65 170.18 11.75 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.278 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 79.7 Cg_exo -45.25 132.52 11.85 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 122.735 2.29 . . . . 0.0 112.459 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -117.79 145.84 44.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.596 -171.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.414 HD11 HD12 ' A' ' 121' ' ' ILE . 75.0 mt -119.8 114.31 43.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.118 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 28.7 t -98.57 110.3 25.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.767 0.317 . . . . 0.0 110.836 -177.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.562 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 7.6 t70 -98.4 111.61 23.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.961 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.573 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 79.9 m-85 -90.38 112.12 23.6 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.768 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.2 p90 -133.77 179.06 6.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.39 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.655 ' HB3' HD13 ' A' ' 93' ' ' ILE . . . -154.79 173.34 16.59 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.484 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.463 ' HA ' ' HE3' ' A' ' 54' ' ' LYS . 20.6 t70 -80.68 -46.43 15.57 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -175.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.404 ' CZ2' HD11 ' A' ' 93' ' ' ILE . 51.8 p-90 -71.04 0.23 7.98 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -173.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.504 ' CB ' HD12 ' A' ' 93' ' ' ILE . 45.4 t -112.85 114.03 26.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.943 0.401 . . . . 0.0 110.292 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.2 -51.62 58.09 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.256 -0.747 . . . . 0.0 113.64 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -47.42 -37.7 25.87 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.969 2.446 . . . . 0.0 112.929 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 59.9 m -59.75 -39.84 86.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.47 0.653 . . . . 0.0 111.485 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HE3' ' HA ' ' A' ' 48' ' ' ASP . 99.4 mttt -79.04 -29.99 43.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.161 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.527 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 4.5 tmm? -62.44 -46.05 90.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.811 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.57 HG22 ' HG ' ' A' ' 60' ' ' LEU . 14.5 p -71.18 -26.21 26.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.944 -175.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.633 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -53.83 -56.33 26.54 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 36.5 Cg_exo -60.04 -47.06 16.31 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 121.708 1.605 . . . . 0.0 112.009 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.0 mt -58.34 -43.3 86.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.759 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.63 HD22 HD13 ' A' ' 73' ' ' ILE . 7.8 mt -64.87 -44.68 88.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.092 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.58 ' HB2' HG12 ' A' ' 11' ' ' VAL . 27.2 t70 -67.61 -40.96 84.72 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.403 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.18 -45.29 95.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.735 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 63' ' ' LEU . 16.6 tp -65.82 -34.76 78.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.823 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.609 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -64.99 -35.09 80.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.907 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.583 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 5.2 tmtm? -75.43 -32.5 60.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.483 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -52.5 -46.83 66.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.561 0.696 . . . . 0.0 109.968 172.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -104.97 28.08 7.53 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.578 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.583 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 9.0 t0 -48.88 131.01 18.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.229 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.34 -18.95 56.41 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.248 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -105.28 -48.81 3.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.635 0.255 . . . . 0.0 111.585 -176.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 40' ' ' PRO . 34.0 pt -122.85 159.82 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.4 0.619 . . . . 0.0 112.544 -173.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 27.4 t -125.39 127.91 72.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.42 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.68 HG22 HG23 ' A' ' 11' ' ' VAL . 20.5 mt -112.09 130.49 65.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.381 0.61 . . . . 0.0 110.824 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -114.2 165.64 12.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.614 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.753 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 47.9 mttm -132.14 153.46 50.49 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.487 173.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.53 HG13 ' HG2' ' A' ' 81' ' ' GLU . 4.7 t -127.14 121.44 57.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.738 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.406 ' HB2' ' HG2' ' A' ' 80' ' ' LYS . 11.3 m-20 -77.98 88.86 4.14 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 92' ' ' SER . 20.8 p -52.85 -30.02 31.25 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.111 0.481 . . . . 0.0 111.445 -175.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.473 ' CD ' ' HB1' ' A' ' 47' ' ' ALA . 2.6 mm-40 -50.56 -44.86 56.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.099 174.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.604 ' HE2' HG22 ' A' ' 15' ' ' THR . 19.3 pttm -103.33 -19.43 14.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.06 0.457 . . . . 0.0 110.672 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.53 ' HG2' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -97.85 42.87 1.08 Allowed 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.27 0.628 . . . . 0.0 111.453 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -57.24 -43.24 82.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.139 0.495 . . . . 0.0 110.812 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.36 -36.27 78.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.531 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.56 -47.77 74.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.565 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.56 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -63.94 -48.34 76.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.682 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.01 -32.76 76.48 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.129 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.06 -40.0 95.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.801 0.334 . . . . 0.0 111.525 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.438 ' HB2' HG13 ' A' ' 90' ' ' ILE . 96.4 m-85 -92.67 5.95 49.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.325 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.49 20.86 78.24 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.153 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 85' ' ' ALA . 26.4 mt -76.84 137.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.749 ' H ' ' HD2' ' A' ' 91' ' ' ARG . 3.0 mpt_? -71.59 -64.68 0.88 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.427 ' O ' HG21 ' A' ' 78' ' ' THR . 5.2 p -177.65 -85.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.368 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.655 HD13 ' HB3' ' A' ' 47' ' ' ALA . 13.9 pt -150.55 146.82 20.18 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -167.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.766 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 11.3 Cg_exo -86.65 150.48 42.09 Favored 'Cis proline' 0 N--CA 1.473 0.282 0 C-N-CA 124.513 -1.036 . . . . 0.0 110.722 -6.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 4.5 m -139.95 128.93 23.5 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 107' ' ' MET . 57.0 mt -128.02 114.32 34.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.745 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.62 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.7 tp -102.45 113.32 26.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.74 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -92.3 102.62 15.11 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.849 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.567 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 65.4 mt -97.61 113.17 63.12 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.61 -175.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -86.5 165.34 9.33 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.742 2.294 . . . . 0.0 111.547 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 93.1 mmm -89.7 2.44 54.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.562 0.696 . . . . 0.0 109.345 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -140.82 98.25 3.36 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.844 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.16 -162.49 13.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.862 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.543 ' NZ ' ' HB2' ' A' ' 33' ' ' TRP . 25.8 mmmt -98.49 150.46 36.74 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.567 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 5.7 Cg_exo -79.36 155.94 25.27 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.196 2.597 . . . . 0.0 112.987 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 107' ' ' MET . 29.3 tt0 -109.07 163.6 13.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.133 174.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.596 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 22.4 ptp -142.74 129.06 19.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.359 0.599 . . . . 0.0 111.202 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.31 156.55 27.63 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.883 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -116.89 137.81 51.96 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.221 0.534 . . . . 0.0 111.364 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.766 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 104.59 150.46 20.55 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.195 178.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -84.5 88.23 7.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.166 0.508 . . . . 0.0 111.342 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.516 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 25.2 ptp -69.68 164.74 47.91 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.524 172.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.606 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 74.3 Cg_endo -75.41 169.27 22.78 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.847 1.698 . . . . 0.0 111.621 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -55.69 -32.15 63.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.516 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 118' ' ' LYS . . . -71.33 -47.51 56.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.167 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.606 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 50.2 m -64.72 -33.8 76.82 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.687 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.696 ' O ' HG12 ' A' ' 121' ' ' ILE . 7.4 m-85 -61.57 -39.56 91.57 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.604 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.597 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 3.8 mmmm -54.01 -52.39 60.95 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.171 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.526 ' HG3' ' OE2' ' A' ' 123' ' ' GLU . 51.7 tttp -64.5 -32.98 74.84 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.677 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.546 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.32 -40.39 70.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.992 0.425 . . . . 0.0 111.214 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.696 HG12 ' O ' ' A' ' 117' ' ' PHE . 31.3 mm -73.58 -55.61 11.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.8 0.333 . . . . 0.0 110.278 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -65.36 -68.47 0.36 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.961 0.41 . . . . 0.0 110.825 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.526 ' OE2' ' HG3' ' A' ' 119' ' ' LYS . 48.2 mt-10 -77.4 12.0 1.74 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -169.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.546 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 77.8 t80 -143.51 -53.4 0.36 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.686 175.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 44.0 tp -69.6 -39.13 77.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.489 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 80.2 mt -88.54 -60.26 2.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.509 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 14.1 ttpp -103.0 81.2 1.95 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.429 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -62.66 123.62 18.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.985 0.421 . . . . 0.0 110.2 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -69.22 165.26 20.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.466 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.43 -41.09 2.63 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.752 -174.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -95.27 10.3 36.63 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 122.75 0.42 . . . . 0.0 110.685 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -69.64 117.85 11.76 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.599 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 45.53 69.84 0.41 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.068 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -135.72 -179.81 5.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.754 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -93.6 0.23 56.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.196 0.522 . . . . 0.0 109.643 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 . . . . . 0 C--O 1.245 0.826 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.815 179.41 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.488 ' H3 ' ' CD ' ' A' ' 6' ' ' GLU . 48.9 mtt . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 110.551 -0.166 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.4 t 71.05 18.98 5.74 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.169 0.509 . . . . 0.0 110.599 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 60.2 tp -100.67 -70.53 0.74 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.232 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -171.81 -62.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.199 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.5 m -84.28 96.43 9.01 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.679 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.488 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 23.1 mm-40 -70.29 -21.14 62.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.347 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.21 29.29 56.71 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.737 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -85.65 167.72 15.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.879 0.371 . . . . 0.0 111.714 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 57.16 41.51 92.78 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -174.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -150.4 152.3 34.14 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.852 0.834 . . . . 0.0 112.456 -167.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.731 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 5.0 p -134.83 119.48 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.098 174.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 60.0 mt -117.37 116.98 53.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.415 -173.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.738 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 11.0 p80 -83.8 119.67 25.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.842 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 2.0 pp -127.84 171.96 11.28 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.229 -171.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.7 p -99.18 177.89 5.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.161 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 19' ' ' PHE . 63.5 pttt -59.22 -25.24 63.83 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 20' ' ' LEU . . . -68.49 -44.17 75.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.284 0.564 . . . . 0.0 110.233 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.842 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 3.2 mp0 -72.24 -33.71 67.75 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.399 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.55 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -55.08 -49.23 72.19 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.007 0.908 . . . . 0.0 109.201 174.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.685 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 13.9 mt -50.58 -61.15 2.36 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.357 -1.747 . . . . 0.0 111.742 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.11 -7.58 59.62 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -169.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.02 -33.88 6.37 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 70.3 t -125.03 -40.78 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -169.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.685 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 21.5 t80 -164.95 117.88 1.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.866 -166.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.621 ' OD1' ' HD3' ' A' ' 28' ' ' LYS . 2.6 t-20 -91.66 89.68 7.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.485 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.657 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 18.9 p90 -81.12 6.89 12.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -86.16 -53.41 5.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.831 0.824 . . . . 0.0 108.903 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.621 ' HD3' ' OD1' ' A' ' 25' ' ' ASN . 11.0 mptt -88.43 -23.41 23.3 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.426 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.743 HD22 ' HE3' ' A' ' 34' ' ' LYS . 2.1 m-20 -118.69 61.54 4.9 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.195 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.17 -44.71 44.04 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.683 2.255 . . . . 0.0 112.112 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.21 -13.7 15.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.852 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.45 ' O ' ' HE1' ' A' ' 24' ' ' TYR . 44.9 mt-10 -91.09 144.08 26.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.271 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.505 ' CZ2' ' HG2' ' A' ' 105' ' ' PRO . 65.0 t-105 -108.36 109.17 20.42 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 171.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.743 ' HE3' HD22 ' A' ' 29' ' ' ASN . 27.1 ttpp -134.21 117.65 16.73 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.621 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 29.4 t80 -90.05 110.97 21.93 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.714 -175.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.413 ' OE1' ' HG2' ' A' ' 34' ' ' LYS . 4.5 mm-40 -84.53 40.81 0.81 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.548 -176.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.613 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -98.3 165.7 21.73 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.731 -171.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -101.47 -56.88 2.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.302 0.572 . . . . 0.0 109.828 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -116.36 166.6 12.2 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.264 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.567 ' HB2' HG22 ' A' ' 71' ' ' ILE . 36.7 Cg_exo -55.83 137.15 77.78 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.165 1.91 . . . . 0.0 111.324 175.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -121.6 146.2 47.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.322 0.582 . . . . 0.0 112.02 -173.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.509 ' HB ' HG12 ' A' ' 73' ' ' ILE . 64.5 mt -113.18 112.31 39.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.905 172.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.793 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 20.7 t -98.94 113.59 34.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.863 0.363 . . . . 0.0 110.848 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.614 ' HB2' HD13 ' A' ' 60' ' ' LEU . 6.7 t70 -92.69 108.69 20.18 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.108 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.545 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 13.7 m-85 -88.07 109.94 20.25 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 171.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.767 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 3.9 p90 -130.25 160.77 32.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.186 0.517 . . . . 0.0 110.671 -175.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 50' ' ' CYS . . . -119.49 131.67 55.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.105 169.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.63 -11.26 59.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.01 0.434 . . . . 0.0 111.152 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.406 ' HE1' ' HG2' ' A' ' 79' ' ' GLU . 65.8 p-90 -102.23 -6.39 23.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.096 176.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 50.2 t -88.73 118.05 28.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.81 0.338 . . . . 0.0 110.954 -174.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 54' ' ' LYS . . . -52.13 -57.3 13.47 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.595 -0.729 . . . . 0.0 113.628 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.462 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 83.2 Cg_exo -47.32 -46.35 20.09 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.026 2.484 . . . . 0.0 113.552 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.767 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 74.9 m -68.78 -37.25 79.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.854 0.359 . . . . 0.0 111.215 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 68.1 mttm -55.25 -28.69 55.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.81 173.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 79.9 mtp -75.08 -50.92 14.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.025 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.58 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 32.8 m -71.82 -39.32 67.78 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -173.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -49.75 -56.8 14.82 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 23.3 Cg_exo -63.9 -35.76 53.84 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.732 1.622 . . . . 0.0 111.574 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.887 HG23 ' HB3' ' A' ' 114' ' ' LYS . 56.6 mt -62.75 -42.55 96.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.677 0.751 . . . . 0.0 110.464 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' A' ' 44' ' ' ASP . 28.2 mt -68.82 -35.51 77.07 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.119 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.563 ' OD1' HG11 ' A' ' 11' ' ' VAL . 57.1 m-20 -62.19 -45.77 91.91 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 173.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -54.92 -47.08 74.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.698 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.48 HD21 ' HB2' ' A' ' 114' ' ' LYS . 74.4 mt -69.3 -29.9 67.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.824 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.79 -42.65 84.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.826 0.346 . . . . 0.0 110.372 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.73 -28.69 58.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.396 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.464 ' CD ' ' HZ1' ' A' ' 114' ' ' LYS . 4.6 tt0 -80.62 -41.52 23.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.473 ' HE1' HD22 ' A' ' 63' ' ' LEU . 57.8 m-85 -98.94 24.96 7.11 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.847 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -64.53 163.57 13.27 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.232 0.539 . . . . 0.0 111.704 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.23 -50.51 3.88 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.296 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.511 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 23.9 pt20 -90.09 -40.33 12.34 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 -177.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.567 HG22 ' HB2' ' A' ' 40' ' ' PRO . 26.9 pt -127.56 166.77 23.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.293 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 51.4 t -134.06 139.5 48.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.731 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 39.1 mt -108.08 142.13 21.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.072 -175.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -127.47 165.96 18.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.799 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.738 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 86.1 mttt -132.39 166.36 22.15 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.56 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 5.1 p -146.06 133.49 15.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.169 0.509 . . . . 0.0 109.673 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 8.0 m-20 -81.98 91.89 6.68 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.489 HG21 ' HA ' ' A' ' 92' ' ' SER . 18.0 m -66.95 -27.66 67.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.304 -167.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.406 ' HG2' ' HE1' ' A' ' 49' ' ' TRP . 3.2 mp0 -54.28 -38.95 66.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.794 0.331 . . . . 0.0 110.917 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -95.7 -34.88 11.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.101 0.477 . . . . 0.0 109.987 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.56 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -82.26 30.75 0.4 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.671 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -63.13 -26.74 68.96 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -61.94 -45.33 94.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.617 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -70.8 -53.19 16.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.142 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -54.3 -51.51 64.41 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.496 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.55 -27.84 66.68 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.322 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.78 -26.99 67.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.645 0.26 . . . . 0.0 111.574 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.574 ' HB2' HG13 ' A' ' 90' ' ' ILE . 83.4 m-85 -100.86 -5.08 26.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.887 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.13 4.77 64.44 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.878 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 85' ' ' ALA . 36.8 mt -65.97 128.93 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -69.13 -53.42 20.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.265 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.489 ' HA ' HG21 ' A' ' 78' ' ' THR . 11.3 p 178.14 -94.83 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.714 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.519 HG21 ' C ' ' A' ' 46' ' ' TYR . 0.2 OUTLIER -145.07 157.59 53.6 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.613 -173.829 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.668 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 8.3 Cg_exo -83.53 133.39 20.86 Favored 'Cis proline' 0 N--CA 1.474 0.367 0 C-N-CA 124.71 -0.954 . . . . 0.0 111.995 -3.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 4.9 m -126.84 122.04 33.59 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 107' ' ' MET . 19.7 mm -114.36 114.66 47.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.205 -176.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.793 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.9 tp -99.77 114.76 28.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.015 0.436 . . . . 0.0 110.761 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 105' ' ' PRO . 97.5 m-85 -97.07 102.86 14.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.086 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.796 HG12 ' HB3' ' A' ' 105' ' ' PRO . 34.2 mt -107.02 106.46 58.35 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -176.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -87.1 165.9 8.36 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.771 2.314 . . . . 0.0 111.665 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.5 mmm -86.74 -1.93 58.13 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.981 0.419 . . . . 0.0 111.064 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -153.28 112.73 3.83 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 129.6 -136.17 8.81 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.536 ' HB3' ' HZ2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -137.38 151.16 70.81 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 175.313 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.796 ' HB3' HG12 ' A' ' 99' ' ' ILE . 3.8 Cg_exo -77.77 114.05 3.58 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.903 2.402 . . . . 0.0 111.22 175.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -95.69 167.18 11.44 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.315 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.508 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 49.0 ttm -140.06 130.97 26.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.444 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.97 141.66 48.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.44 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.508 ' OE1' ' HA ' ' A' ' 95' ' ' SER . 12.3 mm100 -106.13 134.73 48.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.874 0.369 . . . . 0.0 111.616 -175.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.668 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 114.39 177.15 19.06 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 169.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.58 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -94.2 87.61 5.32 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.508 -0.846 . . . . 0.0 111.932 -174.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.589 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 23.3 ptp -96.36 150.85 37.62 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.556 171.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.545 ' HA ' HD13 ' A' ' 59' ' ' ILE . 74.9 Cg_endo -75.49 173.19 14.92 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.343 2.029 . . . . 0.0 111.534 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.887 ' HB3' HG23 ' A' ' 59' ' ' ILE . 21.4 ptmt -63.17 -22.91 67.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.898 0.38 . . . . 0.0 110.284 177.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.97 -52.94 45.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.665 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.589 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 36.0 m -67.58 -34.06 76.27 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.235 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.535 ' HB2' ' HA ' ' A' ' 114' ' ' LYS . 7.3 m-85 -59.25 -47.01 86.97 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.489 174.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.512 ' NZ ' ' HB2' ' A' ' 122' ' ' ASP . 5.8 tmtm? -55.42 -35.92 65.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.346 0.117 . . . . 0.0 110.743 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.551 ' HG2' ' OE1' ' A' ' 123' ' ' GLU . 62.0 tttm -64.03 -57.07 10.76 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.397 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.39 95.8 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.72 HG23 HD23 ' A' ' 125' ' ' LEU . 77.3 mt -59.46 -44.95 93.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.861 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.512 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 10.0 t70 -62.79 -62.97 1.36 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.66 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.731 ' HA ' ' HZ3' ' A' ' 127' ' ' LYS . 62.2 mt-10 -63.13 -0.8 0.82 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -167.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 69.2 t80 -151.63 -48.41 0.11 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.649 -0.821 . . . . 0.0 112.528 175.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.72 HD23 HG23 ' A' ' 121' ' ' ILE . 42.4 tp -66.9 -30.62 70.81 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.633 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 74.6 mt -109.28 -56.3 2.31 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.854 0.835 . . . . 0.0 109.5 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.731 ' HZ3' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -108.13 80.39 1.36 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.331 -179.053 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.835 ' H ' ' HD3' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -80.63 112.28 17.84 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.275 0.56 . . . . 0.0 110.172 179.339 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.53 ' HB2' ' CE1' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -62.78 -22.51 66.66 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.669 177.031 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.3 -102.9 1.64 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.272 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.53 ' CE1' ' HB2' ' A' ' 129' ' ' GLU . 33.8 m80 49.77 -86.95 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.985 0.914 . . . . 0.0 112.694 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -68.06 -8.8 40.97 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.786 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -125.2 -84.77 0.64 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -78.45 97.07 5.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -65.44 -54.41 28.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 69.8 t60 . . . . . 0 C--O 1.241 0.612 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.637 177.417 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttm . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -85.96 -170.89 3.31 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 172.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.79 -68.35 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.702 0.287 . . . . 0.0 110.464 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -168.65 -80.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.686 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.0 m 63.33 88.95 0.09 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.514 0.673 . . . . 0.0 110.177 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.491 ' O ' ' HD3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -98.45 116.82 31.5 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.508 0.671 . . . . 0.0 112.092 -172.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.4 67.05 3.39 Favored Glycine 0 C--O 1.222 -0.597 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.413 ' O ' ' HD2' ' A' ' 10' ' ' LYS . 26.4 t-20 -144.76 109.8 5.1 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 122.324 0.25 . . . . 0.0 110.684 -172.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.2 1.65 81.38 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.488 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -135.8 175.26 9.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.968 0.413 . . . . 0.0 110.431 178.112 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.848 HG22 ' HB ' ' A' ' 73' ' ' ILE . 39.7 t -114.02 143.35 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.244 -172.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.8 mt -124.3 107.96 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.734 172.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.748 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 9.8 p80 -83.32 116.31 22.39 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 173.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.733 HD22 ' HB3' ' A' ' 18' ' ' GLU . 1.1 pp -132.92 179.99 5.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.985 -166.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.698 HG22 ' HE2' ' A' ' 80' ' ' LYS . 66.4 p -94.0 175.25 6.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.589 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.533 ' HD2' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -59.62 -32.28 70.28 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 121.233 -0.187 . . . . 0.0 111.233 177.825 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.559 ' HA ' HD12 ' A' ' 20' ' ' LEU . . . -62.84 -41.89 99.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.468 0.651 . . . . 0.0 110.218 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.733 ' HB3' HD22 ' A' ' 14' ' ' LEU . 8.4 mm-40 -71.72 -36.4 70.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.366 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -56.92 -50.72 71.71 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 122.388 1.089 . . . . 0.0 109.452 175.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.643 HD22 HD22 ' A' ' 25' ' ' ASN . 16.1 mt -50.34 -59.0 4.41 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 112.838 -1.983 . . . . 0.0 111.857 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.3 -17.87 38.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -171.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -110.81 -1.37 16.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.6 t -140.34 -50.69 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 7.5 t80 -175.14 116.02 0.16 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.155 0.502 . . . . 0.0 110.64 -167.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.643 HD22 HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -87.19 90.97 8.55 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.242 -177.265 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.522 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 18.9 p90 -78.4 14.96 1.07 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.83 -46.75 7.7 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.622 ' C ' HD22 ' A' ' 29' ' ' ASN . 49.9 mttp -96.31 -21.1 18.02 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.069 -173.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.622 HD22 ' C ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -121.11 62.97 11.63 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.366 177.212 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -61.26 -42.1 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.762 2.308 . . . . 0.0 112.374 172.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.589 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -103.02 -24.16 13.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.303 -176.365 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.404 ' CD ' ' HZ2' ' A' ' 34' ' ' LYS . 35.8 mt-10 -90.13 148.96 22.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.199 0.523 . . . . 0.0 111.259 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -113.95 93.77 4.52 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 168.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.404 ' HZ2' ' CD ' ' A' ' 32' ' ' GLU . 35.7 mtmm -117.51 106.33 13.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.402 173.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.578 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 30.2 t80 -68.14 105.12 1.97 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.368 0.604 . . . . 0.0 109.831 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -90.22 84.22 6.06 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.565 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -149.52 -135.69 2.51 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.731 -174.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -141.54 -55.34 0.47 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.898 0.38 . . . . 0.0 111.055 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 43.6 mttp -129.33 168.71 15.27 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.814 -177.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 65.8 Cg_exo -49.18 131.36 26.3 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.99 1.794 . . . . 0.0 111.393 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -115.32 143.23 45.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.365 -170.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.676 ' HB ' HG12 ' A' ' 73' ' ' ILE . 65.4 mt -120.33 122.49 68.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.124 176.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 16.5 t -105.74 116.02 48.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.894 0.378 . . . . 0.0 110.984 -178.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.778 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 11.3 t0 -97.78 108.11 20.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.634 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -91.27 111.64 23.21 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.593 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 0.8 OUTLIER -147.02 178.6 8.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.735 0.779 . . . . 0.0 111.286 -172.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.65 124.07 5.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.855 -1.52 . . . . 0.0 107.449 170.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.28 -23.06 67.25 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -169.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -74.95 -14.07 60.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.951 0.405 . . . . 0.0 110.766 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.1 t -99.64 132.93 44.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.475 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.561 ' O ' ' HG2' ' A' ' 54' ' ' LYS . . . -49.14 -68.23 1.42 Allowed Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.716 -0.674 . . . . 0.0 114.672 -175.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -58.71 -34.27 98.84 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.71 2.273 . . . . 0.0 113.107 -175.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.749 ' SG ' ' HB ' ' A' ' 93' ' ' ILE . 11.9 m -73.98 -33.88 64.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.896 0.379 . . . . 0.0 111.514 -176.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 0.2 OUTLIER -78.85 -27.2 44.11 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.581 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 16.4 ttt -66.93 -52.41 43.46 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.166 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.509 HG22 HD22 ' A' ' 60' ' ' LEU . 3.9 p -63.45 -36.77 77.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.046 -174.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.692 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -48.07 -60.28 4.58 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.326 -176.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.692 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 27.3 Cg_exo -62.21 -27.49 78.46 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.231 1.287 . . . . 0.0 112.272 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 55' ' ' MET . 45.0 mm -66.19 -57.28 11.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.34 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.571 HD21 ' NZ ' ' A' ' 75' ' ' LYS . 1.2 pt? -71.69 -30.03 65.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.178 -177.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.49 ' OD1' HG21 ' A' ' 11' ' ' VAL . 5.6 m-20 -66.43 -42.54 87.56 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.458 0.647 . . . . 0.0 109.846 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.531 ' HG3' ' NZ ' ' A' ' 114' ' ' LYS . 9.8 tp10 -54.79 -43.3 72.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.925 172.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.795 HD21 ' HA ' ' A' ' 118' ' ' LYS . 12.9 tp -71.52 -30.79 66.34 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.073 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.69 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -58.73 -59.07 6.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.745 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -64.7 -24.26 67.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.231 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -58.54 -30.86 67.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.462 0.649 . . . . 0.0 110.044 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.501 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 81.3 m-85 -113.75 25.74 10.96 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.447 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -52.36 114.46 1.37 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.93 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.04 -22.24 5.13 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.414 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 6.4 pt20 -127.55 -22.3 3.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 64' ' ' ALA . 44.0 pt -125.24 150.34 30.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.418 0.628 . . . . 0.0 112.218 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 47.2 t -127.27 132.09 69.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.284 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.848 ' HB ' HG22 ' A' ' 11' ' ' VAL . 11.8 mt -115.62 136.45 52.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.474 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -117.1 161.19 19.82 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.778 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 63.8 mttm -129.69 148.21 51.56 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.012 0.434 . . . . 0.0 110.23 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.424 HG13 ' CB ' ' A' ' 81' ' ' GLU . 17.4 t -120.64 111.83 33.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.739 176.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.42 89.2 2.64 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.533 HG21 ' O ' ' A' ' 92' ' ' SER . 7.9 p -52.87 -36.96 59.78 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -168.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.419 ' HG2' ' H ' ' A' ' 79' ' ' GLU . 1.1 mm-40 -53.43 -33.22 53.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.568 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.698 ' HE2' HG22 ' A' ' 15' ' ' THR . 18.1 pttm -103.45 -22.21 13.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.397 0.618 . . . . 0.0 110.161 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -100.11 43.24 1.07 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.657 178.656 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -55.1 -46.71 75.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.964 0.411 . . . . 0.0 111.419 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -64.55 -38.74 92.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.735 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -70.05 -44.88 68.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.966 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.04 89.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.035 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.51 -29.5 73.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.963 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.54 -26.45 65.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 111.54 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -99.17 7.24 45.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.054 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.29 16.64 80.56 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.324 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.4 mm -77.63 122.11 31.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -58.88 -61.8 2.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.505 0.669 . . . . 0.0 109.592 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.533 ' O ' HG21 ' A' ' 78' ' ' THR . 13.9 m -160.82 -79.71 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.674 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.749 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 4.5 pt -162.02 152.77 14.75 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.182 -172.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.719 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.6 Cg_exo -90.01 149.54 22.61 Favored 'Cis proline' 0 C--N 1.348 0.552 0 CA-C-N 118.869 0.632 . . . . 0.0 112.286 -3.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.416 ' HB3' ' SD ' ' A' ' 107' ' ' MET . 50.1 m -142.67 140.99 31.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.58 114.48 20.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.156 0.503 . . . . 0.0 110.138 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.554 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 43.7 tp -97.31 115.25 27.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.455 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.439 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 44.3 m-85 -96.2 104.68 16.65 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.437 HG23 ' HG3' ' A' ' 105' ' ' PRO . 53.8 mt -102.57 102.83 28.33 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.347 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 98' ' ' PHE . 73.8 Cg_endo -83.7 155.66 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.579 2.186 . . . . 0.0 111.763 174.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.403 ' SD ' ' HD3' ' A' ' 40' ' ' PRO . 90.4 mtp -75.27 -30.35 60.41 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -106.5 138.93 41.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.633 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.2 -140.1 16.61 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.922 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.667 ' HE3' ' HA ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -139.38 154.65 71.97 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.613 ' HD3' ' HE3' ' A' ' 104' ' ' LYS . 15.6 Cg_exo -69.47 154.34 69.01 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.1 2.533 . . . . 0.0 113.574 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.475 ' O ' HD12 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.56 169.72 9.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.829 176.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.416 ' SD ' ' HB3' ' A' ' 95' ' ' SER . 32.9 tpp -142.37 105.61 4.61 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.107 -174.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.93 137.37 42.01 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -117.41 137.74 52.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.159 0.504 . . . . 0.0 111.536 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.719 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 103.16 170.43 26.05 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.967 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -94.69 82.75 3.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.095 0.474 . . . . 0.0 111.65 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.586 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 22.0 ptt? -79.59 166.44 41.22 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 170.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.586 ' HD2' ' HB2' ' A' ' 112' ' ' MET . 65.9 Cg_endo -75.17 170.73 19.73 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.558 1.505 . . . . 0.0 112.541 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.531 ' NZ ' ' HG3' ' A' ' 62' ' ' GLU . 60.5 tttp -57.54 -25.37 59.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.971 174.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.64 -52.44 31.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.336 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.5 m -68.04 -37.74 81.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.697 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.679 ' O ' HG12 ' A' ' 121' ' ' ILE . 12.7 m-85 -61.48 -43.56 98.64 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.634 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.795 ' HA ' HD21 ' A' ' 63' ' ' LEU . 64.6 tttp -60.6 -38.84 86.01 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.108 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -62.87 -43.93 97.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.869 0.366 . . . . 0.0 110.741 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -64.0 -41.1 97.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.253 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.679 HG12 ' O ' ' A' ' 117' ' ' PHE . 16.3 mm -74.93 -53.9 15.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.437 0.637 . . . . 0.0 110.998 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.548 ' HA ' HD12 ' A' ' 126' ' ' LEU . 19.0 t70 -68.45 -66.03 0.62 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.314 -173.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.6 -49.36 71.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.767 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.543 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 79.2 t80 -86.09 -37.61 18.65 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -170.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.622 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 29.5 tp -90.52 -38.31 13.29 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 122' ' ' ASP . 79.6 mt -89.07 -66.84 0.88 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.911 0.386 . . . . 0.0 111.689 -173.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.04 81.65 5.61 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -51.69 96.9 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.282 0.989 . . . . 0.0 111.983 -170.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -19.41 12.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.7 170.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.56 -19.01 39.9 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.532 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -58.02 -34.76 70.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.89 0.376 . . . . 0.0 110.162 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -147.82 61.58 1.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.896 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -78.07 68.72 4.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.423 0.63 . . . . 0.0 109.468 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -169.21 155.73 6.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.405 ' O ' ' HB2' ' A' ' 136' ' ' HIS . 73.7 m-70 -76.99 43.92 0.37 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.405 ' HB2' ' O ' ' A' ' 135' ' ' HIS . 58.2 t-80 . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.852 -0.594 . . . . 0.0 109.508 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.51 ' HB3' HD23 ' A' ' 3' ' ' LEU . 1.8 mpt? . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.147 0.022 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.6 m 75.82 -31.2 0.2 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.346 0.658 . . . . 0.0 112.674 174.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 1' ' ' MET . 2.6 pt? -78.15 16.9 0.68 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.76 0.315 . . . . 0.0 111.483 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.64 157.5 9.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.964 0.412 . . . . 0.0 111.047 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.6 t -99.82 14.95 28.56 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.987 0.423 . . . . 0.0 111.372 -175.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.3 125.73 45.58 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.593 ' HA2' ' HE2' ' A' ' 10' ' ' LYS . . . -141.59 28.27 2.31 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.74 -174.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 29.2 m-80 -72.88 134.76 44.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.244 0.522 . . . . 0.0 110.667 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . 69.84 22.2 76.88 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.749 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.593 ' HE2' ' HA2' ' A' ' 7' ' ' GLY . 17.8 pttm -162.83 171.74 16.23 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 121.286 0.565 . . . . 0.0 110.968 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.536 HG21 ' HE3' ' A' ' 75' ' ' LYS . 7.9 m -113.16 145.08 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.382 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.1 mt -114.38 96.76 4.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.058 174.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.538 ' HA ' ' HB2' ' A' ' 75' ' ' LYS . 27.1 p80 -77.71 121.89 24.63 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.76 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.4 pp -138.38 178.63 7.0 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.228 0.537 . . . . 0.0 112.282 -169.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.633 HG22 ' HE2' ' A' ' 80' ' ' LYS . 42.6 p -98.42 171.39 8.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.484 175.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.535 ' HZ1' ' CD ' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -56.06 -33.09 64.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 178.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.05 -42.01 90.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.35 0.595 . . . . 0.0 110.293 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.76 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 30.2 mt-10 -71.62 -32.27 67.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.123 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -57.31 -52.86 63.65 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-O 122.401 1.096 . . . . 0.0 109.285 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.575 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 7.9 mt -50.63 -59.58 3.91 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.634 -2.075 . . . . 0.0 111.893 -176.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.58 -8.01 59.66 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -171.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -109.43 -32.43 7.16 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 31.0 t -123.5 -40.13 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -168.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.585 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 14.6 t80 -167.63 120.04 0.9 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.921 -166.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.72 90.82 7.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.011 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.585 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 27.0 p90 -85.29 18.49 2.62 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 111.667 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -94.54 -49.57 5.59 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -96.65 -21.6 17.52 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.153 -175.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.596 ' ND2' ' HB2' ' A' ' 34' ' ' LYS . 2.4 m-20 -121.7 68.29 22.91 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.618 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.92 -32.28 97.12 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.547 2.831 . . . . 0.0 112.613 173.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -102.52 -40.3 6.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -172.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 3.2 tp10 -100.78 132.29 46.25 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.466 0.65 . . . . 0.0 111.705 -174.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -69.46 93.2 0.65 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.654 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.596 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -93.11 97.15 10.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.529 177.31 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.57 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 23.0 t80 -81.39 127.53 32.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.989 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -109.43 151.95 26.0 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 168.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.88 -127.63 2.19 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.809 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -163.74 -60.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.019 0.437 . . . . 0.0 110.396 -173.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.465 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 22.0 mttm -119.08 165.79 16.08 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.442 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 85.9 Cg_exo -44.2 131.74 8.87 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.68 2.253 . . . . 0.0 111.838 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -113.22 146.31 39.53 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.212 0.529 . . . . 0.0 111.764 -171.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.692 ' HB ' HG12 ' A' ' 73' ' ' ILE . 74.8 mt -122.4 122.53 66.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.063 174.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 21.5 t -107.28 110.06 30.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.399 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.598 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 30.1 t0 -86.74 106.59 17.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.998 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.561 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 96.6 m-85 -91.88 111.89 23.6 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.673 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.6 p90 -140.63 -179.87 6.28 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.832 -171.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.421 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -159.09 142.71 14.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.492 170.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.47 -28.96 68.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -76.75 -9.79 58.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.235 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.466 ' HB2' HD12 ' A' ' 93' ' ' ILE . 47.0 t -99.15 112.38 24.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.936 0.398 . . . . 0.0 110.643 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.08 -54.3 38.6 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.607 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.49 -38.46 27.71 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.952 2.434 . . . . 0.0 113.532 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.726 ' SG ' ' HB ' ' A' ' 93' ' ' ILE . 83.0 m -67.06 -43.86 81.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.38 . . . . 0.0 111.143 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -72.48 -26.04 61.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.93 0.395 . . . . 0.0 110.184 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -60.05 -46.97 87.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.669 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.581 ' HB ' ' HE2' ' A' ' 117' ' ' PHE . 30.4 m -87.16 -25.17 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.481 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -43.74 -59.93 3.08 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 50.2 Cg_endo -68.57 -26.78 33.49 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.725 1.617 . . . . 0.0 112.0 -177.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.07 -54.95 21.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.347 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.583 HD11 ' HE2' ' A' ' 75' ' ' LYS . 1.7 pp -69.03 -30.84 69.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.51 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.08 -49.98 75.53 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.246 0.546 . . . . 0.0 110.741 173.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -64.56 -36.24 83.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.41 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.45 -31.3 67.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.425 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.689 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -56.98 -42.34 80.05 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 173.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.636 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 3.7 tmtm? -71.79 -41.22 68.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.043 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -56.54 -39.54 73.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.964 0.411 . . . . 0.0 110.739 176.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.452 ' OH ' ' HB3' ' A' ' 122' ' ' ASP . 83.8 m-85 -98.54 26.67 5.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.345 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 58.0 t0 -53.39 129.79 33.17 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.477 0.311 . . . . 0.0 110.666 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.53 -6.54 83.49 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.304 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -112.47 -44.34 3.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.607 0.242 . . . . 0.0 111.008 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 40' ' ' PRO . 45.1 pt -128.89 159.05 41.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.147 0.499 . . . . 0.0 111.822 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 96.6 t -126.86 123.82 63.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.233 176.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.692 HG12 ' HB ' ' A' ' 42' ' ' ILE . 15.2 mt -107.62 138.32 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.72 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -118.01 162.31 18.37 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 173.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.598 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 55.8 mttt -135.91 144.46 45.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.889 0.376 . . . . 0.0 111.147 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.691 HG13 ' HG2' ' A' ' 81' ' ' GLU . 37.3 t -138.41 134.48 43.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.853 -175.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.471 ' HB2' ' HG2' ' A' ' 80' ' ' LYS . 7.5 m-20 -94.52 102.06 13.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.449 HG21 ' O ' ' A' ' 92' ' ' SER . 16.8 p -52.94 -37.41 60.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.2 0.524 . . . . 0.0 111.67 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -54.9 -36.28 65.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.981 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.633 ' HE2' HG22 ' A' ' 15' ' ' THR . 21.6 pttm -100.59 -20.39 15.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.357 0.599 . . . . 0.0 110.076 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.691 ' HG2' HG13 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -97.86 45.25 1.03 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.483 176.015 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -55.89 -53.31 58.38 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.58 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.535 ' CD ' ' HZ1' ' A' ' 16' ' ' LYS . 2.2 mp0 -61.85 -36.88 82.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.618 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.466 HD23 ' HG2' ' A' ' 81' ' ' GLU . 41.4 tp -67.86 -41.7 82.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.529 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -67.0 -44.54 80.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.67 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.14 -32.89 82.15 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.684 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.85 -35.37 76.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.814 0.34 . . . . 0.0 111.588 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.532 ' HB2' HG13 ' A' ' 90' ' ' ILE . 94.6 m-85 -97.26 3.06 51.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.854 0.359 . . . . 0.0 110.81 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.13 28.46 73.7 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.11 -176.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 85' ' ' ALA . 28.9 mt -66.08 138.82 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -64.09 -61.39 2.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.449 ' O ' HG21 ' A' ' 78' ' ' THR . 24.3 p 175.65 -91.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.75 175.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.726 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 8.0 pt -151.55 146.34 18.77 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.881 -172.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.68 ' HB2' ' H ' ' A' ' 110' ' ' GLY . 17.3 Cg_exo -78.59 142.78 70.09 Favored 'Cis proline' 0 N--CA 1.478 0.561 0 C-N-CA 124.78 -0.925 . . . . 0.0 112.037 -3.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 14.7 m -139.37 112.35 8.0 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.73 114.39 46.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.028 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.606 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 34.8 tp -92.96 113.18 25.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.714 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -94.23 112.39 24.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.88 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 41' ' ' ALA . 36.9 mt -101.24 102.9 22.88 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.908 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.09 163.09 22.97 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.576 2.184 . . . . 0.0 112.325 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 92.6 mmm -87.39 -0.04 56.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.332 0.587 . . . . 0.0 109.559 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.585 ' HB3' ' HG2' ' A' ' 128' ' ' LYS . 1.1 tm-20 -138.2 123.68 19.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.928 177.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.25 -149.57 19.45 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.08 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 27.2 mmmt -123.31 159.1 56.26 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.467 ' HB2' HD11 ' A' ' 97' ' ' LEU . 57.6 Cg_endo -70.48 154.1 65.13 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.564 2.176 . . . . 0.0 113.45 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -125.83 167.94 14.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.494 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.506 ' SD ' ' HB3' ' A' ' 95' ' ' SER . 42.9 ttm -130.26 122.06 27.31 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.043 0.449 . . . . 0.0 112.029 -175.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.05 132.23 50.51 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -115.37 136.2 53.34 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.284 0.564 . . . . 0.0 112.437 -172.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.68 ' H ' ' HB2' ' A' ' 94' ' ' PRO . . . 104.7 -175.6 22.55 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.173 -0.921 . . . . 0.0 114.898 169.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.482 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -92.12 85.64 5.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.026 -0.587 . . . . 0.0 111.633 -171.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.568 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 25.1 ptp -91.4 154.89 44.52 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.463 172.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 71.7 Cg_endo -75.44 177.54 8.52 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.28 1.987 . . . . 0.0 111.687 -177.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -58.85 -33.77 70.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 174.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.78 -52.86 61.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.529 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.568 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 34.6 m -66.7 -40.73 88.6 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.736 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.581 ' HE2' ' HB ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -60.93 -40.79 94.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.537 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.434 ' C ' ' HD3' ' A' ' 118' ' ' LYS . 14.6 tmtt? -58.97 -49.82 76.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.892 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.559 ' HA ' ' OD1' ' A' ' 122' ' ' ASP . 12.9 mptt -64.64 -39.86 94.43 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.951 0.405 . . . . 0.0 110.797 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -58.51 -38.9 78.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.611 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.514 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 74.7 mt -75.04 -56.29 9.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.472 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.559 ' OD1' ' HA ' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -74.24 -58.87 3.01 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.918 -173.036 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.432 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 6.0 mm-40 -69.26 -22.47 63.83 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -171.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 91.6 t80 -110.47 -46.29 3.42 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.973 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.514 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 36.7 tp -90.39 -41.64 11.36 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -172.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.534 ' HB3' ' HA ' ' A' ' 122' ' ' ASP . 45.3 tp -83.49 -52.5 6.44 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 121.392 0.615 . . . . 0.0 109.751 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 30.1 mtmt -99.97 73.86 1.77 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.585 ' HG2' ' HB3' ' A' ' 102' ' ' GLU . 24.4 tptp -48.42 99.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 O-C-N 124.096 0.873 . . . . 0.0 111.887 -175.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -175.33 2.8 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.704 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.25 8.04 23.93 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -173.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -133.28 58.97 1.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.6 t60 -81.52 66.73 7.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.375 -169.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -89.47 -50.64 5.98 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 164.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -171.66 62.83 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.08 163.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -77.52 -19.54 55.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.691 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.246 0.887 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.348 173.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.69 0.281 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.0 m -83.35 112.51 19.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.619 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.6 tt -98.46 -54.6 2.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.41 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -126.45 29.09 5.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.867 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.569 HG21 HG21 ' A' ' 72' ' ' VAL . 19.4 m 67.14 87.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.231 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 5.0 pm0 -74.2 -11.13 60.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.926 -178.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.411 ' O ' HG13 ' A' ' 72' ' ' VAL . . . -86.43 25.35 7.26 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.29 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.625 HD21 ' HA2' ' A' ' 69' ' ' GLY . 4.5 t30 -69.9 113.04 6.75 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 122.376 0.271 . . . . 0.0 110.823 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.543 ' HA3' ' CG ' ' A' ' 68' ' ' ASP . . . 69.0 31.85 72.76 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.058 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.463 ' HE2' ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -166.98 172.09 10.53 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.339 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.701 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 12.9 p -113.36 132.21 62.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.713 0.768 . . . . 0.0 112.097 -176.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.0 mt -121.49 128.88 75.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.736 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.594 ' CB ' ' HG3' ' A' ' 75' ' ' LYS . 1.9 p80 -88.01 129.53 35.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.3 pp -133.21 173.98 10.87 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.918 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.43 166.97 12.59 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.852 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.759 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 30.7 pttt -62.16 -26.65 68.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.061 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.0 86.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.281 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 28.2 mm-40 -68.61 -43.58 76.08 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.868 176.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -57.39 -49.8 75.03 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 121.933 0.873 . . . . 0.0 109.502 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' ' 25' ' ' ASN . 1.1 tt -48.64 -61.47 2.01 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 113.648 -1.615 . . . . 0.0 112.098 -178.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.09 -18.83 33.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.588 -168.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 34.5 ttmt -108.78 -16.87 14.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -172.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.45 -45.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 18.5 t80 -164.42 116.74 1.31 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.236 0.541 . . . . 0.0 111.261 -169.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.598 ' HA ' HD23 ' A' ' 20' ' ' LEU . 10.4 t-20 -84.15 89.05 7.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.99 -177.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.511 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 27.2 p90 -82.81 4.88 23.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.644 0.735 . . . . 0.0 110.698 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.4 ' OE1' ' HG3' ' A' ' 28' ' ' LYS . 5.4 tm-20 -95.43 -52.27 4.22 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.253 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.538 ' HD2' ' ND2' ' A' ' 25' ' ' ASN . 67.6 mttm -84.27 -27.77 27.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.287 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -120.71 69.04 16.24 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-O 120.862 0.363 . . . . 0.0 111.223 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -64.12 -28.23 65.16 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.449 2.766 . . . . 0.0 112.306 171.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -31.46 8.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.752 -175.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -91.81 144.37 25.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.055 0.455 . . . . 0.0 111.407 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -91.94 89.47 7.02 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 171.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 87.2 tttt -94.23 97.58 10.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.007 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -99.31 120.6 39.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.054 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -112.0 114.51 27.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.218 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.84 163.52 33.16 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.511 ' OD2' ' HG3' ' A' ' 39' ' ' LYS . 12.0 p-10 -95.71 -37.32 10.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.949 0.375 . . . . 0.0 111.181 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.511 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 56.5 mttp -117.54 166.28 13.7 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.505 179.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.577 ' HB2' HD21 ' A' ' 125' ' ' LEU . 32.1 Cg_exo -59.8 141.03 96.03 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.746 2.297 . . . . 0.0 111.56 174.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -119.91 147.43 44.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.342 0.591 . . . . 0.0 112.365 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.745 ' HB ' HG12 ' A' ' 73' ' ' ILE . 4.2 mp -121.12 133.38 67.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.311 172.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 41.9 t -128.31 114.07 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.126 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.608 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 8.6 p-10 -100.41 115.87 31.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 122.222 1.01 . . . . 0.0 111.622 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.535 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 30.0 m-85 -81.1 112.88 18.87 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.431 -1.258 . . . . 0.0 108.936 173.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.71 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.8 p90 -129.91 168.17 17.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.503 0.668 . . . . 0.0 111.415 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.89 131.01 26.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.271 -1.332 . . . . 0.0 107.841 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.542 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 27.9 t70 -60.12 -34.34 73.37 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -171.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -71.57 -9.33 58.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.681 0.277 . . . . 0.0 111.62 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.455 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 48.0 t -95.64 123.55 39.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.92 0.39 . . . . 0.0 110.607 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.55 -59.01 10.27 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.755 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 77.4 Cg_exo -48.78 -36.71 34.04 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.047 2.498 . . . . 0.0 113.202 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.71 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 98.0 m -64.3 -44.89 90.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.99 0.424 . . . . 0.0 111.199 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.542 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 66.6 mttm -59.99 -29.71 68.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.905 175.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.56 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 75.0 mtp -71.59 -54.48 10.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.953 0.406 . . . . 0.0 111.16 177.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 96' ' ' ILE . 10.2 p -68.6 -36.95 76.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -170.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.634 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -52.06 -55.79 27.74 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 16.8 Cg_exo -68.35 -42.62 5.25 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 121.938 1.759 . . . . 0.0 112.14 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.442 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 73.1 mt -58.54 -41.04 80.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.08 0.467 . . . . 0.0 110.769 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.706 HD22 HD13 ' A' ' 73' ' ' ILE . 1.3 mt -67.03 -38.28 85.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.898 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' OD1' HG12 ' A' ' 11' ' ' VAL . 20.8 t70 -68.29 -37.06 80.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.184 0.516 . . . . 0.0 109.802 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 59' ' ' ILE . 14.5 tp10 -54.37 -46.05 72.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.692 174.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.582 HD21 ' HA ' ' A' ' 114' ' ' LYS . 4.3 mm? -72.02 -35.12 69.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.807 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.666 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -57.16 -52.0 67.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.404 ' HD3' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.27 -25.92 62.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.099 -178.15 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.491 ' CD ' ' HZ3' ' A' ' 114' ' ' LYS . 1.8 tt0 -71.73 -19.83 61.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.329 0.585 . . . . 0.0 110.15 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.438 ' HD1' ' O ' ' A' ' 63' ' ' LEU . 85.7 m-85 -117.23 25.84 10.18 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.682 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.543 ' CG ' ' HA3' ' A' ' 9' ' ' GLY . 11.3 t0 -58.65 121.57 11.32 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.234 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.625 ' HA2' HD21 ' A' ' 8' ' ' ASN . . . 118.64 -28.45 6.75 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.26 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.481 ' HG3' HG23 ' A' ' 71' ' ' ILE . 10.3 pt20 -114.73 -28.21 7.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -176.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.481 HG23 ' HG3' ' A' ' 70' ' ' GLN . 37.5 pt -122.99 158.12 27.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.859 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.569 HG21 HG21 ' A' ' 5' ' ' THR . 94.4 t -130.06 128.04 64.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.423 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.745 HG12 ' HB ' ' A' ' 42' ' ' ILE . 29.3 mt -121.6 135.22 62.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.465 0.65 . . . . 0.0 111.371 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 63.8 m-85 -122.7 164.56 18.05 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 173.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.663 ' HB3' ' HZ3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -136.65 149.8 48.17 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 174.185 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.516 HG13 ' HG2' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -122.75 137.14 57.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.441 -171.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.531 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 10.5 m-20 -87.82 86.57 7.18 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.638 HG21 ' HA ' ' A' ' 92' ' ' SER . 15.3 m -56.06 -29.75 60.95 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -169.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -53.42 -31.03 43.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.647 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.531 ' HE3' ' HB2' ' A' ' 77' ' ' ASP . 22.2 pttp -109.82 -23.78 11.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.196 0.522 . . . . 0.0 110.492 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.759 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 1.3 mp0 -85.93 39.63 0.82 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.424 175.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -61.95 -47.92 82.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.696 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -62.22 -38.95 91.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.218 0.532 . . . . 0.0 110.192 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.1 tp -61.03 -44.54 97.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.42 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.583 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -63.96 -49.08 73.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.753 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.65 -30.99 66.4 Favored Glycine 0 CA--C 1.517 0.181 0 CA-C-N 116.081 -0.509 . . . . 0.0 113.206 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.75 -33.32 73.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.752 0.31 . . . . 0.0 111.707 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.572 ' HB2' HG13 ' A' ' 90' ' ' ILE . 89.5 m-85 -104.15 7.47 36.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.174 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.67 30.63 68.35 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.799 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 85' ' ' ALA . 55.6 mt -80.69 131.94 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.642 0.258 . . . . 0.0 110.524 -177.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.0 mtm105 -57.45 -64.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.666 0.746 . . . . 0.0 109.933 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.638 ' HA ' HG21 ' A' ' 78' ' ' THR . 13.0 p 177.17 -93.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.633 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.517 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -139.56 148.37 55.85 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.357 -175.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.712 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.1 Cg_exo -85.36 150.19 50.43 Favored 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 124.077 -1.218 . . . . 0.0 111.279 -3.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 11.6 m -141.36 140.19 33.69 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.558 HD11 HG21 ' A' ' 56' ' ' VAL . 60.1 mt -136.24 117.76 19.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 119.025 0.83 . . . . 0.0 111.201 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 105' ' ' PRO . 20.3 tp -98.26 114.35 26.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.209 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.595 ' HE2' ' HB3' ' A' ' 108' ' ' ALA . 96.6 m-85 -96.78 110.79 23.19 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.0 mt -103.3 105.97 49.13 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.819 0.343 . . . . 0.0 111.899 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 98' ' ' PHE . 2.9 Cg_exo -76.16 159.27 37.25 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.413 2.742 . . . . 0.0 111.5 172.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 89.8 mtp -83.02 -32.15 27.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.636 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.07 -30.91 7.83 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.91 0.862 . . . . 0.0 110.764 -177.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.69 -156.03 24.4 Favored Glycine 0 C--N 1.307 -1.031 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.99 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 35.2 mmtm -129.81 148.54 69.93 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 98' ' ' PHE . 38.3 Cg_endo -63.62 134.38 43.94 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.887 2.391 . . . . 0.0 113.854 -170.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.32 169.64 8.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.423 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 36.1 tpp -136.13 101.92 4.85 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.859 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.595 ' HB3' ' HE2' ' A' ' 98' ' ' PHE . . . -107.8 129.88 55.02 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 173.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.557 ' HB3' ' O ' ' A' ' 94' ' ' PRO . 58.4 mt-30 -117.51 128.52 55.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.149 0.499 . . . . 0.0 111.93 -171.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.712 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 133.12 -169.21 22.69 Favored Glycine 0 CA--C 1.506 -0.487 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.141 176.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.31 80.66 1.44 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.556 0.693 . . . . 0.0 110.858 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.702 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 5.0 mpp? -77.81 147.85 74.91 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.467 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.84 -177.69 3.8 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.052 2.502 . . . . 0.0 111.943 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.582 ' HA ' HD21 ' A' ' 63' ' ' LEU . 36.5 ttmt -60.13 -33.3 71.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 0.0 110.37 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.38 -52.9 59.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.558 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.702 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 20.3 m -70.31 -29.94 66.8 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.932 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.572 ' O ' HG13 ' A' ' 121' ' ' ILE . 5.4 m-85 -71.67 -37.29 70.77 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.426 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -57.75 -43.99 85.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.847 0.356 . . . . 0.0 110.119 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.528 ' HG2' ' OE2' ' A' ' 123' ' ' GLU . 31.0 mtpp -64.14 -38.48 91.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.679 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.561 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -67.5 -45.22 76.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.489 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 117' ' ' PHE . 20.9 mt -74.38 -57.25 6.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.306 0.574 . . . . 0.0 110.472 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.517 ' HA ' HD12 ' A' ' 126' ' ' LEU . 22.2 t70 -72.42 -65.04 0.83 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.285 -175.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.528 ' OE2' ' HG2' ' A' ' 119' ' ' LYS . 34.5 mt-10 -75.47 -9.21 58.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.423 -168.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.561 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 89.2 t80 -120.81 -52.49 2.11 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.938 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 40' ' ' PRO . 32.9 tp -72.75 -32.35 65.6 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.366 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.552 ' O ' ' HE3' ' A' ' 128' ' ' LYS . 64.5 mt -101.17 -59.69 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.112 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -87.29 -10.19 52.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.892 -172.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.552 ' HE3' ' O ' ' A' ' 126' ' ' LEU . 0.7 OUTLIER 30.77 82.66 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.488 1.117 . . . . 0.0 113.312 -177.619 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -67.91 160.61 28.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.523 -176.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 118.45 -9.93 13.04 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.975 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -76.52 73.99 3.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.249 0.547 . . . . 0.0 112.106 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -80.11 -24.46 40.5 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 171.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -111.25 142.86 42.91 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 167.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -89.24 -67.85 0.81 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.075 0.464 . . . . 0.0 109.942 -174.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -143.26 18.23 1.9 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 66.9 t60 . . . . . 0 C--O 1.242 0.704 0 CA-C-N 113.619 -1.628 . . . . 0.0 107.763 -176.261 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -142.23 150.04 40.43 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.2 tp -89.46 -30.72 18.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.313 0.577 . . . . 0.0 110.306 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -118.55 110.29 17.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.839 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER 56.79 -147.21 0.53 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -175.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.432 ' H ' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -131.75 -52.09 0.99 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.612 0.642 . . . . 0.0 111.796 178.278 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.84 22.81 23.28 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.038 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.463 ' HA ' HG22 ' A' ' 72' ' ' VAL . 2.6 t-20 -71.35 119.38 15.41 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.475 ' HA3' ' CG ' ' A' ' 68' ' ' ASP . . . 83.39 1.73 90.27 Favored Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.944 -176.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -131.09 173.05 11.4 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -174.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.655 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.5 p -133.29 134.33 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.183 0.516 . . . . 0.0 110.259 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 69.0 mt -129.57 133.65 64.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.176 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.741 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 6.5 p80 -93.8 116.34 28.8 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.371 0.605 . . . . 0.0 109.842 175.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.3 pp -116.09 179.8 3.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.759 -175.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.403 HG22 ' CE ' ' A' ' 80' ' ' LYS . 23.2 p -100.03 176.6 5.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 60.7 pttt -55.68 -30.74 61.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.521 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.24 78.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.769 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 4.0 mp0 -69.67 -31.66 69.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.33 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -64.61 -51.63 61.68 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.653 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.6 tt -51.76 -61.08 2.48 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 113.312 -1.767 . . . . 0.0 112.155 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.9 -25.69 61.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.781 -168.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 36.7 ttmt -98.45 -34.34 10.67 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.405 HG13 ' HD1' ' A' ' 35' ' ' TYR . 81.0 t -119.28 -47.7 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -167.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.709 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 20.0 t80 -151.54 116.47 5.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.297 0.57 . . . . 0.0 111.852 -165.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.566 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -88.2 90.69 8.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.262 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.709 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 24.3 p90 -84.27 12.09 7.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.154 0.502 . . . . 0.0 111.576 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -94.32 -45.7 7.37 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.505 ' C ' HD22 ' A' ' 29' ' ' ASN . 48.9 mttm -94.67 -25.9 16.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.584 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.612 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -122.26 68.85 29.23 Favored Pre-proline 0 N--CA 1.469 0.494 0 CA-C-O 120.791 0.329 . . . . 0.0 111.198 178.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -55.71 -42.18 70.09 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.163 2.576 . . . . 0.0 112.132 171.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -95.42 -33.25 12.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -173.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.408 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 36.7 mt-10 -91.49 128.45 37.32 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.204 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 53.3 t-105 -82.13 101.37 10.37 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 171.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 32' ' ' GLU . 30.6 mmtp -102.65 139.21 38.54 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.331 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.405 ' HD1' HG13 ' A' ' 23' ' ' VAL . 21.6 t80 -126.92 115.79 19.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.162 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 22' ' ' LYS . 35.0 mm-40 -97.5 123.73 41.47 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.443 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.85 179.48 46.37 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.201 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.483 ' OD2' ' HG3' ' A' ' 39' ' ' LYS . 1.7 p-10 -124.31 -38.51 2.42 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 117.011 0.405 . . . . 0.0 111.333 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.483 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 60.8 mttp -112.43 154.69 44.47 Favored Pre-proline 0 C--N 1.328 -0.348 0 O-C-N 122.474 -0.142 . . . . 0.0 110.86 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.458 ' HB2' HD21 ' A' ' 125' ' ' LEU . 6.2 Cg_endo -48.35 132.81 24.66 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.155 2.57 . . . . 0.0 111.851 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -116.85 149.57 39.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.388 0.613 . . . . 0.0 112.121 -170.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.424 ' HB ' HG12 ' A' ' 73' ' ' ILE . 76.5 mt -132.56 139.78 49.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.996 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.45 116.62 47.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.866 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.537 ' HB3' ' CB ' ' A' ' 75' ' ' LYS . 35.0 t70 -91.24 112.19 24.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.774 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 79.2 m-85 -93.51 110.64 22.22 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.74 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.2 p90 -137.87 162.6 33.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.559 0.695 . . . . 0.0 111.468 -171.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.19 133.4 50.29 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.692 170.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.24 -41.83 93.99 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.91 -172.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -68.25 -17.29 64.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.881 0.372 . . . . 0.0 111.624 -176.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 42.2 t -82.09 123.53 29.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.888 0.375 . . . . 0.0 110.168 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 55' ' ' MET . . . -55.83 -61.01 7.9 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.157 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -47.84 -45.7 23.64 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.842 2.361 . . . . 0.0 112.874 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.74 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 62.1 m -60.19 -45.63 92.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.527 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -76.02 -27.46 57.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.454 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 3.3 tmm? -67.31 -47.86 69.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.32 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.595 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 27.2 m -77.11 -24.95 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.601 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -50.74 -52.73 54.06 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 18.9 Cg_exo -66.81 -37.65 19.91 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.774 1.649 . . . . 0.0 112.339 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.3 mt -65.36 -47.5 86.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.358 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 117' ' ' PHE . 3.5 pp -68.33 -31.75 71.39 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.64 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.51 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 20.7 t70 -68.15 -37.81 81.44 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.153 174.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.95 -46.98 78.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.921 176.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.61 HD11 ' HG3' ' A' ' 114' ' ' LYS . 9.8 mp -65.25 -30.88 71.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.07 176.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.636 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -55.08 -53.78 51.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.635 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.51 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -78.2 -24.83 46.96 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.455 178.671 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -55.83 -33.97 64.95 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.677 0.751 . . . . 0.0 109.366 171.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.613 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 41.2 m-85 -111.34 26.5 10.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.042 176.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 3.1 t70 -55.36 132.6 48.51 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.336 -176.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.26 -21.06 36.29 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.962 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 10.8 pt20 -122.08 -36.0 3.06 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -176.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.551 HG23 ' HG3' ' A' ' 70' ' ' GLN . 45.4 pt -111.63 147.81 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.987 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 8' ' ' ASN . 60.1 t -120.96 120.29 61.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.596 177.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 27.7 mt -115.57 134.98 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 121.612 0.72 . . . . 0.0 111.179 -177.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -121.45 173.27 7.49 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.824 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.741 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 3.5 ptmm? -151.97 156.34 39.82 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.574 HG23 HD12 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -133.62 148.23 30.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.097 -173.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 20.2 m-20 -89.82 85.87 6.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.573 HG21 ' HA ' ' A' ' 92' ' ' SER . 1.7 m -62.0 -27.28 68.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.193 -166.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -54.42 -31.04 54.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.487 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 22.6 pttm -104.76 -26.16 12.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.231 0.538 . . . . 0.0 109.694 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.52 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 1.3 mp0 -84.85 33.6 0.53 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.72 176.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -62.04 -31.61 72.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.819 0.343 . . . . 0.0 110.977 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -63.05 -41.05 99.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.358 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 84' ' ' LEU . 1.7 tm? -70.24 -45.61 66.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.41 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.56 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -61.57 -49.68 75.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.45 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.75 -30.26 72.19 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 116.154 -0.475 . . . . 0.0 113.116 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.57 -34.54 77.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.749 0.309 . . . . 0.0 111.677 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.518 ' HB2' HG13 ' A' ' 90' ' ' ILE . 77.7 m-85 -104.53 5.66 34.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.228 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.31 29.44 70.19 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.084 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 85' ' ' ALA . 22.0 mt -75.1 139.82 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.024 0.44 . . . . 0.0 110.072 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.415 ' HD3' HE22 ' A' ' 109' ' ' GLN . 72.6 mtp180 -74.34 4.05 6.43 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.674 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.573 ' HA ' HG21 ' A' ' 78' ' ' THR . 30.3 t 82.5 -88.0 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.424 -176.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.574 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 2.7 pp -135.29 136.45 24.46 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -169.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.665 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 4.0 Cg_exo -85.35 146.45 42.14 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 124.591 -1.004 . . . . 0.0 111.726 -4.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 37.5 t -142.0 140.85 32.79 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 171.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.6 mt -134.18 115.15 20.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.7 tp -97.64 112.99 24.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.552 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.75 111.48 23.75 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.776 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.563 HG12 ' HB3' ' A' ' 105' ' ' PRO . 44.7 mt -102.17 105.12 40.95 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.127 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.92 161.17 36.39 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.722 2.281 . . . . 0.0 111.636 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 94.1 mmm -83.7 -1.39 53.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 0.0 110.454 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -141.76 112.93 7.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.1 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.89 -153.7 16.8 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.057 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.45 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 28.8 mmmt -116.1 156.9 46.33 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.563 ' HB3' HG12 ' A' ' 99' ' ' ILE . 59.2 Cg_endo -72.12 151.08 54.98 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.678 2.252 . . . . 0.0 113.721 -175.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.637 ' OE2' ' HB2' ' A' ' 131' ' ' HIS . 27.2 tt0 -106.62 157.98 17.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.199 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 45.1 ttm -122.63 116.39 23.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.152 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.01 137.91 48.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 173.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.516 ' HG2' ' HA ' ' A' ' 95' ' ' SER . 43.9 mt-30 -123.06 137.97 54.8 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.389 -174.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.665 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 106.77 178.28 22.96 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.407 -0.815 . . . . 0.0 114.457 170.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.595 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -83.01 89.14 6.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.119 0.485 . . . . 0.0 111.814 -174.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.656 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 22.2 ptp -95.64 149.01 35.5 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.974 173.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 97.4 Cg_endo -76.18 -178.36 4.35 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.825 2.35 . . . . 0.0 112.141 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.61 ' HG3' HD11 ' A' ' 63' ' ' LEU . 20.5 ttmm -57.68 -35.51 70.69 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 120.851 0.357 . . . . 0.0 110.133 174.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.65 -52.54 60.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.445 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.656 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 28.5 m -68.61 -35.63 77.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.624 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.503 ' HB3' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -61.89 -46.4 89.54 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.462 176.645 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -62.63 -33.14 74.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.306 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 51.4 tptt -61.47 -42.75 99.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 174.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.61 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.34 -47.94 53.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.711 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.598 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 1.8 mp -70.63 -56.92 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.871 0.367 . . . . 0.0 110.763 -177.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.403 ' HB2' ' OH ' ' A' ' 67' ' ' TYR . 5.1 t70 -73.5 -62.63 1.42 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.549 0.69 . . . . 0.0 110.396 -176.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 3.9 mm-40 -78.12 11.47 2.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.835 -1.075 . . . . 0.0 113.329 -169.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.61 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 71.8 t80 -143.56 -47.5 0.29 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.441 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.598 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 32.5 tp -76.55 -35.03 58.47 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.488 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.2 mt -89.22 -65.56 1.01 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -92.97 92.07 7.68 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -54.31 100.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.65 0.594 . . . . 0.0 111.113 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -88.84 -34.57 16.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.653 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 73.88 85.56 0.26 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.002 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.637 ' HB2' ' OE2' ' A' ' 106' ' ' GLU . 32.2 m170 -65.36 93.23 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.693 0.759 . . . . 0.0 110.49 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -63.11 103.68 0.5 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.917 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -82.44 37.06 0.5 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.069 -177.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -71.12 138.78 49.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.269 -174.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -128.88 141.57 51.24 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 25.5 p80 . . . . . 0 C--O 1.245 0.855 0 O-C-N 124.508 1.13 . . . . 0.0 111.66 -172.242 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 m -136.16 96.29 3.36 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.003 -175.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 3' ' ' LEU . 3.7 mm? -101.3 -74.46 0.62 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.041 174.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.87 22.84 10.67 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.012 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p -91.51 154.07 19.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.407 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 72.39 -56.57 0.65 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 168.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.99 32.88 5.17 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -165.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -76.34 158.54 31.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.147 -1.027 . . . . 0.0 110.749 -173.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.65 9.1 83.68 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.35 176.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.6 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 2.9 tttm -162.0 175.33 11.92 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.279 0.562 . . . . 0.0 112.299 -175.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 9.9 p -106.7 130.58 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.128 176.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.6 mm -112.24 130.08 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.246 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.568 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 1.8 p80 -90.15 131.83 35.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.565 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.502 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 1.1 pp -131.25 176.1 8.56 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.369 -174.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.0 p -104.53 176.36 5.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.959 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 14.4 pttm -64.19 -30.66 71.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.672 0.273 . . . . 0.0 110.864 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.08 93.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.278 0.561 . . . . 0.0 110.081 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.502 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 2.5 mm-40 -71.92 -38.91 69.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.228 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.86 -49.37 75.69 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.706 175.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.724 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 13.9 mt -57.07 -60.62 3.32 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.253 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.54 -25.45 60.41 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -169.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 4.3 ttpm? -110.05 -16.46 13.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 46.9 t -128.65 -45.24 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -171.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.724 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 17.5 t80 -173.03 132.41 0.51 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 117.925 0.33 . . . . 0.0 111.845 -165.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.813 ' ND2' ' HB3' ' A' ' 28' ' ' LYS . 63.1 t30 -106.79 105.69 15.85 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.589 -177.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.451 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 5.3 p90 -90.5 1.46 56.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -171.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -89.57 -40.69 12.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.813 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . 4.8 tptp -91.29 -24.96 19.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.637 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 25' ' ' ASN . 2.4 m-20 -116.42 55.63 1.35 Allowed Pre-proline 0 N--CA 1.48 1.045 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -62.25 -43.71 22.29 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.246 1.964 . . . . 0.0 111.773 175.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -108.46 -9.26 15.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.18 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.412 ' HB2' ' CB ' ' A' ' 29' ' ' ASN . 67.3 mt-10 -91.59 177.7 6.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.821 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.447 ' HZ3' ' HE1' ' A' ' 88' ' ' PHE . 76.8 t-105 -151.95 88.49 1.4 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.943 0.401 . . . . 0.0 110.195 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.485 ' H ' HD21 ' A' ' 29' ' ' ASN . 59.6 tttm -105.83 98.87 8.5 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 26.2 t80 -91.47 118.8 30.88 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.308 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 22' ' ' LYS . 4.4 mm-40 -89.78 125.96 35.5 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.835 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.99 146.14 4.63 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.037 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -91.73 -27.29 18.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.965 0.412 . . . . 0.0 110.279 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -120.08 159.68 46.21 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.852 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.14 145.58 89.4 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.524 2.15 . . . . 0.0 111.937 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -120.05 150.25 40.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.442 0.639 . . . . 0.0 111.99 -175.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.624 ' HB ' HG23 ' A' ' 73' ' ' ILE . 77.1 mt -119.47 116.07 49.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.341 176.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.3 t -103.22 109.15 26.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.75 0.309 . . . . 0.0 111.204 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 8.4 t70 -90.62 113.92 26.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.042 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -87.68 111.21 21.05 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.729 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.3 p90 -132.56 169.47 16.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.818 0.818 . . . . 0.0 111.783 -174.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.63 126.7 24.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.183 167.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.558 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 31.2 t70 -60.02 -35.0 74.12 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.484 -172.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.434 ' HE1' ' HG2' ' A' ' 79' ' ' GLU . 67.0 p-90 -73.89 -0.65 16.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.785 0.326 . . . . 0.0 111.54 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.443 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 47.7 t -101.69 119.54 38.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.965 0.412 . . . . 0.0 110.316 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.65 -56.62 17.12 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.584 -0.734 . . . . 0.0 114.112 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.443 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . 83.7 Cg_exo -47.74 -37.85 28.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.048 2.498 . . . . 0.0 113.444 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.729 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 78.2 m -69.68 -47.01 64.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.939 0.399 . . . . 0.0 111.155 177.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.558 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 53.6 mttm -52.7 -30.15 30.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.466 177.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.533 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 24.7 ptm -88.12 -40.77 13.51 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.924 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.532 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 31.6 m -69.96 -36.85 70.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.576 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.603 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -53.42 -53.16 59.57 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 16.4 Cg_exo -69.05 -34.96 15.72 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.09 1.86 . . . . 0.0 112.428 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.517 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 68.1 mt -63.58 -48.7 85.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.97 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.601 HD13 HG21 ' A' ' 73' ' ' ILE . 4.2 pp -68.7 -30.69 69.4 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.66 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.6 ' OD1' ' HG2' ' A' ' 10' ' ' LYS . 18.7 t70 -64.76 -37.95 89.33 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.25 0.547 . . . . 0.0 109.815 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 7.2 mm-40 -54.63 -50.26 68.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.759 173.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.604 HD21 ' HG3' ' A' ' 114' ' ' LYS . 3.4 mm? -62.5 -31.81 72.62 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.926 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.646 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -63.29 -37.49 87.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.811 0.338 . . . . 0.0 110.456 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.611 ' HB3' ' HZ2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -74.02 -33.92 63.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.505 178.335 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -41.23 70.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.461 0.648 . . . . 0.0 111.116 176.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.656 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 30.1 m-85 -98.28 27.31 4.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.112 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.41 143.78 14.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.105 0.479 . . . . 0.0 111.432 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.39 -23.77 23.11 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.826 -0.624 . . . . 0.0 113.39 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.656 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 4.2 pt20 -117.28 -24.61 7.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 121' ' ' ILE . 43.6 pt -126.36 145.57 33.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.306 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 68.0 t -120.99 118.75 57.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.646 HD12 ' HB2' ' A' ' 64' ' ' ALA . 14.3 mt -106.89 138.66 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.106 -175.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -123.65 170.37 10.54 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.666 175.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.618 ' HB3' ' HB3' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -152.45 149.42 28.55 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 172.373 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.24 138.2 55.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.263 0.554 . . . . 0.0 110.863 -174.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 1.2 m-20 -70.7 89.13 0.73 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.095 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.497 HG23 ' HB2' ' A' ' 85' ' ' ALA . 23.9 m -62.52 -37.07 84.63 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -169.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HG2' ' HE1' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -70.6 -21.27 62.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -174.235 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.5 ' NZ ' ' HB3' ' A' ' 77' ' ' ASP . 8.9 ptpp? -106.39 -34.93 7.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.772 0.32 . . . . 0.0 110.224 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -82.75 47.35 1.18 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.989 0.515 . . . . 0.0 110.842 174.421 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -57.99 -38.69 76.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.02 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -69.11 -37.52 78.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.251 0.548 . . . . 0.0 110.166 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.53 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 3.4 tm? -67.1 -46.66 73.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.434 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -61.88 -48.18 81.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.135 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.5 -29.81 67.26 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.05 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.85 -27.4 69.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 0.0 111.399 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.58 ' HB2' HG12 ' A' ' 90' ' ' ILE . 68.1 m-85 -104.03 8.74 36.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.792 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.54 19.99 79.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.212 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.58 HG12 ' HB2' ' A' ' 88' ' ' PHE . 33.9 mm -74.77 108.12 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 120.623 0.249 . . . . 0.0 110.538 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -56.39 -56.37 21.98 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.787 0.803 . . . . 0.0 110.871 174.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.1 p -169.72 -137.63 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.167 -1.378 . . . . 0.0 108.985 -172.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.627 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -131.77 155.35 81.51 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.845 -0.161 . . . . 0.0 110.583 -172.7 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.611 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 2.9 Cg_exo -84.96 141.5 33.09 Favored 'Cis proline' 0 C--N 1.346 0.431 0 C-N-CA 124.827 -0.906 . . . . 0.0 112.726 -2.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 t -141.47 137.8 32.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 107' ' ' MET . 44.6 mt -131.53 120.11 44.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.691 -174.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.4 tp -100.05 112.03 24.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.373 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -94.31 109.38 21.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.636 HG12 ' HB3' ' A' ' 105' ' ' PRO . 49.6 mt -101.34 106.66 46.81 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.51 -174.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.43 164.89 25.94 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.836 2.357 . . . . 0.0 111.759 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.1 mtp -87.75 -6.31 58.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.421 0.629 . . . . 0.0 109.946 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -133.15 121.68 22.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.239 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.69 -140.84 15.1 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.198 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 31.9 mmtp -132.27 153.27 81.21 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.636 ' HB3' HG12 ' A' ' 99' ' ' ILE . 35.5 Cg_endo -64.45 143.95 83.81 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.913 2.408 . . . . 0.0 113.543 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -104.8 169.75 8.27 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.506 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 35.0 ttm -142.84 101.59 3.88 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -172.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -96.75 134.0 40.59 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 172.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -120.74 136.86 54.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.143 0.497 . . . . 0.0 112.252 -171.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.611 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 102.17 -168.79 19.23 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.455 -0.793 . . . . 0.0 115.005 168.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.532 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -85.55 88.93 7.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.866 -0.667 . . . . 0.0 112.07 -171.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.595 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 23.3 ptt? -107.28 150.35 39.86 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.259 172.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.478 ' HD2' ' OG ' ' A' ' 116' ' ' SER . 84.6 Cg_endo -76.39 -178.09 4.2 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.987 2.458 . . . . 0.0 112.94 -173.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.604 ' HG3' HD21 ' A' ' 63' ' ' LEU . 29.4 ttmt -57.73 -35.21 70.39 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.391 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.12 -48.8 74.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.629 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 30.0 m -66.02 -41.21 91.27 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.592 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.621 ' O ' HG13 ' A' ' 121' ' ' ILE . 11.9 m-85 -58.46 -49.17 78.28 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.692 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -54.59 -48.63 71.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.444 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -66.5 -34.42 77.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.707 0.289 . . . . 0.0 110.93 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -69.68 -44.19 70.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.083 0.468 . . . . 0.0 111.128 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.621 HG13 ' O ' ' A' ' 117' ' ' PHE . 31.2 mt -70.12 -51.72 36.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.267 0.556 . . . . 0.0 110.33 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -64.0 -69.51 0.27 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.019 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 38.4 mt-10 -80.79 12.31 3.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.399 -167.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.461 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 90.8 t80 -140.09 -49.92 0.47 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.398 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 20.2 tp -75.94 -31.58 59.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.682 0.277 . . . . 0.0 110.686 -175.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -106.0 -57.01 2.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.035 0.445 . . . . 0.0 110.3 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.57 ' HB3' ' HA ' ' A' ' 123' ' ' GLU . 2.3 tmmt? -85.22 93.81 8.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -60.03 100.32 0.09 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.616 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -97.68 167.27 11.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.641 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 125.27 -0.18 8.14 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -84.44 55.23 3.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.869 0.366 . . . . 0.0 111.431 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.4 p80 179.82 107.68 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.43 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.418 ' O ' ' HB2' ' A' ' 134' ' ' HIS . 67.4 t60 -81.15 -33.49 33.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.536 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 133' ' ' HIS . 22.3 t-80 176.34 -30.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.408 0.623 . . . . 0.0 109.765 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -158.16 -26.67 0.08 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 1.9 m170 . . . . . 0 C--O 1.244 0.774 0 CA-C-N 113.979 -1.464 . . . . 0.0 108.037 164.396 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.7 mtm . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.526 ' HB3' ' OE2' ' A' ' 6' ' ' GLU . 34.7 m -76.96 -179.0 5.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.332 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.24 -63.51 1.37 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.925 0.393 . . . . 0.0 110.852 -175.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.8 33.95 0.44 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.169 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.5 m 74.98 96.96 0.07 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.564 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.526 ' OE2' ' HB3' ' A' ' 2' ' ' SER . 7.8 mm-40 -61.82 132.37 52.89 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.476 -174.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.55 137.03 13.4 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.999 -170.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -95.12 165.0 12.63 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.51 44.88 96.95 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.62 -172.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.574 ' HD3' ' H ' ' A' ' 11' ' ' VAL . 15.1 tppt? -150.96 157.47 42.93 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.095 -0.552 . . . . 0.0 109.533 -173.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 14.1 p -108.78 132.62 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.202 0.525 . . . . 0.0 110.758 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.8 mt -122.88 127.43 74.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.951 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.582 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 1.9 p80 -86.26 143.39 27.95 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.4 pp -137.86 168.84 18.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.966 0.412 . . . . 0.0 111.974 -177.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.615 HG22 ' HZ3' ' A' ' 80' ' ' LYS . 40.3 p -92.48 175.33 6.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.43 174.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.52 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 8.6 ptpp? -64.42 -31.83 73.2 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.663 0.268 . . . . 0.0 111.39 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.37 -39.5 92.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.399 0.618 . . . . 0.0 109.845 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 38.3 mt-10 -72.33 -36.02 68.75 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.155 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.451 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 2.5 t80 -54.06 -53.01 59.0 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.241 1.02 . . . . 0.0 108.995 175.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 17.0 mt -59.02 -60.2 4.25 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.274 -1.784 . . . . 0.0 112.213 -175.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.72 -20.53 27.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -169.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.624 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 35.0 ttpt -109.45 -7.49 15.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.64 0.257 . . . . 0.0 111.415 -174.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 68.8 t -134.79 -49.27 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.771 ' HE2' ' HZ ' ' A' ' 88' ' ' PHE . 1.1 t80 -177.88 125.62 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.298 0.571 . . . . 0.0 110.809 -168.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 13.3 t-20 -92.94 87.31 5.74 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.793 -172.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.543 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 18.6 p90 -75.92 12.14 1.2 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -88.34 -53.43 4.69 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.647 ' C ' HD22 ' A' ' 29' ' ' ASN . 0.0 OUTLIER -92.4 -12.26 32.69 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.353 171.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.647 HD22 ' C ' ' A' ' 28' ' ' LYS . 0.9 OUTLIER -111.68 53.45 0.39 Allowed Pre-proline 0 N--CA 1.478 0.935 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -178.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.439 ' HD2' ' OE1' ' A' ' 31' ' ' GLU . 37.6 Cg_endo -74.68 -35.6 3.38 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 121.947 1.765 . . . . 0.0 111.103 166.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.554 ' OE1' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -100.21 -34.75 9.89 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.586 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.554 ' HG2' ' OE1' ' A' ' 31' ' ' GLU . 7.6 pt-20 -97.92 177.4 5.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.002 -177.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.589 ' CB ' ' HE2' ' A' ' 104' ' ' LYS . 76.3 t-105 -148.05 88.92 1.69 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.227 0.537 . . . . 0.0 110.628 -174.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HG2' ' OE2' ' A' ' 36' ' ' GLU . 61.9 tttm -102.92 104.49 14.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.282 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.559 ' OH ' ' HB2' ' A' ' 41' ' ' ALA . 18.9 t80 -96.79 124.3 40.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.018 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.424 ' OE2' ' HG2' ' A' ' 34' ' ' LYS . 7.1 mm-40 -88.61 93.41 9.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.534 177.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.15 129.56 1.39 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.182 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.8 -27.8 58.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.387 0.613 . . . . 0.0 110.399 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HB2' HG23 ' A' ' 72' ' ' VAL . 66.7 mttm -116.63 155.46 48.8 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.339 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.538 ' HG3' ' HG2' ' A' ' 101' ' ' MET . 36.4 Cg_exo -57.73 150.34 62.72 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.777 2.318 . . . . 0.0 111.79 177.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.559 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -120.49 147.55 44.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.423 0.63 . . . . 0.0 112.111 -173.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.57 ' HB ' HG12 ' A' ' 73' ' ' ILE . 74.7 mt -124.03 112.45 32.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 171.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 46.0 t -109.81 110.78 33.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 121.273 -0.171 . . . . 0.0 111.286 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.589 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 8.2 p-10 -101.06 116.66 33.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.217 1.008 . . . . 0.0 111.821 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.432 ' HB3' ' OG1' ' A' ' 78' ' ' THR . 13.2 m-85 -77.85 112.72 15.02 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.058 170.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.678 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.2 p90 -128.59 162.12 28.03 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.615 0.721 . . . . 0.0 111.844 -176.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.96 137.27 37.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.647 170.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.55 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 25.2 t70 -60.75 -42.06 96.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -171.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -67.66 -13.31 61.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.665 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 49.3 t -85.48 115.1 22.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.87 0.367 . . . . 0.0 110.355 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.92 -57.01 10.4 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.575 -0.738 . . . . 0.0 113.507 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.74 -40.97 31.64 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.068 2.512 . . . . 0.0 113.378 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.678 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 84.9 m -63.51 -45.31 91.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.93 0.395 . . . . 0.0 111.087 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.55 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 65.9 mttm -58.41 -29.6 66.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.073 174.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.506 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 74.3 mtp -74.42 -52.45 12.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.073 0.463 . . . . 0.0 111.234 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 53' ' ' CYS . 14.2 p -70.98 -37.97 70.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.581 -170.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.595 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -52.71 -53.38 54.87 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -176.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 29.9 Cg_exo -62.83 -49.04 5.76 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.94 1.76 . . . . 0.0 112.113 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.5 mt -56.48 -40.46 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.155 0.502 . . . . 0.0 110.897 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.488 HD22 HD13 ' A' ' 73' ' ' ILE . 6.9 mt -68.16 -36.17 79.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.348 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD1' ' HD3' ' A' ' 10' ' ' LYS . 28.3 t70 -68.57 -41.12 80.17 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.29 -54.73 39.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.903 173.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.7 tp -61.78 -31.74 71.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.698 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.623 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -59.53 -46.85 87.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.439 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.624 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 3.6 tmtm? -75.71 -40.29 55.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.422 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -55.67 -31.35 62.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.395 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -111.27 25.15 12.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.615 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.426 ' HB2' ' HA ' ' A' ' 65' ' ' LYS . 24.1 t0 -54.13 148.39 11.19 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.736 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.63 -22.11 18.78 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.529 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -95.92 -56.39 2.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.924 0.362 . . . . 0.0 111.206 -175.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -122.69 174.41 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.67 -170.266 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 43.2 t -131.47 129.09 61.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 174.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 17.0 mt -106.19 135.09 45.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.295 0.569 . . . . 0.0 110.875 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 84.3 m-85 -122.04 163.9 18.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.125 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.589 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -147.33 153.47 39.73 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.045 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.666 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 9.4 p -133.94 144.29 36.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.607 -174.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.415 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 6.0 m-20 -86.6 88.66 7.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 45' ' ' PHE . 7.1 m -60.53 -32.65 71.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -169.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -54.42 -30.85 53.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.615 ' HZ3' HG22 ' A' ' 15' ' ' THR . 22.3 pttp -107.75 -17.56 14.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.594 0.711 . . . . 0.0 110.187 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.666 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 0.3 OUTLIER -94.56 38.73 1.1 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.12 175.056 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -66.14 -36.29 82.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.323 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.417 ' HB2' ' HE2' ' A' ' 16' ' ' LYS . 2.5 mp0 -64.32 -34.64 78.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.433 0.635 . . . . 0.0 109.627 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.474 HD13 ' CE2' ' A' ' 26' ' ' PHE . 15.5 tp -70.2 -45.6 66.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.116 177.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.561 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -57.1 -49.47 75.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.879 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.28 -30.05 66.99 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.325 -0.464 . . . . 0.0 113.085 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.81 -32.81 74.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.328 . . . . 0.0 111.37 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.771 ' HZ ' ' HE2' ' A' ' 24' ' ' TYR . 96.6 m-85 -101.4 8.33 42.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.841 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.25 31.62 77.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.892 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.663 ' HA ' ' NH1' ' A' ' 91' ' ' ARG . 42.7 mt -82.26 136.93 21.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.906 0.384 . . . . 0.0 110.394 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.663 ' NH1' ' HA ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -66.52 -50.27 63.74 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.536 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t 170.26 -89.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.231 -1.349 . . . . 0.0 107.949 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.527 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -141.35 155.05 67.8 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.757 -178.316 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.753 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.5 Cg_exo -86.71 143.39 28.22 Favored 'Cis proline' 0 C--N 1.343 0.253 0 C-N-CA 124.585 -1.006 . . . . 0.0 111.983 -3.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 59.0 m -141.4 132.02 25.55 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 107' ' ' MET . 64.0 mt -128.49 118.73 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.109 0.481 . . . . 0.0 111.073 -172.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 106' ' ' GLU . 23.9 tp -98.98 114.75 27.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.227 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -94.23 103.11 15.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 61.5 mt -96.42 111.38 56.66 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.431 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 98.3 Cg_endo -84.39 169.64 10.98 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.808 2.339 . . . . 0.0 111.612 174.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.538 ' HG2' ' HG3' ' A' ' 40' ' ' PRO . 95.1 mmm -89.99 -2.29 58.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 0.0 110.534 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -151.81 115.89 4.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.393 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 116.19 -144.71 18.53 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.77 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.589 ' HE2' ' CB ' ' A' ' 33' ' ' TRP . 28.0 mmtp -126.32 151.61 72.63 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.452 ' HG3' ' CH2' ' A' ' 33' ' ' TRP . 85.8 Cg_endo -73.79 148.65 41.57 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.815 2.344 . . . . 0.0 113.322 -175.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.486 ' HG2' ' N ' ' A' ' 107' ' ' MET . 37.4 tt0 -95.23 166.94 11.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.876 178.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.486 ' N ' ' HG2' ' A' ' 106' ' ' GLU . 32.3 tpp -142.68 107.56 4.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.087 0.47 . . . . 0.0 111.491 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.95 157.26 17.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.239 174.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -126.34 135.44 51.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.942 0.401 . . . . 0.0 111.129 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.753 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 107.15 -171.72 17.08 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.679 -0.691 . . . . 0.0 113.381 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.65 81.02 1.4 Allowed 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.542 0.687 . . . . 0.0 110.997 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.701 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 4.5 mpp? -65.49 148.97 97.75 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.329 172.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.401 ' HG2' ' H ' ' A' ' 116' ' ' SER . 73.4 Cg_endo -74.32 172.65 15.64 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.125 1.883 . . . . 0.0 110.772 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -60.03 -24.53 64.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.109 0.48 . . . . 0.0 109.851 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.51 -53.29 44.44 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.238 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.701 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 18.5 m -71.94 -28.73 63.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.486 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -67.56 -40.2 84.92 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.985 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 122' ' ' ASP . 0.8 OUTLIER -58.25 -37.86 75.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.458 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -67.58 -51.89 45.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.48 -46.56 89.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.152 0.501 . . . . 0.0 111.284 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.44 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 1.7 mp -67.55 -43.89 86.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.14 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.506 ' HA ' HD12 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -72.44 -55.1 7.57 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.666 -177.021 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.671 ' HA ' ' HE2' ' A' ' 127' ' ' LYS . 31.9 tt0 -77.25 -8.33 57.41 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -169.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 90.4 t80 -127.65 -51.74 1.36 Allowed 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.82 -0.55 . . . . 0.0 111.656 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.44 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 32.5 tp -77.71 -29.76 51.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -173.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 122' ' ' ASP . 92.7 mt -96.92 -54.06 3.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.325 0.583 . . . . 0.0 110.009 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.671 ' HE2' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -135.84 82.29 1.94 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.071 179.623 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 124' ' ' PHE . 52.6 pttt -57.77 104.05 0.17 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.551 0.691 . . . . 0.0 110.838 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 133' ' ' HIS . 44.8 mt-10 -77.75 46.41 0.56 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.157 -175.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.62 62.56 4.11 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 171.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -146.45 -157.25 0.79 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -80.0 32.93 0.27 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.862 0.363 . . . . 0.0 111.425 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 33.9 p80 -171.4 136.02 0.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.135 174.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -157.58 139.97 14.59 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -68.52 -52.21 34.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.98 0.419 . . . . 0.0 110.219 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.3 -0.857 . . . . 0.0 109.788 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 110.582 -0.155 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.4 p -177.3 -82.76 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.942 0.401 . . . . 0.0 111.675 -176.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 90.4 mt -71.21 -25.41 62.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.652 -174.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.68 -30.32 67.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.639 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m 58.17 64.57 1.47 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.818 0.818 . . . . 0.0 109.698 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.525 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 1.1 pm0 -86.98 79.24 8.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.07 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.553 ' HA3' HD11 ' A' ' 12' ' ' ILE . . . -83.02 84.63 1.54 Allowed Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.424 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.646 HD21 ' HA2' ' A' ' 69' ' ' GLY . 4.8 t30 -60.33 129.77 43.3 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 177.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . 57.7 36.92 81.22 Favored Glycine 0 CA--C 1.507 -0.457 0 O-C-N 123.552 0.533 . . . . 0.0 112.387 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 163.81 35.15 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -175.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' A' ' 61' ' ' ASP . 26.1 m -89.76 119.15 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.405 0.621 . . . . 0.0 110.874 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.553 HD11 ' HA3' ' A' ' 7' ' ' GLY . 41.5 mm -111.49 105.34 18.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.925 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.553 ' HA ' ' HB2' ' A' ' 75' ' ' LYS . 19.2 p80 -79.77 129.74 34.74 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.6 pp -143.75 168.57 19.61 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.495 -174.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.0 p -86.79 168.02 13.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.747 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -55.65 -34.23 64.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.656 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.71 -36.45 75.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.322 0.582 . . . . 0.0 110.242 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.665 ' HB3' ' HE2' ' A' ' 22' ' ' LYS . 42.6 mt-10 -72.08 -33.32 67.82 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.52 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -61.81 -49.37 76.58 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.993 0.901 . . . . 0.0 108.872 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.8 tt -46.62 -60.26 2.49 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 113.479 -1.691 . . . . 0.0 111.829 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.33 -24.99 31.88 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -170.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.665 ' HE2' ' HB3' ' A' ' 18' ' ' GLU . 47.5 mtmt -109.31 0.86 19.75 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.388 -0.525 . . . . 0.0 112.146 -173.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -142.68 -49.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 83.6 t80 -164.08 116.68 1.39 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.558 -165.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.423 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -80.67 90.75 5.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.814 -178.783 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -83.89 9.69 11.53 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 122.148 -0.345 . . . . 0.0 111.825 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -84.95 -54.34 4.71 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.974 0.892 . . . . 0.0 108.683 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.464 ' C ' HD22 ' A' ' 29' ' ' ASN . 7.6 ptpp? -97.54 -12.0 23.07 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.506 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' A' ' 34' ' ' LYS . 1.1 m-80 -123.08 67.46 33.49 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-O 121.184 0.516 . . . . 0.0 110.998 170.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -59.67 -43.18 40.46 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.096 2.531 . . . . 0.0 111.974 171.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -112.82 -25.51 9.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.797 -174.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.567 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -90.72 154.64 19.4 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.135 0.493 . . . . 0.0 110.903 -176.129 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.459 ' HZ3' ' HE1' ' A' ' 88' ' ' PHE . 76.4 t-105 -97.22 111.57 23.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.643 -177.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.627 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -133.32 115.41 14.87 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.387 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.63 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 26.9 t80 -103.58 107.23 17.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.87 -176.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.512 ' OE2' ' HG3' ' A' ' 34' ' ' LYS . 1.1 mp0 -95.71 76.61 3.24 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.925 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.63 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -133.76 -136.22 3.67 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.401 -173.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -149.57 -58.79 0.2 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.882 0.372 . . . . 0.0 110.998 -173.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.43 ' HB2' HG23 ' A' ' 72' ' ' VAL . 48.8 mttp -125.5 159.04 62.33 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.966 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.567 ' HB2' HG22 ' A' ' 71' ' ' ILE . 83.8 Cg_exo -42.43 131.36 5.08 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.602 2.201 . . . . 0.0 111.65 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -116.52 150.18 38.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.265 0.555 . . . . 0.0 112.24 -167.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.796 ' HB ' HG12 ' A' ' 73' ' ' ILE . 67.8 mt -127.9 116.88 44.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.882 173.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.639 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 38.5 t -98.84 116.31 41.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 120.825 0.345 . . . . 0.0 110.68 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.521 ' HB2' HD13 ' A' ' 60' ' ' LEU . 7.1 t70 -91.09 110.58 21.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.554 177.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.506 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 97.8 m-85 -94.39 111.65 23.41 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 174.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.656 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.1 p90 -133.58 174.9 9.93 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.547 0.689 . . . . 0.0 111.11 -175.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.97 142.61 22.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.298 173.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.476 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 32.4 t70 -62.03 -28.89 69.91 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -83.38 -1.07 52.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.686 0.279 . . . . 0.0 111.553 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 41.1 t -99.68 113.08 25.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.097 0.475 . . . . 0.0 110.805 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 54' ' ' LYS . . . -58.16 -51.36 58.88 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.472 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 97.6 Cg_exo -47.28 -47.74 16.63 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.896 2.397 . . . . 0.0 113.113 175.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 71.0 m -63.78 -36.66 84.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.908 0.385 . . . . 0.0 111.482 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.476 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 67.5 mttm -56.46 -34.78 67.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.831 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.513 ' SD ' ' HB1' ' A' ' 111' ' ' ALA . 26.9 ptm -91.84 -26.95 18.26 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.793 -175.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.633 HG22 ' HA ' ' A' ' 53' ' ' CYS . 25.1 m -76.71 -31.04 19.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.702 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.433 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -47.69 -58.25 8.06 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 33.7 Cg_endo -65.17 -39.64 22.73 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.75 1.634 . . . . 0.0 112.269 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.2 mt -63.59 -43.62 98.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.226 0.536 . . . . 0.0 110.304 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 44' ' ' ASP . 7.8 mt -57.8 -43.81 85.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.129 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.478 ' HA ' HG13 ' A' ' 11' ' ' VAL . 30.7 t70 -68.12 -37.43 81.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.827 0.346 . . . . 0.0 110.557 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.431 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 3.7 tp10 -59.69 -41.88 91.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.472 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.515 HD21 ' HG3' ' A' ' 114' ' ' LYS . 4.1 mm? -71.24 -31.72 67.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.725 176.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.544 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -56.45 -57.11 13.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.769 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -74.83 -24.61 58.63 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.74 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.08 -33.42 75.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.499 0.666 . . . . 0.0 110.167 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -104.2 25.61 9.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.936 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.546 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 6.4 t0 -59.31 133.91 56.53 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 110.138 -176.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.646 ' HA2' HD21 ' A' ' 8' ' ' ASN . . . 92.36 -22.04 34.73 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.769 -176.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -94.97 -53.17 3.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.906 0.384 . . . . 0.0 110.268 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.567 HG22 ' HB2' ' A' ' 40' ' ' PRO . 38.2 pt -127.15 163.5 29.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.216 -176.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 50.9 t -131.01 131.91 63.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.796 HG12 ' HB ' ' A' ' 42' ' ' ILE . 60.3 mt -111.83 133.48 57.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.101 0.477 . . . . 0.0 110.844 -176.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -115.21 160.63 19.49 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 13' ' ' HIS . 44.6 mttm -129.13 136.02 49.64 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.748 0.308 . . . . 0.0 110.902 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.407 HG13 ' HG2' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -138.21 136.89 44.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.665 -178.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 4.4 m-20 -97.32 106.19 18.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.2 p -57.2 -26.97 61.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -67.55 -21.39 65.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.403 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.432 ' HG2' ' HB2' ' A' ' 77' ' ' ASP . 8.5 ptmm? -114.08 -33.67 5.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.448 0.642 . . . . 0.0 109.974 175.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 2.0 mp0 -83.62 36.66 0.55 Allowed 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.979 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -57.27 -47.55 81.14 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.825 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -61.88 -36.76 82.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.377 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.7 tp -70.16 -50.38 40.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.902 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.482 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -63.22 -37.47 87.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.05 -31.36 78.45 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.846 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.02 -33.58 76.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 111.024 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.552 ' HB2' HG12 ' A' ' 90' ' ' ILE . 85.7 m-85 -90.32 -1.24 57.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.18 21.55 75.55 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.01 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.552 HG12 ' HB2' ' A' ' 88' ' ' PHE . 37.3 mm -81.03 126.56 39.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 122.444 0.298 . . . . 0.0 110.67 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -61.99 -64.46 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.047 0.451 . . . . 0.0 110.169 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.9 p -164.6 -101.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.535 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.496 ' HB ' ' HA ' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -142.3 157.75 62.42 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 120.508 0.194 . . . . 0.0 111.383 -173.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.828 ' HB2' ' H ' ' A' ' 110' ' ' GLY . 15.0 Cg_exo -79.66 144.35 70.65 Favored 'Cis proline' 0 N--CA 1.476 0.454 0 C-N-CA 124.241 -1.15 . . . . 0.0 112.162 -3.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 14.8 m -140.91 137.41 33.14 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.662 ' O ' ' HA ' ' A' ' 107' ' ' MET . 66.6 mt -133.13 114.47 21.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.639 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.8 tp -96.45 115.13 26.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 -175.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.432 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 97.3 m-85 -95.23 107.03 19.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.04 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.4 ' HB ' ' HB3' ' A' ' 41' ' ' ALA . 67.5 mt -99.18 105.01 29.76 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -177.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 98' ' ' PHE . 79.4 Cg_endo -88.19 166.03 6.85 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.83 2.353 . . . . 0.0 111.988 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 20.0 mmt -89.86 -6.24 56.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.96 0.41 . . . . 0.0 110.381 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.92 104.96 5.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.876 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.26 -151.38 18.32 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.251 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.437 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 12.1 mmmm -121.1 154.4 58.24 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 104' ' ' LYS . 56.8 Cg_endo -68.85 151.15 74.1 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.976 2.451 . . . . 0.0 114.576 -171.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -104.83 169.45 8.44 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.175 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.662 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 21.3 ptp -143.84 129.62 19.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.688 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.41 140.21 50.21 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -119.93 138.27 53.55 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.495 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.828 ' H ' ' HB2' ' A' ' 94' ' ' PRO . . . 105.04 -178.4 23.64 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.715 -0.675 . . . . 0.0 114.682 170.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.513 ' HB1' ' SD ' ' A' ' 55' ' ' MET . . . -90.75 86.34 6.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.036 -0.582 . . . . 0.0 111.53 -173.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.579 ' HB2' ' HB3' ' A' ' 116' ' ' SER . 23.5 ptp -92.47 151.6 41.43 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.784 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.781 ' HD2' ' HB3' ' A' ' 116' ' ' SER . 85.5 Cg_endo -75.73 177.16 9.06 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.58 2.187 . . . . 0.0 112.129 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.515 ' HG3' HD21 ' A' ' 63' ' ' LEU . 62.9 tttm -57.82 -35.57 71.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.494 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.45 -47.71 59.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.818 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.781 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 47.8 t -66.85 -30.47 70.65 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.336 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.489 ' O ' HG13 ' A' ' 121' ' ' ILE . 3.4 m-85 -58.58 -53.21 60.88 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 173.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -56.82 -42.79 80.22 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.622 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -53.83 -48.35 70.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.022 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.12 -42.75 68.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.408 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 117' ' ' PHE . 68.0 mt -66.72 -55.33 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.088 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.61 -65.34 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.562 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -48.48 -42.18 32.01 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -172.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -104.52 -47.22 4.15 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -171.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 23.9 tp -77.69 -38.73 46.82 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -169.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.6 mp -105.85 -42.8 5.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.097 0.475 . . . . 0.0 111.094 -176.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -80.52 -20.48 43.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.858 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.3 pttt 37.73 33.57 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.65 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -148.93 105.41 3.54 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 133' ' ' HIS . . . -92.85 100.61 2.68 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.654 -175.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -70.46 -35.9 73.59 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -128.08 -22.98 3.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.932 174.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.529 ' O ' ' HA3' ' A' ' 130' ' ' GLY . 14.3 t-160 -102.85 85.09 2.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.105 0.479 . . . . 0.0 110.361 174.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -134.5 134.25 41.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.097 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -71.4 -22.34 61.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.193 0.521 . . . . 0.0 110.373 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.389 177.173 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.7 p 42.64 -113.65 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.14 0.9 . . . . 0.0 112.646 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 pp -101.04 1.36 39.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.747 0.308 . . . . 0.0 111.742 -174.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.56 -9.05 59.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.254 0.55 . . . . 0.0 110.668 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 p -139.88 124.52 18.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.449 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.58 146.05 42.2 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.32 70.47 0.48 Allowed Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.408 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.622 ' ND2' ' H ' ' A' ' 69' ' ' GLY . 2.0 t30 -169.91 163.44 9.56 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 172.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . 63.15 28.32 71.98 Favored Glycine 0 CA--C 1.509 -0.33 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.444 ' HE2' HD11 ' A' ' 12' ' ' ILE . 11.8 ptmt -156.05 155.75 33.19 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 121.126 0.489 . . . . 0.0 110.604 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 6.4 p -112.13 116.46 52.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.904 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.444 HD11 ' HE2' ' A' ' 10' ' ' LYS . 45.3 mm -102.96 115.49 45.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.117 -175.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.656 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 0.6 OUTLIER -85.19 125.43 32.84 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.248 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.7 pp -136.31 168.47 19.36 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.364 -173.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.0 p -102.87 177.12 4.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.114 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.412 ' HB2' ' HZ ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -58.62 -28.31 65.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.82 -43.28 99.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.181 0.515 . . . . 0.0 110.568 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 3.4 mm-40 -71.9 -36.14 69.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.031 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.45 -54.06 50.12 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.587 177.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.653 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 12.5 mt -51.0 -61.02 2.48 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.001 -1.454 . . . . 0.0 112.164 -176.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.18 -31.49 60.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -167.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -108.85 -20.29 13.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 95.9 t -119.43 -45.77 2.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -171.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.653 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 21.6 t80 -169.86 116.62 0.56 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.167 0.508 . . . . 0.0 111.344 -166.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.446 HD22 HD22 ' A' ' 20' ' ' LEU . 2.5 t-20 -89.54 90.32 8.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.708 -178.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.465 ' CE2' HD13 ' A' ' 84' ' ' LEU . 31.9 p90 -82.53 -2.25 52.98 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.41 ' HG3' ' CD2' ' A' ' 20' ' ' LEU . 15.2 mt-10 -70.64 -53.24 16.61 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.93 0.871 . . . . 0.0 108.698 174.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -100.13 -14.88 18.37 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.817 -172.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.419 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 12.7 m-80 -126.75 59.39 33.83 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 29' ' ' ASN . 10.5 Cg_endo -60.12 -30.14 90.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.396 2.731 . . . . 0.0 111.551 167.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -97.66 -41.22 8.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.776 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -94.91 149.6 21.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.204 -173.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.769 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 60.9 t-105 -108.29 109.56 20.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.044 176.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.92 103.17 6.17 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.299 176.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 50.5 t80 -86.22 131.67 34.18 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.207 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.429 ' HA ' ' OE1' ' A' ' 36' ' ' GLU . 14.6 mm-40 -112.1 -167.18 1.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.93 -119.61 3.36 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.787 -1.197 . . . . 0.0 112.991 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -158.92 -50.78 0.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.291 0.567 . . . . 0.0 109.815 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.588 ' HB2' HG23 ' A' ' 72' ' ' VAL . 48.7 mttp -121.76 168.78 10.55 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.864 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.61 ' HB3' HD11 ' A' ' 125' ' ' LEU . 33.1 Cg_exo -60.86 158.99 30.89 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.602 2.201 . . . . 0.0 111.534 173.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -127.61 142.31 51.39 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -169.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.558 ' HB ' HG12 ' A' ' 73' ' ' ILE . 44.0 mm -117.13 110.21 30.44 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.228 168.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 67.8 t -110.7 113.12 43.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 118.032 0.378 . . . . 0.0 111.523 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.666 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 5.8 p-10 -100.38 119.47 38.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.287 1.041 . . . . 0.0 111.477 176.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -77.02 113.87 15.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.297 -1.32 . . . . 0.0 108.84 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.678 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.4 p90 -130.98 168.28 17.62 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.29 0.567 . . . . 0.0 111.169 -176.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.09 135.89 19.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.439 174.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.418 ' O ' ' HE3' ' A' ' 54' ' ' LYS . 27.0 t70 -66.99 -33.13 74.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.761 0.315 . . . . 0.0 111.718 -173.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -71.89 -6.63 43.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.906 0.384 . . . . 0.0 111.236 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.423 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 37.4 t -113.34 113.64 25.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.101 0.477 . . . . 0.0 110.124 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.68 -53.11 41.15 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 119.263 -0.743 . . . . 0.0 113.975 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.423 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 84.3 Cg_exo -47.52 -31.41 13.7 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.099 2.533 . . . . 0.0 114.126 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.678 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 45.3 m -73.94 -45.11 52.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.855 0.36 . . . . 0.0 111.127 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 48' ' ' ASP . 15.1 ptpt -77.15 -27.4 53.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.129 0.49 . . . . 0.0 109.808 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.0 tmm? -51.47 -39.96 58.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.166 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.7 m -88.06 -15.99 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.881 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.7 -52.36 57.19 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.32 -33.68 37.88 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 121.766 1.644 . . . . 0.0 112.216 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 113' ' ' PRO . 92.5 mt -65.44 -44.49 94.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.524 0.678 . . . . 0.0 109.899 175.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.1 mt -67.98 -31.22 70.78 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.123 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -60.82 -48.27 82.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.171 0.51 . . . . 0.0 109.932 170.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -54.81 -46.52 74.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.154 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.821 HD23 HD12 ' A' ' 121' ' ' ILE . 7.7 mp -67.15 -31.25 71.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.363 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.454 ' O ' ' HA2' ' A' ' 9' ' ' GLY . . . -59.38 -42.09 90.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.765 0.317 . . . . 0.0 110.582 177.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -72.39 -49.67 32.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.313 0.577 . . . . 0.0 109.938 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -53.12 -35.79 60.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.705 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.579 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 45.0 m-85 -107.2 26.51 10.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.555 -178.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.575 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 25.5 t70 -67.36 153.92 42.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.268 0.556 . . . . 0.0 111.217 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.622 ' H ' ' ND2' ' A' ' 8' ' ' ASN . . . 85.51 -18.58 28.54 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.508 -0.769 . . . . 0.0 113.496 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 4.2 pt20 -121.65 -53.42 1.99 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -171.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 67' ' ' TYR . 40.8 pt -128.35 156.39 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 118.313 0.506 . . . . 0.0 112.199 -174.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.588 HG23 ' HB2' ' A' ' 39' ' ' LYS . 6.8 t -111.91 144.71 19.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.851 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 68.5 mt -112.59 128.99 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.139 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 36.3 m-85 -117.15 159.72 22.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.666 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -140.88 144.73 35.42 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.188 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.557 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 7.4 p -122.03 136.16 59.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.274 0.559 . . . . 0.0 111.057 -173.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.587 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 1.1 m-20 -73.56 87.08 1.61 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.962 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.528 HG23 ' HB2' ' A' ' 85' ' ' ALA . 4.4 m -65.5 -31.64 72.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -167.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.41 ' HG3' ' H ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -69.92 -18.19 63.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.228 -0.295 . . . . 0.0 111.662 -178.546 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.567 ' NZ ' ' HB3' ' A' ' 77' ' ' ASP . 8.7 ptpp? -110.32 -26.81 9.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.519 0.675 . . . . 0.0 110.033 175.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -89.47 42.73 1.1 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.669 172.318 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -64.48 -41.47 96.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.205 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -31.15 67.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.473 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.482 HD23 HG21 ' A' ' 76' ' ' VAL . 27.4 tp -66.79 -46.39 75.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.067 174.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.55 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -63.64 -43.01 98.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.967 177.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.69 -29.15 69.28 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.701 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.82 -32.21 73.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.903 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -89.28 -16.42 31.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.781 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.89 20.44 28.52 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.097 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.55 ' HB ' ' HB1' ' A' ' 85' ' ' ALA . 35.6 mm -80.51 135.89 24.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -69.22 -62.82 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.157 0.503 . . . . 0.0 110.215 177.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.506 ' O ' HG21 ' A' ' 78' ' ' THR . 36.2 m -156.25 -88.44 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.615 176.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.656 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 1.8 pp -160.19 154.9 20.64 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.608 -172.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -97.11 144.88 5.7 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 124.548 -1.022 . . . . 0.0 112.215 -2.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.714 ' HB3' ' SD ' ' A' ' 107' ' ' MET . 61.3 m -141.07 143.26 34.25 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.411 HD12 ' C ' ' A' ' 95' ' ' SER . 3.7 mp -127.96 121.78 57.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.332 0.587 . . . . 0.0 110.734 -175.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.1 tp -98.02 112.5 24.42 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.764 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.594 ' HE2' ' HB3' ' A' ' 108' ' ' ALA . 93.1 m-85 -90.14 104.03 16.65 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.567 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 64.9 mt -101.73 113.51 65.82 Favored Pre-proline 0 C--O 1.235 0.312 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -169.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -87.47 174.64 4.95 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.124 2.549 . . . . 0.0 111.725 171.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.9 mmt -97.7 -24.73 15.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.251 0.548 . . . . 0.0 110.362 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.78 21.98 16.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.376 -171.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 178.62 -176.29 47.9 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.172 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.769 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 14.3 mptt -77.19 149.98 79.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.584 0.231 . . . . 0.0 110.689 177.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.567 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 91.1 Cg_endo -82.54 155.23 16.08 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.925 2.417 . . . . 0.0 113.068 -176.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -104.09 168.27 9.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.466 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.714 ' SD ' ' HB3' ' A' ' 95' ' ' SER . 27.2 tpp -132.59 124.15 27.82 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.608 -174.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.594 ' HB3' ' HE2' ' A' ' 98' ' ' PHE . . . -130.89 129.32 42.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.438 174.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 95' ' ' SER . 86.0 mt-30 -74.01 151.49 40.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.806 0.336 . . . . 0.0 110.977 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.79 -153.61 3.58 Favored Glycine 0 C--O 1.227 -0.336 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 -168.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 69.62 19.64 7.29 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.496 0.718 . . . . 0.0 111.025 -174.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.642 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 76.0 mtm -89.98 147.35 37.06 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.376 177.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.431 ' HA ' HD13 ' A' ' 59' ' ' ILE . 72.2 Cg_endo -75.74 -174.85 2.18 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.411 2.074 . . . . 0.0 110.782 175.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.534 ' HG3' HD11 ' A' ' 63' ' ' LEU . 19.5 ttmt -56.83 -41.98 78.81 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.57 173.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.12 -51.96 67.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.642 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 19.8 m -69.51 -36.91 76.91 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.986 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.572 ' O ' HG13 ' A' ' 121' ' ' ILE . 3.5 m-85 -65.47 -52.24 54.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.935 0.398 . . . . 0.0 110.414 175.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 114' ' ' LYS . 2.8 tmtm? -55.71 -44.1 77.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.103 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.501 ' HG3' ' OE2' ' A' ' 123' ' ' GLU . 28.1 tptp -56.57 -57.12 13.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.326 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.15 90.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.145 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.821 HD12 HD23 ' A' ' 63' ' ' LEU . 23.8 mt -67.71 -50.75 57.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 0.0 110.715 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.66 -56.35 14.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.834 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.696 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . 9.1 pt-20 -76.04 6.96 4.53 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.731 0.644 . . . . 0.0 112.688 -169.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -131.74 -48.19 0.96 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.4 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' A' ' 40' ' ' PRO . 31.1 tp -82.56 -46.26 13.58 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.413 -174.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.45 HD11 ' CE1' ' A' ' 67' ' ' TYR . 72.7 mt -81.32 -60.0 2.43 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.696 ' HG3' ' HA ' ' A' ' 123' ' ' GLU . 8.2 ptpp? -105.1 101.11 10.68 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.346 173.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.441 ' H ' ' HG2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -71.45 70.37 0.63 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.069 0.461 . . . . 0.0 111.073 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.438 ' HG2' ' N ' ' A' ' 130' ' ' GLY . 6.1 tt0 73.52 150.27 0.11 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.164 175.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.438 ' N ' ' HG2' ' A' ' 129' ' ' GLU . . . -74.48 70.84 1.61 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 174.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 133' ' ' HIS . 14.1 m80 -73.08 67.46 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.699 0.761 . . . . 0.0 111.649 -177.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -116.68 38.86 3.33 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.366 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 131' ' ' HIS . 20.3 m-70 -76.91 2.41 14.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.832 -175.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -82.76 85.72 7.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -99.83 153.63 18.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.47 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 33.8 m80 . . . . . 0 C--O 1.244 0.764 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 169.043 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.858 0.361 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.5 m -145.6 -44.75 0.21 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.167 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 3' ' ' LEU . 6.2 mp -99.34 -47.43 5.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -162.94 -66.67 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.042 177.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.5 p -133.47 -37.44 0.95 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.13 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 55.92 -90.72 0.03 OUTLIER 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.573 -173.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -109.56 87.41 0.48 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.418 ' H ' ' CD ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -164.29 102.43 0.85 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.583 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.23 36.84 19.91 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 116.108 -0.497 . . . . 0.0 113.762 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.418 ' CD ' ' H ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -164.69 166.85 19.66 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 122.017 0.913 . . . . 0.0 112.879 178.201 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.743 HG13 HG22 ' A' ' 73' ' ' ILE . 42.0 t -110.61 115.04 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.421 170.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.402 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 50.0 mm -80.8 99.18 4.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.023 0.439 . . . . 0.0 110.546 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 14.4 p80 -74.09 112.68 10.47 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 171.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.809 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.8 pp -139.42 -179.88 6.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -167.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.3 p -109.25 177.73 4.66 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.582 173.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.576 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -59.5 -27.32 66.04 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 117.598 0.181 . . . . 0.0 111.221 -178.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.87 -39.78 76.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.287 0.565 . . . . 0.0 110.592 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.809 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 5.2 mm-40 -72.13 -35.88 69.23 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.519 175.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.421 ' CG ' HD11 ' A' ' 84' ' ' LEU . 13.8 t80 -61.23 -45.33 94.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 122.173 0.987 . . . . 0.0 108.588 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.686 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.7 tt -46.83 -61.05 2.03 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 113.19 -1.823 . . . . 0.0 111.868 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.81 -13.25 51.66 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -170.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -109.49 -18.94 13.4 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 47.2 t -133.66 -45.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -171.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.686 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 9.5 t80 -161.32 115.38 1.99 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.232 0.539 . . . . 0.0 111.622 -167.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.433 ' ND2' HD21 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -91.91 95.51 9.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.602 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.423 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 6.2 p90 -73.89 7.38 2.61 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -97.55 -17.36 19.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.881 0.372 . . . . 0.0 110.27 170.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -90.38 -34.26 15.73 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.205 0.526 . . . . 0.0 110.296 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.752 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -147.98 62.08 6.49 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.289 -175.527 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 29' ' ' ASN . 4.8 Cg_exo -44.03 -35.28 7.31 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 124.907 3.738 . . . . 0.0 112.771 170.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -103.46 -30.87 10.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.77 -176.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.78 178.55 5.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.47 0.652 . . . . 0.0 112.017 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.564 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 59.2 t-105 -123.14 104.92 9.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.947 175.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -119.12 105.79 11.74 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.483 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.549 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 38.2 t80 -72.09 123.48 22.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.342 178.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -97.15 15.61 22.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.371 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -98.98 -152.28 27.43 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.759 -173.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -124.79 -52.57 1.68 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 111.196 -172.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.559 ' HB2' HG23 ' A' ' 72' ' ' VAL . 36.5 mttm -113.35 165.27 13.66 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.493 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.546 ' HB3' HD11 ' A' ' 125' ' ' LEU . 73.8 Cg_exo -47.77 131.74 20.64 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.158 1.905 . . . . 0.0 110.972 172.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -113.09 143.57 44.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.292 0.568 . . . . 0.0 111.811 -170.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.616 ' HB ' HG12 ' A' ' 73' ' ' ILE . 61.3 mt -130.26 110.4 19.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.034 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.571 HG23 ' HB2' ' A' ' 74' ' ' TYR . 8.3 p -111.76 134.52 53.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.545 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 2.4 t70 -100.72 118.96 37.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.492 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.445 ' O ' HG22 ' A' ' 93' ' ' ILE . 97.3 m-85 -95.85 112.58 24.27 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.676 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 10.7 p90 -127.28 173.98 9.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.815 0.817 . . . . 0.0 111.762 -175.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.28 120.03 5.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 113.53 -1.668 . . . . 0.0 107.352 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.18 -34.7 68.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -169.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -67.86 -12.88 61.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.865 0.364 . . . . 0.0 111.383 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.51 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 42.4 t -99.01 117.3 33.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.805 0.336 . . . . 0.0 110.427 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.02 -54.62 22.09 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.701 -0.681 . . . . 0.0 114.21 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.51 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 81.6 Cg_exo -47.59 -36.68 25.32 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.025 2.484 . . . . 0.0 114.034 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.676 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 61.5 m -68.21 -31.86 71.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.205 0.526 . . . . 0.0 111.196 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -63.85 -28.63 69.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.857 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.535 ' O ' HD13 ' A' ' 59' ' ' ILE . 41.4 mmm -76.16 -42.97 44.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.106 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 53' ' ' CYS . 6.5 p -75.29 -39.18 42.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -173.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.52 -55.4 19.47 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.04 -46.2 6.56 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.075 1.85 . . . . 0.0 112.446 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.535 HD13 ' O ' ' A' ' 55' ' ' MET . 1.8 mp -55.71 -42.08 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 121.301 0.572 . . . . 0.0 110.333 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -58.68 -39.03 79.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.592 176.152 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.546 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 33.0 t70 -69.19 -42.64 75.55 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.662 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 66' ' ' GLU . 43.4 mt-10 -54.13 -55.22 29.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.371 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.578 HD11 ' HG3' ' A' ' 114' ' ' LYS . 10.9 mp -61.23 -30.67 70.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.3 -178.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 61' ' ' ASP . . . -53.55 -56.56 16.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.081 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.546 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -77.96 -29.23 49.7 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.132 178.835 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 57.9 mt-10 -66.15 -38.06 87.19 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.93 0.395 . . . . 0.0 111.63 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -105.47 19.33 20.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.037 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.54 ' HB2' ' HA ' ' A' ' 65' ' ' LYS . 33.5 t0 -59.24 157.49 10.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.552 0.692 . . . . 0.0 112.82 -170.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.58 -32.8 7.14 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.428 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.597 ' HG3' HG23 ' A' ' 71' ' ' ILE . 23.6 pt20 -111.91 -35.14 5.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -174.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.597 HG23 ' HG3' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -119.44 162.47 17.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.503 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.559 HG23 ' HB2' ' A' ' 39' ' ' LYS . 40.7 t -125.34 129.29 73.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.743 HG22 HG13 ' A' ' 11' ' ' VAL . 26.7 mt -107.57 142.15 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.03 -176.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.571 ' HB2' HG23 ' A' ' 43' ' ' VAL . 44.0 m-85 -127.08 166.69 17.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.981 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.551 ' HG2' HG12 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -155.11 146.32 22.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.757 0.313 . . . . 0.0 110.219 171.321 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.673 HG21 ' HG2' ' A' ' 81' ' ' GLU . 8.1 p -152.33 159.94 3.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.396 -172.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.604 ' HB2' ' HG2' ' A' ' 80' ' ' LYS . 10.7 m-20 -99.46 111.85 24.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.844 -0.162 . . . . 0.0 110.736 -175.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.713 HG21 ' HA ' ' A' ' 92' ' ' SER . 59.6 m -57.21 -31.52 65.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.01 0.433 . . . . 0.0 111.695 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.87 -33.19 71.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.751 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.604 ' HG2' ' HB2' ' A' ' 77' ' ' ASP . 11.5 ptpt -102.04 -27.57 12.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.416 0.627 . . . . 0.0 109.669 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.673 ' HG2' HG21 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -93.91 46.21 1.17 Allowed 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.25 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.61 -35.89 81.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.475 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.78 -40.39 84.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.245 0.545 . . . . 0.0 109.669 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.421 HD11 ' CG ' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -62.47 -47.62 83.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.375 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.639 ' HB2' HG23 ' A' ' 78' ' ' THR . . . -66.03 -46.0 79.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.491 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.27 -29.67 71.96 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.151 -176.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.78 -35.34 79.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.895 0.378 . . . . 0.0 111.459 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.463 ' HB2' HG13 ' A' ' 90' ' ' ILE . 97.1 m-85 -100.09 7.64 44.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.408 -177.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.24 32.54 84.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.0 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' A' ' 85' ' ' ALA . 39.5 mt -75.13 128.22 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -52.04 -64.37 0.84 Allowed 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.563 0.539 . . . . 0.0 110.25 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.713 ' HA ' HG21 ' A' ' 78' ' ' THR . 23.2 p -179.66 -85.45 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.558 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.463 ' O ' HD12 ' A' ' 93' ' ' ILE . 1.9 pp -156.26 148.24 17.36 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.622 -176.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.658 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 13.7 Cg_exo -78.89 148.68 83.29 Favored 'Cis proline' 0 N--CA 1.477 0.544 0 C-N-CA 124.856 -0.893 . . . . 0.0 112.395 -2.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.401 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 67.7 m -142.8 139.21 30.87 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.6 127.96 62.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 122.113 -0.367 . . . . 0.0 110.034 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.531 ' CB ' HG12 ' A' ' 43' ' ' VAL . 2.6 tp -97.05 127.89 43.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.629 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -108.74 100.19 9.46 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 105' ' ' PRO . 50.3 mt -101.23 104.91 36.2 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.18 -172.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.62 158.79 22.0 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.39 2.06 . . . . 0.0 111.088 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.3 mmm -76.9 -26.84 54.59 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 175.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -102.44 103.84 14.26 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.053 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.38 -141.97 15.91 Favored Glycine 0 C--N 1.315 -0.626 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.446 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.564 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 21.8 mmmt -124.07 163.57 34.88 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.566 ' HB3' HG12 ' A' ' 99' ' ' ILE . 84.9 Cg_endo -82.45 140.03 10.55 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.359 2.039 . . . . 0.0 114.205 -173.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.49 171.24 9.03 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.111 173.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 41.8 ttm -142.89 135.22 27.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.811 -177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.32 157.34 30.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 169.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -137.67 130.57 30.18 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.135 -0.626 . . . . 0.0 112.385 -175.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.658 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 117.78 -176.21 16.05 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.178 -0.919 . . . . 0.0 113.985 169.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -83.9 86.98 7.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.39 0.614 . . . . 0.0 110.604 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.545 ' HB2' ' HB3' ' A' ' 116' ' ' SER . 7.5 ptm -103.98 141.23 22.08 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.625 175.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 116' ' ' SER . 91.1 Cg_endo -75.24 177.3 8.81 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.59 2.193 . . . . 0.0 112.687 -173.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.578 ' HG3' HD11 ' A' ' 63' ' ' LEU . 37.8 ttmt -58.2 -30.47 66.49 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.262 175.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.7 -49.56 68.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.202 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.545 ' HB3' ' HB2' ' A' ' 112' ' ' MET . 17.0 t -67.74 -33.37 74.73 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.569 -0.453 . . . . 0.0 110.051 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.437 ' HB3' HD21 ' A' ' 63' ' ' LEU . 5.6 m-85 -72.52 -29.59 63.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.186 176.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.516 ' C ' ' HD3' ' A' ' 118' ' ' LYS . 12.7 tmtt? -56.44 -50.3 72.07 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.514 ' HG2' ' OE2' ' A' ' 123' ' ' GLU . 54.9 mttm -66.61 -38.23 86.52 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.539 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.651 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -66.74 -45.9 77.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.987 0.423 . . . . 0.0 111.402 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.502 HG13 HD13 ' A' ' 42' ' ' ILE . 1.6 mp -75.95 -56.03 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.052 0.453 . . . . 0.0 110.968 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.547 ' HA ' HD13 ' A' ' 126' ' ' LEU . 25.7 t70 -72.6 -60.55 2.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.566 -174.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.514 ' OE2' ' HG2' ' A' ' 119' ' ' LYS . 50.1 mt-10 -80.34 11.57 3.51 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -170.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.651 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 69.6 t80 -138.11 -42.57 0.52 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.568 0.211 . . . . 0.0 111.568 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.546 HD11 ' HB3' ' A' ' 40' ' ' PRO . 26.6 tp -90.53 -37.93 13.54 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.89 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.547 HD13 ' HA ' ' A' ' 122' ' ' ASP . 10.8 mp -78.13 -48.47 15.88 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -87.95 71.69 9.39 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 168.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.742 ' H ' ' HD3' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -76.84 83.35 3.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.756 0.788 . . . . 0.0 112.24 -173.196 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -111.72 28.5 8.69 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.058 169.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -43.48 141.05 2.67 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.475 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 36.7 m80 62.93 -93.93 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -170.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 160.39 21.92 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.487 1.117 . . . . 0.0 110.914 169.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -77.47 82.64 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.958 0.409 . . . . 0.0 110.163 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -139.73 89.94 2.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.467 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 3.3 t60 179.05 -44.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 17.7 p80 . . . . . 0 C--O 1.249 1.043 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.119 171.665 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m 65.26 -80.12 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.936 0.772 . . . . 0.0 111.415 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.59 -73.79 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.175 0.512 . . . . 0.0 110.327 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.98 125.87 35.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.701 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.7 m -121.65 -76.29 0.59 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.209 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -151.65 -169.67 3.43 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.19 39.42 97.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.437 -176.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.685 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -175.34 112.32 0.13 Allowed 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 122.408 0.283 . . . . 0.0 110.909 -175.277 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.652 ' CA ' ' HA ' ' A' ' 68' ' ' ASP . . . 56.44 35.39 66.02 Favored Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 115.096 0.798 . . . . 0.0 115.096 164.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.685 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 1.3 ptpp? -168.52 173.39 7.51 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 117.035 0.417 . . . . 0.0 110.155 176.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 19.4 m -109.13 133.41 54.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.322 -174.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.0 mm -103.09 98.48 6.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.608 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -72.97 111.6 8.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 173.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.868 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.9 pp -140.21 179.15 6.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -168.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.0 p -109.74 177.94 4.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.599 173.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.554 ' HA ' ' HB2' ' A' ' 19' ' ' PHE . 14.8 pttm -59.04 -23.2 61.77 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.9 -48.9 72.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.375 0.607 . . . . 0.0 110.257 176.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.868 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 6.1 mp0 -71.54 -34.19 69.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.761 177.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.554 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 2.0 t80 -54.36 -48.58 71.32 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 122.266 1.031 . . . . 0.0 109.224 174.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.543 HD22 HD22 ' A' ' 25' ' ' ASN . 2.9 mt -52.43 -59.77 4.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.161 -1.836 . . . . 0.0 111.153 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.94 -27.67 49.38 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -104.41 -14.18 15.82 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -173.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 21.4 t -126.9 -49.21 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.51 -0.476 . . . . 0.0 112.104 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 14.3 t80 -163.72 115.74 1.42 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.168 0.508 . . . . 0.0 110.66 -170.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.543 HD22 HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -90.45 90.07 7.86 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.921 -176.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.551 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 23.9 p90 -90.58 22.1 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.46 -29.47 9.21 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.873 171.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.708 ' C ' HD22 ' A' ' 29' ' ' ASN . 6.5 ptpp? -106.77 -16.61 14.44 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.769 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.708 HD22 ' C ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -120.85 63.38 11.1 Favored Pre-proline 0 N--CA 1.474 0.739 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.0 174.343 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.453 ' HG2' ' OE1' ' A' ' 31' ' ' GLU . 12.0 Cg_endo -65.68 -44.98 7.29 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.437 2.091 . . . . 0.0 112.509 173.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.453 ' OE1' ' HG2' ' A' ' 30' ' ' PRO . 25.6 mp0 -88.41 -26.15 22.3 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.005 0.431 . . . . 0.0 110.88 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.28 147.99 22.65 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.202 0.525 . . . . 0.0 111.423 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.658 ' HD1' ' HZ1' ' A' ' 104' ' ' LYS . 35.7 t-105 -109.15 103.5 12.5 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 164.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -119.02 124.25 46.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.046 173.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.543 ' OH ' ' HB2' ' A' ' 41' ' ' ALA . 18.3 t80 -85.17 108.8 17.88 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.4 0.45 33.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.147 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.46 162.63 36.52 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -93.1 -42.42 9.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.758 0.779 . . . . 0.0 111.76 -175.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.524 ' HB2' HG23 ' A' ' 72' ' ' VAL . 44.2 mttp -102.27 147.86 34.58 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 122.355 -0.215 . . . . 0.0 110.636 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -42.97 136.55 4.84 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.656 2.904 . . . . 0.0 112.818 176.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.543 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -119.07 149.01 42.39 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -170.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.9 ' HB ' HG12 ' A' ' 73' ' ' ILE . 45.3 mm -120.37 115.41 47.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.439 171.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.4 t -100.13 117.12 44.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.699 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.841 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 14.9 t70 -96.59 106.62 18.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.356 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.543 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 77.5 m-85 -94.65 112.13 23.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.434 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.641 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 52.3 p90 -134.7 176.31 8.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.611 0.72 . . . . 0.0 111.477 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.497 ' HB3' HD13 ' A' ' 93' ' ' ILE . . . -149.89 127.48 11.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.891 170.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.603 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 26.3 t70 -61.39 -24.83 66.77 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -168.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 55.6 p-90 -72.63 -9.36 58.51 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.747 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.569 ' HB3' ' SG ' ' A' ' 53' ' ' CYS . 26.0 t -105.74 137.68 43.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.057 0.456 . . . . 0.0 111.396 -174.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.404 ' N ' ' HD2' ' A' ' 52' ' ' PRO . . . -57.94 -62.01 6.79 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.336 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 51' ' ' GLY . 9.3 Cg_endo -55.33 -26.92 55.03 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.105 2.537 . . . . 0.0 112.831 -178.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.641 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 70.7 m -66.45 -50.61 62.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.079 0.466 . . . . 0.0 110.31 174.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.603 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 67.8 mttm -59.07 -29.88 67.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.833 175.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 84.5 mtp -66.29 -53.31 38.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.614 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.9 m -82.96 -34.52 11.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -170.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -47.16 -61.28 2.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -175.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 38.0 Cg_endo -66.43 -33.22 38.34 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.581 1.521 . . . . 0.0 112.078 -175.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.6 mt -66.46 -38.41 81.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.613 HD21 ' CZ ' ' A' ' 117' ' ' PHE . 0.8 OUTLIER -67.37 -39.91 85.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.845 177.268 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.579 ' OD2' HG21 ' A' ' 11' ' ' VAL . 1.2 m-20 -61.26 -49.78 75.72 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-O 121.869 0.842 . . . . 0.0 109.557 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.474 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 42.8 tt0 -62.17 -46.87 87.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.193 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.496 HD13 ' HG3' ' A' ' 114' ' ' LYS . 12.8 tp -61.14 -31.15 70.87 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -177.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.522 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -60.68 -54.16 48.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.023 177.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -73.25 -24.76 60.51 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.959 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.8 -38.66 75.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.257 0.551 . . . . 0.0 110.753 174.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -103.44 27.36 7.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.153 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.652 ' HA ' ' CA ' ' A' ' 9' ' ' GLY . 10.1 t70 -52.21 129.62 28.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.141 0.496 . . . . 0.0 110.773 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.08 -42.19 1.92 Allowed Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.46 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -101.19 -47.81 4.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -173.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.8 pt -117.82 164.52 14.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.647 -171.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.524 HG23 ' HB2' ' A' ' 39' ' ' LYS . 14.5 t -128.34 139.12 52.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.189 176.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.9 HG12 ' HB ' ' A' ' 42' ' ' ILE . 53.9 mt -122.89 121.13 62.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.639 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -101.77 159.09 15.63 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.841 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 30.3 mttm -143.76 145.65 32.55 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.621 -176.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.486 HG21 ' HG2' ' A' ' 81' ' ' GLU . 9.8 p -156.15 156.02 5.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -177.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.798 ' HB3' ' HG2' ' A' ' 80' ' ' LYS . 11.3 t70 -98.27 116.76 31.17 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.481 HG23 ' HB3' ' A' ' 45' ' ' PHE . 21.0 p -63.69 -35.2 79.77 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -68.25 -31.69 71.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.798 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 4.5 mmtm -74.83 -55.14 6.12 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.486 ' HG2' HG21 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -87.52 57.92 4.67 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 113.608 -1.633 . . . . 0.0 112.278 -174.476 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -56.48 -46.02 80.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.75 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -68.98 -38.25 79.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.984 0.421 . . . . 0.0 110.572 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.441 ' CB ' ' HG3' ' A' ' 81' ' ' GLU . 3.0 tm? -66.86 -43.46 83.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.81 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -64.62 -47.05 80.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.894 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.22 -32.6 81.22 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.723 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.49 -27.51 68.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.701 0.286 . . . . 0.0 111.751 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -104.29 7.03 35.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.618 0.247 . . . . 0.0 111.271 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.98 22.26 79.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.381 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 85' ' ' ALA . 23.6 mt -72.74 119.75 20.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -62.04 -46.68 88.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.745 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.4 p -179.23 -93.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.535 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.588 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 2.7 pt -152.66 147.62 19.54 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -168.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -95.31 134.1 4.89 Favored 'Cis proline' 0 N--CA 1.46 -0.458 0 C-N-CA 124.3 -1.125 . . . . 0.0 111.34 -3.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 17.2 t -108.26 146.76 32.39 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.561 HD13 ' CE1' ' A' ' 117' ' ' PHE . 27.6 mt -136.55 114.91 14.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.789 0.328 . . . . 0.0 110.146 -176.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.0 tp -103.28 116.7 32.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.4 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -93.32 103.83 16.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.457 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.46 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 41.9 mt -103.8 106.84 54.48 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -173.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.33 148.57 13.02 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.892 2.395 . . . . 0.0 111.625 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -42.26 99.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.25 0.548 . . . . 0.0 110.67 175.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.795 ' HB3' ' HE3' ' A' ' 128' ' ' LYS . 18.8 tt0 -99.37 105.77 17.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.302 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.495 ' C ' ' HD2' ' A' ' 104' ' ' LYS . . . 114.53 -146.82 18.78 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.284 177.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.658 ' HZ1' ' HD1' ' A' ' 33' ' ' TRP . 0.8 OUTLIER -128.27 159.69 65.97 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.303 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.469 ' HG3' ' CZ2' ' A' ' 33' ' ' TRP . 97.0 Cg_endo -81.25 152.23 18.18 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.753 2.302 . . . . 0.0 113.838 -170.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -110.02 166.81 10.65 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.642 172.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 43.3 ttm -137.11 140.51 41.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.247 0.546 . . . . 0.0 112.118 -172.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -133.52 157.19 46.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.948 172.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -96.52 150.41 20.66 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.56 -142.72 1.36 Allowed Glycine 0 CA--C 1.518 0.23 0 N-CA-C 114.628 0.611 . . . . 0.0 114.628 -171.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 71.86 18.68 5.02 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.622 0.769 . . . . 0.0 111.441 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.503 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 23.0 ptt? -117.37 154.2 50.3 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.46 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.28 178.39 7.58 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.999 2.466 . . . . 0.0 113.003 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.496 ' HG3' HD13 ' A' ' 63' ' ' LEU . 41.9 ttmt -59.45 -28.54 67.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.634 174.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.13 -52.99 61.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.411 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 35.1 m -65.89 -37.16 85.38 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.894 0.378 . . . . 0.0 110.67 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.613 ' CZ ' HD21 ' A' ' 60' ' ' LEU . 16.0 m-85 -61.49 -48.24 81.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.256 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -55.74 -40.03 71.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.552 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.558 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -56.06 -55.63 30.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.798 177.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -69.06 -42.34 76.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.783 -175.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 117' ' ' PHE . 43.5 mt -64.61 -53.46 42.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.91 0.386 . . . . 0.0 111.104 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 38.8 t70 -65.02 -59.0 4.63 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.517 -173.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -83.35 11.26 7.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -168.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.466 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 42.0 t80 -134.38 -52.35 0.82 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.593 0.235 . . . . 0.0 111.123 174.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.678 HD22 HD11 ' A' ' 42' ' ' ILE . 16.8 tp -74.58 -38.52 62.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.725 -175.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 122' ' ' ASP . 4.2 mm? -82.45 -59.94 2.36 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.486 178.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 21.8 pttp -104.73 97.77 7.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.757 0.789 . . . . 0.0 110.267 175.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.795 ' HE3' ' HB3' ' A' ' 102' ' ' GLU . 9.1 ptmm? -73.38 72.75 1.34 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.7 175.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -44.38 -76.69 0.02 OUTLIER 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.606 -171.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.63 12.87 1.35 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.228 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -56.88 -30.24 63.69 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.82 0.343 . . . . 0.0 111.433 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -138.95 51.45 1.8 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -77.3 151.1 35.15 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.043 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -159.11 74.74 0.65 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.067 0.46 . . . . 0.0 111.844 -174.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -177.35 138.86 0.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.487 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.385 -0.817 . . . . 0.0 109.626 177.353 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -142.5 171.74 13.65 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.4 -48.3 81.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.108 0.48 . . . . 0.0 109.998 176.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.44 76.7 9.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.873 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -112.14 6.61 19.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.857 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.91 165.49 29.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.793 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 139.38 -3.28 2.67 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.989 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -87.48 138.24 31.65 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.672 ' O ' ' HE3' ' A' ' 10' ' ' LYS . . . 57.46 34.36 68.58 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.65 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.672 ' HE3' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -138.63 164.33 29.77 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -170.13 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 14.7 p -102.98 123.57 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.518 0.675 . . . . 0.0 111.431 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.1 mt -132.97 124.34 50.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.696 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.875 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 7.7 p80 -91.73 138.8 31.27 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.176 177.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.674 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.7 pp -139.5 168.62 19.42 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.179 -176.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.0 p -95.33 177.17 5.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.909 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -55.66 -33.32 63.99 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.2 90.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.351 0.596 . . . . 0.0 110.165 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.674 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 8.3 mm-40 -71.1 -34.07 70.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.298 178.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -60.81 -50.58 72.87 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.836 0.827 . . . . 0.0 109.308 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.671 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -49.25 -60.43 2.82 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.607 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.25 -19.45 39.6 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -169.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -109.66 -12.39 14.65 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 72.6 t -136.34 -49.99 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -172.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.671 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 12.2 t80 -154.27 116.74 4.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.315 0.579 . . . . 0.0 112.023 -164.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.624 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -82.6 88.65 6.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.687 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -88.75 11.26 18.18 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.014 0.435 . . . . 0.0 111.275 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.649 ' HG2' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -93.92 -48.31 6.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.37 0.605 . . . . 0.0 109.392 174.356 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -90.46 -22.97 21.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.267 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 25' ' ' ASN . 2.3 m-20 -120.85 67.48 14.96 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.819 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -58.29 -44.11 41.23 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.228 2.619 . . . . 0.0 112.382 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -103.2 -22.22 13.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.194 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -91.05 178.13 6.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.346 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -128.69 106.35 8.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.233 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 18.8 tptm -113.55 113.13 24.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.846 174.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.586 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 25.4 t80 -92.59 119.53 32.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.842 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -102.65 28.28 6.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.038 -176.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.81 156.92 18.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.245 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.74 -40.32 11.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.716 0.293 . . . . 0.0 111.037 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -107.61 158.45 33.29 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.339 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.548 ' HG2' HG22 ' A' ' 71' ' ' ILE . 18.6 Cg_endo -59.51 140.72 95.36 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.588 2.192 . . . . 0.0 111.094 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -131.54 157.17 44.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.665 0.745 . . . . 0.0 112.812 -170.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.717 ' HB ' HG12 ' A' ' 73' ' ' ILE . 3.6 mp -120.0 116.5 50.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.633 174.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 35.9 t -100.32 111.97 31.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.739 0.304 . . . . 0.0 110.898 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.651 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 15.6 t70 -95.92 110.31 22.53 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.292 0.567 . . . . 0.0 111.562 -179.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -83.4 111.75 19.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.875 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.708 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 4.1 p90 -141.27 171.28 14.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.209 0.528 . . . . 0.0 111.07 -173.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.72 146.77 51.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.081 173.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -65.72 -38.01 87.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.657 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -80.43 -6.96 58.9 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 49.5 t -97.32 134.95 39.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.089 0.471 . . . . 0.0 111.506 -174.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.96 -63.77 4.15 Favored Glycine 0 C--O 1.224 -0.528 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.356 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.618 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 82.0 Cg_exo -47.26 -35.07 19.58 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.008 2.472 . . . . 0.0 113.145 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.708 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 71.6 m -62.66 -47.71 82.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.244 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -77.6 -28.56 51.59 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -55.75 -43.71 76.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.307 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.0 m -83.21 -16.84 11.16 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -174.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.424 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -49.63 -55.6 21.89 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 38.2 Cg_endo -68.49 -41.03 6.91 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.547 1.498 . . . . 0.0 111.725 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 69.0 mt -58.14 -43.98 86.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.272 0.558 . . . . 0.0 110.528 176.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' A' ' 60' ' ' LEU . 12.7 mt -63.33 -45.39 91.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.677 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -64.93 -35.6 81.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 110.002 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 8.3 mm-40 -52.63 -52.86 53.66 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.175 176.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.483 HD21 ' HG3' ' A' ' 114' ' ' LYS . 3.4 mm? -67.96 -42.69 80.52 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.188 -0.205 . . . . 0.0 110.848 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.505 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -56.14 -50.03 72.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.814 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -71.04 -31.7 68.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.403 -178.322 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -67.47 -29.01 68.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.448 0.642 . . . . 0.0 110.367 179.218 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -111.82 26.4 10.66 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.219 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.44 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 23.0 t0 -53.93 131.55 40.4 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.249 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.18 -43.83 1.61 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.141 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -101.85 -32.67 10.13 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.548 HG22 ' HG2' ' A' ' 40' ' ' PRO . 39.6 pt -124.43 159.04 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.684 -178.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 93.2 t -138.05 136.48 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.471 176.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.717 HG12 ' HB ' ' A' ' 42' ' ' ILE . 40.2 mt -114.78 131.95 65.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.312 0.577 . . . . 0.0 111.091 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -115.99 166.16 12.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.102 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.875 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 46.8 mttm -128.88 162.71 26.89 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.491 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 9.2 p -139.86 136.74 39.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.405 ' HB3' ' HG2' ' A' ' 80' ' ' LYS . 0.9 OUTLIER -83.66 86.74 7.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.86 -176.486 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.1 p -51.58 -41.83 61.46 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -53.78 -23.58 12.5 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.436 ' HG3' ' OE1' ' A' ' 81' ' ' GLU . 7.4 ptpp? -115.37 -34.34 4.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.187 0.518 . . . . 0.0 109.947 177.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.491 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 1.3 mp0 -81.5 39.48 0.53 Allowed 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 123.711 0.804 . . . . 0.0 110.992 173.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.66 -41.16 94.44 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.932 0.396 . . . . 0.0 110.942 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -61.66 -47.78 83.79 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.042 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.0 tp -62.66 -48.51 79.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.182 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.34 -40.97 94.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.814 0.34 . . . . 0.0 111.341 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.46 -28.33 72.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.638 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.82 -27.59 68.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.322 . . . . 0.0 111.276 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.504 ' HB2' HG12 ' A' ' 90' ' ' ILE . 82.0 m-85 -89.71 -16.53 30.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.739 0.304 . . . . 0.0 110.975 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.93 4.68 56.69 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.075 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 88' ' ' PHE . 33.1 mm -67.45 126.21 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -63.96 -60.81 2.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.068 0.461 . . . . 0.0 110.251 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.1 m -158.19 -84.3 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.943 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 8.8 pt -153.93 146.14 17.21 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.28 -167.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -105.2 147.57 1.18 Allowed 'Cis proline' 0 N--CA 1.461 -0.423 0 C-N-CA 124.833 -0.903 . . . . 0.0 111.405 -5.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.438 ' C ' HD12 ' A' ' 96' ' ' ILE . 18.9 t -131.74 138.39 48.61 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.438 HD12 ' C ' ' A' ' 95' ' ' SER . 3.0 mp -125.93 116.16 45.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.733 -177.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 105' ' ' PRO . 37.4 tp -94.19 112.12 23.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.112 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.41 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 96.4 m-85 -90.2 107.31 19.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.461 178.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 55.2 mt -96.92 109.47 49.09 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.318 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.556 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 84.9 Cg_endo -87.96 169.31 6.5 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.221 2.614 . . . . 0.0 112.422 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 89.7 mmm -96.4 3.03 53.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.56 0.695 . . . . 0.0 109.236 173.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -138.66 118.67 13.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.355 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.19 -141.36 15.51 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.52 176.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -120.78 151.0 53.94 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.556 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 17.2 Cg_exo -68.04 122.51 9.61 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.483 2.122 . . . . 0.0 112.05 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -90.79 160.68 15.64 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 18.4 ptp -141.79 144.35 33.91 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.213 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.3 145.84 49.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.231 174.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -72.15 137.23 46.83 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.34 -143.38 3.85 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 115.363 0.905 . . . . 0.0 115.363 -167.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' A' ' 52' ' ' PRO . . . 70.86 20.2 5.54 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.829 0.852 . . . . 0.0 110.403 -171.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.611 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 6.6 mtp -84.33 150.28 57.1 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.769 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.44 178.31 7.52 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.43 2.087 . . . . 0.0 111.141 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.483 ' HG3' HD21 ' A' ' 63' ' ' LEU . 86.3 tttt -61.73 -26.29 67.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.05 0.452 . . . . 0.0 109.953 176.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.84 -52.38 20.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.043 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.611 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 18.8 m -68.61 -35.14 76.92 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.618 -177.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.49 ' O ' HG13 ' A' ' 121' ' ' ILE . 3.7 m-85 -64.77 -44.4 90.15 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.578 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -57.98 -48.81 78.87 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.87 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -57.42 -37.06 72.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.831 0.348 . . . . 0.0 110.772 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.42 -48.6 48.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.196 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 117' ' ' PHE . 56.8 mt -65.68 -52.1 54.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.237 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.42 -62.42 1.79 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.893 0.378 . . . . 0.0 110.942 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.662 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 18.2 mt-10 -64.25 -44.56 91.41 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -172.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -94.44 -35.16 12.45 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.217 -172.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 40' ' ' PRO . 17.9 tp -89.02 -47.57 8.03 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.796 -175.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.8 mt -80.23 -58.92 2.91 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.662 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 25.1 ttpp -76.11 159.32 30.86 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.449 ' HG3' ' H ' ' A' ' 130' ' ' GLY . 0.3 OUTLIER -138.23 117.17 12.43 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.535 -178.495 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -66.43 -6.38 14.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.447 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.449 ' H ' ' HG3' ' A' ' 128' ' ' LYS . . . 64.52 69.66 1.27 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -66.04 -69.15 0.32 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -171.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 47.6 m80 56.04 -79.54 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 174.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -109.57 -100.7 0.39 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.562 0.22 . . . . 0.0 110.621 -175.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.531 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 6.3 m80 -129.16 -12.15 4.62 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.531 ' HB2' ' O ' ' A' ' 134' ' ' HIS . 57.9 m80 73.31 18.85 3.64 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -164.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 63.7 t60 . . . . . 0 C--O 1.242 0.682 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.013 -177.036 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.713 ' HB3' ' HA ' ' A' ' 5' ' ' THR . 55.5 tpp . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.9 m 59.04 -91.39 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 O-C-N 123.835 0.709 . . . . 0.0 110.278 -172.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.9 mp -100.41 -72.93 0.66 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -107.64 -81.12 0.56 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.86 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.713 ' HA ' ' HB3' ' A' ' 1' ' ' MET . 8.9 t -132.83 5.26 3.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.183 0.516 . . . . 0.0 109.92 175.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.65 ' HG2' ' H ' ' A' ' 7' ' ' GLY . 26.0 tt0 -171.85 -178.66 2.24 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.055 -175.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.65 ' H ' ' HG2' ' A' ' 6' ' ' GLU . . . -114.01 45.99 1.23 Allowed Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.575 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 18.1 m120 -52.61 119.86 5.0 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 122.782 0.433 . . . . 0.0 111.704 -178.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.513 ' CA ' ' HA ' ' A' ' 68' ' ' ASP . . . 69.98 18.55 74.62 Favored Glycine 0 CA--C 1.502 -0.738 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.764 173.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -124.8 172.32 9.42 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.9 p -142.2 132.36 24.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.119 0.485 . . . . 0.0 111.073 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.8 mm -131.45 124.95 55.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.544 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.645 ' CB ' ' HB2' ' A' ' 75' ' ' LYS . 6.0 p80 -82.81 116.13 22.01 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 172.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.486 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -116.99 179.73 3.94 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.464 -170.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.514 HG22 ' HE2' ' A' ' 80' ' ' LYS . 56.8 p -89.58 163.35 15.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.016 176.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.712 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 33.2 pttt -61.94 -24.1 66.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.681 175.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.3 -39.52 71.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.272 0.558 . . . . 0.0 110.08 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.486 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 10.4 mm-40 -65.89 -38.75 89.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.074 175.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -62.04 -51.26 68.73 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.965 0.888 . . . . 0.0 109.115 175.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.637 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -51.64 -60.73 2.83 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.466 -1.697 . . . . 0.0 111.733 -175.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.54 -24.17 45.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -168.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -109.15 -23.33 11.69 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 48.5 t -121.33 -41.46 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -172.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.637 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 30.1 t80 -160.82 115.05 2.1 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.142 0.496 . . . . 0.0 111.011 -169.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.624 ' HA ' HD23 ' A' ' 20' ' ' LEU . 3.1 t-20 -89.96 90.45 8.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.685 -175.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.613 ' CE2' ' HG ' ' A' ' 20' ' ' LEU . 28.6 p90 -85.26 20.68 1.9 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.417 0.627 . . . . 0.0 111.248 177.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.533 ' HG3' HD21 ' A' ' 20' ' ' LEU . 39.8 mt-10 -92.93 -47.33 7.07 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.501 ' HG3' ' ND2' ' A' ' 29' ' ' ASN . 18.3 ptmt -98.25 -11.09 23.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.412 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.631 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 9.9 m-80 -128.69 73.44 80.98 Favored Pre-proline 0 CA--C 1.515 -0.396 0 CA-C-O 121.686 0.755 . . . . 0.0 110.93 171.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -57.58 -43.47 50.48 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 123.744 2.962 . . . . 0.0 112.167 171.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.526 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -111.12 -31.5 7.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.016 -174.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.631 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -90.87 157.43 17.35 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.295 0.569 . . . . 0.0 111.317 -174.817 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.586 ' HB3' ' NZ ' ' A' ' 104' ' ' LYS . 40.7 t-105 -112.54 112.96 24.87 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.613 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -132.79 110.4 10.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.661 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 5.2 t80 -87.81 133.56 33.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.908 -177.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -107.25 144.71 33.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 171.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.21 -122.58 1.48 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.798 -175.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.504 ' OD1' ' HG3' ' A' ' 39' ' ' LYS . 16.6 t70 -165.41 -61.38 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.117 0.484 . . . . 0.0 110.188 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.504 ' HG3' ' OD1' ' A' ' 38' ' ' ASP . 44.8 mttp -105.54 156.21 36.79 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.761 -173.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.538 ' HG2' HG22 ' A' ' 71' ' ' ILE . 6.0 Cg_endo -49.46 133.61 31.46 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.259 2.64 . . . . 0.0 111.999 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -118.51 146.67 44.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.438 -173.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.794 HD11 HD22 ' A' ' 125' ' ' LEU . 50.1 mm -115.71 136.5 52.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.74 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 17.5 t -120.69 120.28 62.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.061 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.663 ' HB2' HD13 ' A' ' 60' ' ' LEU . 13.5 t0 -94.26 103.55 15.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.754 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.428 ' HE1' ' HB2' ' A' ' 97' ' ' LEU . 80.8 m-85 -88.81 110.95 21.46 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 176.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.665 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.9 p90 -145.95 177.32 9.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.259 0.552 . . . . 0.0 111.456 -172.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.504 ' HB3' HD13 ' A' ' 93' ' ' ILE . . . -157.95 152.05 24.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.492 171.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -60.6 -44.83 95.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -173.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -69.4 -10.91 60.06 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -171.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 45.9 t -93.71 129.21 40.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.065 0.459 . . . . 0.0 110.838 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.73 -60.5 7.66 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.811 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.551 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 81.6 Cg_exo -47.61 -35.66 23.23 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.315 2.676 . . . . 0.0 113.381 176.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.665 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 67.6 m -64.07 -50.64 67.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.985 0.422 . . . . 0.0 111.061 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -61.62 -28.11 69.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.006 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.404 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 84.3 mtp -66.97 -51.58 53.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.463 176.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.408 ' HB ' ' HZ ' ' A' ' 117' ' ' PHE . 30.0 m -77.29 -33.53 20.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -171.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -48.22 -56.64 13.2 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 21.7 Cg_exo -65.68 -35.72 35.92 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.057 1.838 . . . . 0.0 112.168 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.455 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 67.6 mt -64.19 -41.38 92.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.432 0.634 . . . . 0.0 109.536 176.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.663 HD13 ' HB2' ' A' ' 44' ' ' ASP . 7.6 mt -68.36 -33.49 74.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.454 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD1' HG11 ' A' ' 11' ' ' VAL . 58.9 m-20 -63.73 -42.66 97.85 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.661 0.743 . . . . 0.0 109.25 173.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.579 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 16.9 tp10 -57.09 -53.39 58.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.682 177.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.537 HD21 ' HG3' ' A' ' 114' ' ' LYS . 4.4 mm? -61.76 -31.91 72.13 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.626 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.531 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -58.49 -60.23 4.12 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.74 0.305 . . . . 0.0 110.921 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.579 ' HE3' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -75.17 -23.85 57.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.196 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -61.37 -38.57 87.48 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.246 0.546 . . . . 0.0 110.535 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -103.67 27.1 7.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.298 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 6.7 t0 -48.43 134.42 15.18 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.366 -177.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.472 ' HA2' ' HB3' ' A' ' 8' ' ' ASN . . . 92.61 -33.84 4.79 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.658 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -86.53 -47.65 9.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.609 0.242 . . . . 0.0 111.384 -175.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.538 HG22 ' HG2' ' A' ' 40' ' ' PRO . 40.5 pt -125.1 164.01 24.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.186 0.517 . . . . 0.0 111.644 -175.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 60.3 t -128.27 127.78 67.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.3 175.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.763 HG12 ' HB ' ' A' ' 42' ' ' ILE . 46.7 mt -111.71 137.99 42.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.196 0.522 . . . . 0.0 111.118 -177.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -121.13 161.8 21.17 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.645 ' HB2' ' CB ' ' A' ' 13' ' ' HIS . 79.8 mttt -124.34 150.62 45.29 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.016 0.436 . . . . 0.0 110.034 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.717 HG13 ' HG2' ' A' ' 81' ' ' GLU . 2.8 t -127.95 126.13 65.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.025 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -90.33 89.64 7.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.657 HG21 ' HA ' ' A' ' 92' ' ' SER . 33.1 m -52.09 -30.04 24.23 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.215 -171.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -51.97 -34.23 41.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.76 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.514 ' HE2' HG22 ' A' ' 15' ' ' THR . 22.7 pttm -108.27 -20.89 12.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.207 0.527 . . . . 0.0 110.348 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.717 ' HG2' HG13 ' A' ' 76' ' ' VAL . 1.5 mp0 -91.18 40.99 1.05 Allowed 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.572 0.749 . . . . 0.0 111.67 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -55.6 -53.6 54.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.444 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -62.85 -36.39 83.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.631 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.6 tp -64.1 -43.33 95.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.541 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.568 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -65.25 -47.15 77.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.669 175.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.88 -33.93 80.66 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.87 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.54 -35.18 77.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 111.402 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -95.3 4.06 53.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.941 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.16 10.17 85.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.867 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.568 ' HB ' ' HB1' ' A' ' 85' ' ' ALA . 6.4 mt -69.72 143.01 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -72.09 -48.17 46.0 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.657 ' HA ' HG21 ' A' ' 78' ' ' THR . 15.0 p 179.69 -80.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.712 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.576 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 16.7 pt -149.2 149.83 30.43 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.107 -172.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.483 ' HG3' ' HB2' ' A' ' 52' ' ' PRO . 10.7 Cg_endo -101.2 150.27 3.44 Favored 'Cis proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.649 -0.979 . . . . 0.0 112.046 -3.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.6 t -138.95 136.66 35.65 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 107' ' ' MET . 15.3 mm -114.55 113.42 43.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.74 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 41.5 tp -94.58 119.44 33.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.03 0.443 . . . . 0.0 110.689 -175.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -100.72 107.89 19.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.424 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.13 108.12 50.62 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.393 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -84.65 168.77 11.02 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.744 2.296 . . . . 0.0 112.098 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 86.5 mtp -87.23 -12.34 47.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.503 0.668 . . . . 0.0 110.155 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -140.09 127.05 20.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.581 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.67 -151.93 18.19 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.227 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.586 ' NZ ' ' HB3' ' A' ' 33' ' ' TRP . 29.3 mmmt -115.4 155.13 47.46 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.441 ' HD3' ' CD1' ' A' ' 33' ' ' TRP . 92.3 Cg_endo -81.79 144.5 13.84 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.505 2.136 . . . . 0.0 112.302 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.2 169.92 8.67 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.318 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.534 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 22.3 ptp -142.19 121.33 12.98 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.775 0.798 . . . . 0.0 111.41 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.54 128.38 49.21 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -67.52 150.95 48.17 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.317 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.96 -162.99 2.27 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.559 -0.746 . . . . 0.0 114.753 -168.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.551 ' HB2' ' HB3' ' A' ' 52' ' ' PRO . . . 75.84 17.24 2.29 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.164 0.985 . . . . 0.0 111.55 -176.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.642 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 73.0 mtm -86.75 144.31 36.95 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.85 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 71.7 Cg_endo -75.43 178.92 6.72 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.567 2.178 . . . . 0.0 110.5 172.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.537 ' HG3' HD21 ' A' ' 63' ' ' LEU . 64.3 tttm -62.06 -27.83 69.18 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.75 -45.89 63.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.037 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.642 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 50.7 m -70.62 -30.14 66.71 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.184 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.512 ' O ' HG13 ' A' ' 121' ' ' ILE . 13.7 m-85 -64.08 -52.44 59.27 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.172 172.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.456 ' O ' ' HD3' ' A' ' 118' ' ' LYS . 11.6 tmtt? -58.53 -38.32 77.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.83 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.508 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -56.59 -52.29 65.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.894 176.64 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.05 -43.28 68.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.853 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 117' ' ' PHE . 58.6 mt -62.97 -44.16 99.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 109.965 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -62.88 -68.4 0.34 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.596 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.798 ' HA ' ' HE2' ' A' ' 127' ' ' LYS . 3.8 tt0 -80.06 11.06 3.65 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.836 -163.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -143.17 -47.51 0.31 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.614 177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.794 HD22 HD11 ' A' ' 42' ' ' ILE . 28.4 tp -79.44 -38.86 33.7 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.139 -174.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.2 mt -98.54 -47.91 5.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.666 0.746 . . . . 0.0 109.923 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.798 ' HE2' ' HA ' ' A' ' 123' ' ' GLU . 19.0 ttpt -96.47 84.44 3.7 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.693 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -67.7 109.15 3.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.173 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 76.89 144.75 0.08 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 124.277 0.986 . . . . 0.0 110.868 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.94 -20.05 79.64 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.274 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.4 m170 70.97 89.09 0.1 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.674 0.75 . . . . 0.0 109.927 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -80.32 92.34 5.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.076 -171.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -74.47 99.43 3.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.615 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -89.25 150.57 22.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.892 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -89.23 150.37 22.67 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 . . . . . 0 C--O 1.245 0.818 0 CA-C-O 117.802 -1.094 . . . . 0.0 108.4 170.135 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptm . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.765 0.316 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -91.56 113.09 25.26 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 175.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.424 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 2.6 pp -85.75 -4.44 59.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.658 -177.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -163.29 127.69 2.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.959 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 p -109.24 141.14 41.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.173 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.65 77.17 5.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.332 1.063 . . . . 0.0 110.261 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.19 89.7 0.1 OUTLIER Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.234 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -155.22 106.0 2.56 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.846 -0.208 . . . . 0.0 110.655 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.513 ' CA ' ' HA ' ' A' ' 68' ' ' ASP . . . 67.44 28.26 73.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.541 173.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -162.74 166.55 24.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.757 0.279 . . . . 0.0 110.295 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.537 HG23 HG22 ' A' ' 73' ' ' ILE . 9.0 p -98.85 133.59 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.495 0.664 . . . . 0.0 111.029 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 73.8 mt -111.61 122.25 65.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.732 177.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.476 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 2.2 p80 -91.84 119.36 31.57 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.589 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.72 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.2 pp -138.8 168.17 20.4 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.677 -178.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.9 p -94.25 176.61 6.25 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.396 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 13.8 pttm -57.21 -24.83 57.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 177.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.53 -47.43 69.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.308 0.575 . . . . 0.0 109.727 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.72 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 3.9 mp0 -71.13 -33.87 70.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.109 176.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.413 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 7.2 t80 -59.41 -47.9 83.68 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 122.195 0.997 . . . . 0.0 109.151 176.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -50.26 -59.35 4.04 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 113.155 -1.838 . . . . 0.0 111.046 -179.545 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.0 -45.03 36.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 19.1 tptm -89.04 -7.85 55.12 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.027 -168.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 62.1 t -134.52 -54.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.506 -0.477 . . . . 0.0 112.252 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.492 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 11.8 t80 -169.63 126.12 0.87 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.268 0.556 . . . . 0.0 112.025 -164.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.528 ' HA ' HD23 ' A' ' 20' ' ' LEU . 24.3 t-20 -82.46 89.91 6.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.71 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.492 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 34.8 p90 -81.96 10.71 6.02 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.381 0.61 . . . . 0.0 111.092 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -107.78 -47.63 3.56 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.568 ' NZ ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -89.26 -28.31 20.0 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.29 -178.751 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.435 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 2.8 m-20 -121.15 62.94 11.77 Favored Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.933 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -59.43 -35.73 95.52 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.706 2.271 . . . . 0.0 112.076 175.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.512 ' HG3' ' HG2' ' A' ' 32' ' ' GLU . 16.0 pt-20 -98.26 -23.77 15.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.47 -176.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.512 ' HG2' ' HG3' ' A' ' 31' ' ' GLU . 34.5 mm-40 -100.99 155.0 18.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.832 0.349 . . . . 0.0 110.982 -174.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.532 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 76.2 t-105 -105.71 92.07 4.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.205 0.526 . . . . 0.0 110.009 175.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.606 ' HG3' ' OE2' ' A' ' 36' ' ' GLU . 25.3 tptp -100.95 104.63 15.81 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.58 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 21.8 t80 -107.97 118.49 36.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.568 -177.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.606 ' OE2' ' HG3' ' A' ' 34' ' ' LYS . 12.9 mm-40 -86.32 87.76 7.49 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA3' ' CE2' ' A' ' 35' ' ' TYR . . . -106.89 129.19 9.59 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.142 -1.028 . . . . 0.0 114.306 -169.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -87.94 -53.32 4.8 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 170.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HB2' HG23 ' A' ' 72' ' ' VAL . 47.1 mttp -126.16 171.52 7.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 172.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 9.1 Cg_endo -54.74 144.92 63.19 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.486 2.124 . . . . 0.0 111.283 170.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -128.04 155.88 43.64 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -170.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.856 ' HB ' HG23 ' A' ' 73' ' ' ILE . 21.4 mm -125.87 147.05 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.462 173.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 66.4 t -133.6 119.41 33.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 118.782 0.719 . . . . 0.0 111.412 176.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.58 113.38 26.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.636 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.576 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 69.7 m-85 -94.05 111.51 23.23 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 172.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.688 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.2 p90 -141.21 -177.1 4.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.342 0.591 . . . . 0.0 110.968 -172.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.47 139.3 25.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.614 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -61.39 -37.7 84.39 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -174.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -66.99 -16.31 64.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.008 0.432 . . . . 0.0 111.301 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.2 t -88.21 116.48 26.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.515 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.33 -53.9 37.86 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.758 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 55' ' ' MET . 84.9 Cg_exo -48.07 -37.85 31.08 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.909 2.406 . . . . 0.0 113.214 175.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.688 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 93.0 m -66.75 -48.03 70.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.395 0.617 . . . . 0.0 110.475 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 mttp -53.59 -30.79 44.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.646 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 76.2 mtp -64.59 -49.1 72.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.993 0.425 . . . . 0.0 111.439 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.478 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 35.1 m -79.54 -27.9 12.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.757 -171.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.516 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -50.31 -59.97 6.15 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 55.7 Cg_endo -71.15 -40.76 3.02 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.733 1.622 . . . . 0.0 112.495 -177.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 64.4 mt -64.99 -51.63 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.331 -176.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -68.25 -29.9 68.82 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.487 -176.722 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.535 ' OD1' HG12 ' A' ' 11' ' ' VAL . 23.4 t70 -61.75 -40.21 94.29 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.423 0.63 . . . . 0.0 109.775 172.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 59' ' ' ILE . 8.5 tm-20 -63.31 -41.01 98.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.321 176.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.537 HD21 ' HA ' ' A' ' 114' ' ' LYS . 3.1 mm? -58.71 -36.7 74.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.926 0.393 . . . . 0.0 110.699 174.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.658 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -60.97 -37.94 84.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.315 177.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 5.4 tmtm? -75.67 -33.12 60.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.527 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -55.32 -44.62 76.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.424 0.63 . . . . 0.0 109.931 172.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.599 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 48.0 m-85 -99.36 27.32 5.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.68 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 15.4 t0 -49.93 129.71 20.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.499 -177.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.49 -30.87 9.46 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.451 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 13.1 pt20 -106.86 -21.27 13.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 64' ' ' ALA . 30.6 pt -125.22 155.95 34.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.185 0.517 . . . . 0.0 112.059 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 40.5 t -127.96 129.93 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.348 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.856 HG23 ' HB ' ' A' ' 42' ' ' ILE . 24.8 mt -117.18 142.34 31.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 41.9 m-85 -124.47 158.57 32.53 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 0.2 OUTLIER -148.52 150.45 33.4 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 175.006 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.972 HG22 ' HG3' ' A' ' 81' ' ' GLU . 2.8 p -141.21 156.55 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.555 -173.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.516 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 10.8 m-20 -96.38 90.95 5.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.368 -175.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.547 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 10.2 m -50.05 -34.79 22.72 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -173.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' A' ' 79' ' ' GLU . 2.6 mm-40 -53.78 -41.04 66.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.98 0.419 . . . . 0.0 111.768 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 13.3 ptpt -94.57 -20.36 19.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.807 0.813 . . . . 0.0 109.344 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.972 ' HG3' HG22 ' A' ' 76' ' ' VAL . 10.3 mm-40 -98.2 39.71 1.22 Allowed 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.442 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -66.85 -30.98 71.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.625 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.55 -39.59 70.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.478 0.656 . . . . 0.0 109.243 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 33.4 tp -68.56 -37.8 80.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.832 176.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.618 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -63.9 -44.81 91.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.816 176.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.79 -29.16 66.85 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.92 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.29 -33.39 75.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.338 . . . . 0.0 111.444 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.607 ' HB2' HG13 ' A' ' 90' ' ' ILE . 91.2 m-85 -103.15 6.53 38.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.774 0.321 . . . . 0.0 110.626 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.39 33.67 87.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.862 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.618 HD12 ' HA ' ' A' ' 85' ' ' ALA . 41.9 mt -71.14 133.39 31.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.97 0.414 . . . . 0.0 110.745 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.458 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 0.4 OUTLIER -70.18 -51.41 31.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.096 178.761 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.9 p 175.39 -99.65 0.0 OUTLIER 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.145 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 26.6 pt -147.55 143.01 17.36 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.708 -172.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.733 ' HB2' ' H ' ' A' ' 110' ' ' GLY . 11.9 Cg_exo -81.95 149.25 71.77 Favored 'Cis proline' 0 N--CA 1.474 0.368 0 C-N-CA 124.934 -0.861 . . . . 0.0 111.921 -3.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.576 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 14.5 m -140.19 128.28 22.26 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 107' ' ' MET . 52.5 mt -127.94 122.66 59.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.837 0.351 . . . . 0.0 110.603 -174.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 32.8 tp -104.81 122.13 45.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.397 -177.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -100.07 111.35 23.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 54.9 mt -109.51 113.62 57.97 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -170.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.604 ' CB ' ' HE2' ' A' ' 128' ' ' LYS . 88.1 Cg_endo -85.0 159.97 11.66 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.096 2.531 . . . . 0.0 111.621 172.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 86.1 mtp -80.28 -35.99 35.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -118.87 122.54 42.56 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.469 0.652 . . . . 0.0 109.54 173.842 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.0 -171.19 13.65 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -174.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.532 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 8.9 mmmm -117.97 150.31 47.07 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 117.335 0.567 . . . . 0.0 110.083 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.24 148.11 21.06 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.933 2.422 . . . . 0.0 114.216 -173.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -111.09 169.3 8.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.279 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 46.5 ttm -134.59 124.9 26.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.057 0.456 . . . . 0.0 111.695 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.88 157.71 21.09 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.469 ' HG2' ' HA ' ' A' ' 95' ' ' SER . 39.4 mt-30 -131.38 141.12 49.82 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.715 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.733 ' H ' ' HB2' ' A' ' 94' ' ' PRO . . . 115.46 177.87 18.56 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.507 -0.77 . . . . 0.0 114.125 172.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.478 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -87.75 86.07 7.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.281 0.562 . . . . 0.0 111.227 -175.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.639 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 72.6 mtm -78.93 136.89 57.78 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.828 175.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -75.46 -171.65 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.846 2.364 . . . . 0.0 111.792 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.537 ' HA ' HD21 ' A' ' 63' ' ' LEU . 13.8 tttm -57.97 -37.12 73.61 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.5 -50.59 62.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.326 -175.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.639 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 45.0 m -70.1 -37.47 75.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.926 -177.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.643 ' O ' HG13 ' A' ' 121' ' ' ILE . 4.6 m-85 -64.89 -44.51 89.41 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.829 176.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.526 ' HG2' ' OH ' ' A' ' 67' ' ' TYR . 11.3 tmtt? -53.83 -47.68 70.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.673 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -65.15 -38.08 89.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.754 -177.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.06 78.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.257 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.643 HG13 ' O ' ' A' ' 117' ' ' PHE . 23.1 mt -74.19 -55.23 12.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.884 0.373 . . . . 0.0 110.821 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.52 ' HA ' HD12 ' A' ' 126' ' ' LEU . 12.4 t70 -71.43 -65.54 0.74 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.687 0.28 . . . . 0.0 111.623 -176.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.437 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 32.8 mt-10 -75.82 -4.76 42.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -166.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -128.04 -38.61 1.81 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.572 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 40.5 tp -88.87 -43.2 11.38 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.887 -0.508 . . . . 0.0 110.742 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 122' ' ' ASP . 81.8 mt -82.92 -58.49 2.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.415 0.626 . . . . 0.0 109.68 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 12.7 ttpp -89.1 45.89 1.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.588 177.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.604 ' HE2' ' CB ' ' A' ' 100' ' ' PRO . 23.5 ttpp -59.18 116.69 4.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.232 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -74.31 63.8 1.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.698 0.761 . . . . 0.0 112.644 -176.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -114.53 24.88 10.81 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 167.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -70.27 -12.12 61.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.406 -0.897 . . . . 0.0 111.571 -173.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -141.75 94.45 2.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -88.3 -43.99 11.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.694 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -107.43 125.03 50.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.817 0.341 . . . . 0.0 110.847 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -151.57 -52.46 0.12 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.082 174.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 48.1 t60 . . . . . 0 C--O 1.247 0.924 0 O-C-N 124.059 0.849 . . . . 0.0 109.177 -170.542 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 mtm . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 121.185 0.516 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.67 ' HB2' ' HB ' ' A' ' 5' ' ' THR . 7.0 m -82.39 153.17 25.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.585 -176.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.76 -30.4 29.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.33 0.586 . . . . 0.0 109.886 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.19 20.32 13.71 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.004 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.67 ' HB ' ' HB2' ' A' ' 2' ' ' SER . 53.1 m -151.57 105.78 3.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.067 0.461 . . . . 0.0 110.92 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.615 ' HG2' ' H ' ' A' ' 7' ' ' GLY . 2.0 tt0 -138.24 -163.03 1.38 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.615 ' H ' ' HG2' ' A' ' 6' ' ' GLU . . . -80.22 57.2 4.65 Favored Glycine 0 C--O 1.228 -0.222 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 172.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -100.51 115.16 29.44 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.068 -0.566 . . . . 0.0 111.435 -168.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 56.23 40.72 85.14 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.473 177.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.488 ' HZ1' ' CG ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -152.98 151.47 30.33 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 121.519 0.676 . . . . 0.0 111.865 -172.42 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 5.1 p -103.79 108.18 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.006 168.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 63.0 mt -88.99 123.76 41.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.721 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.695 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 2.3 p80 -88.86 133.26 34.33 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.796 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.586 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 1.7 pp -140.65 172.8 12.21 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.887 -174.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.7 p -106.17 178.35 4.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.357 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.459 ' HB2' ' HZ ' ' A' ' 26' ' ' PHE . 14.2 ptmm? -55.32 -35.72 65.45 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.83 -38.64 79.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.232 0.539 . . . . 0.0 110.286 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.586 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 2.6 mm-40 -71.0 -35.74 72.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.142 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -64.05 -48.34 76.67 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.78 0.8 . . . . 0.0 109.116 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.643 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.7 tt -50.82 -60.77 2.72 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.265 -178.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.6 -18.91 39.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -168.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 34.5 ttmt -108.5 -12.71 14.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.972 0.415 . . . . 0.0 111.397 -174.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 57.6 t -135.85 -55.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -174.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.653 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 9.7 t80 -167.09 122.53 1.09 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.261 0.553 . . . . 0.0 111.7 -164.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.505 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 1.8 t-20 -86.74 89.68 8.03 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.031 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.653 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 10.5 p90 -89.4 0.37 56.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.379 -174.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -104.98 -22.1 13.18 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.928 ' HE3' HD21 ' A' ' 29' ' ' ASN . 3.7 ttpp -105.96 -26.04 11.85 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.409 167.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.928 HD21 ' HE3' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -119.12 67.97 9.03 Favored Pre-proline 0 N--CA 1.471 0.591 0 CA-C-O 120.886 0.374 . . . . 0.0 111.635 -178.132 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.77 -34.66 39.56 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.92 2.413 . . . . 0.0 111.527 167.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -97.52 -30.6 12.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.841 -177.534 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.681 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 22.9 mt-10 -91.36 128.6 37.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.063 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.486 ' CZ2' ' HG3' ' A' ' 105' ' ' PRO . 72.8 t-105 -91.16 103.44 16.12 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.784 172.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -107.93 134.66 50.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.56 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.575 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 37.3 t80 -133.0 96.72 3.83 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.82 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -90.32 31.43 1.01 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.51 -174.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.5 135.25 12.69 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.421 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' OD2' ' HG3' ' A' ' 39' ' ' LYS . 25.2 t70 -65.6 -41.47 92.77 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.19 0.519 . . . . 0.0 111.081 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.414 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 72.5 mttt -125.32 158.79 62.74 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.548 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.662 ' HB3' HD11 ' A' ' 125' ' ' LEU . 50.3 Cg_exo -54.64 140.22 76.2 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.362 2.041 . . . . 0.0 111.157 173.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -124.44 152.37 43.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.669 0.747 . . . . 0.0 112.391 -172.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.8 mt -117.95 114.17 44.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.128 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 21.4 t -99.78 120.26 48.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.397 -175.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.682 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 21.8 t70 -103.69 111.12 23.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.57 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -83.45 111.94 19.5 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 172.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.71 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.8 p90 -132.58 158.23 42.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.775 0.798 . . . . 0.0 112.031 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.524 ' HB3' HG12 ' A' ' 93' ' ' ILE . . . -133.4 108.85 8.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.244 -1.343 . . . . 0.0 107.706 167.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.541 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 33.9 t70 -55.4 -31.03 61.49 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -167.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 59.6 p-90 -69.95 -1.43 9.63 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.625 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 27.9 t -114.14 137.03 52.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.933 0.397 . . . . 0.0 110.627 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.4 -57.46 18.47 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 115.612 -0.722 . . . . 0.0 114.669 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.625 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 84.1 Cg_exo -47.37 -37.49 25.19 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.158 2.572 . . . . 0.0 113.636 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.71 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 30.1 m -64.11 -50.36 68.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.334 0.588 . . . . 0.0 111.022 177.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.541 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 66.7 mttm -58.23 -28.59 65.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.339 174.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.443 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 53.2 mmm -70.63 -50.77 33.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.794 0.33 . . . . 0.0 111.398 176.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.84 -38.73 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -172.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.613 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -49.17 -54.49 28.58 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 15.8 Cg_exo -68.44 -42.67 5.01 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.212 1.941 . . . . 0.0 112.032 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.617 HD13 ' HA ' ' A' ' 113' ' ' PRO . 74.3 mt -57.26 -44.03 83.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.302 0.572 . . . . 0.0 110.497 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 44' ' ' ASP . 5.8 mt -68.37 -35.15 77.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.621 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.547 ' OD1' HG12 ' A' ' 11' ' ' VAL . 14.7 t70 -68.02 -35.53 78.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.134 0.493 . . . . 0.0 109.69 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.639 ' HA ' ' HD2' ' A' ' 65' ' ' LYS . 13.9 mm-40 -54.09 -44.63 71.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.768 172.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' A' ' 117' ' ' PHE . 11.1 mp -65.4 -30.89 71.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.727 0.298 . . . . 0.0 110.833 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -61.7 -53.2 59.35 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.657 -178.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.639 ' HD2' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -76.09 -24.97 55.06 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.795 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -42.73 61.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.88 0.372 . . . . 0.0 111.478 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.415 ' O ' HG12 ' A' ' 71' ' ' ILE . 94.0 m-85 -107.26 26.95 9.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.684 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.48 159.8 7.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.353 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.2 -52.89 4.13 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.262 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.534 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 7.1 pt20 -80.96 -33.77 33.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.495 0.188 . . . . 0.0 111.049 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 40' ' ' PRO . 42.2 pt -131.77 156.49 42.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.088 0.47 . . . . 0.0 111.763 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 86.8 t -124.28 136.49 60.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.648 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 21.9 mt -108.74 139.23 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.337 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -125.71 166.93 15.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.706 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.695 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -147.75 148.89 31.45 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 171.097 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.497 HG21 HD23 ' A' ' 84' ' ' LEU . 8.1 p -121.17 138.24 52.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.116 0.484 . . . . 0.0 110.524 -175.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.572 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -72.84 85.69 1.25 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.427 179.402 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.576 HG23 ' HB2' ' A' ' 85' ' ' ALA . 17.3 m -66.38 -31.77 72.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -167.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -65.9 -27.23 68.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.609 0.242 . . . . 0.0 111.199 -178.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.504 ' HZ2' ' HB3' ' A' ' 77' ' ' ASP . 8.6 ptpp? -99.79 -37.18 9.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.898 0.38 . . . . 0.0 110.108 175.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.572 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -78.86 39.63 0.37 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.36 0.664 . . . . 0.0 110.972 174.037 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -59.16 -43.98 92.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.529 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -65.15 -35.41 81.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.301 0.572 . . . . 0.0 110.379 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.497 HD23 HG21 ' A' ' 76' ' ' VAL . 14.8 tp -67.58 -48.94 65.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.322 177.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.576 ' HB2' HG23 ' A' ' 78' ' ' THR . . . -62.95 -36.28 82.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.915 0.388 . . . . 0.0 111.196 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.29 -27.75 71.18 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.777 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.37 -22.57 66.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.982 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -101.0 0.8 38.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.513 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.79 6.26 89.13 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.008 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.0 mm -68.72 130.29 33.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.514 0.197 . . . . 0.0 110.519 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 91' ' ' ARG . 39.2 mtm180 -59.27 -55.79 30.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.61 0.719 . . . . 0.0 110.394 176.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.544 ' O ' HG21 ' A' ' 78' ' ' THR . 14.2 t -167.48 -88.15 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.902 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.547 HG21 ' C ' ' A' ' 46' ' ' TYR . 2.3 pp -152.5 157.47 33.61 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -173.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.574 ' HG3' ' HB2' ' A' ' 52' ' ' PRO . 10.9 Cg_endo -99.42 148.06 4.51 Favored 'Cis proline' 0 N--CA 1.458 -0.571 0 C-N-CA 124.365 -1.098 . . . . 0.0 112.018 -3.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.8 t -139.89 142.51 36.5 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.73 128.03 71.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.465 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.595 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.5 tp -106.14 116.85 32.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.077 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 105' ' ' PRO . 20.0 m-85 -93.74 107.4 19.28 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.471 HG12 ' HB3' ' A' ' 105' ' ' PRO . 42.5 mt -110.11 109.78 58.8 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -173.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.73 165.91 13.62 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.402 2.734 . . . . 0.0 111.144 170.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.487 ' HG2' ' HE2' ' A' ' 35' ' ' TYR . 82.7 mtp -97.0 -34.17 11.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.712 0.768 . . . . 0.0 109.304 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -96.83 2.81 52.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.363 -176.183 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -137.45 -156.33 7.21 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.051 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 60.6 mmtt -126.34 154.43 74.76 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.486 ' HG3' ' CZ2' ' A' ' 33' ' ' TRP . 98.3 Cg_endo -78.21 148.26 24.06 Favored 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.677 2.251 . . . . 0.0 114.168 -169.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.507 ' HG2' ' N ' ' A' ' 107' ' ' MET . 34.9 tt0 -119.33 163.25 17.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.716 172.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.507 ' N ' ' HG2' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -142.51 137.98 30.6 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.372 0.606 . . . . 0.0 111.766 -177.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -133.98 156.77 47.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.622 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -75.41 148.52 39.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.15 -144.06 6.82 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.743 -0.742 . . . . 0.0 113.804 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 52' ' ' PRO . . . 71.99 20.86 4.26 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.435 0.694 . . . . 0.0 111.883 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.558 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 20.3 ptt? -112.37 153.7 44.73 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.529 177.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.617 ' HA ' HD13 ' A' ' 59' ' ' ILE . 93.6 Cg_endo -76.58 -177.56 3.83 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.13 2.553 . . . . 0.0 113.05 -173.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.46 ' HG3' HD11 ' A' ' 63' ' ' LEU . 38.8 ttmt -61.77 -29.39 70.1 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.024 174.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . -64.72 -47.38 78.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.215 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.558 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 18.6 m -70.88 -38.45 73.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.881 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.482 ' HB3' HD21 ' A' ' 63' ' ' LEU . 9.0 m-85 -65.41 -40.83 93.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.305 177.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.674 ' O ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -57.31 -37.24 72.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.741 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.583 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 43.2 mmtm -65.88 -57.96 6.69 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.252 175.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.51 -46.78 86.04 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -174.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.8 mp -64.37 -48.09 86.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.666 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.419 ' HA ' HD23 ' A' ' 126' ' ' LEU . 3.8 t0 -66.37 -50.27 64.07 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.841 -178.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.583 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 4.0 mm-40 -54.98 -30.2 58.78 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -174.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -115.45 -35.98 4.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.964 0.411 . . . . 0.0 111.854 -172.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.662 HD11 ' HB3' ' A' ' 40' ' ' PRO . 20.0 tp -90.6 -47.26 7.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.88 -174.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 122' ' ' ASP . 3.8 mm? -87.51 -53.43 4.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.261 0.553 . . . . 0.0 110.377 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.771 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -76.9 105.19 7.82 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 175.248 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 2.6 tppt? -72.65 78.26 1.09 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.492 177.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 128' ' ' LYS . 26.1 mm-40 80.42 57.65 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.34 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.3 -48.57 57.68 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 175.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -48.76 104.4 0.06 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.594 0.711 . . . . 0.0 110.968 170.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -70.26 126.72 30.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.791 -174.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -64.69 135.01 55.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.943 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -95.65 21.72 8.02 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -173.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.12 150.78 15.14 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.289 -0.862 . . . . 0.0 109.529 177.19 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.453 ' OG ' ' HB ' ' A' ' 5' ' ' THR . 22.7 t -164.56 90.79 0.56 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.115 0.483 . . . . 0.0 109.83 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 tt -95.89 -37.24 10.79 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.71 28.99 0.46 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.45 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.453 ' HB ' ' OG ' ' A' ' 2' ' ' SER . 8.9 t -79.56 -11.15 59.89 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.199 0.523 . . . . 0.0 110.464 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -111.11 102.53 10.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.535 ' H ' ' HD3' ' A' ' 10' ' ' LYS . . . 96.66 -173.13 29.31 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -172.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.708 ' H ' HG22 ' A' ' 72' ' ' VAL . 3.1 m-20 64.02 96.82 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.059 0.457 . . . . 0.0 111.052 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.63 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . 68.32 34.74 80.83 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.332 -177.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.703 ' HE2' HD11 ' A' ' 12' ' ' ILE . 84.3 tttt -151.19 138.89 19.73 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -172.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 10.5 p -110.95 132.13 60.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.128 0.489 . . . . 0.0 110.693 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.703 HD11 ' HE2' ' A' ' 10' ' ' LYS . 36.9 mm -120.95 117.15 52.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.096 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.446 ' CB ' ' HG3' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -84.83 121.36 27.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 171.248 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.739 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.3 pp -120.68 178.27 4.76 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.751 -170.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.475 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -107.86 172.84 6.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.818 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.649 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 10.8 ptpt -54.68 -37.31 65.61 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.92 85.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.106 0.479 . . . . 0.0 110.971 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.739 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 30.8 mm-40 -71.97 -39.46 69.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.455 177.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -63.36 -50.24 70.72 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.163 0.983 . . . . 0.0 109.065 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.649 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -47.06 -60.95 2.12 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.152 -1.84 . . . . 0.0 112.232 -178.858 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.06 -28.14 27.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.799 -170.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 24.2 ttpt -110.56 1.5 18.17 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.933 0.397 . . . . 0.0 111.704 -170.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 40.7 t -141.46 -47.76 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 22.6 t80 -167.41 119.61 0.91 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.122 0.487 . . . . 0.0 111.737 -167.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -93.67 91.93 7.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.102 -178.374 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 2.9 p90 -80.41 8.9 6.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.309 0.576 . . . . 0.0 111.532 -177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -91.91 -50.15 5.86 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.046 176.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.456 ' HG3' ' OD1' ' A' ' 29' ' ' ASN . 14.9 pttm -89.66 -15.45 32.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.656 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 2.5 m-20 -123.33 68.79 39.52 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.505 174.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -59.5 -37.26 90.23 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.996 2.464 . . . . 0.0 112.447 173.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.85 -35.57 4.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -173.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.656 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 4.6 tp10 -90.96 153.71 19.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.038 0.447 . . . . 0.0 110.417 -176.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.653 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 33.4 t-105 -103.1 113.85 27.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.612 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -125.03 110.88 14.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.759 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.635 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 37.9 t80 -76.18 114.59 15.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.194 177.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -94.22 71.21 3.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.862 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.635 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -143.74 -139.76 3.56 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.522 -175.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -149.27 -42.47 0.14 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 111.892 -173.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' A' ' 70' ' ' GLN . 35.2 mttp -126.14 165.65 26.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.245 -175.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.614 ' HD3' ' SD ' ' A' ' 101' ' ' MET . 10.3 Cg_endo -52.88 132.31 46.34 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.452 2.102 . . . . 0.0 111.237 177.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -124.42 149.97 46.15 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.174 0.512 . . . . 0.0 111.572 -172.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.509 ' HB ' HG12 ' A' ' 73' ' ' ILE . 75.7 mt -127.17 134.01 66.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 175.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 60.5 t -125.28 112.42 31.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.022 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.548 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 8.5 p-10 -102.28 114.12 28.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.962 0.887 . . . . 0.0 111.266 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 42.0 m-85 -80.3 112.55 17.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.884 172.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.776 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.9 p90 -127.39 159.91 33.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.376 0.608 . . . . 0.0 110.759 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.459 ' N ' HG21 ' A' ' 93' ' ' ILE . . . -130.86 122.99 28.04 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 170.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.576 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 15.8 t70 -66.06 -26.18 67.38 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.803 -169.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -75.78 -2.88 31.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.994 0.426 . . . . 0.0 111.17 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.577 ' HB3' ' SG ' ' A' ' 53' ' ' CYS . 32.6 t -108.28 122.34 46.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.197 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.28 -55.28 25.26 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.638 -0.71 . . . . 0.0 114.792 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.498 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 82.5 Cg_exo -47.2 -41.14 27.6 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.206 2.604 . . . . 0.0 113.786 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.776 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 3.0 m -63.63 -37.75 88.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.291 0.567 . . . . 0.0 110.921 -177.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.576 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 67.0 mttm -61.46 -28.61 69.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.071 176.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 76.6 mtp -65.57 -48.44 72.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.875 0.369 . . . . 0.0 111.573 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.435 HG21 HD11 ' A' ' 96' ' ' ILE . 12.8 p -77.59 -32.33 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -169.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.448 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -48.02 -57.34 10.56 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 43.1 Cg_endo -69.21 -35.31 14.51 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.911 1.74 . . . . 0.0 112.702 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.6 mt -63.74 -50.86 76.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.681 HD22 HD13 ' A' ' 73' ' ' ILE . 5.6 mt -60.74 -36.09 78.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.361 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -62.03 -50.35 72.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.053 0.454 . . . . 0.0 110.673 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.13 -43.97 98.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.481 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HA ' HD13 ' A' ' 63' ' ' LEU . 3.8 mm? -62.63 -32.48 73.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.112 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.658 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -63.17 -53.55 51.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.345 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 8.8 tmtm? -67.4 -34.28 76.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.644 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -58.63 -47.03 85.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.187 0.518 . . . . 0.0 110.274 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -95.04 26.33 3.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.102 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -47.12 136.56 8.69 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.918 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.23 -23.98 17.18 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.75 176.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.542 ' HG3' HG23 ' A' ' 71' ' ' ILE . 12.5 pt20 -125.88 -49.02 1.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.542 HG23 ' HG3' ' A' ' 70' ' ' GLN . 43.0 pt -95.15 148.59 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.327 0.584 . . . . 0.0 112.188 -173.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.708 HG22 ' H ' ' A' ' 8' ' ' ASN . 39.8 t -128.26 125.26 63.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.098 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.681 HD13 HD22 ' A' ' 60' ' ' LEU . 27.8 mt -109.24 131.44 60.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.308 0.575 . . . . 0.0 111.379 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.5 m-85 -116.94 156.85 26.71 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.548 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -136.07 148.29 48.24 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.452 175.224 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.58 HG13 ' HG2' ' A' ' 81' ' ' GLU . 20.8 t -117.11 126.39 74.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.536 -171.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 4.7 m-20 -83.4 95.42 8.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.417 HG21 ' O ' ' A' ' 92' ' ' SER . 16.6 p -55.56 -35.66 65.98 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -171.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -54.76 -29.94 55.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.353 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 54.6 pttt -103.14 -32.85 9.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.56 0.695 . . . . 0.0 109.726 178.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.58 ' HG2' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -88.73 41.97 1.05 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.155 -179.016 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.1 -49.58 77.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.904 -176.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.19 -36.46 81.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.934 0.397 . . . . 0.0 110.232 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.04 -53.12 58.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.951 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.14 -40.01 93.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.688 178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.84 -28.26 72.41 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.704 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.81 -32.8 74.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.807 0.336 . . . . 0.0 110.963 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.429 ' HB2' HG12 ' A' ' 90' ' ' ILE . 74.5 m-85 -89.29 0.75 56.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.933 0.397 . . . . 0.0 110.698 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.33 8.68 84.85 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.974 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.429 HG12 ' HB2' ' A' ' 88' ' ' PHE . 50.0 mm -75.01 130.21 36.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 122.341 0.257 . . . . 0.0 110.74 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -66.37 -64.28 0.89 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.221 0.534 . . . . 0.0 110.093 175.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.417 ' O ' HG21 ' A' ' 78' ' ' THR . 29.7 m -155.72 -90.3 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.589 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.534 HG13 ' SG ' ' A' ' 53' ' ' CYS . 0.2 OUTLIER -146.56 161.35 38.51 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.43 -172.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.717 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.1 Cg_exo -87.98 148.08 30.05 Favored 'Cis proline' 0 C--N 1.345 0.346 0 C-N-CA 124.507 -1.039 . . . . 0.0 111.705 -4.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.406 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 9.5 m -140.39 122.78 16.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.547 HD13 ' HZ ' ' A' ' 117' ' ' PHE . 64.5 mt -124.25 116.68 48.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.311 -175.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 105' ' ' PRO . 39.3 tp -100.38 124.09 45.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.718 -176.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -100.05 105.59 17.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.722 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.495 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 45.8 mt -100.99 108.36 54.07 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.055 -175.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -87.46 169.24 7.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.815 2.343 . . . . 0.0 112.235 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.614 ' SD ' ' HD3' ' A' ' 40' ' ' PRO . 84.2 mtp -93.89 1.0 56.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.654 0.74 . . . . 0.0 109.427 175.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -139.39 102.95 4.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.025 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.11 -153.76 16.76 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.561 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.653 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 15.4 tptt -112.35 153.63 44.75 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.537 ' HB2' HD11 ' A' ' 97' ' ' LEU . 5.7 Cg_exo -79.41 144.89 18.35 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.028 2.485 . . . . 0.0 112.781 -176.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -107.99 168.3 9.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.522 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 49.3 ttm -142.48 139.1 31.4 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.939 0.4 . . . . 0.0 111.44 -174.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -126.9 137.78 53.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.566 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -100.12 123.4 44.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.02 0.438 . . . . 0.0 110.772 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.717 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 126.58 -169.02 18.56 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.268 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.24 80.01 1.4 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.601 0.715 . . . . 0.0 110.721 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.674 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 5.0 mpp? -59.05 144.47 82.48 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.626 174.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.29 -175.96 2.83 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.891 2.394 . . . . 0.0 112.14 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -56.6 -39.63 73.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.465 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.75 -51.15 66.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.096 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.674 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 33.1 m -68.17 -29.13 67.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.75 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.647 ' O ' HG12 ' A' ' 121' ' ' ILE . 10.6 m-85 -75.41 -39.1 59.42 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.293 176.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -53.88 -37.46 63.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.035 0.445 . . . . 0.0 110.388 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 45.3 tttp -69.06 -46.34 68.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.354 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -66.79 -44.46 81.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.049 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.647 HG12 ' O ' ' A' ' 117' ' ' PHE . 17.4 mm -74.0 -50.57 27.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.736 0.303 . . . . 0.0 111.098 -174.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 126' ' ' LEU . 11.9 t70 -68.37 -60.93 2.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.014 0.435 . . . . 0.0 110.808 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.872 ' HA ' ' HD2' ' A' ' 127' ' ' LYS . 22.2 mt-10 -75.73 -9.69 58.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.164 -167.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.411 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 79.9 t80 -127.69 -39.54 1.81 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.25 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 125' ' ' LEU . 3.3 tp -91.01 -32.42 15.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.458 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 23.8 tp -84.01 -65.26 1.03 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.872 ' HD2' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -101.05 -156.72 0.57 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 167.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.68 ' HG3' ' HB2' ' A' ' 132' ' ' HIS . 0.2 OUTLIER -147.92 93.96 2.27 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.162 -176.747 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.767 ' HB2' ' HE2' ' A' ' 127' ' ' LYS . 0.8 OUTLIER -105.13 -175.33 2.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.256 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.42 -87.03 0.25 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.729 176.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -69.71 -27.03 64.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.955 0.407 . . . . 0.0 110.801 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.68 ' HB2' ' HG3' ' A' ' 128' ' ' LYS . 0.6 OUTLIER -95.39 -30.35 13.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.383 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -132.74 92.03 2.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.289 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -78.11 -64.19 1.22 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -91.82 126.83 37.05 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.679 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 . . . . . 0 C--O 1.244 0.813 0 CA-C-O 118.521 -0.752 . . . . 0.0 109.877 -179.66 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 m -80.48 -45.5 17.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.251 0.548 . . . . 0.0 110.099 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.82 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.3 pt? -100.27 10.94 40.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.974 -177.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -149.8 148.04 28.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.474 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 t -116.07 97.38 6.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.18 0.514 . . . . 0.0 110.759 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.9 -85.44 0.09 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.634 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.417 ' HA2' HG21 ' A' ' 72' ' ' VAL . . . -84.34 64.97 4.18 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.053 -0.521 . . . . 0.0 113.39 -173.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.446 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 2.6 m120 -147.92 123.22 10.27 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 65' ' ' LYS . . . 58.01 38.68 90.12 Favored Glycine 0 CA--C 1.51 -0.279 0 O-C-N 124.558 1.161 . . . . 0.0 115.426 166.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 20.5 pttm -169.6 173.06 6.56 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.906 0.86 . . . . 0.0 113.03 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 12.9 m -100.43 110.67 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 113.469 -1.696 . . . . 0.0 109.57 171.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.401 HD12 ' CE2' ' A' ' 74' ' ' TYR . 47.2 mt -83.84 103.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.113 -175.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -75.63 112.12 11.66 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 2.9 pp -140.28 158.31 44.23 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.744 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.501 HG22 ' CE ' ' A' ' 80' ' ' LYS . 40.0 p -82.49 166.15 19.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.774 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.731 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 42.8 pttt -56.15 -34.12 65.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.682 177.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.57 -37.47 82.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.102 0.477 . . . . 0.0 110.416 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 42.5 mt-10 -71.99 -34.84 69.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.504 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -63.47 -48.28 78.3 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.086 0.946 . . . . 0.0 108.935 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.6 tt -46.83 -61.33 1.9 Allowed 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.281 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.94 -25.02 40.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.428 -170.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -93.7 -37.68 11.7 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.644 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.0 t -118.82 -41.12 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -167.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.578 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 30.0 t80 -166.99 118.83 0.93 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.05 0.452 . . . . 0.0 111.809 -165.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.57 HD22 ' HD3' ' A' ' 28' ' ' LYS . 25.4 t-20 -85.25 91.06 8.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.528 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.557 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 49.0 p90 -86.17 18.81 2.92 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.698 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 27.6 mt-10 -102.1 -54.73 2.64 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 175.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.698 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 8.1 mptt -91.68 -19.56 22.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.694 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.555 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 2.4 m-20 -119.79 65.63 9.75 Favored Pre-proline 0 C--O 1.224 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.972 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -63.78 -44.98 11.85 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.754 2.302 . . . . 0.0 112.189 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -106.58 -11.73 15.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.014 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 40.7 mt-10 -91.05 131.21 36.78 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.643 ' HZ3' ' HE1' ' A' ' 88' ' ' PHE . 69.9 t-105 -94.54 88.79 5.57 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.222 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -97.37 106.35 18.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.262 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -108.94 124.76 51.19 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.969 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -119.16 131.51 55.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.985 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 167.12 162.14 18.08 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.885 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -97.53 -14.95 20.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.969 0.414 . . . . 0.0 110.803 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.457 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 9.9 mmtp -127.17 161.25 55.28 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HB3' HD11 ' A' ' 125' ' ' LEU . 23.4 Cg_exo -65.01 132.41 32.04 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.752 2.301 . . . . 0.0 110.1 166.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.52 138.36 43.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -168.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.757 ' HB ' HG12 ' A' ' 73' ' ' ILE . 4.6 mp -113.4 112.49 40.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 165.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.652 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 21.5 t -98.28 112.18 29.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.079 0.466 . . . . 0.0 110.297 -177.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.39 109.44 20.73 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.306 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 97.3 m-85 -94.14 111.68 23.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 174.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.695 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.7 p90 -132.66 167.71 19.6 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.493 0.663 . . . . 0.0 110.852 -175.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.411 ' H ' ' CB ' ' A' ' 53' ' ' CYS . . . -140.18 125.94 19.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.042 -1.435 . . . . 0.0 107.803 172.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -56.82 -40.33 75.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.437 ' HE1' ' HG2' ' A' ' 79' ' ' GLU . 62.2 p-90 -67.69 -8.61 36.55 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.6 t -98.37 126.63 43.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.942 0.401 . . . . 0.0 110.521 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.82 -61.85 6.97 Favored Glycine 0 CA--C 1.518 0.246 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.255 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -47.65 -41.44 30.59 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.959 2.439 . . . . 0.0 113.149 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.695 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 97.2 m -66.26 -44.26 84.15 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.78 -27.73 61.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.313 0.578 . . . . 0.0 109.502 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -61.23 -43.82 98.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.26 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.619 ' HB ' HD23 ' A' ' 60' ' ' LEU . 24.1 m -84.97 -20.52 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -174.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.467 ' HA ' ' NZ ' ' A' ' 75' ' ' LYS . . . -41.58 -53.31 7.55 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.91 -40.98 5.96 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 121.735 1.623 . . . . 0.0 112.448 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.2 mt -60.6 -42.72 92.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.238 0.542 . . . . 0.0 110.503 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.619 HD23 ' HB ' ' A' ' 56' ' ' VAL . 2.6 mm? -56.42 -42.35 77.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.46 176.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.493 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 11.1 t70 -62.97 -42.41 99.82 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.406 176.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.833 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 21.5 mm-40 -54.08 -56.63 16.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.25 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.538 HD21 ' HG3' ' A' ' 114' ' ' LYS . 3.7 mm? -67.07 -31.82 72.58 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.103 -175.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.416 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -59.83 -57.47 12.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.459 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.833 ' HE2' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -76.39 -25.98 55.13 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.825 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.23 -47.51 67.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.992 0.425 . . . . 0.0 111.39 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.511 ' HB2' HD11 ' A' ' 71' ' ' ILE . 12.4 m-85 -101.88 24.8 9.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.323 -175.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.41 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 19.9 t70 -55.79 143.6 30.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.172 0.51 . . . . 0.0 111.439 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.87 -37.58 3.68 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.631 -178.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 8.8 pt20 -110.08 -12.63 14.49 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.178 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 67' ' ' TYR . 43.9 pt -147.01 167.87 5.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.935 0.398 . . . . 0.0 110.685 174.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 39' ' ' LYS . 13.3 p -145.73 144.7 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 172.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.757 HG12 ' HB ' ' A' ' 42' ' ' ILE . 40.9 mt -121.07 139.12 49.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.322 -177.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.401 ' CE2' HD12 ' A' ' 12' ' ' ILE . 67.5 m-85 -115.49 162.93 16.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.431 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.545 ' HB3' ' CE1' ' A' ' 46' ' ' TYR . 54.1 mttm -135.64 132.06 36.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.849 0.357 . . . . 0.0 110.533 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.481 HG13 ' HG2' ' A' ' 81' ' ' GLU . 1.0 OUTLIER -131.46 137.32 55.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.482 -176.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -90.98 96.07 10.44 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.461 HG21 ' HA ' ' A' ' 92' ' ' SER . 17.0 m -60.13 -25.6 65.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -168.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.437 ' HG2' ' HE1' ' A' ' 49' ' ' TRP . 2.8 mp0 -55.28 -40.43 71.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.462 0.172 . . . . 0.0 111.191 175.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.501 ' CE ' HG22 ' A' ' 15' ' ' THR . 22.6 pttm -98.71 -22.19 16.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.304 0.573 . . . . 0.0 110.2 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.731 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 1.3 mp0 -89.53 34.89 0.82 Allowed 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.281 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.411 ' HA ' ' OE1' ' A' ' 82' ' ' GLN . 14.2 mm-40 -64.01 -42.49 97.13 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -64.52 -35.33 80.62 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.254 0.55 . . . . 0.0 110.062 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.6 tp -63.7 -47.6 80.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.901 176.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.537 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -60.71 -42.27 96.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.797 176.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.4 -31.05 75.95 Favored Glycine 0 CA--C 1.517 0.168 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.698 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.19 -41.5 97.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.789 0.328 . . . . 0.0 111.012 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.643 ' HE1' ' HZ3' ' A' ' 33' ' ' TRP . 76.2 m-85 -82.7 -22.2 34.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.692 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.13 31.67 9.58 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.582 HG13 ' HB2' ' A' ' 88' ' ' PHE . 6.2 mt -85.4 154.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.717 0.294 . . . . 0.0 110.544 -176.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -69.11 -81.82 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.436 0.636 . . . . 0.0 109.373 171.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.461 ' HA ' HG21 ' A' ' 78' ' ' THR . 65.9 m -158.99 -81.26 0.05 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.925 173.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.638 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 2.2 pp -151.08 149.67 25.5 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.237 -174.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.721 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 5.1 Cg_exo -83.5 149.2 62.66 Favored 'Cis proline' 0 C--N 1.346 0.437 0 C-N-CA 124.743 -0.94 . . . . 0.0 112.356 -2.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.556 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 39.6 t -140.99 130.61 24.04 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 107' ' ' MET . 23.3 mm -120.92 113.96 41.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.652 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 31.4 tp -102.05 115.5 30.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.792 -175.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -97.78 106.09 18.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.972 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 105' ' ' PRO . 53.6 mt -105.08 113.44 64.69 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.704 -174.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.8 155.54 20.55 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.466 2.111 . . . . 0.0 111.491 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 82.2 mtp -81.39 4.23 21.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.628 0.728 . . . . 0.0 110.823 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.833 ' HB3' ' HE3' ' A' ' 128' ' ' LYS . 2.9 tm-20 -151.27 117.43 5.59 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.974 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.14 -147.29 18.17 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.935 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.427 ' NZ ' ' HB3' ' A' ' 33' ' ' TRP . 51.7 mmtt -128.49 152.11 77.82 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.558 ' HB3' HG12 ' A' ' 99' ' ' ILE . 88.2 Cg_endo -79.59 147.96 20.16 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.752 2.301 . . . . 0.0 113.829 -172.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.439 ' O ' HD12 ' A' ' 97' ' ' LEU . 23.4 mm-40 -103.47 167.68 9.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.572 176.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 38.3 ttm -141.32 130.0 22.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.124 0.487 . . . . 0.0 111.958 -178.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.96 127.32 53.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.106 173.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -99.56 136.73 39.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.927 0.394 . . . . 0.0 111.541 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.721 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 106.95 174.13 22.78 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.806 -0.634 . . . . 0.0 114.635 171.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.92 86.7 5.54 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.818 -0.691 . . . . 0.0 111.464 -175.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.586 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 22.7 ptt? -87.53 158.43 51.47 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.651 171.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 74.4 Cg_endo -75.19 178.58 7.11 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.312 2.008 . . . . 0.0 112.847 -173.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.538 ' HG3' HD21 ' A' ' 63' ' ' LEU . 54.8 tttm -61.07 -28.7 69.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.047 177.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.79 -52.53 20.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.394 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 21.6 m -67.48 -32.76 73.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.774 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.52 ' O ' HG13 ' A' ' 121' ' ' ILE . 1.4 m-85 -62.23 -46.59 88.17 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.492 174.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -56.39 -44.27 80.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.525 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.59 ' HB3' ' OE1' ' A' ' 123' ' ' GLU . 9.2 mtpm? -63.06 -50.37 70.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.44 75.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.843 0.354 . . . . 0.0 111.32 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 117' ' ' PHE . 70.9 mt -74.23 -55.11 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.04 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.556 ' HA ' ' HB2' ' A' ' 126' ' ' LEU . 31.0 t0 -69.68 -57.93 4.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.573 -173.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.59 ' OE1' ' HB3' ' A' ' 119' ' ' LYS . 44.6 mt-10 -58.15 -23.12 54.09 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -170.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -116.22 -47.8 2.74 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 40' ' ' PRO . 30.1 tp -88.26 -38.7 15.01 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.488 -171.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 122' ' ' ASP . 73.5 mt -83.09 -52.96 6.16 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.431 0.634 . . . . 0.0 109.388 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.687 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -80.92 81.27 7.21 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 167.215 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.833 ' HE3' ' HB3' ' A' ' 102' ' ' GLU . 48.5 tttm -64.97 84.12 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.575 0.703 . . . . 0.0 112.61 -166.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -53.39 134.11 40.18 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.064 164.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -86.14 29.99 4.53 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.881 -172.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 54.45 55.41 8.08 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -18.66 112.89 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 O-C-N 125.299 1.625 . . . . 0.0 114.66 -172.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -83.76 148.68 26.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.751 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -73.66 -44.61 56.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.041 0.448 . . . . 0.0 110.051 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -140.58 -49.34 0.44 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 21.8 p80 . . . . . 0 C--O 1.242 0.665 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.696 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 120.729 0.3 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -122.42 151.71 40.97 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.728 ' H ' HD23 ' A' ' 3' ' ' LEU . 1.9 pt? -84.47 -4.55 59.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.702 0.287 . . . . 0.0 111.387 -174.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.46 34.4 0.75 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.734 0.302 . . . . 0.0 110.627 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.43 ' HB ' ' H ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER 48.43 -98.18 0.04 OUTLIER 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.681 -175.195 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.43 ' H ' ' HB ' ' A' ' 5' ' ' THR . 16.3 tp10 -176.65 -72.51 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.726 0.298 . . . . 0.0 110.518 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.35 43.62 3.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.131 -176.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.417 ' HA ' HG22 ' A' ' 72' ' ' VAL . 32.4 t-20 -76.0 128.36 34.88 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . 98.24 18.98 24.88 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.465 177.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.492 ' HG3' ' OD2' ' A' ' 61' ' ' ASP . 54.9 tttp -160.23 173.33 15.89 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.3 p -112.41 113.15 43.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.431 0.634 . . . . 0.0 110.129 174.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.8 mm -109.38 131.23 60.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.058 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.709 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 3.7 p80 -85.8 116.62 24.17 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.56 174.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.508 HD12 HG23 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -109.52 179.23 4.2 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.355 -176.099 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.6 p -100.53 164.23 11.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.952 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.706 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 35.6 pttt -61.91 -27.0 68.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.815 0.34 . . . . 0.0 110.511 176.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -41.09 96.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.656 174.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -71.71 -38.22 70.56 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.197 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.443 ' HE1' HG11 ' A' ' 43' ' ' VAL . 2.3 t80 -54.21 -53.81 48.44 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.813 0.816 . . . . 0.0 109.305 176.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.582 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 30.0 mt -50.56 -60.07 3.4 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 113.598 -1.637 . . . . 0.0 111.929 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.22 -36.63 39.75 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -102.79 -4.59 24.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -171.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 58.2 t -132.96 -51.99 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.582 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 7.5 t80 -179.19 131.0 0.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 110.746 -167.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.635 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 25.9 t-20 -91.21 136.24 33.23 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.655 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.404 ' HZ ' ' HB2' ' A' ' 16' ' ' LYS . 7.6 p90 -123.91 20.8 9.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.171 0.51 . . . . 0.0 110.547 175.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -105.64 -53.93 2.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.593 0.711 . . . . 0.0 109.798 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.498 ' HG2' ' OD1' ' A' ' 25' ' ' ASN . 22.0 ptmt -97.02 -12.61 23.05 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.526 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.859 HD22 ' HD2' ' A' ' 34' ' ' LYS . 5.0 m-20 -116.89 62.55 2.84 Favored Pre-proline 0 N--CA 1.473 0.723 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.239 174.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -63.43 -43.06 19.05 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.705 2.27 . . . . 0.0 112.614 174.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.516 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -100.59 -27.7 13.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.607 -175.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 37.7 mt-10 -92.69 128.67 38.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.044 0.449 . . . . 0.0 110.795 -177.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.421 ' HA ' ' CE1' ' A' ' 24' ' ' TYR . 44.3 t-105 -92.55 93.13 8.38 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.859 ' HD2' HD22 ' A' ' 29' ' ' ASN . 92.2 mttt -104.95 97.26 7.15 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.107 176.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.481 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 28.5 t80 -79.69 104.39 10.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.642 175.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -98.91 84.0 3.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.611 177.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.481 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -129.68 -143.51 5.47 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.844 -175.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -147.92 -64.64 0.26 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.8 0.333 . . . . 0.0 110.104 -173.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 70' ' ' GLN . 45.8 mttp -120.85 159.5 48.58 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.862 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.47 ' HG2' HG22 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -45.29 131.92 11.79 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.073 2.516 . . . . 0.0 112.084 179.054 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.52 139.18 54.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.567 -172.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.9 mt -117.76 114.57 45.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.418 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 16.4 t -101.76 112.99 36.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.791 0.329 . . . . 0.0 111.219 -176.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 8.2 t70 -92.56 112.13 23.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.969 176.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.477 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 75.6 m-85 -87.55 110.58 20.45 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 173.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.728 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 0.8 OUTLIER -132.11 163.83 27.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.159 0.504 . . . . 0.0 110.84 -175.365 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.406 ' N ' HG21 ' A' ' 93' ' ' ILE . . . -116.72 137.03 52.49 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.497 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 19.6 t70 -62.98 -29.48 70.85 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -174.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -85.74 -6.91 59.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.79 0.328 . . . . 0.0 111.177 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.7 t -84.27 106.95 16.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.903 0.382 . . . . 0.0 111.081 -175.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.09 -50.76 54.11 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.673 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -46.92 -47.93 15.43 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.71 2.273 . . . . 0.0 113.191 175.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.728 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 83.0 m -66.97 -32.54 73.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.477 . . . . 0.0 111.257 -177.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 71.1 mmtt -58.76 -29.51 66.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.597 175.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.545 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 31.2 mtm -67.69 -39.56 84.43 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.712 0.291 . . . . 0.0 111.239 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 53' ' ' CYS . 16.6 m -78.21 -26.47 14.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -172.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.608 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -51.31 -54.24 40.69 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.608 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 35.4 Cg_exo -61.61 -43.65 25.88 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 122.045 1.83 . . . . 0.0 112.283 176.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.5 mt -58.46 -49.9 80.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.305 0.574 . . . . 0.0 110.591 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.432 HD22 HD13 ' A' ' 73' ' ' ILE . 20.0 mt -61.92 -40.84 96.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.39 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.492 ' OD2' ' HG3' ' A' ' 10' ' ' LYS . 12.7 t70 -64.79 -45.71 85.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.956 0.408 . . . . 0.0 110.806 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -62.36 -51.1 68.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.999 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.66 -32.57 72.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.181 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.552 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -62.28 -34.96 77.57 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.465 ' C ' ' HD3' ' A' ' 65' ' ' LYS . 2.8 tmtm? -73.96 -38.17 64.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.885 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -62.27 -48.14 81.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.238 0.542 . . . . 0.0 110.573 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -90.89 26.09 2.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.8 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -57.07 139.76 51.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.678 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.83 -25.98 26.19 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.955 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.549 ' HG3' HG23 ' A' ' 71' ' ' ILE . 11.7 pt20 -116.23 -44.46 2.89 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -177.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.549 HG23 ' HG3' ' A' ' 70' ' ' GLN . 33.6 pt -117.38 150.3 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.798 -177.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.417 HG22 ' HA ' ' A' ' 8' ' ' ASN . 48.8 t -121.56 127.25 75.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.268 176.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.671 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 31.8 mt -109.63 133.67 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 121.331 0.586 . . . . 0.0 110.278 -178.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -121.43 171.65 8.62 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.732 0.777 . . . . 0.0 110.373 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.709 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 1.1 ptpm? -146.09 159.15 43.68 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 168.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.685 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 2.6 p -140.38 143.52 29.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.596 -174.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' HB2' ' NZ ' ' A' ' 80' ' ' LYS . 20.2 m-20 -82.97 90.73 7.03 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -174.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 85' ' ' ALA . 27.0 m -57.91 -24.54 58.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.085 -173.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.6 -40.84 84.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.762 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.409 ' NZ ' ' HB2' ' A' ' 77' ' ' ASP . 23.9 pttm -101.15 -22.59 14.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.097 0.475 . . . . 0.0 110.527 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.706 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 1.4 mp0 -89.06 42.89 1.11 Allowed 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.534 175.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -66.11 -38.39 88.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.072 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -65.92 -38.02 87.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.363 0.602 . . . . 0.0 109.672 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.1 tp -65.68 -50.43 64.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.734 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.509 ' HB2' HG23 ' A' ' 78' ' ' THR . . . -65.36 -39.89 92.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.989 0.423 . . . . 0.0 110.899 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.3 -27.58 69.49 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.882 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.04 -32.92 72.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.935 0.398 . . . . 0.0 110.85 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.551 ' HB2' HG12 ' A' ' 90' ' ' ILE . 90.5 m-85 -93.48 -3.41 53.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.646 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.15 13.39 74.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.005 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.551 HG12 ' HB2' ' A' ' 88' ' ' PHE . 26.9 mm -83.63 119.54 33.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.543 0.211 . . . . 0.0 110.517 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -59.53 -58.04 10.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 110.953 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.402 ' O ' HG21 ' A' ' 78' ' ' THR . 32.1 m -150.92 -96.96 0.06 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.7 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -146.86 163.18 30.21 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.903 -0.135 . . . . 0.0 111.043 -170.79 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.666 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 2.7 Cg_exo -89.18 150.16 26.81 Favored 'Cis proline' 0 C--N 1.347 0.498 0 C-N-CA 124.72 -0.95 . . . . 0.0 112.509 -4.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.477 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 34.7 t -140.68 145.28 36.32 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 107' ' ' MET . 30.5 mt -135.25 116.24 19.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.825 0.345 . . . . 0.0 110.304 -178.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.497 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 47.3 tp -102.91 116.61 32.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.403 -177.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -98.67 109.11 21.92 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.55 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 58.2 mt -104.48 113.39 65.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.691 -174.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -84.34 168.54 11.58 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.851 2.367 . . . . 0.0 111.786 174.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 87.2 mtp -82.31 -26.04 33.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.243 0.544 . . . . 0.0 109.949 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -130.66 138.1 49.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.223 176.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.69 161.35 36.66 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -92.37 143.93 28.12 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 117.377 0.589 . . . . 0.0 110.093 -177.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.55 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 27.5 Cg_endo -61.03 159.59 29.24 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.722 2.948 . . . . 0.0 114.3 -170.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.522 ' HG2' ' CE1' ' A' ' 131' ' ' HIS . 21.1 mt-10 -117.15 168.84 9.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.091 176.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 47.7 ttm -142.03 127.04 18.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.285 0.564 . . . . 0.0 112.224 -175.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.5 140.54 49.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -114.59 141.41 47.8 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.904 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.666 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 107.46 169.75 21.98 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.378 174.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.06 85.29 6.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.218 0.532 . . . . 0.0 111.358 -176.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.593 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 24.1 ptp -80.85 152.11 71.58 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.029 176.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.636 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 98.2 Cg_endo -75.26 -178.24 4.08 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.681 2.254 . . . . 0.0 112.062 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -62.24 -36.75 82.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.142 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.38 -37.63 74.56 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.941 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.636 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 71.8 m -72.82 -34.62 66.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.756 174.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.661 ' O ' HG12 ' A' ' 121' ' ' ILE . 2.1 m-85 -63.27 -51.82 64.58 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 121.126 -0.229 . . . . 0.0 110.792 176.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -57.02 -36.53 70.55 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.964 0.411 . . . . 0.0 110.503 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.467 ' NZ ' ' HB2' ' A' ' 119' ' ' LYS . 4.8 ttmp? -57.22 -42.7 81.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.884 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.83 -34.96 69.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.047 176.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.661 HG12 ' O ' ' A' ' 117' ' ' PHE . 37.2 mm -64.85 -56.02 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.698 -178.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.477 ' HA ' HD12 ' A' ' 126' ' ' LEU . 2.0 m-20 -66.64 -64.39 0.86 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.011 0.434 . . . . 0.0 110.951 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.75 -34.39 69.49 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.535 -171.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.719 ' HE1' ' HA2' ' A' ' 130' ' ' GLY . 63.4 t80 -108.26 -50.27 3.06 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 18.1 tp -81.43 -30.99 33.33 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.476 -169.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 122' ' ' ASP . 80.4 mt -87.44 -50.54 6.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.297 0.57 . . . . 0.0 109.635 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -96.8 90.99 5.46 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 171.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -49.44 96.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.613 0.72 . . . . 0.0 112.391 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -114.76 46.72 1.36 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.359 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.719 ' HA2' ' HE1' ' A' ' 124' ' ' PHE . . . -58.79 101.64 0.23 Allowed Glycine 0 C--N 1.33 0.241 0 CA-C-N 115.503 -0.772 . . . . 0.0 113.626 -175.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.522 ' CE1' ' HG2' ' A' ' 106' ' ' GLU . 97.8 m-70 59.37 74.37 0.44 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.319 0.648 . . . . 0.0 111.657 177.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -145.26 -56.65 0.32 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.179 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -172.12 130.23 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.403 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.463 ' CE1' ' HB2' ' A' ' 124' ' ' PHE . 45.1 m-70 -138.66 8.48 2.59 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 110.467 174.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -113.57 -8.52 13.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.918 0.39 . . . . 0.0 110.332 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 117.396 -1.288 . . . . 0.0 108.289 -179.716 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HG3' ' H ' ' A' ' 11' ' ' VAL . 43.1 tptt -137.12 173.23 11.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.2 p -122.18 107.99 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.578 0.704 . . . . 0.0 110.296 175.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 43.8 mm -108.81 132.21 57.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.202 -176.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.657 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 4.6 p80 -89.09 127.9 35.73 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.475 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 1.1 pp -128.28 -179.99 5.31 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.968 -172.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.443 ' HA ' ' OE1' ' A' ' 81' ' ' GLU . 45.3 p -104.36 174.84 5.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.244 177.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.498 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 13.0 pttm -64.45 -26.69 68.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 111.198 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.468 ' HA ' HD12 ' A' ' 20' ' ' LEU . . . -65.97 -40.31 91.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.311 0.577 . . . . 0.0 110.404 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.475 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -71.86 -34.51 69.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.804 178.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.458 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -59.07 -53.79 54.4 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.476 174.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.712 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 18.1 mt -46.91 -59.7 2.92 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.655 -1.612 . . . . 0.0 111.919 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.64 -48.48 72.06 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -170.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -104.13 -3.1 24.9 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.401 -170.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 61.1 t -129.06 -52.9 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.712 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 11.7 t80 -167.62 124.73 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.01 -164.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.71 91.4 7.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.951 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.512 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 25.2 p90 -79.99 12.99 2.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.11 0.481 . . . . 0.0 111.412 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -93.88 -53.07 4.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.646 ' C ' HD22 ' A' ' 29' ' ' ASN . 60.3 mttp -83.46 -23.71 32.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.735 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.653 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -121.58 69.37 23.63 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.376 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -57.58 -37.05 98.29 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.311 2.674 . . . . 0.0 112.279 173.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -105.13 -42.43 5.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.983 -174.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -94.98 178.19 5.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.362 0.601 . . . . 0.0 112.375 -174.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.799 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 19.1 t-105 -125.19 108.6 11.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.569 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.476 ' C ' ' HD3' ' A' ' 34' ' ' LYS . 8.6 tmtt? -110.7 112.63 24.64 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 172.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.527 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 13.9 t80 -80.8 124.95 29.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.548 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -101.05 8.48 42.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.422 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.423 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -88.4 150.56 21.99 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 -177.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -92.29 -30.07 16.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.078 0.465 . . . . 0.0 110.961 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -115.09 155.22 46.93 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.912 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 70' ' ' GLN . 47.8 Cg_exo -56.92 132.17 50.01 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.352 2.034 . . . . 0.0 111.381 174.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -117.05 154.98 30.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.476 0.655 . . . . 0.0 111.676 -175.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.429 HD13 HG12 ' A' ' 121' ' ' ILE . 78.3 mt -128.1 110.3 21.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.077 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 23.9 t -100.54 114.07 38.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.974 0.416 . . . . 0.0 111.114 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.609 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 4.4 t70 -90.8 113.8 26.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.181 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -84.88 111.04 19.29 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 170.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.689 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.4 p90 -132.33 159.0 40.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.289 0.566 . . . . 0.0 111.089 -177.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.447 ' CB ' HG12 ' A' ' 93' ' ' ILE . . . -128.14 128.85 45.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.007 171.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.532 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 28.3 t70 -63.47 -28.86 70.25 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.565 -170.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -75.63 -2.78 30.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.683 0.277 . . . . 0.0 111.732 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 42.5 t -103.43 127.72 50.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.939 0.4 . . . . 0.0 110.785 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.81 -61.43 7.34 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.661 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 72.1 Cg_exo -47.84 -47.54 18.46 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.761 2.307 . . . . 0.0 112.537 176.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.689 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 65.1 m -56.86 -29.45 62.9 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.03 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 62.8 mttm -73.8 -42.95 60.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.172 174.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.652 ' O ' HG12 ' A' ' 59' ' ' ILE . 26.1 mtm -59.89 -40.13 87.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.917 0.389 . . . . 0.0 111.396 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.501 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 11.5 p -64.04 -30.53 50.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.161 -171.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.684 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -57.53 -57.55 24.49 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 118.833 -0.603 . . . . 0.0 112.021 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.684 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 47.0 Cg_exo -57.82 -39.96 82.72 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 121.811 1.674 . . . . 0.0 112.539 174.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.652 HG12 ' O ' ' A' ' 55' ' ' MET . 21.0 mm -61.15 -49.42 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 121.709 0.766 . . . . 0.0 109.916 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.683 HD22 HD13 ' A' ' 73' ' ' ILE . 11.6 mt -63.93 -37.51 87.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.543 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -62.4 -44.29 96.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.418 0.628 . . . . 0.0 109.451 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -58.71 -55.61 32.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.363 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.431 HD21 ' HG3' ' A' ' 114' ' ' LYS . 4.4 mm? -66.72 -33.93 76.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.315 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.55 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -60.79 -46.05 92.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.952 0.406 . . . . 0.0 110.239 177.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.561 ' NZ ' ' HB3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -69.45 -31.52 69.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.716 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.02 -35.96 69.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.27 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -109.22 27.74 9.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.876 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.91 148.97 9.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.388 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.54 -44.5 2.59 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.843 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.442 ' HG3' HG23 ' A' ' 71' ' ' ILE . 16.5 pt20 -93.33 -38.62 11.39 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.442 HG23 ' HG3' ' A' ' 70' ' ' GLN . 38.9 pt -118.74 159.98 18.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.009 0.433 . . . . 0.0 111.713 -177.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 63.6 t -133.36 121.69 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.683 HD13 HD22 ' A' ' 60' ' ' LEU . 46.0 mt -103.86 139.43 24.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.486 0.66 . . . . 0.0 111.253 -175.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -128.04 173.49 10.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.898 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 0.6 OUTLIER -149.34 158.45 44.19 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 170.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.496 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 9.9 p -133.88 136.06 54.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.203 0.525 . . . . 0.0 110.438 -177.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.469 ' HB2' ' HZ2' ' A' ' 80' ' ' LYS . 3.6 m-20 -80.1 94.37 5.97 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.377 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.666 HG21 ' HA ' ' A' ' 92' ' ' SER . 74.6 m -58.49 -33.8 70.21 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -174.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -53.93 -31.16 49.4 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HZ2' ' HB2' ' A' ' 77' ' ' ASP . 14.6 pttp -106.21 -32.04 8.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.179 0.514 . . . . 0.0 110.504 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.498 ' OE2' ' HG2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -90.83 44.23 1.19 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.367 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -61.06 -37.18 81.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.428 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -70.58 -37.72 73.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.228 0.537 . . . . 0.0 110.072 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.1 -49.14 59.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.789 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.14 84.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.969 0.414 . . . . 0.0 111.077 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -66.84 -31.18 77.49 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.903 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.68 93.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 0.0 111.616 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.602 ' HB2' HG12 ' A' ' 90' ' ' ILE . 72.5 m-85 -85.91 -1.68 57.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.84 0.352 . . . . 0.0 110.898 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.01 15.85 78.07 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.33 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.602 HG12 ' HB2' ' A' ' 88' ' ' PHE . 48.9 mm -65.46 -25.14 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 122.587 0.355 . . . . 0.0 110.866 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 72.03 -67.77 0.25 Allowed 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.744 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.666 ' HA ' HG21 ' A' ' 78' ' ' THR . 33.7 m -151.77 -89.31 0.06 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.932 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.531 HG21 ' C ' ' A' ' 46' ' ' TYR . 2.4 pp -163.29 159.92 18.24 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.595 -170.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.577 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 2.3 Cg_endo -95.22 147.1 8.4 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 124.821 -0.908 . . . . 0.0 111.803 -4.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.4 t -141.73 138.77 32.6 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 107' ' ' MET . 30.7 mm -118.77 113.8 42.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 25.6 tp -98.0 112.71 24.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.527 -176.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.24 110.11 22.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.545 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 32.2 mt -101.69 106.17 45.1 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.153 -174.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.36 163.27 27.5 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.583 2.189 . . . . 0.0 111.95 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 92.3 mmm -85.16 0.29 52.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.479 0.657 . . . . 0.0 110.082 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -138.77 111.1 7.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.117 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.71 -158.83 18.5 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.24 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.799 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 42.7 mtpt -113.24 154.36 45.27 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.545 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 73.1 Cg_endo -75.34 140.49 24.6 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.83 2.353 . . . . 0.0 114.563 -170.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.432 ' CG ' ' HZ ' ' A' ' 124' ' ' PHE . 18.8 mp0 -91.35 169.93 10.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.578 173.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.555 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 21.4 ptp -142.01 144.38 33.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.025 0.441 . . . . 0.0 111.177 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -124.68 126.43 45.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.292 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -86.49 126.72 34.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.089 0.471 . . . . 0.0 111.375 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.577 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 100.29 155.72 27.78 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.436 175.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.501 ' HB1' ' HB ' ' A' ' 56' ' ' VAL . . . -87.59 87.33 7.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.342 0.591 . . . . 0.0 111.068 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.61 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 12.7 ptt? -68.26 162.95 56.72 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.283 173.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.566 ' HD2' ' HB2' ' A' ' 112' ' ' MET . 97.1 Cg_endo -75.09 179.14 6.4 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.633 2.222 . . . . 0.0 113.009 -173.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.431 ' HG3' HD21 ' A' ' 63' ' ' LEU . 58.3 tttp -54.81 -35.77 64.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.847 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.62 -52.76 19.18 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.915 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.61 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 18.8 m -66.12 -34.66 78.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.559 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.535 ' O ' HG13 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -63.94 -43.18 96.64 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.049 178.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.409 ' HZ2' ' HB3' ' A' ' 122' ' ' ASP . 1.6 ttpp -57.03 -40.67 77.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 0.0 110.075 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -66.74 -41.36 87.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.609 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.33 -36.88 71.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.977 0.418 . . . . 0.0 111.583 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.581 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 62.9 mt -73.99 -56.64 8.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.493 0.664 . . . . 0.0 110.69 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.409 ' HB3' ' HZ2' ' A' ' 118' ' ' LYS . 14.6 t0 -72.47 -64.77 0.88 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.169 -174.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.646 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 24.4 mt-10 -80.04 11.93 3.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.595 -169.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.609 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 58.5 t80 -138.46 -50.35 0.56 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.164 -0.214 . . . . 0.0 111.554 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.581 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 42.8 tp -73.54 -40.91 63.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.65 0.262 . . . . 0.0 110.59 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -90.81 -53.82 4.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.418 0.628 . . . . 0.0 109.306 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.646 ' HB3' ' HA ' ' A' ' 123' ' ' GLU . 52.1 tptt . . . . . 0 C--N 1.322 -0.608 0 CA-C-O 121.702 0.763 . . . . 0.0 109.219 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.481 ' C ' ' HD2' ' A' ' 10' ' ' LYS . . . . . . . . 0 CA--C 1.51 -0.271 0 CA-C-O 121.089 0.272 . . . . 0.0 112.445 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.481 ' HD2' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -131.77 174.62 9.95 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.618 -0.342 . . . . 0.0 110.265 -176.213 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.68 HG23 HG22 ' A' ' 73' ' ' ILE . 13.0 p -113.58 123.46 69.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.323 0.582 . . . . 0.0 110.653 173.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.6 mm -124.67 120.4 58.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.254 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.753 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 7.1 p80 -86.74 129.91 34.69 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.154 175.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -124.01 178.56 5.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.981 -172.172 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.604 HG22 ' HE2' ' A' ' 80' ' ' LYS . 41.3 p -93.07 171.46 8.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.686 175.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.457 ' HE3' ' HB3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -58.54 -37.4 75.6 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 178.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.44 ' N ' ' HG2' ' A' ' 16' ' ' LYS . . . -63.37 -37.93 89.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.477 0.656 . . . . 0.0 110.161 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 40.0 mt-10 -72.9 -34.82 66.89 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.751 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.474 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 6.8 t80 -54.89 -51.47 65.9 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 122.638 1.208 . . . . 0.0 108.761 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.656 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 25.9 mt -54.76 -58.39 7.76 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 112.481 -2.145 . . . . 0.0 111.931 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.94 -14.53 41.57 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -170.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 94.3 mttt -109.93 -5.84 15.37 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.202 -0.311 . . . . 0.0 111.368 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 59.4 t -141.02 -56.34 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.656 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 45.1 t80 -167.26 125.34 1.28 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.054 -164.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.539 ' OD1' ' HD3' ' A' ' 28' ' ' LYS . 2.8 t-20 -86.46 90.25 8.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.621 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -85.82 11.97 10.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.743 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 6.6 mt-10 -94.5 -54.29 3.58 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.938 0.875 . . . . 0.0 108.813 175.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.743 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 12.2 mptt -88.12 -23.45 23.67 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.628 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.666 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -120.62 68.64 15.4 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.899 -179.242 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -61.27 -43.7 27.36 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.966 2.444 . . . . 0.0 112.24 170.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -100.97 -29.93 11.92 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.161 0.505 . . . . 0.0 110.824 -175.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.57 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 22.9 mp0 -89.79 127.92 36.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.999 -169.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.543 ' HB2' ' NZ ' ' A' ' 104' ' ' LYS . 72.8 t-105 -89.95 89.57 7.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.223 0.535 . . . . 0.0 110.432 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -106.24 97.74 7.51 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.764 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 83.0 t80 -85.41 119.64 26.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.893 176.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -112.62 85.54 2.18 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.451 0.643 . . . . 0.0 110.184 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -147.24 -154.04 6.1 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.984 -176.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -115.12 -58.84 2.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.247 0.546 . . . . 0.0 110.534 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 51.0 mttp -135.65 170.18 11.75 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.278 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 79.7 Cg_exo -45.25 132.52 11.85 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 122.735 2.29 . . . . 0.0 112.459 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -117.79 145.84 44.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.596 -171.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.414 HD11 HD12 ' A' ' 121' ' ' ILE . 75.0 mt -119.8 114.31 43.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.118 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 28.7 t -98.57 110.3 25.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.767 0.317 . . . . 0.0 110.836 -177.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.562 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 7.6 t70 -98.4 111.61 23.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.961 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.573 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 79.9 m-85 -90.38 112.12 23.6 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.768 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.2 p90 -133.77 179.06 6.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.39 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.655 ' HB3' HD13 ' A' ' 93' ' ' ILE . . . -154.79 173.34 16.59 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.484 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.463 ' HA ' ' HE3' ' A' ' 54' ' ' LYS . 20.6 t70 -80.68 -46.43 15.57 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -175.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.404 ' CZ2' HD11 ' A' ' 93' ' ' ILE . 51.8 p-90 -71.04 0.23 7.98 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -173.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.504 ' CB ' HD12 ' A' ' 93' ' ' ILE . 45.4 t -112.85 114.03 26.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.943 0.401 . . . . 0.0 110.292 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.2 -51.62 58.09 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.256 -0.747 . . . . 0.0 113.64 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -47.42 -37.7 25.87 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.969 2.446 . . . . 0.0 112.929 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 59.9 m -59.75 -39.84 86.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.47 0.653 . . . . 0.0 111.485 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HE3' ' HA ' ' A' ' 48' ' ' ASP . 99.4 mttt -79.04 -29.99 43.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.161 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.527 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 4.5 tmm? -62.44 -46.05 90.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.811 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.57 HG22 ' HG ' ' A' ' 60' ' ' LEU . 14.5 p -71.18 -26.21 26.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.944 -175.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.633 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -53.83 -56.33 26.54 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 36.5 Cg_exo -60.04 -47.06 16.31 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 121.708 1.605 . . . . 0.0 112.009 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.0 mt -58.34 -43.3 86.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.759 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.63 HD22 HD13 ' A' ' 73' ' ' ILE . 7.8 mt -64.87 -44.68 88.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.092 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.58 ' HB2' HG12 ' A' ' 11' ' ' VAL . 27.2 t70 -67.61 -40.96 84.72 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.403 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.18 -45.29 95.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.735 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 63' ' ' LEU . 16.6 tp -65.82 -34.76 78.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.823 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.609 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -64.99 -35.09 80.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.907 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.583 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 5.2 tmtm? -75.43 -32.5 60.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.483 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -52.5 -46.83 66.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.561 0.696 . . . . 0.0 109.968 172.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -104.97 28.08 7.53 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.578 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.583 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 9.0 t0 -48.88 131.01 18.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.229 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.34 -18.95 56.41 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.248 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -105.28 -48.81 3.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.635 0.255 . . . . 0.0 111.585 -176.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 40' ' ' PRO . 34.0 pt -122.85 159.82 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.4 0.619 . . . . 0.0 112.544 -173.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 27.4 t -125.39 127.91 72.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.42 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.68 HG22 HG23 ' A' ' 11' ' ' VAL . 20.5 mt -112.09 130.49 65.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.381 0.61 . . . . 0.0 110.824 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -114.2 165.64 12.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.614 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.753 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 47.9 mttm -132.14 153.46 50.49 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.487 173.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.53 HG13 ' HG2' ' A' ' 81' ' ' GLU . 4.7 t -127.14 121.44 57.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.738 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.406 ' HB2' ' HG2' ' A' ' 80' ' ' LYS . 11.3 m-20 -77.98 88.86 4.14 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 92' ' ' SER . 20.8 p -52.85 -30.02 31.25 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.111 0.481 . . . . 0.0 111.445 -175.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.473 ' CD ' ' HB1' ' A' ' 47' ' ' ALA . 2.6 mm-40 -50.56 -44.86 56.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.099 174.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.604 ' HE2' HG22 ' A' ' 15' ' ' THR . 19.3 pttm -103.33 -19.43 14.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.06 0.457 . . . . 0.0 110.672 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.53 ' HG2' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -97.85 42.87 1.08 Allowed 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.27 0.628 . . . . 0.0 111.453 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -57.24 -43.24 82.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.139 0.495 . . . . 0.0 110.812 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.36 -36.27 78.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.531 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.56 -47.77 74.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.565 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.56 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -63.94 -48.34 76.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.682 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.01 -32.76 76.48 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.129 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.06 -40.0 95.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.801 0.334 . . . . 0.0 111.525 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.438 ' HB2' HG13 ' A' ' 90' ' ' ILE . 96.4 m-85 -92.67 5.95 49.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.325 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.49 20.86 78.24 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.153 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 85' ' ' ALA . 26.4 mt -76.84 137.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.749 ' H ' ' HD2' ' A' ' 91' ' ' ARG . 3.0 mpt_? -71.59 -64.68 0.88 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.427 ' O ' HG21 ' A' ' 78' ' ' THR . 5.2 p -177.65 -85.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.368 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.655 HD13 ' HB3' ' A' ' 47' ' ' ALA . 13.9 pt -150.55 146.82 20.18 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -167.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.766 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 11.3 Cg_exo -86.65 150.48 42.09 Favored 'Cis proline' 0 N--CA 1.473 0.282 0 C-N-CA 124.513 -1.036 . . . . 0.0 110.722 -6.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 4.5 m -139.95 128.93 23.5 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 107' ' ' MET . 57.0 mt -128.02 114.32 34.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.745 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.62 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.7 tp -102.45 113.32 26.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.74 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -92.3 102.62 15.11 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.849 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.567 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 65.4 mt -97.61 113.17 63.12 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.61 -175.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -86.5 165.34 9.33 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.742 2.294 . . . . 0.0 111.547 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 93.1 mmm -89.7 2.44 54.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.562 0.696 . . . . 0.0 109.345 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -140.82 98.25 3.36 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.844 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.16 -162.49 13.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.862 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.543 ' NZ ' ' HB2' ' A' ' 33' ' ' TRP . 25.8 mmmt -98.49 150.46 36.74 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.567 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 5.7 Cg_exo -79.36 155.94 25.27 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.196 2.597 . . . . 0.0 112.987 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 107' ' ' MET . 29.3 tt0 -109.07 163.6 13.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.133 174.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.596 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 22.4 ptp -142.74 129.06 19.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.359 0.599 . . . . 0.0 111.202 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.31 156.55 27.63 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.883 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -116.89 137.81 51.96 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.221 0.534 . . . . 0.0 111.364 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.766 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 104.59 150.46 20.55 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.195 178.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -84.5 88.23 7.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.166 0.508 . . . . 0.0 111.342 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.516 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 25.2 ptp -69.68 164.74 47.91 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.524 172.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.606 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 74.3 Cg_endo -75.41 169.27 22.78 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.847 1.698 . . . . 0.0 111.621 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -55.69 -32.15 63.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.516 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 118' ' ' LYS . . . -71.33 -47.51 56.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.167 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.606 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 50.2 m -64.72 -33.8 76.82 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.687 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.696 ' O ' HG12 ' A' ' 121' ' ' ILE . 7.4 m-85 -61.57 -39.56 91.57 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.604 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.597 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 3.8 mmmm -54.01 -52.39 60.95 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.171 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.526 ' HG3' ' OE2' ' A' ' 123' ' ' GLU . 51.7 tttp -64.5 -32.98 74.84 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.677 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.546 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.32 -40.39 70.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.992 0.425 . . . . 0.0 111.214 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.696 HG12 ' O ' ' A' ' 117' ' ' PHE . 31.3 mm -73.58 -55.61 11.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.8 0.333 . . . . 0.0 110.278 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -65.36 -68.47 0.36 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.961 0.41 . . . . 0.0 110.825 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.526 ' OE2' ' HG3' ' A' ' 119' ' ' LYS . 48.2 mt-10 -77.4 12.0 1.74 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -169.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.546 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 77.8 t80 -143.51 -53.4 0.36 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.686 175.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 44.0 tp -69.6 -39.13 77.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.489 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 80.2 mt -88.54 -60.26 2.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.509 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 14.1 ttpp . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.429 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.57 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -150.4 152.3 34.14 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.852 0.834 . . . . 0.0 112.456 -167.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.731 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 5.0 p -134.83 119.48 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.098 174.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 60.0 mt -117.37 116.98 53.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.415 -173.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.738 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 11.0 p80 -83.8 119.67 25.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.842 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 2.0 pp -127.84 171.96 11.28 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.229 -171.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.7 p -99.18 177.89 5.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.161 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 19' ' ' PHE . 63.5 pttt -59.22 -25.24 63.83 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 20' ' ' LEU . . . -68.49 -44.17 75.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.284 0.564 . . . . 0.0 110.233 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.842 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 3.2 mp0 -72.24 -33.71 67.75 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.399 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.55 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -55.08 -49.23 72.19 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.007 0.908 . . . . 0.0 109.201 174.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.685 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 13.9 mt -50.58 -61.15 2.36 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.357 -1.747 . . . . 0.0 111.742 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.11 -7.58 59.62 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -169.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.02 -33.88 6.37 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 70.3 t -125.03 -40.78 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -169.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.685 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 21.5 t80 -164.95 117.88 1.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.866 -166.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.621 ' OD1' ' HD3' ' A' ' 28' ' ' LYS . 2.6 t-20 -91.66 89.68 7.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.485 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.657 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 18.9 p90 -81.12 6.89 12.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -86.16 -53.41 5.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.831 0.824 . . . . 0.0 108.903 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.635 ' C ' HD22 ' A' ' 29' ' ' ASN . 11.0 mptt -88.43 -23.41 23.3 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.426 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.695 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -118.69 61.54 4.9 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.195 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.17 -44.71 44.04 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.683 2.255 . . . . 0.0 112.112 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.21 -13.7 15.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.852 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.45 ' O ' ' HE1' ' A' ' 24' ' ' TYR . 44.9 mt-10 -91.09 144.08 26.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.271 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.505 ' CZ2' ' HG2' ' A' ' 105' ' ' PRO . 65.0 t-105 -108.36 109.17 20.42 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 171.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HG2' ' OE1' ' A' ' 36' ' ' GLU . 27.1 ttpp -134.21 117.65 16.73 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.621 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 29.4 t80 -90.05 110.97 21.93 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.714 -175.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.413 ' OE1' ' HG2' ' A' ' 34' ' ' LYS . 4.5 mm-40 -84.53 40.81 0.81 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.548 -176.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.613 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -98.3 165.7 21.73 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.731 -171.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -101.47 -56.88 2.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.302 0.572 . . . . 0.0 109.828 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -116.36 166.6 12.2 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.264 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.567 ' HB2' HG22 ' A' ' 71' ' ' ILE . 36.7 Cg_exo -55.83 137.15 77.78 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.165 1.91 . . . . 0.0 111.324 175.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -121.6 146.2 47.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.322 0.582 . . . . 0.0 112.02 -173.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.509 ' HB ' HG12 ' A' ' 73' ' ' ILE . 64.5 mt -113.18 112.31 39.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.905 172.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.793 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 20.7 t -98.94 113.59 34.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.863 0.363 . . . . 0.0 110.848 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.614 ' HB2' HD13 ' A' ' 60' ' ' LEU . 6.7 t70 -92.69 108.69 20.18 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.108 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.545 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 13.7 m-85 -88.07 109.94 20.25 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 171.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.767 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 3.9 p90 -130.25 160.77 32.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.186 0.517 . . . . 0.0 110.671 -175.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 50' ' ' CYS . . . -119.49 131.67 55.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.105 169.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.63 -11.26 59.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.01 0.434 . . . . 0.0 111.152 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.406 ' HE1' ' HG2' ' A' ' 79' ' ' GLU . 65.8 p-90 -102.23 -6.39 23.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.096 176.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 50.2 t -88.73 118.05 28.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.81 0.338 . . . . 0.0 110.954 -174.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 54' ' ' LYS . . . -52.13 -57.3 13.47 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.595 -0.729 . . . . 0.0 113.628 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.462 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 83.2 Cg_exo -47.32 -46.35 20.09 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.026 2.484 . . . . 0.0 113.552 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.767 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 74.9 m -68.78 -37.25 79.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.854 0.359 . . . . 0.0 111.215 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 68.1 mttm -55.25 -28.69 55.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.81 173.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 79.9 mtp -75.08 -50.92 14.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.025 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.58 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 32.8 m -71.82 -39.32 67.78 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -173.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -49.75 -56.8 14.82 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 23.3 Cg_exo -63.9 -35.76 53.84 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.732 1.622 . . . . 0.0 111.574 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.887 HG23 ' HB3' ' A' ' 114' ' ' LYS . 56.6 mt -62.75 -42.55 96.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.677 0.751 . . . . 0.0 110.464 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' A' ' 44' ' ' ASP . 28.2 mt -68.82 -35.51 77.07 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.119 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.563 ' OD1' HG11 ' A' ' 11' ' ' VAL . 57.1 m-20 -62.19 -45.77 91.91 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 173.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -54.92 -47.08 74.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.698 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.48 HD21 ' HB2' ' A' ' 114' ' ' LYS . 74.4 mt -69.3 -29.9 67.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.824 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.79 -42.65 84.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.826 0.346 . . . . 0.0 110.372 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.73 -28.69 58.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.396 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.464 ' CD ' ' HZ1' ' A' ' 114' ' ' LYS . 4.6 tt0 -80.62 -41.52 23.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.473 ' HE1' HD22 ' A' ' 63' ' ' LEU . 57.8 m-85 -98.94 24.96 7.11 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.847 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -64.53 163.57 13.27 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.232 0.539 . . . . 0.0 111.704 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.23 -50.51 3.88 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.296 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.511 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 23.9 pt20 -90.09 -40.33 12.34 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 -177.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.567 HG22 ' HB2' ' A' ' 40' ' ' PRO . 26.9 pt -127.56 166.77 23.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.293 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 51.4 t -134.06 139.5 48.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.731 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 39.1 mt -108.08 142.13 21.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.072 -175.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -127.47 165.96 18.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.799 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.738 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 86.1 mttt -132.39 166.36 22.15 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.56 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 5.1 p -146.06 133.49 15.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.169 0.509 . . . . 0.0 109.673 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 8.0 m-20 -81.98 91.89 6.68 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.489 HG21 ' HA ' ' A' ' 92' ' ' SER . 18.0 m -66.95 -27.66 67.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.304 -167.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.406 ' HG2' ' HE1' ' A' ' 49' ' ' TRP . 3.2 mp0 -54.28 -38.95 66.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.794 0.331 . . . . 0.0 110.917 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -95.7 -34.88 11.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.101 0.477 . . . . 0.0 109.987 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.56 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -82.26 30.75 0.4 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.671 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -63.13 -26.74 68.96 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -61.94 -45.33 94.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.617 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -70.8 -53.19 16.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.142 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -54.3 -51.51 64.41 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.496 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.55 -27.84 66.68 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.322 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.78 -26.99 67.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.645 0.26 . . . . 0.0 111.574 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.574 ' HB2' HG13 ' A' ' 90' ' ' ILE . 83.4 m-85 -100.86 -5.08 26.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.887 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.13 4.77 64.44 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.878 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 85' ' ' ALA . 36.8 mt -65.97 128.93 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -69.13 -53.42 20.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.265 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.489 ' HA ' HG21 ' A' ' 78' ' ' THR . 11.3 p 178.14 -94.83 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.714 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.519 HG21 ' C ' ' A' ' 46' ' ' TYR . 0.2 OUTLIER -145.07 157.59 53.6 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.613 -173.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.668 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 8.3 Cg_exo -83.53 133.39 20.86 Favored 'Cis proline' 0 N--CA 1.474 0.367 0 C-N-CA 124.71 -0.954 . . . . 0.0 111.995 -3.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 4.9 m -126.84 122.04 33.59 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 107' ' ' MET . 19.7 mm -114.36 114.66 47.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.205 -176.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.793 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.9 tp -99.77 114.76 28.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.015 0.436 . . . . 0.0 110.761 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 105' ' ' PRO . 97.5 m-85 -97.07 102.86 14.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.086 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.796 HG12 ' HB3' ' A' ' 105' ' ' PRO . 34.2 mt -107.02 106.46 58.35 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -176.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -87.1 165.9 8.36 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.771 2.314 . . . . 0.0 111.665 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.5 mmm -86.74 -1.93 58.13 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.981 0.419 . . . . 0.0 111.064 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -153.28 112.73 3.83 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 129.6 -136.17 8.81 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.536 ' HB3' ' HZ2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -137.38 151.16 70.81 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 175.313 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.796 ' HB3' HG12 ' A' ' 99' ' ' ILE . 3.8 Cg_exo -77.77 114.05 3.58 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.903 2.402 . . . . 0.0 111.22 175.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -95.69 167.18 11.44 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.315 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.508 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 49.0 ttm -140.06 130.97 26.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.444 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.97 141.66 48.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.44 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.508 ' OE1' ' HA ' ' A' ' 95' ' ' SER . 12.3 mm100 -106.13 134.73 48.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.874 0.369 . . . . 0.0 111.616 -175.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.668 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 114.39 177.15 19.06 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 169.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.58 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -94.2 87.61 5.32 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.508 -0.846 . . . . 0.0 111.932 -174.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.589 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 23.3 ptp -96.36 150.85 37.62 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.556 171.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.545 ' HA ' HD13 ' A' ' 59' ' ' ILE . 74.9 Cg_endo -75.49 173.19 14.92 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.343 2.029 . . . . 0.0 111.534 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.887 ' HB3' HG23 ' A' ' 59' ' ' ILE . 21.4 ptmt -63.17 -22.91 67.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.898 0.38 . . . . 0.0 110.284 177.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.97 -52.94 45.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.665 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.589 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 36.0 m -67.58 -34.06 76.27 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.235 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.535 ' HB2' ' HA ' ' A' ' 114' ' ' LYS . 7.3 m-85 -59.25 -47.01 86.97 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.489 174.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.512 ' NZ ' ' HB2' ' A' ' 122' ' ' ASP . 5.8 tmtm? -55.42 -35.92 65.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.346 0.117 . . . . 0.0 110.743 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.551 ' HG2' ' OE1' ' A' ' 123' ' ' GLU . 62.0 tttm -64.03 -57.07 10.76 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.397 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.39 95.8 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.72 HG23 HD23 ' A' ' 125' ' ' LEU . 77.3 mt -59.46 -44.95 93.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.861 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.512 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 10.0 t70 -62.79 -62.97 1.36 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.66 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.731 ' HA ' ' HZ3' ' A' ' 127' ' ' LYS . 62.2 mt-10 -63.13 -0.8 0.82 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -167.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -151.63 -48.41 0.11 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.649 -0.821 . . . . 0.0 112.528 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.72 HD23 HG23 ' A' ' 121' ' ' ILE . 42.4 tp -66.9 -30.62 70.81 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.633 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 74.6 mt -109.28 -56.3 2.31 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.854 0.835 . . . . 0.0 109.5 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.731 ' HZ3' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.852 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.331 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.325 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.439 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -135.8 175.26 9.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.968 0.413 . . . . 0.0 110.431 178.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.848 HG22 ' HB ' ' A' ' 73' ' ' ILE . 39.7 t -114.02 143.35 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.244 -172.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.8 mt -124.3 107.96 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.734 172.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.748 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 9.8 p80 -83.32 116.31 22.39 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 173.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.733 HD22 ' HB3' ' A' ' 18' ' ' GLU . 1.1 pp -132.92 179.99 5.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.985 -166.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.698 HG22 ' HE2' ' A' ' 80' ' ' LYS . 66.4 p -94.0 175.25 6.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.589 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.533 ' HD2' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -59.62 -32.28 70.28 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 121.233 -0.187 . . . . 0.0 111.233 177.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.559 ' HA ' HD12 ' A' ' 20' ' ' LEU . . . -62.84 -41.89 99.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.468 0.651 . . . . 0.0 110.218 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.733 ' HB3' HD22 ' A' ' 14' ' ' LEU . 8.4 mm-40 -71.72 -36.4 70.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.366 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -56.92 -50.72 71.71 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 122.388 1.089 . . . . 0.0 109.452 175.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.643 HD22 HD22 ' A' ' 25' ' ' ASN . 16.1 mt -50.34 -59.0 4.41 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 112.838 -1.983 . . . . 0.0 111.857 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.3 -17.87 38.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -171.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -110.81 -1.37 16.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.6 t -140.34 -50.69 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 7.5 t80 -175.14 116.02 0.16 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.155 0.502 . . . . 0.0 110.64 -167.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.643 HD22 HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -87.19 90.97 8.55 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.242 -177.265 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.522 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 18.9 p90 -78.4 14.96 1.07 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.83 -46.75 7.7 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.622 ' C ' HD22 ' A' ' 29' ' ' ASN . 49.9 mttp -96.31 -21.1 18.02 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.069 -173.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.622 HD22 ' C ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -121.11 62.97 11.63 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.366 177.212 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -61.26 -42.1 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.762 2.308 . . . . 0.0 112.374 172.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.589 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -103.02 -24.16 13.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.303 -176.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.404 ' CD ' ' HZ2' ' A' ' 34' ' ' LYS . 35.8 mt-10 -90.13 148.96 22.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.199 0.523 . . . . 0.0 111.259 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -113.95 93.77 4.52 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 168.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.404 ' HZ2' ' CD ' ' A' ' 32' ' ' GLU . 35.7 mtmm -117.51 106.33 13.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.402 173.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.578 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 30.2 t80 -68.14 105.12 1.97 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.368 0.604 . . . . 0.0 109.831 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -90.22 84.22 6.06 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.565 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -149.52 -135.69 2.51 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.731 -174.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -141.54 -55.34 0.47 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.898 0.38 . . . . 0.0 111.055 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 43.6 mttp -129.33 168.71 15.27 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.814 -177.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 65.8 Cg_exo -49.18 131.36 26.3 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.99 1.794 . . . . 0.0 111.393 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -115.32 143.23 45.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.365 -170.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.676 ' HB ' HG12 ' A' ' 73' ' ' ILE . 65.4 mt -120.33 122.49 68.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.124 176.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 16.5 t -105.74 116.02 48.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.894 0.378 . . . . 0.0 110.984 -178.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.778 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 11.3 t0 -97.78 108.11 20.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.634 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -91.27 111.64 23.21 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.593 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 0.8 OUTLIER -147.02 178.6 8.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.735 0.779 . . . . 0.0 111.286 -172.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.65 124.07 5.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.855 -1.52 . . . . 0.0 107.449 170.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.28 -23.06 67.25 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -169.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -74.95 -14.07 60.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.951 0.405 . . . . 0.0 110.766 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.1 t -99.64 132.93 44.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.475 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.561 ' O ' ' HG2' ' A' ' 54' ' ' LYS . . . -49.14 -68.23 1.42 Allowed Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.716 -0.674 . . . . 0.0 114.672 -175.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -58.71 -34.27 98.84 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.71 2.273 . . . . 0.0 113.107 -175.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.749 ' SG ' ' HB ' ' A' ' 93' ' ' ILE . 11.9 m -73.98 -33.88 64.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.896 0.379 . . . . 0.0 111.514 -176.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 0.2 OUTLIER -78.85 -27.2 44.11 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.581 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 16.4 ttt -66.93 -52.41 43.46 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.166 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.509 HG22 HD22 ' A' ' 60' ' ' LEU . 3.9 p -63.45 -36.77 77.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.046 -174.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.692 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -48.07 -60.28 4.58 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.326 -176.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.692 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 27.3 Cg_exo -62.21 -27.49 78.46 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.231 1.287 . . . . 0.0 112.272 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 55' ' ' MET . 45.0 mm -66.19 -57.28 11.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.34 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.571 HD21 ' NZ ' ' A' ' 75' ' ' LYS . 1.2 pt? -71.69 -30.03 65.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.178 -177.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.49 ' OD1' HG21 ' A' ' 11' ' ' VAL . 5.6 m-20 -66.43 -42.54 87.56 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.458 0.647 . . . . 0.0 109.846 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.531 ' HG3' ' NZ ' ' A' ' 114' ' ' LYS . 9.8 tp10 -54.79 -43.3 72.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.925 172.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.795 HD21 ' HA ' ' A' ' 118' ' ' LYS . 12.9 tp -71.52 -30.79 66.34 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.073 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.69 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -58.73 -59.07 6.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.745 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -64.7 -24.26 67.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.231 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -58.54 -30.86 67.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.462 0.649 . . . . 0.0 110.044 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.501 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 81.3 m-85 -113.75 25.74 10.96 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.447 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -52.36 114.46 1.37 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.93 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.04 -22.24 5.13 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.414 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 6.4 pt20 -127.55 -22.3 3.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 64' ' ' ALA . 44.0 pt -125.24 150.34 30.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.418 0.628 . . . . 0.0 112.218 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 47.2 t -127.27 132.09 69.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.284 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.848 ' HB ' HG22 ' A' ' 11' ' ' VAL . 11.8 mt -115.62 136.45 52.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.474 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -117.1 161.19 19.82 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.778 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 63.8 mttm -129.69 148.21 51.56 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.012 0.434 . . . . 0.0 110.23 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.424 HG13 ' CB ' ' A' ' 81' ' ' GLU . 17.4 t -120.64 111.83 33.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.739 176.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.42 89.2 2.64 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.533 HG21 ' O ' ' A' ' 92' ' ' SER . 7.9 p -52.87 -36.96 59.78 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -168.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.419 ' HG2' ' H ' ' A' ' 79' ' ' GLU . 1.1 mm-40 -53.43 -33.22 53.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.568 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.698 ' HE2' HG22 ' A' ' 15' ' ' THR . 18.1 pttm -103.45 -22.21 13.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.397 0.618 . . . . 0.0 110.161 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -100.11 43.24 1.07 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.657 178.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -55.1 -46.71 75.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.964 0.411 . . . . 0.0 111.419 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -64.55 -38.74 92.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.735 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -70.05 -44.88 68.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.966 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.04 89.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.035 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.51 -29.5 73.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.963 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.54 -26.45 65.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 111.54 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -99.17 7.24 45.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.054 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.29 16.64 80.56 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.324 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.4 mm -77.63 122.11 31.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -58.88 -61.8 2.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.505 0.669 . . . . 0.0 109.592 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.533 ' O ' HG21 ' A' ' 78' ' ' THR . 13.9 m -160.82 -79.71 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.674 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.749 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 4.5 pt -162.02 152.77 14.75 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.182 -172.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.719 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.6 Cg_exo -90.01 149.54 22.61 Favored 'Cis proline' 0 C--N 1.348 0.552 0 CA-C-N 118.869 0.632 . . . . 0.0 112.286 -3.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.416 ' HB3' ' SD ' ' A' ' 107' ' ' MET . 50.1 m -142.67 140.99 31.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.58 114.48 20.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.156 0.503 . . . . 0.0 110.138 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.554 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 43.7 tp -97.31 115.25 27.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.455 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.439 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 44.3 m-85 -96.2 104.68 16.65 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.437 HG23 ' HG3' ' A' ' 105' ' ' PRO . 53.8 mt -102.57 102.83 28.33 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.347 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 98' ' ' PHE . 73.8 Cg_endo -83.7 155.66 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.579 2.186 . . . . 0.0 111.763 174.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.403 ' SD ' ' HD3' ' A' ' 40' ' ' PRO . 90.4 mtp -75.27 -30.35 60.41 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -106.5 138.93 41.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.633 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.2 -140.1 16.61 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.922 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.667 ' HE3' ' HA ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -139.38 154.65 71.97 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.613 ' HD3' ' HE3' ' A' ' 104' ' ' LYS . 15.6 Cg_exo -69.47 154.34 69.01 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.1 2.533 . . . . 0.0 113.574 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.475 ' O ' HD12 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.56 169.72 9.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.829 176.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.416 ' SD ' ' HB3' ' A' ' 95' ' ' SER . 32.9 tpp -142.37 105.61 4.61 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.107 -174.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.93 137.37 42.01 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -117.41 137.74 52.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.159 0.504 . . . . 0.0 111.536 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.719 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 103.16 170.43 26.05 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.967 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -94.69 82.75 3.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.095 0.474 . . . . 0.0 111.65 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.586 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 22.0 ptt? -79.59 166.44 41.22 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 170.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.586 ' HD2' ' HB2' ' A' ' 112' ' ' MET . 65.9 Cg_endo -75.17 170.73 19.73 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.558 1.505 . . . . 0.0 112.541 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.531 ' NZ ' ' HG3' ' A' ' 62' ' ' GLU . 60.5 tttp -57.54 -25.37 59.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.971 174.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.64 -52.44 31.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.336 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.5 m -68.04 -37.74 81.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.697 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.679 ' O ' HG12 ' A' ' 121' ' ' ILE . 12.7 m-85 -61.48 -43.56 98.64 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.634 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.795 ' HA ' HD21 ' A' ' 63' ' ' LEU . 64.6 tttp -60.6 -38.84 86.01 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.108 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -62.87 -43.93 97.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.869 0.366 . . . . 0.0 110.741 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -64.0 -41.1 97.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.253 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.679 HG12 ' O ' ' A' ' 117' ' ' PHE . 16.3 mm -74.93 -53.9 15.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.437 0.637 . . . . 0.0 110.998 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.548 ' HA ' HD12 ' A' ' 126' ' ' LEU . 19.0 t70 -68.45 -66.03 0.62 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.314 -173.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.6 -49.36 71.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.767 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.543 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 79.2 t80 -86.09 -37.61 18.65 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -170.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.622 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 29.5 tp -90.52 -38.31 13.29 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 122' ' ' ASP . 79.6 mt -89.07 -66.84 0.88 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.911 0.386 . . . . 0.0 111.689 -173.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.507 -0.707 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 112.749 -0.14 . . . . 0.0 112.749 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -162.83 171.74 16.23 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 121.286 0.565 . . . . 0.0 110.968 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.536 HG21 ' HE3' ' A' ' 75' ' ' LYS . 7.9 m -113.16 145.08 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.382 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.1 mt -114.38 96.76 4.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.058 174.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.538 ' HA ' ' HB2' ' A' ' 75' ' ' LYS . 27.1 p80 -77.71 121.89 24.63 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.76 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.4 pp -138.38 178.63 7.0 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.228 0.537 . . . . 0.0 112.282 -169.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.633 HG22 ' HE2' ' A' ' 80' ' ' LYS . 42.6 p -98.42 171.39 8.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.484 175.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.535 ' HZ1' ' CD ' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -56.06 -33.09 64.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 178.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.05 -42.01 90.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.35 0.595 . . . . 0.0 110.293 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.76 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 30.2 mt-10 -71.62 -32.27 67.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.123 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -57.31 -52.86 63.65 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-O 122.401 1.096 . . . . 0.0 109.285 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.575 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 7.9 mt -50.63 -59.58 3.91 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.634 -2.075 . . . . 0.0 111.893 -176.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.58 -8.01 59.66 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -171.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -109.43 -32.43 7.16 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 31.0 t -123.5 -40.13 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -168.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.585 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 14.6 t80 -167.63 120.04 0.9 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.921 -166.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.72 90.82 7.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.011 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.585 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 27.0 p90 -85.29 18.49 2.62 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 111.667 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -94.54 -49.57 5.59 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.598 ' C ' HD22 ' A' ' 29' ' ' ASN . 47.4 mttp -96.65 -21.6 17.52 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.153 -175.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.629 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -121.7 68.29 22.91 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.618 176.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.92 -32.28 97.12 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.547 2.831 . . . . 0.0 112.613 173.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -102.52 -40.3 6.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -172.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 3.2 tp10 -100.78 132.29 46.25 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.466 0.65 . . . . 0.0 111.705 -174.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -69.46 93.2 0.65 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.654 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -93.11 97.15 10.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.529 177.31 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.57 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 23.0 t80 -81.39 127.53 32.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.989 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -109.43 151.95 26.0 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 168.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.88 -127.63 2.19 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.809 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -163.74 -60.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.019 0.437 . . . . 0.0 110.396 -173.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.465 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 22.0 mttm -119.08 165.79 16.08 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.442 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 85.9 Cg_exo -44.2 131.74 8.87 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.68 2.253 . . . . 0.0 111.838 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -113.22 146.31 39.53 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.212 0.529 . . . . 0.0 111.764 -171.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.692 ' HB ' HG12 ' A' ' 73' ' ' ILE . 74.8 mt -122.4 122.53 66.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.063 174.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 21.5 t -107.28 110.06 30.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.399 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.598 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 30.1 t0 -86.74 106.59 17.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.998 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.561 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 96.6 m-85 -91.88 111.89 23.6 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.673 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.6 p90 -140.63 -179.87 6.28 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.832 -171.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.421 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -159.09 142.71 14.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.492 170.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.47 -28.96 68.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -76.75 -9.79 58.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.235 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.466 ' HB2' HD12 ' A' ' 93' ' ' ILE . 47.0 t -99.15 112.38 24.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.936 0.398 . . . . 0.0 110.643 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.08 -54.3 38.6 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.607 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.49 -38.46 27.71 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.952 2.434 . . . . 0.0 113.532 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.726 ' SG ' ' HB ' ' A' ' 93' ' ' ILE . 83.0 m -67.06 -43.86 81.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.38 . . . . 0.0 111.143 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -72.48 -26.04 61.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.93 0.395 . . . . 0.0 110.184 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -60.05 -46.97 87.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.669 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.581 ' HB ' ' HE2' ' A' ' 117' ' ' PHE . 30.4 m -87.16 -25.17 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.481 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -43.74 -59.93 3.08 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 50.2 Cg_endo -68.57 -26.78 33.49 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.725 1.617 . . . . 0.0 112.0 -177.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.07 -54.95 21.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.347 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.583 HD11 ' HE2' ' A' ' 75' ' ' LYS . 1.7 pp -69.03 -30.84 69.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.51 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.08 -49.98 75.53 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.246 0.546 . . . . 0.0 110.741 173.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -64.56 -36.24 83.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.41 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.45 -31.3 67.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.425 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.689 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -56.98 -42.34 80.05 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 173.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.636 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 3.7 tmtm? -71.79 -41.22 68.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.043 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -56.54 -39.54 73.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.964 0.411 . . . . 0.0 110.739 176.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.481 ' HA ' HE21 ' A' ' 70' ' ' GLN . 83.8 m-85 -98.54 26.67 5.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.345 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 58.0 t0 -53.39 129.79 33.17 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.477 0.311 . . . . 0.0 110.666 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.53 -6.54 83.49 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.304 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.481 HE21 ' HA ' ' A' ' 67' ' ' TYR . 44.1 mt-30 -112.47 -44.34 3.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.607 0.242 . . . . 0.0 111.008 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 40' ' ' PRO . 45.1 pt -128.89 159.05 41.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.147 0.499 . . . . 0.0 111.822 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 96.6 t -126.86 123.82 63.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.233 176.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.692 HG12 ' HB ' ' A' ' 42' ' ' ILE . 15.2 mt -107.62 138.32 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.72 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -118.01 162.31 18.37 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 173.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.598 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 55.8 mttt -135.91 144.46 45.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.889 0.376 . . . . 0.0 111.147 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.691 HG13 ' HG2' ' A' ' 81' ' ' GLU . 37.3 t -138.41 134.48 43.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.853 -175.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.471 ' HB2' ' HG2' ' A' ' 80' ' ' LYS . 7.5 m-20 -94.52 102.06 13.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.449 HG21 ' O ' ' A' ' 92' ' ' SER . 16.8 p -52.94 -37.41 60.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.2 0.524 . . . . 0.0 111.67 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -54.9 -36.28 65.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.981 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.633 ' HE2' HG22 ' A' ' 15' ' ' THR . 21.6 pttm -100.59 -20.39 15.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.357 0.599 . . . . 0.0 110.076 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.691 ' HG2' HG13 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -97.86 45.25 1.03 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.483 176.015 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -55.89 -53.31 58.38 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.58 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.535 ' CD ' ' HZ1' ' A' ' 16' ' ' LYS . 2.2 mp0 -61.85 -36.88 82.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.618 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.466 HD23 ' HG2' ' A' ' 81' ' ' GLU . 41.4 tp -67.86 -41.7 82.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.529 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -67.0 -44.54 80.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.67 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.14 -32.89 82.15 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.684 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.85 -35.37 76.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.814 0.34 . . . . 0.0 111.588 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.532 ' HB2' HG13 ' A' ' 90' ' ' ILE . 94.6 m-85 -97.26 3.06 51.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.854 0.359 . . . . 0.0 110.81 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.13 28.46 73.7 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.11 -176.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 85' ' ' ALA . 28.9 mt -66.08 138.82 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -64.09 -61.39 2.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.449 ' O ' HG21 ' A' ' 78' ' ' THR . 24.3 p 175.65 -91.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.75 175.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.726 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 8.0 pt -151.55 146.34 18.77 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.881 -172.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.68 ' HB2' ' H ' ' A' ' 110' ' ' GLY . 17.3 Cg_exo -78.59 142.78 70.09 Favored 'Cis proline' 0 N--CA 1.478 0.561 0 C-N-CA 124.78 -0.925 . . . . 0.0 112.037 -3.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 14.7 m -139.37 112.35 8.0 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.73 114.39 46.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.028 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.606 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 34.8 tp -92.96 113.18 25.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.714 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -94.23 112.39 24.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.88 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 41' ' ' ALA . 36.9 mt -101.24 102.9 22.88 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.908 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.09 163.09 22.97 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.576 2.184 . . . . 0.0 112.325 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 92.6 mmm -87.39 -0.04 56.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.332 0.587 . . . . 0.0 109.559 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -138.2 123.68 19.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.928 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.25 -149.57 19.45 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.08 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 27.2 mmmt -123.31 159.1 56.26 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.467 ' HB2' HD11 ' A' ' 97' ' ' LEU . 57.6 Cg_endo -70.48 154.1 65.13 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.564 2.176 . . . . 0.0 113.45 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -125.83 167.94 14.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.494 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.506 ' SD ' ' HB3' ' A' ' 95' ' ' SER . 42.9 ttm -130.26 122.06 27.31 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.043 0.449 . . . . 0.0 112.029 -175.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.05 132.23 50.51 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -115.37 136.2 53.34 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.284 0.564 . . . . 0.0 112.437 -172.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.68 ' H ' ' HB2' ' A' ' 94' ' ' PRO . . . 104.7 -175.6 22.55 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.173 -0.921 . . . . 0.0 114.898 169.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.482 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -92.12 85.64 5.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.026 -0.587 . . . . 0.0 111.633 -171.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.568 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 25.1 ptp -91.4 154.89 44.52 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.463 172.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 71.7 Cg_endo -75.44 177.54 8.52 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.28 1.987 . . . . 0.0 111.687 -177.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -58.85 -33.77 70.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 174.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.78 -52.86 61.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.529 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.568 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 34.6 m -66.7 -40.73 88.6 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.736 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.581 ' HE2' ' HB ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -60.93 -40.79 94.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.537 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.434 ' C ' ' HD3' ' A' ' 118' ' ' LYS . 14.6 tmtt? -58.97 -49.82 76.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.892 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.559 ' HA ' ' OD1' ' A' ' 122' ' ' ASP . 12.9 mptt -64.64 -39.86 94.43 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.951 0.405 . . . . 0.0 110.797 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -58.51 -38.9 78.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.611 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.514 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 74.7 mt -75.04 -56.29 9.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.472 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.559 ' OD1' ' HA ' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -74.24 -58.87 3.01 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.918 -173.036 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.432 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 6.0 mm-40 -69.26 -22.47 63.83 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -171.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 91.6 t80 -110.47 -46.29 3.42 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.973 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.514 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 36.7 tp -90.39 -41.64 11.36 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -172.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.534 ' HB3' ' HA ' ' A' ' 122' ' ' ASP . 45.3 tp -83.49 -52.5 6.44 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 121.392 0.615 . . . . 0.0 109.751 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 30.1 mtmt . . . . . 0 C--N 1.318 -0.781 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 173.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.543 ' HA3' ' CG ' ' A' ' 68' ' ' ASP . . . . . . . . 0 C--O 1.227 -0.312 0 CA-C-O 120.514 -0.048 . . . . 0.0 113.058 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.98 172.09 10.53 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.701 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 12.9 p -113.36 132.21 62.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.713 0.768 . . . . 0.0 112.097 -176.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.0 mt -121.49 128.88 75.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.736 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.594 ' CB ' ' HG3' ' A' ' 75' ' ' LYS . 1.9 p80 -88.01 129.53 35.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.3 pp -133.21 173.98 10.87 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.918 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.43 166.97 12.59 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.852 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.759 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 30.7 pttt -62.16 -26.65 68.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.061 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.0 86.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.281 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 28.2 mm-40 -68.61 -43.58 76.08 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.868 176.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -57.39 -49.8 75.03 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 121.933 0.873 . . . . 0.0 109.502 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' ' 25' ' ' ASN . 1.1 tt -48.64 -61.47 2.01 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 113.648 -1.615 . . . . 0.0 112.098 -178.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.09 -18.83 33.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.588 -168.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 34.5 ttmt -108.78 -16.87 14.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -172.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.45 -45.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 18.5 t80 -164.42 116.74 1.31 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.236 0.541 . . . . 0.0 111.261 -169.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.598 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -84.15 89.05 7.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.99 -177.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.511 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 27.2 p90 -82.81 4.88 23.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.644 0.735 . . . . 0.0 110.698 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.427 ' H ' HD22 ' A' ' 25' ' ' ASN . 5.4 tm-20 -95.43 -52.27 4.22 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.253 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.636 ' C ' HD22 ' A' ' 29' ' ' ASN . 67.6 mttm -84.27 -27.77 27.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.287 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.654 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -120.71 69.04 16.24 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-O 120.862 0.363 . . . . 0.0 111.223 -177.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -64.12 -28.23 65.16 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.449 2.766 . . . . 0.0 112.306 171.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -31.46 8.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.752 -175.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -91.81 144.37 25.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.055 0.455 . . . . 0.0 111.407 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -91.94 89.47 7.02 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 171.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 87.2 tttt -94.23 97.58 10.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.007 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -99.31 120.6 39.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.054 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -112.0 114.51 27.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.218 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.84 163.52 33.16 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.511 ' OD2' ' HG3' ' A' ' 39' ' ' LYS . 12.0 p-10 -95.71 -37.32 10.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.949 0.375 . . . . 0.0 111.181 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.511 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 56.5 mttp -117.54 166.28 13.7 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.505 179.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.577 ' HB2' HD21 ' A' ' 125' ' ' LEU . 32.1 Cg_exo -59.8 141.03 96.03 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.746 2.297 . . . . 0.0 111.56 174.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -119.91 147.43 44.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.342 0.591 . . . . 0.0 112.365 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.745 ' HB ' HG12 ' A' ' 73' ' ' ILE . 4.2 mp -121.12 133.38 67.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.311 172.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 41.9 t -128.31 114.07 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.126 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.608 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 8.6 p-10 -100.41 115.87 31.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 122.222 1.01 . . . . 0.0 111.622 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.535 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 30.0 m-85 -81.1 112.88 18.87 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.431 -1.258 . . . . 0.0 108.936 173.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.71 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.8 p90 -129.91 168.17 17.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.503 0.668 . . . . 0.0 111.415 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.89 131.01 26.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.271 -1.332 . . . . 0.0 107.841 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.542 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 27.9 t70 -60.12 -34.34 73.37 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -171.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -71.57 -9.33 58.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.681 0.277 . . . . 0.0 111.62 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.455 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 48.0 t -95.64 123.55 39.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.92 0.39 . . . . 0.0 110.607 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.55 -59.01 10.27 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.755 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 77.4 Cg_exo -48.78 -36.71 34.04 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.047 2.498 . . . . 0.0 113.202 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.71 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 98.0 m -64.3 -44.89 90.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.99 0.424 . . . . 0.0 111.199 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.542 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 66.6 mttm -59.99 -29.71 68.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.905 175.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.56 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 75.0 mtp -71.59 -54.48 10.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.953 0.406 . . . . 0.0 111.16 177.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 96' ' ' ILE . 10.2 p -68.6 -36.95 76.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -170.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.634 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -52.06 -55.79 27.74 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 16.8 Cg_exo -68.35 -42.62 5.25 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 121.938 1.759 . . . . 0.0 112.14 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.442 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 73.1 mt -58.54 -41.04 80.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.08 0.467 . . . . 0.0 110.769 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.706 HD22 HD13 ' A' ' 73' ' ' ILE . 1.3 mt -67.03 -38.28 85.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.898 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.405 ' OD1' HG12 ' A' ' 11' ' ' VAL . 20.8 t70 -68.29 -37.06 80.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.184 0.516 . . . . 0.0 109.802 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 59' ' ' ILE . 14.5 tp10 -54.37 -46.05 72.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.692 174.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.582 HD21 ' HA ' ' A' ' 114' ' ' LYS . 4.3 mm? -72.02 -35.12 69.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.807 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.666 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -57.16 -52.0 67.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.404 ' HD3' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.27 -25.92 62.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.099 -178.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.491 ' CD ' ' HZ3' ' A' ' 114' ' ' LYS . 1.8 tt0 -71.73 -19.83 61.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.329 0.585 . . . . 0.0 110.15 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.438 ' HD1' ' O ' ' A' ' 63' ' ' LEU . 85.7 m-85 -117.23 25.84 10.18 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.682 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.543 ' CG ' ' HA3' ' A' ' 9' ' ' GLY . 11.3 t0 -58.65 121.57 11.32 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.234 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.64 -28.45 6.75 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.26 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.481 ' HG3' HG23 ' A' ' 71' ' ' ILE . 17.6 pt20 -114.73 -28.21 7.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -176.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.481 HG23 ' HG3' ' A' ' 70' ' ' GLN . 37.5 pt -122.99 158.12 27.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.859 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 94.4 t -130.06 128.04 64.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.423 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.745 HG12 ' HB ' ' A' ' 42' ' ' ILE . 29.3 mt -121.6 135.22 62.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.465 0.65 . . . . 0.0 111.371 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 63.8 m-85 -122.7 164.56 18.05 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 173.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.663 ' HB3' ' HZ3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -136.65 149.8 48.17 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 174.185 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.516 HG13 ' HG2' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -122.75 137.14 57.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.441 -171.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.531 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 10.5 m-20 -87.82 86.57 7.18 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.638 HG21 ' HA ' ' A' ' 92' ' ' SER . 15.3 m -56.06 -29.75 60.95 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -169.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -53.42 -31.03 43.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.647 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.531 ' HE3' ' HB2' ' A' ' 77' ' ' ASP . 22.2 pttp -109.82 -23.78 11.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.196 0.522 . . . . 0.0 110.492 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.759 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 1.3 mp0 -85.93 39.63 0.82 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.424 175.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -61.95 -47.92 82.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.696 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -62.22 -38.95 91.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.218 0.532 . . . . 0.0 110.192 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.1 tp -61.03 -44.54 97.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.42 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.583 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -63.96 -49.08 73.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.753 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.65 -30.99 66.4 Favored Glycine 0 CA--C 1.517 0.181 0 CA-C-N 116.081 -0.509 . . . . 0.0 113.206 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.75 -33.32 73.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.752 0.31 . . . . 0.0 111.707 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.572 ' HB2' HG13 ' A' ' 90' ' ' ILE . 89.5 m-85 -104.15 7.47 36.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.174 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.67 30.63 68.35 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.799 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 85' ' ' ALA . 55.6 mt -80.69 131.94 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.642 0.258 . . . . 0.0 110.524 -177.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.0 mtm105 -57.45 -64.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.666 0.746 . . . . 0.0 109.933 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.638 ' HA ' HG21 ' A' ' 78' ' ' THR . 13.0 p 177.17 -93.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.633 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.517 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -139.56 148.37 55.85 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.357 -175.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.712 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.1 Cg_exo -85.36 150.19 50.43 Favored 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 124.077 -1.218 . . . . 0.0 111.279 -3.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 11.6 m -141.36 140.19 33.69 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.558 HD11 HG21 ' A' ' 56' ' ' VAL . 60.1 mt -136.24 117.76 19.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 119.025 0.83 . . . . 0.0 111.201 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 105' ' ' PRO . 20.3 tp -98.26 114.35 26.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.209 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.595 ' HE2' ' HB3' ' A' ' 108' ' ' ALA . 96.6 m-85 -96.78 110.79 23.19 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.0 mt -103.3 105.97 49.13 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.819 0.343 . . . . 0.0 111.899 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 98' ' ' PHE . 2.9 Cg_exo -76.16 159.27 37.25 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.413 2.742 . . . . 0.0 111.5 172.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 89.8 mtp -83.02 -32.15 27.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.636 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.07 -30.91 7.83 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.91 0.862 . . . . 0.0 110.764 -177.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.69 -156.03 24.4 Favored Glycine 0 C--N 1.307 -1.031 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.99 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 35.2 mmtm -129.81 148.54 69.93 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 98' ' ' PHE . 38.3 Cg_endo -63.62 134.38 43.94 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.887 2.391 . . . . 0.0 113.854 -170.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.32 169.64 8.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.423 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 36.1 tpp -136.13 101.92 4.85 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.859 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.595 ' HB3' ' HE2' ' A' ' 98' ' ' PHE . . . -107.8 129.88 55.02 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 173.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.557 ' HB3' ' O ' ' A' ' 94' ' ' PRO . 58.4 mt-30 -117.51 128.52 55.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.149 0.499 . . . . 0.0 111.93 -171.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.712 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 133.12 -169.21 22.69 Favored Glycine 0 CA--C 1.506 -0.487 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.141 176.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.31 80.66 1.44 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.556 0.693 . . . . 0.0 110.858 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.702 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 5.0 mpp? -77.81 147.85 74.91 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.467 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.84 -177.69 3.8 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.052 2.502 . . . . 0.0 111.943 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.582 ' HA ' HD21 ' A' ' 63' ' ' LEU . 36.5 ttmt -60.13 -33.3 71.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 0.0 110.37 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.38 -52.9 59.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.558 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.702 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 20.3 m -70.31 -29.94 66.8 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.932 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.572 ' O ' HG13 ' A' ' 121' ' ' ILE . 5.4 m-85 -71.67 -37.29 70.77 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.426 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -57.75 -43.99 85.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.847 0.356 . . . . 0.0 110.119 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.528 ' HG2' ' OE2' ' A' ' 123' ' ' GLU . 31.0 mtpp -64.14 -38.48 91.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.679 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.561 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -67.5 -45.22 76.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.489 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 117' ' ' PHE . 20.9 mt -74.38 -57.25 6.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.306 0.574 . . . . 0.0 110.472 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.517 ' HA ' HD12 ' A' ' 126' ' ' LEU . 22.2 t70 -72.42 -65.04 0.83 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.285 -175.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.528 ' OE2' ' HG2' ' A' ' 119' ' ' LYS . 34.5 mt-10 -75.47 -9.21 58.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.423 -168.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.561 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 89.2 t80 -120.81 -52.49 2.11 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.938 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 40' ' ' PRO . 32.9 tp -72.75 -32.35 65.6 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.366 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 122' ' ' ASP . 64.5 mt -101.17 -59.69 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.112 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.892 -172.737 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.475 ' HA3' ' CG ' ' A' ' 68' ' ' ASP . . . . . . . . 0 CA--C 1.507 -0.468 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -131.09 173.05 11.4 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -174.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.655 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.5 p -133.29 134.33 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.183 0.516 . . . . 0.0 110.259 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 69.0 mt -129.57 133.65 64.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.176 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.741 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 6.5 p80 -93.8 116.34 28.8 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.371 0.605 . . . . 0.0 109.842 175.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.3 pp -116.09 179.8 3.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.759 -175.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.403 HG22 ' CE ' ' A' ' 80' ' ' LYS . 23.2 p -100.03 176.6 5.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 60.7 pttt -55.68 -30.74 61.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.521 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.24 78.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.769 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 4.0 mp0 -69.67 -31.66 69.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.33 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -64.61 -51.63 61.68 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.653 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.6 tt -51.76 -61.08 2.48 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 113.312 -1.767 . . . . 0.0 112.155 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.9 -25.69 61.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.781 -168.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 36.7 ttmt -98.45 -34.34 10.67 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.405 HG13 ' HD1' ' A' ' 35' ' ' TYR . 81.0 t -119.28 -47.7 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -167.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.709 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 20.0 t80 -151.54 116.47 5.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.297 0.57 . . . . 0.0 111.852 -165.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.566 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -88.2 90.69 8.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.262 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.709 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 24.3 p90 -84.27 12.09 7.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.154 0.502 . . . . 0.0 111.576 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -94.32 -45.7 7.37 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.505 ' C ' HD22 ' A' ' 29' ' ' ASN . 48.9 mttm -94.67 -25.9 16.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.584 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.612 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -122.26 68.85 29.23 Favored Pre-proline 0 N--CA 1.469 0.494 0 CA-C-O 120.791 0.329 . . . . 0.0 111.198 178.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -55.71 -42.18 70.09 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.163 2.576 . . . . 0.0 112.132 171.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -95.42 -33.25 12.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -173.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.408 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 36.7 mt-10 -91.49 128.45 37.32 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.204 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 53.3 t-105 -82.13 101.37 10.37 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 171.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 32' ' ' GLU . 30.6 mmtp -102.65 139.21 38.54 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.331 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.405 ' HD1' HG13 ' A' ' 23' ' ' VAL . 21.6 t80 -126.92 115.79 19.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.162 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 22' ' ' LYS . 35.0 mm-40 -97.5 123.73 41.47 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.443 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.85 179.48 46.37 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.201 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.483 ' OD2' ' HG3' ' A' ' 39' ' ' LYS . 1.7 p-10 -124.31 -38.51 2.42 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 117.011 0.405 . . . . 0.0 111.333 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.483 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 60.8 mttp -112.43 154.69 44.47 Favored Pre-proline 0 C--N 1.328 -0.348 0 O-C-N 122.474 -0.142 . . . . 0.0 110.86 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.458 ' HB2' HD21 ' A' ' 125' ' ' LEU . 6.2 Cg_endo -48.35 132.81 24.66 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.155 2.57 . . . . 0.0 111.851 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -116.85 149.57 39.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.388 0.613 . . . . 0.0 112.121 -170.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.424 ' HB ' HG12 ' A' ' 73' ' ' ILE . 76.5 mt -132.56 139.78 49.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.996 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.45 116.62 47.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.866 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.537 ' HB3' ' CB ' ' A' ' 75' ' ' LYS . 35.0 t70 -91.24 112.19 24.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.774 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 79.2 m-85 -93.51 110.64 22.22 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.74 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.2 p90 -137.87 162.6 33.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.559 0.695 . . . . 0.0 111.468 -171.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.19 133.4 50.29 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.692 170.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.24 -41.83 93.99 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.91 -172.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -68.25 -17.29 64.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.881 0.372 . . . . 0.0 111.624 -176.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 42.2 t -82.09 123.53 29.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.888 0.375 . . . . 0.0 110.168 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 55' ' ' MET . . . -55.83 -61.01 7.9 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.157 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -47.84 -45.7 23.64 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.842 2.361 . . . . 0.0 112.874 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.74 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 62.1 m -60.19 -45.63 92.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.527 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -76.02 -27.46 57.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.454 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 3.3 tmm? -67.31 -47.86 69.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.32 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.595 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 27.2 m -77.11 -24.95 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.601 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -50.74 -52.73 54.06 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 18.9 Cg_exo -66.81 -37.65 19.91 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.774 1.649 . . . . 0.0 112.339 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.3 mt -65.36 -47.5 86.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.358 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 117' ' ' PHE . 3.5 pp -68.33 -31.75 71.39 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.64 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.51 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 20.7 t70 -68.15 -37.81 81.44 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.153 174.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.95 -46.98 78.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.921 176.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.61 HD11 ' HG3' ' A' ' 114' ' ' LYS . 9.8 mp -65.25 -30.88 71.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.07 176.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.636 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -55.08 -53.78 51.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.635 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.51 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -78.2 -24.83 46.96 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.455 178.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -55.83 -33.97 64.95 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.677 0.751 . . . . 0.0 109.366 171.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.613 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 41.2 m-85 -111.34 26.5 10.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.042 176.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 3.1 t70 -55.36 132.6 48.51 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.336 -176.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.26 -21.06 36.29 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.962 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 10.8 pt20 -122.08 -36.0 3.06 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -176.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.551 HG23 ' HG3' ' A' ' 70' ' ' GLN . 45.4 pt -111.63 147.81 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.987 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 60.1 t -120.96 120.29 61.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.596 177.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 27.7 mt -115.57 134.98 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 121.612 0.72 . . . . 0.0 111.179 -177.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -121.45 173.27 7.49 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.824 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.741 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 3.5 ptmm? -151.97 156.34 39.82 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.574 HG23 HD12 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -133.62 148.23 30.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.097 -173.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 20.2 m-20 -89.82 85.87 6.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.573 HG21 ' HA ' ' A' ' 92' ' ' SER . 1.7 m -62.0 -27.28 68.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.193 -166.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -54.42 -31.04 54.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.487 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 22.6 pttm -104.76 -26.16 12.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.231 0.538 . . . . 0.0 109.694 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.52 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 1.3 mp0 -84.85 33.6 0.53 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.72 176.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -62.04 -31.61 72.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.819 0.343 . . . . 0.0 110.977 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -63.05 -41.05 99.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.358 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 84' ' ' LEU . 1.7 tm? -70.24 -45.61 66.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.41 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.56 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -61.57 -49.68 75.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.45 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.75 -30.26 72.19 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 116.154 -0.475 . . . . 0.0 113.116 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.57 -34.54 77.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.749 0.309 . . . . 0.0 111.677 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.518 ' HB2' HG13 ' A' ' 90' ' ' ILE . 77.7 m-85 -104.53 5.66 34.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.228 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.31 29.44 70.19 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.084 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 85' ' ' ALA . 22.0 mt -75.1 139.82 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.024 0.44 . . . . 0.0 110.072 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.415 ' HD3' HE22 ' A' ' 109' ' ' GLN . 72.6 mtp180 -74.34 4.05 6.43 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.674 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.573 ' HA ' HG21 ' A' ' 78' ' ' THR . 30.3 t 82.5 -88.0 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.424 -176.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.574 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 2.7 pp -135.29 136.45 24.46 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -169.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.665 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 4.0 Cg_exo -85.35 146.45 42.14 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 124.591 -1.004 . . . . 0.0 111.726 -4.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 37.5 t -142.0 140.85 32.79 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 171.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.6 mt -134.18 115.15 20.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.7 tp -97.64 112.99 24.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.552 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.75 111.48 23.75 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.776 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.563 HG12 ' HB3' ' A' ' 105' ' ' PRO . 44.7 mt -102.17 105.12 40.95 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.127 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.92 161.17 36.39 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.722 2.281 . . . . 0.0 111.636 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 94.1 mmm -83.7 -1.39 53.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 0.0 110.454 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -141.76 112.93 7.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.1 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.89 -153.7 16.8 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.057 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.45 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 28.8 mmmt -116.1 156.9 46.33 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.563 ' HB3' HG12 ' A' ' 99' ' ' ILE . 59.2 Cg_endo -72.12 151.08 54.98 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.678 2.252 . . . . 0.0 113.721 -175.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -106.62 157.98 17.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.199 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 45.1 ttm -122.63 116.39 23.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.152 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.01 137.91 48.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 173.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.516 ' HG2' ' HA ' ' A' ' 95' ' ' SER . 43.9 mt-30 -123.06 137.97 54.8 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.389 -174.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.665 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 106.77 178.28 22.96 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.407 -0.815 . . . . 0.0 114.457 170.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.595 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -83.01 89.14 6.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.119 0.485 . . . . 0.0 111.814 -174.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.656 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 22.2 ptp -95.64 149.01 35.5 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.974 173.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 97.4 Cg_endo -76.18 -178.36 4.35 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.825 2.35 . . . . 0.0 112.141 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.61 ' HG3' HD11 ' A' ' 63' ' ' LEU . 20.5 ttmm -57.68 -35.51 70.69 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 120.851 0.357 . . . . 0.0 110.133 174.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.65 -52.54 60.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.445 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.656 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 28.5 m -68.61 -35.63 77.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.624 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.503 ' HB3' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -61.89 -46.4 89.54 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.462 176.645 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -62.63 -33.14 74.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.306 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 51.4 tptt -61.47 -42.75 99.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 174.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.61 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.34 -47.94 53.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.711 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.598 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 1.8 mp -70.63 -56.92 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.871 0.367 . . . . 0.0 110.763 -177.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.403 ' HB2' ' OH ' ' A' ' 67' ' ' TYR . 5.1 t70 -73.5 -62.63 1.42 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.549 0.69 . . . . 0.0 110.396 -176.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 3.9 mm-40 -78.12 11.47 2.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.835 -1.075 . . . . 0.0 113.329 -169.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.61 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 71.8 t80 -143.56 -47.5 0.29 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.441 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.598 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 32.5 tp -76.55 -35.03 58.47 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.488 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.2 mt -89.22 -65.56 1.01 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.132 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 113.35 0.1 . . . . 0.0 113.35 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.6 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 2.9 tttm -162.0 175.33 11.92 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.279 0.562 . . . . 0.0 112.299 -175.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 9.9 p -106.7 130.58 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.128 176.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.6 mm -112.24 130.08 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.246 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.568 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 1.8 p80 -90.15 131.83 35.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.565 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.502 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 1.1 pp -131.25 176.1 8.56 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.369 -174.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.0 p -104.53 176.36 5.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.959 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 14.4 pttm -64.19 -30.66 71.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.672 0.273 . . . . 0.0 110.864 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.08 93.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.278 0.561 . . . . 0.0 110.081 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.502 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 2.5 mm-40 -71.92 -38.91 69.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.228 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.86 -49.37 75.69 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.706 175.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.724 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 13.9 mt -57.07 -60.62 3.32 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.253 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.54 -25.45 60.41 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -169.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 4.3 ttpm? -110.05 -16.46 13.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 46.9 t -128.65 -45.24 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -171.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.724 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 17.5 t80 -173.03 132.41 0.51 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 117.925 0.33 . . . . 0.0 111.845 -165.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.684 HD22 HD22 ' A' ' 20' ' ' LEU . 2.5 t-20 -106.79 105.69 15.85 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.589 -177.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.451 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 5.3 p90 -90.5 1.46 56.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -171.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -89.57 -40.69 12.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.663 ' HB3' ' OD1' ' A' ' 25' ' ' ASN . 4.8 tptp -91.29 -24.96 19.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.637 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.689 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -116.42 55.63 1.35 Allowed Pre-proline 0 N--CA 1.48 1.045 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 178.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -62.25 -43.71 22.29 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.246 1.964 . . . . 0.0 111.773 175.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -108.46 -9.26 15.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.18 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.412 ' HB2' ' CB ' ' A' ' 29' ' ' ASN . 67.3 mt-10 -91.59 177.7 6.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.821 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.447 ' HZ3' ' HE1' ' A' ' 88' ' ' PHE . 76.8 t-105 -151.95 88.49 1.4 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.943 0.401 . . . . 0.0 110.195 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -105.83 98.87 8.5 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 26.2 t80 -91.47 118.8 30.88 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.308 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 22' ' ' LYS . 4.4 mm-40 -89.78 125.96 35.5 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.835 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.99 146.14 4.63 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.037 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -91.73 -27.29 18.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.965 0.412 . . . . 0.0 110.279 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -120.08 159.68 46.21 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.852 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.14 145.58 89.4 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.524 2.15 . . . . 0.0 111.937 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -120.05 150.25 40.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.442 0.639 . . . . 0.0 111.99 -175.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.624 ' HB ' HG23 ' A' ' 73' ' ' ILE . 77.1 mt -119.47 116.07 49.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.341 176.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.3 t -103.22 109.15 26.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.75 0.309 . . . . 0.0 111.204 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 8.4 t70 -90.62 113.92 26.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.042 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -87.68 111.21 21.05 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.729 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.3 p90 -132.56 169.47 16.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.818 0.818 . . . . 0.0 111.783 -174.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.63 126.7 24.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.183 167.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.558 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 31.2 t70 -60.02 -35.0 74.12 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.484 -172.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.434 ' HE1' ' HG2' ' A' ' 79' ' ' GLU . 67.0 p-90 -73.89 -0.65 16.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.785 0.326 . . . . 0.0 111.54 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.443 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 47.7 t -101.69 119.54 38.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.965 0.412 . . . . 0.0 110.316 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.65 -56.62 17.12 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.584 -0.734 . . . . 0.0 114.112 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.443 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . 83.7 Cg_exo -47.74 -37.85 28.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.048 2.498 . . . . 0.0 113.444 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.729 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 78.2 m -69.68 -47.01 64.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.939 0.399 . . . . 0.0 111.155 177.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.558 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 53.6 mttm -52.7 -30.15 30.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.466 177.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.533 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 24.7 ptm -88.12 -40.77 13.51 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.924 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.532 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 31.6 m -69.96 -36.85 70.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.576 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.603 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -53.42 -53.16 59.57 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 16.4 Cg_exo -69.05 -34.96 15.72 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.09 1.86 . . . . 0.0 112.428 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.517 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 68.1 mt -63.58 -48.7 85.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.97 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.601 HD13 HG21 ' A' ' 73' ' ' ILE . 4.2 pp -68.7 -30.69 69.4 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.66 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.6 ' OD1' ' HG2' ' A' ' 10' ' ' LYS . 18.7 t70 -64.76 -37.95 89.33 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.25 0.547 . . . . 0.0 109.815 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 7.2 mm-40 -54.63 -50.26 68.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.759 173.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.604 HD21 ' HG3' ' A' ' 114' ' ' LYS . 3.4 mm? -62.5 -31.81 72.62 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.926 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.646 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -63.29 -37.49 87.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.811 0.338 . . . . 0.0 110.456 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.611 ' HB3' ' HZ2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -74.02 -33.92 63.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.505 178.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -41.23 70.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.461 0.648 . . . . 0.0 111.116 176.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.656 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 30.1 m-85 -98.28 27.31 4.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.112 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.41 143.78 14.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.105 0.479 . . . . 0.0 111.432 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.39 -23.77 23.11 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.826 -0.624 . . . . 0.0 113.39 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.656 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 4.2 pt20 -117.28 -24.61 7.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 121' ' ' ILE . 43.6 pt -126.36 145.57 33.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.306 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 68.0 t -120.99 118.75 57.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.646 HD12 ' HB2' ' A' ' 64' ' ' ALA . 14.3 mt -106.89 138.66 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.106 -175.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -123.65 170.37 10.54 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.666 175.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.618 ' HB3' ' HB3' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -152.45 149.42 28.55 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 172.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.24 138.2 55.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.263 0.554 . . . . 0.0 110.863 -174.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 1.2 m-20 -70.7 89.13 0.73 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.095 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.497 HG23 ' HB2' ' A' ' 85' ' ' ALA . 23.9 m -62.52 -37.07 84.63 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -169.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HG2' ' HE1' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -70.6 -21.27 62.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -174.235 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.5 ' NZ ' ' HB3' ' A' ' 77' ' ' ASP . 8.9 ptpp? -106.39 -34.93 7.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.772 0.32 . . . . 0.0 110.224 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -82.75 47.35 1.18 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.989 0.515 . . . . 0.0 110.842 174.421 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -57.99 -38.69 76.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.02 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -69.11 -37.52 78.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.251 0.548 . . . . 0.0 110.166 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.53 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 3.4 tm? -67.1 -46.66 73.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.434 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -61.88 -48.18 81.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.135 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.5 -29.81 67.26 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.05 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.85 -27.4 69.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 0.0 111.399 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.58 ' HB2' HG12 ' A' ' 90' ' ' ILE . 68.1 m-85 -104.03 8.74 36.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.792 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.54 19.99 79.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.212 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.58 HG12 ' HB2' ' A' ' 88' ' ' PHE . 33.9 mm -74.77 108.12 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 120.623 0.249 . . . . 0.0 110.538 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -56.39 -56.37 21.98 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.787 0.803 . . . . 0.0 110.871 174.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.1 p -169.72 -137.63 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.167 -1.378 . . . . 0.0 108.985 -172.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.627 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -131.77 155.35 81.51 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.845 -0.161 . . . . 0.0 110.583 -172.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.611 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 2.9 Cg_exo -84.96 141.5 33.09 Favored 'Cis proline' 0 C--N 1.346 0.431 0 C-N-CA 124.827 -0.906 . . . . 0.0 112.726 -2.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 t -141.47 137.8 32.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 107' ' ' MET . 44.6 mt -131.53 120.11 44.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.691 -174.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.4 tp -100.05 112.03 24.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.373 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -94.31 109.38 21.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.636 HG12 ' HB3' ' A' ' 105' ' ' PRO . 49.6 mt -101.34 106.66 46.81 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.51 -174.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.43 164.89 25.94 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.836 2.357 . . . . 0.0 111.759 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.1 mtp -87.75 -6.31 58.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.421 0.629 . . . . 0.0 109.946 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -133.15 121.68 22.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.239 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.69 -140.84 15.1 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.198 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 31.9 mmtp -132.27 153.27 81.21 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.636 ' HB3' HG12 ' A' ' 99' ' ' ILE . 35.5 Cg_endo -64.45 143.95 83.81 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.913 2.408 . . . . 0.0 113.543 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -104.8 169.75 8.27 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.506 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 35.0 ttm -142.84 101.59 3.88 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -172.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -96.75 134.0 40.59 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 172.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -120.74 136.86 54.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.143 0.497 . . . . 0.0 112.252 -171.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.611 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 102.17 -168.79 19.23 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.455 -0.793 . . . . 0.0 115.005 168.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.532 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -85.55 88.93 7.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.866 -0.667 . . . . 0.0 112.07 -171.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.595 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 23.3 ptt? -107.28 150.35 39.86 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.259 172.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.478 ' HD2' ' OG ' ' A' ' 116' ' ' SER . 84.6 Cg_endo -76.39 -178.09 4.2 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.987 2.458 . . . . 0.0 112.94 -173.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.604 ' HG3' HD21 ' A' ' 63' ' ' LEU . 29.4 ttmt -57.73 -35.21 70.39 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.391 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.12 -48.8 74.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.629 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 30.0 m -66.02 -41.21 91.27 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.592 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.621 ' O ' HG13 ' A' ' 121' ' ' ILE . 11.9 m-85 -58.46 -49.17 78.28 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.692 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -54.59 -48.63 71.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.444 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -66.5 -34.42 77.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.707 0.289 . . . . 0.0 110.93 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -69.68 -44.19 70.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.083 0.468 . . . . 0.0 111.128 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.621 HG13 ' O ' ' A' ' 117' ' ' PHE . 31.2 mt -70.12 -51.72 36.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.267 0.556 . . . . 0.0 110.33 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -64.0 -69.51 0.27 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.019 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 38.4 mt-10 -80.79 12.31 3.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.399 -167.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.461 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 90.8 t80 -140.09 -49.92 0.47 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.398 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 20.2 tp -75.94 -31.58 59.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.682 0.277 . . . . 0.0 110.686 -175.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -106.0 -57.01 2.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.035 0.445 . . . . 0.0 110.3 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.57 ' HB3' ' HA ' ' A' ' 123' ' ' GLU . 2.3 tmmt? . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.574 ' HD3' ' H ' ' A' ' 11' ' ' VAL . 15.1 tppt? -150.96 157.47 42.93 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.095 -0.552 . . . . 0.0 109.533 -173.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 14.1 p -108.78 132.62 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.202 0.525 . . . . 0.0 110.758 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.8 mt -122.88 127.43 74.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.951 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.582 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 1.9 p80 -86.26 143.39 27.95 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.4 pp -137.86 168.84 18.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.966 0.412 . . . . 0.0 111.974 -177.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.615 HG22 ' HZ3' ' A' ' 80' ' ' LYS . 40.3 p -92.48 175.33 6.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.43 174.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.52 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 8.6 ptpp? -64.42 -31.83 73.2 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.663 0.268 . . . . 0.0 111.39 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.37 -39.5 92.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.399 0.618 . . . . 0.0 109.845 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 38.3 mt-10 -72.33 -36.02 68.75 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.155 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.451 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 2.5 t80 -54.06 -53.01 59.0 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.241 1.02 . . . . 0.0 108.995 175.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 17.0 mt -59.02 -60.2 4.25 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.274 -1.784 . . . . 0.0 112.213 -175.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.72 -20.53 27.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -169.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.624 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 35.0 ttpt -109.45 -7.49 15.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.64 0.257 . . . . 0.0 111.415 -174.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 68.8 t -134.79 -49.27 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.771 ' HE2' ' HZ ' ' A' ' 88' ' ' PHE . 1.1 t80 -177.88 125.62 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.298 0.571 . . . . 0.0 110.809 -168.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -92.94 87.31 5.74 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.793 -172.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.543 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 18.6 p90 -75.92 12.14 1.2 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.418 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . 11.2 tm-20 -88.34 -53.43 4.69 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.647 ' C ' HD22 ' A' ' 29' ' ' ASN . 0.0 OUTLIER -92.4 -12.26 32.69 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.353 171.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.647 HD22 ' C ' ' A' ' 28' ' ' LYS . 0.9 OUTLIER -111.68 53.45 0.39 Allowed Pre-proline 0 N--CA 1.478 0.935 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -178.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.439 ' HD2' ' OE1' ' A' ' 31' ' ' GLU . 37.6 Cg_endo -74.68 -35.6 3.38 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 121.947 1.765 . . . . 0.0 111.103 166.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.554 ' OE1' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -100.21 -34.75 9.89 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.586 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.554 ' HG2' ' OE1' ' A' ' 31' ' ' GLU . 7.6 pt-20 -97.92 177.4 5.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.002 -177.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.589 ' CB ' ' HE2' ' A' ' 104' ' ' LYS . 76.3 t-105 -148.05 88.92 1.69 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.227 0.537 . . . . 0.0 110.628 -174.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HG2' ' OE2' ' A' ' 36' ' ' GLU . 61.9 tttm -102.92 104.49 14.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.282 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.559 ' OH ' ' HB2' ' A' ' 41' ' ' ALA . 18.9 t80 -96.79 124.3 40.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.018 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.424 ' OE2' ' HG2' ' A' ' 34' ' ' LYS . 7.1 mm-40 -88.61 93.41 9.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.534 177.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.15 129.56 1.39 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.182 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.8 -27.8 58.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.387 0.613 . . . . 0.0 110.399 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HB2' HG23 ' A' ' 72' ' ' VAL . 66.7 mttm -116.63 155.46 48.8 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.339 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.538 ' HG3' ' HG2' ' A' ' 101' ' ' MET . 36.4 Cg_exo -57.73 150.34 62.72 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.777 2.318 . . . . 0.0 111.79 177.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.559 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -120.49 147.55 44.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.423 0.63 . . . . 0.0 112.111 -173.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.57 ' HB ' HG12 ' A' ' 73' ' ' ILE . 74.7 mt -124.03 112.45 32.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 171.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 46.0 t -109.81 110.78 33.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 121.273 -0.171 . . . . 0.0 111.286 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.589 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 8.2 p-10 -101.06 116.66 33.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.217 1.008 . . . . 0.0 111.821 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.432 ' HB3' ' OG1' ' A' ' 78' ' ' THR . 13.2 m-85 -77.85 112.72 15.02 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.058 170.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.678 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.2 p90 -128.59 162.12 28.03 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.615 0.721 . . . . 0.0 111.844 -176.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.96 137.27 37.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.647 170.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.55 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 25.2 t70 -60.75 -42.06 96.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -171.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -67.66 -13.31 61.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.665 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 49.3 t -85.48 115.1 22.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.87 0.367 . . . . 0.0 110.355 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.92 -57.01 10.4 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.575 -0.738 . . . . 0.0 113.507 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.74 -40.97 31.64 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.068 2.512 . . . . 0.0 113.378 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.678 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 84.9 m -63.51 -45.31 91.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.93 0.395 . . . . 0.0 111.087 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.55 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 65.9 mttm -58.41 -29.6 66.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.073 174.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.506 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 74.3 mtp -74.42 -52.45 12.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.073 0.463 . . . . 0.0 111.234 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 53' ' ' CYS . 14.2 p -70.98 -37.97 70.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.581 -170.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.595 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -52.71 -53.38 54.87 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -176.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 29.9 Cg_exo -62.83 -49.04 5.76 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.94 1.76 . . . . 0.0 112.113 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.5 mt -56.48 -40.46 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.155 0.502 . . . . 0.0 110.897 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.488 HD22 HD13 ' A' ' 73' ' ' ILE . 6.9 mt -68.16 -36.17 79.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.348 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD1' ' HD3' ' A' ' 10' ' ' LYS . 28.3 t70 -68.57 -41.12 80.17 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.29 -54.73 39.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.903 173.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.7 tp -61.78 -31.74 71.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.698 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.623 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -59.53 -46.85 87.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.439 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.624 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 3.6 tmtm? -75.71 -40.29 55.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.422 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -55.67 -31.35 62.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.395 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.434 ' HD2' ' NE2' ' A' ' 70' ' ' GLN . 72.8 m-85 -111.27 25.15 12.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.615 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.426 ' HB2' ' HA ' ' A' ' 65' ' ' LYS . 24.1 t0 -54.13 148.39 11.19 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.736 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.63 -22.11 18.78 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.529 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.434 ' NE2' ' HD2' ' A' ' 67' ' ' TYR . 16.9 mt-30 -95.92 -56.39 2.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.924 0.362 . . . . 0.0 111.206 -175.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -122.69 174.41 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.67 -170.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 43.2 t -131.47 129.09 61.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 174.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 17.0 mt -106.19 135.09 45.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.295 0.569 . . . . 0.0 110.875 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 84.3 m-85 -122.04 163.9 18.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.125 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.589 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -147.33 153.47 39.73 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.045 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.666 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 9.4 p -133.94 144.29 36.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.607 -174.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.415 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 6.0 m-20 -86.6 88.66 7.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 45' ' ' PHE . 7.1 m -60.53 -32.65 71.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -169.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.449 ' HA ' HE21 ' A' ' 82' ' ' GLN . 5.7 mm-40 -54.42 -30.85 53.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.615 ' HZ3' HG22 ' A' ' 15' ' ' THR . 22.3 pttp -107.75 -17.56 14.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.594 0.711 . . . . 0.0 110.187 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.666 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 0.3 OUTLIER -94.56 38.73 1.1 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.12 175.056 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.449 HE21 ' HA ' ' A' ' 79' ' ' GLU . 72.8 mm-40 -66.14 -36.29 82.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.323 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.417 ' HB2' ' HE2' ' A' ' 16' ' ' LYS . 2.5 mp0 -64.32 -34.64 78.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.433 0.635 . . . . 0.0 109.627 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.474 HD13 ' CE2' ' A' ' 26' ' ' PHE . 15.5 tp -70.2 -45.6 66.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.116 177.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.561 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -57.1 -49.47 75.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.879 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.28 -30.05 66.99 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.325 -0.464 . . . . 0.0 113.085 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.81 -32.81 74.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.328 . . . . 0.0 111.37 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.771 ' HZ ' ' HE2' ' A' ' 24' ' ' TYR . 96.6 m-85 -101.4 8.33 42.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.841 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.25 31.62 77.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.892 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.663 ' HA ' ' NH1' ' A' ' 91' ' ' ARG . 42.7 mt -82.26 136.93 21.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.906 0.384 . . . . 0.0 110.394 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.663 ' NH1' ' HA ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -66.52 -50.27 63.74 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t 170.26 -89.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.231 -1.349 . . . . 0.0 107.949 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.527 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -141.35 155.05 67.8 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.757 -178.316 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.753 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.5 Cg_exo -86.71 143.39 28.22 Favored 'Cis proline' 0 C--N 1.343 0.253 0 C-N-CA 124.585 -1.006 . . . . 0.0 111.983 -3.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 59.0 m -141.4 132.02 25.55 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 107' ' ' MET . 64.0 mt -128.49 118.73 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.109 0.481 . . . . 0.0 111.073 -172.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 106' ' ' GLU . 23.9 tp -98.98 114.75 27.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.227 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -94.23 103.11 15.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 61.5 mt -96.42 111.38 56.66 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.431 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 98.3 Cg_endo -84.39 169.64 10.98 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.808 2.339 . . . . 0.0 111.612 174.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.538 ' HG2' ' HG3' ' A' ' 40' ' ' PRO . 95.1 mmm -89.99 -2.29 58.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 0.0 110.534 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -151.81 115.89 4.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.393 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 116.19 -144.71 18.53 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.77 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.589 ' HE2' ' CB ' ' A' ' 33' ' ' TRP . 28.0 mmtp -126.32 151.61 72.63 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.452 ' HG3' ' CH2' ' A' ' 33' ' ' TRP . 85.8 Cg_endo -73.79 148.65 41.57 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.815 2.344 . . . . 0.0 113.322 -175.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.486 ' HG2' ' N ' ' A' ' 107' ' ' MET . 37.4 tt0 -95.23 166.94 11.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.876 178.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.486 ' N ' ' HG2' ' A' ' 106' ' ' GLU . 32.3 tpp -142.68 107.56 4.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.087 0.47 . . . . 0.0 111.491 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.95 157.26 17.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.239 174.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -126.34 135.44 51.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.942 0.401 . . . . 0.0 111.129 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.753 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 107.15 -171.72 17.08 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.679 -0.691 . . . . 0.0 113.381 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.65 81.02 1.4 Allowed 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.542 0.687 . . . . 0.0 110.997 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.701 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 4.5 mpp? -65.49 148.97 97.75 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.329 172.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.401 ' HG2' ' H ' ' A' ' 116' ' ' SER . 73.4 Cg_endo -74.32 172.65 15.64 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.125 1.883 . . . . 0.0 110.772 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -60.03 -24.53 64.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.109 0.48 . . . . 0.0 109.851 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.51 -53.29 44.44 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.238 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.701 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 18.5 m -71.94 -28.73 63.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.486 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -67.56 -40.2 84.92 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.985 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 122' ' ' ASP . 0.8 OUTLIER -58.25 -37.86 75.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -67.58 -51.89 45.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.48 -46.56 89.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.152 0.501 . . . . 0.0 111.284 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.44 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 1.7 mp -67.55 -43.89 86.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.14 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.506 ' HA ' HD12 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -72.44 -55.1 7.57 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.666 -177.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.671 ' HA ' ' HE2' ' A' ' 127' ' ' LYS . 31.9 tt0 -77.25 -8.33 57.41 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -169.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -127.65 -51.74 1.36 Allowed 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.82 -0.55 . . . . 0.0 111.656 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.44 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 32.5 tp -77.71 -29.76 51.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -173.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 122' ' ' ASP . 92.7 mt -96.92 -54.06 3.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.325 0.583 . . . . 0.0 110.009 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.671 ' HE2' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.726 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.071 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 CA--C 1.507 -0.457 0 N-CA-C 112.387 -0.285 . . . . 0.0 112.387 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 163.81 35.15 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -175.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' A' ' 61' ' ' ASP . 26.1 m -89.76 119.15 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.405 0.621 . . . . 0.0 110.874 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.5 mm -111.49 105.34 18.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.925 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.553 ' HA ' ' HB2' ' A' ' 75' ' ' LYS . 19.2 p80 -79.77 129.74 34.74 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.6 pp -143.75 168.57 19.61 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.495 -174.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.0 p -86.79 168.02 13.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.747 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -55.65 -34.23 64.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.656 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.71 -36.45 75.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.322 0.582 . . . . 0.0 110.242 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.665 ' HB3' ' HE2' ' A' ' 22' ' ' LYS . 42.6 mt-10 -72.08 -33.32 67.82 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.52 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -61.81 -49.37 76.58 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.993 0.901 . . . . 0.0 108.872 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.8 tt -46.62 -60.26 2.49 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 113.479 -1.691 . . . . 0.0 111.829 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.33 -24.99 31.88 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -170.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.665 ' HE2' ' HB3' ' A' ' 18' ' ' GLU . 47.5 mtmt -109.31 0.86 19.75 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.388 -0.525 . . . . 0.0 112.146 -173.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -142.68 -49.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 83.6 t80 -164.08 116.68 1.39 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.558 -165.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.423 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -80.67 90.75 5.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.814 -178.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -83.89 9.69 11.53 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 122.148 -0.345 . . . . 0.0 111.825 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -84.95 -54.34 4.71 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.974 0.892 . . . . 0.0 108.683 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.464 ' C ' HD22 ' A' ' 29' ' ' ASN . 7.6 ptpp? -97.54 -12.0 23.07 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.506 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' A' ' 34' ' ' LYS . 1.1 m-80 -123.08 67.46 33.49 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-O 121.184 0.516 . . . . 0.0 110.998 170.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -59.67 -43.18 40.46 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.096 2.531 . . . . 0.0 111.974 171.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -112.82 -25.51 9.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.797 -174.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.567 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -90.72 154.64 19.4 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.135 0.493 . . . . 0.0 110.903 -176.129 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.459 ' HZ3' ' HE1' ' A' ' 88' ' ' PHE . 76.4 t-105 -97.22 111.57 23.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.643 -177.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.627 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -133.32 115.41 14.87 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.63 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 26.9 t80 -103.58 107.23 17.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.87 -176.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.512 ' OE2' ' HG3' ' A' ' 34' ' ' LYS . 1.1 mp0 -95.71 76.61 3.24 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.925 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.63 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -133.76 -136.22 3.67 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.401 -173.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -149.57 -58.79 0.2 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.882 0.372 . . . . 0.0 110.998 -173.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.43 ' HB2' HG23 ' A' ' 72' ' ' VAL . 48.8 mttp -125.5 159.04 62.33 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.966 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.567 ' HB2' HG22 ' A' ' 71' ' ' ILE . 83.8 Cg_exo -42.43 131.36 5.08 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.602 2.201 . . . . 0.0 111.65 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -116.52 150.18 38.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.265 0.555 . . . . 0.0 112.24 -167.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.796 ' HB ' HG12 ' A' ' 73' ' ' ILE . 67.8 mt -127.9 116.88 44.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.882 173.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.639 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 38.5 t -98.84 116.31 41.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 120.825 0.345 . . . . 0.0 110.68 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.521 ' HB2' HD13 ' A' ' 60' ' ' LEU . 7.1 t70 -91.09 110.58 21.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.554 177.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.506 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 97.8 m-85 -94.39 111.65 23.41 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 174.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.656 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.1 p90 -133.58 174.9 9.93 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.547 0.689 . . . . 0.0 111.11 -175.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.97 142.61 22.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.298 173.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.476 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 32.4 t70 -62.03 -28.89 69.91 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -83.38 -1.07 52.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.686 0.279 . . . . 0.0 111.553 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 41.1 t -99.68 113.08 25.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.097 0.475 . . . . 0.0 110.805 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 54' ' ' LYS . . . -58.16 -51.36 58.88 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.472 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 97.6 Cg_exo -47.28 -47.74 16.63 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.896 2.397 . . . . 0.0 113.113 175.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 71.0 m -63.78 -36.66 84.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.908 0.385 . . . . 0.0 111.482 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.476 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 67.5 mttm -56.46 -34.78 67.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.831 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.513 ' SD ' ' HB1' ' A' ' 111' ' ' ALA . 26.9 ptm -91.84 -26.95 18.26 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.793 -175.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.633 HG22 ' HA ' ' A' ' 53' ' ' CYS . 25.1 m -76.71 -31.04 19.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.702 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.433 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -47.69 -58.25 8.06 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 33.7 Cg_endo -65.17 -39.64 22.73 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.75 1.634 . . . . 0.0 112.269 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.2 mt -63.59 -43.62 98.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.226 0.536 . . . . 0.0 110.304 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 44' ' ' ASP . 7.8 mt -57.8 -43.81 85.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.129 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.478 ' HA ' HG13 ' A' ' 11' ' ' VAL . 30.7 t70 -68.12 -37.43 81.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.827 0.346 . . . . 0.0 110.557 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.431 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 3.7 tp10 -59.69 -41.88 91.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.472 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.515 HD21 ' HG3' ' A' ' 114' ' ' LYS . 4.1 mm? -71.24 -31.72 67.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.725 176.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.544 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -56.45 -57.11 13.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.769 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -74.83 -24.61 58.63 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.74 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.08 -33.42 75.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.499 0.666 . . . . 0.0 110.167 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -104.2 25.61 9.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.936 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.546 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 6.4 t0 -59.31 133.91 56.53 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 110.138 -176.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.36 -22.04 34.73 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.769 -176.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -94.97 -53.17 3.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.906 0.384 . . . . 0.0 110.268 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.567 HG22 ' HB2' ' A' ' 40' ' ' PRO . 38.2 pt -127.15 163.5 29.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.216 -176.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 50.9 t -131.01 131.91 63.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.796 HG12 ' HB ' ' A' ' 42' ' ' ILE . 60.3 mt -111.83 133.48 57.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.101 0.477 . . . . 0.0 110.844 -176.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -115.21 160.63 19.49 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 13' ' ' HIS . 44.6 mttm -129.13 136.02 49.64 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.748 0.308 . . . . 0.0 110.902 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.407 HG13 ' HG2' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -138.21 136.89 44.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.665 -178.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 4.4 m-20 -97.32 106.19 18.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.2 p -57.2 -26.97 61.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -67.55 -21.39 65.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.403 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.432 ' HG2' ' HB2' ' A' ' 77' ' ' ASP . 8.5 ptmm? -114.08 -33.67 5.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.448 0.642 . . . . 0.0 109.974 175.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 2.0 mp0 -83.62 36.66 0.55 Allowed 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.979 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -57.27 -47.55 81.14 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.825 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -61.88 -36.76 82.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.377 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.7 tp -70.16 -50.38 40.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.902 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.482 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -63.22 -37.47 87.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.05 -31.36 78.45 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.846 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.02 -33.58 76.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 111.024 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.552 ' HB2' HG12 ' A' ' 90' ' ' ILE . 85.7 m-85 -90.32 -1.24 57.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.18 21.55 75.55 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.01 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.552 HG12 ' HB2' ' A' ' 88' ' ' PHE . 37.3 mm -81.03 126.56 39.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 122.444 0.298 . . . . 0.0 110.67 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -61.99 -64.46 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.047 0.451 . . . . 0.0 110.169 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.9 p -164.6 -101.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.535 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.496 ' HB ' ' HA ' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -142.3 157.75 62.42 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 120.508 0.194 . . . . 0.0 111.383 -173.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.828 ' HB2' ' H ' ' A' ' 110' ' ' GLY . 15.0 Cg_exo -79.66 144.35 70.65 Favored 'Cis proline' 0 N--CA 1.476 0.454 0 C-N-CA 124.241 -1.15 . . . . 0.0 112.162 -3.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 14.8 m -140.91 137.41 33.14 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.662 ' O ' ' HA ' ' A' ' 107' ' ' MET . 66.6 mt -133.13 114.47 21.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.639 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.8 tp -96.45 115.13 26.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 -175.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.432 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 97.3 m-85 -95.23 107.03 19.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.04 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.4 ' HB ' ' HB3' ' A' ' 41' ' ' ALA . 67.5 mt -99.18 105.01 29.76 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -177.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 98' ' ' PHE . 79.4 Cg_endo -88.19 166.03 6.85 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.83 2.353 . . . . 0.0 111.988 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 20.0 mmt -89.86 -6.24 56.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.96 0.41 . . . . 0.0 110.381 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.92 104.96 5.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.876 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.26 -151.38 18.32 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.251 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.437 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 12.1 mmmm -121.1 154.4 58.24 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 104' ' ' LYS . 56.8 Cg_endo -68.85 151.15 74.1 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.976 2.451 . . . . 0.0 114.576 -171.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -104.83 169.45 8.44 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.175 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.662 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 21.3 ptp -143.84 129.62 19.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.688 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.41 140.21 50.21 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -119.93 138.27 53.55 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.495 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.828 ' H ' ' HB2' ' A' ' 94' ' ' PRO . . . 105.04 -178.4 23.64 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.715 -0.675 . . . . 0.0 114.682 170.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.513 ' HB1' ' SD ' ' A' ' 55' ' ' MET . . . -90.75 86.34 6.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.036 -0.582 . . . . 0.0 111.53 -173.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.579 ' HB2' ' HB3' ' A' ' 116' ' ' SER . 23.5 ptp -92.47 151.6 41.43 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.784 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.781 ' HD2' ' HB3' ' A' ' 116' ' ' SER . 85.5 Cg_endo -75.73 177.16 9.06 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.58 2.187 . . . . 0.0 112.129 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.515 ' HG3' HD21 ' A' ' 63' ' ' LEU . 62.9 tttm -57.82 -35.57 71.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.494 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.45 -47.71 59.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.818 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.781 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 47.8 t -66.85 -30.47 70.65 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.336 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.489 ' O ' HG13 ' A' ' 121' ' ' ILE . 3.4 m-85 -58.58 -53.21 60.88 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 173.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -56.82 -42.79 80.22 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.622 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -53.83 -48.35 70.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.022 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.12 -42.75 68.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.408 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 117' ' ' PHE . 68.0 mt -66.72 -55.33 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.088 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.61 -65.34 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.562 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -48.48 -42.18 32.01 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -172.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -104.52 -47.22 4.15 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -171.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 23.9 tp -77.69 -38.73 46.82 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -169.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.6 mp -105.85 -42.8 5.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.097 0.475 . . . . 0.0 111.094 -176.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 37.7 tttm . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.858 -176.233 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . . . . . . 0 CA--C 1.509 -0.33 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.444 ' HE2' HD11 ' A' ' 12' ' ' ILE . 11.8 ptmt -156.05 155.75 33.19 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 121.126 0.489 . . . . 0.0 110.604 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 6.4 p -112.13 116.46 52.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.904 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.444 HD11 ' HE2' ' A' ' 10' ' ' LYS . 45.3 mm -102.96 115.49 45.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.117 -175.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.656 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 0.6 OUTLIER -85.19 125.43 32.84 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.248 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.7 pp -136.31 168.47 19.36 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.364 -173.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.0 p -102.87 177.12 4.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.114 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.412 ' HB2' ' HZ ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -58.62 -28.31 65.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.82 -43.28 99.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.181 0.515 . . . . 0.0 110.568 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 3.4 mm-40 -71.9 -36.14 69.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.031 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.45 -54.06 50.12 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.587 177.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.653 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 12.5 mt -51.0 -61.02 2.48 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.001 -1.454 . . . . 0.0 112.164 -176.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.18 -31.49 60.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -167.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -108.85 -20.29 13.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 95.9 t -119.43 -45.77 2.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -171.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.653 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 21.6 t80 -169.86 116.62 0.56 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.167 0.508 . . . . 0.0 111.344 -166.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.446 HD22 HD22 ' A' ' 20' ' ' LEU . 2.5 t-20 -89.54 90.32 8.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.708 -178.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.465 ' CE2' HD13 ' A' ' 84' ' ' LEU . 31.9 p90 -82.53 -2.25 52.98 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.41 ' HG3' ' CD2' ' A' ' 20' ' ' LEU . 15.2 mt-10 -70.64 -53.24 16.61 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.93 0.871 . . . . 0.0 108.698 174.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -100.13 -14.88 18.37 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.817 -172.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.419 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 12.7 m-80 -126.75 59.39 33.83 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 29' ' ' ASN . 10.5 Cg_endo -60.12 -30.14 90.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.396 2.731 . . . . 0.0 111.551 167.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -97.66 -41.22 8.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.776 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -94.91 149.6 21.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.204 -173.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.769 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 60.9 t-105 -108.29 109.56 20.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.044 176.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.92 103.17 6.17 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.299 176.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 50.5 t80 -86.22 131.67 34.18 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.207 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.429 ' HA ' ' OE1' ' A' ' 36' ' ' GLU . 14.6 mm-40 -112.1 -167.18 1.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.93 -119.61 3.36 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.787 -1.197 . . . . 0.0 112.991 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -158.92 -50.78 0.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.291 0.567 . . . . 0.0 109.815 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.588 ' HB2' HG23 ' A' ' 72' ' ' VAL . 48.7 mttp -121.76 168.78 10.55 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.864 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.61 ' HB3' HD11 ' A' ' 125' ' ' LEU . 33.1 Cg_exo -60.86 158.99 30.89 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.602 2.201 . . . . 0.0 111.534 173.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -127.61 142.31 51.39 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -169.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.558 ' HB ' HG12 ' A' ' 73' ' ' ILE . 44.0 mm -117.13 110.21 30.44 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.228 168.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 67.8 t -110.7 113.12 43.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 118.032 0.378 . . . . 0.0 111.523 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.666 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 5.8 p-10 -100.38 119.47 38.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.287 1.041 . . . . 0.0 111.477 176.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -77.02 113.87 15.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.297 -1.32 . . . . 0.0 108.84 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.678 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.4 p90 -130.98 168.28 17.62 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.29 0.567 . . . . 0.0 111.169 -176.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.09 135.89 19.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.439 174.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.418 ' O ' ' HE3' ' A' ' 54' ' ' LYS . 27.0 t70 -66.99 -33.13 74.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.761 0.315 . . . . 0.0 111.718 -173.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -71.89 -6.63 43.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.906 0.384 . . . . 0.0 111.236 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.423 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 37.4 t -113.34 113.64 25.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.101 0.477 . . . . 0.0 110.124 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.68 -53.11 41.15 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 119.263 -0.743 . . . . 0.0 113.975 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.423 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 84.3 Cg_exo -47.52 -31.41 13.7 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.099 2.533 . . . . 0.0 114.126 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.678 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 45.3 m -73.94 -45.11 52.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.855 0.36 . . . . 0.0 111.127 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 48' ' ' ASP . 15.1 ptpt -77.15 -27.4 53.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.129 0.49 . . . . 0.0 109.808 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.0 tmm? -51.47 -39.96 58.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.166 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.7 m -88.06 -15.99 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.881 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.7 -52.36 57.19 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.32 -33.68 37.88 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 121.766 1.644 . . . . 0.0 112.216 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 113' ' ' PRO . 92.5 mt -65.44 -44.49 94.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.524 0.678 . . . . 0.0 109.899 175.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.1 mt -67.98 -31.22 70.78 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.123 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -60.82 -48.27 82.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.171 0.51 . . . . 0.0 109.932 170.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -54.81 -46.52 74.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.154 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.821 HD23 HD12 ' A' ' 121' ' ' ILE . 7.7 mp -67.15 -31.25 71.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.363 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.454 ' O ' ' HA2' ' A' ' 9' ' ' GLY . . . -59.38 -42.09 90.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.765 0.317 . . . . 0.0 110.582 177.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -72.39 -49.67 32.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.313 0.577 . . . . 0.0 109.938 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -53.12 -35.79 60.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.705 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.579 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 45.0 m-85 -107.2 26.51 10.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.555 -178.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.36 153.92 42.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.268 0.556 . . . . 0.0 111.217 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.51 -18.58 28.54 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.508 -0.769 . . . . 0.0 113.496 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 4.2 pt20 -121.65 -53.42 1.99 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -171.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 67' ' ' TYR . 40.8 pt -128.35 156.39 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 118.313 0.506 . . . . 0.0 112.199 -174.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.588 HG23 ' HB2' ' A' ' 39' ' ' LYS . 6.8 t -111.91 144.71 19.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.851 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 68.5 mt -112.59 128.99 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.139 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 36.3 m-85 -117.15 159.72 22.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.666 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -140.88 144.73 35.42 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.188 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.557 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 7.4 p -122.03 136.16 59.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.274 0.559 . . . . 0.0 111.057 -173.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.587 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 1.1 m-20 -73.56 87.08 1.61 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.962 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.528 HG23 ' HB2' ' A' ' 85' ' ' ALA . 4.4 m -65.5 -31.64 72.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -167.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.41 ' HG3' ' H ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -69.92 -18.19 63.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.228 -0.295 . . . . 0.0 111.662 -178.546 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.567 ' NZ ' ' HB3' ' A' ' 77' ' ' ASP . 8.7 ptpp? -110.32 -26.81 9.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.519 0.675 . . . . 0.0 110.033 175.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -89.47 42.73 1.1 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.669 172.318 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -64.48 -41.47 96.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.205 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -31.15 67.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.473 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.482 HD23 HG21 ' A' ' 76' ' ' VAL . 27.4 tp -66.79 -46.39 75.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.067 174.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.55 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -63.64 -43.01 98.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.967 177.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.69 -29.15 69.28 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.701 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.82 -32.21 73.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.903 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -89.28 -16.42 31.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.781 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.89 20.44 28.52 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.097 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.55 ' HB ' ' HB1' ' A' ' 85' ' ' ALA . 35.6 mm -80.51 135.89 24.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -69.22 -62.82 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.157 0.503 . . . . 0.0 110.215 177.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.506 ' O ' HG21 ' A' ' 78' ' ' THR . 36.2 m -156.25 -88.44 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.615 176.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.656 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 1.8 pp -160.19 154.9 20.64 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.608 -172.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -97.11 144.88 5.7 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 124.548 -1.022 . . . . 0.0 112.215 -2.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.714 ' HB3' ' SD ' ' A' ' 107' ' ' MET . 61.3 m -141.07 143.26 34.25 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.411 HD12 ' C ' ' A' ' 95' ' ' SER . 3.7 mp -127.96 121.78 57.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.332 0.587 . . . . 0.0 110.734 -175.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.1 tp -98.02 112.5 24.42 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.764 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.594 ' HE2' ' HB3' ' A' ' 108' ' ' ALA . 93.1 m-85 -90.14 104.03 16.65 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.567 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 64.9 mt -101.73 113.51 65.82 Favored Pre-proline 0 C--O 1.235 0.312 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -169.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -87.47 174.64 4.95 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.124 2.549 . . . . 0.0 111.725 171.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.9 mmt -97.7 -24.73 15.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.251 0.548 . . . . 0.0 110.362 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.78 21.98 16.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.376 -171.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 178.62 -176.29 47.9 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.172 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.769 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 14.3 mptt -77.19 149.98 79.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.584 0.231 . . . . 0.0 110.689 177.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.567 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 91.1 Cg_endo -82.54 155.23 16.08 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.925 2.417 . . . . 0.0 113.068 -176.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -104.09 168.27 9.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.466 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.714 ' SD ' ' HB3' ' A' ' 95' ' ' SER . 27.2 tpp -132.59 124.15 27.82 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.608 -174.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.594 ' HB3' ' HE2' ' A' ' 98' ' ' PHE . . . -130.89 129.32 42.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.438 174.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 95' ' ' SER . 86.0 mt-30 -74.01 151.49 40.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.806 0.336 . . . . 0.0 110.977 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.79 -153.61 3.58 Favored Glycine 0 C--O 1.227 -0.336 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 -168.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 69.62 19.64 7.29 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.496 0.718 . . . . 0.0 111.025 -174.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.642 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 76.0 mtm -89.98 147.35 37.06 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.376 177.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.431 ' HA ' HD13 ' A' ' 59' ' ' ILE . 72.2 Cg_endo -75.74 -174.85 2.18 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.411 2.074 . . . . 0.0 110.782 175.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.534 ' HG3' HD11 ' A' ' 63' ' ' LEU . 19.5 ttmt -56.83 -41.98 78.81 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.57 173.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.12 -51.96 67.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.642 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 19.8 m -69.51 -36.91 76.91 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.986 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.572 ' O ' HG13 ' A' ' 121' ' ' ILE . 3.5 m-85 -65.47 -52.24 54.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.935 0.398 . . . . 0.0 110.414 175.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 114' ' ' LYS . 2.8 tmtm? -55.71 -44.1 77.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.103 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.501 ' HG3' ' OE2' ' A' ' 123' ' ' GLU . 28.1 tptp -56.57 -57.12 13.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.326 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.15 90.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.145 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.821 HD12 HD23 ' A' ' 63' ' ' LEU . 23.8 mt -67.71 -50.75 57.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 0.0 110.715 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.66 -56.35 14.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.834 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.696 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . 9.1 pt-20 -76.04 6.96 4.53 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.731 0.644 . . . . 0.0 112.688 -169.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -131.74 -48.19 0.96 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.4 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' A' ' 40' ' ' PRO . 31.1 tp -82.56 -46.26 13.58 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.413 -174.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.45 HD11 ' CE1' ' A' ' 67' ' ' TYR . 72.7 mt -81.32 -60.0 2.43 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.696 ' HG3' ' HA ' ' A' ' 123' ' ' GLU . 8.2 ptpp? . . . . . 0 N--CA 1.44 -0.966 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.346 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 CA-C-O 120.028 -0.318 . . . . 0.0 113.762 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.69 166.85 19.66 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 122.017 0.913 . . . . 0.0 112.879 178.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.743 HG13 HG22 ' A' ' 73' ' ' ILE . 42.0 t -110.61 115.04 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.421 170.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.402 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 50.0 mm -80.8 99.18 4.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.023 0.439 . . . . 0.0 110.546 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 14.4 p80 -74.09 112.68 10.47 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 171.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.809 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.8 pp -139.42 -179.88 6.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -167.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.3 p -109.25 177.73 4.66 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.582 173.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.576 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -59.5 -27.32 66.04 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 117.598 0.181 . . . . 0.0 111.221 -178.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.87 -39.78 76.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.287 0.565 . . . . 0.0 110.592 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.809 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 5.2 mm-40 -72.13 -35.88 69.23 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.519 175.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.421 ' CG ' HD11 ' A' ' 84' ' ' LEU . 13.8 t80 -61.23 -45.33 94.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 122.173 0.987 . . . . 0.0 108.588 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.686 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.7 tt -46.83 -61.05 2.03 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 113.19 -1.823 . . . . 0.0 111.868 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.81 -13.25 51.66 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -170.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -109.49 -18.94 13.4 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 47.2 t -133.66 -45.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -171.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.686 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 9.5 t80 -161.32 115.38 1.99 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.232 0.539 . . . . 0.0 111.622 -167.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.433 ' ND2' HD21 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -91.91 95.51 9.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.602 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.423 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 6.2 p90 -73.89 7.38 2.61 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -97.55 -17.36 19.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.881 0.372 . . . . 0.0 110.27 170.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -90.38 -34.26 15.73 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.205 0.526 . . . . 0.0 110.296 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.752 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -147.98 62.08 6.49 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.289 -175.527 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 29' ' ' ASN . 4.8 Cg_exo -44.03 -35.28 7.31 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 124.907 3.738 . . . . 0.0 112.771 170.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -103.46 -30.87 10.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.77 -176.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.78 178.55 5.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.47 0.652 . . . . 0.0 112.017 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.564 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 59.2 t-105 -123.14 104.92 9.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.947 175.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -119.12 105.79 11.74 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.483 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.549 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 38.2 t80 -72.09 123.48 22.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.342 178.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -97.15 15.61 22.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.371 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -98.98 -152.28 27.43 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.759 -173.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -124.79 -52.57 1.68 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 111.196 -172.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.559 ' HB2' HG23 ' A' ' 72' ' ' VAL . 36.5 mttm -113.35 165.27 13.66 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.493 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.546 ' HB3' HD11 ' A' ' 125' ' ' LEU . 73.8 Cg_exo -47.77 131.74 20.64 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.158 1.905 . . . . 0.0 110.972 172.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -113.09 143.57 44.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.292 0.568 . . . . 0.0 111.811 -170.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.616 ' HB ' HG12 ' A' ' 73' ' ' ILE . 61.3 mt -130.26 110.4 19.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.034 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.571 HG23 ' HB2' ' A' ' 74' ' ' TYR . 8.3 p -111.76 134.52 53.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.545 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 2.4 t70 -100.72 118.96 37.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.492 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.445 ' O ' HG22 ' A' ' 93' ' ' ILE . 97.3 m-85 -95.85 112.58 24.27 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.676 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 10.7 p90 -127.28 173.98 9.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.815 0.817 . . . . 0.0 111.762 -175.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.28 120.03 5.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 113.53 -1.668 . . . . 0.0 107.352 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.18 -34.7 68.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -169.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -67.86 -12.88 61.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.865 0.364 . . . . 0.0 111.383 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.51 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 42.4 t -99.01 117.3 33.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.805 0.336 . . . . 0.0 110.427 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.02 -54.62 22.09 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.701 -0.681 . . . . 0.0 114.21 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.51 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 81.6 Cg_exo -47.59 -36.68 25.32 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.025 2.484 . . . . 0.0 114.034 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.676 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 61.5 m -68.21 -31.86 71.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.205 0.526 . . . . 0.0 111.196 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -63.85 -28.63 69.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.857 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.535 ' O ' HD13 ' A' ' 59' ' ' ILE . 41.4 mmm -76.16 -42.97 44.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.106 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 53' ' ' CYS . 6.5 p -75.29 -39.18 42.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -173.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.52 -55.4 19.47 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.04 -46.2 6.56 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.075 1.85 . . . . 0.0 112.446 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.535 HD13 ' O ' ' A' ' 55' ' ' MET . 1.8 mp -55.71 -42.08 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 121.301 0.572 . . . . 0.0 110.333 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -58.68 -39.03 79.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.592 176.152 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.546 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 33.0 t70 -69.19 -42.64 75.55 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.662 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 66' ' ' GLU . 43.4 mt-10 -54.13 -55.22 29.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.371 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.578 HD11 ' HG3' ' A' ' 114' ' ' LYS . 10.9 mp -61.23 -30.67 70.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.3 -178.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 61' ' ' ASP . . . -53.55 -56.56 16.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.081 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.546 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -77.96 -29.23 49.7 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.132 178.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 57.9 mt-10 -66.15 -38.06 87.19 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.93 0.395 . . . . 0.0 111.63 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -105.47 19.33 20.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.037 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.54 ' HB2' ' HA ' ' A' ' 65' ' ' LYS . 33.5 t0 -59.24 157.49 10.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.552 0.692 . . . . 0.0 112.82 -170.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.58 -32.8 7.14 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.428 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.597 ' HG3' HG23 ' A' ' 71' ' ' ILE . 23.6 pt20 -111.91 -35.14 5.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -174.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.597 HG23 ' HG3' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -119.44 162.47 17.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.503 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.559 HG23 ' HB2' ' A' ' 39' ' ' LYS . 40.7 t -125.34 129.29 73.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.743 HG22 HG13 ' A' ' 11' ' ' VAL . 26.7 mt -107.57 142.15 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.03 -176.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.571 ' HB2' HG23 ' A' ' 43' ' ' VAL . 44.0 m-85 -127.08 166.69 17.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.981 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.551 ' HG2' HG12 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -155.11 146.32 22.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.757 0.313 . . . . 0.0 110.219 171.321 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.673 HG21 ' HG2' ' A' ' 81' ' ' GLU . 8.1 p -152.33 159.94 3.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.396 -172.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.604 ' HB2' ' HG2' ' A' ' 80' ' ' LYS . 10.7 m-20 -99.46 111.85 24.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.844 -0.162 . . . . 0.0 110.736 -175.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.713 HG21 ' HA ' ' A' ' 92' ' ' SER . 59.6 m -57.21 -31.52 65.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.01 0.433 . . . . 0.0 111.695 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.87 -33.19 71.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.751 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.604 ' HG2' ' HB2' ' A' ' 77' ' ' ASP . 11.5 ptpt -102.04 -27.57 12.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.416 0.627 . . . . 0.0 109.669 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.673 ' HG2' HG21 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -93.91 46.21 1.17 Allowed 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.25 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.61 -35.89 81.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.475 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.78 -40.39 84.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.245 0.545 . . . . 0.0 109.669 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.421 HD11 ' CG ' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -62.47 -47.62 83.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.375 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.639 ' HB2' HG23 ' A' ' 78' ' ' THR . . . -66.03 -46.0 79.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.491 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.27 -29.67 71.96 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.151 -176.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.78 -35.34 79.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.895 0.378 . . . . 0.0 111.459 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.463 ' HB2' HG13 ' A' ' 90' ' ' ILE . 97.1 m-85 -100.09 7.64 44.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.408 -177.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.24 32.54 84.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.0 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' A' ' 85' ' ' ALA . 39.5 mt -75.13 128.22 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -52.04 -64.37 0.84 Allowed 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.563 0.539 . . . . 0.0 110.25 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.713 ' HA ' HG21 ' A' ' 78' ' ' THR . 23.2 p -179.66 -85.45 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.558 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.463 ' O ' HD12 ' A' ' 93' ' ' ILE . 1.9 pp -156.26 148.24 17.36 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.622 -176.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.658 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 13.7 Cg_exo -78.89 148.68 83.29 Favored 'Cis proline' 0 N--CA 1.477 0.544 0 C-N-CA 124.856 -0.893 . . . . 0.0 112.395 -2.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.401 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 67.7 m -142.8 139.21 30.87 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.6 127.96 62.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 122.113 -0.367 . . . . 0.0 110.034 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.531 ' CB ' HG12 ' A' ' 43' ' ' VAL . 2.6 tp -97.05 127.89 43.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.629 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -108.74 100.19 9.46 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 105' ' ' PRO . 50.3 mt -101.23 104.91 36.2 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.18 -172.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.62 158.79 22.0 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.39 2.06 . . . . 0.0 111.088 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.3 mmm -76.9 -26.84 54.59 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 175.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -102.44 103.84 14.26 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.053 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.38 -141.97 15.91 Favored Glycine 0 C--N 1.315 -0.626 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.446 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.564 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 21.8 mmmt -124.07 163.57 34.88 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.566 ' HB3' HG12 ' A' ' 99' ' ' ILE . 84.9 Cg_endo -82.45 140.03 10.55 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.359 2.039 . . . . 0.0 114.205 -173.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.49 171.24 9.03 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.111 173.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 41.8 ttm -142.89 135.22 27.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.811 -177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.32 157.34 30.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 169.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -137.67 130.57 30.18 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.135 -0.626 . . . . 0.0 112.385 -175.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.658 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 117.78 -176.21 16.05 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.178 -0.919 . . . . 0.0 113.985 169.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -83.9 86.98 7.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.39 0.614 . . . . 0.0 110.604 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.545 ' HB2' ' HB3' ' A' ' 116' ' ' SER . 7.5 ptm -103.98 141.23 22.08 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.625 175.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 116' ' ' SER . 91.1 Cg_endo -75.24 177.3 8.81 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.59 2.193 . . . . 0.0 112.687 -173.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.578 ' HG3' HD11 ' A' ' 63' ' ' LEU . 37.8 ttmt -58.2 -30.47 66.49 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.262 175.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.7 -49.56 68.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.202 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.545 ' HB3' ' HB2' ' A' ' 112' ' ' MET . 17.0 t -67.74 -33.37 74.73 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.569 -0.453 . . . . 0.0 110.051 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.437 ' HB3' HD21 ' A' ' 63' ' ' LEU . 5.6 m-85 -72.52 -29.59 63.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.186 176.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.516 ' C ' ' HD3' ' A' ' 118' ' ' LYS . 12.7 tmtt? -56.44 -50.3 72.07 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.514 ' HG2' ' OE2' ' A' ' 123' ' ' GLU . 54.9 mttm -66.61 -38.23 86.52 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.539 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.651 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -66.74 -45.9 77.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.987 0.423 . . . . 0.0 111.402 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.502 HG13 HD13 ' A' ' 42' ' ' ILE . 1.6 mp -75.95 -56.03 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.052 0.453 . . . . 0.0 110.968 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.547 ' HA ' HD13 ' A' ' 126' ' ' LEU . 25.7 t70 -72.6 -60.55 2.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.566 -174.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.514 ' OE2' ' HG2' ' A' ' 119' ' ' LYS . 50.1 mt-10 -80.34 11.57 3.51 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -170.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.651 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 69.6 t80 -138.11 -42.57 0.52 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.568 0.211 . . . . 0.0 111.568 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.546 HD11 ' HB3' ' A' ' 40' ' ' PRO . 26.6 tp -90.53 -37.93 13.54 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.89 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.547 HD13 ' HA ' ' A' ' 122' ' ' ASP . 10.8 mp -78.13 -48.47 15.88 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.5 tptm . . . . . 0 C--N 1.322 -0.607 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 168.179 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.652 ' CA ' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 CA--C 1.507 -0.415 0 N-CA-C 115.096 0.798 . . . . 0.0 115.096 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.463 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 1.3 ptpp? -168.52 173.39 7.51 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 117.035 0.417 . . . . 0.0 110.155 176.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 19.4 m -109.13 133.41 54.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.322 -174.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.0 mm -103.09 98.48 6.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.608 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -72.97 111.6 8.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 173.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.868 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.9 pp -140.21 179.15 6.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -168.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.0 p -109.74 177.94 4.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.599 173.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.554 ' HA ' ' HB2' ' A' ' 19' ' ' PHE . 14.8 pttm -59.04 -23.2 61.77 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.9 -48.9 72.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.375 0.607 . . . . 0.0 110.257 176.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.868 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 6.1 mp0 -71.54 -34.19 69.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.761 177.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.554 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 2.0 t80 -54.36 -48.58 71.32 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 122.266 1.031 . . . . 0.0 109.224 174.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.543 HD22 HD22 ' A' ' 25' ' ' ASN . 2.9 mt -52.43 -59.77 4.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.161 -1.836 . . . . 0.0 111.153 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.94 -27.67 49.38 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -104.41 -14.18 15.82 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -173.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 21.4 t -126.9 -49.21 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.51 -0.476 . . . . 0.0 112.104 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 14.3 t80 -163.72 115.74 1.42 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.168 0.508 . . . . 0.0 110.66 -170.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.543 HD22 HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -90.45 90.07 7.86 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.921 -176.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.551 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 23.9 p90 -90.58 22.1 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.46 -29.47 9.21 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.873 171.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.708 ' C ' HD22 ' A' ' 29' ' ' ASN . 6.5 ptpp? -106.77 -16.61 14.44 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.769 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.708 HD22 ' C ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -120.85 63.38 11.1 Favored Pre-proline 0 N--CA 1.474 0.739 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.0 174.343 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.453 ' HG2' ' OE1' ' A' ' 31' ' ' GLU . 12.0 Cg_endo -65.68 -44.98 7.29 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.437 2.091 . . . . 0.0 112.509 173.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.453 ' OE1' ' HG2' ' A' ' 30' ' ' PRO . 25.6 mp0 -88.41 -26.15 22.3 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.005 0.431 . . . . 0.0 110.88 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.28 147.99 22.65 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.202 0.525 . . . . 0.0 111.423 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.658 ' HD1' ' HZ1' ' A' ' 104' ' ' LYS . 35.7 t-105 -109.15 103.5 12.5 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 164.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -119.02 124.25 46.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.046 173.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.543 ' OH ' ' HB2' ' A' ' 41' ' ' ALA . 18.3 t80 -85.17 108.8 17.88 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.4 0.45 33.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.147 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.46 162.63 36.52 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -93.1 -42.42 9.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.758 0.779 . . . . 0.0 111.76 -175.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.524 ' HB2' HG23 ' A' ' 72' ' ' VAL . 44.2 mttp -102.27 147.86 34.58 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 122.355 -0.215 . . . . 0.0 110.636 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -42.97 136.55 4.84 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.656 2.904 . . . . 0.0 112.818 176.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.543 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -119.07 149.01 42.39 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -170.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.9 ' HB ' HG12 ' A' ' 73' ' ' ILE . 45.3 mm -120.37 115.41 47.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.439 171.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.4 t -100.13 117.12 44.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.699 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.841 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 14.9 t70 -96.59 106.62 18.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.356 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.543 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 77.5 m-85 -94.65 112.13 23.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.434 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.641 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 52.3 p90 -134.7 176.31 8.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.611 0.72 . . . . 0.0 111.477 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.497 ' HB3' HD13 ' A' ' 93' ' ' ILE . . . -149.89 127.48 11.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.891 170.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.603 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 26.3 t70 -61.39 -24.83 66.77 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -168.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 55.6 p-90 -72.63 -9.36 58.51 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.747 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.569 ' HB3' ' SG ' ' A' ' 53' ' ' CYS . 26.0 t -105.74 137.68 43.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.057 0.456 . . . . 0.0 111.396 -174.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.404 ' N ' ' HD2' ' A' ' 52' ' ' PRO . . . -57.94 -62.01 6.79 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.336 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 51' ' ' GLY . 9.3 Cg_endo -55.33 -26.92 55.03 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.105 2.537 . . . . 0.0 112.831 -178.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.641 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 70.7 m -66.45 -50.61 62.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.079 0.466 . . . . 0.0 110.31 174.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.603 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 67.8 mttm -59.07 -29.88 67.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.833 175.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 84.5 mtp -66.29 -53.31 38.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.614 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.9 m -82.96 -34.52 11.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -170.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -47.16 -61.28 2.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -175.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 38.0 Cg_endo -66.43 -33.22 38.34 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.581 1.521 . . . . 0.0 112.078 -175.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.6 mt -66.46 -38.41 81.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.613 HD21 ' CZ ' ' A' ' 117' ' ' PHE . 0.8 OUTLIER -67.37 -39.91 85.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.845 177.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.579 ' OD2' HG21 ' A' ' 11' ' ' VAL . 1.2 m-20 -61.26 -49.78 75.72 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-O 121.869 0.842 . . . . 0.0 109.557 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.474 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 42.8 tt0 -62.17 -46.87 87.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.193 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.496 HD13 ' HG3' ' A' ' 114' ' ' LYS . 12.8 tp -61.14 -31.15 70.87 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -177.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.522 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -60.68 -54.16 48.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.023 177.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -73.25 -24.76 60.51 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.959 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.8 -38.66 75.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.257 0.551 . . . . 0.0 110.753 174.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -103.44 27.36 7.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.153 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.652 ' HA ' ' CA ' ' A' ' 9' ' ' GLY . 10.1 t70 -52.21 129.62 28.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.141 0.496 . . . . 0.0 110.773 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.08 -42.19 1.92 Allowed Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.46 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -101.19 -47.81 4.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -173.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.8 pt -117.82 164.52 14.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.647 -171.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.524 HG23 ' HB2' ' A' ' 39' ' ' LYS . 14.5 t -128.34 139.12 52.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.189 176.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.9 HG12 ' HB ' ' A' ' 42' ' ' ILE . 53.9 mt -122.89 121.13 62.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.639 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -101.77 159.09 15.63 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.841 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 30.3 mttm -143.76 145.65 32.55 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.621 -176.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.486 HG21 ' HG2' ' A' ' 81' ' ' GLU . 9.8 p -156.15 156.02 5.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -177.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.798 ' HB3' ' HG2' ' A' ' 80' ' ' LYS . 11.3 t70 -98.27 116.76 31.17 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.481 HG23 ' HB3' ' A' ' 45' ' ' PHE . 21.0 p -63.69 -35.2 79.77 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -68.25 -31.69 71.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.798 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 4.5 mmtm -74.83 -55.14 6.12 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.486 ' HG2' HG21 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -87.52 57.92 4.67 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 113.608 -1.633 . . . . 0.0 112.278 -174.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -56.48 -46.02 80.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.75 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -68.98 -38.25 79.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.984 0.421 . . . . 0.0 110.572 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.441 ' CB ' ' HG3' ' A' ' 81' ' ' GLU . 3.0 tm? -66.86 -43.46 83.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.81 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -64.62 -47.05 80.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.894 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.22 -32.6 81.22 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.723 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.49 -27.51 68.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.701 0.286 . . . . 0.0 111.751 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -104.29 7.03 35.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.618 0.247 . . . . 0.0 111.271 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.98 22.26 79.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.381 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 85' ' ' ALA . 23.6 mt -72.74 119.75 20.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -62.04 -46.68 88.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.745 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.4 p -179.23 -93.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.535 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.588 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 2.7 pt -152.66 147.62 19.54 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -168.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -95.31 134.1 4.89 Favored 'Cis proline' 0 N--CA 1.46 -0.458 0 C-N-CA 124.3 -1.125 . . . . 0.0 111.34 -3.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 17.2 t -108.26 146.76 32.39 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.561 HD13 ' CE1' ' A' ' 117' ' ' PHE . 27.6 mt -136.55 114.91 14.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.789 0.328 . . . . 0.0 110.146 -176.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.0 tp -103.28 116.7 32.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.4 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -93.32 103.83 16.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.457 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.46 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 41.9 mt -103.8 106.84 54.48 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -173.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.33 148.57 13.02 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.892 2.395 . . . . 0.0 111.625 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -42.26 99.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.25 0.548 . . . . 0.0 110.67 175.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -99.37 105.77 17.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.302 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.495 ' C ' ' HD2' ' A' ' 104' ' ' LYS . . . 114.53 -146.82 18.78 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.284 177.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.658 ' HZ1' ' HD1' ' A' ' 33' ' ' TRP . 0.8 OUTLIER -128.27 159.69 65.97 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.303 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.469 ' HG3' ' CZ2' ' A' ' 33' ' ' TRP . 97.0 Cg_endo -81.25 152.23 18.18 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.753 2.302 . . . . 0.0 113.838 -170.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -110.02 166.81 10.65 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.642 172.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 43.3 ttm -137.11 140.51 41.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.247 0.546 . . . . 0.0 112.118 -172.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -133.52 157.19 46.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.948 172.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -96.52 150.41 20.66 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.56 -142.72 1.36 Allowed Glycine 0 CA--C 1.518 0.23 0 N-CA-C 114.628 0.611 . . . . 0.0 114.628 -171.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 71.86 18.68 5.02 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.622 0.769 . . . . 0.0 111.441 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.503 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 23.0 ptt? -117.37 154.2 50.3 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.46 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.28 178.39 7.58 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.999 2.466 . . . . 0.0 113.003 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.496 ' HG3' HD13 ' A' ' 63' ' ' LEU . 41.9 ttmt -59.45 -28.54 67.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.634 174.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.13 -52.99 61.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.411 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 35.1 m -65.89 -37.16 85.38 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.894 0.378 . . . . 0.0 110.67 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.613 ' CZ ' HD21 ' A' ' 60' ' ' LEU . 16.0 m-85 -61.49 -48.24 81.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.256 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -55.74 -40.03 71.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.552 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.558 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -56.06 -55.63 30.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.798 177.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -69.06 -42.34 76.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.783 -175.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 117' ' ' PHE . 43.5 mt -64.61 -53.46 42.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.91 0.386 . . . . 0.0 111.104 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 38.8 t70 -65.02 -59.0 4.63 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.517 -173.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -83.35 11.26 7.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -168.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.466 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 42.0 t80 -134.38 -52.35 0.82 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.593 0.235 . . . . 0.0 111.123 174.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.678 HD22 HD11 ' A' ' 42' ' ' ILE . 16.8 tp -74.58 -38.52 62.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.725 -175.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 122' ' ' ASP . 4.2 mm? -82.45 -59.94 2.36 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.486 178.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 21.8 pttp . . . . . 0 N--CA 1.447 -0.597 0 CA-C-O 121.757 0.789 . . . . 0.0 110.267 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.672 ' O ' ' HE3' ' A' ' 10' ' ' LYS . . . . . . . . 0 C--O 1.223 -0.533 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.672 ' HE3' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -138.63 164.33 29.77 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -170.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 14.7 p -102.98 123.57 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.518 0.675 . . . . 0.0 111.431 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.1 mt -132.97 124.34 50.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.696 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.875 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 7.7 p80 -91.73 138.8 31.27 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.176 177.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.674 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.7 pp -139.5 168.62 19.42 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.179 -176.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.0 p -95.33 177.17 5.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.909 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -55.66 -33.32 63.99 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.2 90.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.351 0.596 . . . . 0.0 110.165 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.674 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 8.3 mm-40 -71.1 -34.07 70.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.298 178.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -60.81 -50.58 72.87 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.836 0.827 . . . . 0.0 109.308 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.671 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -49.25 -60.43 2.82 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.607 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.25 -19.45 39.6 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -169.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -109.66 -12.39 14.65 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 72.6 t -136.34 -49.99 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -172.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.671 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 12.2 t80 -154.27 116.74 4.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.315 0.579 . . . . 0.0 112.023 -164.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.624 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -82.6 88.65 6.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.687 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -88.75 11.26 18.18 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.014 0.435 . . . . 0.0 111.275 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.649 ' HG2' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -93.92 -48.31 6.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.37 0.605 . . . . 0.0 109.392 174.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.606 ' C ' HD22 ' A' ' 29' ' ' ASN . 53.7 mttp -90.46 -22.97 21.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.267 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.634 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -120.85 67.48 14.96 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.819 178.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -58.29 -44.11 41.23 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.228 2.619 . . . . 0.0 112.382 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -103.2 -22.22 13.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.194 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -91.05 178.13 6.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.346 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -128.69 106.35 8.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.233 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 18.8 tptm -113.55 113.13 24.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.846 174.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.586 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 25.4 t80 -92.59 119.53 32.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.842 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -102.65 28.28 6.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.038 -176.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.81 156.92 18.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.245 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.74 -40.32 11.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.716 0.293 . . . . 0.0 111.037 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -107.61 158.45 33.29 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.339 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.548 ' HG2' HG22 ' A' ' 71' ' ' ILE . 18.6 Cg_endo -59.51 140.72 95.36 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.588 2.192 . . . . 0.0 111.094 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -131.54 157.17 44.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.665 0.745 . . . . 0.0 112.812 -170.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.717 ' HB ' HG12 ' A' ' 73' ' ' ILE . 3.6 mp -120.0 116.5 50.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.633 174.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 35.9 t -100.32 111.97 31.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.739 0.304 . . . . 0.0 110.898 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.651 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 15.6 t70 -95.92 110.31 22.53 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.292 0.567 . . . . 0.0 111.562 -179.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -83.4 111.75 19.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.875 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.708 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 4.1 p90 -141.27 171.28 14.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.209 0.528 . . . . 0.0 111.07 -173.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.72 146.77 51.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.081 173.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -65.72 -38.01 87.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.657 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -80.43 -6.96 58.9 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 49.5 t -97.32 134.95 39.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.089 0.471 . . . . 0.0 111.506 -174.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.96 -63.77 4.15 Favored Glycine 0 C--O 1.224 -0.528 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.356 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.618 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 82.0 Cg_exo -47.26 -35.07 19.58 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.008 2.472 . . . . 0.0 113.145 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.708 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 71.6 m -62.66 -47.71 82.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.244 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -77.6 -28.56 51.59 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -55.75 -43.71 76.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.307 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.0 m -83.21 -16.84 11.16 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -174.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.424 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -49.63 -55.6 21.89 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 38.2 Cg_endo -68.49 -41.03 6.91 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.547 1.498 . . . . 0.0 111.725 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 69.0 mt -58.14 -43.98 86.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.272 0.558 . . . . 0.0 110.528 176.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' A' ' 60' ' ' LEU . 12.7 mt -63.33 -45.39 91.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.677 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -64.93 -35.6 81.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 110.002 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 8.3 mm-40 -52.63 -52.86 53.66 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.175 176.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.483 HD21 ' HG3' ' A' ' 114' ' ' LYS . 3.4 mm? -67.96 -42.69 80.52 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.188 -0.205 . . . . 0.0 110.848 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.505 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -56.14 -50.03 72.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.814 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -71.04 -31.7 68.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.403 -178.322 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -67.47 -29.01 68.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.448 0.642 . . . . 0.0 110.367 179.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.537 ' HB3' HE21 ' A' ' 70' ' ' GLN . 26.3 m-85 -111.82 26.4 10.66 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.219 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.44 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 23.0 t0 -53.93 131.55 40.4 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.249 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.18 -43.83 1.61 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.141 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.537 HE21 ' HB3' ' A' ' 67' ' ' TYR . 11.2 pt20 -101.85 -32.67 10.13 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -175.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.548 HG22 ' HG2' ' A' ' 40' ' ' PRO . 39.6 pt -124.43 159.04 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.684 -178.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 93.2 t -138.05 136.48 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.471 176.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.717 HG12 ' HB ' ' A' ' 42' ' ' ILE . 40.2 mt -114.78 131.95 65.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.312 0.577 . . . . 0.0 111.091 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -115.99 166.16 12.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.102 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.875 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 46.8 mttm -128.88 162.71 26.89 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.491 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 9.2 p -139.86 136.74 39.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.405 ' HB3' ' HG2' ' A' ' 80' ' ' LYS . 0.9 OUTLIER -83.66 86.74 7.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.86 -176.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.1 p -51.58 -41.83 61.46 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -53.78 -23.58 12.5 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.436 ' HG3' ' OE1' ' A' ' 81' ' ' GLU . 7.4 ptpp? -115.37 -34.34 4.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.187 0.518 . . . . 0.0 109.947 177.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.491 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 1.3 mp0 -81.5 39.48 0.53 Allowed 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 123.711 0.804 . . . . 0.0 110.992 173.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.66 -41.16 94.44 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.932 0.396 . . . . 0.0 110.942 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -61.66 -47.78 83.79 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.042 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.0 tp -62.66 -48.51 79.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.182 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.34 -40.97 94.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.814 0.34 . . . . 0.0 111.341 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.46 -28.33 72.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.638 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.82 -27.59 68.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.322 . . . . 0.0 111.276 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.504 ' HB2' HG12 ' A' ' 90' ' ' ILE . 82.0 m-85 -89.71 -16.53 30.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.739 0.304 . . . . 0.0 110.975 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.93 4.68 56.69 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.075 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 88' ' ' PHE . 33.1 mm -67.45 126.21 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -63.96 -60.81 2.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.068 0.461 . . . . 0.0 110.251 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.1 m -158.19 -84.3 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.943 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 8.8 pt -153.93 146.14 17.21 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.28 -167.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -105.2 147.57 1.18 Allowed 'Cis proline' 0 N--CA 1.461 -0.423 0 C-N-CA 124.833 -0.903 . . . . 0.0 111.405 -5.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.438 ' C ' HD12 ' A' ' 96' ' ' ILE . 18.9 t -131.74 138.39 48.61 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.438 HD12 ' C ' ' A' ' 95' ' ' SER . 3.0 mp -125.93 116.16 45.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.733 -177.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 105' ' ' PRO . 37.4 tp -94.19 112.12 23.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.112 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.41 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 96.4 m-85 -90.2 107.31 19.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.461 178.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 55.2 mt -96.92 109.47 49.09 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.318 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.556 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 84.9 Cg_endo -87.96 169.31 6.5 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.221 2.614 . . . . 0.0 112.422 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 89.7 mmm -96.4 3.03 53.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.56 0.695 . . . . 0.0 109.236 173.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -138.66 118.67 13.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.355 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.19 -141.36 15.51 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.52 176.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -120.78 151.0 53.94 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.556 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 17.2 Cg_exo -68.04 122.51 9.61 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.483 2.122 . . . . 0.0 112.05 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -90.79 160.68 15.64 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 18.4 ptp -141.79 144.35 33.91 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.213 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.3 145.84 49.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.231 174.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -72.15 137.23 46.83 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.34 -143.38 3.85 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 115.363 0.905 . . . . 0.0 115.363 -167.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' A' ' 52' ' ' PRO . . . 70.86 20.2 5.54 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.829 0.852 . . . . 0.0 110.403 -171.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.611 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 6.6 mtp -84.33 150.28 57.1 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.769 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.44 178.31 7.52 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.43 2.087 . . . . 0.0 111.141 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.483 ' HG3' HD21 ' A' ' 63' ' ' LEU . 86.3 tttt -61.73 -26.29 67.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.05 0.452 . . . . 0.0 109.953 176.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.84 -52.38 20.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.043 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.611 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 18.8 m -68.61 -35.14 76.92 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.618 -177.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.49 ' O ' HG13 ' A' ' 121' ' ' ILE . 3.7 m-85 -64.77 -44.4 90.15 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.578 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -57.98 -48.81 78.87 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.87 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -57.42 -37.06 72.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.831 0.348 . . . . 0.0 110.772 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.42 -48.6 48.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.196 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 117' ' ' PHE . 56.8 mt -65.68 -52.1 54.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.237 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.42 -62.42 1.79 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.893 0.378 . . . . 0.0 110.942 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.662 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 18.2 mt-10 -64.25 -44.56 91.41 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -172.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -94.44 -35.16 12.45 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.217 -172.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 40' ' ' PRO . 17.9 tp -89.02 -47.57 8.03 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.796 -175.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.8 mt -80.23 -58.92 2.91 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.662 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 25.1 ttpp . . . . . 0 N--CA 1.432 -1.355 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.513 ' CA ' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 CA--C 1.502 -0.738 0 N-CA-C 113.764 0.265 . . . . 0.0 113.764 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -124.8 172.32 9.42 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.9 p -142.2 132.36 24.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.119 0.485 . . . . 0.0 111.073 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.8 mm -131.45 124.95 55.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.544 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.645 ' CB ' ' HB2' ' A' ' 75' ' ' LYS . 6.0 p80 -82.81 116.13 22.01 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 172.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.486 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -116.99 179.73 3.94 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.464 -170.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.514 HG22 ' HE2' ' A' ' 80' ' ' LYS . 56.8 p -89.58 163.35 15.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.016 176.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.712 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 33.2 pttt -61.94 -24.1 66.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.681 175.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.3 -39.52 71.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.272 0.558 . . . . 0.0 110.08 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.486 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 10.4 mm-40 -65.89 -38.75 89.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.074 175.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -62.04 -51.26 68.73 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.965 0.888 . . . . 0.0 109.115 175.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.637 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -51.64 -60.73 2.83 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.466 -1.697 . . . . 0.0 111.733 -175.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.54 -24.17 45.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -168.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -109.15 -23.33 11.69 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 48.5 t -121.33 -41.46 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -172.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.637 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 30.1 t80 -160.82 115.05 2.1 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.142 0.496 . . . . 0.0 111.011 -169.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.624 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -89.96 90.45 8.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.685 -175.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.613 ' CE2' ' HG ' ' A' ' 20' ' ' LEU . 28.6 p90 -85.26 20.68 1.9 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.417 0.627 . . . . 0.0 111.248 177.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.533 ' HG3' HD21 ' A' ' 20' ' ' LEU . 39.8 mt-10 -92.93 -47.33 7.07 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.501 ' HG3' ' ND2' ' A' ' 29' ' ' ASN . 18.3 ptmt -98.25 -11.09 23.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.412 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.631 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 9.9 m-80 -128.69 73.44 80.98 Favored Pre-proline 0 CA--C 1.515 -0.396 0 CA-C-O 121.686 0.755 . . . . 0.0 110.93 171.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -57.58 -43.47 50.48 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 123.744 2.962 . . . . 0.0 112.167 171.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.526 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -111.12 -31.5 7.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.016 -174.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.631 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -90.87 157.43 17.35 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.295 0.569 . . . . 0.0 111.317 -174.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.586 ' HB3' ' NZ ' ' A' ' 104' ' ' LYS . 40.7 t-105 -112.54 112.96 24.87 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.613 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -132.79 110.4 10.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.661 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 5.2 t80 -87.81 133.56 33.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.908 -177.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -107.25 144.71 33.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 171.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.21 -122.58 1.48 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.798 -175.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.504 ' OD1' ' HG3' ' A' ' 39' ' ' LYS . 16.6 t70 -165.41 -61.38 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.117 0.484 . . . . 0.0 110.188 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.504 ' HG3' ' OD1' ' A' ' 38' ' ' ASP . 44.8 mttp -105.54 156.21 36.79 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.761 -173.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.538 ' HG2' HG22 ' A' ' 71' ' ' ILE . 6.0 Cg_endo -49.46 133.61 31.46 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.259 2.64 . . . . 0.0 111.999 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -118.51 146.67 44.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.438 -173.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.794 HD11 HD22 ' A' ' 125' ' ' LEU . 50.1 mm -115.71 136.5 52.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.74 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 17.5 t -120.69 120.28 62.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.061 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.663 ' HB2' HD13 ' A' ' 60' ' ' LEU . 13.5 t0 -94.26 103.55 15.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.754 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.428 ' HE1' ' HB2' ' A' ' 97' ' ' LEU . 80.8 m-85 -88.81 110.95 21.46 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 176.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.665 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.9 p90 -145.95 177.32 9.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.259 0.552 . . . . 0.0 111.456 -172.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.504 ' HB3' HD13 ' A' ' 93' ' ' ILE . . . -157.95 152.05 24.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.492 171.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -60.6 -44.83 95.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -173.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -69.4 -10.91 60.06 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -171.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 45.9 t -93.71 129.21 40.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.065 0.459 . . . . 0.0 110.838 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.73 -60.5 7.66 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.811 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.551 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 81.6 Cg_exo -47.61 -35.66 23.23 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.315 2.676 . . . . 0.0 113.381 176.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.665 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 67.6 m -64.07 -50.64 67.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.985 0.422 . . . . 0.0 111.061 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -61.62 -28.11 69.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.006 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.404 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 84.3 mtp -66.97 -51.58 53.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.463 176.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.408 ' HB ' ' HZ ' ' A' ' 117' ' ' PHE . 30.0 m -77.29 -33.53 20.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -171.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -48.22 -56.64 13.2 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 21.7 Cg_exo -65.68 -35.72 35.92 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.057 1.838 . . . . 0.0 112.168 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.455 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 67.6 mt -64.19 -41.38 92.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.432 0.634 . . . . 0.0 109.536 176.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.663 HD13 ' HB2' ' A' ' 44' ' ' ASP . 7.6 mt -68.36 -33.49 74.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.454 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD1' HG11 ' A' ' 11' ' ' VAL . 58.9 m-20 -63.73 -42.66 97.85 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.661 0.743 . . . . 0.0 109.25 173.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.579 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 16.9 tp10 -57.09 -53.39 58.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.682 177.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.537 HD21 ' HG3' ' A' ' 114' ' ' LYS . 4.4 mm? -61.76 -31.91 72.13 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.626 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.531 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -58.49 -60.23 4.12 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.74 0.305 . . . . 0.0 110.921 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.579 ' HE3' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -75.17 -23.85 57.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.196 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -61.37 -38.57 87.48 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.246 0.546 . . . . 0.0 110.535 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.467 ' HD2' ' NE2' ' A' ' 70' ' ' GLN . 75.1 m-85 -103.67 27.1 7.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.298 178.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 6.7 t0 -48.43 134.42 15.18 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.366 -177.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.61 -33.84 4.79 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.658 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.467 ' NE2' ' HD2' ' A' ' 67' ' ' TYR . 14.1 mt-30 -86.53 -47.65 9.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.609 0.242 . . . . 0.0 111.384 -175.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.538 HG22 ' HG2' ' A' ' 40' ' ' PRO . 40.5 pt -125.1 164.01 24.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.186 0.517 . . . . 0.0 111.644 -175.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 60.3 t -128.27 127.78 67.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.3 175.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.763 HG12 ' HB ' ' A' ' 42' ' ' ILE . 46.7 mt -111.71 137.99 42.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.196 0.522 . . . . 0.0 111.118 -177.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -121.13 161.8 21.17 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.645 ' HB2' ' CB ' ' A' ' 13' ' ' HIS . 79.8 mttt -124.34 150.62 45.29 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.016 0.436 . . . . 0.0 110.034 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.717 HG13 ' HG2' ' A' ' 81' ' ' GLU . 2.8 t -127.95 126.13 65.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.025 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -90.33 89.64 7.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.657 HG21 ' HA ' ' A' ' 92' ' ' SER . 33.1 m -52.09 -30.04 24.23 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.215 -171.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -51.97 -34.23 41.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.76 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.514 ' HE2' HG22 ' A' ' 15' ' ' THR . 22.7 pttm -108.27 -20.89 12.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.207 0.527 . . . . 0.0 110.348 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.717 ' HG2' HG13 ' A' ' 76' ' ' VAL . 1.5 mp0 -91.18 40.99 1.05 Allowed 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.572 0.749 . . . . 0.0 111.67 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -55.6 -53.6 54.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.444 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -62.85 -36.39 83.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.631 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.6 tp -64.1 -43.33 95.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.541 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.568 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -65.25 -47.15 77.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.669 175.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.88 -33.93 80.66 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.87 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.54 -35.18 77.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 111.402 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -95.3 4.06 53.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.941 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.16 10.17 85.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.867 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.568 ' HB ' ' HB1' ' A' ' 85' ' ' ALA . 6.4 mt -69.72 143.01 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -72.09 -48.17 46.0 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.657 ' HA ' HG21 ' A' ' 78' ' ' THR . 15.0 p 179.69 -80.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.712 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.576 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 16.7 pt -149.2 149.83 30.43 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.107 -172.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.483 ' HG3' ' HB2' ' A' ' 52' ' ' PRO . 10.7 Cg_endo -101.2 150.27 3.44 Favored 'Cis proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.649 -0.979 . . . . 0.0 112.046 -3.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.6 t -138.95 136.66 35.65 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 107' ' ' MET . 15.3 mm -114.55 113.42 43.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.74 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 41.5 tp -94.58 119.44 33.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.03 0.443 . . . . 0.0 110.689 -175.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -100.72 107.89 19.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.424 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.13 108.12 50.62 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.393 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -84.65 168.77 11.02 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.744 2.296 . . . . 0.0 112.098 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 86.5 mtp -87.23 -12.34 47.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.503 0.668 . . . . 0.0 110.155 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -140.09 127.05 20.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.581 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.67 -151.93 18.19 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.227 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.586 ' NZ ' ' HB3' ' A' ' 33' ' ' TRP . 29.3 mmmt -115.4 155.13 47.46 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.441 ' HD3' ' CD1' ' A' ' 33' ' ' TRP . 92.3 Cg_endo -81.79 144.5 13.84 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.505 2.136 . . . . 0.0 112.302 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.2 169.92 8.67 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.318 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.534 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 22.3 ptp -142.19 121.33 12.98 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.775 0.798 . . . . 0.0 111.41 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.54 128.38 49.21 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -67.52 150.95 48.17 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.317 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.96 -162.99 2.27 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.559 -0.746 . . . . 0.0 114.753 -168.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.551 ' HB2' ' HB3' ' A' ' 52' ' ' PRO . . . 75.84 17.24 2.29 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.164 0.985 . . . . 0.0 111.55 -176.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.642 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 73.0 mtm -86.75 144.31 36.95 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.85 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 71.7 Cg_endo -75.43 178.92 6.72 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.567 2.178 . . . . 0.0 110.5 172.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.537 ' HG3' HD21 ' A' ' 63' ' ' LEU . 64.3 tttm -62.06 -27.83 69.18 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.75 -45.89 63.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.037 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.642 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 50.7 m -70.62 -30.14 66.71 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.184 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.512 ' O ' HG13 ' A' ' 121' ' ' ILE . 13.7 m-85 -64.08 -52.44 59.27 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.172 172.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.456 ' O ' ' HD3' ' A' ' 118' ' ' LYS . 11.6 tmtt? -58.53 -38.32 77.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.83 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.508 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -56.59 -52.29 65.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.894 176.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.05 -43.28 68.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.853 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 117' ' ' PHE . 58.6 mt -62.97 -44.16 99.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 109.965 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -62.88 -68.4 0.34 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.596 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.798 ' HA ' ' HE2' ' A' ' 127' ' ' LYS . 3.8 tt0 -80.06 11.06 3.65 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.836 -163.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -143.17 -47.51 0.31 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.614 177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.794 HD22 HD11 ' A' ' 42' ' ' ILE . 28.4 tp -79.44 -38.86 33.7 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.139 -174.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.2 mt -98.54 -47.91 5.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.666 0.746 . . . . 0.0 109.923 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.798 ' HE2' ' HA ' ' A' ' 123' ' ' GLU . 19.0 ttpt . . . . . 0 C--N 1.316 -0.872 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.693 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.513 ' CA ' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.229 0 N-CA-C 113.541 0.176 . . . . 0.0 113.541 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -162.74 166.55 24.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.757 0.279 . . . . 0.0 110.295 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.537 HG23 HG22 ' A' ' 73' ' ' ILE . 9.0 p -98.85 133.59 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.495 0.664 . . . . 0.0 111.029 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 73.8 mt -111.61 122.25 65.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.732 177.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.476 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 2.2 p80 -91.84 119.36 31.57 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.589 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.72 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.2 pp -138.8 168.17 20.4 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.677 -178.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.9 p -94.25 176.61 6.25 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.396 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 13.8 pttm -57.21 -24.83 57.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 177.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.53 -47.43 69.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.308 0.575 . . . . 0.0 109.727 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.72 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 3.9 mp0 -71.13 -33.87 70.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.109 176.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.413 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 7.2 t80 -59.41 -47.9 83.68 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 122.195 0.997 . . . . 0.0 109.151 176.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -50.26 -59.35 4.04 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 113.155 -1.838 . . . . 0.0 111.046 -179.545 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.0 -45.03 36.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 19.1 tptm -89.04 -7.85 55.12 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.027 -168.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 62.1 t -134.52 -54.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.506 -0.477 . . . . 0.0 112.252 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.492 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 11.8 t80 -169.63 126.12 0.87 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.268 0.556 . . . . 0.0 112.025 -164.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.528 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -82.46 89.91 6.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.71 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.492 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 34.8 p90 -81.96 10.71 6.02 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.381 0.61 . . . . 0.0 111.092 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.409 ' H ' HD22 ' A' ' 25' ' ' ASN . 4.1 tm-20 -107.78 -47.63 3.56 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.692 ' C ' HD22 ' A' ' 29' ' ' ASN . 0.0 OUTLIER -89.26 -28.31 20.0 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.29 -178.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.692 HD22 ' C ' ' A' ' 28' ' ' LYS . 0.7 OUTLIER -121.15 62.94 11.77 Favored Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.933 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -59.43 -35.73 95.52 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.706 2.271 . . . . 0.0 112.076 175.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.512 ' HG3' ' HG2' ' A' ' 32' ' ' GLU . 16.0 pt-20 -98.26 -23.77 15.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.47 -176.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.512 ' HG2' ' HG3' ' A' ' 31' ' ' GLU . 34.5 mm-40 -100.99 155.0 18.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.832 0.349 . . . . 0.0 110.982 -174.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.532 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 76.2 t-105 -105.71 92.07 4.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.205 0.526 . . . . 0.0 110.009 175.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.606 ' HG3' ' OE2' ' A' ' 36' ' ' GLU . 25.3 tptp -100.95 104.63 15.81 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.58 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 21.8 t80 -107.97 118.49 36.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.568 -177.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.606 ' OE2' ' HG3' ' A' ' 34' ' ' LYS . 12.9 mm-40 -86.32 87.76 7.49 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA3' ' CE2' ' A' ' 35' ' ' TYR . . . -106.89 129.19 9.59 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.142 -1.028 . . . . 0.0 114.306 -169.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -87.94 -53.32 4.8 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 170.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HB2' HG23 ' A' ' 72' ' ' VAL . 47.1 mttp -126.16 171.52 7.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 172.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 9.1 Cg_endo -54.74 144.92 63.19 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.486 2.124 . . . . 0.0 111.283 170.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -128.04 155.88 43.64 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -170.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.856 ' HB ' HG23 ' A' ' 73' ' ' ILE . 21.4 mm -125.87 147.05 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.462 173.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 66.4 t -133.6 119.41 33.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 118.782 0.719 . . . . 0.0 111.412 176.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.58 113.38 26.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.636 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.576 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 69.7 m-85 -94.05 111.51 23.23 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 172.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.688 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.2 p90 -141.21 -177.1 4.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.342 0.591 . . . . 0.0 110.968 -172.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.47 139.3 25.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.614 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -61.39 -37.7 84.39 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -174.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -66.99 -16.31 64.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.008 0.432 . . . . 0.0 111.301 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.2 t -88.21 116.48 26.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.515 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.33 -53.9 37.86 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.758 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 55' ' ' MET . 84.9 Cg_exo -48.07 -37.85 31.08 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.909 2.406 . . . . 0.0 113.214 175.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.688 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 93.0 m -66.75 -48.03 70.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.395 0.617 . . . . 0.0 110.475 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 mttp -53.59 -30.79 44.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.646 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 76.2 mtp -64.59 -49.1 72.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.993 0.425 . . . . 0.0 111.439 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.478 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 35.1 m -79.54 -27.9 12.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.757 -171.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.516 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -50.31 -59.97 6.15 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 55.7 Cg_endo -71.15 -40.76 3.02 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.733 1.622 . . . . 0.0 112.495 -177.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 64.4 mt -64.99 -51.63 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.331 -176.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -68.25 -29.9 68.82 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.487 -176.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.535 ' OD1' HG12 ' A' ' 11' ' ' VAL . 23.4 t70 -61.75 -40.21 94.29 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.423 0.63 . . . . 0.0 109.775 172.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 59' ' ' ILE . 8.5 tm-20 -63.31 -41.01 98.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.321 176.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.537 HD21 ' HA ' ' A' ' 114' ' ' LYS . 3.1 mm? -58.71 -36.7 74.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.926 0.393 . . . . 0.0 110.699 174.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.658 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -60.97 -37.94 84.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.315 177.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 5.4 tmtm? -75.67 -33.12 60.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.527 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -55.32 -44.62 76.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.424 0.63 . . . . 0.0 109.931 172.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.599 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 48.0 m-85 -99.36 27.32 5.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.68 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 15.4 t0 -49.93 129.71 20.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.499 -177.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.49 -30.87 9.46 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.451 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 2.8 pt20 -106.86 -21.27 13.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 64' ' ' ALA . 30.6 pt -125.22 155.95 34.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.185 0.517 . . . . 0.0 112.059 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 40.5 t -127.96 129.93 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.348 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.856 HG23 ' HB ' ' A' ' 42' ' ' ILE . 24.8 mt -117.18 142.34 31.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 41.9 m-85 -124.47 158.57 32.53 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 0.2 OUTLIER -148.52 150.45 33.4 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 175.006 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.972 HG22 ' HG3' ' A' ' 81' ' ' GLU . 2.8 p -141.21 156.55 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.555 -173.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.516 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 10.8 m-20 -96.38 90.95 5.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.368 -175.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.547 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 10.2 m -50.05 -34.79 22.72 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -173.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' A' ' 79' ' ' GLU . 2.6 mm-40 -53.78 -41.04 66.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.98 0.419 . . . . 0.0 111.768 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 13.3 ptpt -94.57 -20.36 19.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.807 0.813 . . . . 0.0 109.344 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.972 ' HG3' HG22 ' A' ' 76' ' ' VAL . 10.3 mm-40 -98.2 39.71 1.22 Allowed 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.442 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -66.85 -30.98 71.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.625 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.55 -39.59 70.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.478 0.656 . . . . 0.0 109.243 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 33.4 tp -68.56 -37.8 80.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.832 176.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.618 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -63.9 -44.81 91.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.816 176.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.79 -29.16 66.85 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.92 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.29 -33.39 75.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.338 . . . . 0.0 111.444 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.607 ' HB2' HG13 ' A' ' 90' ' ' ILE . 91.2 m-85 -103.15 6.53 38.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.774 0.321 . . . . 0.0 110.626 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.39 33.67 87.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.862 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.618 HD12 ' HA ' ' A' ' 85' ' ' ALA . 41.9 mt -71.14 133.39 31.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.97 0.414 . . . . 0.0 110.745 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.458 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 0.4 OUTLIER -70.18 -51.41 31.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.096 178.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.9 p 175.39 -99.65 0.0 OUTLIER 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.145 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 26.6 pt -147.55 143.01 17.36 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.708 -172.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.733 ' HB2' ' H ' ' A' ' 110' ' ' GLY . 11.9 Cg_exo -81.95 149.25 71.77 Favored 'Cis proline' 0 N--CA 1.474 0.368 0 C-N-CA 124.934 -0.861 . . . . 0.0 111.921 -3.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.576 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 14.5 m -140.19 128.28 22.26 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 107' ' ' MET . 52.5 mt -127.94 122.66 59.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.837 0.351 . . . . 0.0 110.603 -174.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 32.8 tp -104.81 122.13 45.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.397 -177.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -100.07 111.35 23.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 54.9 mt -109.51 113.62 57.97 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -170.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -85.0 159.97 11.66 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.096 2.531 . . . . 0.0 111.621 172.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 86.1 mtp -80.28 -35.99 35.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -118.87 122.54 42.56 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.469 0.652 . . . . 0.0 109.54 173.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.0 -171.19 13.65 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -174.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.532 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 8.9 mmmm -117.97 150.31 47.07 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 117.335 0.567 . . . . 0.0 110.083 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.24 148.11 21.06 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.933 2.422 . . . . 0.0 114.216 -173.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -111.09 169.3 8.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.279 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 46.5 ttm -134.59 124.9 26.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.057 0.456 . . . . 0.0 111.695 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.88 157.71 21.09 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.469 ' HG2' ' HA ' ' A' ' 95' ' ' SER . 39.4 mt-30 -131.38 141.12 49.82 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.715 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.733 ' H ' ' HB2' ' A' ' 94' ' ' PRO . . . 115.46 177.87 18.56 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.507 -0.77 . . . . 0.0 114.125 172.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.478 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -87.75 86.07 7.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.281 0.562 . . . . 0.0 111.227 -175.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.639 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 72.6 mtm -78.93 136.89 57.78 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.828 175.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -75.46 -171.65 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.846 2.364 . . . . 0.0 111.792 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.537 ' HA ' HD21 ' A' ' 63' ' ' LEU . 13.8 tttm -57.97 -37.12 73.61 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.5 -50.59 62.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.326 -175.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.639 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 45.0 m -70.1 -37.47 75.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.926 -177.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.643 ' O ' HG13 ' A' ' 121' ' ' ILE . 4.6 m-85 -64.89 -44.51 89.41 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.829 176.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.526 ' HG2' ' OH ' ' A' ' 67' ' ' TYR . 11.3 tmtt? -53.83 -47.68 70.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.673 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -65.15 -38.08 89.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.754 -177.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.06 78.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.257 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.643 HG13 ' O ' ' A' ' 117' ' ' PHE . 23.1 mt -74.19 -55.23 12.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.884 0.373 . . . . 0.0 110.821 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.52 ' HA ' HD12 ' A' ' 126' ' ' LEU . 12.4 t70 -71.43 -65.54 0.74 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.687 0.28 . . . . 0.0 111.623 -176.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.437 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 32.8 mt-10 -75.82 -4.76 42.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -166.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -128.04 -38.61 1.81 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.572 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 40.5 tp -88.87 -43.2 11.38 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.887 -0.508 . . . . 0.0 110.742 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 122' ' ' ASP . 81.8 mt -82.92 -58.49 2.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.415 0.626 . . . . 0.0 109.68 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 12.7 ttpp . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.588 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.488 ' HZ1' ' CG ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -152.98 151.47 30.33 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 121.519 0.676 . . . . 0.0 111.865 -172.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 5.1 p -103.79 108.18 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.006 168.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 63.0 mt -88.99 123.76 41.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.721 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.695 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 2.3 p80 -88.86 133.26 34.33 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.796 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.586 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 1.7 pp -140.65 172.8 12.21 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.887 -174.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.7 p -106.17 178.35 4.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.357 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.459 ' HB2' ' HZ ' ' A' ' 26' ' ' PHE . 14.2 ptmm? -55.32 -35.72 65.45 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.83 -38.64 79.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.232 0.539 . . . . 0.0 110.286 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.586 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 2.6 mm-40 -71.0 -35.74 72.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.142 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -64.05 -48.34 76.67 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.78 0.8 . . . . 0.0 109.116 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.643 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.7 tt -50.82 -60.77 2.72 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.265 -178.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.6 -18.91 39.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -168.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 34.5 ttmt -108.5 -12.71 14.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.972 0.415 . . . . 0.0 111.397 -174.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 57.6 t -135.85 -55.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -174.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.653 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 9.7 t80 -167.09 122.53 1.09 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.261 0.553 . . . . 0.0 111.7 -164.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.505 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 1.8 t-20 -86.74 89.68 8.03 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.031 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.653 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 10.5 p90 -89.4 0.37 56.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.379 -174.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -104.98 -22.1 13.18 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.928 ' HE3' HD21 ' A' ' 29' ' ' ASN . 3.7 ttpp -105.96 -26.04 11.85 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.409 167.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.928 HD21 ' HE3' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -119.12 67.97 9.03 Favored Pre-proline 0 N--CA 1.471 0.591 0 CA-C-O 120.886 0.374 . . . . 0.0 111.635 -178.132 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.77 -34.66 39.56 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.92 2.413 . . . . 0.0 111.527 167.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -97.52 -30.6 12.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.841 -177.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.681 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 22.9 mt-10 -91.36 128.6 37.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.063 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.486 ' CZ2' ' HG3' ' A' ' 105' ' ' PRO . 72.8 t-105 -91.16 103.44 16.12 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.784 172.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -107.93 134.66 50.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.56 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.575 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 37.3 t80 -133.0 96.72 3.83 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.82 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -90.32 31.43 1.01 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.51 -174.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.5 135.25 12.69 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.421 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' OD2' ' HG3' ' A' ' 39' ' ' LYS . 25.2 t70 -65.6 -41.47 92.77 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.19 0.519 . . . . 0.0 111.081 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.414 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 72.5 mttt -125.32 158.79 62.74 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.548 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.662 ' HB3' HD11 ' A' ' 125' ' ' LEU . 50.3 Cg_exo -54.64 140.22 76.2 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.362 2.041 . . . . 0.0 111.157 173.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -124.44 152.37 43.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.669 0.747 . . . . 0.0 112.391 -172.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.8 mt -117.95 114.17 44.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.128 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 21.4 t -99.78 120.26 48.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.397 -175.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.682 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 21.8 t70 -103.69 111.12 23.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.57 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -83.45 111.94 19.5 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 172.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.71 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.8 p90 -132.58 158.23 42.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.775 0.798 . . . . 0.0 112.031 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.524 ' HB3' HG12 ' A' ' 93' ' ' ILE . . . -133.4 108.85 8.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.244 -1.343 . . . . 0.0 107.706 167.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.541 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 33.9 t70 -55.4 -31.03 61.49 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -167.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 59.6 p-90 -69.95 -1.43 9.63 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.625 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 27.9 t -114.14 137.03 52.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.933 0.397 . . . . 0.0 110.627 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.4 -57.46 18.47 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 115.612 -0.722 . . . . 0.0 114.669 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.625 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 84.1 Cg_exo -47.37 -37.49 25.19 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.158 2.572 . . . . 0.0 113.636 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.71 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 30.1 m -64.11 -50.36 68.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.334 0.588 . . . . 0.0 111.022 177.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.541 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 66.7 mttm -58.23 -28.59 65.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.339 174.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.443 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 53.2 mmm -70.63 -50.77 33.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.794 0.33 . . . . 0.0 111.398 176.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.84 -38.73 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -172.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.613 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -49.17 -54.49 28.58 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 15.8 Cg_exo -68.44 -42.67 5.01 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.212 1.941 . . . . 0.0 112.032 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.617 HD13 ' HA ' ' A' ' 113' ' ' PRO . 74.3 mt -57.26 -44.03 83.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.302 0.572 . . . . 0.0 110.497 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 44' ' ' ASP . 5.8 mt -68.37 -35.15 77.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.621 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.547 ' OD1' HG12 ' A' ' 11' ' ' VAL . 14.7 t70 -68.02 -35.53 78.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.134 0.493 . . . . 0.0 109.69 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.639 ' HA ' ' HD2' ' A' ' 65' ' ' LYS . 13.9 mm-40 -54.09 -44.63 71.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.768 172.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' A' ' 117' ' ' PHE . 11.1 mp -65.4 -30.89 71.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.727 0.298 . . . . 0.0 110.833 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -61.7 -53.2 59.35 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.657 -178.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.639 ' HD2' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -76.09 -24.97 55.06 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.795 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -42.73 61.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.88 0.372 . . . . 0.0 111.478 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.415 ' O ' HG12 ' A' ' 71' ' ' ILE . 94.0 m-85 -107.26 26.95 9.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.684 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.48 159.8 7.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.353 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.2 -52.89 4.13 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.262 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.755 HE22 HD11 ' A' ' 126' ' ' LEU . 10.2 pt20 -80.96 -33.77 33.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.495 0.188 . . . . 0.0 111.049 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 40' ' ' PRO . 42.2 pt -131.77 156.49 42.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.088 0.47 . . . . 0.0 111.763 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 86.8 t -124.28 136.49 60.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.648 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 21.9 mt -108.74 139.23 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.337 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -125.71 166.93 15.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.706 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.695 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -147.75 148.89 31.45 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 171.097 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.497 HG21 HD23 ' A' ' 84' ' ' LEU . 8.1 p -121.17 138.24 52.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.116 0.484 . . . . 0.0 110.524 -175.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.572 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -72.84 85.69 1.25 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.427 179.402 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.576 HG23 ' HB2' ' A' ' 85' ' ' ALA . 17.3 m -66.38 -31.77 72.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -167.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -65.9 -27.23 68.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.609 0.242 . . . . 0.0 111.199 -178.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.504 ' HZ2' ' HB3' ' A' ' 77' ' ' ASP . 8.6 ptpp? -99.79 -37.18 9.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.898 0.38 . . . . 0.0 110.108 175.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.572 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -78.86 39.63 0.37 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.36 0.664 . . . . 0.0 110.972 174.037 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -59.16 -43.98 92.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.529 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -65.15 -35.41 81.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.301 0.572 . . . . 0.0 110.379 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.497 HD23 HG21 ' A' ' 76' ' ' VAL . 14.8 tp -67.58 -48.94 65.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.322 177.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.576 ' HB2' HG23 ' A' ' 78' ' ' THR . . . -62.95 -36.28 82.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.915 0.388 . . . . 0.0 111.196 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.29 -27.75 71.18 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.777 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.37 -22.57 66.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.982 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -101.0 0.8 38.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.513 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.79 6.26 89.13 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.008 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.0 mm -68.72 130.29 33.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.514 0.197 . . . . 0.0 110.519 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 91' ' ' ARG . 39.2 mtm180 -59.27 -55.79 30.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.61 0.719 . . . . 0.0 110.394 176.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.544 ' O ' HG21 ' A' ' 78' ' ' THR . 14.2 t -167.48 -88.15 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.902 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.547 HG21 ' C ' ' A' ' 46' ' ' TYR . 2.3 pp -152.5 157.47 33.61 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -173.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.574 ' HG3' ' HB2' ' A' ' 52' ' ' PRO . 10.9 Cg_endo -99.42 148.06 4.51 Favored 'Cis proline' 0 N--CA 1.458 -0.571 0 C-N-CA 124.365 -1.098 . . . . 0.0 112.018 -3.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.8 t -139.89 142.51 36.5 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.73 128.03 71.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.465 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.595 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.5 tp -106.14 116.85 32.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.077 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 105' ' ' PRO . 20.0 m-85 -93.74 107.4 19.28 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.471 HG12 ' HB3' ' A' ' 105' ' ' PRO . 42.5 mt -110.11 109.78 58.8 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -173.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.73 165.91 13.62 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.402 2.734 . . . . 0.0 111.144 170.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.487 ' HG2' ' HE2' ' A' ' 35' ' ' TYR . 82.7 mtp -97.0 -34.17 11.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.712 0.768 . . . . 0.0 109.304 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -96.83 2.81 52.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.363 -176.183 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -137.45 -156.33 7.21 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.051 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 60.6 mmtt -126.34 154.43 74.76 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.486 ' HG3' ' CZ2' ' A' ' 33' ' ' TRP . 98.3 Cg_endo -78.21 148.26 24.06 Favored 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.677 2.251 . . . . 0.0 114.168 -169.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.507 ' HG2' ' N ' ' A' ' 107' ' ' MET . 34.9 tt0 -119.33 163.25 17.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.716 172.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.507 ' N ' ' HG2' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -142.51 137.98 30.6 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.372 0.606 . . . . 0.0 111.766 -177.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -133.98 156.77 47.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.622 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -75.41 148.52 39.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.15 -144.06 6.82 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.743 -0.742 . . . . 0.0 113.804 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 52' ' ' PRO . . . 71.99 20.86 4.26 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.435 0.694 . . . . 0.0 111.883 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.558 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 20.3 ptt? -112.37 153.7 44.73 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.529 177.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.617 ' HA ' HD13 ' A' ' 59' ' ' ILE . 93.6 Cg_endo -76.58 -177.56 3.83 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.13 2.553 . . . . 0.0 113.05 -173.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.46 ' HG3' HD11 ' A' ' 63' ' ' LEU . 38.8 ttmt -61.77 -29.39 70.1 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.024 174.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . -64.72 -47.38 78.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.215 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.558 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 18.6 m -70.88 -38.45 73.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.881 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.482 ' HB3' HD21 ' A' ' 63' ' ' LEU . 9.0 m-85 -65.41 -40.83 93.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.305 177.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.674 ' O ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -57.31 -37.24 72.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.583 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 43.2 mmtm -65.88 -57.96 6.69 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.252 175.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.51 -46.78 86.04 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -174.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.8 mp -64.37 -48.09 86.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.666 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.419 ' HA ' HD23 ' A' ' 126' ' ' LEU . 3.8 t0 -66.37 -50.27 64.07 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.841 -178.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.583 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 4.0 mm-40 -54.98 -30.2 58.78 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -174.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -115.45 -35.98 4.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.964 0.411 . . . . 0.0 111.854 -172.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.662 HD11 ' HB3' ' A' ' 40' ' ' PRO . 20.0 tp -90.6 -47.26 7.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.88 -174.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.755 HD11 HE22 ' A' ' 70' ' ' GLN . 3.8 mm? -87.51 -53.43 4.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.261 0.553 . . . . 0.0 110.377 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.771 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.865 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 175.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.63 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . . . . . . 0 N--CA 1.448 -0.52 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.703 ' HE2' HD11 ' A' ' 12' ' ' ILE . 84.3 tttt -151.19 138.89 19.73 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -172.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 10.5 p -110.95 132.13 60.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.128 0.489 . . . . 0.0 110.693 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.703 HD11 ' HE2' ' A' ' 10' ' ' LYS . 36.9 mm -120.95 117.15 52.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.096 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.446 ' CB ' ' HG3' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -84.83 121.36 27.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 171.248 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.739 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.3 pp -120.68 178.27 4.76 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.751 -170.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.475 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -107.86 172.84 6.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.649 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 10.8 ptpt -54.68 -37.31 65.61 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.92 85.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.106 0.479 . . . . 0.0 110.971 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.739 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 30.8 mm-40 -71.97 -39.46 69.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.455 177.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -63.36 -50.24 70.72 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.163 0.983 . . . . 0.0 109.065 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.649 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -47.06 -60.95 2.12 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.152 -1.84 . . . . 0.0 112.232 -178.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.06 -28.14 27.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.799 -170.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 24.2 ttpt -110.56 1.5 18.17 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.933 0.397 . . . . 0.0 111.704 -170.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 40.7 t -141.46 -47.76 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 22.6 t80 -167.41 119.61 0.91 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.122 0.487 . . . . 0.0 111.737 -167.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -93.67 91.93 7.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.102 -178.374 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 2.9 p90 -80.41 8.9 6.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.309 0.576 . . . . 0.0 111.532 -177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -91.91 -50.15 5.86 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.046 176.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.669 ' C ' HD22 ' A' ' 29' ' ' ASN . 14.9 pttm -89.66 -15.45 32.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.669 HD22 ' C ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -123.33 68.79 39.52 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.505 174.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -59.5 -37.26 90.23 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.996 2.464 . . . . 0.0 112.447 173.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.85 -35.57 4.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -173.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.656 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 4.6 tp10 -90.96 153.71 19.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.038 0.447 . . . . 0.0 110.417 -176.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.653 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 33.4 t-105 -103.1 113.85 27.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.612 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -125.03 110.88 14.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.759 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.635 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 37.9 t80 -76.18 114.59 15.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.194 177.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -94.22 71.21 3.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.862 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.635 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -143.74 -139.76 3.56 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.522 -175.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -149.27 -42.47 0.14 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 111.892 -173.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' A' ' 70' ' ' GLN . 35.2 mttp -126.14 165.65 26.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.245 -175.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.614 ' HD3' ' SD ' ' A' ' 101' ' ' MET . 10.3 Cg_endo -52.88 132.31 46.34 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.452 2.102 . . . . 0.0 111.237 177.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -124.42 149.97 46.15 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.174 0.512 . . . . 0.0 111.572 -172.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.509 ' HB ' HG12 ' A' ' 73' ' ' ILE . 75.7 mt -127.17 134.01 66.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 175.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 60.5 t -125.28 112.42 31.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.022 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.548 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 8.5 p-10 -102.28 114.12 28.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.962 0.887 . . . . 0.0 111.266 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 42.0 m-85 -80.3 112.55 17.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.884 172.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.776 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.9 p90 -127.39 159.91 33.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.376 0.608 . . . . 0.0 110.759 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.459 ' N ' HG21 ' A' ' 93' ' ' ILE . . . -130.86 122.99 28.04 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 170.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.576 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 15.8 t70 -66.06 -26.18 67.38 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.803 -169.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -75.78 -2.88 31.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.994 0.426 . . . . 0.0 111.17 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.577 ' HB3' ' SG ' ' A' ' 53' ' ' CYS . 32.6 t -108.28 122.34 46.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.197 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.28 -55.28 25.26 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.638 -0.71 . . . . 0.0 114.792 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.498 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 82.5 Cg_exo -47.2 -41.14 27.6 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.206 2.604 . . . . 0.0 113.786 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.776 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 3.0 m -63.63 -37.75 88.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.291 0.567 . . . . 0.0 110.921 -177.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.576 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 67.0 mttm -61.46 -28.61 69.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.071 176.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 76.6 mtp -65.57 -48.44 72.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.875 0.369 . . . . 0.0 111.573 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.435 HG21 HD11 ' A' ' 96' ' ' ILE . 12.8 p -77.59 -32.33 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -169.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.448 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -48.02 -57.34 10.56 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 43.1 Cg_endo -69.21 -35.31 14.51 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.911 1.74 . . . . 0.0 112.702 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.6 mt -63.74 -50.86 76.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.681 HD22 HD13 ' A' ' 73' ' ' ILE . 5.6 mt -60.74 -36.09 78.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.361 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -62.03 -50.35 72.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.053 0.454 . . . . 0.0 110.673 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.13 -43.97 98.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.481 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HA ' HD13 ' A' ' 63' ' ' LEU . 3.8 mm? -62.63 -32.48 73.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.112 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.658 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -63.17 -53.55 51.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.345 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 8.8 tmtm? -67.4 -34.28 76.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.644 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -58.63 -47.03 85.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.187 0.518 . . . . 0.0 110.274 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -95.04 26.33 3.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.102 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -47.12 136.56 8.69 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.918 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.23 -23.98 17.18 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.75 176.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.542 ' HG3' HG23 ' A' ' 71' ' ' ILE . 12.5 pt20 -125.88 -49.02 1.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.542 HG23 ' HG3' ' A' ' 70' ' ' GLN . 43.0 pt -95.15 148.59 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.327 0.584 . . . . 0.0 112.188 -173.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 39.8 t -128.26 125.26 63.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.098 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.681 HD13 HD22 ' A' ' 60' ' ' LEU . 27.8 mt -109.24 131.44 60.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.308 0.575 . . . . 0.0 111.379 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.5 m-85 -116.94 156.85 26.71 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.548 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -136.07 148.29 48.24 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.452 175.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.58 HG13 ' HG2' ' A' ' 81' ' ' GLU . 20.8 t -117.11 126.39 74.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.536 -171.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 4.7 m-20 -83.4 95.42 8.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.417 HG21 ' O ' ' A' ' 92' ' ' SER . 16.6 p -55.56 -35.66 65.98 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -171.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -54.76 -29.94 55.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.353 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 54.6 pttt -103.14 -32.85 9.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.56 0.695 . . . . 0.0 109.726 178.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.58 ' HG2' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -88.73 41.97 1.05 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.155 -179.016 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.1 -49.58 77.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.904 -176.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.19 -36.46 81.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.934 0.397 . . . . 0.0 110.232 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.04 -53.12 58.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.951 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.14 -40.01 93.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.688 178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.84 -28.26 72.41 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.704 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.81 -32.8 74.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.807 0.336 . . . . 0.0 110.963 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.429 ' HB2' HG12 ' A' ' 90' ' ' ILE . 74.5 m-85 -89.29 0.75 56.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.933 0.397 . . . . 0.0 110.698 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.33 8.68 84.85 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.974 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.429 HG12 ' HB2' ' A' ' 88' ' ' PHE . 50.0 mm -75.01 130.21 36.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 122.341 0.257 . . . . 0.0 110.74 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -66.37 -64.28 0.89 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.221 0.534 . . . . 0.0 110.093 175.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.417 ' O ' HG21 ' A' ' 78' ' ' THR . 29.7 m -155.72 -90.3 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.589 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.534 HG13 ' SG ' ' A' ' 53' ' ' CYS . 0.2 OUTLIER -146.56 161.35 38.51 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.43 -172.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.717 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.1 Cg_exo -87.98 148.08 30.05 Favored 'Cis proline' 0 C--N 1.345 0.346 0 C-N-CA 124.507 -1.039 . . . . 0.0 111.705 -4.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.406 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 9.5 m -140.39 122.78 16.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.547 HD13 ' HZ ' ' A' ' 117' ' ' PHE . 64.5 mt -124.25 116.68 48.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.311 -175.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 105' ' ' PRO . 39.3 tp -100.38 124.09 45.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.718 -176.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -100.05 105.59 17.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.722 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.495 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 45.8 mt -100.99 108.36 54.07 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.055 -175.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -87.46 169.24 7.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.815 2.343 . . . . 0.0 112.235 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.614 ' SD ' ' HD3' ' A' ' 40' ' ' PRO . 84.2 mtp -93.89 1.0 56.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.654 0.74 . . . . 0.0 109.427 175.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -139.39 102.95 4.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.025 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.11 -153.76 16.76 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.561 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.653 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 15.4 tptt -112.35 153.63 44.75 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.537 ' HB2' HD11 ' A' ' 97' ' ' LEU . 5.7 Cg_exo -79.41 144.89 18.35 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.028 2.485 . . . . 0.0 112.781 -176.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -107.99 168.3 9.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.522 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 49.3 ttm -142.48 139.1 31.4 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.939 0.4 . . . . 0.0 111.44 -174.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -126.9 137.78 53.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.566 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -100.12 123.4 44.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.02 0.438 . . . . 0.0 110.772 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.717 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 126.58 -169.02 18.56 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.268 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.24 80.01 1.4 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.601 0.715 . . . . 0.0 110.721 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.674 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 5.0 mpp? -59.05 144.47 82.48 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.626 174.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.29 -175.96 2.83 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.891 2.394 . . . . 0.0 112.14 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -56.6 -39.63 73.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.465 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.75 -51.15 66.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.096 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.674 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 33.1 m -68.17 -29.13 67.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.75 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.647 ' O ' HG12 ' A' ' 121' ' ' ILE . 10.6 m-85 -75.41 -39.1 59.42 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.293 176.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -53.88 -37.46 63.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.035 0.445 . . . . 0.0 110.388 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 45.3 tttp -69.06 -46.34 68.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.354 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -66.79 -44.46 81.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.049 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.647 HG12 ' O ' ' A' ' 117' ' ' PHE . 17.4 mm -74.0 -50.57 27.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.736 0.303 . . . . 0.0 111.098 -174.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 126' ' ' LEU . 11.9 t70 -68.37 -60.93 2.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.014 0.435 . . . . 0.0 110.808 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.872 ' HA ' ' HD2' ' A' ' 127' ' ' LYS . 22.2 mt-10 -75.73 -9.69 58.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.164 -167.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.411 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 79.9 t80 -127.69 -39.54 1.81 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.25 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 125' ' ' LEU . 3.3 tp -91.01 -32.42 15.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.458 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 23.8 tp -84.01 -65.26 1.03 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.872 ' HD2' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.747 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 167.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 65' ' ' LYS . . . . . . . . 0 CA--C 1.51 -0.279 0 N-CA-C 115.426 0.93 . . . . 0.0 115.426 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -169.6 173.06 6.56 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.906 0.86 . . . . 0.0 113.03 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 12.9 m -100.43 110.67 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 113.469 -1.696 . . . . 0.0 109.57 171.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.401 HD12 ' CE2' ' A' ' 74' ' ' TYR . 47.2 mt -83.84 103.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.113 -175.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -75.63 112.12 11.66 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 2.9 pp -140.28 158.31 44.23 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.744 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.501 HG22 ' CE ' ' A' ' 80' ' ' LYS . 40.0 p -82.49 166.15 19.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.774 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.731 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 42.8 pttt -56.15 -34.12 65.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.682 177.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.57 -37.47 82.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.102 0.477 . . . . 0.0 110.416 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 42.5 mt-10 -71.99 -34.84 69.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.504 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -63.47 -48.28 78.3 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.086 0.946 . . . . 0.0 108.935 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.6 tt -46.83 -61.33 1.9 Allowed 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.281 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.94 -25.02 40.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.428 -170.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -93.7 -37.68 11.7 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.644 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.0 t -118.82 -41.12 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -167.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.578 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 30.0 t80 -166.99 118.83 0.93 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.05 0.452 . . . . 0.0 111.809 -165.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.443 ' ND2' HD21 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -85.25 91.06 8.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.528 -178.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.557 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 49.0 p90 -86.17 18.81 2.92 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.698 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 27.6 mt-10 -102.1 -54.73 2.64 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 175.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.698 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 8.1 mptt -91.68 -19.56 22.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.694 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.64 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -119.79 65.63 9.75 Favored Pre-proline 0 C--O 1.224 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.972 178.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -63.78 -44.98 11.85 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.754 2.302 . . . . 0.0 112.189 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -106.58 -11.73 15.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.014 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 40.7 mt-10 -91.05 131.21 36.78 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.643 ' HZ3' ' HE1' ' A' ' 88' ' ' PHE . 69.9 t-105 -94.54 88.79 5.57 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.222 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -97.37 106.35 18.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.262 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -108.94 124.76 51.19 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.969 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -119.16 131.51 55.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.985 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 167.12 162.14 18.08 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.885 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -97.53 -14.95 20.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.969 0.414 . . . . 0.0 110.803 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.457 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 9.9 mmtp -127.17 161.25 55.28 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HB3' HD11 ' A' ' 125' ' ' LEU . 23.4 Cg_exo -65.01 132.41 32.04 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.752 2.301 . . . . 0.0 110.1 166.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.52 138.36 43.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -168.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.757 ' HB ' HG12 ' A' ' 73' ' ' ILE . 4.6 mp -113.4 112.49 40.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 165.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.652 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 21.5 t -98.28 112.18 29.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.079 0.466 . . . . 0.0 110.297 -177.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.39 109.44 20.73 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.306 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 97.3 m-85 -94.14 111.68 23.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 174.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.695 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.7 p90 -132.66 167.71 19.6 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.493 0.663 . . . . 0.0 110.852 -175.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.411 ' H ' ' CB ' ' A' ' 53' ' ' CYS . . . -140.18 125.94 19.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.042 -1.435 . . . . 0.0 107.803 172.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -56.82 -40.33 75.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.437 ' HE1' ' HG2' ' A' ' 79' ' ' GLU . 62.2 p-90 -67.69 -8.61 36.55 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.6 t -98.37 126.63 43.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.942 0.401 . . . . 0.0 110.521 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.82 -61.85 6.97 Favored Glycine 0 CA--C 1.518 0.246 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.255 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -47.65 -41.44 30.59 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.959 2.439 . . . . 0.0 113.149 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.695 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 97.2 m -66.26 -44.26 84.15 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.78 -27.73 61.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.313 0.578 . . . . 0.0 109.502 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -61.23 -43.82 98.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.26 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.619 ' HB ' HD23 ' A' ' 60' ' ' LEU . 24.1 m -84.97 -20.52 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -174.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.467 ' HA ' ' NZ ' ' A' ' 75' ' ' LYS . . . -41.58 -53.31 7.55 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.91 -40.98 5.96 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 121.735 1.623 . . . . 0.0 112.448 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.2 mt -60.6 -42.72 92.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.238 0.542 . . . . 0.0 110.503 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.619 HD23 ' HB ' ' A' ' 56' ' ' VAL . 2.6 mm? -56.42 -42.35 77.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.46 176.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.493 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 11.1 t70 -62.97 -42.41 99.82 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.406 176.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.833 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 21.5 mm-40 -54.08 -56.63 16.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.25 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.538 HD21 ' HG3' ' A' ' 114' ' ' LYS . 3.7 mm? -67.07 -31.82 72.58 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.103 -175.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.416 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -59.83 -57.47 12.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.459 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.833 ' HE2' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -76.39 -25.98 55.13 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.23 -47.51 67.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.992 0.425 . . . . 0.0 111.39 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.511 ' HB2' HD11 ' A' ' 71' ' ' ILE . 12.4 m-85 -101.88 24.8 9.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.323 -175.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.41 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 19.9 t70 -55.79 143.6 30.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.172 0.51 . . . . 0.0 111.439 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.87 -37.58 3.68 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.631 -178.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 8.8 pt20 -110.08 -12.63 14.49 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.178 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 67' ' ' TYR . 43.9 pt -147.01 167.87 5.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.935 0.398 . . . . 0.0 110.685 174.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 39' ' ' LYS . 13.3 p -145.73 144.7 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 172.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.757 HG12 ' HB ' ' A' ' 42' ' ' ILE . 40.9 mt -121.07 139.12 49.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.322 -177.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.401 ' CE2' HD12 ' A' ' 12' ' ' ILE . 67.5 m-85 -115.49 162.93 16.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.431 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.545 ' HB3' ' CE1' ' A' ' 46' ' ' TYR . 54.1 mttm -135.64 132.06 36.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.849 0.357 . . . . 0.0 110.533 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.481 HG13 ' HG2' ' A' ' 81' ' ' GLU . 1.0 OUTLIER -131.46 137.32 55.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.482 -176.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -90.98 96.07 10.44 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.461 HG21 ' HA ' ' A' ' 92' ' ' SER . 17.0 m -60.13 -25.6 65.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -168.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.437 ' HG2' ' HE1' ' A' ' 49' ' ' TRP . 2.8 mp0 -55.28 -40.43 71.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.462 0.172 . . . . 0.0 111.191 175.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.501 ' CE ' HG22 ' A' ' 15' ' ' THR . 22.6 pttm -98.71 -22.19 16.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.304 0.573 . . . . 0.0 110.2 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.731 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 1.3 mp0 -89.53 34.89 0.82 Allowed 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.281 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.411 ' HA ' ' OE1' ' A' ' 82' ' ' GLN . 14.2 mm-40 -64.01 -42.49 97.13 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -64.52 -35.33 80.62 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.254 0.55 . . . . 0.0 110.062 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.6 tp -63.7 -47.6 80.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.901 176.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.537 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -60.71 -42.27 96.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.797 176.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.4 -31.05 75.95 Favored Glycine 0 CA--C 1.517 0.168 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.698 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.19 -41.5 97.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.789 0.328 . . . . 0.0 111.012 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.643 ' HE1' ' HZ3' ' A' ' 33' ' ' TRP . 76.2 m-85 -82.7 -22.2 34.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.692 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.13 31.67 9.58 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.582 HG13 ' HB2' ' A' ' 88' ' ' PHE . 6.2 mt -85.4 154.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.717 0.294 . . . . 0.0 110.544 -176.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -69.11 -81.82 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.436 0.636 . . . . 0.0 109.373 171.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.461 ' HA ' HG21 ' A' ' 78' ' ' THR . 65.9 m -158.99 -81.26 0.05 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.925 173.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.638 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 2.2 pp -151.08 149.67 25.5 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.237 -174.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.721 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 5.1 Cg_exo -83.5 149.2 62.66 Favored 'Cis proline' 0 C--N 1.346 0.437 0 C-N-CA 124.743 -0.94 . . . . 0.0 112.356 -2.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.556 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 39.6 t -140.99 130.61 24.04 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 107' ' ' MET . 23.3 mm -120.92 113.96 41.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.652 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 31.4 tp -102.05 115.5 30.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.792 -175.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -97.78 106.09 18.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.972 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 105' ' ' PRO . 53.6 mt -105.08 113.44 64.69 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.704 -174.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.8 155.54 20.55 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.466 2.111 . . . . 0.0 111.491 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 82.2 mtp -81.39 4.23 21.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.628 0.728 . . . . 0.0 110.823 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -151.27 117.43 5.59 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.974 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.14 -147.29 18.17 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.935 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.427 ' NZ ' ' HB3' ' A' ' 33' ' ' TRP . 51.7 mmtt -128.49 152.11 77.82 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.558 ' HB3' HG12 ' A' ' 99' ' ' ILE . 88.2 Cg_endo -79.59 147.96 20.16 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.752 2.301 . . . . 0.0 113.829 -172.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.439 ' O ' HD12 ' A' ' 97' ' ' LEU . 23.4 mm-40 -103.47 167.68 9.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.572 176.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 38.3 ttm -141.32 130.0 22.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.124 0.487 . . . . 0.0 111.958 -178.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.96 127.32 53.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.106 173.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -99.56 136.73 39.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.927 0.394 . . . . 0.0 111.541 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.721 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 106.95 174.13 22.78 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.806 -0.634 . . . . 0.0 114.635 171.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.92 86.7 5.54 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.818 -0.691 . . . . 0.0 111.464 -175.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.586 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 22.7 ptt? -87.53 158.43 51.47 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.651 171.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 74.4 Cg_endo -75.19 178.58 7.11 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.312 2.008 . . . . 0.0 112.847 -173.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.538 ' HG3' HD21 ' A' ' 63' ' ' LEU . 54.8 tttm -61.07 -28.7 69.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.047 177.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.79 -52.53 20.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.394 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 21.6 m -67.48 -32.76 73.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.774 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.52 ' O ' HG13 ' A' ' 121' ' ' ILE . 1.4 m-85 -62.23 -46.59 88.17 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.492 174.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -56.39 -44.27 80.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.525 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.59 ' HB3' ' OE1' ' A' ' 123' ' ' GLU . 9.2 mtpm? -63.06 -50.37 70.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.44 75.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.843 0.354 . . . . 0.0 111.32 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 117' ' ' PHE . 70.9 mt -74.23 -55.11 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.04 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.556 ' HA ' ' HB2' ' A' ' 126' ' ' LEU . 31.0 t0 -69.68 -57.93 4.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.573 -173.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.59 ' OE1' ' HB3' ' A' ' 119' ' ' LYS . 44.6 mt-10 -58.15 -23.12 54.09 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -170.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -116.22 -47.8 2.74 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 40' ' ' PRO . 30.1 tp -88.26 -38.7 15.01 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.488 -171.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 122' ' ' ASP . 73.5 mt -83.09 -52.96 6.16 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.431 0.634 . . . . 0.0 109.388 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.687 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 167.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . . . . . . 0 N--CA 1.448 -0.524 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.492 ' HG3' ' OD2' ' A' ' 61' ' ' ASP . 54.9 tttp -160.23 173.33 15.89 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.3 p -112.41 113.15 43.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.431 0.634 . . . . 0.0 110.129 174.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.8 mm -109.38 131.23 60.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.058 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.709 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 3.7 p80 -85.8 116.62 24.17 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.56 174.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.508 HD12 HG23 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -109.52 179.23 4.2 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.355 -176.099 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.6 p -100.53 164.23 11.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.952 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.706 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 35.6 pttt -61.91 -27.0 68.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.815 0.34 . . . . 0.0 110.511 176.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -41.09 96.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.656 174.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -71.71 -38.22 70.56 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.197 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.443 ' HE1' HG11 ' A' ' 43' ' ' VAL . 2.3 t80 -54.21 -53.81 48.44 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.813 0.816 . . . . 0.0 109.305 176.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.582 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 30.0 mt -50.56 -60.07 3.4 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 113.598 -1.637 . . . . 0.0 111.929 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.22 -36.63 39.75 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -102.79 -4.59 24.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -171.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 58.2 t -132.96 -51.99 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.582 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 7.5 t80 -179.19 131.0 0.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 110.746 -167.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.635 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 25.9 t-20 -91.21 136.24 33.23 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.655 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.404 ' HZ ' ' HB2' ' A' ' 16' ' ' LYS . 7.6 p90 -123.91 20.8 9.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.171 0.51 . . . . 0.0 110.547 175.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -105.64 -53.93 2.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.593 0.711 . . . . 0.0 109.798 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.614 ' C ' HD22 ' A' ' 29' ' ' ASN . 22.0 ptmt -97.02 -12.61 23.05 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.526 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.635 ' HB2' ' O ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -116.89 62.55 2.84 Favored Pre-proline 0 N--CA 1.473 0.723 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.239 174.451 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -63.43 -43.06 19.05 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.705 2.27 . . . . 0.0 112.614 174.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.516 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -100.59 -27.7 13.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.607 -175.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 37.7 mt-10 -92.69 128.67 38.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.044 0.449 . . . . 0.0 110.795 -177.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.421 ' HA ' ' CE1' ' A' ' 24' ' ' TYR . 44.3 t-105 -92.55 93.13 8.38 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HD2' ' OD1' ' A' ' 29' ' ' ASN . 92.2 mttt -104.95 97.26 7.15 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.107 176.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.481 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 28.5 t80 -79.69 104.39 10.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.642 175.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -98.91 84.0 3.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.611 177.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.481 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -129.68 -143.51 5.47 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.844 -175.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -147.92 -64.64 0.26 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.8 0.333 . . . . 0.0 110.104 -173.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 70' ' ' GLN . 45.8 mttp -120.85 159.5 48.58 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.862 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.47 ' HG2' HG22 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -45.29 131.92 11.79 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.073 2.516 . . . . 0.0 112.084 179.054 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.52 139.18 54.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.567 -172.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.9 mt -117.76 114.57 45.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.418 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 16.4 t -101.76 112.99 36.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.791 0.329 . . . . 0.0 111.219 -176.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 8.2 t70 -92.56 112.13 23.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.969 176.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.477 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 75.6 m-85 -87.55 110.58 20.45 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 173.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.728 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 0.8 OUTLIER -132.11 163.83 27.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.159 0.504 . . . . 0.0 110.84 -175.365 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.406 ' N ' HG21 ' A' ' 93' ' ' ILE . . . -116.72 137.03 52.49 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.497 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 19.6 t70 -62.98 -29.48 70.85 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -174.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -85.74 -6.91 59.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.79 0.328 . . . . 0.0 111.177 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.7 t -84.27 106.95 16.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.903 0.382 . . . . 0.0 111.081 -175.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.09 -50.76 54.11 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.673 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -46.92 -47.93 15.43 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.71 2.273 . . . . 0.0 113.191 175.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.728 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 83.0 m -66.97 -32.54 73.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.477 . . . . 0.0 111.257 -177.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 71.1 mmtt -58.76 -29.51 66.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.597 175.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.545 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 31.2 mtm -67.69 -39.56 84.43 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.712 0.291 . . . . 0.0 111.239 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 53' ' ' CYS . 16.6 m -78.21 -26.47 14.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -172.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.608 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -51.31 -54.24 40.69 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.608 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 35.4 Cg_exo -61.61 -43.65 25.88 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 122.045 1.83 . . . . 0.0 112.283 176.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.5 mt -58.46 -49.9 80.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.305 0.574 . . . . 0.0 110.591 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.432 HD22 HD13 ' A' ' 73' ' ' ILE . 20.0 mt -61.92 -40.84 96.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.39 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.492 ' OD2' ' HG3' ' A' ' 10' ' ' LYS . 12.7 t70 -64.79 -45.71 85.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.956 0.408 . . . . 0.0 110.806 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -62.36 -51.1 68.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.999 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.66 -32.57 72.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.181 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.552 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -62.28 -34.96 77.57 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.465 ' C ' ' HD3' ' A' ' 65' ' ' LYS . 2.8 tmtm? -73.96 -38.17 64.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.885 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -62.27 -48.14 81.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.238 0.542 . . . . 0.0 110.573 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -90.89 26.09 2.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.8 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -57.07 139.76 51.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.678 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.83 -25.98 26.19 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.955 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.549 ' HG3' HG23 ' A' ' 71' ' ' ILE . 11.7 pt20 -116.23 -44.46 2.89 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -177.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.549 HG23 ' HG3' ' A' ' 70' ' ' GLN . 33.6 pt -117.38 150.3 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.798 -177.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.8 t -121.56 127.25 75.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.268 176.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.671 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 31.8 mt -109.63 133.67 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 121.331 0.586 . . . . 0.0 110.278 -178.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -121.43 171.65 8.62 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.732 0.777 . . . . 0.0 110.373 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.709 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 1.1 ptpm? -146.09 159.15 43.68 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 168.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.685 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 2.6 p -140.38 143.52 29.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.596 -174.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' HB2' ' NZ ' ' A' ' 80' ' ' LYS . 20.2 m-20 -82.97 90.73 7.03 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -174.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 85' ' ' ALA . 27.0 m -57.91 -24.54 58.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.085 -173.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.6 -40.84 84.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.762 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.409 ' NZ ' ' HB2' ' A' ' 77' ' ' ASP . 23.9 pttm -101.15 -22.59 14.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.097 0.475 . . . . 0.0 110.527 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.706 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 1.4 mp0 -89.06 42.89 1.11 Allowed 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.534 175.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -66.11 -38.39 88.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.072 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -65.92 -38.02 87.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.363 0.602 . . . . 0.0 109.672 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.1 tp -65.68 -50.43 64.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.734 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.509 ' HB2' HG23 ' A' ' 78' ' ' THR . . . -65.36 -39.89 92.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.989 0.423 . . . . 0.0 110.899 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.3 -27.58 69.49 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.882 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.04 -32.92 72.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.935 0.398 . . . . 0.0 110.85 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.551 ' HB2' HG12 ' A' ' 90' ' ' ILE . 90.5 m-85 -93.48 -3.41 53.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.646 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.15 13.39 74.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.005 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.551 HG12 ' HB2' ' A' ' 88' ' ' PHE . 26.9 mm -83.63 119.54 33.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.543 0.211 . . . . 0.0 110.517 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -59.53 -58.04 10.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 110.953 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.402 ' O ' HG21 ' A' ' 78' ' ' THR . 32.1 m -150.92 -96.96 0.06 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.7 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -146.86 163.18 30.21 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.903 -0.135 . . . . 0.0 111.043 -170.79 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.666 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 2.7 Cg_exo -89.18 150.16 26.81 Favored 'Cis proline' 0 C--N 1.347 0.498 0 C-N-CA 124.72 -0.95 . . . . 0.0 112.509 -4.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.477 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 34.7 t -140.68 145.28 36.32 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 107' ' ' MET . 30.5 mt -135.25 116.24 19.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.825 0.345 . . . . 0.0 110.304 -178.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.497 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 47.3 tp -102.91 116.61 32.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.403 -177.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -98.67 109.11 21.92 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.55 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 58.2 mt -104.48 113.39 65.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.691 -174.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -84.34 168.54 11.58 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.851 2.367 . . . . 0.0 111.786 174.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 87.2 mtp -82.31 -26.04 33.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.243 0.544 . . . . 0.0 109.949 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -130.66 138.1 49.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.223 176.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.69 161.35 36.66 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -92.37 143.93 28.12 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 117.377 0.589 . . . . 0.0 110.093 -177.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.55 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 27.5 Cg_endo -61.03 159.59 29.24 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.722 2.948 . . . . 0.0 114.3 -170.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -117.15 168.84 9.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.091 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 47.7 ttm -142.03 127.04 18.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.285 0.564 . . . . 0.0 112.224 -175.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.5 140.54 49.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -114.59 141.41 47.8 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.904 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.666 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 107.46 169.75 21.98 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.378 174.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.06 85.29 6.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.218 0.532 . . . . 0.0 111.358 -176.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.593 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 24.1 ptp -80.85 152.11 71.58 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.029 176.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.636 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 98.2 Cg_endo -75.26 -178.24 4.08 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.681 2.254 . . . . 0.0 112.062 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -62.24 -36.75 82.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.142 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.38 -37.63 74.56 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.941 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.636 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 71.8 m -72.82 -34.62 66.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.756 174.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.661 ' O ' HG12 ' A' ' 121' ' ' ILE . 2.1 m-85 -63.27 -51.82 64.58 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 121.126 -0.229 . . . . 0.0 110.792 176.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -57.02 -36.53 70.55 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.964 0.411 . . . . 0.0 110.503 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.467 ' NZ ' ' HB2' ' A' ' 119' ' ' LYS . 4.8 ttmp? -57.22 -42.7 81.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.884 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.83 -34.96 69.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.047 176.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.661 HG12 ' O ' ' A' ' 117' ' ' PHE . 37.2 mm -64.85 -56.02 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.698 -178.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.477 ' HA ' HD12 ' A' ' 126' ' ' LEU . 2.0 m-20 -66.64 -64.39 0.86 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.011 0.434 . . . . 0.0 110.951 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.75 -34.39 69.49 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.535 -171.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.453 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 63.4 t80 -108.26 -50.27 3.06 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 18.1 tp -81.43 -30.99 33.33 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.476 -169.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 122' ' ' ASP . 80.4 mt -87.44 -50.54 6.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.297 0.57 . . . . 0.0 109.635 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp . . . . . 0 C--N 1.322 -0.594 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 171.638 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.0 mmm . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.859 0.362 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.8 m -101.71 81.02 2.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.056 0.455 . . . . 0.0 110.877 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.815 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.2 pt? -97.1 -34.4 11.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.291 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.14 87.44 1.33 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.0 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 p -108.94 19.85 19.11 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.215 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.437 ' HG2' ' H ' ' A' ' 7' ' ' GLY . 24.9 tt0 56.59 -132.85 1.47 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.738 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.437 ' H ' ' HG2' ' A' ' 6' ' ' GLU . . . 81.81 -58.02 4.92 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.326 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -72.08 133.99 45.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 68.83 29.49 72.59 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.731 -175.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HG3' ' H ' ' A' ' 11' ' ' VAL . 43.1 tptt -137.12 173.23 11.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.2 p -122.18 107.99 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.578 0.704 . . . . 0.0 110.296 175.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 43.8 mm -108.81 132.21 57.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.202 -176.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.657 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 4.6 p80 -89.09 127.9 35.73 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.475 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 1.1 pp -128.28 -179.99 5.31 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.968 -172.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.443 ' HA ' ' OE1' ' A' ' 81' ' ' GLU . 45.3 p -104.36 174.84 5.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.244 177.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.498 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 13.0 pttm -64.45 -26.69 68.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 111.198 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.468 ' HA ' HD12 ' A' ' 20' ' ' LEU . . . -65.97 -40.31 91.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.311 0.577 . . . . 0.0 110.404 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.475 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -71.86 -34.51 69.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.804 178.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.458 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -59.07 -53.79 54.4 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.476 174.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.712 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 18.1 mt -46.91 -59.7 2.92 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.655 -1.612 . . . . 0.0 111.919 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.64 -48.48 72.06 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -170.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -104.13 -3.1 24.9 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.401 -170.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 61.1 t -129.06 -52.9 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.712 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 11.7 t80 -167.62 124.73 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.01 -164.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.71 91.4 7.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.951 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.512 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 25.2 p90 -79.99 12.99 2.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.11 0.481 . . . . 0.0 111.412 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -93.88 -53.07 4.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.646 ' C ' HD22 ' A' ' 29' ' ' ASN . 60.3 mttp -83.46 -23.71 32.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.735 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.653 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -121.58 69.37 23.63 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.376 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -57.58 -37.05 98.29 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.311 2.674 . . . . 0.0 112.279 173.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -105.13 -42.43 5.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.983 -174.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -94.98 178.19 5.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.362 0.601 . . . . 0.0 112.375 -174.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.799 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 19.1 t-105 -125.19 108.6 11.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.569 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.476 ' C ' ' HD3' ' A' ' 34' ' ' LYS . 8.6 tmtt? -110.7 112.63 24.64 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 172.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.527 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 13.9 t80 -80.8 124.95 29.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.548 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -101.05 8.48 42.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.422 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.423 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -88.4 150.56 21.99 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 -177.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -92.29 -30.07 16.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.078 0.465 . . . . 0.0 110.961 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -115.09 155.22 46.93 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.912 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 70' ' ' GLN . 47.8 Cg_exo -56.92 132.17 50.01 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.352 2.034 . . . . 0.0 111.381 174.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -117.05 154.98 30.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.476 0.655 . . . . 0.0 111.676 -175.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.429 HD13 HG12 ' A' ' 121' ' ' ILE . 78.3 mt -128.1 110.3 21.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.077 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 23.9 t -100.54 114.07 38.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.974 0.416 . . . . 0.0 111.114 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.609 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 4.4 t70 -90.8 113.8 26.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.181 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -84.88 111.04 19.29 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 170.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.689 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.4 p90 -132.33 159.0 40.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.289 0.566 . . . . 0.0 111.089 -177.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.447 ' CB ' HG12 ' A' ' 93' ' ' ILE . . . -128.14 128.85 45.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.007 171.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.532 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 28.3 t70 -63.47 -28.86 70.25 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.565 -170.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -75.63 -2.78 30.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.683 0.277 . . . . 0.0 111.732 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 42.5 t -103.43 127.72 50.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.939 0.4 . . . . 0.0 110.785 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.81 -61.43 7.34 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.661 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 72.1 Cg_exo -47.84 -47.54 18.46 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.761 2.307 . . . . 0.0 112.537 176.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.689 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 65.1 m -56.86 -29.45 62.9 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.03 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 62.8 mttm -73.8 -42.95 60.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.172 174.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.652 ' O ' HG12 ' A' ' 59' ' ' ILE . 26.1 mtm -59.89 -40.13 87.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.917 0.389 . . . . 0.0 111.396 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.501 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 11.5 p -64.04 -30.53 50.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.161 -171.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.684 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -57.53 -57.55 24.49 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 118.833 -0.603 . . . . 0.0 112.021 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.684 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 47.0 Cg_exo -57.82 -39.96 82.72 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 121.811 1.674 . . . . 0.0 112.539 174.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.652 HG12 ' O ' ' A' ' 55' ' ' MET . 21.0 mm -61.15 -49.42 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 121.709 0.766 . . . . 0.0 109.916 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.683 HD22 HD13 ' A' ' 73' ' ' ILE . 11.6 mt -63.93 -37.51 87.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.543 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -62.4 -44.29 96.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.418 0.628 . . . . 0.0 109.451 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -58.71 -55.61 32.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.363 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.431 HD21 ' HG3' ' A' ' 114' ' ' LYS . 4.4 mm? -66.72 -33.93 76.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.315 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.55 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -60.79 -46.05 92.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.952 0.406 . . . . 0.0 110.239 177.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.561 ' NZ ' ' HB3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -69.45 -31.52 69.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.716 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.02 -35.96 69.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.27 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -109.22 27.74 9.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.876 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.91 148.97 9.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.388 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.54 -44.5 2.59 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.843 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.442 ' HG3' HG23 ' A' ' 71' ' ' ILE . 16.5 pt20 -93.33 -38.62 11.39 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.442 HG23 ' HG3' ' A' ' 70' ' ' GLN . 38.9 pt -118.74 159.98 18.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.009 0.433 . . . . 0.0 111.713 -177.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 63.6 t -133.36 121.69 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.683 HD13 HD22 ' A' ' 60' ' ' LEU . 46.0 mt -103.86 139.43 24.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.486 0.66 . . . . 0.0 111.253 -175.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -128.04 173.49 10.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.898 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 0.6 OUTLIER -149.34 158.45 44.19 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 170.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.496 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 9.9 p -133.88 136.06 54.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.203 0.525 . . . . 0.0 110.438 -177.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.469 ' HB2' ' HZ2' ' A' ' 80' ' ' LYS . 3.6 m-20 -80.1 94.37 5.97 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.377 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.666 HG21 ' HA ' ' A' ' 92' ' ' SER . 74.6 m -58.49 -33.8 70.21 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -174.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -53.93 -31.16 49.4 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HZ2' ' HB2' ' A' ' 77' ' ' ASP . 14.6 pttp -106.21 -32.04 8.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.179 0.514 . . . . 0.0 110.504 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.498 ' OE2' ' HG2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -90.83 44.23 1.19 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.367 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -61.06 -37.18 81.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.428 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -70.58 -37.72 73.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.228 0.537 . . . . 0.0 110.072 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.1 -49.14 59.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.789 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.14 84.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.969 0.414 . . . . 0.0 111.077 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -66.84 -31.18 77.49 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.903 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.68 93.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 0.0 111.616 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.602 ' HB2' HG12 ' A' ' 90' ' ' ILE . 72.5 m-85 -85.91 -1.68 57.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.84 0.352 . . . . 0.0 110.898 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.01 15.85 78.07 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.33 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.602 HG12 ' HB2' ' A' ' 88' ' ' PHE . 48.9 mm -65.46 -25.14 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 122.587 0.355 . . . . 0.0 110.866 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 72.03 -67.77 0.25 Allowed 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.744 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.666 ' HA ' HG21 ' A' ' 78' ' ' THR . 33.7 m -151.77 -89.31 0.06 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.932 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.531 HG21 ' C ' ' A' ' 46' ' ' TYR . 2.4 pp -163.29 159.92 18.24 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.595 -170.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.577 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 2.3 Cg_endo -95.22 147.1 8.4 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 124.821 -0.908 . . . . 0.0 111.803 -4.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.4 t -141.73 138.77 32.6 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 107' ' ' MET . 30.7 mm -118.77 113.8 42.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 25.6 tp -98.0 112.71 24.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.527 -176.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.24 110.11 22.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.545 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 32.2 mt -101.69 106.17 45.1 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.153 -174.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.36 163.27 27.5 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.583 2.189 . . . . 0.0 111.95 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 92.3 mmm -85.16 0.29 52.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.479 0.657 . . . . 0.0 110.082 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -138.77 111.1 7.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.117 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.71 -158.83 18.5 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.24 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.799 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 42.7 mtpt -113.24 154.36 45.27 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.545 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 73.1 Cg_endo -75.34 140.49 24.6 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.83 2.353 . . . . 0.0 114.563 -170.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.432 ' CG ' ' HZ ' ' A' ' 124' ' ' PHE . 18.8 mp0 -91.35 169.93 10.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.578 173.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.555 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 21.4 ptp -142.01 144.38 33.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.025 0.441 . . . . 0.0 111.177 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -124.68 126.43 45.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.292 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -86.49 126.72 34.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.089 0.471 . . . . 0.0 111.375 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.577 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 100.29 155.72 27.78 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.436 175.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.501 ' HB1' ' HB ' ' A' ' 56' ' ' VAL . . . -87.59 87.33 7.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.342 0.591 . . . . 0.0 111.068 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.61 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 12.7 ptt? -68.26 162.95 56.72 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.283 173.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.566 ' HD2' ' HB2' ' A' ' 112' ' ' MET . 97.1 Cg_endo -75.09 179.14 6.4 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.633 2.222 . . . . 0.0 113.009 -173.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.431 ' HG3' HD21 ' A' ' 63' ' ' LEU . 58.3 tttp -54.81 -35.77 64.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.847 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.62 -52.76 19.18 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.915 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.61 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 18.8 m -66.12 -34.66 78.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.559 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.535 ' O ' HG13 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -63.94 -43.18 96.64 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.049 178.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.409 ' HZ2' ' HB3' ' A' ' 122' ' ' ASP . 1.6 ttpp -57.03 -40.67 77.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 0.0 110.075 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -66.74 -41.36 87.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.609 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.33 -36.88 71.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.977 0.418 . . . . 0.0 111.583 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.581 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 62.9 mt -73.99 -56.64 8.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.493 0.664 . . . . 0.0 110.69 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.409 ' HB3' ' HZ2' ' A' ' 118' ' ' LYS . 14.6 t0 -72.47 -64.77 0.88 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.169 -174.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.646 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 24.4 mt-10 -80.04 11.93 3.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.595 -169.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.609 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 58.5 t80 -138.46 -50.35 0.56 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.164 -0.214 . . . . 0.0 111.554 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.581 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 42.8 tp -73.54 -40.91 63.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.65 0.262 . . . . 0.0 110.59 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -90.81 -53.82 4.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.418 0.628 . . . . 0.0 109.306 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.646 ' HB3' ' HA ' ' A' ' 123' ' ' GLU . 52.1 tptt -81.52 70.47 8.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.702 0.763 . . . . 0.0 109.219 173.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 131' ' ' HIS . 17.8 pttp -77.31 67.66 3.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.916 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 133' ' ' HIS . 1.7 tp10 -72.7 -15.93 61.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.736 -176.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -100.24 7.5 58.48 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.492 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 128' ' ' LYS . 1.7 m-70 -118.05 106.51 12.97 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.54 -0.388 . . . . 0.0 111.377 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.9 m80 66.72 7.8 5.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.342 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.478 ' HB3' ' O ' ' A' ' 129' ' ' GLU . 70.7 t60 -100.09 106.33 18.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.195 0.522 . . . . 0.0 111.319 -176.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.41 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 3.9 p-80 -113.06 -19.52 11.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.128 173.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 134' ' ' HIS . 36.6 t-80 167.59 -46.8 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 113.372 -1.74 . . . . 0.0 107.1 165.805 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.415 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 110.695 -0.113 . . . . 0.0 110.695 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -171.37 157.26 4.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 tt -101.33 -72.08 0.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -161.03 136.61 7.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.908 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.5 m -156.49 98.06 1.79 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -114.6 -42.44 3.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.591 -179.229 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.8 -27.11 4.98 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.396 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.444 ' HA ' HG22 ' A' ' 72' ' ' VAL . 21.9 t-20 -67.67 133.7 49.8 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.481 ' C ' ' HD2' ' A' ' 10' ' ' LYS . . . 83.9 -8.59 65.81 Favored Glycine 0 CA--C 1.51 -0.271 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.445 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.481 ' HD2' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -131.77 174.62 9.95 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.618 -0.342 . . . . 0.0 110.265 -176.213 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.68 HG23 HG22 ' A' ' 73' ' ' ILE . 13.0 p -113.58 123.46 69.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.323 0.582 . . . . 0.0 110.653 173.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.6 mm -124.67 120.4 58.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.254 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.753 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 7.1 p80 -86.74 129.91 34.69 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.154 175.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -124.01 178.56 5.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.981 -172.172 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.604 HG22 ' HE2' ' A' ' 80' ' ' LYS . 41.3 p -93.07 171.46 8.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.686 175.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.457 ' HE3' ' HB3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -58.54 -37.4 75.6 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 178.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.44 ' N ' ' HG2' ' A' ' 16' ' ' LYS . . . -63.37 -37.93 89.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.477 0.656 . . . . 0.0 110.161 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 40.0 mt-10 -72.9 -34.82 66.89 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.751 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.474 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 6.8 t80 -54.89 -51.47 65.9 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 122.638 1.208 . . . . 0.0 108.761 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.656 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 25.9 mt -54.76 -58.39 7.76 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 112.481 -2.145 . . . . 0.0 111.931 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.94 -14.53 41.57 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -170.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 94.3 mttt -109.93 -5.84 15.37 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.202 -0.311 . . . . 0.0 111.368 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 59.4 t -141.02 -56.34 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.656 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 45.1 t80 -167.26 125.34 1.28 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.054 -164.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.539 ' OD1' ' HD3' ' A' ' 28' ' ' LYS . 2.8 t-20 -86.46 90.25 8.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.621 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -85.82 11.97 10.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.743 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 6.6 mt-10 -94.5 -54.29 3.58 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.938 0.875 . . . . 0.0 108.813 175.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.743 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 12.2 mptt -88.12 -23.45 23.67 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.628 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.666 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -120.62 68.64 15.4 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.899 -179.242 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -61.27 -43.7 27.36 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.966 2.444 . . . . 0.0 112.24 170.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -100.97 -29.93 11.92 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.161 0.505 . . . . 0.0 110.824 -175.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.57 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 22.9 mp0 -89.79 127.92 36.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.999 -169.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.543 ' HB2' ' NZ ' ' A' ' 104' ' ' LYS . 72.8 t-105 -89.95 89.57 7.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.223 0.535 . . . . 0.0 110.432 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -106.24 97.74 7.51 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.764 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 83.0 t80 -85.41 119.64 26.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.893 176.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -112.62 85.54 2.18 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.451 0.643 . . . . 0.0 110.184 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -147.24 -154.04 6.1 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.984 -176.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -115.12 -58.84 2.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.247 0.546 . . . . 0.0 110.534 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 51.0 mttp -135.65 170.18 11.75 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.278 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 79.7 Cg_exo -45.25 132.52 11.85 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 122.735 2.29 . . . . 0.0 112.459 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -117.79 145.84 44.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.596 -171.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.414 HD11 HD12 ' A' ' 121' ' ' ILE . 75.0 mt -119.8 114.31 43.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.118 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 28.7 t -98.57 110.3 25.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.767 0.317 . . . . 0.0 110.836 -177.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.562 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 7.6 t70 -98.4 111.61 23.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.961 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.573 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 79.9 m-85 -90.38 112.12 23.6 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.768 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.2 p90 -133.77 179.06 6.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.39 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.655 ' HB3' HD13 ' A' ' 93' ' ' ILE . . . -154.79 173.34 16.59 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.484 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.463 ' HA ' ' HE3' ' A' ' 54' ' ' LYS . 20.6 t70 -80.68 -46.43 15.57 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -175.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.404 ' CZ2' HD11 ' A' ' 93' ' ' ILE . 51.8 p-90 -71.04 0.23 7.98 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -173.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.504 ' CB ' HD12 ' A' ' 93' ' ' ILE . 45.4 t -112.85 114.03 26.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.943 0.401 . . . . 0.0 110.292 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.2 -51.62 58.09 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.256 -0.747 . . . . 0.0 113.64 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -47.42 -37.7 25.87 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.969 2.446 . . . . 0.0 112.929 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 59.9 m -59.75 -39.84 86.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.47 0.653 . . . . 0.0 111.485 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HE3' ' HA ' ' A' ' 48' ' ' ASP . 99.4 mttt -79.04 -29.99 43.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.161 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.527 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 4.5 tmm? -62.44 -46.05 90.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.811 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.57 HG22 ' HG ' ' A' ' 60' ' ' LEU . 14.5 p -71.18 -26.21 26.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.944 -175.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.633 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -53.83 -56.33 26.54 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 36.5 Cg_exo -60.04 -47.06 16.31 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 121.708 1.605 . . . . 0.0 112.009 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.0 mt -58.34 -43.3 86.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.759 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.63 HD22 HD13 ' A' ' 73' ' ' ILE . 7.8 mt -64.87 -44.68 88.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.092 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.58 ' HB2' HG12 ' A' ' 11' ' ' VAL . 27.2 t70 -67.61 -40.96 84.72 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.403 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.18 -45.29 95.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.735 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 63' ' ' LEU . 16.6 tp -65.82 -34.76 78.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.823 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.609 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -64.99 -35.09 80.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.907 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.583 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 5.2 tmtm? -75.43 -32.5 60.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.483 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -52.5 -46.83 66.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.561 0.696 . . . . 0.0 109.968 172.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -104.97 28.08 7.53 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.578 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.583 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 9.0 t0 -48.88 131.01 18.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.229 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.34 -18.95 56.41 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.248 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -105.28 -48.81 3.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.635 0.255 . . . . 0.0 111.585 -176.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 40' ' ' PRO . 34.0 pt -122.85 159.82 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.4 0.619 . . . . 0.0 112.544 -173.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 27.4 t -125.39 127.91 72.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.42 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.68 HG22 HG23 ' A' ' 11' ' ' VAL . 20.5 mt -112.09 130.49 65.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.381 0.61 . . . . 0.0 110.824 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -114.2 165.64 12.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.614 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.753 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 47.9 mttm -132.14 153.46 50.49 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.487 173.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.53 HG13 ' HG2' ' A' ' 81' ' ' GLU . 4.7 t -127.14 121.44 57.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.738 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.406 ' HB2' ' HG2' ' A' ' 80' ' ' LYS . 11.3 m-20 -77.98 88.86 4.14 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 92' ' ' SER . 20.8 p -52.85 -30.02 31.25 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.111 0.481 . . . . 0.0 111.445 -175.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.473 ' CD ' ' HB1' ' A' ' 47' ' ' ALA . 2.6 mm-40 -50.56 -44.86 56.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.099 174.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.604 ' HE2' HG22 ' A' ' 15' ' ' THR . 19.3 pttm -103.33 -19.43 14.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.06 0.457 . . . . 0.0 110.672 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.53 ' HG2' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -97.85 42.87 1.08 Allowed 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.27 0.628 . . . . 0.0 111.453 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -57.24 -43.24 82.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.139 0.495 . . . . 0.0 110.812 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.36 -36.27 78.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.531 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.56 -47.77 74.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.565 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.56 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -63.94 -48.34 76.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.682 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.01 -32.76 76.48 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.129 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.06 -40.0 95.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.801 0.334 . . . . 0.0 111.525 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.438 ' HB2' HG13 ' A' ' 90' ' ' ILE . 96.4 m-85 -92.67 5.95 49.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.325 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.49 20.86 78.24 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.153 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 85' ' ' ALA . 26.4 mt -76.84 137.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.749 ' H ' ' HD2' ' A' ' 91' ' ' ARG . 3.0 mpt_? -71.59 -64.68 0.88 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.427 ' O ' HG21 ' A' ' 78' ' ' THR . 5.2 p -177.65 -85.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.368 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.655 HD13 ' HB3' ' A' ' 47' ' ' ALA . 13.9 pt -150.55 146.82 20.18 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -167.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.766 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 11.3 Cg_exo -86.65 150.48 42.09 Favored 'Cis proline' 0 N--CA 1.473 0.282 0 C-N-CA 124.513 -1.036 . . . . 0.0 110.722 -6.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 4.5 m -139.95 128.93 23.5 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 107' ' ' MET . 57.0 mt -128.02 114.32 34.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.745 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.62 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.7 tp -102.45 113.32 26.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.74 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -92.3 102.62 15.11 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.849 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.567 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 65.4 mt -97.61 113.17 63.12 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.61 -175.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -86.5 165.34 9.33 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.742 2.294 . . . . 0.0 111.547 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 93.1 mmm -89.7 2.44 54.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.562 0.696 . . . . 0.0 109.345 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -140.82 98.25 3.36 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.844 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.16 -162.49 13.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.862 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.543 ' NZ ' ' HB2' ' A' ' 33' ' ' TRP . 25.8 mmmt -98.49 150.46 36.74 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.567 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 5.7 Cg_exo -79.36 155.94 25.27 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.196 2.597 . . . . 0.0 112.987 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 107' ' ' MET . 29.3 tt0 -109.07 163.6 13.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.133 174.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.596 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 22.4 ptp -142.74 129.06 19.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.359 0.599 . . . . 0.0 111.202 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.31 156.55 27.63 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.883 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -116.89 137.81 51.96 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.221 0.534 . . . . 0.0 111.364 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.766 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 104.59 150.46 20.55 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.195 178.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -84.5 88.23 7.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.166 0.508 . . . . 0.0 111.342 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.516 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 25.2 ptp -69.68 164.74 47.91 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.524 172.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.606 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 74.3 Cg_endo -75.41 169.27 22.78 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.847 1.698 . . . . 0.0 111.621 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -55.69 -32.15 63.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.516 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 118' ' ' LYS . . . -71.33 -47.51 56.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.167 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.606 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 50.2 m -64.72 -33.8 76.82 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.687 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.696 ' O ' HG12 ' A' ' 121' ' ' ILE . 7.4 m-85 -61.57 -39.56 91.57 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.604 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.597 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 3.8 mmmm -54.01 -52.39 60.95 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.171 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.526 ' HG3' ' OE2' ' A' ' 123' ' ' GLU . 51.7 tttp -64.5 -32.98 74.84 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.677 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.546 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.32 -40.39 70.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.992 0.425 . . . . 0.0 111.214 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.696 HG12 ' O ' ' A' ' 117' ' ' PHE . 31.3 mm -73.58 -55.61 11.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.8 0.333 . . . . 0.0 110.278 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -65.36 -68.47 0.36 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.961 0.41 . . . . 0.0 110.825 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.526 ' OE2' ' HG3' ' A' ' 119' ' ' LYS . 48.2 mt-10 -77.4 12.0 1.74 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -169.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.546 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 77.8 t80 -143.51 -53.4 0.36 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.686 175.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 44.0 tp -69.6 -39.13 77.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.489 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 80.2 mt -88.54 -60.26 2.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.509 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 14.1 ttpp -103.0 81.2 1.95 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.429 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -62.66 123.62 18.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.985 0.421 . . . . 0.0 110.2 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -69.22 165.26 20.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.466 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.43 -41.09 2.63 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.752 -174.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -95.27 10.3 36.63 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 122.75 0.42 . . . . 0.0 110.685 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -69.64 117.85 11.76 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.599 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 45.53 69.84 0.41 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.068 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -135.72 -179.81 5.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.754 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -93.6 0.23 56.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.196 0.522 . . . . 0.0 109.643 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 . . . . . 0 C--O 1.245 0.826 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.815 179.41 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.488 ' H3 ' ' CD ' ' A' ' 6' ' ' GLU . 48.9 mtt . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 110.551 -0.166 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.4 t 71.05 18.98 5.74 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.169 0.509 . . . . 0.0 110.599 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 60.2 tp -100.67 -70.53 0.74 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.232 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -171.81 -62.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.199 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.5 m -84.28 96.43 9.01 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.679 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.488 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 23.1 mm-40 -70.29 -21.14 62.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.347 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.21 29.29 56.71 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.737 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -85.65 167.72 15.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.879 0.371 . . . . 0.0 111.714 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 57.16 41.51 92.78 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -174.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -150.4 152.3 34.14 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.852 0.834 . . . . 0.0 112.456 -167.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.731 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 5.0 p -134.83 119.48 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.098 174.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 60.0 mt -117.37 116.98 53.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.415 -173.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.738 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 11.0 p80 -83.8 119.67 25.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.842 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 2.0 pp -127.84 171.96 11.28 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.229 -171.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.7 p -99.18 177.89 5.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.161 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 19' ' ' PHE . 63.5 pttt -59.22 -25.24 63.83 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 20' ' ' LEU . . . -68.49 -44.17 75.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.284 0.564 . . . . 0.0 110.233 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.842 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 3.2 mp0 -72.24 -33.71 67.75 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.399 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.55 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -55.08 -49.23 72.19 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.007 0.908 . . . . 0.0 109.201 174.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.685 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 13.9 mt -50.58 -61.15 2.36 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.357 -1.747 . . . . 0.0 111.742 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.11 -7.58 59.62 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -169.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.02 -33.88 6.37 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 70.3 t -125.03 -40.78 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -169.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.685 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 21.5 t80 -164.95 117.88 1.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.866 -166.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.621 ' OD1' ' HD3' ' A' ' 28' ' ' LYS . 2.6 t-20 -91.66 89.68 7.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.485 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.657 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 18.9 p90 -81.12 6.89 12.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -86.16 -53.41 5.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.831 0.824 . . . . 0.0 108.903 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.635 ' C ' HD22 ' A' ' 29' ' ' ASN . 11.0 mptt -88.43 -23.41 23.3 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.426 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.695 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -118.69 61.54 4.9 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.195 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.17 -44.71 44.04 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.683 2.255 . . . . 0.0 112.112 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.21 -13.7 15.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.852 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.45 ' O ' ' HE1' ' A' ' 24' ' ' TYR . 44.9 mt-10 -91.09 144.08 26.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.271 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.505 ' CZ2' ' HG2' ' A' ' 105' ' ' PRO . 65.0 t-105 -108.36 109.17 20.42 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 171.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HG2' ' OE1' ' A' ' 36' ' ' GLU . 27.1 ttpp -134.21 117.65 16.73 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.621 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 29.4 t80 -90.05 110.97 21.93 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.714 -175.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.413 ' OE1' ' HG2' ' A' ' 34' ' ' LYS . 4.5 mm-40 -84.53 40.81 0.81 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.548 -176.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.613 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -98.3 165.7 21.73 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.731 -171.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -101.47 -56.88 2.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.302 0.572 . . . . 0.0 109.828 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -116.36 166.6 12.2 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.264 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.567 ' HB2' HG22 ' A' ' 71' ' ' ILE . 36.7 Cg_exo -55.83 137.15 77.78 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.165 1.91 . . . . 0.0 111.324 175.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -121.6 146.2 47.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.322 0.582 . . . . 0.0 112.02 -173.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.509 ' HB ' HG12 ' A' ' 73' ' ' ILE . 64.5 mt -113.18 112.31 39.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.905 172.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.793 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 20.7 t -98.94 113.59 34.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.863 0.363 . . . . 0.0 110.848 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.614 ' HB2' HD13 ' A' ' 60' ' ' LEU . 6.7 t70 -92.69 108.69 20.18 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.108 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.545 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 13.7 m-85 -88.07 109.94 20.25 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 171.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.767 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 3.9 p90 -130.25 160.77 32.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.186 0.517 . . . . 0.0 110.671 -175.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 50' ' ' CYS . . . -119.49 131.67 55.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.105 169.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.63 -11.26 59.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.01 0.434 . . . . 0.0 111.152 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.406 ' HE1' ' HG2' ' A' ' 79' ' ' GLU . 65.8 p-90 -102.23 -6.39 23.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.096 176.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 50.2 t -88.73 118.05 28.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.81 0.338 . . . . 0.0 110.954 -174.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 54' ' ' LYS . . . -52.13 -57.3 13.47 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.595 -0.729 . . . . 0.0 113.628 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.462 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 83.2 Cg_exo -47.32 -46.35 20.09 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.026 2.484 . . . . 0.0 113.552 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.767 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 74.9 m -68.78 -37.25 79.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.854 0.359 . . . . 0.0 111.215 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 68.1 mttm -55.25 -28.69 55.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.81 173.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 79.9 mtp -75.08 -50.92 14.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.025 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.58 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 32.8 m -71.82 -39.32 67.78 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -173.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -49.75 -56.8 14.82 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 23.3 Cg_exo -63.9 -35.76 53.84 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.732 1.622 . . . . 0.0 111.574 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.887 HG23 ' HB3' ' A' ' 114' ' ' LYS . 56.6 mt -62.75 -42.55 96.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.677 0.751 . . . . 0.0 110.464 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' A' ' 44' ' ' ASP . 28.2 mt -68.82 -35.51 77.07 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.119 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.563 ' OD1' HG11 ' A' ' 11' ' ' VAL . 57.1 m-20 -62.19 -45.77 91.91 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 173.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -54.92 -47.08 74.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.698 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.48 HD21 ' HB2' ' A' ' 114' ' ' LYS . 74.4 mt -69.3 -29.9 67.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.824 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.79 -42.65 84.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.826 0.346 . . . . 0.0 110.372 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.73 -28.69 58.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.396 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.464 ' CD ' ' HZ1' ' A' ' 114' ' ' LYS . 4.6 tt0 -80.62 -41.52 23.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.473 ' HE1' HD22 ' A' ' 63' ' ' LEU . 57.8 m-85 -98.94 24.96 7.11 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.847 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -64.53 163.57 13.27 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.232 0.539 . . . . 0.0 111.704 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.23 -50.51 3.88 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.296 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.511 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 23.9 pt20 -90.09 -40.33 12.34 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 -177.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.567 HG22 ' HB2' ' A' ' 40' ' ' PRO . 26.9 pt -127.56 166.77 23.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.293 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 51.4 t -134.06 139.5 48.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.731 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 39.1 mt -108.08 142.13 21.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.072 -175.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -127.47 165.96 18.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.799 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.738 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 86.1 mttt -132.39 166.36 22.15 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.56 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 5.1 p -146.06 133.49 15.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.169 0.509 . . . . 0.0 109.673 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 8.0 m-20 -81.98 91.89 6.68 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.489 HG21 ' HA ' ' A' ' 92' ' ' SER . 18.0 m -66.95 -27.66 67.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.304 -167.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.406 ' HG2' ' HE1' ' A' ' 49' ' ' TRP . 3.2 mp0 -54.28 -38.95 66.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.794 0.331 . . . . 0.0 110.917 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -95.7 -34.88 11.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.101 0.477 . . . . 0.0 109.987 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.56 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -82.26 30.75 0.4 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.671 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -63.13 -26.74 68.96 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -61.94 -45.33 94.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.617 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -70.8 -53.19 16.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.142 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -54.3 -51.51 64.41 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.496 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.55 -27.84 66.68 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.322 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.78 -26.99 67.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.645 0.26 . . . . 0.0 111.574 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.574 ' HB2' HG13 ' A' ' 90' ' ' ILE . 83.4 m-85 -100.86 -5.08 26.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.887 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.13 4.77 64.44 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.878 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 85' ' ' ALA . 36.8 mt -65.97 128.93 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -69.13 -53.42 20.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.265 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.489 ' HA ' HG21 ' A' ' 78' ' ' THR . 11.3 p 178.14 -94.83 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.714 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.519 HG21 ' C ' ' A' ' 46' ' ' TYR . 0.2 OUTLIER -145.07 157.59 53.6 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.613 -173.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.668 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 8.3 Cg_exo -83.53 133.39 20.86 Favored 'Cis proline' 0 N--CA 1.474 0.367 0 C-N-CA 124.71 -0.954 . . . . 0.0 111.995 -3.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 4.9 m -126.84 122.04 33.59 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 107' ' ' MET . 19.7 mm -114.36 114.66 47.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.205 -176.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.793 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.9 tp -99.77 114.76 28.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.015 0.436 . . . . 0.0 110.761 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 105' ' ' PRO . 97.5 m-85 -97.07 102.86 14.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.086 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.796 HG12 ' HB3' ' A' ' 105' ' ' PRO . 34.2 mt -107.02 106.46 58.35 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -176.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -87.1 165.9 8.36 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.771 2.314 . . . . 0.0 111.665 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.5 mmm -86.74 -1.93 58.13 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.981 0.419 . . . . 0.0 111.064 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -153.28 112.73 3.83 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 129.6 -136.17 8.81 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.536 ' HB3' ' HZ2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -137.38 151.16 70.81 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 175.313 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.796 ' HB3' HG12 ' A' ' 99' ' ' ILE . 3.8 Cg_exo -77.77 114.05 3.58 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.903 2.402 . . . . 0.0 111.22 175.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -95.69 167.18 11.44 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.315 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.508 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 49.0 ttm -140.06 130.97 26.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.444 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.97 141.66 48.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.44 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.508 ' OE1' ' HA ' ' A' ' 95' ' ' SER . 12.3 mm100 -106.13 134.73 48.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.874 0.369 . . . . 0.0 111.616 -175.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.668 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 114.39 177.15 19.06 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 169.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.58 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -94.2 87.61 5.32 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.508 -0.846 . . . . 0.0 111.932 -174.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.589 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 23.3 ptp -96.36 150.85 37.62 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.556 171.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.545 ' HA ' HD13 ' A' ' 59' ' ' ILE . 74.9 Cg_endo -75.49 173.19 14.92 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.343 2.029 . . . . 0.0 111.534 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.887 ' HB3' HG23 ' A' ' 59' ' ' ILE . 21.4 ptmt -63.17 -22.91 67.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.898 0.38 . . . . 0.0 110.284 177.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.97 -52.94 45.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.665 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.589 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 36.0 m -67.58 -34.06 76.27 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.235 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.535 ' HB2' ' HA ' ' A' ' 114' ' ' LYS . 7.3 m-85 -59.25 -47.01 86.97 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.489 174.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.512 ' NZ ' ' HB2' ' A' ' 122' ' ' ASP . 5.8 tmtm? -55.42 -35.92 65.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.346 0.117 . . . . 0.0 110.743 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.551 ' HG2' ' OE1' ' A' ' 123' ' ' GLU . 62.0 tttm -64.03 -57.07 10.76 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.397 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.39 95.8 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.72 HG23 HD23 ' A' ' 125' ' ' LEU . 77.3 mt -59.46 -44.95 93.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.861 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.512 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 10.0 t70 -62.79 -62.97 1.36 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.66 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.731 ' HA ' ' HZ3' ' A' ' 127' ' ' LYS . 62.2 mt-10 -63.13 -0.8 0.82 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -167.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 69.2 t80 -151.63 -48.41 0.11 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.649 -0.821 . . . . 0.0 112.528 175.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.72 HD23 HG23 ' A' ' 121' ' ' ILE . 42.4 tp -66.9 -30.62 70.81 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.633 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 74.6 mt -109.28 -56.3 2.31 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.854 0.835 . . . . 0.0 109.5 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.731 ' HZ3' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -108.13 80.39 1.36 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.331 -179.053 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.835 ' H ' ' HD3' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -80.63 112.28 17.84 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.275 0.56 . . . . 0.0 110.172 179.339 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.53 ' HB2' ' CE1' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -62.78 -22.51 66.66 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.669 177.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.3 -102.9 1.64 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.272 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.53 ' CE1' ' HB2' ' A' ' 129' ' ' GLU . 33.8 m80 49.77 -86.95 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.985 0.914 . . . . 0.0 112.694 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -68.06 -8.8 40.97 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.786 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -125.2 -84.77 0.64 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -78.45 97.07 5.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -65.44 -54.41 28.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 69.8 t60 . . . . . 0 C--O 1.241 0.612 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.637 177.417 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttm . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -85.96 -170.89 3.31 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 172.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.79 -68.35 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.702 0.287 . . . . 0.0 110.464 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -168.65 -80.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.686 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.0 m 63.33 88.95 0.09 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.514 0.673 . . . . 0.0 110.177 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.491 ' O ' ' HD3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -98.45 116.82 31.5 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.508 0.671 . . . . 0.0 112.092 -172.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.4 67.05 3.39 Favored Glycine 0 C--O 1.222 -0.597 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.627 HD21 ' HA2' ' A' ' 69' ' ' GLY . 6.0 t30 -144.76 109.8 5.1 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 122.324 0.25 . . . . 0.0 110.684 -172.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.2 1.65 81.38 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.488 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -135.8 175.26 9.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.968 0.413 . . . . 0.0 110.431 178.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.848 HG22 ' HB ' ' A' ' 73' ' ' ILE . 39.7 t -114.02 143.35 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.244 -172.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.8 mt -124.3 107.96 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.734 172.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.748 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 9.8 p80 -83.32 116.31 22.39 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 173.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.733 HD22 ' HB3' ' A' ' 18' ' ' GLU . 1.1 pp -132.92 179.99 5.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.985 -166.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.698 HG22 ' HE2' ' A' ' 80' ' ' LYS . 66.4 p -94.0 175.25 6.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.589 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.533 ' HD2' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -59.62 -32.28 70.28 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 121.233 -0.187 . . . . 0.0 111.233 177.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.559 ' HA ' HD12 ' A' ' 20' ' ' LEU . . . -62.84 -41.89 99.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.468 0.651 . . . . 0.0 110.218 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.733 ' HB3' HD22 ' A' ' 14' ' ' LEU . 8.4 mm-40 -71.72 -36.4 70.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.366 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -56.92 -50.72 71.71 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 122.388 1.089 . . . . 0.0 109.452 175.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.643 HD22 HD22 ' A' ' 25' ' ' ASN . 16.1 mt -50.34 -59.0 4.41 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 112.838 -1.983 . . . . 0.0 111.857 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.3 -17.87 38.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -171.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -110.81 -1.37 16.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.6 t -140.34 -50.69 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 7.5 t80 -175.14 116.02 0.16 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.155 0.502 . . . . 0.0 110.64 -167.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.643 HD22 HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -87.19 90.97 8.55 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.242 -177.265 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.522 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 18.9 p90 -78.4 14.96 1.07 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.83 -46.75 7.7 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.622 ' C ' HD22 ' A' ' 29' ' ' ASN . 49.9 mttp -96.31 -21.1 18.02 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.069 -173.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.622 HD22 ' C ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -121.11 62.97 11.63 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.366 177.212 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -61.26 -42.1 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.762 2.308 . . . . 0.0 112.374 172.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.589 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -103.02 -24.16 13.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.303 -176.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.404 ' CD ' ' HZ2' ' A' ' 34' ' ' LYS . 35.8 mt-10 -90.13 148.96 22.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.199 0.523 . . . . 0.0 111.259 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -113.95 93.77 4.52 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 168.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.404 ' HZ2' ' CD ' ' A' ' 32' ' ' GLU . 35.7 mtmm -117.51 106.33 13.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.402 173.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.578 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 30.2 t80 -68.14 105.12 1.97 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.368 0.604 . . . . 0.0 109.831 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -90.22 84.22 6.06 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.565 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -149.52 -135.69 2.51 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.731 -174.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -141.54 -55.34 0.47 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.898 0.38 . . . . 0.0 111.055 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 43.6 mttp -129.33 168.71 15.27 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.814 -177.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 65.8 Cg_exo -49.18 131.36 26.3 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.99 1.794 . . . . 0.0 111.393 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -115.32 143.23 45.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.365 -170.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.676 ' HB ' HG12 ' A' ' 73' ' ' ILE . 65.4 mt -120.33 122.49 68.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.124 176.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 16.5 t -105.74 116.02 48.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.894 0.378 . . . . 0.0 110.984 -178.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.778 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 11.3 t0 -97.78 108.11 20.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.634 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -91.27 111.64 23.21 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.593 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 0.8 OUTLIER -147.02 178.6 8.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.735 0.779 . . . . 0.0 111.286 -172.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.65 124.07 5.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 113.855 -1.52 . . . . 0.0 107.449 170.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.28 -23.06 67.25 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -169.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -74.95 -14.07 60.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.951 0.405 . . . . 0.0 110.766 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.1 t -99.64 132.93 44.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.475 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.561 ' O ' ' HG2' ' A' ' 54' ' ' LYS . . . -49.14 -68.23 1.42 Allowed Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.716 -0.674 . . . . 0.0 114.672 -175.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -58.71 -34.27 98.84 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.71 2.273 . . . . 0.0 113.107 -175.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.749 ' SG ' ' HB ' ' A' ' 93' ' ' ILE . 11.9 m -73.98 -33.88 64.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.896 0.379 . . . . 0.0 111.514 -176.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 0.2 OUTLIER -78.85 -27.2 44.11 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.581 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 16.4 ttt -66.93 -52.41 43.46 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.166 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.509 HG22 HD22 ' A' ' 60' ' ' LEU . 3.9 p -63.45 -36.77 77.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.046 -174.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.692 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -48.07 -60.28 4.58 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.326 -176.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.692 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 27.3 Cg_exo -62.21 -27.49 78.46 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.231 1.287 . . . . 0.0 112.272 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 55' ' ' MET . 45.0 mm -66.19 -57.28 11.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.34 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.571 HD21 ' NZ ' ' A' ' 75' ' ' LYS . 1.2 pt? -71.69 -30.03 65.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.178 -177.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.49 ' OD1' HG21 ' A' ' 11' ' ' VAL . 5.6 m-20 -66.43 -42.54 87.56 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.458 0.647 . . . . 0.0 109.846 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.531 ' HG3' ' NZ ' ' A' ' 114' ' ' LYS . 9.8 tp10 -54.79 -43.3 72.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.925 172.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.795 HD21 ' HA ' ' A' ' 118' ' ' LYS . 12.9 tp -71.52 -30.79 66.34 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.073 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.69 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -58.73 -59.07 6.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.745 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -64.7 -24.26 67.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.231 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -58.54 -30.86 67.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.462 0.649 . . . . 0.0 110.044 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.501 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 81.3 m-85 -113.75 25.74 10.96 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.447 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -52.36 114.46 1.37 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.93 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.627 ' HA2' HD21 ' A' ' 8' ' ' ASN . . . 129.04 -22.24 5.13 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.414 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 6.4 pt20 -127.55 -22.3 3.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 64' ' ' ALA . 44.0 pt -125.24 150.34 30.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.418 0.628 . . . . 0.0 112.218 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 47.2 t -127.27 132.09 69.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.284 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.848 ' HB ' HG22 ' A' ' 11' ' ' VAL . 11.8 mt -115.62 136.45 52.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.474 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -117.1 161.19 19.82 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.778 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 63.8 mttm -129.69 148.21 51.56 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.012 0.434 . . . . 0.0 110.23 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.424 HG13 ' CB ' ' A' ' 81' ' ' GLU . 17.4 t -120.64 111.83 33.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.739 176.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.42 89.2 2.64 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.533 HG21 ' O ' ' A' ' 92' ' ' SER . 7.9 p -52.87 -36.96 59.78 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -168.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.419 ' HG2' ' H ' ' A' ' 79' ' ' GLU . 1.1 mm-40 -53.43 -33.22 53.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.568 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.698 ' HE2' HG22 ' A' ' 15' ' ' THR . 18.1 pttm -103.45 -22.21 13.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.397 0.618 . . . . 0.0 110.161 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -100.11 43.24 1.07 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.657 178.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -55.1 -46.71 75.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.964 0.411 . . . . 0.0 111.419 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -64.55 -38.74 92.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.735 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -70.05 -44.88 68.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.966 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.04 89.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.035 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.51 -29.5 73.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.963 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.54 -26.45 65.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 111.54 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -99.17 7.24 45.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.054 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.29 16.64 80.56 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.324 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.4 mm -77.63 122.11 31.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -58.88 -61.8 2.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.505 0.669 . . . . 0.0 109.592 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.533 ' O ' HG21 ' A' ' 78' ' ' THR . 13.9 m -160.82 -79.71 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.674 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.749 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 4.5 pt -162.02 152.77 14.75 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.182 -172.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.719 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.6 Cg_exo -90.01 149.54 22.61 Favored 'Cis proline' 0 C--N 1.348 0.552 0 CA-C-N 118.869 0.632 . . . . 0.0 112.286 -3.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.416 ' HB3' ' SD ' ' A' ' 107' ' ' MET . 50.1 m -142.67 140.99 31.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.58 114.48 20.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.156 0.503 . . . . 0.0 110.138 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.554 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 43.7 tp -97.31 115.25 27.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.455 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.439 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 44.3 m-85 -96.2 104.68 16.65 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.437 HG23 ' HG3' ' A' ' 105' ' ' PRO . 53.8 mt -102.57 102.83 28.33 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.347 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 98' ' ' PHE . 73.8 Cg_endo -83.7 155.66 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.579 2.186 . . . . 0.0 111.763 174.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.403 ' SD ' ' HD3' ' A' ' 40' ' ' PRO . 90.4 mtp -75.27 -30.35 60.41 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -106.5 138.93 41.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.633 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.2 -140.1 16.61 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.922 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.667 ' HE3' ' HA ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -139.38 154.65 71.97 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.613 ' HD3' ' HE3' ' A' ' 104' ' ' LYS . 15.6 Cg_exo -69.47 154.34 69.01 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.1 2.533 . . . . 0.0 113.574 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.475 ' O ' HD12 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.56 169.72 9.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.829 176.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.416 ' SD ' ' HB3' ' A' ' 95' ' ' SER . 32.9 tpp -142.37 105.61 4.61 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.107 -174.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.93 137.37 42.01 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -117.41 137.74 52.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.159 0.504 . . . . 0.0 111.536 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.719 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 103.16 170.43 26.05 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.967 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -94.69 82.75 3.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.095 0.474 . . . . 0.0 111.65 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.586 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 22.0 ptt? -79.59 166.44 41.22 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 170.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.586 ' HD2' ' HB2' ' A' ' 112' ' ' MET . 65.9 Cg_endo -75.17 170.73 19.73 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.558 1.505 . . . . 0.0 112.541 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.531 ' NZ ' ' HG3' ' A' ' 62' ' ' GLU . 60.5 tttp -57.54 -25.37 59.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.971 174.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.64 -52.44 31.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.336 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.5 m -68.04 -37.74 81.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.697 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.679 ' O ' HG12 ' A' ' 121' ' ' ILE . 12.7 m-85 -61.48 -43.56 98.64 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.634 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.795 ' HA ' HD21 ' A' ' 63' ' ' LEU . 64.6 tttp -60.6 -38.84 86.01 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.108 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -62.87 -43.93 97.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.869 0.366 . . . . 0.0 110.741 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -64.0 -41.1 97.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.253 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.679 HG12 ' O ' ' A' ' 117' ' ' PHE . 16.3 mm -74.93 -53.9 15.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.437 0.637 . . . . 0.0 110.998 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.548 ' HA ' HD12 ' A' ' 126' ' ' LEU . 19.0 t70 -68.45 -66.03 0.62 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.314 -173.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.6 -49.36 71.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.767 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.543 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 79.2 t80 -86.09 -37.61 18.65 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -170.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.622 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 29.5 tp -90.52 -38.31 13.29 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 122' ' ' ASP . 79.6 mt -89.07 -66.84 0.88 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.911 0.386 . . . . 0.0 111.689 -173.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.04 81.65 5.61 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -51.69 96.9 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.282 0.989 . . . . 0.0 111.983 -170.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -19.41 12.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.7 170.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.56 -19.01 39.9 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.532 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -58.02 -34.76 70.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.89 0.376 . . . . 0.0 110.162 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -147.82 61.58 1.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.896 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -78.07 68.72 4.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.423 0.63 . . . . 0.0 109.468 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -169.21 155.73 6.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.405 ' O ' ' HB2' ' A' ' 136' ' ' HIS . 73.7 m-70 -76.99 43.92 0.37 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.405 ' HB2' ' O ' ' A' ' 135' ' ' HIS . 58.2 t-80 . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.852 -0.594 . . . . 0.0 109.508 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.51 ' HB3' HD23 ' A' ' 3' ' ' LEU . 1.8 mpt? . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.147 0.022 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.6 m 75.82 -31.2 0.2 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.346 0.658 . . . . 0.0 112.674 174.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 1' ' ' MET . 2.6 pt? -78.15 16.9 0.68 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.76 0.315 . . . . 0.0 111.483 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.64 157.5 9.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.964 0.412 . . . . 0.0 111.047 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.6 t -99.82 14.95 28.56 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.987 0.423 . . . . 0.0 111.372 -175.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.3 125.73 45.58 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.593 ' HA2' ' HE2' ' A' ' 10' ' ' LYS . . . -141.59 28.27 2.31 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.74 -174.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 29.2 m-80 -72.88 134.76 44.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.244 0.522 . . . . 0.0 110.667 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . 69.84 22.2 76.88 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.749 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.593 ' HE2' ' HA2' ' A' ' 7' ' ' GLY . 17.8 pttm -162.83 171.74 16.23 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 121.286 0.565 . . . . 0.0 110.968 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.536 HG21 ' HE3' ' A' ' 75' ' ' LYS . 7.9 m -113.16 145.08 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.382 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.1 mt -114.38 96.76 4.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.058 174.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.538 ' HA ' ' HB2' ' A' ' 75' ' ' LYS . 27.1 p80 -77.71 121.89 24.63 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.76 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.4 pp -138.38 178.63 7.0 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.228 0.537 . . . . 0.0 112.282 -169.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.633 HG22 ' HE2' ' A' ' 80' ' ' LYS . 42.6 p -98.42 171.39 8.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.484 175.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.535 ' HZ1' ' CD ' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -56.06 -33.09 64.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 178.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.05 -42.01 90.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.35 0.595 . . . . 0.0 110.293 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.76 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 30.2 mt-10 -71.62 -32.27 67.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.123 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -57.31 -52.86 63.65 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-O 122.401 1.096 . . . . 0.0 109.285 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.575 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 7.9 mt -50.63 -59.58 3.91 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.634 -2.075 . . . . 0.0 111.893 -176.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.58 -8.01 59.66 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -171.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -109.43 -32.43 7.16 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 31.0 t -123.5 -40.13 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -168.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.585 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 14.6 t80 -167.63 120.04 0.9 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.921 -166.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.72 90.82 7.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.011 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.585 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 27.0 p90 -85.29 18.49 2.62 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 111.667 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -94.54 -49.57 5.59 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.598 ' C ' HD22 ' A' ' 29' ' ' ASN . 47.4 mttp -96.65 -21.6 17.52 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.153 -175.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.629 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -121.7 68.29 22.91 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.618 176.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.92 -32.28 97.12 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.547 2.831 . . . . 0.0 112.613 173.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -102.52 -40.3 6.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -172.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 3.2 tp10 -100.78 132.29 46.25 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.466 0.65 . . . . 0.0 111.705 -174.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -69.46 93.2 0.65 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.654 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -93.11 97.15 10.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.529 177.31 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.57 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 23.0 t80 -81.39 127.53 32.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.989 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -109.43 151.95 26.0 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 168.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.88 -127.63 2.19 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.809 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -163.74 -60.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.019 0.437 . . . . 0.0 110.396 -173.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.465 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 22.0 mttm -119.08 165.79 16.08 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.442 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 85.9 Cg_exo -44.2 131.74 8.87 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.68 2.253 . . . . 0.0 111.838 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -113.22 146.31 39.53 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.212 0.529 . . . . 0.0 111.764 -171.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.692 ' HB ' HG12 ' A' ' 73' ' ' ILE . 74.8 mt -122.4 122.53 66.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.063 174.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 21.5 t -107.28 110.06 30.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.399 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.598 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 30.1 t0 -86.74 106.59 17.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.998 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.561 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 96.6 m-85 -91.88 111.89 23.6 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.673 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.6 p90 -140.63 -179.87 6.28 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.832 -171.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.421 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -159.09 142.71 14.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.492 170.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.47 -28.96 68.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -76.75 -9.79 58.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.235 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.466 ' HB2' HD12 ' A' ' 93' ' ' ILE . 47.0 t -99.15 112.38 24.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.936 0.398 . . . . 0.0 110.643 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.08 -54.3 38.6 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.607 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.49 -38.46 27.71 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.952 2.434 . . . . 0.0 113.532 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.726 ' SG ' ' HB ' ' A' ' 93' ' ' ILE . 83.0 m -67.06 -43.86 81.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.38 . . . . 0.0 111.143 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -72.48 -26.04 61.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.93 0.395 . . . . 0.0 110.184 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -60.05 -46.97 87.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.669 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.581 ' HB ' ' HE2' ' A' ' 117' ' ' PHE . 30.4 m -87.16 -25.17 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.481 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -43.74 -59.93 3.08 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 50.2 Cg_endo -68.57 -26.78 33.49 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.725 1.617 . . . . 0.0 112.0 -177.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.07 -54.95 21.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.347 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.583 HD11 ' HE2' ' A' ' 75' ' ' LYS . 1.7 pp -69.03 -30.84 69.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.51 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.08 -49.98 75.53 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.246 0.546 . . . . 0.0 110.741 173.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -64.56 -36.24 83.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.41 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.45 -31.3 67.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.425 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.689 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -56.98 -42.34 80.05 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 173.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.636 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 3.7 tmtm? -71.79 -41.22 68.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.043 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -56.54 -39.54 73.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.964 0.411 . . . . 0.0 110.739 176.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.481 ' HA ' HE21 ' A' ' 70' ' ' GLN . 83.8 m-85 -98.54 26.67 5.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.345 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 58.0 t0 -53.39 129.79 33.17 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.477 0.311 . . . . 0.0 110.666 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.53 -6.54 83.49 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.304 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.481 HE21 ' HA ' ' A' ' 67' ' ' TYR . 44.1 mt-30 -112.47 -44.34 3.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.607 0.242 . . . . 0.0 111.008 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 40' ' ' PRO . 45.1 pt -128.89 159.05 41.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.147 0.499 . . . . 0.0 111.822 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 96.6 t -126.86 123.82 63.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.233 176.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.692 HG12 ' HB ' ' A' ' 42' ' ' ILE . 15.2 mt -107.62 138.32 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.72 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -118.01 162.31 18.37 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 173.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.598 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 55.8 mttt -135.91 144.46 45.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.889 0.376 . . . . 0.0 111.147 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.691 HG13 ' HG2' ' A' ' 81' ' ' GLU . 37.3 t -138.41 134.48 43.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.853 -175.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.471 ' HB2' ' HG2' ' A' ' 80' ' ' LYS . 7.5 m-20 -94.52 102.06 13.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.449 HG21 ' O ' ' A' ' 92' ' ' SER . 16.8 p -52.94 -37.41 60.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.2 0.524 . . . . 0.0 111.67 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -54.9 -36.28 65.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.981 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.633 ' HE2' HG22 ' A' ' 15' ' ' THR . 21.6 pttm -100.59 -20.39 15.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.357 0.599 . . . . 0.0 110.076 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.691 ' HG2' HG13 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -97.86 45.25 1.03 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.483 176.015 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -55.89 -53.31 58.38 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.58 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.535 ' CD ' ' HZ1' ' A' ' 16' ' ' LYS . 2.2 mp0 -61.85 -36.88 82.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.618 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.466 HD23 ' HG2' ' A' ' 81' ' ' GLU . 41.4 tp -67.86 -41.7 82.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.529 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -67.0 -44.54 80.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.67 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.14 -32.89 82.15 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.684 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.85 -35.37 76.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.814 0.34 . . . . 0.0 111.588 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.532 ' HB2' HG13 ' A' ' 90' ' ' ILE . 94.6 m-85 -97.26 3.06 51.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.854 0.359 . . . . 0.0 110.81 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.13 28.46 73.7 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.11 -176.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 85' ' ' ALA . 28.9 mt -66.08 138.82 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -64.09 -61.39 2.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.449 ' O ' HG21 ' A' ' 78' ' ' THR . 24.3 p 175.65 -91.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.75 175.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.726 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 8.0 pt -151.55 146.34 18.77 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.881 -172.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.68 ' HB2' ' H ' ' A' ' 110' ' ' GLY . 17.3 Cg_exo -78.59 142.78 70.09 Favored 'Cis proline' 0 N--CA 1.478 0.561 0 C-N-CA 124.78 -0.925 . . . . 0.0 112.037 -3.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 14.7 m -139.37 112.35 8.0 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.73 114.39 46.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.028 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.606 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 34.8 tp -92.96 113.18 25.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.714 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -94.23 112.39 24.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.88 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 41' ' ' ALA . 36.9 mt -101.24 102.9 22.88 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.908 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.09 163.09 22.97 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.576 2.184 . . . . 0.0 112.325 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 92.6 mmm -87.39 -0.04 56.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.332 0.587 . . . . 0.0 109.559 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.585 ' HB3' ' HG2' ' A' ' 128' ' ' LYS . 1.1 tm-20 -138.2 123.68 19.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.928 177.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.25 -149.57 19.45 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.08 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 27.2 mmmt -123.31 159.1 56.26 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.467 ' HB2' HD11 ' A' ' 97' ' ' LEU . 57.6 Cg_endo -70.48 154.1 65.13 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.564 2.176 . . . . 0.0 113.45 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -125.83 167.94 14.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.494 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.506 ' SD ' ' HB3' ' A' ' 95' ' ' SER . 42.9 ttm -130.26 122.06 27.31 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.043 0.449 . . . . 0.0 112.029 -175.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.05 132.23 50.51 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -115.37 136.2 53.34 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.284 0.564 . . . . 0.0 112.437 -172.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.68 ' H ' ' HB2' ' A' ' 94' ' ' PRO . . . 104.7 -175.6 22.55 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.173 -0.921 . . . . 0.0 114.898 169.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.482 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -92.12 85.64 5.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.026 -0.587 . . . . 0.0 111.633 -171.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.568 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 25.1 ptp -91.4 154.89 44.52 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.463 172.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 71.7 Cg_endo -75.44 177.54 8.52 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.28 1.987 . . . . 0.0 111.687 -177.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -58.85 -33.77 70.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 174.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.78 -52.86 61.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.529 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.568 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 34.6 m -66.7 -40.73 88.6 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.736 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.581 ' HE2' ' HB ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -60.93 -40.79 94.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.537 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.434 ' C ' ' HD3' ' A' ' 118' ' ' LYS . 14.6 tmtt? -58.97 -49.82 76.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.892 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.559 ' HA ' ' OD1' ' A' ' 122' ' ' ASP . 12.9 mptt -64.64 -39.86 94.43 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.951 0.405 . . . . 0.0 110.797 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -58.51 -38.9 78.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.611 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.514 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 74.7 mt -75.04 -56.29 9.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.472 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.559 ' OD1' ' HA ' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -74.24 -58.87 3.01 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.918 -173.036 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.432 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 6.0 mm-40 -69.26 -22.47 63.83 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -171.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 91.6 t80 -110.47 -46.29 3.42 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.973 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.514 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 36.7 tp -90.39 -41.64 11.36 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -172.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.534 ' HB3' ' HA ' ' A' ' 122' ' ' ASP . 45.3 tp -83.49 -52.5 6.44 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 121.392 0.615 . . . . 0.0 109.751 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 30.1 mtmt -99.97 73.86 1.77 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.585 ' HG2' ' HB3' ' A' ' 102' ' ' GLU . 24.4 tptp -48.42 99.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 O-C-N 124.096 0.873 . . . . 0.0 111.887 -175.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -175.33 2.8 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.704 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.25 8.04 23.93 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -173.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -133.28 58.97 1.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.6 t60 -81.52 66.73 7.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.375 -169.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -89.47 -50.64 5.98 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 164.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -171.66 62.83 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.08 163.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -77.52 -19.54 55.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.691 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.246 0.887 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.348 173.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.69 0.281 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.0 m -83.35 112.51 19.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.619 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.6 tt -98.46 -54.6 2.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.41 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -126.45 29.09 5.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.867 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.569 HG21 HG21 ' A' ' 72' ' ' VAL . 19.4 m 67.14 87.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.231 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 5.0 pm0 -74.2 -11.13 60.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.926 -178.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.411 ' O ' HG13 ' A' ' 72' ' ' VAL . . . -86.43 25.35 7.26 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.29 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.625 HD21 ' HA2' ' A' ' 69' ' ' GLY . 4.5 t30 -69.9 113.04 6.75 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 122.376 0.271 . . . . 0.0 110.823 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.543 ' HA3' ' CG ' ' A' ' 68' ' ' ASP . . . 69.0 31.85 72.76 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.058 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.463 ' HE2' ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -166.98 172.09 10.53 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.339 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.701 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 12.9 p -113.36 132.21 62.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.713 0.768 . . . . 0.0 112.097 -176.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.0 mt -121.49 128.88 75.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.736 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.594 ' CB ' ' HG3' ' A' ' 75' ' ' LYS . 1.9 p80 -88.01 129.53 35.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.3 pp -133.21 173.98 10.87 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.918 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.43 166.97 12.59 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.852 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.759 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 30.7 pttt -62.16 -26.65 68.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.061 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.0 86.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.281 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 28.2 mm-40 -68.61 -43.58 76.08 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.868 176.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -57.39 -49.8 75.03 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 121.933 0.873 . . . . 0.0 109.502 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' ' 25' ' ' ASN . 1.1 tt -48.64 -61.47 2.01 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 113.648 -1.615 . . . . 0.0 112.098 -178.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.09 -18.83 33.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.588 -168.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 34.5 ttmt -108.78 -16.87 14.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -172.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.45 -45.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 18.5 t80 -164.42 116.74 1.31 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.236 0.541 . . . . 0.0 111.261 -169.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.598 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -84.15 89.05 7.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.99 -177.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.511 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 27.2 p90 -82.81 4.88 23.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.644 0.735 . . . . 0.0 110.698 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.427 ' H ' HD22 ' A' ' 25' ' ' ASN . 5.4 tm-20 -95.43 -52.27 4.22 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.253 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.636 ' C ' HD22 ' A' ' 29' ' ' ASN . 67.6 mttm -84.27 -27.77 27.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.287 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.654 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -120.71 69.04 16.24 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-O 120.862 0.363 . . . . 0.0 111.223 -177.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -64.12 -28.23 65.16 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.449 2.766 . . . . 0.0 112.306 171.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -31.46 8.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.752 -175.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -91.81 144.37 25.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.055 0.455 . . . . 0.0 111.407 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -91.94 89.47 7.02 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 171.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 87.2 tttt -94.23 97.58 10.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.007 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -99.31 120.6 39.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.054 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -112.0 114.51 27.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.218 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.84 163.52 33.16 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.511 ' OD2' ' HG3' ' A' ' 39' ' ' LYS . 12.0 p-10 -95.71 -37.32 10.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.949 0.375 . . . . 0.0 111.181 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.511 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 56.5 mttp -117.54 166.28 13.7 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.505 179.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.577 ' HB2' HD21 ' A' ' 125' ' ' LEU . 32.1 Cg_exo -59.8 141.03 96.03 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.746 2.297 . . . . 0.0 111.56 174.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -119.91 147.43 44.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.342 0.591 . . . . 0.0 112.365 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.745 ' HB ' HG12 ' A' ' 73' ' ' ILE . 4.2 mp -121.12 133.38 67.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.311 172.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 41.9 t -128.31 114.07 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.126 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.608 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 8.6 p-10 -100.41 115.87 31.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 122.222 1.01 . . . . 0.0 111.622 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.535 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 30.0 m-85 -81.1 112.88 18.87 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.431 -1.258 . . . . 0.0 108.936 173.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.71 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.8 p90 -129.91 168.17 17.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.503 0.668 . . . . 0.0 111.415 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.89 131.01 26.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.271 -1.332 . . . . 0.0 107.841 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.542 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 27.9 t70 -60.12 -34.34 73.37 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -171.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -71.57 -9.33 58.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.681 0.277 . . . . 0.0 111.62 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.455 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 48.0 t -95.64 123.55 39.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.92 0.39 . . . . 0.0 110.607 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.55 -59.01 10.27 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.755 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 77.4 Cg_exo -48.78 -36.71 34.04 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.047 2.498 . . . . 0.0 113.202 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.71 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 98.0 m -64.3 -44.89 90.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.99 0.424 . . . . 0.0 111.199 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.542 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 66.6 mttm -59.99 -29.71 68.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.905 175.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.56 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 75.0 mtp -71.59 -54.48 10.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.953 0.406 . . . . 0.0 111.16 177.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 96' ' ' ILE . 10.2 p -68.6 -36.95 76.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -170.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.634 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -52.06 -55.79 27.74 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 16.8 Cg_exo -68.35 -42.62 5.25 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 121.938 1.759 . . . . 0.0 112.14 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.442 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 73.1 mt -58.54 -41.04 80.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.08 0.467 . . . . 0.0 110.769 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.706 HD22 HD13 ' A' ' 73' ' ' ILE . 1.3 mt -67.03 -38.28 85.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.898 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' OD1' HG12 ' A' ' 11' ' ' VAL . 20.8 t70 -68.29 -37.06 80.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.184 0.516 . . . . 0.0 109.802 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 59' ' ' ILE . 14.5 tp10 -54.37 -46.05 72.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.692 174.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.582 HD21 ' HA ' ' A' ' 114' ' ' LYS . 4.3 mm? -72.02 -35.12 69.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.807 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.666 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -57.16 -52.0 67.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.404 ' HD3' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.27 -25.92 62.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.099 -178.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.491 ' CD ' ' HZ3' ' A' ' 114' ' ' LYS . 1.8 tt0 -71.73 -19.83 61.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.329 0.585 . . . . 0.0 110.15 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.438 ' HD1' ' O ' ' A' ' 63' ' ' LEU . 85.7 m-85 -117.23 25.84 10.18 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.682 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.543 ' CG ' ' HA3' ' A' ' 9' ' ' GLY . 11.3 t0 -58.65 121.57 11.32 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.234 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.625 ' HA2' HD21 ' A' ' 8' ' ' ASN . . . 118.64 -28.45 6.75 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.26 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.481 ' HG3' HG23 ' A' ' 71' ' ' ILE . 17.6 pt20 -114.73 -28.21 7.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -176.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.481 HG23 ' HG3' ' A' ' 70' ' ' GLN . 37.5 pt -122.99 158.12 27.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.859 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.569 HG21 HG21 ' A' ' 5' ' ' THR . 94.4 t -130.06 128.04 64.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.423 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.745 HG12 ' HB ' ' A' ' 42' ' ' ILE . 29.3 mt -121.6 135.22 62.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.465 0.65 . . . . 0.0 111.371 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 63.8 m-85 -122.7 164.56 18.05 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 173.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.663 ' HB3' ' HZ3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -136.65 149.8 48.17 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 174.185 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.516 HG13 ' HG2' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -122.75 137.14 57.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.441 -171.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.531 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 10.5 m-20 -87.82 86.57 7.18 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.638 HG21 ' HA ' ' A' ' 92' ' ' SER . 15.3 m -56.06 -29.75 60.95 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -169.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -53.42 -31.03 43.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.647 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.531 ' HE3' ' HB2' ' A' ' 77' ' ' ASP . 22.2 pttp -109.82 -23.78 11.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.196 0.522 . . . . 0.0 110.492 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.759 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 1.3 mp0 -85.93 39.63 0.82 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.424 175.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -61.95 -47.92 82.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.696 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -62.22 -38.95 91.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.218 0.532 . . . . 0.0 110.192 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.1 tp -61.03 -44.54 97.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.42 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.583 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -63.96 -49.08 73.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.753 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.65 -30.99 66.4 Favored Glycine 0 CA--C 1.517 0.181 0 CA-C-N 116.081 -0.509 . . . . 0.0 113.206 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.75 -33.32 73.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.752 0.31 . . . . 0.0 111.707 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.572 ' HB2' HG13 ' A' ' 90' ' ' ILE . 89.5 m-85 -104.15 7.47 36.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.174 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.67 30.63 68.35 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.799 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 85' ' ' ALA . 55.6 mt -80.69 131.94 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.642 0.258 . . . . 0.0 110.524 -177.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.0 mtm105 -57.45 -64.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.666 0.746 . . . . 0.0 109.933 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.638 ' HA ' HG21 ' A' ' 78' ' ' THR . 13.0 p 177.17 -93.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.633 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.517 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -139.56 148.37 55.85 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.357 -175.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.712 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.1 Cg_exo -85.36 150.19 50.43 Favored 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 124.077 -1.218 . . . . 0.0 111.279 -3.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 11.6 m -141.36 140.19 33.69 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.558 HD11 HG21 ' A' ' 56' ' ' VAL . 60.1 mt -136.24 117.76 19.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 119.025 0.83 . . . . 0.0 111.201 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 105' ' ' PRO . 20.3 tp -98.26 114.35 26.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.209 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.595 ' HE2' ' HB3' ' A' ' 108' ' ' ALA . 96.6 m-85 -96.78 110.79 23.19 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.0 mt -103.3 105.97 49.13 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.819 0.343 . . . . 0.0 111.899 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 98' ' ' PHE . 2.9 Cg_exo -76.16 159.27 37.25 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.413 2.742 . . . . 0.0 111.5 172.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 89.8 mtp -83.02 -32.15 27.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.636 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.07 -30.91 7.83 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.91 0.862 . . . . 0.0 110.764 -177.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.69 -156.03 24.4 Favored Glycine 0 C--N 1.307 -1.031 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.99 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 35.2 mmtm -129.81 148.54 69.93 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 98' ' ' PHE . 38.3 Cg_endo -63.62 134.38 43.94 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.887 2.391 . . . . 0.0 113.854 -170.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.32 169.64 8.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.423 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 36.1 tpp -136.13 101.92 4.85 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.859 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.595 ' HB3' ' HE2' ' A' ' 98' ' ' PHE . . . -107.8 129.88 55.02 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 173.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.557 ' HB3' ' O ' ' A' ' 94' ' ' PRO . 58.4 mt-30 -117.51 128.52 55.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.149 0.499 . . . . 0.0 111.93 -171.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.712 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 133.12 -169.21 22.69 Favored Glycine 0 CA--C 1.506 -0.487 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.141 176.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -107.31 80.66 1.44 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.556 0.693 . . . . 0.0 110.858 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.702 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 5.0 mpp? -77.81 147.85 74.91 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.467 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.84 -177.69 3.8 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.052 2.502 . . . . 0.0 111.943 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.582 ' HA ' HD21 ' A' ' 63' ' ' LEU . 36.5 ttmt -60.13 -33.3 71.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 0.0 110.37 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.38 -52.9 59.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.558 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.702 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 20.3 m -70.31 -29.94 66.8 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.932 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.572 ' O ' HG13 ' A' ' 121' ' ' ILE . 5.4 m-85 -71.67 -37.29 70.77 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.426 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -57.75 -43.99 85.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.847 0.356 . . . . 0.0 110.119 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.528 ' HG2' ' OE2' ' A' ' 123' ' ' GLU . 31.0 mtpp -64.14 -38.48 91.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.679 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.561 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -67.5 -45.22 76.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.489 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 117' ' ' PHE . 20.9 mt -74.38 -57.25 6.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.306 0.574 . . . . 0.0 110.472 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.517 ' HA ' HD12 ' A' ' 126' ' ' LEU . 22.2 t70 -72.42 -65.04 0.83 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.285 -175.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.528 ' OE2' ' HG2' ' A' ' 119' ' ' LYS . 34.5 mt-10 -75.47 -9.21 58.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.423 -168.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.561 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 89.2 t80 -120.81 -52.49 2.11 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.938 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 40' ' ' PRO . 32.9 tp -72.75 -32.35 65.6 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.366 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.552 ' O ' ' HE3' ' A' ' 128' ' ' LYS . 64.5 mt -101.17 -59.69 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.112 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -87.29 -10.19 52.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.892 -172.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.552 ' HE3' ' O ' ' A' ' 126' ' ' LEU . 0.7 OUTLIER 30.77 82.66 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.488 1.117 . . . . 0.0 113.312 -177.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -67.91 160.61 28.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.523 -176.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 118.45 -9.93 13.04 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.975 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.406 ' HD2' ' O ' ' A' ' 128' ' ' LYS . 82.7 m-70 -76.52 73.99 3.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.249 0.547 . . . . 0.0 112.106 -174.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -80.11 -24.46 40.5 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 171.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -111.25 142.86 42.91 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 167.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -89.24 -67.85 0.81 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.075 0.464 . . . . 0.0 109.942 -174.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -143.26 18.23 1.9 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 66.9 t60 . . . . . 0 C--O 1.242 0.704 0 CA-C-N 113.619 -1.628 . . . . 0.0 107.763 -176.261 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -142.23 150.04 40.43 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.2 tp -89.46 -30.72 18.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.313 0.577 . . . . 0.0 110.306 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -118.55 110.29 17.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.839 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER 56.79 -147.21 0.53 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -175.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.432 ' H ' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -131.75 -52.09 0.99 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.612 0.642 . . . . 0.0 111.796 178.278 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.84 22.81 23.28 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.038 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.463 ' HA ' HG22 ' A' ' 72' ' ' VAL . 2.6 t-20 -71.35 119.38 15.41 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.475 ' HA3' ' CG ' ' A' ' 68' ' ' ASP . . . 83.39 1.73 90.27 Favored Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.944 -176.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -131.09 173.05 11.4 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -174.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.655 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.5 p -133.29 134.33 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.183 0.516 . . . . 0.0 110.259 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 69.0 mt -129.57 133.65 64.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.176 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.741 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 6.5 p80 -93.8 116.34 28.8 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.371 0.605 . . . . 0.0 109.842 175.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.3 pp -116.09 179.8 3.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.759 -175.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.403 HG22 ' CE ' ' A' ' 80' ' ' LYS . 23.2 p -100.03 176.6 5.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 60.7 pttt -55.68 -30.74 61.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.521 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.24 78.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.769 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 4.0 mp0 -69.67 -31.66 69.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.33 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -64.61 -51.63 61.68 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.653 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.6 tt -51.76 -61.08 2.48 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 113.312 -1.767 . . . . 0.0 112.155 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.9 -25.69 61.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.781 -168.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 36.7 ttmt -98.45 -34.34 10.67 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.405 HG13 ' HD1' ' A' ' 35' ' ' TYR . 81.0 t -119.28 -47.7 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -167.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.709 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 20.0 t80 -151.54 116.47 5.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.297 0.57 . . . . 0.0 111.852 -165.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.566 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -88.2 90.69 8.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.262 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.709 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 24.3 p90 -84.27 12.09 7.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.154 0.502 . . . . 0.0 111.576 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -94.32 -45.7 7.37 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.505 ' C ' HD22 ' A' ' 29' ' ' ASN . 48.9 mttm -94.67 -25.9 16.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.584 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.612 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -122.26 68.85 29.23 Favored Pre-proline 0 N--CA 1.469 0.494 0 CA-C-O 120.791 0.329 . . . . 0.0 111.198 178.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -55.71 -42.18 70.09 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.163 2.576 . . . . 0.0 112.132 171.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -95.42 -33.25 12.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -173.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.408 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 36.7 mt-10 -91.49 128.45 37.32 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.204 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 53.3 t-105 -82.13 101.37 10.37 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 171.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 32' ' ' GLU . 30.6 mmtp -102.65 139.21 38.54 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.331 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.405 ' HD1' HG13 ' A' ' 23' ' ' VAL . 21.6 t80 -126.92 115.79 19.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.162 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 22' ' ' LYS . 35.0 mm-40 -97.5 123.73 41.47 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.443 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.85 179.48 46.37 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.201 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.483 ' OD2' ' HG3' ' A' ' 39' ' ' LYS . 1.7 p-10 -124.31 -38.51 2.42 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 117.011 0.405 . . . . 0.0 111.333 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.483 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 60.8 mttp -112.43 154.69 44.47 Favored Pre-proline 0 C--N 1.328 -0.348 0 O-C-N 122.474 -0.142 . . . . 0.0 110.86 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.458 ' HB2' HD21 ' A' ' 125' ' ' LEU . 6.2 Cg_endo -48.35 132.81 24.66 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.155 2.57 . . . . 0.0 111.851 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -116.85 149.57 39.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.388 0.613 . . . . 0.0 112.121 -170.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.424 ' HB ' HG12 ' A' ' 73' ' ' ILE . 76.5 mt -132.56 139.78 49.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.996 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.45 116.62 47.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.866 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.537 ' HB3' ' CB ' ' A' ' 75' ' ' LYS . 35.0 t70 -91.24 112.19 24.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.774 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 79.2 m-85 -93.51 110.64 22.22 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.74 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.2 p90 -137.87 162.6 33.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.559 0.695 . . . . 0.0 111.468 -171.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.19 133.4 50.29 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.692 170.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.24 -41.83 93.99 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.91 -172.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -68.25 -17.29 64.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.881 0.372 . . . . 0.0 111.624 -176.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 42.2 t -82.09 123.53 29.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.888 0.375 . . . . 0.0 110.168 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 55' ' ' MET . . . -55.83 -61.01 7.9 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.157 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -47.84 -45.7 23.64 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.842 2.361 . . . . 0.0 112.874 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.74 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 62.1 m -60.19 -45.63 92.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.527 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -76.02 -27.46 57.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.454 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 3.3 tmm? -67.31 -47.86 69.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.32 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.595 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 27.2 m -77.11 -24.95 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.601 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -50.74 -52.73 54.06 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 18.9 Cg_exo -66.81 -37.65 19.91 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.774 1.649 . . . . 0.0 112.339 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.3 mt -65.36 -47.5 86.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.358 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 117' ' ' PHE . 3.5 pp -68.33 -31.75 71.39 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.64 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.51 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 20.7 t70 -68.15 -37.81 81.44 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.153 174.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.95 -46.98 78.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.921 176.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.61 HD11 ' HG3' ' A' ' 114' ' ' LYS . 9.8 mp -65.25 -30.88 71.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.07 176.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.636 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -55.08 -53.78 51.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.635 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.51 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -78.2 -24.83 46.96 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.455 178.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -55.83 -33.97 64.95 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.677 0.751 . . . . 0.0 109.366 171.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.613 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 41.2 m-85 -111.34 26.5 10.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.042 176.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 3.1 t70 -55.36 132.6 48.51 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.336 -176.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.26 -21.06 36.29 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.962 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 10.8 pt20 -122.08 -36.0 3.06 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -176.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.551 HG23 ' HG3' ' A' ' 70' ' ' GLN . 45.4 pt -111.63 147.81 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.987 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 8' ' ' ASN . 60.1 t -120.96 120.29 61.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.596 177.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 27.7 mt -115.57 134.98 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 121.612 0.72 . . . . 0.0 111.179 -177.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -121.45 173.27 7.49 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.824 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.741 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 3.5 ptmm? -151.97 156.34 39.82 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.574 HG23 HD12 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -133.62 148.23 30.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.097 -173.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 20.2 m-20 -89.82 85.87 6.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.573 HG21 ' HA ' ' A' ' 92' ' ' SER . 1.7 m -62.0 -27.28 68.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.193 -166.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -54.42 -31.04 54.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.487 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 22.6 pttm -104.76 -26.16 12.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.231 0.538 . . . . 0.0 109.694 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.52 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 1.3 mp0 -84.85 33.6 0.53 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.72 176.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -62.04 -31.61 72.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.819 0.343 . . . . 0.0 110.977 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -63.05 -41.05 99.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.358 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 84' ' ' LEU . 1.7 tm? -70.24 -45.61 66.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.41 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.56 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -61.57 -49.68 75.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.45 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.75 -30.26 72.19 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 116.154 -0.475 . . . . 0.0 113.116 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.57 -34.54 77.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.749 0.309 . . . . 0.0 111.677 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.518 ' HB2' HG13 ' A' ' 90' ' ' ILE . 77.7 m-85 -104.53 5.66 34.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.228 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.31 29.44 70.19 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.084 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 85' ' ' ALA . 22.0 mt -75.1 139.82 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.024 0.44 . . . . 0.0 110.072 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.415 ' HD3' HE22 ' A' ' 109' ' ' GLN . 72.6 mtp180 -74.34 4.05 6.43 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.674 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.573 ' HA ' HG21 ' A' ' 78' ' ' THR . 30.3 t 82.5 -88.0 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.424 -176.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.574 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 2.7 pp -135.29 136.45 24.46 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -169.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.665 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 4.0 Cg_exo -85.35 146.45 42.14 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 124.591 -1.004 . . . . 0.0 111.726 -4.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 37.5 t -142.0 140.85 32.79 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 171.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.6 mt -134.18 115.15 20.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.7 tp -97.64 112.99 24.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.552 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.75 111.48 23.75 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.776 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.563 HG12 ' HB3' ' A' ' 105' ' ' PRO . 44.7 mt -102.17 105.12 40.95 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.127 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.92 161.17 36.39 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.722 2.281 . . . . 0.0 111.636 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 94.1 mmm -83.7 -1.39 53.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 0.0 110.454 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -141.76 112.93 7.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.1 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.89 -153.7 16.8 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.057 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.45 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 28.8 mmmt -116.1 156.9 46.33 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.563 ' HB3' HG12 ' A' ' 99' ' ' ILE . 59.2 Cg_endo -72.12 151.08 54.98 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.678 2.252 . . . . 0.0 113.721 -175.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.637 ' OE2' ' HB2' ' A' ' 131' ' ' HIS . 27.2 tt0 -106.62 157.98 17.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.199 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 45.1 ttm -122.63 116.39 23.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.152 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.01 137.91 48.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 173.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.516 ' HG2' ' HA ' ' A' ' 95' ' ' SER . 43.9 mt-30 -123.06 137.97 54.8 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.389 -174.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.665 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 106.77 178.28 22.96 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.407 -0.815 . . . . 0.0 114.457 170.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.595 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -83.01 89.14 6.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.119 0.485 . . . . 0.0 111.814 -174.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.656 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 22.2 ptp -95.64 149.01 35.5 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.974 173.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 97.4 Cg_endo -76.18 -178.36 4.35 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.825 2.35 . . . . 0.0 112.141 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.61 ' HG3' HD11 ' A' ' 63' ' ' LEU . 20.5 ttmm -57.68 -35.51 70.69 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 120.851 0.357 . . . . 0.0 110.133 174.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.65 -52.54 60.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.445 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.656 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 28.5 m -68.61 -35.63 77.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.624 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.503 ' HB3' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -61.89 -46.4 89.54 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.462 176.645 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -62.63 -33.14 74.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.306 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 51.4 tptt -61.47 -42.75 99.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 174.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.61 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.34 -47.94 53.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.711 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.598 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 1.8 mp -70.63 -56.92 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.871 0.367 . . . . 0.0 110.763 -177.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.403 ' HB2' ' OH ' ' A' ' 67' ' ' TYR . 5.1 t70 -73.5 -62.63 1.42 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.549 0.69 . . . . 0.0 110.396 -176.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 3.9 mm-40 -78.12 11.47 2.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.835 -1.075 . . . . 0.0 113.329 -169.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.61 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 71.8 t80 -143.56 -47.5 0.29 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.441 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.598 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 32.5 tp -76.55 -35.03 58.47 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.488 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.2 mt -89.22 -65.56 1.01 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -92.97 92.07 7.68 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -54.31 100.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.65 0.594 . . . . 0.0 111.113 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -88.84 -34.57 16.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.653 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 73.88 85.56 0.26 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.002 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.637 ' HB2' ' OE2' ' A' ' 106' ' ' GLU . 32.2 m170 -65.36 93.23 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.693 0.759 . . . . 0.0 110.49 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -63.11 103.68 0.5 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.917 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -82.44 37.06 0.5 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.069 -177.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -71.12 138.78 49.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.269 -174.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -128.88 141.57 51.24 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 25.5 p80 . . . . . 0 C--O 1.245 0.855 0 O-C-N 124.508 1.13 . . . . 0.0 111.66 -172.242 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 m -136.16 96.29 3.36 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.003 -175.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 3' ' ' LEU . 3.7 mm? -101.3 -74.46 0.62 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.041 174.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.87 22.84 10.67 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.012 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p -91.51 154.07 19.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.407 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 72.39 -56.57 0.65 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 168.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.99 32.88 5.17 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -165.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -76.34 158.54 31.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.147 -1.027 . . . . 0.0 110.749 -173.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.65 9.1 83.68 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.35 176.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.6 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 2.9 tttm -162.0 175.33 11.92 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.279 0.562 . . . . 0.0 112.299 -175.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 9.9 p -106.7 130.58 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.128 176.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.6 mm -112.24 130.08 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.246 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.568 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 1.8 p80 -90.15 131.83 35.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.565 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.502 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 1.1 pp -131.25 176.1 8.56 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.369 -174.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.0 p -104.53 176.36 5.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.959 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 14.4 pttm -64.19 -30.66 71.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.672 0.273 . . . . 0.0 110.864 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.08 93.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.278 0.561 . . . . 0.0 110.081 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.502 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 2.5 mm-40 -71.92 -38.91 69.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.228 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.86 -49.37 75.69 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.706 175.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.724 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 13.9 mt -57.07 -60.62 3.32 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.253 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.54 -25.45 60.41 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -169.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 4.3 ttpm? -110.05 -16.46 13.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 46.9 t -128.65 -45.24 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -171.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.724 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 17.5 t80 -173.03 132.41 0.51 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 117.925 0.33 . . . . 0.0 111.845 -165.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.684 HD22 HD22 ' A' ' 20' ' ' LEU . 2.5 t-20 -106.79 105.69 15.85 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.589 -177.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.451 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 5.3 p90 -90.5 1.46 56.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -171.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -89.57 -40.69 12.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.663 ' HB3' ' OD1' ' A' ' 25' ' ' ASN . 4.8 tptp -91.29 -24.96 19.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.637 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.689 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -116.42 55.63 1.35 Allowed Pre-proline 0 N--CA 1.48 1.045 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 178.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -62.25 -43.71 22.29 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.246 1.964 . . . . 0.0 111.773 175.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -108.46 -9.26 15.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.18 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.412 ' HB2' ' CB ' ' A' ' 29' ' ' ASN . 67.3 mt-10 -91.59 177.7 6.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.821 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.447 ' HZ3' ' HE1' ' A' ' 88' ' ' PHE . 76.8 t-105 -151.95 88.49 1.4 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.943 0.401 . . . . 0.0 110.195 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -105.83 98.87 8.5 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 26.2 t80 -91.47 118.8 30.88 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.308 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 22' ' ' LYS . 4.4 mm-40 -89.78 125.96 35.5 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.835 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.99 146.14 4.63 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.037 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -91.73 -27.29 18.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.965 0.412 . . . . 0.0 110.279 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -120.08 159.68 46.21 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.852 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.14 145.58 89.4 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.524 2.15 . . . . 0.0 111.937 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -120.05 150.25 40.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.442 0.639 . . . . 0.0 111.99 -175.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.624 ' HB ' HG23 ' A' ' 73' ' ' ILE . 77.1 mt -119.47 116.07 49.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.341 176.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.3 t -103.22 109.15 26.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.75 0.309 . . . . 0.0 111.204 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 8.4 t70 -90.62 113.92 26.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.042 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -87.68 111.21 21.05 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.729 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.3 p90 -132.56 169.47 16.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.818 0.818 . . . . 0.0 111.783 -174.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.63 126.7 24.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.183 167.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.558 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 31.2 t70 -60.02 -35.0 74.12 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.484 -172.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.434 ' HE1' ' HG2' ' A' ' 79' ' ' GLU . 67.0 p-90 -73.89 -0.65 16.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.785 0.326 . . . . 0.0 111.54 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.443 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 47.7 t -101.69 119.54 38.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.965 0.412 . . . . 0.0 110.316 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.65 -56.62 17.12 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.584 -0.734 . . . . 0.0 114.112 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.443 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . 83.7 Cg_exo -47.74 -37.85 28.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.048 2.498 . . . . 0.0 113.444 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.729 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 78.2 m -69.68 -47.01 64.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.939 0.399 . . . . 0.0 111.155 177.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.558 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 53.6 mttm -52.7 -30.15 30.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.466 177.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.533 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 24.7 ptm -88.12 -40.77 13.51 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.924 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.532 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 31.6 m -69.96 -36.85 70.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.576 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.603 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -53.42 -53.16 59.57 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 16.4 Cg_exo -69.05 -34.96 15.72 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.09 1.86 . . . . 0.0 112.428 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.517 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 68.1 mt -63.58 -48.7 85.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.97 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.601 HD13 HG21 ' A' ' 73' ' ' ILE . 4.2 pp -68.7 -30.69 69.4 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.66 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.6 ' OD1' ' HG2' ' A' ' 10' ' ' LYS . 18.7 t70 -64.76 -37.95 89.33 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.25 0.547 . . . . 0.0 109.815 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 7.2 mm-40 -54.63 -50.26 68.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.759 173.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.604 HD21 ' HG3' ' A' ' 114' ' ' LYS . 3.4 mm? -62.5 -31.81 72.62 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.926 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.646 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -63.29 -37.49 87.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.811 0.338 . . . . 0.0 110.456 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.611 ' HB3' ' HZ2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -74.02 -33.92 63.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.505 178.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -41.23 70.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.461 0.648 . . . . 0.0 111.116 176.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.656 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 30.1 m-85 -98.28 27.31 4.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.112 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.41 143.78 14.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.105 0.479 . . . . 0.0 111.432 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.39 -23.77 23.11 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.826 -0.624 . . . . 0.0 113.39 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.656 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 4.2 pt20 -117.28 -24.61 7.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 121' ' ' ILE . 43.6 pt -126.36 145.57 33.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.306 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 68.0 t -120.99 118.75 57.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.646 HD12 ' HB2' ' A' ' 64' ' ' ALA . 14.3 mt -106.89 138.66 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.106 -175.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -123.65 170.37 10.54 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.666 175.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.618 ' HB3' ' HB3' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -152.45 149.42 28.55 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 172.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.24 138.2 55.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.263 0.554 . . . . 0.0 110.863 -174.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 1.2 m-20 -70.7 89.13 0.73 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.095 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.497 HG23 ' HB2' ' A' ' 85' ' ' ALA . 23.9 m -62.52 -37.07 84.63 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -169.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HG2' ' HE1' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -70.6 -21.27 62.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -174.235 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.5 ' NZ ' ' HB3' ' A' ' 77' ' ' ASP . 8.9 ptpp? -106.39 -34.93 7.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.772 0.32 . . . . 0.0 110.224 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -82.75 47.35 1.18 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.989 0.515 . . . . 0.0 110.842 174.421 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -57.99 -38.69 76.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.02 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -69.11 -37.52 78.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.251 0.548 . . . . 0.0 110.166 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.53 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 3.4 tm? -67.1 -46.66 73.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.434 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -61.88 -48.18 81.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.135 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.5 -29.81 67.26 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.05 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.85 -27.4 69.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 0.0 111.399 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.58 ' HB2' HG12 ' A' ' 90' ' ' ILE . 68.1 m-85 -104.03 8.74 36.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.792 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.54 19.99 79.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.212 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.58 HG12 ' HB2' ' A' ' 88' ' ' PHE . 33.9 mm -74.77 108.12 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 120.623 0.249 . . . . 0.0 110.538 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -56.39 -56.37 21.98 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.787 0.803 . . . . 0.0 110.871 174.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.1 p -169.72 -137.63 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.167 -1.378 . . . . 0.0 108.985 -172.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.627 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -131.77 155.35 81.51 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.845 -0.161 . . . . 0.0 110.583 -172.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.611 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 2.9 Cg_exo -84.96 141.5 33.09 Favored 'Cis proline' 0 C--N 1.346 0.431 0 C-N-CA 124.827 -0.906 . . . . 0.0 112.726 -2.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 t -141.47 137.8 32.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 107' ' ' MET . 44.6 mt -131.53 120.11 44.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.691 -174.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.4 tp -100.05 112.03 24.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.373 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -94.31 109.38 21.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.636 HG12 ' HB3' ' A' ' 105' ' ' PRO . 49.6 mt -101.34 106.66 46.81 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.51 -174.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.43 164.89 25.94 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.836 2.357 . . . . 0.0 111.759 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.1 mtp -87.75 -6.31 58.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.421 0.629 . . . . 0.0 109.946 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -133.15 121.68 22.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.239 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.69 -140.84 15.1 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.198 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 31.9 mmtp -132.27 153.27 81.21 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.636 ' HB3' HG12 ' A' ' 99' ' ' ILE . 35.5 Cg_endo -64.45 143.95 83.81 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.913 2.408 . . . . 0.0 113.543 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -104.8 169.75 8.27 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.506 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 35.0 ttm -142.84 101.59 3.88 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -172.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -96.75 134.0 40.59 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 172.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -120.74 136.86 54.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.143 0.497 . . . . 0.0 112.252 -171.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.611 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 102.17 -168.79 19.23 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.455 -0.793 . . . . 0.0 115.005 168.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.532 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -85.55 88.93 7.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.866 -0.667 . . . . 0.0 112.07 -171.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.595 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 23.3 ptt? -107.28 150.35 39.86 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.259 172.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.478 ' HD2' ' OG ' ' A' ' 116' ' ' SER . 84.6 Cg_endo -76.39 -178.09 4.2 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.987 2.458 . . . . 0.0 112.94 -173.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.604 ' HG3' HD21 ' A' ' 63' ' ' LEU . 29.4 ttmt -57.73 -35.21 70.39 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.391 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.12 -48.8 74.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.629 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 30.0 m -66.02 -41.21 91.27 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.592 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.621 ' O ' HG13 ' A' ' 121' ' ' ILE . 11.9 m-85 -58.46 -49.17 78.28 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.692 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -54.59 -48.63 71.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.444 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -66.5 -34.42 77.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.707 0.289 . . . . 0.0 110.93 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -69.68 -44.19 70.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.083 0.468 . . . . 0.0 111.128 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.621 HG13 ' O ' ' A' ' 117' ' ' PHE . 31.2 mt -70.12 -51.72 36.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.267 0.556 . . . . 0.0 110.33 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -64.0 -69.51 0.27 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.019 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 38.4 mt-10 -80.79 12.31 3.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.399 -167.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.461 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 90.8 t80 -140.09 -49.92 0.47 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.398 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 20.2 tp -75.94 -31.58 59.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.682 0.277 . . . . 0.0 110.686 -175.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -106.0 -57.01 2.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.035 0.445 . . . . 0.0 110.3 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.57 ' HB3' ' HA ' ' A' ' 123' ' ' GLU . 2.3 tmmt? -85.22 93.81 8.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -60.03 100.32 0.09 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.616 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -97.68 167.27 11.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.641 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 125.27 -0.18 8.14 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -84.44 55.23 3.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.869 0.366 . . . . 0.0 111.431 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.4 p80 179.82 107.68 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.43 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.418 ' O ' ' HB2' ' A' ' 134' ' ' HIS . 67.4 t60 -81.15 -33.49 33.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.536 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 133' ' ' HIS . 22.3 t-80 176.34 -30.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.408 0.623 . . . . 0.0 109.765 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -158.16 -26.67 0.08 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 1.9 m170 . . . . . 0 C--O 1.244 0.774 0 CA-C-N 113.979 -1.464 . . . . 0.0 108.037 164.396 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.7 mtm . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.526 ' HB3' ' OE2' ' A' ' 6' ' ' GLU . 34.7 m -76.96 -179.0 5.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.332 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.24 -63.51 1.37 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.925 0.393 . . . . 0.0 110.852 -175.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.8 33.95 0.44 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.169 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.5 m 74.98 96.96 0.07 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.564 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.526 ' OE2' ' HB3' ' A' ' 2' ' ' SER . 7.8 mm-40 -61.82 132.37 52.89 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.476 -174.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.55 137.03 13.4 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.999 -170.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.414 HD22 ' HA ' ' A' ' 8' ' ' ASN . 2.3 t-20 -95.12 165.0 12.63 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.51 44.88 96.95 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.62 -172.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.574 ' HD3' ' H ' ' A' ' 11' ' ' VAL . 15.1 tppt? -150.96 157.47 42.93 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.095 -0.552 . . . . 0.0 109.533 -173.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 14.1 p -108.78 132.62 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.202 0.525 . . . . 0.0 110.758 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.8 mt -122.88 127.43 74.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.951 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.582 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 1.9 p80 -86.26 143.39 27.95 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.4 pp -137.86 168.84 18.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.966 0.412 . . . . 0.0 111.974 -177.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.615 HG22 ' HZ3' ' A' ' 80' ' ' LYS . 40.3 p -92.48 175.33 6.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.43 174.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.52 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 8.6 ptpp? -64.42 -31.83 73.2 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.663 0.268 . . . . 0.0 111.39 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.37 -39.5 92.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.399 0.618 . . . . 0.0 109.845 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 38.3 mt-10 -72.33 -36.02 68.75 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.155 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.451 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 2.5 t80 -54.06 -53.01 59.0 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.241 1.02 . . . . 0.0 108.995 175.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 17.0 mt -59.02 -60.2 4.25 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.274 -1.784 . . . . 0.0 112.213 -175.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.72 -20.53 27.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -169.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.624 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 35.0 ttpt -109.45 -7.49 15.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.64 0.257 . . . . 0.0 111.415 -174.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 68.8 t -134.79 -49.27 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.771 ' HE2' ' HZ ' ' A' ' 88' ' ' PHE . 1.1 t80 -177.88 125.62 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.298 0.571 . . . . 0.0 110.809 -168.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -92.94 87.31 5.74 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.793 -172.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.543 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 18.6 p90 -75.92 12.14 1.2 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.418 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . 11.2 tm-20 -88.34 -53.43 4.69 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.647 ' C ' HD22 ' A' ' 29' ' ' ASN . 0.0 OUTLIER -92.4 -12.26 32.69 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.353 171.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.647 HD22 ' C ' ' A' ' 28' ' ' LYS . 0.9 OUTLIER -111.68 53.45 0.39 Allowed Pre-proline 0 N--CA 1.478 0.935 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -178.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.439 ' HD2' ' OE1' ' A' ' 31' ' ' GLU . 37.6 Cg_endo -74.68 -35.6 3.38 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 121.947 1.765 . . . . 0.0 111.103 166.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.554 ' OE1' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -100.21 -34.75 9.89 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.586 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.554 ' HG2' ' OE1' ' A' ' 31' ' ' GLU . 7.6 pt-20 -97.92 177.4 5.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.002 -177.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.589 ' CB ' ' HE2' ' A' ' 104' ' ' LYS . 76.3 t-105 -148.05 88.92 1.69 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.227 0.537 . . . . 0.0 110.628 -174.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HG2' ' OE2' ' A' ' 36' ' ' GLU . 61.9 tttm -102.92 104.49 14.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.282 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.559 ' OH ' ' HB2' ' A' ' 41' ' ' ALA . 18.9 t80 -96.79 124.3 40.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.018 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.424 ' OE2' ' HG2' ' A' ' 34' ' ' LYS . 7.1 mm-40 -88.61 93.41 9.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.534 177.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.15 129.56 1.39 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.182 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.8 -27.8 58.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.387 0.613 . . . . 0.0 110.399 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HB2' HG23 ' A' ' 72' ' ' VAL . 66.7 mttm -116.63 155.46 48.8 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.339 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.538 ' HG3' ' HG2' ' A' ' 101' ' ' MET . 36.4 Cg_exo -57.73 150.34 62.72 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.777 2.318 . . . . 0.0 111.79 177.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.559 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -120.49 147.55 44.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.423 0.63 . . . . 0.0 112.111 -173.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.57 ' HB ' HG12 ' A' ' 73' ' ' ILE . 74.7 mt -124.03 112.45 32.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 171.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 46.0 t -109.81 110.78 33.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 121.273 -0.171 . . . . 0.0 111.286 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.589 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 8.2 p-10 -101.06 116.66 33.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.217 1.008 . . . . 0.0 111.821 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.432 ' HB3' ' OG1' ' A' ' 78' ' ' THR . 13.2 m-85 -77.85 112.72 15.02 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.058 170.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.678 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.2 p90 -128.59 162.12 28.03 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.615 0.721 . . . . 0.0 111.844 -176.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.96 137.27 37.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.647 170.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.55 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 25.2 t70 -60.75 -42.06 96.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -171.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -67.66 -13.31 61.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.665 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 49.3 t -85.48 115.1 22.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.87 0.367 . . . . 0.0 110.355 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.92 -57.01 10.4 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.575 -0.738 . . . . 0.0 113.507 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.74 -40.97 31.64 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.068 2.512 . . . . 0.0 113.378 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.678 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 84.9 m -63.51 -45.31 91.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.93 0.395 . . . . 0.0 111.087 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.55 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 65.9 mttm -58.41 -29.6 66.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.073 174.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.506 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 74.3 mtp -74.42 -52.45 12.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.073 0.463 . . . . 0.0 111.234 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 53' ' ' CYS . 14.2 p -70.98 -37.97 70.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.581 -170.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.595 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -52.71 -53.38 54.87 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -176.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 29.9 Cg_exo -62.83 -49.04 5.76 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.94 1.76 . . . . 0.0 112.113 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.5 mt -56.48 -40.46 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.155 0.502 . . . . 0.0 110.897 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.488 HD22 HD13 ' A' ' 73' ' ' ILE . 6.9 mt -68.16 -36.17 79.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.348 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD1' ' HD3' ' A' ' 10' ' ' LYS . 28.3 t70 -68.57 -41.12 80.17 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.29 -54.73 39.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.903 173.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.7 tp -61.78 -31.74 71.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.698 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.623 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -59.53 -46.85 87.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.439 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.624 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 3.6 tmtm? -75.71 -40.29 55.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.422 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -55.67 -31.35 62.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.395 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.434 ' HD2' ' NE2' ' A' ' 70' ' ' GLN . 72.8 m-85 -111.27 25.15 12.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.615 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.426 ' HB2' ' HA ' ' A' ' 65' ' ' LYS . 24.1 t0 -54.13 148.39 11.19 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.736 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.63 -22.11 18.78 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.529 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.434 ' NE2' ' HD2' ' A' ' 67' ' ' TYR . 16.9 mt-30 -95.92 -56.39 2.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.924 0.362 . . . . 0.0 111.206 -175.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -122.69 174.41 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.67 -170.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 43.2 t -131.47 129.09 61.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 174.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 17.0 mt -106.19 135.09 45.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.295 0.569 . . . . 0.0 110.875 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 84.3 m-85 -122.04 163.9 18.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.125 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.589 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -147.33 153.47 39.73 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.045 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.666 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 9.4 p -133.94 144.29 36.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.607 -174.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.415 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 6.0 m-20 -86.6 88.66 7.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 45' ' ' PHE . 7.1 m -60.53 -32.65 71.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -169.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.449 ' HA ' HE21 ' A' ' 82' ' ' GLN . 5.7 mm-40 -54.42 -30.85 53.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.615 ' HZ3' HG22 ' A' ' 15' ' ' THR . 22.3 pttp -107.75 -17.56 14.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.594 0.711 . . . . 0.0 110.187 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.666 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 0.3 OUTLIER -94.56 38.73 1.1 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.12 175.056 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.449 HE21 ' HA ' ' A' ' 79' ' ' GLU . 72.8 mm-40 -66.14 -36.29 82.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.323 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.417 ' HB2' ' HE2' ' A' ' 16' ' ' LYS . 2.5 mp0 -64.32 -34.64 78.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.433 0.635 . . . . 0.0 109.627 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.474 HD13 ' CE2' ' A' ' 26' ' ' PHE . 15.5 tp -70.2 -45.6 66.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.116 177.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.561 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -57.1 -49.47 75.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.879 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.28 -30.05 66.99 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.325 -0.464 . . . . 0.0 113.085 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.81 -32.81 74.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.328 . . . . 0.0 111.37 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.771 ' HZ ' ' HE2' ' A' ' 24' ' ' TYR . 96.6 m-85 -101.4 8.33 42.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.841 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.25 31.62 77.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.892 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.663 ' HA ' ' NH1' ' A' ' 91' ' ' ARG . 42.7 mt -82.26 136.93 21.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.906 0.384 . . . . 0.0 110.394 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.663 ' NH1' ' HA ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -66.52 -50.27 63.74 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t 170.26 -89.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.231 -1.349 . . . . 0.0 107.949 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.527 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -141.35 155.05 67.8 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.757 -178.316 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.753 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.5 Cg_exo -86.71 143.39 28.22 Favored 'Cis proline' 0 C--N 1.343 0.253 0 C-N-CA 124.585 -1.006 . . . . 0.0 111.983 -3.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 59.0 m -141.4 132.02 25.55 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 107' ' ' MET . 64.0 mt -128.49 118.73 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.109 0.481 . . . . 0.0 111.073 -172.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 106' ' ' GLU . 23.9 tp -98.98 114.75 27.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.227 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -94.23 103.11 15.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 61.5 mt -96.42 111.38 56.66 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.431 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 98.3 Cg_endo -84.39 169.64 10.98 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.808 2.339 . . . . 0.0 111.612 174.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.538 ' HG2' ' HG3' ' A' ' 40' ' ' PRO . 95.1 mmm -89.99 -2.29 58.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 0.0 110.534 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -151.81 115.89 4.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.393 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 116.19 -144.71 18.53 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.77 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.589 ' HE2' ' CB ' ' A' ' 33' ' ' TRP . 28.0 mmtp -126.32 151.61 72.63 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.452 ' HG3' ' CH2' ' A' ' 33' ' ' TRP . 85.8 Cg_endo -73.79 148.65 41.57 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.815 2.344 . . . . 0.0 113.322 -175.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.486 ' HG2' ' N ' ' A' ' 107' ' ' MET . 37.4 tt0 -95.23 166.94 11.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.876 178.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.486 ' N ' ' HG2' ' A' ' 106' ' ' GLU . 32.3 tpp -142.68 107.56 4.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.087 0.47 . . . . 0.0 111.491 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.95 157.26 17.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.239 174.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -126.34 135.44 51.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.942 0.401 . . . . 0.0 111.129 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.753 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 107.15 -171.72 17.08 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.679 -0.691 . . . . 0.0 113.381 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.65 81.02 1.4 Allowed 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.542 0.687 . . . . 0.0 110.997 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.701 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 4.5 mpp? -65.49 148.97 97.75 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.329 172.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.401 ' HG2' ' H ' ' A' ' 116' ' ' SER . 73.4 Cg_endo -74.32 172.65 15.64 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.125 1.883 . . . . 0.0 110.772 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -60.03 -24.53 64.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.109 0.48 . . . . 0.0 109.851 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.51 -53.29 44.44 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.238 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.701 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 18.5 m -71.94 -28.73 63.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.486 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -67.56 -40.2 84.92 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.985 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 122' ' ' ASP . 0.8 OUTLIER -58.25 -37.86 75.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -67.58 -51.89 45.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.48 -46.56 89.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.152 0.501 . . . . 0.0 111.284 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.44 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 1.7 mp -67.55 -43.89 86.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.14 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.506 ' HA ' HD12 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -72.44 -55.1 7.57 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.666 -177.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.671 ' HA ' ' HE2' ' A' ' 127' ' ' LYS . 31.9 tt0 -77.25 -8.33 57.41 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -169.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 90.4 t80 -127.65 -51.74 1.36 Allowed 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.82 -0.55 . . . . 0.0 111.656 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.44 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 32.5 tp -77.71 -29.76 51.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -173.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 122' ' ' ASP . 92.7 mt -96.92 -54.06 3.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.325 0.583 . . . . 0.0 110.009 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.671 ' HE2' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -135.84 82.29 1.94 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.071 179.623 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 124' ' ' PHE . 52.6 pttt -57.77 104.05 0.17 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.551 0.691 . . . . 0.0 110.838 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.623 ' HB2' ' HD2' ' A' ' 134' ' ' HIS . 44.8 mt-10 -77.75 46.41 0.56 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.157 -175.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.62 62.56 4.11 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 171.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -146.45 -157.25 0.79 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -80.0 32.93 0.27 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.862 0.363 . . . . 0.0 111.425 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 33.9 p80 -171.4 136.02 0.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.135 174.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.623 ' HD2' ' HB2' ' A' ' 129' ' ' GLU . 11.6 t-80 -157.58 139.97 14.59 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -68.52 -52.21 34.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.98 0.419 . . . . 0.0 110.219 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.3 -0.857 . . . . 0.0 109.788 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 110.582 -0.155 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.4 p -177.3 -82.76 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.942 0.401 . . . . 0.0 111.675 -176.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 90.4 mt -71.21 -25.41 62.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.652 -174.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.68 -30.32 67.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.639 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m 58.17 64.57 1.47 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.818 0.818 . . . . 0.0 109.698 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.525 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 1.1 pm0 -86.98 79.24 8.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.07 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.553 ' HA3' HD11 ' A' ' 12' ' ' ILE . . . -83.02 84.63 1.54 Allowed Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.424 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.646 HD21 ' HA2' ' A' ' 69' ' ' GLY . 4.8 t30 -60.33 129.77 43.3 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 177.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . 57.7 36.92 81.22 Favored Glycine 0 CA--C 1.507 -0.457 0 O-C-N 123.552 0.533 . . . . 0.0 112.387 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 163.81 35.15 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -175.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' A' ' 61' ' ' ASP . 26.1 m -89.76 119.15 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.405 0.621 . . . . 0.0 110.874 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.553 HD11 ' HA3' ' A' ' 7' ' ' GLY . 41.5 mm -111.49 105.34 18.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.925 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.553 ' HA ' ' HB2' ' A' ' 75' ' ' LYS . 19.2 p80 -79.77 129.74 34.74 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.6 pp -143.75 168.57 19.61 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.495 -174.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.0 p -86.79 168.02 13.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.747 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -55.65 -34.23 64.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.656 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.71 -36.45 75.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.322 0.582 . . . . 0.0 110.242 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.665 ' HB3' ' HE2' ' A' ' 22' ' ' LYS . 42.6 mt-10 -72.08 -33.32 67.82 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.52 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -61.81 -49.37 76.58 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.993 0.901 . . . . 0.0 108.872 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.8 tt -46.62 -60.26 2.49 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 113.479 -1.691 . . . . 0.0 111.829 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.33 -24.99 31.88 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -170.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.665 ' HE2' ' HB3' ' A' ' 18' ' ' GLU . 47.5 mtmt -109.31 0.86 19.75 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.388 -0.525 . . . . 0.0 112.146 -173.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -142.68 -49.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 83.6 t80 -164.08 116.68 1.39 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.558 -165.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.423 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -80.67 90.75 5.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.814 -178.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -83.89 9.69 11.53 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 122.148 -0.345 . . . . 0.0 111.825 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -84.95 -54.34 4.71 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.974 0.892 . . . . 0.0 108.683 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.464 ' C ' HD22 ' A' ' 29' ' ' ASN . 7.6 ptpp? -97.54 -12.0 23.07 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.506 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' A' ' 34' ' ' LYS . 1.1 m-80 -123.08 67.46 33.49 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-O 121.184 0.516 . . . . 0.0 110.998 170.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -59.67 -43.18 40.46 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.096 2.531 . . . . 0.0 111.974 171.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -112.82 -25.51 9.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.797 -174.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.567 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -90.72 154.64 19.4 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.135 0.493 . . . . 0.0 110.903 -176.129 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.459 ' HZ3' ' HE1' ' A' ' 88' ' ' PHE . 76.4 t-105 -97.22 111.57 23.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.643 -177.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.627 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -133.32 115.41 14.87 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.63 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 26.9 t80 -103.58 107.23 17.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.87 -176.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.512 ' OE2' ' HG3' ' A' ' 34' ' ' LYS . 1.1 mp0 -95.71 76.61 3.24 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.925 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.63 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -133.76 -136.22 3.67 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.401 -173.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -149.57 -58.79 0.2 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.882 0.372 . . . . 0.0 110.998 -173.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.43 ' HB2' HG23 ' A' ' 72' ' ' VAL . 48.8 mttp -125.5 159.04 62.33 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.966 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.567 ' HB2' HG22 ' A' ' 71' ' ' ILE . 83.8 Cg_exo -42.43 131.36 5.08 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.602 2.201 . . . . 0.0 111.65 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -116.52 150.18 38.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.265 0.555 . . . . 0.0 112.24 -167.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.796 ' HB ' HG12 ' A' ' 73' ' ' ILE . 67.8 mt -127.9 116.88 44.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.882 173.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.639 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 38.5 t -98.84 116.31 41.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 120.825 0.345 . . . . 0.0 110.68 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.521 ' HB2' HD13 ' A' ' 60' ' ' LEU . 7.1 t70 -91.09 110.58 21.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.554 177.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.506 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 97.8 m-85 -94.39 111.65 23.41 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 174.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.656 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.1 p90 -133.58 174.9 9.93 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.547 0.689 . . . . 0.0 111.11 -175.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.97 142.61 22.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.298 173.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.476 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 32.4 t70 -62.03 -28.89 69.91 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -83.38 -1.07 52.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.686 0.279 . . . . 0.0 111.553 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 41.1 t -99.68 113.08 25.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.097 0.475 . . . . 0.0 110.805 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 54' ' ' LYS . . . -58.16 -51.36 58.88 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.472 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 97.6 Cg_exo -47.28 -47.74 16.63 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.896 2.397 . . . . 0.0 113.113 175.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 71.0 m -63.78 -36.66 84.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.908 0.385 . . . . 0.0 111.482 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.476 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 67.5 mttm -56.46 -34.78 67.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.831 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.513 ' SD ' ' HB1' ' A' ' 111' ' ' ALA . 26.9 ptm -91.84 -26.95 18.26 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.793 -175.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.633 HG22 ' HA ' ' A' ' 53' ' ' CYS . 25.1 m -76.71 -31.04 19.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.702 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.433 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -47.69 -58.25 8.06 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 33.7 Cg_endo -65.17 -39.64 22.73 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.75 1.634 . . . . 0.0 112.269 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.2 mt -63.59 -43.62 98.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.226 0.536 . . . . 0.0 110.304 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 44' ' ' ASP . 7.8 mt -57.8 -43.81 85.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.129 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.478 ' HA ' HG13 ' A' ' 11' ' ' VAL . 30.7 t70 -68.12 -37.43 81.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.827 0.346 . . . . 0.0 110.557 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.431 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 3.7 tp10 -59.69 -41.88 91.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.472 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.515 HD21 ' HG3' ' A' ' 114' ' ' LYS . 4.1 mm? -71.24 -31.72 67.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.725 176.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.544 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -56.45 -57.11 13.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.769 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -74.83 -24.61 58.63 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.74 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.08 -33.42 75.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.499 0.666 . . . . 0.0 110.167 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -104.2 25.61 9.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.936 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.546 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 6.4 t0 -59.31 133.91 56.53 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 110.138 -176.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.646 ' HA2' HD21 ' A' ' 8' ' ' ASN . . . 92.36 -22.04 34.73 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.769 -176.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -94.97 -53.17 3.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.906 0.384 . . . . 0.0 110.268 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.567 HG22 ' HB2' ' A' ' 40' ' ' PRO . 38.2 pt -127.15 163.5 29.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.216 -176.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 50.9 t -131.01 131.91 63.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.796 HG12 ' HB ' ' A' ' 42' ' ' ILE . 60.3 mt -111.83 133.48 57.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.101 0.477 . . . . 0.0 110.844 -176.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -115.21 160.63 19.49 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 13' ' ' HIS . 44.6 mttm -129.13 136.02 49.64 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.748 0.308 . . . . 0.0 110.902 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.407 HG13 ' HG2' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -138.21 136.89 44.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.665 -178.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 4.4 m-20 -97.32 106.19 18.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.2 p -57.2 -26.97 61.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -67.55 -21.39 65.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.403 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.432 ' HG2' ' HB2' ' A' ' 77' ' ' ASP . 8.5 ptmm? -114.08 -33.67 5.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.448 0.642 . . . . 0.0 109.974 175.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 2.0 mp0 -83.62 36.66 0.55 Allowed 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.979 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -57.27 -47.55 81.14 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.825 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -61.88 -36.76 82.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.377 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.7 tp -70.16 -50.38 40.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.902 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.482 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -63.22 -37.47 87.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.05 -31.36 78.45 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.846 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.02 -33.58 76.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 111.024 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.552 ' HB2' HG12 ' A' ' 90' ' ' ILE . 85.7 m-85 -90.32 -1.24 57.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.18 21.55 75.55 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.01 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.552 HG12 ' HB2' ' A' ' 88' ' ' PHE . 37.3 mm -81.03 126.56 39.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 122.444 0.298 . . . . 0.0 110.67 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -61.99 -64.46 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.047 0.451 . . . . 0.0 110.169 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.9 p -164.6 -101.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.535 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.496 ' HB ' ' HA ' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -142.3 157.75 62.42 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 120.508 0.194 . . . . 0.0 111.383 -173.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.828 ' HB2' ' H ' ' A' ' 110' ' ' GLY . 15.0 Cg_exo -79.66 144.35 70.65 Favored 'Cis proline' 0 N--CA 1.476 0.454 0 C-N-CA 124.241 -1.15 . . . . 0.0 112.162 -3.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 14.8 m -140.91 137.41 33.14 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.662 ' O ' ' HA ' ' A' ' 107' ' ' MET . 66.6 mt -133.13 114.47 21.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.639 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.8 tp -96.45 115.13 26.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 -175.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.432 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 97.3 m-85 -95.23 107.03 19.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.04 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.4 ' HB ' ' HB3' ' A' ' 41' ' ' ALA . 67.5 mt -99.18 105.01 29.76 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -177.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 98' ' ' PHE . 79.4 Cg_endo -88.19 166.03 6.85 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.83 2.353 . . . . 0.0 111.988 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 20.0 mmt -89.86 -6.24 56.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.96 0.41 . . . . 0.0 110.381 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.92 104.96 5.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.876 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.26 -151.38 18.32 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.251 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.437 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 12.1 mmmm -121.1 154.4 58.24 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 104' ' ' LYS . 56.8 Cg_endo -68.85 151.15 74.1 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.976 2.451 . . . . 0.0 114.576 -171.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -104.83 169.45 8.44 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.175 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.662 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 21.3 ptp -143.84 129.62 19.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.688 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.41 140.21 50.21 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -119.93 138.27 53.55 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.495 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.828 ' H ' ' HB2' ' A' ' 94' ' ' PRO . . . 105.04 -178.4 23.64 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.715 -0.675 . . . . 0.0 114.682 170.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.513 ' HB1' ' SD ' ' A' ' 55' ' ' MET . . . -90.75 86.34 6.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.036 -0.582 . . . . 0.0 111.53 -173.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.579 ' HB2' ' HB3' ' A' ' 116' ' ' SER . 23.5 ptp -92.47 151.6 41.43 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.784 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.781 ' HD2' ' HB3' ' A' ' 116' ' ' SER . 85.5 Cg_endo -75.73 177.16 9.06 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.58 2.187 . . . . 0.0 112.129 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.515 ' HG3' HD21 ' A' ' 63' ' ' LEU . 62.9 tttm -57.82 -35.57 71.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.494 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.45 -47.71 59.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.818 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.781 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 47.8 t -66.85 -30.47 70.65 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.336 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.489 ' O ' HG13 ' A' ' 121' ' ' ILE . 3.4 m-85 -58.58 -53.21 60.88 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 173.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -56.82 -42.79 80.22 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.622 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -53.83 -48.35 70.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.022 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.12 -42.75 68.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.408 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 117' ' ' PHE . 68.0 mt -66.72 -55.33 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.088 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.61 -65.34 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.562 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -48.48 -42.18 32.01 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -172.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -104.52 -47.22 4.15 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -171.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 23.9 tp -77.69 -38.73 46.82 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -169.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.6 mp -105.85 -42.8 5.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.097 0.475 . . . . 0.0 111.094 -176.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -80.52 -20.48 43.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.858 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.3 pttt 37.73 33.57 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.65 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -148.93 105.41 3.54 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 133' ' ' HIS . . . -92.85 100.61 2.68 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.654 -175.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -70.46 -35.9 73.59 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -128.08 -22.98 3.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.932 174.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.529 ' O ' ' HA3' ' A' ' 130' ' ' GLY . 14.3 t-160 -102.85 85.09 2.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.105 0.479 . . . . 0.0 110.361 174.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -134.5 134.25 41.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.097 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -71.4 -22.34 61.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.193 0.521 . . . . 0.0 110.373 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.389 177.173 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.7 p 42.64 -113.65 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.14 0.9 . . . . 0.0 112.646 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 pp -101.04 1.36 39.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.747 0.308 . . . . 0.0 111.742 -174.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.56 -9.05 59.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.254 0.55 . . . . 0.0 110.668 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 p -139.88 124.52 18.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.449 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.58 146.05 42.2 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.32 70.47 0.48 Allowed Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.408 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.622 ' ND2' ' H ' ' A' ' 69' ' ' GLY . 2.0 t30 -169.91 163.44 9.56 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 172.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . 63.15 28.32 71.98 Favored Glycine 0 CA--C 1.509 -0.33 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.444 ' HE2' HD11 ' A' ' 12' ' ' ILE . 11.8 ptmt -156.05 155.75 33.19 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 121.126 0.489 . . . . 0.0 110.604 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 6.4 p -112.13 116.46 52.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.904 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.444 HD11 ' HE2' ' A' ' 10' ' ' LYS . 45.3 mm -102.96 115.49 45.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.117 -175.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.656 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 0.6 OUTLIER -85.19 125.43 32.84 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.248 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.7 pp -136.31 168.47 19.36 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.364 -173.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.0 p -102.87 177.12 4.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.114 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.412 ' HB2' ' HZ ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -58.62 -28.31 65.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.82 -43.28 99.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.181 0.515 . . . . 0.0 110.568 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 3.4 mm-40 -71.9 -36.14 69.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.031 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.45 -54.06 50.12 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.587 177.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.653 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 12.5 mt -51.0 -61.02 2.48 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.001 -1.454 . . . . 0.0 112.164 -176.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.18 -31.49 60.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -167.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -108.85 -20.29 13.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 95.9 t -119.43 -45.77 2.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -171.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.653 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 21.6 t80 -169.86 116.62 0.56 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.167 0.508 . . . . 0.0 111.344 -166.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.446 HD22 HD22 ' A' ' 20' ' ' LEU . 2.5 t-20 -89.54 90.32 8.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.708 -178.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.465 ' CE2' HD13 ' A' ' 84' ' ' LEU . 31.9 p90 -82.53 -2.25 52.98 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.41 ' HG3' ' CD2' ' A' ' 20' ' ' LEU . 15.2 mt-10 -70.64 -53.24 16.61 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.93 0.871 . . . . 0.0 108.698 174.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -100.13 -14.88 18.37 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.817 -172.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.419 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 12.7 m-80 -126.75 59.39 33.83 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 29' ' ' ASN . 10.5 Cg_endo -60.12 -30.14 90.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.396 2.731 . . . . 0.0 111.551 167.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -97.66 -41.22 8.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.776 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -94.91 149.6 21.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.204 -173.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.769 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 60.9 t-105 -108.29 109.56 20.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.044 176.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.92 103.17 6.17 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.299 176.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 50.5 t80 -86.22 131.67 34.18 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.207 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.429 ' HA ' ' OE1' ' A' ' 36' ' ' GLU . 14.6 mm-40 -112.1 -167.18 1.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.93 -119.61 3.36 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.787 -1.197 . . . . 0.0 112.991 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -158.92 -50.78 0.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.291 0.567 . . . . 0.0 109.815 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.588 ' HB2' HG23 ' A' ' 72' ' ' VAL . 48.7 mttp -121.76 168.78 10.55 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.864 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.61 ' HB3' HD11 ' A' ' 125' ' ' LEU . 33.1 Cg_exo -60.86 158.99 30.89 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.602 2.201 . . . . 0.0 111.534 173.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -127.61 142.31 51.39 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -169.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.558 ' HB ' HG12 ' A' ' 73' ' ' ILE . 44.0 mm -117.13 110.21 30.44 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.228 168.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 67.8 t -110.7 113.12 43.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 118.032 0.378 . . . . 0.0 111.523 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.666 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 5.8 p-10 -100.38 119.47 38.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.287 1.041 . . . . 0.0 111.477 176.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -77.02 113.87 15.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.297 -1.32 . . . . 0.0 108.84 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.678 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.4 p90 -130.98 168.28 17.62 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.29 0.567 . . . . 0.0 111.169 -176.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.09 135.89 19.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.439 174.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.418 ' O ' ' HE3' ' A' ' 54' ' ' LYS . 27.0 t70 -66.99 -33.13 74.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.761 0.315 . . . . 0.0 111.718 -173.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -71.89 -6.63 43.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.906 0.384 . . . . 0.0 111.236 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.423 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 37.4 t -113.34 113.64 25.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.101 0.477 . . . . 0.0 110.124 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.68 -53.11 41.15 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 119.263 -0.743 . . . . 0.0 113.975 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.423 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 84.3 Cg_exo -47.52 -31.41 13.7 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.099 2.533 . . . . 0.0 114.126 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.678 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 45.3 m -73.94 -45.11 52.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.855 0.36 . . . . 0.0 111.127 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 48' ' ' ASP . 15.1 ptpt -77.15 -27.4 53.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.129 0.49 . . . . 0.0 109.808 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.0 tmm? -51.47 -39.96 58.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.166 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.7 m -88.06 -15.99 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.881 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.7 -52.36 57.19 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.32 -33.68 37.88 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 121.766 1.644 . . . . 0.0 112.216 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 113' ' ' PRO . 92.5 mt -65.44 -44.49 94.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.524 0.678 . . . . 0.0 109.899 175.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.1 mt -67.98 -31.22 70.78 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.123 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -60.82 -48.27 82.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.171 0.51 . . . . 0.0 109.932 170.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -54.81 -46.52 74.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.154 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.821 HD23 HD12 ' A' ' 121' ' ' ILE . 7.7 mp -67.15 -31.25 71.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.363 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.454 ' O ' ' HA2' ' A' ' 9' ' ' GLY . . . -59.38 -42.09 90.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.765 0.317 . . . . 0.0 110.582 177.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -72.39 -49.67 32.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.313 0.577 . . . . 0.0 109.938 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -53.12 -35.79 60.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.705 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.579 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 45.0 m-85 -107.2 26.51 10.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.555 -178.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.575 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 25.5 t70 -67.36 153.92 42.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.268 0.556 . . . . 0.0 111.217 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.622 ' H ' ' ND2' ' A' ' 8' ' ' ASN . . . 85.51 -18.58 28.54 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.508 -0.769 . . . . 0.0 113.496 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 4.2 pt20 -121.65 -53.42 1.99 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -171.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 67' ' ' TYR . 40.8 pt -128.35 156.39 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 118.313 0.506 . . . . 0.0 112.199 -174.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.588 HG23 ' HB2' ' A' ' 39' ' ' LYS . 6.8 t -111.91 144.71 19.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.851 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 68.5 mt -112.59 128.99 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.139 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 36.3 m-85 -117.15 159.72 22.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.666 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -140.88 144.73 35.42 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.188 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.557 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 7.4 p -122.03 136.16 59.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.274 0.559 . . . . 0.0 111.057 -173.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.587 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 1.1 m-20 -73.56 87.08 1.61 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.962 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.528 HG23 ' HB2' ' A' ' 85' ' ' ALA . 4.4 m -65.5 -31.64 72.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -167.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.41 ' HG3' ' H ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -69.92 -18.19 63.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.228 -0.295 . . . . 0.0 111.662 -178.546 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.567 ' NZ ' ' HB3' ' A' ' 77' ' ' ASP . 8.7 ptpp? -110.32 -26.81 9.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.519 0.675 . . . . 0.0 110.033 175.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -89.47 42.73 1.1 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.669 172.318 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -64.48 -41.47 96.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.205 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -31.15 67.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.473 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.482 HD23 HG21 ' A' ' 76' ' ' VAL . 27.4 tp -66.79 -46.39 75.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.067 174.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.55 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -63.64 -43.01 98.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.967 177.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.69 -29.15 69.28 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.701 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.82 -32.21 73.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.903 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -89.28 -16.42 31.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.781 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.89 20.44 28.52 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.097 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.55 ' HB ' ' HB1' ' A' ' 85' ' ' ALA . 35.6 mm -80.51 135.89 24.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -69.22 -62.82 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.157 0.503 . . . . 0.0 110.215 177.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.506 ' O ' HG21 ' A' ' 78' ' ' THR . 36.2 m -156.25 -88.44 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.615 176.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.656 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 1.8 pp -160.19 154.9 20.64 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.608 -172.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -97.11 144.88 5.7 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 124.548 -1.022 . . . . 0.0 112.215 -2.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.714 ' HB3' ' SD ' ' A' ' 107' ' ' MET . 61.3 m -141.07 143.26 34.25 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.411 HD12 ' C ' ' A' ' 95' ' ' SER . 3.7 mp -127.96 121.78 57.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.332 0.587 . . . . 0.0 110.734 -175.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.1 tp -98.02 112.5 24.42 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.764 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.594 ' HE2' ' HB3' ' A' ' 108' ' ' ALA . 93.1 m-85 -90.14 104.03 16.65 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.567 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 64.9 mt -101.73 113.51 65.82 Favored Pre-proline 0 C--O 1.235 0.312 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -169.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -87.47 174.64 4.95 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.124 2.549 . . . . 0.0 111.725 171.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.9 mmt -97.7 -24.73 15.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.251 0.548 . . . . 0.0 110.362 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.78 21.98 16.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.376 -171.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 178.62 -176.29 47.9 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.172 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.769 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 14.3 mptt -77.19 149.98 79.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.584 0.231 . . . . 0.0 110.689 177.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.567 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 91.1 Cg_endo -82.54 155.23 16.08 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.925 2.417 . . . . 0.0 113.068 -176.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -104.09 168.27 9.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.466 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.714 ' SD ' ' HB3' ' A' ' 95' ' ' SER . 27.2 tpp -132.59 124.15 27.82 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.608 -174.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.594 ' HB3' ' HE2' ' A' ' 98' ' ' PHE . . . -130.89 129.32 42.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.438 174.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 95' ' ' SER . 86.0 mt-30 -74.01 151.49 40.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.806 0.336 . . . . 0.0 110.977 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.79 -153.61 3.58 Favored Glycine 0 C--O 1.227 -0.336 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 -168.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 69.62 19.64 7.29 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.496 0.718 . . . . 0.0 111.025 -174.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.642 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 76.0 mtm -89.98 147.35 37.06 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.376 177.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.431 ' HA ' HD13 ' A' ' 59' ' ' ILE . 72.2 Cg_endo -75.74 -174.85 2.18 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.411 2.074 . . . . 0.0 110.782 175.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.534 ' HG3' HD11 ' A' ' 63' ' ' LEU . 19.5 ttmt -56.83 -41.98 78.81 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.57 173.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.12 -51.96 67.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.642 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 19.8 m -69.51 -36.91 76.91 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.986 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.572 ' O ' HG13 ' A' ' 121' ' ' ILE . 3.5 m-85 -65.47 -52.24 54.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.935 0.398 . . . . 0.0 110.414 175.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 114' ' ' LYS . 2.8 tmtm? -55.71 -44.1 77.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.103 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.501 ' HG3' ' OE2' ' A' ' 123' ' ' GLU . 28.1 tptp -56.57 -57.12 13.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.326 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.15 90.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.145 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.821 HD12 HD23 ' A' ' 63' ' ' LEU . 23.8 mt -67.71 -50.75 57.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 0.0 110.715 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.66 -56.35 14.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.834 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.696 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . 9.1 pt-20 -76.04 6.96 4.53 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.731 0.644 . . . . 0.0 112.688 -169.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -131.74 -48.19 0.96 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.4 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' A' ' 40' ' ' PRO . 31.1 tp -82.56 -46.26 13.58 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.413 -174.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.45 HD11 ' CE1' ' A' ' 67' ' ' TYR . 72.7 mt -81.32 -60.0 2.43 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.696 ' HG3' ' HA ' ' A' ' 123' ' ' GLU . 8.2 ptpp? -105.1 101.11 10.68 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.346 173.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.441 ' H ' ' HG2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -71.45 70.37 0.63 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.069 0.461 . . . . 0.0 111.073 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.438 ' HG2' ' N ' ' A' ' 130' ' ' GLY . 6.1 tt0 73.52 150.27 0.11 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.164 175.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.438 ' N ' ' HG2' ' A' ' 129' ' ' GLU . . . -74.48 70.84 1.61 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 174.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 133' ' ' HIS . 14.1 m80 -73.08 67.46 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.699 0.761 . . . . 0.0 111.649 -177.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -116.68 38.86 3.33 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.366 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 131' ' ' HIS . 20.3 m-70 -76.91 2.41 14.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.832 -175.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -82.76 85.72 7.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -99.83 153.63 18.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.47 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 33.8 m80 . . . . . 0 C--O 1.244 0.764 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 169.043 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.858 0.361 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.5 m -145.6 -44.75 0.21 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.167 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 3' ' ' LEU . 6.2 mp -99.34 -47.43 5.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -162.94 -66.67 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.042 177.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.5 p -133.47 -37.44 0.95 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.13 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 55.92 -90.72 0.03 OUTLIER 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.573 -173.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -109.56 87.41 0.48 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.418 ' H ' ' CD ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -164.29 102.43 0.85 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.23 36.84 19.91 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 116.108 -0.497 . . . . 0.0 113.762 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.418 ' CD ' ' H ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -164.69 166.85 19.66 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 122.017 0.913 . . . . 0.0 112.879 178.201 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.743 HG13 HG22 ' A' ' 73' ' ' ILE . 42.0 t -110.61 115.04 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.421 170.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.402 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 50.0 mm -80.8 99.18 4.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.023 0.439 . . . . 0.0 110.546 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 14.4 p80 -74.09 112.68 10.47 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 171.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.809 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.8 pp -139.42 -179.88 6.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -167.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.3 p -109.25 177.73 4.66 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.582 173.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.576 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -59.5 -27.32 66.04 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 117.598 0.181 . . . . 0.0 111.221 -178.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.87 -39.78 76.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.287 0.565 . . . . 0.0 110.592 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.809 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 5.2 mm-40 -72.13 -35.88 69.23 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.519 175.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.421 ' CG ' HD11 ' A' ' 84' ' ' LEU . 13.8 t80 -61.23 -45.33 94.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 122.173 0.987 . . . . 0.0 108.588 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.686 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.7 tt -46.83 -61.05 2.03 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 113.19 -1.823 . . . . 0.0 111.868 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.81 -13.25 51.66 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -170.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -109.49 -18.94 13.4 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 47.2 t -133.66 -45.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -171.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.686 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 9.5 t80 -161.32 115.38 1.99 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.232 0.539 . . . . 0.0 111.622 -167.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.433 ' ND2' HD21 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -91.91 95.51 9.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.602 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.423 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 6.2 p90 -73.89 7.38 2.61 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -97.55 -17.36 19.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.881 0.372 . . . . 0.0 110.27 170.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -90.38 -34.26 15.73 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.205 0.526 . . . . 0.0 110.296 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.752 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -147.98 62.08 6.49 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.289 -175.527 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 29' ' ' ASN . 4.8 Cg_exo -44.03 -35.28 7.31 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 124.907 3.738 . . . . 0.0 112.771 170.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -103.46 -30.87 10.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.77 -176.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.78 178.55 5.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.47 0.652 . . . . 0.0 112.017 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.564 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 59.2 t-105 -123.14 104.92 9.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.947 175.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -119.12 105.79 11.74 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.483 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.549 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 38.2 t80 -72.09 123.48 22.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.342 178.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -97.15 15.61 22.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.371 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -98.98 -152.28 27.43 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.759 -173.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -124.79 -52.57 1.68 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 111.196 -172.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.559 ' HB2' HG23 ' A' ' 72' ' ' VAL . 36.5 mttm -113.35 165.27 13.66 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.493 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.546 ' HB3' HD11 ' A' ' 125' ' ' LEU . 73.8 Cg_exo -47.77 131.74 20.64 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.158 1.905 . . . . 0.0 110.972 172.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -113.09 143.57 44.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.292 0.568 . . . . 0.0 111.811 -170.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.616 ' HB ' HG12 ' A' ' 73' ' ' ILE . 61.3 mt -130.26 110.4 19.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.034 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.571 HG23 ' HB2' ' A' ' 74' ' ' TYR . 8.3 p -111.76 134.52 53.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.545 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 2.4 t70 -100.72 118.96 37.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.492 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.445 ' O ' HG22 ' A' ' 93' ' ' ILE . 97.3 m-85 -95.85 112.58 24.27 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.676 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 10.7 p90 -127.28 173.98 9.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.815 0.817 . . . . 0.0 111.762 -175.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.28 120.03 5.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 113.53 -1.668 . . . . 0.0 107.352 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.18 -34.7 68.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -169.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -67.86 -12.88 61.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.865 0.364 . . . . 0.0 111.383 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.51 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 42.4 t -99.01 117.3 33.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.805 0.336 . . . . 0.0 110.427 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.02 -54.62 22.09 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.701 -0.681 . . . . 0.0 114.21 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.51 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 81.6 Cg_exo -47.59 -36.68 25.32 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.025 2.484 . . . . 0.0 114.034 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.676 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 61.5 m -68.21 -31.86 71.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.205 0.526 . . . . 0.0 111.196 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -63.85 -28.63 69.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.857 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.535 ' O ' HD13 ' A' ' 59' ' ' ILE . 41.4 mmm -76.16 -42.97 44.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.106 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 53' ' ' CYS . 6.5 p -75.29 -39.18 42.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -173.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.52 -55.4 19.47 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.04 -46.2 6.56 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.075 1.85 . . . . 0.0 112.446 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.535 HD13 ' O ' ' A' ' 55' ' ' MET . 1.8 mp -55.71 -42.08 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 121.301 0.572 . . . . 0.0 110.333 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -58.68 -39.03 79.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.592 176.152 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.546 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 33.0 t70 -69.19 -42.64 75.55 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.662 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 66' ' ' GLU . 43.4 mt-10 -54.13 -55.22 29.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.371 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.578 HD11 ' HG3' ' A' ' 114' ' ' LYS . 10.9 mp -61.23 -30.67 70.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.3 -178.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 61' ' ' ASP . . . -53.55 -56.56 16.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.081 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.546 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -77.96 -29.23 49.7 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.132 178.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 57.9 mt-10 -66.15 -38.06 87.19 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.93 0.395 . . . . 0.0 111.63 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -105.47 19.33 20.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.037 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.54 ' HB2' ' HA ' ' A' ' 65' ' ' LYS . 33.5 t0 -59.24 157.49 10.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.552 0.692 . . . . 0.0 112.82 -170.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.58 -32.8 7.14 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.428 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.597 ' HG3' HG23 ' A' ' 71' ' ' ILE . 23.6 pt20 -111.91 -35.14 5.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -174.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.597 HG23 ' HG3' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -119.44 162.47 17.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.503 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.559 HG23 ' HB2' ' A' ' 39' ' ' LYS . 40.7 t -125.34 129.29 73.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.743 HG22 HG13 ' A' ' 11' ' ' VAL . 26.7 mt -107.57 142.15 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.03 -176.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.571 ' HB2' HG23 ' A' ' 43' ' ' VAL . 44.0 m-85 -127.08 166.69 17.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.981 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.551 ' HG2' HG12 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -155.11 146.32 22.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.757 0.313 . . . . 0.0 110.219 171.321 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.673 HG21 ' HG2' ' A' ' 81' ' ' GLU . 8.1 p -152.33 159.94 3.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.396 -172.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.604 ' HB2' ' HG2' ' A' ' 80' ' ' LYS . 10.7 m-20 -99.46 111.85 24.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.844 -0.162 . . . . 0.0 110.736 -175.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.713 HG21 ' HA ' ' A' ' 92' ' ' SER . 59.6 m -57.21 -31.52 65.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.01 0.433 . . . . 0.0 111.695 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.87 -33.19 71.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.751 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.604 ' HG2' ' HB2' ' A' ' 77' ' ' ASP . 11.5 ptpt -102.04 -27.57 12.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.416 0.627 . . . . 0.0 109.669 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.673 ' HG2' HG21 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -93.91 46.21 1.17 Allowed 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.25 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.61 -35.89 81.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.475 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.78 -40.39 84.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.245 0.545 . . . . 0.0 109.669 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.421 HD11 ' CG ' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -62.47 -47.62 83.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.375 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.639 ' HB2' HG23 ' A' ' 78' ' ' THR . . . -66.03 -46.0 79.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.491 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.27 -29.67 71.96 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.151 -176.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.78 -35.34 79.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.895 0.378 . . . . 0.0 111.459 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.463 ' HB2' HG13 ' A' ' 90' ' ' ILE . 97.1 m-85 -100.09 7.64 44.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.408 -177.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.24 32.54 84.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.0 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' A' ' 85' ' ' ALA . 39.5 mt -75.13 128.22 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -52.04 -64.37 0.84 Allowed 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.563 0.539 . . . . 0.0 110.25 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.713 ' HA ' HG21 ' A' ' 78' ' ' THR . 23.2 p -179.66 -85.45 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.558 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.463 ' O ' HD12 ' A' ' 93' ' ' ILE . 1.9 pp -156.26 148.24 17.36 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.622 -176.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.658 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 13.7 Cg_exo -78.89 148.68 83.29 Favored 'Cis proline' 0 N--CA 1.477 0.544 0 C-N-CA 124.856 -0.893 . . . . 0.0 112.395 -2.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.401 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 67.7 m -142.8 139.21 30.87 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.6 127.96 62.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 122.113 -0.367 . . . . 0.0 110.034 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.531 ' CB ' HG12 ' A' ' 43' ' ' VAL . 2.6 tp -97.05 127.89 43.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.629 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -108.74 100.19 9.46 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 105' ' ' PRO . 50.3 mt -101.23 104.91 36.2 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.18 -172.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.62 158.79 22.0 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.39 2.06 . . . . 0.0 111.088 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.3 mmm -76.9 -26.84 54.59 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 175.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -102.44 103.84 14.26 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.053 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.38 -141.97 15.91 Favored Glycine 0 C--N 1.315 -0.626 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.446 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.564 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 21.8 mmmt -124.07 163.57 34.88 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.566 ' HB3' HG12 ' A' ' 99' ' ' ILE . 84.9 Cg_endo -82.45 140.03 10.55 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.359 2.039 . . . . 0.0 114.205 -173.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.49 171.24 9.03 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.111 173.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 41.8 ttm -142.89 135.22 27.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.811 -177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.32 157.34 30.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 169.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -137.67 130.57 30.18 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.135 -0.626 . . . . 0.0 112.385 -175.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.658 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 117.78 -176.21 16.05 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.178 -0.919 . . . . 0.0 113.985 169.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -83.9 86.98 7.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.39 0.614 . . . . 0.0 110.604 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.545 ' HB2' ' HB3' ' A' ' 116' ' ' SER . 7.5 ptm -103.98 141.23 22.08 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.625 175.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 116' ' ' SER . 91.1 Cg_endo -75.24 177.3 8.81 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.59 2.193 . . . . 0.0 112.687 -173.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.578 ' HG3' HD11 ' A' ' 63' ' ' LEU . 37.8 ttmt -58.2 -30.47 66.49 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.262 175.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.7 -49.56 68.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.202 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.545 ' HB3' ' HB2' ' A' ' 112' ' ' MET . 17.0 t -67.74 -33.37 74.73 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.569 -0.453 . . . . 0.0 110.051 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.437 ' HB3' HD21 ' A' ' 63' ' ' LEU . 5.6 m-85 -72.52 -29.59 63.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.186 176.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.516 ' C ' ' HD3' ' A' ' 118' ' ' LYS . 12.7 tmtt? -56.44 -50.3 72.07 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.514 ' HG2' ' OE2' ' A' ' 123' ' ' GLU . 54.9 mttm -66.61 -38.23 86.52 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.539 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.651 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -66.74 -45.9 77.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.987 0.423 . . . . 0.0 111.402 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.502 HG13 HD13 ' A' ' 42' ' ' ILE . 1.6 mp -75.95 -56.03 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.052 0.453 . . . . 0.0 110.968 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.547 ' HA ' HD13 ' A' ' 126' ' ' LEU . 25.7 t70 -72.6 -60.55 2.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.566 -174.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.514 ' OE2' ' HG2' ' A' ' 119' ' ' LYS . 50.1 mt-10 -80.34 11.57 3.51 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -170.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.651 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 69.6 t80 -138.11 -42.57 0.52 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.568 0.211 . . . . 0.0 111.568 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.546 HD11 ' HB3' ' A' ' 40' ' ' PRO . 26.6 tp -90.53 -37.93 13.54 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.89 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.547 HD13 ' HA ' ' A' ' 122' ' ' ASP . 10.8 mp -78.13 -48.47 15.88 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -87.95 71.69 9.39 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 168.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.742 ' H ' ' HD3' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -76.84 83.35 3.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.756 0.788 . . . . 0.0 112.24 -173.196 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.737 ' HA ' ' HE1' ' A' ' 134' ' ' HIS . 14.9 pt-20 -111.72 28.5 8.69 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.058 169.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -43.48 141.05 2.67 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.475 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 36.7 m80 62.93 -93.93 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -170.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 160.39 21.92 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.487 1.117 . . . . 0.0 110.914 169.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -77.47 82.64 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.958 0.409 . . . . 0.0 110.163 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.737 ' HE1' ' HA ' ' A' ' 129' ' ' GLU . 35.0 m80 -139.73 89.94 2.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.467 178.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 3.3 t60 179.05 -44.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 17.7 p80 . . . . . 0 C--O 1.249 1.043 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.119 171.665 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m 65.26 -80.12 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.936 0.772 . . . . 0.0 111.415 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.59 -73.79 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.175 0.512 . . . . 0.0 110.327 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.98 125.87 35.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.701 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.7 m -121.65 -76.29 0.59 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.209 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -151.65 -169.67 3.43 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.19 39.42 97.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.437 -176.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.685 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -175.34 112.32 0.13 Allowed 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 122.408 0.283 . . . . 0.0 110.909 -175.277 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.652 ' CA ' ' HA ' ' A' ' 68' ' ' ASP . . . 56.44 35.39 66.02 Favored Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 115.096 0.798 . . . . 0.0 115.096 164.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.685 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 1.3 ptpp? -168.52 173.39 7.51 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 117.035 0.417 . . . . 0.0 110.155 176.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 19.4 m -109.13 133.41 54.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.322 -174.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.0 mm -103.09 98.48 6.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.608 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -72.97 111.6 8.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 173.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.868 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.9 pp -140.21 179.15 6.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -168.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.0 p -109.74 177.94 4.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.599 173.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.554 ' HA ' ' HB2' ' A' ' 19' ' ' PHE . 14.8 pttm -59.04 -23.2 61.77 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.9 -48.9 72.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.375 0.607 . . . . 0.0 110.257 176.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.868 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 6.1 mp0 -71.54 -34.19 69.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.761 177.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.554 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 2.0 t80 -54.36 -48.58 71.32 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 122.266 1.031 . . . . 0.0 109.224 174.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.543 HD22 HD22 ' A' ' 25' ' ' ASN . 2.9 mt -52.43 -59.77 4.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.161 -1.836 . . . . 0.0 111.153 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.94 -27.67 49.38 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -104.41 -14.18 15.82 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -173.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 21.4 t -126.9 -49.21 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.51 -0.476 . . . . 0.0 112.104 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 14.3 t80 -163.72 115.74 1.42 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.168 0.508 . . . . 0.0 110.66 -170.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.543 HD22 HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -90.45 90.07 7.86 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.921 -176.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.551 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 23.9 p90 -90.58 22.1 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.46 -29.47 9.21 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.873 171.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.708 ' C ' HD22 ' A' ' 29' ' ' ASN . 6.5 ptpp? -106.77 -16.61 14.44 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.769 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.708 HD22 ' C ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -120.85 63.38 11.1 Favored Pre-proline 0 N--CA 1.474 0.739 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.0 174.343 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.453 ' HG2' ' OE1' ' A' ' 31' ' ' GLU . 12.0 Cg_endo -65.68 -44.98 7.29 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.437 2.091 . . . . 0.0 112.509 173.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.453 ' OE1' ' HG2' ' A' ' 30' ' ' PRO . 25.6 mp0 -88.41 -26.15 22.3 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.005 0.431 . . . . 0.0 110.88 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.28 147.99 22.65 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.202 0.525 . . . . 0.0 111.423 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.658 ' HD1' ' HZ1' ' A' ' 104' ' ' LYS . 35.7 t-105 -109.15 103.5 12.5 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 164.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -119.02 124.25 46.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.046 173.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.543 ' OH ' ' HB2' ' A' ' 41' ' ' ALA . 18.3 t80 -85.17 108.8 17.88 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.4 0.45 33.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.147 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.46 162.63 36.52 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -93.1 -42.42 9.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.758 0.779 . . . . 0.0 111.76 -175.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.524 ' HB2' HG23 ' A' ' 72' ' ' VAL . 44.2 mttp -102.27 147.86 34.58 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 122.355 -0.215 . . . . 0.0 110.636 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -42.97 136.55 4.84 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.656 2.904 . . . . 0.0 112.818 176.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.543 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -119.07 149.01 42.39 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -170.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.9 ' HB ' HG12 ' A' ' 73' ' ' ILE . 45.3 mm -120.37 115.41 47.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.439 171.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.4 t -100.13 117.12 44.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.699 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.841 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 14.9 t70 -96.59 106.62 18.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.356 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.543 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 77.5 m-85 -94.65 112.13 23.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.434 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.641 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 52.3 p90 -134.7 176.31 8.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.611 0.72 . . . . 0.0 111.477 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.497 ' HB3' HD13 ' A' ' 93' ' ' ILE . . . -149.89 127.48 11.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.891 170.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.603 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 26.3 t70 -61.39 -24.83 66.77 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -168.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 55.6 p-90 -72.63 -9.36 58.51 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.747 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.569 ' HB3' ' SG ' ' A' ' 53' ' ' CYS . 26.0 t -105.74 137.68 43.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.057 0.456 . . . . 0.0 111.396 -174.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.404 ' N ' ' HD2' ' A' ' 52' ' ' PRO . . . -57.94 -62.01 6.79 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.336 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 51' ' ' GLY . 9.3 Cg_endo -55.33 -26.92 55.03 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.105 2.537 . . . . 0.0 112.831 -178.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.641 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 70.7 m -66.45 -50.61 62.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.079 0.466 . . . . 0.0 110.31 174.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.603 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 67.8 mttm -59.07 -29.88 67.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.833 175.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 84.5 mtp -66.29 -53.31 38.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.614 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.9 m -82.96 -34.52 11.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -170.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -47.16 -61.28 2.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -175.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 38.0 Cg_endo -66.43 -33.22 38.34 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.581 1.521 . . . . 0.0 112.078 -175.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.6 mt -66.46 -38.41 81.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.613 HD21 ' CZ ' ' A' ' 117' ' ' PHE . 0.8 OUTLIER -67.37 -39.91 85.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.845 177.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.579 ' OD2' HG21 ' A' ' 11' ' ' VAL . 1.2 m-20 -61.26 -49.78 75.72 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-O 121.869 0.842 . . . . 0.0 109.557 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.474 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 42.8 tt0 -62.17 -46.87 87.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.193 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.496 HD13 ' HG3' ' A' ' 114' ' ' LYS . 12.8 tp -61.14 -31.15 70.87 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -177.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.522 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -60.68 -54.16 48.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.023 177.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -73.25 -24.76 60.51 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.959 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.8 -38.66 75.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.257 0.551 . . . . 0.0 110.753 174.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -103.44 27.36 7.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.153 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.652 ' HA ' ' CA ' ' A' ' 9' ' ' GLY . 10.1 t70 -52.21 129.62 28.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.141 0.496 . . . . 0.0 110.773 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.08 -42.19 1.92 Allowed Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.46 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -101.19 -47.81 4.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -173.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.8 pt -117.82 164.52 14.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.647 -171.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.524 HG23 ' HB2' ' A' ' 39' ' ' LYS . 14.5 t -128.34 139.12 52.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.189 176.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.9 HG12 ' HB ' ' A' ' 42' ' ' ILE . 53.9 mt -122.89 121.13 62.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.639 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -101.77 159.09 15.63 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.841 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 30.3 mttm -143.76 145.65 32.55 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.621 -176.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.486 HG21 ' HG2' ' A' ' 81' ' ' GLU . 9.8 p -156.15 156.02 5.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -177.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.798 ' HB3' ' HG2' ' A' ' 80' ' ' LYS . 11.3 t70 -98.27 116.76 31.17 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.481 HG23 ' HB3' ' A' ' 45' ' ' PHE . 21.0 p -63.69 -35.2 79.77 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -68.25 -31.69 71.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.798 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 4.5 mmtm -74.83 -55.14 6.12 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.486 ' HG2' HG21 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -87.52 57.92 4.67 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 113.608 -1.633 . . . . 0.0 112.278 -174.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -56.48 -46.02 80.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.75 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -68.98 -38.25 79.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.984 0.421 . . . . 0.0 110.572 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.441 ' CB ' ' HG3' ' A' ' 81' ' ' GLU . 3.0 tm? -66.86 -43.46 83.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.81 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -64.62 -47.05 80.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.894 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.22 -32.6 81.22 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.723 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.49 -27.51 68.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.701 0.286 . . . . 0.0 111.751 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -104.29 7.03 35.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.618 0.247 . . . . 0.0 111.271 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.98 22.26 79.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.381 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 85' ' ' ALA . 23.6 mt -72.74 119.75 20.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -62.04 -46.68 88.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.745 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.4 p -179.23 -93.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.535 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.588 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 2.7 pt -152.66 147.62 19.54 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -168.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -95.31 134.1 4.89 Favored 'Cis proline' 0 N--CA 1.46 -0.458 0 C-N-CA 124.3 -1.125 . . . . 0.0 111.34 -3.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 17.2 t -108.26 146.76 32.39 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.561 HD13 ' CE1' ' A' ' 117' ' ' PHE . 27.6 mt -136.55 114.91 14.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.789 0.328 . . . . 0.0 110.146 -176.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.0 tp -103.28 116.7 32.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.4 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -93.32 103.83 16.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.457 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.46 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 41.9 mt -103.8 106.84 54.48 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -173.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.33 148.57 13.02 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.892 2.395 . . . . 0.0 111.625 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -42.26 99.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.25 0.548 . . . . 0.0 110.67 175.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.795 ' HB3' ' HE3' ' A' ' 128' ' ' LYS . 18.8 tt0 -99.37 105.77 17.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.302 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.495 ' C ' ' HD2' ' A' ' 104' ' ' LYS . . . 114.53 -146.82 18.78 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.284 177.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.658 ' HZ1' ' HD1' ' A' ' 33' ' ' TRP . 0.8 OUTLIER -128.27 159.69 65.97 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.303 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.469 ' HG3' ' CZ2' ' A' ' 33' ' ' TRP . 97.0 Cg_endo -81.25 152.23 18.18 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.753 2.302 . . . . 0.0 113.838 -170.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -110.02 166.81 10.65 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.642 172.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 43.3 ttm -137.11 140.51 41.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.247 0.546 . . . . 0.0 112.118 -172.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -133.52 157.19 46.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.948 172.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -96.52 150.41 20.66 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.56 -142.72 1.36 Allowed Glycine 0 CA--C 1.518 0.23 0 N-CA-C 114.628 0.611 . . . . 0.0 114.628 -171.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 71.86 18.68 5.02 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.622 0.769 . . . . 0.0 111.441 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.503 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 23.0 ptt? -117.37 154.2 50.3 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.46 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.28 178.39 7.58 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.999 2.466 . . . . 0.0 113.003 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.496 ' HG3' HD13 ' A' ' 63' ' ' LEU . 41.9 ttmt -59.45 -28.54 67.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.634 174.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.13 -52.99 61.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.411 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 35.1 m -65.89 -37.16 85.38 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.894 0.378 . . . . 0.0 110.67 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.613 ' CZ ' HD21 ' A' ' 60' ' ' LEU . 16.0 m-85 -61.49 -48.24 81.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.256 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -55.74 -40.03 71.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.552 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.558 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -56.06 -55.63 30.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.798 177.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -69.06 -42.34 76.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.783 -175.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 117' ' ' PHE . 43.5 mt -64.61 -53.46 42.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.91 0.386 . . . . 0.0 111.104 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 38.8 t70 -65.02 -59.0 4.63 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.517 -173.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -83.35 11.26 7.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -168.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.466 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 42.0 t80 -134.38 -52.35 0.82 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.593 0.235 . . . . 0.0 111.123 174.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.678 HD22 HD11 ' A' ' 42' ' ' ILE . 16.8 tp -74.58 -38.52 62.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.725 -175.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 122' ' ' ASP . 4.2 mm? -82.45 -59.94 2.36 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.486 178.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 21.8 pttp -104.73 97.77 7.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.757 0.789 . . . . 0.0 110.267 175.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.795 ' HE3' ' HB3' ' A' ' 102' ' ' GLU . 9.1 ptmm? -73.38 72.75 1.34 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.7 175.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -44.38 -76.69 0.02 OUTLIER 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.606 -171.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.63 12.87 1.35 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.228 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -56.88 -30.24 63.69 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.82 0.343 . . . . 0.0 111.433 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -138.95 51.45 1.8 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -77.3 151.1 35.15 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.043 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -159.11 74.74 0.65 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.067 0.46 . . . . 0.0 111.844 -174.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -177.35 138.86 0.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.487 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.385 -0.817 . . . . 0.0 109.626 177.353 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -142.5 171.74 13.65 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.4 -48.3 81.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.108 0.48 . . . . 0.0 109.998 176.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.44 76.7 9.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.873 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -112.14 6.61 19.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.857 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.91 165.49 29.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.793 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 139.38 -3.28 2.67 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.989 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -87.48 138.24 31.65 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.672 ' O ' ' HE3' ' A' ' 10' ' ' LYS . . . 57.46 34.36 68.58 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.65 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.672 ' HE3' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -138.63 164.33 29.77 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -170.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 14.7 p -102.98 123.57 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.518 0.675 . . . . 0.0 111.431 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.1 mt -132.97 124.34 50.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.696 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.875 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 7.7 p80 -91.73 138.8 31.27 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.176 177.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.674 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.7 pp -139.5 168.62 19.42 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.179 -176.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.0 p -95.33 177.17 5.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.909 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -55.66 -33.32 63.99 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.2 90.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.351 0.596 . . . . 0.0 110.165 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.674 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 8.3 mm-40 -71.1 -34.07 70.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.298 178.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -60.81 -50.58 72.87 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.836 0.827 . . . . 0.0 109.308 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.671 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -49.25 -60.43 2.82 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.607 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.25 -19.45 39.6 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -169.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -109.66 -12.39 14.65 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 72.6 t -136.34 -49.99 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -172.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.671 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 12.2 t80 -154.27 116.74 4.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.315 0.579 . . . . 0.0 112.023 -164.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.624 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -82.6 88.65 6.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.687 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -88.75 11.26 18.18 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.014 0.435 . . . . 0.0 111.275 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.649 ' HG2' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -93.92 -48.31 6.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.37 0.605 . . . . 0.0 109.392 174.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.606 ' C ' HD22 ' A' ' 29' ' ' ASN . 53.7 mttp -90.46 -22.97 21.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.267 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.634 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -120.85 67.48 14.96 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.819 178.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -58.29 -44.11 41.23 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.228 2.619 . . . . 0.0 112.382 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -103.2 -22.22 13.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.194 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -91.05 178.13 6.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.346 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -128.69 106.35 8.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.233 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 18.8 tptm -113.55 113.13 24.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.846 174.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.586 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 25.4 t80 -92.59 119.53 32.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.842 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -102.65 28.28 6.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.038 -176.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.81 156.92 18.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.245 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.74 -40.32 11.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.716 0.293 . . . . 0.0 111.037 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -107.61 158.45 33.29 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.339 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.548 ' HG2' HG22 ' A' ' 71' ' ' ILE . 18.6 Cg_endo -59.51 140.72 95.36 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.588 2.192 . . . . 0.0 111.094 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -131.54 157.17 44.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.665 0.745 . . . . 0.0 112.812 -170.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.717 ' HB ' HG12 ' A' ' 73' ' ' ILE . 3.6 mp -120.0 116.5 50.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.633 174.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 35.9 t -100.32 111.97 31.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.739 0.304 . . . . 0.0 110.898 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.651 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 15.6 t70 -95.92 110.31 22.53 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.292 0.567 . . . . 0.0 111.562 -179.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -83.4 111.75 19.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.875 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.708 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 4.1 p90 -141.27 171.28 14.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.209 0.528 . . . . 0.0 111.07 -173.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.72 146.77 51.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.081 173.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -65.72 -38.01 87.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.657 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -80.43 -6.96 58.9 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 49.5 t -97.32 134.95 39.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.089 0.471 . . . . 0.0 111.506 -174.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.96 -63.77 4.15 Favored Glycine 0 C--O 1.224 -0.528 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.356 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.618 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 82.0 Cg_exo -47.26 -35.07 19.58 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.008 2.472 . . . . 0.0 113.145 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.708 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 71.6 m -62.66 -47.71 82.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.244 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -77.6 -28.56 51.59 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -55.75 -43.71 76.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.307 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.0 m -83.21 -16.84 11.16 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -174.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.424 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -49.63 -55.6 21.89 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 38.2 Cg_endo -68.49 -41.03 6.91 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.547 1.498 . . . . 0.0 111.725 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 69.0 mt -58.14 -43.98 86.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.272 0.558 . . . . 0.0 110.528 176.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' A' ' 60' ' ' LEU . 12.7 mt -63.33 -45.39 91.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.677 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -64.93 -35.6 81.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 110.002 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 8.3 mm-40 -52.63 -52.86 53.66 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.175 176.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.483 HD21 ' HG3' ' A' ' 114' ' ' LYS . 3.4 mm? -67.96 -42.69 80.52 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.188 -0.205 . . . . 0.0 110.848 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.505 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -56.14 -50.03 72.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.814 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -71.04 -31.7 68.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.403 -178.322 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -67.47 -29.01 68.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.448 0.642 . . . . 0.0 110.367 179.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.537 ' HB3' HE21 ' A' ' 70' ' ' GLN . 26.3 m-85 -111.82 26.4 10.66 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.219 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.44 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 23.0 t0 -53.93 131.55 40.4 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.249 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.18 -43.83 1.61 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.141 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.537 HE21 ' HB3' ' A' ' 67' ' ' TYR . 11.2 pt20 -101.85 -32.67 10.13 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -175.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.548 HG22 ' HG2' ' A' ' 40' ' ' PRO . 39.6 pt -124.43 159.04 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.684 -178.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 93.2 t -138.05 136.48 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.471 176.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.717 HG12 ' HB ' ' A' ' 42' ' ' ILE . 40.2 mt -114.78 131.95 65.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.312 0.577 . . . . 0.0 111.091 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -115.99 166.16 12.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.102 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.875 ' HB2' ' HB3' ' A' ' 13' ' ' HIS . 46.8 mttm -128.88 162.71 26.89 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.491 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 9.2 p -139.86 136.74 39.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.405 ' HB3' ' HG2' ' A' ' 80' ' ' LYS . 0.9 OUTLIER -83.66 86.74 7.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.86 -176.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.1 p -51.58 -41.83 61.46 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -53.78 -23.58 12.5 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.436 ' HG3' ' OE1' ' A' ' 81' ' ' GLU . 7.4 ptpp? -115.37 -34.34 4.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.187 0.518 . . . . 0.0 109.947 177.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.491 ' HG2' ' CG2' ' A' ' 76' ' ' VAL . 1.3 mp0 -81.5 39.48 0.53 Allowed 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 123.711 0.804 . . . . 0.0 110.992 173.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.66 -41.16 94.44 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.932 0.396 . . . . 0.0 110.942 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -61.66 -47.78 83.79 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.042 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.0 tp -62.66 -48.51 79.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.182 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.34 -40.97 94.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.814 0.34 . . . . 0.0 111.341 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.46 -28.33 72.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.638 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.82 -27.59 68.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.322 . . . . 0.0 111.276 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.504 ' HB2' HG12 ' A' ' 90' ' ' ILE . 82.0 m-85 -89.71 -16.53 30.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.739 0.304 . . . . 0.0 110.975 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.93 4.68 56.69 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.075 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 88' ' ' PHE . 33.1 mm -67.45 126.21 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -63.96 -60.81 2.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.068 0.461 . . . . 0.0 110.251 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.1 m -158.19 -84.3 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.943 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 8.8 pt -153.93 146.14 17.21 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.28 -167.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -105.2 147.57 1.18 Allowed 'Cis proline' 0 N--CA 1.461 -0.423 0 C-N-CA 124.833 -0.903 . . . . 0.0 111.405 -5.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.438 ' C ' HD12 ' A' ' 96' ' ' ILE . 18.9 t -131.74 138.39 48.61 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.438 HD12 ' C ' ' A' ' 95' ' ' SER . 3.0 mp -125.93 116.16 45.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.733 -177.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 105' ' ' PRO . 37.4 tp -94.19 112.12 23.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.112 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.41 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 96.4 m-85 -90.2 107.31 19.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.461 178.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 55.2 mt -96.92 109.47 49.09 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.318 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.556 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 84.9 Cg_endo -87.96 169.31 6.5 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.221 2.614 . . . . 0.0 112.422 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 89.7 mmm -96.4 3.03 53.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.56 0.695 . . . . 0.0 109.236 173.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -138.66 118.67 13.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.355 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.19 -141.36 15.51 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.52 176.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -120.78 151.0 53.94 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.556 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 17.2 Cg_exo -68.04 122.51 9.61 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.483 2.122 . . . . 0.0 112.05 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -90.79 160.68 15.64 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 18.4 ptp -141.79 144.35 33.91 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.213 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.3 145.84 49.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.231 174.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -72.15 137.23 46.83 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.34 -143.38 3.85 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 115.363 0.905 . . . . 0.0 115.363 -167.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' A' ' 52' ' ' PRO . . . 70.86 20.2 5.54 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.829 0.852 . . . . 0.0 110.403 -171.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.611 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 6.6 mtp -84.33 150.28 57.1 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.769 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.44 178.31 7.52 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.43 2.087 . . . . 0.0 111.141 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.483 ' HG3' HD21 ' A' ' 63' ' ' LEU . 86.3 tttt -61.73 -26.29 67.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.05 0.452 . . . . 0.0 109.953 176.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.84 -52.38 20.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.043 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.611 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 18.8 m -68.61 -35.14 76.92 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.618 -177.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.49 ' O ' HG13 ' A' ' 121' ' ' ILE . 3.7 m-85 -64.77 -44.4 90.15 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.578 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -57.98 -48.81 78.87 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.87 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -57.42 -37.06 72.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.831 0.348 . . . . 0.0 110.772 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.42 -48.6 48.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.196 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 117' ' ' PHE . 56.8 mt -65.68 -52.1 54.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.237 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.42 -62.42 1.79 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.893 0.378 . . . . 0.0 110.942 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.662 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 18.2 mt-10 -64.25 -44.56 91.41 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -172.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -94.44 -35.16 12.45 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.217 -172.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 40' ' ' PRO . 17.9 tp -89.02 -47.57 8.03 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.796 -175.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.8 mt -80.23 -58.92 2.91 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.662 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 25.1 ttpp -76.11 159.32 30.86 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.449 ' HG3' ' H ' ' A' ' 130' ' ' GLY . 0.3 OUTLIER -138.23 117.17 12.43 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.535 -178.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -66.43 -6.38 14.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.447 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.449 ' H ' ' HG3' ' A' ' 128' ' ' LYS . . . 64.52 69.66 1.27 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -66.04 -69.15 0.32 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -171.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 47.6 m80 56.04 -79.54 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 174.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -109.57 -100.7 0.39 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.562 0.22 . . . . 0.0 110.621 -175.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.531 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 6.3 m80 -129.16 -12.15 4.62 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.531 ' HB2' ' O ' ' A' ' 134' ' ' HIS . 57.9 m80 73.31 18.85 3.64 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -164.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 63.7 t60 . . . . . 0 C--O 1.242 0.682 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.013 -177.036 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.713 ' HB3' ' HA ' ' A' ' 5' ' ' THR . 55.5 tpp . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.9 m 59.04 -91.39 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 O-C-N 123.835 0.709 . . . . 0.0 110.278 -172.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.9 mp -100.41 -72.93 0.66 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -107.64 -81.12 0.56 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.86 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.713 ' HA ' ' HB3' ' A' ' 1' ' ' MET . 8.9 t -132.83 5.26 3.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.183 0.516 . . . . 0.0 109.92 175.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.65 ' HG2' ' H ' ' A' ' 7' ' ' GLY . 26.0 tt0 -171.85 -178.66 2.24 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.055 -175.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.65 ' H ' ' HG2' ' A' ' 6' ' ' GLU . . . -114.01 45.99 1.23 Allowed Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.575 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 18.1 m120 -52.61 119.86 5.0 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 122.782 0.433 . . . . 0.0 111.704 -178.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.513 ' CA ' ' HA ' ' A' ' 68' ' ' ASP . . . 69.98 18.55 74.62 Favored Glycine 0 CA--C 1.502 -0.738 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.764 173.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -124.8 172.32 9.42 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.9 p -142.2 132.36 24.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.119 0.485 . . . . 0.0 111.073 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.8 mm -131.45 124.95 55.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.544 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.645 ' CB ' ' HB2' ' A' ' 75' ' ' LYS . 6.0 p80 -82.81 116.13 22.01 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 172.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.486 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -116.99 179.73 3.94 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.464 -170.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.514 HG22 ' HE2' ' A' ' 80' ' ' LYS . 56.8 p -89.58 163.35 15.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.016 176.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.712 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 33.2 pttt -61.94 -24.1 66.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.681 175.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.3 -39.52 71.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.272 0.558 . . . . 0.0 110.08 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.486 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 10.4 mm-40 -65.89 -38.75 89.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.074 175.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -62.04 -51.26 68.73 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.965 0.888 . . . . 0.0 109.115 175.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.637 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -51.64 -60.73 2.83 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.466 -1.697 . . . . 0.0 111.733 -175.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.54 -24.17 45.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -168.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -109.15 -23.33 11.69 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 48.5 t -121.33 -41.46 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -172.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.637 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 30.1 t80 -160.82 115.05 2.1 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.142 0.496 . . . . 0.0 111.011 -169.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.624 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -89.96 90.45 8.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.685 -175.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.613 ' CE2' ' HG ' ' A' ' 20' ' ' LEU . 28.6 p90 -85.26 20.68 1.9 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.417 0.627 . . . . 0.0 111.248 177.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.533 ' HG3' HD21 ' A' ' 20' ' ' LEU . 39.8 mt-10 -92.93 -47.33 7.07 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.501 ' HG3' ' ND2' ' A' ' 29' ' ' ASN . 18.3 ptmt -98.25 -11.09 23.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.412 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.631 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 9.9 m-80 -128.69 73.44 80.98 Favored Pre-proline 0 CA--C 1.515 -0.396 0 CA-C-O 121.686 0.755 . . . . 0.0 110.93 171.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -57.58 -43.47 50.48 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 123.744 2.962 . . . . 0.0 112.167 171.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.526 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -111.12 -31.5 7.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.016 -174.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.631 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -90.87 157.43 17.35 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.295 0.569 . . . . 0.0 111.317 -174.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.586 ' HB3' ' NZ ' ' A' ' 104' ' ' LYS . 40.7 t-105 -112.54 112.96 24.87 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.613 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -132.79 110.4 10.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.661 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 5.2 t80 -87.81 133.56 33.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.908 -177.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -107.25 144.71 33.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 171.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.21 -122.58 1.48 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.798 -175.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.504 ' OD1' ' HG3' ' A' ' 39' ' ' LYS . 16.6 t70 -165.41 -61.38 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.117 0.484 . . . . 0.0 110.188 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.504 ' HG3' ' OD1' ' A' ' 38' ' ' ASP . 44.8 mttp -105.54 156.21 36.79 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.761 -173.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.538 ' HG2' HG22 ' A' ' 71' ' ' ILE . 6.0 Cg_endo -49.46 133.61 31.46 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.259 2.64 . . . . 0.0 111.999 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -118.51 146.67 44.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.438 -173.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.794 HD11 HD22 ' A' ' 125' ' ' LEU . 50.1 mm -115.71 136.5 52.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.74 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 17.5 t -120.69 120.28 62.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.061 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.663 ' HB2' HD13 ' A' ' 60' ' ' LEU . 13.5 t0 -94.26 103.55 15.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.754 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.428 ' HE1' ' HB2' ' A' ' 97' ' ' LEU . 80.8 m-85 -88.81 110.95 21.46 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 176.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.665 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.9 p90 -145.95 177.32 9.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.259 0.552 . . . . 0.0 111.456 -172.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.504 ' HB3' HD13 ' A' ' 93' ' ' ILE . . . -157.95 152.05 24.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.492 171.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -60.6 -44.83 95.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -173.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -69.4 -10.91 60.06 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -171.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 45.9 t -93.71 129.21 40.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.065 0.459 . . . . 0.0 110.838 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.73 -60.5 7.66 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.811 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.551 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 81.6 Cg_exo -47.61 -35.66 23.23 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.315 2.676 . . . . 0.0 113.381 176.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.665 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 67.6 m -64.07 -50.64 67.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.985 0.422 . . . . 0.0 111.061 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -61.62 -28.11 69.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.006 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.404 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 84.3 mtp -66.97 -51.58 53.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.463 176.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.408 ' HB ' ' HZ ' ' A' ' 117' ' ' PHE . 30.0 m -77.29 -33.53 20.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -171.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -48.22 -56.64 13.2 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 21.7 Cg_exo -65.68 -35.72 35.92 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.057 1.838 . . . . 0.0 112.168 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.455 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 67.6 mt -64.19 -41.38 92.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.432 0.634 . . . . 0.0 109.536 176.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.663 HD13 ' HB2' ' A' ' 44' ' ' ASP . 7.6 mt -68.36 -33.49 74.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.454 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD1' HG11 ' A' ' 11' ' ' VAL . 58.9 m-20 -63.73 -42.66 97.85 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.661 0.743 . . . . 0.0 109.25 173.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.579 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 16.9 tp10 -57.09 -53.39 58.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.682 177.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.537 HD21 ' HG3' ' A' ' 114' ' ' LYS . 4.4 mm? -61.76 -31.91 72.13 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.626 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.531 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -58.49 -60.23 4.12 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.74 0.305 . . . . 0.0 110.921 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.579 ' HE3' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -75.17 -23.85 57.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.196 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -61.37 -38.57 87.48 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.246 0.546 . . . . 0.0 110.535 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.467 ' HD2' ' NE2' ' A' ' 70' ' ' GLN . 75.1 m-85 -103.67 27.1 7.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.298 178.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 6.7 t0 -48.43 134.42 15.18 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.366 -177.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.472 ' HA2' ' HB3' ' A' ' 8' ' ' ASN . . . 92.61 -33.84 4.79 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.658 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.467 ' NE2' ' HD2' ' A' ' 67' ' ' TYR . 14.1 mt-30 -86.53 -47.65 9.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.609 0.242 . . . . 0.0 111.384 -175.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.538 HG22 ' HG2' ' A' ' 40' ' ' PRO . 40.5 pt -125.1 164.01 24.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.186 0.517 . . . . 0.0 111.644 -175.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 60.3 t -128.27 127.78 67.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.3 175.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.763 HG12 ' HB ' ' A' ' 42' ' ' ILE . 46.7 mt -111.71 137.99 42.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.196 0.522 . . . . 0.0 111.118 -177.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -121.13 161.8 21.17 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.645 ' HB2' ' CB ' ' A' ' 13' ' ' HIS . 79.8 mttt -124.34 150.62 45.29 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.016 0.436 . . . . 0.0 110.034 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.717 HG13 ' HG2' ' A' ' 81' ' ' GLU . 2.8 t -127.95 126.13 65.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.025 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -90.33 89.64 7.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.657 HG21 ' HA ' ' A' ' 92' ' ' SER . 33.1 m -52.09 -30.04 24.23 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.215 -171.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -51.97 -34.23 41.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.76 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.514 ' HE2' HG22 ' A' ' 15' ' ' THR . 22.7 pttm -108.27 -20.89 12.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.207 0.527 . . . . 0.0 110.348 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.717 ' HG2' HG13 ' A' ' 76' ' ' VAL . 1.5 mp0 -91.18 40.99 1.05 Allowed 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.572 0.749 . . . . 0.0 111.67 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -55.6 -53.6 54.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.444 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -62.85 -36.39 83.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.631 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.6 tp -64.1 -43.33 95.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.541 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.568 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -65.25 -47.15 77.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.669 175.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.88 -33.93 80.66 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.87 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.54 -35.18 77.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 111.402 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -95.3 4.06 53.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.941 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.16 10.17 85.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.867 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.568 ' HB ' ' HB1' ' A' ' 85' ' ' ALA . 6.4 mt -69.72 143.01 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -72.09 -48.17 46.0 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.657 ' HA ' HG21 ' A' ' 78' ' ' THR . 15.0 p 179.69 -80.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.712 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.576 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 16.7 pt -149.2 149.83 30.43 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.107 -172.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.483 ' HG3' ' HB2' ' A' ' 52' ' ' PRO . 10.7 Cg_endo -101.2 150.27 3.44 Favored 'Cis proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.649 -0.979 . . . . 0.0 112.046 -3.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.6 t -138.95 136.66 35.65 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 107' ' ' MET . 15.3 mm -114.55 113.42 43.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.74 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 41.5 tp -94.58 119.44 33.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.03 0.443 . . . . 0.0 110.689 -175.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -100.72 107.89 19.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.424 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.13 108.12 50.62 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.393 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -84.65 168.77 11.02 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.744 2.296 . . . . 0.0 112.098 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 86.5 mtp -87.23 -12.34 47.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.503 0.668 . . . . 0.0 110.155 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -140.09 127.05 20.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.581 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.67 -151.93 18.19 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.227 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.586 ' NZ ' ' HB3' ' A' ' 33' ' ' TRP . 29.3 mmmt -115.4 155.13 47.46 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.441 ' HD3' ' CD1' ' A' ' 33' ' ' TRP . 92.3 Cg_endo -81.79 144.5 13.84 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.505 2.136 . . . . 0.0 112.302 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.2 169.92 8.67 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.318 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.534 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 22.3 ptp -142.19 121.33 12.98 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.775 0.798 . . . . 0.0 111.41 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.54 128.38 49.21 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -67.52 150.95 48.17 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.317 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.96 -162.99 2.27 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.559 -0.746 . . . . 0.0 114.753 -168.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.551 ' HB2' ' HB3' ' A' ' 52' ' ' PRO . . . 75.84 17.24 2.29 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.164 0.985 . . . . 0.0 111.55 -176.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.642 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 73.0 mtm -86.75 144.31 36.95 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.85 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 71.7 Cg_endo -75.43 178.92 6.72 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.567 2.178 . . . . 0.0 110.5 172.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.537 ' HG3' HD21 ' A' ' 63' ' ' LEU . 64.3 tttm -62.06 -27.83 69.18 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.75 -45.89 63.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.037 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.642 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 50.7 m -70.62 -30.14 66.71 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.184 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.512 ' O ' HG13 ' A' ' 121' ' ' ILE . 13.7 m-85 -64.08 -52.44 59.27 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.172 172.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.456 ' O ' ' HD3' ' A' ' 118' ' ' LYS . 11.6 tmtt? -58.53 -38.32 77.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.83 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.508 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -56.59 -52.29 65.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.894 176.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.05 -43.28 68.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.853 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 117' ' ' PHE . 58.6 mt -62.97 -44.16 99.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 109.965 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -62.88 -68.4 0.34 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.596 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.798 ' HA ' ' HE2' ' A' ' 127' ' ' LYS . 3.8 tt0 -80.06 11.06 3.65 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.836 -163.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -143.17 -47.51 0.31 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.614 177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.794 HD22 HD11 ' A' ' 42' ' ' ILE . 28.4 tp -79.44 -38.86 33.7 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.139 -174.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.2 mt -98.54 -47.91 5.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.666 0.746 . . . . 0.0 109.923 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.798 ' HE2' ' HA ' ' A' ' 123' ' ' GLU . 19.0 ttpt -96.47 84.44 3.7 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.693 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -67.7 109.15 3.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.173 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 76.89 144.75 0.08 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 124.277 0.986 . . . . 0.0 110.868 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.94 -20.05 79.64 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.274 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.4 m170 70.97 89.09 0.1 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.674 0.75 . . . . 0.0 109.927 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -80.32 92.34 5.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.076 -171.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -74.47 99.43 3.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.615 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -89.25 150.57 22.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.892 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -89.23 150.37 22.67 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 . . . . . 0 C--O 1.245 0.818 0 CA-C-O 117.802 -1.094 . . . . 0.0 108.4 170.135 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptm . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.765 0.316 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -91.56 113.09 25.26 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 175.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.424 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 2.6 pp -85.75 -4.44 59.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.658 -177.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -163.29 127.69 2.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.959 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 p -109.24 141.14 41.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.173 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.65 77.17 5.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.332 1.063 . . . . 0.0 110.261 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.19 89.7 0.1 OUTLIER Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.234 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -155.22 106.0 2.56 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.846 -0.208 . . . . 0.0 110.655 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.513 ' CA ' ' HA ' ' A' ' 68' ' ' ASP . . . 67.44 28.26 73.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.541 173.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -162.74 166.55 24.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.757 0.279 . . . . 0.0 110.295 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.537 HG23 HG22 ' A' ' 73' ' ' ILE . 9.0 p -98.85 133.59 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.495 0.664 . . . . 0.0 111.029 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 73.8 mt -111.61 122.25 65.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.732 177.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.476 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 2.2 p80 -91.84 119.36 31.57 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.589 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.72 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.2 pp -138.8 168.17 20.4 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.677 -178.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.9 p -94.25 176.61 6.25 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.396 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 13.8 pttm -57.21 -24.83 57.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 177.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.53 -47.43 69.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.308 0.575 . . . . 0.0 109.727 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.72 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 3.9 mp0 -71.13 -33.87 70.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.109 176.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.413 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 7.2 t80 -59.41 -47.9 83.68 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 122.195 0.997 . . . . 0.0 109.151 176.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -50.26 -59.35 4.04 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 113.155 -1.838 . . . . 0.0 111.046 -179.545 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.0 -45.03 36.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 19.1 tptm -89.04 -7.85 55.12 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.027 -168.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 62.1 t -134.52 -54.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.506 -0.477 . . . . 0.0 112.252 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.492 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 11.8 t80 -169.63 126.12 0.87 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.268 0.556 . . . . 0.0 112.025 -164.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.528 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -82.46 89.91 6.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.71 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.492 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 34.8 p90 -81.96 10.71 6.02 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.381 0.61 . . . . 0.0 111.092 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.409 ' H ' HD22 ' A' ' 25' ' ' ASN . 4.1 tm-20 -107.78 -47.63 3.56 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.692 ' C ' HD22 ' A' ' 29' ' ' ASN . 0.0 OUTLIER -89.26 -28.31 20.0 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.29 -178.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.692 HD22 ' C ' ' A' ' 28' ' ' LYS . 0.7 OUTLIER -121.15 62.94 11.77 Favored Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.933 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -59.43 -35.73 95.52 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.706 2.271 . . . . 0.0 112.076 175.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.512 ' HG3' ' HG2' ' A' ' 32' ' ' GLU . 16.0 pt-20 -98.26 -23.77 15.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.47 -176.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.512 ' HG2' ' HG3' ' A' ' 31' ' ' GLU . 34.5 mm-40 -100.99 155.0 18.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.832 0.349 . . . . 0.0 110.982 -174.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.532 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 76.2 t-105 -105.71 92.07 4.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.205 0.526 . . . . 0.0 110.009 175.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.606 ' HG3' ' OE2' ' A' ' 36' ' ' GLU . 25.3 tptp -100.95 104.63 15.81 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.58 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 21.8 t80 -107.97 118.49 36.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.568 -177.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.606 ' OE2' ' HG3' ' A' ' 34' ' ' LYS . 12.9 mm-40 -86.32 87.76 7.49 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA3' ' CE2' ' A' ' 35' ' ' TYR . . . -106.89 129.19 9.59 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.142 -1.028 . . . . 0.0 114.306 -169.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -87.94 -53.32 4.8 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 170.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HB2' HG23 ' A' ' 72' ' ' VAL . 47.1 mttp -126.16 171.52 7.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 172.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 39' ' ' LYS . 9.1 Cg_endo -54.74 144.92 63.19 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.486 2.124 . . . . 0.0 111.283 170.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -128.04 155.88 43.64 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -170.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.856 ' HB ' HG23 ' A' ' 73' ' ' ILE . 21.4 mm -125.87 147.05 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.462 173.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 66.4 t -133.6 119.41 33.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 118.782 0.719 . . . . 0.0 111.412 176.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.58 113.38 26.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.636 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.576 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 69.7 m-85 -94.05 111.51 23.23 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 172.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.688 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.2 p90 -141.21 -177.1 4.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.342 0.591 . . . . 0.0 110.968 -172.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.47 139.3 25.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.614 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -61.39 -37.7 84.39 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -174.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -66.99 -16.31 64.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.008 0.432 . . . . 0.0 111.301 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.2 t -88.21 116.48 26.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.515 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.33 -53.9 37.86 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.758 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 55' ' ' MET . 84.9 Cg_exo -48.07 -37.85 31.08 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.909 2.406 . . . . 0.0 113.214 175.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.688 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 93.0 m -66.75 -48.03 70.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.395 0.617 . . . . 0.0 110.475 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 mttp -53.59 -30.79 44.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.646 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 76.2 mtp -64.59 -49.1 72.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.993 0.425 . . . . 0.0 111.439 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.478 ' CG1' ' HA ' ' A' ' 111' ' ' ALA . 35.1 m -79.54 -27.9 12.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.757 -171.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.516 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -50.31 -59.97 6.15 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 55.7 Cg_endo -71.15 -40.76 3.02 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.733 1.622 . . . . 0.0 112.495 -177.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 64.4 mt -64.99 -51.63 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.331 -176.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -68.25 -29.9 68.82 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.487 -176.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.535 ' OD1' HG12 ' A' ' 11' ' ' VAL . 23.4 t70 -61.75 -40.21 94.29 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.423 0.63 . . . . 0.0 109.775 172.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 59' ' ' ILE . 8.5 tm-20 -63.31 -41.01 98.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.321 176.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.537 HD21 ' HA ' ' A' ' 114' ' ' LYS . 3.1 mm? -58.71 -36.7 74.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.926 0.393 . . . . 0.0 110.699 174.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.658 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -60.97 -37.94 84.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.315 177.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 5.4 tmtm? -75.67 -33.12 60.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.527 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -55.32 -44.62 76.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.424 0.63 . . . . 0.0 109.931 172.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.599 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 48.0 m-85 -99.36 27.32 5.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.68 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 15.4 t0 -49.93 129.71 20.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.499 -177.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.49 -30.87 9.46 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.451 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 2.8 pt20 -106.86 -21.27 13.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 64' ' ' ALA . 30.6 pt -125.22 155.95 34.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.185 0.517 . . . . 0.0 112.059 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 40.5 t -127.96 129.93 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.348 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.856 HG23 ' HB ' ' A' ' 42' ' ' ILE . 24.8 mt -117.18 142.34 31.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 41.9 m-85 -124.47 158.57 32.53 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 0.2 OUTLIER -148.52 150.45 33.4 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 175.006 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.972 HG22 ' HG3' ' A' ' 81' ' ' GLU . 2.8 p -141.21 156.55 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.555 -173.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.516 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 10.8 m-20 -96.38 90.95 5.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.368 -175.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.547 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 10.2 m -50.05 -34.79 22.72 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -173.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' A' ' 79' ' ' GLU . 2.6 mm-40 -53.78 -41.04 66.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.98 0.419 . . . . 0.0 111.768 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 13.3 ptpt -94.57 -20.36 19.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.807 0.813 . . . . 0.0 109.344 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.972 ' HG3' HG22 ' A' ' 76' ' ' VAL . 10.3 mm-40 -98.2 39.71 1.22 Allowed 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.442 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -66.85 -30.98 71.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.625 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.55 -39.59 70.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.478 0.656 . . . . 0.0 109.243 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 33.4 tp -68.56 -37.8 80.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.832 176.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.618 ' HA ' HD12 ' A' ' 90' ' ' ILE . . . -63.9 -44.81 91.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.816 176.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.79 -29.16 66.85 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.92 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.29 -33.39 75.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.338 . . . . 0.0 111.444 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.607 ' HB2' HG13 ' A' ' 90' ' ' ILE . 91.2 m-85 -103.15 6.53 38.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.774 0.321 . . . . 0.0 110.626 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.39 33.67 87.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.862 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.618 HD12 ' HA ' ' A' ' 85' ' ' ALA . 41.9 mt -71.14 133.39 31.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.97 0.414 . . . . 0.0 110.745 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.458 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 0.4 OUTLIER -70.18 -51.41 31.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.096 178.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.9 p 175.39 -99.65 0.0 OUTLIER 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.145 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 26.6 pt -147.55 143.01 17.36 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.708 -172.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.733 ' HB2' ' H ' ' A' ' 110' ' ' GLY . 11.9 Cg_exo -81.95 149.25 71.77 Favored 'Cis proline' 0 N--CA 1.474 0.368 0 C-N-CA 124.934 -0.861 . . . . 0.0 111.921 -3.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.576 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 14.5 m -140.19 128.28 22.26 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 107' ' ' MET . 52.5 mt -127.94 122.66 59.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.837 0.351 . . . . 0.0 110.603 -174.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 32.8 tp -104.81 122.13 45.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.397 -177.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -100.07 111.35 23.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 54.9 mt -109.51 113.62 57.97 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -170.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.604 ' CB ' ' HE2' ' A' ' 128' ' ' LYS . 88.1 Cg_endo -85.0 159.97 11.66 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.096 2.531 . . . . 0.0 111.621 172.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 86.1 mtp -80.28 -35.99 35.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -118.87 122.54 42.56 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.469 0.652 . . . . 0.0 109.54 173.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.0 -171.19 13.65 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -174.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.532 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 8.9 mmmm -117.97 150.31 47.07 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 117.335 0.567 . . . . 0.0 110.083 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.24 148.11 21.06 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.933 2.422 . . . . 0.0 114.216 -173.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -111.09 169.3 8.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.279 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 46.5 ttm -134.59 124.9 26.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.057 0.456 . . . . 0.0 111.695 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.88 157.71 21.09 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.469 ' HG2' ' HA ' ' A' ' 95' ' ' SER . 39.4 mt-30 -131.38 141.12 49.82 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.715 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.733 ' H ' ' HB2' ' A' ' 94' ' ' PRO . . . 115.46 177.87 18.56 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.507 -0.77 . . . . 0.0 114.125 172.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.478 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . . . -87.75 86.07 7.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.281 0.562 . . . . 0.0 111.227 -175.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.639 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 72.6 mtm -78.93 136.89 57.78 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.828 175.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -75.46 -171.65 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.846 2.364 . . . . 0.0 111.792 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.537 ' HA ' HD21 ' A' ' 63' ' ' LEU . 13.8 tttm -57.97 -37.12 73.61 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.5 -50.59 62.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.326 -175.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.639 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 45.0 m -70.1 -37.47 75.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.926 -177.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.643 ' O ' HG13 ' A' ' 121' ' ' ILE . 4.6 m-85 -64.89 -44.51 89.41 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.829 176.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.526 ' HG2' ' OH ' ' A' ' 67' ' ' TYR . 11.3 tmtt? -53.83 -47.68 70.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.673 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -65.15 -38.08 89.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.754 -177.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.06 78.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.257 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.643 HG13 ' O ' ' A' ' 117' ' ' PHE . 23.1 mt -74.19 -55.23 12.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.884 0.373 . . . . 0.0 110.821 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.52 ' HA ' HD12 ' A' ' 126' ' ' LEU . 12.4 t70 -71.43 -65.54 0.74 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.687 0.28 . . . . 0.0 111.623 -176.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.437 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 32.8 mt-10 -75.82 -4.76 42.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -166.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -128.04 -38.61 1.81 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.572 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 40.5 tp -88.87 -43.2 11.38 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.887 -0.508 . . . . 0.0 110.742 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 122' ' ' ASP . 81.8 mt -82.92 -58.49 2.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.415 0.626 . . . . 0.0 109.68 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 123' ' ' GLU . 12.7 ttpp -89.1 45.89 1.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.588 177.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.604 ' HE2' ' CB ' ' A' ' 100' ' ' PRO . 23.5 ttpp -59.18 116.69 4.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.232 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -74.31 63.8 1.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.698 0.761 . . . . 0.0 112.644 -176.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -114.53 24.88 10.81 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 167.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -70.27 -12.12 61.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.406 -0.897 . . . . 0.0 111.571 -173.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -141.75 94.45 2.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -88.3 -43.99 11.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.694 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -107.43 125.03 50.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.817 0.341 . . . . 0.0 110.847 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -151.57 -52.46 0.12 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.082 174.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 48.1 t60 . . . . . 0 C--O 1.247 0.924 0 O-C-N 124.059 0.849 . . . . 0.0 109.177 -170.542 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 mtm . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 121.185 0.516 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.67 ' HB2' ' HB ' ' A' ' 5' ' ' THR . 7.0 m -82.39 153.17 25.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.585 -176.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.76 -30.4 29.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.33 0.586 . . . . 0.0 109.886 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.19 20.32 13.71 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.004 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.67 ' HB ' ' HB2' ' A' ' 2' ' ' SER . 53.1 m -151.57 105.78 3.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.067 0.461 . . . . 0.0 110.92 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.615 ' HG2' ' H ' ' A' ' 7' ' ' GLY . 2.0 tt0 -138.24 -163.03 1.38 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.615 ' H ' ' HG2' ' A' ' 6' ' ' GLU . . . -80.22 57.2 4.65 Favored Glycine 0 C--O 1.228 -0.222 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 172.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -100.51 115.16 29.44 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.068 -0.566 . . . . 0.0 111.435 -168.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 56.23 40.72 85.14 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.473 177.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.488 ' HZ1' ' CG ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -152.98 151.47 30.33 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 121.519 0.676 . . . . 0.0 111.865 -172.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 5.1 p -103.79 108.18 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.006 168.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 63.0 mt -88.99 123.76 41.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.721 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.695 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 2.3 p80 -88.86 133.26 34.33 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.796 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.586 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 1.7 pp -140.65 172.8 12.21 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.887 -174.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.7 p -106.17 178.35 4.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.357 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.459 ' HB2' ' HZ ' ' A' ' 26' ' ' PHE . 14.2 ptmm? -55.32 -35.72 65.45 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.83 -38.64 79.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.232 0.539 . . . . 0.0 110.286 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.586 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 2.6 mm-40 -71.0 -35.74 72.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.142 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -64.05 -48.34 76.67 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.78 0.8 . . . . 0.0 109.116 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.643 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.7 tt -50.82 -60.77 2.72 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.265 -178.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.6 -18.91 39.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -168.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 34.5 ttmt -108.5 -12.71 14.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.972 0.415 . . . . 0.0 111.397 -174.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 57.6 t -135.85 -55.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -174.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.653 ' CE2' ' HB3' ' A' ' 26' ' ' PHE . 9.7 t80 -167.09 122.53 1.09 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.261 0.553 . . . . 0.0 111.7 -164.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.505 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 1.8 t-20 -86.74 89.68 8.03 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.031 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.653 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 10.5 p90 -89.4 0.37 56.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.379 -174.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -104.98 -22.1 13.18 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.928 ' HE3' HD21 ' A' ' 29' ' ' ASN . 3.7 ttpp -105.96 -26.04 11.85 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.409 167.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.928 HD21 ' HE3' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -119.12 67.97 9.03 Favored Pre-proline 0 N--CA 1.471 0.591 0 CA-C-O 120.886 0.374 . . . . 0.0 111.635 -178.132 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.77 -34.66 39.56 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.92 2.413 . . . . 0.0 111.527 167.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -97.52 -30.6 12.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.841 -177.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.681 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 22.9 mt-10 -91.36 128.6 37.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.063 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.486 ' CZ2' ' HG3' ' A' ' 105' ' ' PRO . 72.8 t-105 -91.16 103.44 16.12 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.784 172.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -107.93 134.66 50.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.56 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.575 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 37.3 t80 -133.0 96.72 3.83 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.82 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -90.32 31.43 1.01 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.51 -174.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.5 135.25 12.69 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.421 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' OD2' ' HG3' ' A' ' 39' ' ' LYS . 25.2 t70 -65.6 -41.47 92.77 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.19 0.519 . . . . 0.0 111.081 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.414 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 72.5 mttt -125.32 158.79 62.74 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.548 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.662 ' HB3' HD11 ' A' ' 125' ' ' LEU . 50.3 Cg_exo -54.64 140.22 76.2 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.362 2.041 . . . . 0.0 111.157 173.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -124.44 152.37 43.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.669 0.747 . . . . 0.0 112.391 -172.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.8 mt -117.95 114.17 44.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.128 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 21.4 t -99.78 120.26 48.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.397 -175.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.682 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 21.8 t70 -103.69 111.12 23.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.57 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -83.45 111.94 19.5 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 172.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.71 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 2.8 p90 -132.58 158.23 42.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.775 0.798 . . . . 0.0 112.031 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.524 ' HB3' HG12 ' A' ' 93' ' ' ILE . . . -133.4 108.85 8.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.244 -1.343 . . . . 0.0 107.706 167.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.541 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 33.9 t70 -55.4 -31.03 61.49 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -167.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 59.6 p-90 -69.95 -1.43 9.63 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.625 ' SG ' ' HD2' ' A' ' 52' ' ' PRO . 27.9 t -114.14 137.03 52.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.933 0.397 . . . . 0.0 110.627 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.4 -57.46 18.47 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 115.612 -0.722 . . . . 0.0 114.669 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.625 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 84.1 Cg_exo -47.37 -37.49 25.19 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.158 2.572 . . . . 0.0 113.636 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.71 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 30.1 m -64.11 -50.36 68.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.334 0.588 . . . . 0.0 111.022 177.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.541 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 66.7 mttm -58.23 -28.59 65.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.339 174.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.443 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 53.2 mmm -70.63 -50.77 33.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.794 0.33 . . . . 0.0 111.398 176.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.84 -38.73 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -172.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.613 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -49.17 -54.49 28.58 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 15.8 Cg_exo -68.44 -42.67 5.01 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.212 1.941 . . . . 0.0 112.032 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.617 HD13 ' HA ' ' A' ' 113' ' ' PRO . 74.3 mt -57.26 -44.03 83.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.302 0.572 . . . . 0.0 110.497 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 44' ' ' ASP . 5.8 mt -68.37 -35.15 77.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.621 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.547 ' OD1' HG12 ' A' ' 11' ' ' VAL . 14.7 t70 -68.02 -35.53 78.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.134 0.493 . . . . 0.0 109.69 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.639 ' HA ' ' HD2' ' A' ' 65' ' ' LYS . 13.9 mm-40 -54.09 -44.63 71.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.768 172.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' A' ' 117' ' ' PHE . 11.1 mp -65.4 -30.89 71.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.727 0.298 . . . . 0.0 110.833 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -61.7 -53.2 59.35 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.657 -178.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.639 ' HD2' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -76.09 -24.97 55.06 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.795 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -42.73 61.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.88 0.372 . . . . 0.0 111.478 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.415 ' O ' HG12 ' A' ' 71' ' ' ILE . 94.0 m-85 -107.26 26.95 9.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.684 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.48 159.8 7.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.353 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.2 -52.89 4.13 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.262 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.755 HE22 HD11 ' A' ' 126' ' ' LEU . 10.2 pt20 -80.96 -33.77 33.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.495 0.188 . . . . 0.0 111.049 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 40' ' ' PRO . 42.2 pt -131.77 156.49 42.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.088 0.47 . . . . 0.0 111.763 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 86.8 t -124.28 136.49 60.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.648 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 21.9 mt -108.74 139.23 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.337 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -125.71 166.93 15.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.706 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.695 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -147.75 148.89 31.45 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 171.097 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.497 HG21 HD23 ' A' ' 84' ' ' LEU . 8.1 p -121.17 138.24 52.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.116 0.484 . . . . 0.0 110.524 -175.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.572 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -72.84 85.69 1.25 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.427 179.402 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.576 HG23 ' HB2' ' A' ' 85' ' ' ALA . 17.3 m -66.38 -31.77 72.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -167.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -65.9 -27.23 68.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.609 0.242 . . . . 0.0 111.199 -178.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.504 ' HZ2' ' HB3' ' A' ' 77' ' ' ASP . 8.6 ptpp? -99.79 -37.18 9.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.898 0.38 . . . . 0.0 110.108 175.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.572 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -78.86 39.63 0.37 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.36 0.664 . . . . 0.0 110.972 174.037 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -59.16 -43.98 92.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.529 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -65.15 -35.41 81.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.301 0.572 . . . . 0.0 110.379 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.497 HD23 HG21 ' A' ' 76' ' ' VAL . 14.8 tp -67.58 -48.94 65.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.322 177.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.576 ' HB2' HG23 ' A' ' 78' ' ' THR . . . -62.95 -36.28 82.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.915 0.388 . . . . 0.0 111.196 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.29 -27.75 71.18 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.777 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.37 -22.57 66.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.982 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -101.0 0.8 38.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.513 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.79 6.26 89.13 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.008 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.0 mm -68.72 130.29 33.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.514 0.197 . . . . 0.0 110.519 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 91' ' ' ARG . 39.2 mtm180 -59.27 -55.79 30.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.61 0.719 . . . . 0.0 110.394 176.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.544 ' O ' HG21 ' A' ' 78' ' ' THR . 14.2 t -167.48 -88.15 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.902 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.547 HG21 ' C ' ' A' ' 46' ' ' TYR . 2.3 pp -152.5 157.47 33.61 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -173.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.574 ' HG3' ' HB2' ' A' ' 52' ' ' PRO . 10.9 Cg_endo -99.42 148.06 4.51 Favored 'Cis proline' 0 N--CA 1.458 -0.571 0 C-N-CA 124.365 -1.098 . . . . 0.0 112.018 -3.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.8 t -139.89 142.51 36.5 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.73 128.03 71.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.465 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.595 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 35.5 tp -106.14 116.85 32.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.077 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 105' ' ' PRO . 20.0 m-85 -93.74 107.4 19.28 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.471 HG12 ' HB3' ' A' ' 105' ' ' PRO . 42.5 mt -110.11 109.78 58.8 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -173.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.73 165.91 13.62 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.402 2.734 . . . . 0.0 111.144 170.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.487 ' HG2' ' HE2' ' A' ' 35' ' ' TYR . 82.7 mtp -97.0 -34.17 11.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.712 0.768 . . . . 0.0 109.304 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -96.83 2.81 52.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.363 -176.183 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -137.45 -156.33 7.21 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.051 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 60.6 mmtt -126.34 154.43 74.76 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.486 ' HG3' ' CZ2' ' A' ' 33' ' ' TRP . 98.3 Cg_endo -78.21 148.26 24.06 Favored 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.677 2.251 . . . . 0.0 114.168 -169.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.507 ' HG2' ' N ' ' A' ' 107' ' ' MET . 34.9 tt0 -119.33 163.25 17.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.716 172.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.507 ' N ' ' HG2' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -142.51 137.98 30.6 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.372 0.606 . . . . 0.0 111.766 -177.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -133.98 156.77 47.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.622 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -75.41 148.52 39.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.15 -144.06 6.82 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.743 -0.742 . . . . 0.0 113.804 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 52' ' ' PRO . . . 71.99 20.86 4.26 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.435 0.694 . . . . 0.0 111.883 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.558 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 20.3 ptt? -112.37 153.7 44.73 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.529 177.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.617 ' HA ' HD13 ' A' ' 59' ' ' ILE . 93.6 Cg_endo -76.58 -177.56 3.83 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.13 2.553 . . . . 0.0 113.05 -173.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.46 ' HG3' HD11 ' A' ' 63' ' ' LEU . 38.8 ttmt -61.77 -29.39 70.1 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.024 174.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . -64.72 -47.38 78.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.215 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.558 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 18.6 m -70.88 -38.45 73.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.881 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.482 ' HB3' HD21 ' A' ' 63' ' ' LEU . 9.0 m-85 -65.41 -40.83 93.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.305 177.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.674 ' O ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -57.31 -37.24 72.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.583 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 43.2 mmtm -65.88 -57.96 6.69 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.252 175.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.51 -46.78 86.04 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -174.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.8 mp -64.37 -48.09 86.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.666 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.419 ' HA ' HD23 ' A' ' 126' ' ' LEU . 3.8 t0 -66.37 -50.27 64.07 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.841 -178.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.583 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 4.0 mm-40 -54.98 -30.2 58.78 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -174.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -115.45 -35.98 4.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.964 0.411 . . . . 0.0 111.854 -172.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.662 HD11 ' HB3' ' A' ' 40' ' ' PRO . 20.0 tp -90.6 -47.26 7.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.88 -174.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.755 HD11 HE22 ' A' ' 70' ' ' GLN . 3.8 mm? -87.51 -53.43 4.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.261 0.553 . . . . 0.0 110.377 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.771 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -76.9 105.19 7.82 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 175.248 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 2.6 tppt? -72.65 78.26 1.09 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.492 177.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 128' ' ' LYS . 26.1 mm-40 80.42 57.65 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.34 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.3 -48.57 57.68 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 175.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -48.76 104.4 0.06 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.594 0.711 . . . . 0.0 110.968 170.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -70.26 126.72 30.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.791 -174.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -64.69 135.01 55.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.943 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -95.65 21.72 8.02 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -173.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.12 150.78 15.14 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.289 -0.862 . . . . 0.0 109.529 177.19 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.453 ' OG ' ' HB ' ' A' ' 5' ' ' THR . 22.7 t -164.56 90.79 0.56 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.115 0.483 . . . . 0.0 109.83 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 tt -95.89 -37.24 10.79 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.71 28.99 0.46 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.45 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.453 ' HB ' ' OG ' ' A' ' 2' ' ' SER . 8.9 t -79.56 -11.15 59.89 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.199 0.523 . . . . 0.0 110.464 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -111.11 102.53 10.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.535 ' H ' ' HD3' ' A' ' 10' ' ' LYS . . . 96.66 -173.13 29.31 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -172.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.708 ' H ' HG22 ' A' ' 72' ' ' VAL . 0.9 OUTLIER 64.02 96.82 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.059 0.457 . . . . 0.0 111.052 178.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.63 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . 68.32 34.74 80.83 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.332 -177.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.703 ' HE2' HD11 ' A' ' 12' ' ' ILE . 84.3 tttt -151.19 138.89 19.73 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -172.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 10.5 p -110.95 132.13 60.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.128 0.489 . . . . 0.0 110.693 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.703 HD11 ' HE2' ' A' ' 10' ' ' LYS . 36.9 mm -120.95 117.15 52.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.096 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.446 ' CB ' ' HG3' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -84.83 121.36 27.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 171.248 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.739 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 1.3 pp -120.68 178.27 4.76 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.751 -170.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.475 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -107.86 172.84 6.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.649 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 10.8 ptpt -54.68 -37.31 65.61 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.92 85.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.106 0.479 . . . . 0.0 110.971 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.739 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 30.8 mm-40 -71.97 -39.46 69.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.455 177.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -63.36 -50.24 70.72 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.163 0.983 . . . . 0.0 109.065 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.649 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -47.06 -60.95 2.12 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.152 -1.84 . . . . 0.0 112.232 -178.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.06 -28.14 27.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.799 -170.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 24.2 ttpt -110.56 1.5 18.17 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.933 0.397 . . . . 0.0 111.704 -170.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 40.7 t -141.46 -47.76 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 22.6 t80 -167.41 119.61 0.91 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.122 0.487 . . . . 0.0 111.737 -167.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -93.67 91.93 7.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.102 -178.374 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 2.9 p90 -80.41 8.9 6.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.309 0.576 . . . . 0.0 111.532 -177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -91.91 -50.15 5.86 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.046 176.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.669 ' C ' HD22 ' A' ' 29' ' ' ASN . 14.9 pttm -89.66 -15.45 32.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.669 HD22 ' C ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -123.33 68.79 39.52 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.505 174.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -59.5 -37.26 90.23 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.996 2.464 . . . . 0.0 112.447 173.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.85 -35.57 4.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -173.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.656 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 4.6 tp10 -90.96 153.71 19.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.038 0.447 . . . . 0.0 110.417 -176.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.653 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 33.4 t-105 -103.1 113.85 27.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.612 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -125.03 110.88 14.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.759 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.635 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 37.9 t80 -76.18 114.59 15.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.194 177.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -94.22 71.21 3.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.862 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.635 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -143.74 -139.76 3.56 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.522 -175.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -149.27 -42.47 0.14 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 111.892 -173.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' A' ' 70' ' ' GLN . 35.2 mttp -126.14 165.65 26.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.245 -175.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.614 ' HD3' ' SD ' ' A' ' 101' ' ' MET . 10.3 Cg_endo -52.88 132.31 46.34 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.452 2.102 . . . . 0.0 111.237 177.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 72' ' ' VAL . . . -124.42 149.97 46.15 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.174 0.512 . . . . 0.0 111.572 -172.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.509 ' HB ' HG12 ' A' ' 73' ' ' ILE . 75.7 mt -127.17 134.01 66.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 175.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 60.5 t -125.28 112.42 31.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.022 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.548 ' OD1' ' HB3' ' A' ' 75' ' ' LYS . 8.5 p-10 -102.28 114.12 28.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.962 0.887 . . . . 0.0 111.266 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 42.0 m-85 -80.3 112.55 17.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.884 172.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.776 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.9 p90 -127.39 159.91 33.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.376 0.608 . . . . 0.0 110.759 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.459 ' N ' HG21 ' A' ' 93' ' ' ILE . . . -130.86 122.99 28.04 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 170.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.576 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 15.8 t70 -66.06 -26.18 67.38 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.803 -169.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -75.78 -2.88 31.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.994 0.426 . . . . 0.0 111.17 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.577 ' HB3' ' SG ' ' A' ' 53' ' ' CYS . 32.6 t -108.28 122.34 46.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.197 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.28 -55.28 25.26 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.638 -0.71 . . . . 0.0 114.792 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.498 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 82.5 Cg_exo -47.2 -41.14 27.6 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.206 2.604 . . . . 0.0 113.786 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.776 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 3.0 m -63.63 -37.75 88.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.291 0.567 . . . . 0.0 110.921 -177.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.576 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 67.0 mttm -61.46 -28.61 69.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.071 176.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 76.6 mtp -65.57 -48.44 72.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.875 0.369 . . . . 0.0 111.573 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.435 HG21 HD11 ' A' ' 96' ' ' ILE . 12.8 p -77.59 -32.33 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -169.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.448 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -48.02 -57.34 10.56 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 43.1 Cg_endo -69.21 -35.31 14.51 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.911 1.74 . . . . 0.0 112.702 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.6 mt -63.74 -50.86 76.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.681 HD22 HD13 ' A' ' 73' ' ' ILE . 5.6 mt -60.74 -36.09 78.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.361 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -62.03 -50.35 72.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.053 0.454 . . . . 0.0 110.673 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.13 -43.97 98.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.481 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HA ' HD13 ' A' ' 63' ' ' LEU . 3.8 mm? -62.63 -32.48 73.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.112 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.658 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -63.17 -53.55 51.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.345 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 8.8 tmtm? -67.4 -34.28 76.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.644 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -58.63 -47.03 85.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.187 0.518 . . . . 0.0 110.274 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -95.04 26.33 3.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.102 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -47.12 136.56 8.69 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.918 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.23 -23.98 17.18 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.75 176.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.542 ' HG3' HG23 ' A' ' 71' ' ' ILE . 12.5 pt20 -125.88 -49.02 1.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.542 HG23 ' HG3' ' A' ' 70' ' ' GLN . 43.0 pt -95.15 148.59 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.327 0.584 . . . . 0.0 112.188 -173.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.708 HG22 ' H ' ' A' ' 8' ' ' ASN . 39.8 t -128.26 125.26 63.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.098 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.681 HD13 HD22 ' A' ' 60' ' ' LEU . 27.8 mt -109.24 131.44 60.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.308 0.575 . . . . 0.0 111.379 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.5 m-85 -116.94 156.85 26.71 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.548 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -136.07 148.29 48.24 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.452 175.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.58 HG13 ' HG2' ' A' ' 81' ' ' GLU . 20.8 t -117.11 126.39 74.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.536 -171.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 4.7 m-20 -83.4 95.42 8.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.417 HG21 ' O ' ' A' ' 92' ' ' SER . 16.6 p -55.56 -35.66 65.98 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -171.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -54.76 -29.94 55.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.353 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 54.6 pttt -103.14 -32.85 9.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.56 0.695 . . . . 0.0 109.726 178.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.58 ' HG2' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -88.73 41.97 1.05 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.155 -179.016 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.1 -49.58 77.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.904 -176.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.19 -36.46 81.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.934 0.397 . . . . 0.0 110.232 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.04 -53.12 58.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.951 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.14 -40.01 93.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.688 178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.84 -28.26 72.41 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.704 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.81 -32.8 74.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.807 0.336 . . . . 0.0 110.963 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.429 ' HB2' HG12 ' A' ' 90' ' ' ILE . 74.5 m-85 -89.29 0.75 56.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.933 0.397 . . . . 0.0 110.698 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.33 8.68 84.85 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.974 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.429 HG12 ' HB2' ' A' ' 88' ' ' PHE . 50.0 mm -75.01 130.21 36.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 122.341 0.257 . . . . 0.0 110.74 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -66.37 -64.28 0.89 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.221 0.534 . . . . 0.0 110.093 175.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.417 ' O ' HG21 ' A' ' 78' ' ' THR . 29.7 m -155.72 -90.3 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.589 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.534 HG13 ' SG ' ' A' ' 53' ' ' CYS . 0.2 OUTLIER -146.56 161.35 38.51 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.43 -172.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.717 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 3.1 Cg_exo -87.98 148.08 30.05 Favored 'Cis proline' 0 C--N 1.345 0.346 0 C-N-CA 124.507 -1.039 . . . . 0.0 111.705 -4.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.406 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 9.5 m -140.39 122.78 16.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.547 HD13 ' HZ ' ' A' ' 117' ' ' PHE . 64.5 mt -124.25 116.68 48.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.311 -175.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 105' ' ' PRO . 39.3 tp -100.38 124.09 45.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.718 -176.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -100.05 105.59 17.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.722 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.495 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 45.8 mt -100.99 108.36 54.07 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.055 -175.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -87.46 169.24 7.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.815 2.343 . . . . 0.0 112.235 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.614 ' SD ' ' HD3' ' A' ' 40' ' ' PRO . 84.2 mtp -93.89 1.0 56.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.654 0.74 . . . . 0.0 109.427 175.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -139.39 102.95 4.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.025 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.11 -153.76 16.76 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.561 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.653 ' HE3' ' HB3' ' A' ' 33' ' ' TRP . 15.4 tptt -112.35 153.63 44.75 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.537 ' HB2' HD11 ' A' ' 97' ' ' LEU . 5.7 Cg_exo -79.41 144.89 18.35 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.028 2.485 . . . . 0.0 112.781 -176.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -107.99 168.3 9.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.522 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 49.3 ttm -142.48 139.1 31.4 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.939 0.4 . . . . 0.0 111.44 -174.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -126.9 137.78 53.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.566 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -100.12 123.4 44.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.02 0.438 . . . . 0.0 110.772 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.717 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 126.58 -169.02 18.56 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.268 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.24 80.01 1.4 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.601 0.715 . . . . 0.0 110.721 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.674 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 5.0 mpp? -59.05 144.47 82.48 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.626 174.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.29 -175.96 2.83 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.891 2.394 . . . . 0.0 112.14 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -56.6 -39.63 73.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.465 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.75 -51.15 66.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.096 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.674 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 33.1 m -68.17 -29.13 67.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.75 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.647 ' O ' HG12 ' A' ' 121' ' ' ILE . 10.6 m-85 -75.41 -39.1 59.42 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.293 176.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -53.88 -37.46 63.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.035 0.445 . . . . 0.0 110.388 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 45.3 tttp -69.06 -46.34 68.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.354 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -66.79 -44.46 81.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.049 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.647 HG12 ' O ' ' A' ' 117' ' ' PHE . 17.4 mm -74.0 -50.57 27.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.736 0.303 . . . . 0.0 111.098 -174.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 126' ' ' LEU . 11.9 t70 -68.37 -60.93 2.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.014 0.435 . . . . 0.0 110.808 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.872 ' HA ' ' HD2' ' A' ' 127' ' ' LYS . 22.2 mt-10 -75.73 -9.69 58.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.164 -167.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.411 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 79.9 t80 -127.69 -39.54 1.81 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.25 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 125' ' ' LEU . 3.3 tp -91.01 -32.42 15.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.458 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 23.8 tp -84.01 -65.26 1.03 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.872 ' HD2' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -101.05 -156.72 0.57 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 167.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.68 ' HG3' ' HB2' ' A' ' 132' ' ' HIS . 0.2 OUTLIER -147.92 93.96 2.27 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.162 -176.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.767 ' HB2' ' HE2' ' A' ' 127' ' ' LYS . 0.8 OUTLIER -105.13 -175.33 2.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.256 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.42 -87.03 0.25 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.729 176.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -69.71 -27.03 64.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.955 0.407 . . . . 0.0 110.801 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.68 ' HB2' ' HG3' ' A' ' 128' ' ' LYS . 0.6 OUTLIER -95.39 -30.35 13.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.383 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -132.74 92.03 2.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.289 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -78.11 -64.19 1.22 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -91.82 126.83 37.05 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.679 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 . . . . . 0 C--O 1.244 0.813 0 CA-C-O 118.521 -0.752 . . . . 0.0 109.877 -179.66 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 m -80.48 -45.5 17.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.251 0.548 . . . . 0.0 110.099 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.82 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.3 pt? -100.27 10.94 40.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.974 -177.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -149.8 148.04 28.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.474 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 t -116.07 97.38 6.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.18 0.514 . . . . 0.0 110.759 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.9 -85.44 0.09 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.634 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.417 ' HA2' HG21 ' A' ' 72' ' ' VAL . . . -84.34 64.97 4.18 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.053 -0.521 . . . . 0.0 113.39 -173.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.446 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 2.6 m120 -147.92 123.22 10.27 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 65' ' ' LYS . . . 58.01 38.68 90.12 Favored Glycine 0 CA--C 1.51 -0.279 0 O-C-N 124.558 1.161 . . . . 0.0 115.426 166.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 20.5 pttm -169.6 173.06 6.56 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.906 0.86 . . . . 0.0 113.03 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 12.9 m -100.43 110.67 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 113.469 -1.696 . . . . 0.0 109.57 171.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.401 HD12 ' CE2' ' A' ' 74' ' ' TYR . 47.2 mt -83.84 103.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.113 -175.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -75.63 112.12 11.66 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 2.9 pp -140.28 158.31 44.23 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.744 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.501 HG22 ' CE ' ' A' ' 80' ' ' LYS . 40.0 p -82.49 166.15 19.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.774 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.731 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 42.8 pttt -56.15 -34.12 65.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.682 177.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.57 -37.47 82.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.102 0.477 . . . . 0.0 110.416 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 42.5 mt-10 -71.99 -34.84 69.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.504 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -63.47 -48.28 78.3 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.086 0.946 . . . . 0.0 108.935 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 1.6 tt -46.83 -61.33 1.9 Allowed 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.281 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.94 -25.02 40.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.428 -170.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -93.7 -37.68 11.7 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.644 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.0 t -118.82 -41.12 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -167.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.578 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 30.0 t80 -166.99 118.83 0.93 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.05 0.452 . . . . 0.0 111.809 -165.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.443 ' ND2' HD21 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -85.25 91.06 8.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.528 -178.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.557 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 49.0 p90 -86.17 18.81 2.92 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.698 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 27.6 mt-10 -102.1 -54.73 2.64 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 175.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.698 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 8.1 mptt -91.68 -19.56 22.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.694 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.64 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -119.79 65.63 9.75 Favored Pre-proline 0 C--O 1.224 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.972 178.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -63.78 -44.98 11.85 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.754 2.302 . . . . 0.0 112.189 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -106.58 -11.73 15.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.014 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 40.7 mt-10 -91.05 131.21 36.78 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.643 ' HZ3' ' HE1' ' A' ' 88' ' ' PHE . 69.9 t-105 -94.54 88.79 5.57 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.222 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -97.37 106.35 18.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.262 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -108.94 124.76 51.19 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.969 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -119.16 131.51 55.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.985 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 167.12 162.14 18.08 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.885 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -97.53 -14.95 20.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.969 0.414 . . . . 0.0 110.803 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.457 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 9.9 mmtp -127.17 161.25 55.28 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HB3' HD11 ' A' ' 125' ' ' LEU . 23.4 Cg_exo -65.01 132.41 32.04 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.752 2.301 . . . . 0.0 110.1 166.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.52 138.36 43.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -168.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.757 ' HB ' HG12 ' A' ' 73' ' ' ILE . 4.6 mp -113.4 112.49 40.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 165.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.652 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 21.5 t -98.28 112.18 29.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.079 0.466 . . . . 0.0 110.297 -177.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.39 109.44 20.73 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.306 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 97.3 m-85 -94.14 111.68 23.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 174.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.695 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 1.7 p90 -132.66 167.71 19.6 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.493 0.663 . . . . 0.0 110.852 -175.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.411 ' H ' ' CB ' ' A' ' 53' ' ' CYS . . . -140.18 125.94 19.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.042 -1.435 . . . . 0.0 107.803 172.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -56.82 -40.33 75.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.437 ' HE1' ' HG2' ' A' ' 79' ' ' GLU . 62.2 p-90 -67.69 -8.61 36.55 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.6 t -98.37 126.63 43.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.942 0.401 . . . . 0.0 110.521 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.82 -61.85 6.97 Favored Glycine 0 CA--C 1.518 0.246 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.255 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -47.65 -41.44 30.59 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.959 2.439 . . . . 0.0 113.149 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.695 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 97.2 m -66.26 -44.26 84.15 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.78 -27.73 61.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.313 0.578 . . . . 0.0 109.502 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -61.23 -43.82 98.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.26 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.619 ' HB ' HD23 ' A' ' 60' ' ' LEU . 24.1 m -84.97 -20.52 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -174.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.467 ' HA ' ' NZ ' ' A' ' 75' ' ' LYS . . . -41.58 -53.31 7.55 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.91 -40.98 5.96 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 121.735 1.623 . . . . 0.0 112.448 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.2 mt -60.6 -42.72 92.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.238 0.542 . . . . 0.0 110.503 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.619 HD23 ' HB ' ' A' ' 56' ' ' VAL . 2.6 mm? -56.42 -42.35 77.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.46 176.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.493 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 11.1 t70 -62.97 -42.41 99.82 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.406 176.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.833 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 21.5 mm-40 -54.08 -56.63 16.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.25 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.538 HD21 ' HG3' ' A' ' 114' ' ' LYS . 3.7 mm? -67.07 -31.82 72.58 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.103 -175.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.416 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -59.83 -57.47 12.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.459 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.833 ' HE2' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -76.39 -25.98 55.13 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.23 -47.51 67.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.992 0.425 . . . . 0.0 111.39 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.511 ' HB2' HD11 ' A' ' 71' ' ' ILE . 12.4 m-85 -101.88 24.8 9.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.323 -175.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.41 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 19.9 t70 -55.79 143.6 30.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.172 0.51 . . . . 0.0 111.439 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.87 -37.58 3.68 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.631 -178.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 67' ' ' TYR . 8.8 pt20 -110.08 -12.63 14.49 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.178 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 67' ' ' TYR . 43.9 pt -147.01 167.87 5.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.935 0.398 . . . . 0.0 110.685 174.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 39' ' ' LYS . 13.3 p -145.73 144.7 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 172.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.757 HG12 ' HB ' ' A' ' 42' ' ' ILE . 40.9 mt -121.07 139.12 49.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.322 -177.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.401 ' CE2' HD12 ' A' ' 12' ' ' ILE . 67.5 m-85 -115.49 162.93 16.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.431 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.545 ' HB3' ' CE1' ' A' ' 46' ' ' TYR . 54.1 mttm -135.64 132.06 36.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.849 0.357 . . . . 0.0 110.533 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.481 HG13 ' HG2' ' A' ' 81' ' ' GLU . 1.0 OUTLIER -131.46 137.32 55.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.482 -176.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -90.98 96.07 10.44 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.461 HG21 ' HA ' ' A' ' 92' ' ' SER . 17.0 m -60.13 -25.6 65.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -168.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.437 ' HG2' ' HE1' ' A' ' 49' ' ' TRP . 2.8 mp0 -55.28 -40.43 71.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.462 0.172 . . . . 0.0 111.191 175.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.501 ' CE ' HG22 ' A' ' 15' ' ' THR . 22.6 pttm -98.71 -22.19 16.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.304 0.573 . . . . 0.0 110.2 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.731 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 1.3 mp0 -89.53 34.89 0.82 Allowed 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.281 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.411 ' HA ' ' OE1' ' A' ' 82' ' ' GLN . 14.2 mm-40 -64.01 -42.49 97.13 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -64.52 -35.33 80.62 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.254 0.55 . . . . 0.0 110.062 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.6 tp -63.7 -47.6 80.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.901 176.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.537 ' HB1' ' HB ' ' A' ' 90' ' ' ILE . . . -60.71 -42.27 96.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.797 176.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.4 -31.05 75.95 Favored Glycine 0 CA--C 1.517 0.168 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.698 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.19 -41.5 97.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.789 0.328 . . . . 0.0 111.012 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.643 ' HE1' ' HZ3' ' A' ' 33' ' ' TRP . 76.2 m-85 -82.7 -22.2 34.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.692 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.13 31.67 9.58 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.582 HG13 ' HB2' ' A' ' 88' ' ' PHE . 6.2 mt -85.4 154.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.717 0.294 . . . . 0.0 110.544 -176.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -69.11 -81.82 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.436 0.636 . . . . 0.0 109.373 171.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.461 ' HA ' HG21 ' A' ' 78' ' ' THR . 65.9 m -158.99 -81.26 0.05 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.925 173.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.638 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 2.2 pp -151.08 149.67 25.5 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.237 -174.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.721 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 5.1 Cg_exo -83.5 149.2 62.66 Favored 'Cis proline' 0 C--N 1.346 0.437 0 C-N-CA 124.743 -0.94 . . . . 0.0 112.356 -2.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.556 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 39.6 t -140.99 130.61 24.04 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 107' ' ' MET . 23.3 mm -120.92 113.96 41.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.652 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 31.4 tp -102.05 115.5 30.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.792 -175.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -97.78 106.09 18.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.972 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 105' ' ' PRO . 53.6 mt -105.08 113.44 64.69 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.704 -174.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.8 155.54 20.55 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.466 2.111 . . . . 0.0 111.491 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 82.2 mtp -81.39 4.23 21.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.628 0.728 . . . . 0.0 110.823 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.833 ' HB3' ' HE3' ' A' ' 128' ' ' LYS . 2.9 tm-20 -151.27 117.43 5.59 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.974 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.14 -147.29 18.17 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.935 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.427 ' NZ ' ' HB3' ' A' ' 33' ' ' TRP . 51.7 mmtt -128.49 152.11 77.82 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.558 ' HB3' HG12 ' A' ' 99' ' ' ILE . 88.2 Cg_endo -79.59 147.96 20.16 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.752 2.301 . . . . 0.0 113.829 -172.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.439 ' O ' HD12 ' A' ' 97' ' ' LEU . 23.4 mm-40 -103.47 167.68 9.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.572 176.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 38.3 ttm -141.32 130.0 22.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.124 0.487 . . . . 0.0 111.958 -178.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.96 127.32 53.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.106 173.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -99.56 136.73 39.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.927 0.394 . . . . 0.0 111.541 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.721 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 106.95 174.13 22.78 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.806 -0.634 . . . . 0.0 114.635 171.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.92 86.7 5.54 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.818 -0.691 . . . . 0.0 111.464 -175.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.586 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 22.7 ptt? -87.53 158.43 51.47 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.651 171.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 74.4 Cg_endo -75.19 178.58 7.11 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.312 2.008 . . . . 0.0 112.847 -173.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.538 ' HG3' HD21 ' A' ' 63' ' ' LEU . 54.8 tttm -61.07 -28.7 69.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.047 177.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.79 -52.53 20.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.394 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 21.6 m -67.48 -32.76 73.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.774 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.52 ' O ' HG13 ' A' ' 121' ' ' ILE . 1.4 m-85 -62.23 -46.59 88.17 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.492 174.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -56.39 -44.27 80.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.525 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.59 ' HB3' ' OE1' ' A' ' 123' ' ' GLU . 9.2 mtpm? -63.06 -50.37 70.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.44 75.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.843 0.354 . . . . 0.0 111.32 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 117' ' ' PHE . 70.9 mt -74.23 -55.11 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.04 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.556 ' HA ' ' HB2' ' A' ' 126' ' ' LEU . 31.0 t0 -69.68 -57.93 4.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.573 -173.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.59 ' OE1' ' HB3' ' A' ' 119' ' ' LYS . 44.6 mt-10 -58.15 -23.12 54.09 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -170.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -116.22 -47.8 2.74 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 40' ' ' PRO . 30.1 tp -88.26 -38.7 15.01 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.488 -171.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 122' ' ' ASP . 73.5 mt -83.09 -52.96 6.16 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.431 0.634 . . . . 0.0 109.388 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.687 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -80.92 81.27 7.21 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 167.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.833 ' HE3' ' HB3' ' A' ' 102' ' ' GLU . 48.5 tttm -64.97 84.12 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.575 0.703 . . . . 0.0 112.61 -166.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -53.39 134.11 40.18 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.064 164.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -86.14 29.99 4.53 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.881 -172.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 54.45 55.41 8.08 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -18.66 112.89 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 O-C-N 125.299 1.625 . . . . 0.0 114.66 -172.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -83.76 148.68 26.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.751 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -73.66 -44.61 56.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.041 0.448 . . . . 0.0 110.051 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -140.58 -49.34 0.44 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 21.8 p80 . . . . . 0 C--O 1.242 0.665 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.696 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 120.729 0.3 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -122.42 151.71 40.97 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.728 ' H ' HD23 ' A' ' 3' ' ' LEU . 1.9 pt? -84.47 -4.55 59.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.702 0.287 . . . . 0.0 111.387 -174.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.46 34.4 0.75 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.734 0.302 . . . . 0.0 110.627 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.43 ' HB ' ' H ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER 48.43 -98.18 0.04 OUTLIER 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.681 -175.195 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.43 ' H ' ' HB ' ' A' ' 5' ' ' THR . 16.3 tp10 -176.65 -72.51 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.726 0.298 . . . . 0.0 110.518 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.35 43.62 3.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.131 -176.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.649 HD22 ' N ' ' A' ' 9' ' ' GLY . 0.2 OUTLIER -76.0 128.36 34.88 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.649 ' N ' HD22 ' A' ' 8' ' ' ASN . . . 98.24 18.98 24.88 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.465 177.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.492 ' HG3' ' OD2' ' A' ' 61' ' ' ASP . 54.9 tttp -160.23 173.33 15.89 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.3 p -112.41 113.15 43.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.431 0.634 . . . . 0.0 110.129 174.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.8 mm -109.38 131.23 60.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.058 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.709 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 3.7 p80 -85.8 116.62 24.17 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.56 174.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.508 HD12 HG23 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -109.52 179.23 4.2 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.355 -176.099 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.6 p -100.53 164.23 11.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.952 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.706 ' HB3' ' HG3' ' A' ' 81' ' ' GLU . 35.6 pttt -61.91 -27.0 68.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.815 0.34 . . . . 0.0 110.511 176.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -41.09 96.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.656 174.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -71.71 -38.22 70.56 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.197 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.443 ' HE1' HG11 ' A' ' 43' ' ' VAL . 2.3 t80 -54.21 -53.81 48.44 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.813 0.816 . . . . 0.0 109.305 176.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.582 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 30.0 mt -50.56 -60.07 3.4 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 113.598 -1.637 . . . . 0.0 111.929 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.22 -36.63 39.75 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -102.79 -4.59 24.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -171.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 58.2 t -132.96 -51.99 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.582 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 7.5 t80 -179.19 131.0 0.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 110.746 -167.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.635 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 25.9 t-20 -91.21 136.24 33.23 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.655 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.404 ' HZ ' ' HB2' ' A' ' 16' ' ' LYS . 7.6 p90 -123.91 20.8 9.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.171 0.51 . . . . 0.0 110.547 175.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -105.64 -53.93 2.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.593 0.711 . . . . 0.0 109.798 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.614 ' C ' HD22 ' A' ' 29' ' ' ASN . 22.0 ptmt -97.02 -12.61 23.05 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.526 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.635 ' HB2' ' O ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -116.89 62.55 2.84 Favored Pre-proline 0 N--CA 1.473 0.723 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.239 174.451 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -63.43 -43.06 19.05 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.705 2.27 . . . . 0.0 112.614 174.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.516 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -100.59 -27.7 13.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.607 -175.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' A' ' 29' ' ' ASN . 37.7 mt-10 -92.69 128.67 38.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.044 0.449 . . . . 0.0 110.795 -177.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.421 ' HA ' ' CE1' ' A' ' 24' ' ' TYR . 44.3 t-105 -92.55 93.13 8.38 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HD2' ' OD1' ' A' ' 29' ' ' ASN . 92.2 mttt -104.95 97.26 7.15 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.107 176.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.481 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 28.5 t80 -79.69 104.39 10.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.642 175.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -98.91 84.0 3.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.611 177.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.481 ' HA3' ' CZ ' ' A' ' 35' ' ' TYR . . . -129.68 -143.51 5.47 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.844 -175.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -147.92 -64.64 0.26 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.8 0.333 . . . . 0.0 110.104 -173.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 70' ' ' GLN . 45.8 mttp -120.85 159.5 48.58 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.862 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.47 ' HG2' HG22 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -45.29 131.92 11.79 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.073 2.516 . . . . 0.0 112.084 179.054 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.52 139.18 54.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.567 -172.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.9 mt -117.76 114.57 45.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.418 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 97' ' ' LEU . 16.4 t -101.76 112.99 36.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.791 0.329 . . . . 0.0 111.219 -176.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 8.2 t70 -92.56 112.13 23.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.969 176.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.477 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 75.6 m-85 -87.55 110.58 20.45 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 173.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.728 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 0.8 OUTLIER -132.11 163.83 27.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.159 0.504 . . . . 0.0 110.84 -175.365 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.406 ' N ' HG21 ' A' ' 93' ' ' ILE . . . -116.72 137.03 52.49 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.497 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 19.6 t70 -62.98 -29.48 70.85 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -174.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -85.74 -6.91 59.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.79 0.328 . . . . 0.0 111.177 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.7 t -84.27 106.95 16.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.903 0.382 . . . . 0.0 111.081 -175.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.09 -50.76 54.11 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.673 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -46.92 -47.93 15.43 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.71 2.273 . . . . 0.0 113.191 175.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.728 ' HB3' ' HB2' ' A' ' 46' ' ' TYR . 83.0 m -66.97 -32.54 73.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.477 . . . . 0.0 111.257 -177.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 48' ' ' ASP . 71.1 mmtt -58.76 -29.51 66.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.597 175.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.545 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 31.2 mtm -67.69 -39.56 84.43 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.712 0.291 . . . . 0.0 111.239 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 53' ' ' CYS . 16.6 m -78.21 -26.47 14.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -172.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.608 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -51.31 -54.24 40.69 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.608 ' HD3' ' HB3' ' A' ' 57' ' ' ALA . 35.4 Cg_exo -61.61 -43.65 25.88 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 122.045 1.83 . . . . 0.0 112.283 176.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.5 mt -58.46 -49.9 80.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.305 0.574 . . . . 0.0 110.591 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.432 HD22 HD13 ' A' ' 73' ' ' ILE . 20.0 mt -61.92 -40.84 96.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.39 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.492 ' OD2' ' HG3' ' A' ' 10' ' ' LYS . 12.7 t70 -64.79 -45.71 85.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.956 0.408 . . . . 0.0 110.806 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -62.36 -51.1 68.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.999 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.66 -32.57 72.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.181 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.552 ' HB2' HD12 ' A' ' 73' ' ' ILE . . . -62.28 -34.96 77.57 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.465 ' C ' ' HD3' ' A' ' 65' ' ' LYS . 2.8 tmtm? -73.96 -38.17 64.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.885 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -62.27 -48.14 81.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.238 0.542 . . . . 0.0 110.573 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -90.89 26.09 2.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.8 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -57.07 139.76 51.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.678 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.578 ' H ' ' ND2' ' A' ' 8' ' ' ASN . . . 99.83 -25.98 26.19 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.955 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.549 ' HG3' HG23 ' A' ' 71' ' ' ILE . 11.7 pt20 -116.23 -44.46 2.89 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -177.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.549 HG23 ' HG3' ' A' ' 70' ' ' GLN . 33.6 pt -117.38 150.3 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.798 -177.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.417 HG22 ' HA ' ' A' ' 8' ' ' ASN . 48.8 t -121.56 127.25 75.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.268 176.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.671 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 31.8 mt -109.63 133.67 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 121.331 0.586 . . . . 0.0 110.278 -178.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -121.43 171.65 8.62 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.732 0.777 . . . . 0.0 110.373 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.709 ' O ' ' HA ' ' A' ' 13' ' ' HIS . 1.1 ptpm? -146.09 159.15 43.68 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 168.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.685 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 2.6 p -140.38 143.52 29.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.596 -174.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' HB2' ' NZ ' ' A' ' 80' ' ' LYS . 20.2 m-20 -82.97 90.73 7.03 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -174.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 85' ' ' ALA . 27.0 m -57.91 -24.54 58.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.085 -173.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.6 -40.84 84.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.762 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.409 ' NZ ' ' HB2' ' A' ' 77' ' ' ASP . 23.9 pttm -101.15 -22.59 14.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.097 0.475 . . . . 0.0 110.527 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.706 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 1.4 mp0 -89.06 42.89 1.11 Allowed 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.534 175.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -66.11 -38.39 88.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.072 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -65.92 -38.02 87.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.363 0.602 . . . . 0.0 109.672 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.1 tp -65.68 -50.43 64.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.734 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.509 ' HB2' HG23 ' A' ' 78' ' ' THR . . . -65.36 -39.89 92.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.989 0.423 . . . . 0.0 110.899 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.3 -27.58 69.49 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.882 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.04 -32.92 72.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.935 0.398 . . . . 0.0 110.85 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.551 ' HB2' HG12 ' A' ' 90' ' ' ILE . 90.5 m-85 -93.48 -3.41 53.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.646 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.15 13.39 74.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.005 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.551 HG12 ' HB2' ' A' ' 88' ' ' PHE . 26.9 mm -83.63 119.54 33.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.543 0.211 . . . . 0.0 110.517 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -59.53 -58.04 10.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 110.953 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.402 ' O ' HG21 ' A' ' 78' ' ' THR . 32.1 m -150.92 -96.96 0.06 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.7 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -146.86 163.18 30.21 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.903 -0.135 . . . . 0.0 111.043 -170.79 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.666 ' HG2' ' HA2' ' A' ' 110' ' ' GLY . 2.7 Cg_exo -89.18 150.16 26.81 Favored 'Cis proline' 0 C--N 1.347 0.498 0 C-N-CA 124.72 -0.95 . . . . 0.0 112.509 -4.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.477 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 34.7 t -140.68 145.28 36.32 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 107' ' ' MET . 30.5 mt -135.25 116.24 19.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.825 0.345 . . . . 0.0 110.304 -178.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.497 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 47.3 tp -102.91 116.61 32.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.403 -177.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -98.67 109.11 21.92 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.55 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 58.2 mt -104.48 113.39 65.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.691 -174.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -84.34 168.54 11.58 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.851 2.367 . . . . 0.0 111.786 174.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 87.2 mtp -82.31 -26.04 33.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.243 0.544 . . . . 0.0 109.949 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -130.66 138.1 49.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.223 176.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.69 161.35 36.66 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -92.37 143.93 28.12 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 117.377 0.589 . . . . 0.0 110.093 -177.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.55 ' HB3' ' HA ' ' A' ' 99' ' ' ILE . 27.5 Cg_endo -61.03 159.59 29.24 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.722 2.948 . . . . 0.0 114.3 -170.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.522 ' HG2' ' CE1' ' A' ' 131' ' ' HIS . 21.1 mt-10 -117.15 168.84 9.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.091 176.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 47.7 ttm -142.03 127.04 18.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.285 0.564 . . . . 0.0 112.224 -175.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.5 140.54 49.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -114.59 141.41 47.8 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.904 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.666 ' HA2' ' HG2' ' A' ' 94' ' ' PRO . . . 107.46 169.75 21.98 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.378 174.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.06 85.29 6.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.218 0.532 . . . . 0.0 111.358 -176.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.593 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 24.1 ptp -80.85 152.11 71.58 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.029 176.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.636 ' HD2' ' HB2' ' A' ' 116' ' ' SER . 98.2 Cg_endo -75.26 -178.24 4.08 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.681 2.254 . . . . 0.0 112.062 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -62.24 -36.75 82.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.142 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.38 -37.63 74.56 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.941 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.636 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 71.8 m -72.82 -34.62 66.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.756 174.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.661 ' O ' HG12 ' A' ' 121' ' ' ILE . 2.1 m-85 -63.27 -51.82 64.58 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 121.126 -0.229 . . . . 0.0 110.792 176.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -57.02 -36.53 70.55 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.964 0.411 . . . . 0.0 110.503 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.467 ' NZ ' ' HB2' ' A' ' 119' ' ' LYS . 4.8 ttmp? -57.22 -42.7 81.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.884 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 124' ' ' PHE . . . -71.83 -34.96 69.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.047 176.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.661 HG12 ' O ' ' A' ' 117' ' ' PHE . 37.2 mm -64.85 -56.02 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.698 -178.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.477 ' HA ' HD12 ' A' ' 126' ' ' LEU . 2.0 m-20 -66.64 -64.39 0.86 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.011 0.434 . . . . 0.0 110.951 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.75 -34.39 69.49 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.535 -171.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.719 ' HE1' ' HA2' ' A' ' 130' ' ' GLY . 63.4 t80 -108.26 -50.27 3.06 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 18.1 tp -81.43 -30.99 33.33 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.476 -169.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 122' ' ' ASP . 80.4 mt -87.44 -50.54 6.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.297 0.57 . . . . 0.0 109.635 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -96.8 90.99 5.46 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 171.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -49.44 96.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.613 0.72 . . . . 0.0 112.391 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -114.76 46.72 1.36 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.359 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.719 ' HA2' ' HE1' ' A' ' 124' ' ' PHE . . . -58.79 101.64 0.23 Allowed Glycine 0 C--N 1.33 0.241 0 CA-C-N 115.503 -0.772 . . . . 0.0 113.626 -175.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.522 ' CE1' ' HG2' ' A' ' 106' ' ' GLU . 97.8 m-70 59.37 74.37 0.44 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.319 0.648 . . . . 0.0 111.657 177.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -145.26 -56.65 0.32 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.179 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -172.12 130.23 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.403 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.463 ' CE1' ' HB2' ' A' ' 124' ' ' PHE . 45.1 m-70 -138.66 8.48 2.59 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 110.467 174.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -113.57 -8.52 13.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.918 0.39 . . . . 0.0 110.332 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 117.396 -1.288 . . . . 0.0 108.289 -179.716 . . . . . . . . 0 0 . 1 stop_ save_